"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34267846","10.14740/jh824","Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients?","Blood group type A has been associated with increased susceptibility for coronavirus disease 2019 (COVID-19) infection when compared to group O. The aim of our study was to examine outcomes in hospitalized COVID-19 patients among blood groups A and O. This is an observational study. Kruskal-Wallis and Chi-square tests were used to compare continuous and categorical variables. Multivariable logistic regression models were used to examine association of blood groups with rates of mortality and sev","2021","07","17","J Hematol","Journal of hematology","ABO blood group; COVID-19; In-hospital mortality","Kumar","Gagan","Department of Pulmonary and Critical Care, Northeast Georgia Health System, Gainesville, GA 30501, USA",NA
"2","34267846","10.14740/jh824","Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients?","Blood group type A has been associated with increased susceptibility for coronavirus disease 2019 (COVID-19) infection when compared to group O. The aim of our study was to examine outcomes in hospitalized COVID-19 patients among blood groups A and O. This is an observational study. Kruskal-Wallis and Chi-square tests were used to compare continuous and categorical variables. Multivariable logistic regression models were used to examine association of blood groups with rates of mortality and sev","2021","07","17","J Hematol","Journal of hematology","ABO blood group; COVID-19; In-hospital mortality","Nanchal","Rahul","Division of Pulmonary and Critical Care, Medical College of Wisconsin, Milwaukee, WI 53226, USA",NA
"3","34267846","10.14740/jh824","Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients?","Blood group type A has been associated with increased susceptibility for coronavirus disease 2019 (COVID-19) infection when compared to group O. The aim of our study was to examine outcomes in hospitalized COVID-19 patients among blood groups A and O. This is an observational study. Kruskal-Wallis and Chi-square tests were used to compare continuous and categorical variables. Multivariable logistic regression models were used to examine association of blood groups with rates of mortality and sev","2021","07","17","J Hematol","Journal of hematology","ABO blood group; COVID-19; In-hospital mortality","Hererra","Martin","Department of Internal Medicine, Northeast Georgia Health System, Gainesville, GA 30501, USA",NA
"4","34267846","10.14740/jh824","Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients?","Blood group type A has been associated with increased susceptibility for coronavirus disease 2019 (COVID-19) infection when compared to group O. The aim of our study was to examine outcomes in hospitalized COVID-19 patients among blood groups A and O. This is an observational study. Kruskal-Wallis and Chi-square tests were used to compare continuous and categorical variables. Multivariable logistic regression models were used to examine association of blood groups with rates of mortality and sev","2021","07","17","J Hematol","Journal of hematology","ABO blood group; COVID-19; In-hospital mortality","Sakhuja","Ankit","Division of Cardiovascular Critical Care, Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV 26506, USA",NA
"5","34267846","10.14740/jh824","Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients?","Blood group type A has been associated with increased susceptibility for coronavirus disease 2019 (COVID-19) infection when compared to group O. The aim of our study was to examine outcomes in hospitalized COVID-19 patients among blood groups A and O. This is an observational study. Kruskal-Wallis and Chi-square tests were used to compare continuous and categorical variables. Multivariable logistic regression models were used to examine association of blood groups with rates of mortality and sev","2021","07","17","J Hematol","Journal of hematology","ABO blood group; COVID-19; In-hospital mortality","Patel","Dhaval","Department of Pulmonary and Critical Care, Northeast Georgia Health System, Gainesville, GA 30501, USA",NA
"6","34267846","10.14740/jh824","Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients?","Blood group type A has been associated with increased susceptibility for coronavirus disease 2019 (COVID-19) infection when compared to group O. The aim of our study was to examine outcomes in hospitalized COVID-19 patients among blood groups A and O. This is an observational study. Kruskal-Wallis and Chi-square tests were used to compare continuous and categorical variables. Multivariable logistic regression models were used to examine association of blood groups with rates of mortality and sev","2021","07","17","J Hematol","Journal of hematology","ABO blood group; COVID-19; In-hospital mortality","Meersman","Mark","IPC Global, Atlanta, GA 30005, USA",NA
"7","34267846","10.14740/jh824","Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients?","Blood group type A has been associated with increased susceptibility for coronavirus disease 2019 (COVID-19) infection when compared to group O. The aim of our study was to examine outcomes in hospitalized COVID-19 patients among blood groups A and O. This is an observational study. Kruskal-Wallis and Chi-square tests were used to compare continuous and categorical variables. Multivariable logistic regression models were used to examine association of blood groups with rates of mortality and sev","2021","07","17","J Hematol","Journal of hematology","ABO blood group; COVID-19; In-hospital mortality","Dalton","Drew","IPC Global, Atlanta, GA 30005, USA",NA
"8","34267846","10.14740/jh824","Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients?","Blood group type A has been associated with increased susceptibility for coronavirus disease 2019 (COVID-19) infection when compared to group O. The aim of our study was to examine outcomes in hospitalized COVID-19 patients among blood groups A and O. This is an observational study. Kruskal-Wallis and Chi-square tests were used to compare continuous and categorical variables. Multivariable logistic regression models were used to examine association of blood groups with rates of mortality and sev","2021","07","17","J Hematol","Journal of hematology","ABO blood group; COVID-19; In-hospital mortality","Guddati","Achuta Kumar","Division of Hematology/Oncology, Georgia Cancer Center, Augusta University, Augusta, GA 30909, USA",NA
"9","34267844","10.14740/jocmr4531","The Contribution of COVID-19-Forced Transformations in Critical Care Delivery to Patient Mortality: Still an Underexplored Association.",NA,"2021","07","17","J Clin Med Res","Journal of clinical medicine research",NA,"Oud","Lavi","Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Texas Tech University Health Sciences Center at the Permian Basin, Odessa, TX 79763, USA. Email: lavi.oud@ttuhsc","lavi.oud@ttuhsc.edu"
"10","34267839","10.14740/jocmr4518","Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus that belongs to the Coronaviridae family. SARS-CoV-2 is an enveloped spherical-shaped virus. The ribonucleic acid (RNA) is oriented in a 5'-3'direction which makes it a positive sense RNA virus, and the RNA can be read directly as a messenger RNA. The nonstructural protein 14 (nsp14) has proofreading activity which allows the rate of mutations to stay low. A change in the genetic sequence is called a mutation. Gen","2021","07","17","J Clin Med Res","Journal of clinical medicine research","COVID-19; Double mutant variant; Mutations; SARS-CoV-2; Triple mutant variant; Vaccine breakthrough cases; Vaccines; Variants","Vasireddy","Deepa","Department of Pediatrics, Pediatric Group of Acadiana, Lafayette, LA, USA",NA
"11","34267839","10.14740/jocmr4518","Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus that belongs to the Coronaviridae family. SARS-CoV-2 is an enveloped spherical-shaped virus. The ribonucleic acid (RNA) is oriented in a 5'-3'direction which makes it a positive sense RNA virus, and the RNA can be read directly as a messenger RNA. The nonstructural protein 14 (nsp14) has proofreading activity which allows the rate of mutations to stay low. A change in the genetic sequence is called a mutation. Gen","2021","07","17","J Clin Med Res","Journal of clinical medicine research","COVID-19; Double mutant variant; Mutations; SARS-CoV-2; Triple mutant variant; Vaccine breakthrough cases; Vaccines; Variants","Vanaparthy","Rachana","Department of Medicine, Oregon Health and Science University, Portland, OR, USA",NA
"12","34267839","10.14740/jocmr4518","Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus that belongs to the Coronaviridae family. SARS-CoV-2 is an enveloped spherical-shaped virus. The ribonucleic acid (RNA) is oriented in a 5'-3'direction which makes it a positive sense RNA virus, and the RNA can be read directly as a messenger RNA. The nonstructural protein 14 (nsp14) has proofreading activity which allows the rate of mutations to stay low. A change in the genetic sequence is called a mutation. Gen","2021","07","17","J Clin Med Res","Journal of clinical medicine research","COVID-19; Double mutant variant; Mutations; SARS-CoV-2; Triple mutant variant; Vaccine breakthrough cases; Vaccines; Variants","Mohan","Gisha","Physicians for American Health Care Access, Philadelphia, PA, USA",NA
"13","34267839","10.14740/jocmr4518","Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus that belongs to the Coronaviridae family. SARS-CoV-2 is an enveloped spherical-shaped virus. The ribonucleic acid (RNA) is oriented in a 5'-3'direction which makes it a positive sense RNA virus, and the RNA can be read directly as a messenger RNA. The nonstructural protein 14 (nsp14) has proofreading activity which allows the rate of mutations to stay low. A change in the genetic sequence is called a mutation. Gen","2021","07","17","J Clin Med Res","Journal of clinical medicine research","COVID-19; Double mutant variant; Mutations; SARS-CoV-2; Triple mutant variant; Vaccine breakthrough cases; Vaccines; Variants","Malayala","Srikrishna Varun","Department of Medicine, Jeanes Campus-Temple University Hospital, Philadelphia, PA, USA",NA
"14","34267839","10.14740/jocmr4518","Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus that belongs to the Coronaviridae family. SARS-CoV-2 is an enveloped spherical-shaped virus. The ribonucleic acid (RNA) is oriented in a 5'-3'direction which makes it a positive sense RNA virus, and the RNA can be read directly as a messenger RNA. The nonstructural protein 14 (nsp14) has proofreading activity which allows the rate of mutations to stay low. A change in the genetic sequence is called a mutation. Gen","2021","07","17","J Clin Med Res","Journal of clinical medicine research","COVID-19; Double mutant variant; Mutations; SARS-CoV-2; Triple mutant variant; Vaccine breakthrough cases; Vaccines; Variants","Atluri","Paavani","Department of Medicine, Bay Area Hospital, Coos Bay, OR, USA",NA
"15","34267833","10.14740/gr1389","Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19.","Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort. We retrospectively identified patients with COVID-19 infection admitted to two US academic hospitals. Outcomes were length of stay, intensive care ","2021","07","17","Gastroenterology Res","Gastroenterology research","Coronavirus; Fatty liver; Metabolic syndrome; Steatosis","Trivedi","Hirsh D","Division of Gastroenterology, Hepatology, &amp",NA
"16","34267833","10.14740/gr1389","Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19.","Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort. We retrospectively identified patients with COVID-19 infection admitted to two US academic hospitals. Outcomes were length of stay, intensive care ","2021","07","17","Gastroenterology Res","Gastroenterology research","Coronavirus; Fatty liver; Metabolic syndrome; Steatosis","Wilechansky","Robert","Evans Department of Medicine, Section of Gastroenterology, Boston University School of Medicine, Boston, MA, USA",NA
"17","34267833","10.14740/gr1389","Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19.","Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort. We retrospectively identified patients with COVID-19 infection admitted to two US academic hospitals. Outcomes were length of stay, intensive care ","2021","07","17","Gastroenterology Res","Gastroenterology research","Coronavirus; Fatty liver; Metabolic syndrome; Steatosis","Goyes","Daniela","Division of Gastroenterology, Hepatology, &amp",NA
"18","34267833","10.14740/gr1389","Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19.","Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort. We retrospectively identified patients with COVID-19 infection admitted to two US academic hospitals. Outcomes were length of stay, intensive care ","2021","07","17","Gastroenterology Res","Gastroenterology research","Coronavirus; Fatty liver; Metabolic syndrome; Steatosis","Vieira Barbosa","Joana","Division of Gastroenterology, Hepatology, &amp",NA
"19","34267833","10.14740/gr1389","Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19.","Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort. We retrospectively identified patients with COVID-19 infection admitted to two US academic hospitals. Outcomes were length of stay, intensive care ","2021","07","17","Gastroenterology Res","Gastroenterology research","Coronavirus; Fatty liver; Metabolic syndrome; Steatosis","Canakis","Andrew","Evans Department of Medicine, Section of Gastroenterology, Boston University School of Medicine, Boston, MA, USA",NA
"20","34267833","10.14740/gr1389","Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19.","Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort. We retrospectively identified patients with COVID-19 infection admitted to two US academic hospitals. Outcomes were length of stay, intensive care ","2021","07","17","Gastroenterology Res","Gastroenterology research","Coronavirus; Fatty liver; Metabolic syndrome; Steatosis","Lai","Michelle","Division of Gastroenterology, Hepatology, &amp",NA
"21","34267833","10.14740/gr1389","Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19.","Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort. We retrospectively identified patients with COVID-19 infection admitted to two US academic hospitals. Outcomes were length of stay, intensive care ","2021","07","17","Gastroenterology Res","Gastroenterology research","Coronavirus; Fatty liver; Metabolic syndrome; Steatosis","Long","Michelle T","Evans Department of Medicine, Section of Gastroenterology, Boston University School of Medicine, Boston, MA, USA",NA
"22","34267833","10.14740/gr1389","Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19.","Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort. We retrospectively identified patients with COVID-19 infection admitted to two US academic hospitals. Outcomes were length of stay, intensive care ","2021","07","17","Gastroenterology Res","Gastroenterology research","Coronavirus; Fatty liver; Metabolic syndrome; Steatosis","Fricker","Zachary","Division of Gastroenterology, Hepatology, &amp",NA
"23","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Payet","Eduardo","Departamento de Cirugía en Abdomen, Instituto Nacional de Enfermedades Neoplásicas, Av Angamos 2520, Surquillo, Lima 34, Peru",NA
"24","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Perez","Joan","Departamento de Cirugía Ginecológica, Instituto Nacional de Enfermedades Neoplásicas, Av Angamos 2520, Surquillo, Lima 34, Peru",NA
"25","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Sarria","Gustavo","Departamento de Radioterapia, Instituto Nacional de Enfermedades Neoplásicas, Av Angamos 2520, Surquillo, Lima 34, Peru",NA
"26","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Neciosup","Silvia","Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Av Angamos 2520, Surquillo, Lima 34, Peru",NA
"27","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Berrospi","Francisco","Departamento de Cirugía en Abdomen, Instituto Nacional de Enfermedades Neoplásicas, Av Angamos 2520, Surquillo, Lima 34, Peru",NA
"28","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Vilchez","Sheila","Departamento de Cirugía en Mamas y Tejidos Blandos, Instituto Nacional de Enfermedades Neoplásicas, Av Angamos 2520, Surquillo, Lima 34, Peru",NA
"29","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Dunstan","Jorge","Departamento de Cirugía en Mamas y Tejidos Blandos, Instituto Nacional de Enfermedades Neoplásicas, Av Angamos 2520, Surquillo, Lima 34, Peru",NA
"30","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Perez","Ronald","Departamento de Medicina Crítica, Instituto Nacional de Enfermedades Neoplásicas, Av Angamos 2520, Surquillo, Lima 34, Peru",NA
"31","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Vassallo","Mauricio","Escuela Profesional de Medicina, Universidad Peruana de Ciencias Aplicadas, Av Prolongación Primavera 2390, Lima 15023, Peru",NA
"32","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Salgado","Santiago","Escuela Profesional de Medicina, Universidad Peruana de Ciencias Aplicadas, Av Prolongación Primavera 2390, Lima 15023, Peru",NA
"33","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Caparachín","Nanto","Unidad de Gestión de Riesgos y Seguridad del Paciente, Instituto Nacional de Enfermedades Neoplásicas, Av Angamos 2520, Surquillo, Lima 34, Peru",NA
"34","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Pinto","Joseph A","Escuela Profesional de Medicina Humana, Filial Ica, Universidad Privada San Juan Bautista, Carretera Panamericana Sur Km 300, Ica, 11004, Peru",NA
"35","34267802","10.3332/ecancer.2021.1246","Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru.","Cancer patients are at higher risk of infection and severity of Coronavirus Disease-19 (COVID-19). Management of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is challenging due to the scarce scientific information and treatment guidelines. In this work, we present our Institutional experience with our first 100 patients with oncological malignancies and COVID-19. We conducted a cross-sectional study of the first 100 patients hospitalised at the Instituto Naci","2021","07","17","Ecancermedicalscience","Ecancermedicalscience","COVID-19; SARS-CoV-2; cancer; mortality","Holguin","Alexis","Departamento de Infectología, Instituto Nacional de Enfermedades Neoplásicas, Av Angamos 2520, Surquillo, Lima 34, Peru",NA
"36","34267788","10.1590/1677-5449.200173","Emergency endovascular repair of aortoiliac aneurysms in COVID-19 times.","In this paper, we describe a case series of four patients who were admitted with emergencies related to aortic aneurysms over a 3-day period and were treated with endovascular repair. The first patient was an 81-year-old female with a history of abdominal pain and a ruptured aortic aneurysm diagnosed by AngioCT-scan. The second patient was a 63-year-old male with a history of oral digestive bleeding and an AngioCT-scan showing an aortoenteric fistula. The third patient was a 77-year-old female w","2021","07","17","J Vasc Bras","Jornal vascular brasileiro","COVID-19; aortic surgery; endovascular surgery; ruptured aortic aneurysms","Soares","Rafael de Athayde","Hospital do Servidor Público Estadual de São Paulo, Division of Vascular and Endovascular Surgery, São Paulo, SP, Brasil",NA
"37","34267788","10.1590/1677-5449.200173","Emergency endovascular repair of aortoiliac aneurysms in COVID-19 times.","In this paper, we describe a case series of four patients who were admitted with emergencies related to aortic aneurysms over a 3-day period and were treated with endovascular repair. The first patient was an 81-year-old female with a history of abdominal pain and a ruptured aortic aneurysm diagnosed by AngioCT-scan. The second patient was a 63-year-old male with a history of oral digestive bleeding and an AngioCT-scan showing an aortoenteric fistula. The third patient was a 77-year-old female w","2021","07","17","J Vasc Bras","Jornal vascular brasileiro","COVID-19; aortic surgery; endovascular surgery; ruptured aortic aneurysms","Cury","Marcus Vinícius Martins","Hospital do Servidor Público Estadual de São Paulo, Division of Vascular and Endovascular Surgery, São Paulo, SP, Brasil",NA
"38","34267788","10.1590/1677-5449.200173","Emergency endovascular repair of aortoiliac aneurysms in COVID-19 times.","In this paper, we describe a case series of four patients who were admitted with emergencies related to aortic aneurysms over a 3-day period and were treated with endovascular repair. The first patient was an 81-year-old female with a history of abdominal pain and a ruptured aortic aneurysm diagnosed by AngioCT-scan. The second patient was a 63-year-old male with a history of oral digestive bleeding and an AngioCT-scan showing an aortoenteric fistula. The third patient was a 77-year-old female w","2021","07","17","J Vasc Bras","Jornal vascular brasileiro","COVID-19; aortic surgery; endovascular surgery; ruptured aortic aneurysms","da Silva","Luiz Maurício","Hospital do Servidor Público Estadual de São Paulo, Division of Vascular and Endovascular Surgery, São Paulo, SP, Brasil",NA
"39","34267788","10.1590/1677-5449.200173","Emergency endovascular repair of aortoiliac aneurysms in COVID-19 times.","In this paper, we describe a case series of four patients who were admitted with emergencies related to aortic aneurysms over a 3-day period and were treated with endovascular repair. The first patient was an 81-year-old female with a history of abdominal pain and a ruptured aortic aneurysm diagnosed by AngioCT-scan. The second patient was a 63-year-old male with a history of oral digestive bleeding and an AngioCT-scan showing an aortoenteric fistula. The third patient was a 77-year-old female w","2021","07","17","J Vasc Bras","Jornal vascular brasileiro","COVID-19; aortic surgery; endovascular surgery; ruptured aortic aneurysms","Figueiredo","Patrícia Weiber Schettini","Hospital do Servidor Público Estadual de São Paulo, Division of Vascular and Endovascular Surgery, São Paulo, SP, Brasil",NA
"40","34267788","10.1590/1677-5449.200173","Emergency endovascular repair of aortoiliac aneurysms in COVID-19 times.","In this paper, we describe a case series of four patients who were admitted with emergencies related to aortic aneurysms over a 3-day period and were treated with endovascular repair. The first patient was an 81-year-old female with a history of abdominal pain and a ruptured aortic aneurysm diagnosed by AngioCT-scan. The second patient was a 63-year-old male with a history of oral digestive bleeding and an AngioCT-scan showing an aortoenteric fistula. The third patient was a 77-year-old female w","2021","07","17","J Vasc Bras","Jornal vascular brasileiro","COVID-19; aortic surgery; endovascular surgery; ruptured aortic aneurysms","da Costa","Danilo Augusto Pereira Nery","Hospital do Servidor Público Estadual de São Paulo, Division of Vascular and Endovascular Surgery, São Paulo, SP, Brasil",NA
"41","34267788","10.1590/1677-5449.200173","Emergency endovascular repair of aortoiliac aneurysms in COVID-19 times.","In this paper, we describe a case series of four patients who were admitted with emergencies related to aortic aneurysms over a 3-day period and were treated with endovascular repair. The first patient was an 81-year-old female with a history of abdominal pain and a ruptured aortic aneurysm diagnosed by AngioCT-scan. The second patient was a 63-year-old male with a history of oral digestive bleeding and an AngioCT-scan showing an aortoenteric fistula. The third patient was a 77-year-old female w","2021","07","17","J Vasc Bras","Jornal vascular brasileiro","COVID-19; aortic surgery; endovascular surgery; ruptured aortic aneurysms","Correa","Camila de Freitas","Hospital do Servidor Público Estadual de São Paulo, Division of Vascular and Endovascular Surgery, São Paulo, SP, Brasil",NA
"42","34267788","10.1590/1677-5449.200173","Emergency endovascular repair of aortoiliac aneurysms in COVID-19 times.","In this paper, we describe a case series of four patients who were admitted with emergencies related to aortic aneurysms over a 3-day period and were treated with endovascular repair. The first patient was an 81-year-old female with a history of abdominal pain and a ruptured aortic aneurysm diagnosed by AngioCT-scan. The second patient was a 63-year-old male with a history of oral digestive bleeding and an AngioCT-scan showing an aortoenteric fistula. The third patient was a 77-year-old female w","2021","07","17","J Vasc Bras","Jornal vascular brasileiro","COVID-19; aortic surgery; endovascular surgery; ruptured aortic aneurysms","Cáceres","Nayara de Arruda","Hospital do Servidor Público Estadual de São Paulo, Division of Vascular and Endovascular Surgery, São Paulo, SP, Brasil",NA
"43","34267788","10.1590/1677-5449.200173","Emergency endovascular repair of aortoiliac aneurysms in COVID-19 times.","In this paper, we describe a case series of four patients who were admitted with emergencies related to aortic aneurysms over a 3-day period and were treated with endovascular repair. The first patient was an 81-year-old female with a history of abdominal pain and a ruptured aortic aneurysm diagnosed by AngioCT-scan. The second patient was a 63-year-old male with a history of oral digestive bleeding and an AngioCT-scan showing an aortoenteric fistula. The third patient was a 77-year-old female w","2021","07","17","J Vasc Bras","Jornal vascular brasileiro","COVID-19; aortic surgery; endovascular surgery; ruptured aortic aneurysms","Saciloto","Roberto","Hospital do Servidor Público Estadual de São Paulo, Division of Vascular and Endovascular Surgery, São Paulo, SP, Brasil",NA
"44","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Ellis","Daniel","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"45","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Brunette","Natalie","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"46","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Crawford","Katharine H D","Basic Sciences and Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States",NA
"47","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Walls","Alexandra C","Department of Biochemistry, University of Washington, Seattle, WA, United States",NA
"48","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Pham","Minh N","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"49","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Chen","Chengbo","Department of Medicinal Chemistry, University of Washington, Seattle, WA, United States",NA
"50","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Herpoldt","Karla-Luise","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"51","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Fiala","Brooke","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"52","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Murphy","Michael","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"53","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Pettie","Deleah","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"54","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Kraft","John C","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"55","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Malone","Keara D","Basic Sciences and Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States",NA
"56","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Navarro","Mary Jane","Department of Biochemistry, University of Washington, Seattle, WA, United States",NA
"57","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Ogohara","Cassandra","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"58","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Kepl","Elizabeth","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"59","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Ravichandran","Rashmi","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"60","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Sydeman","Claire","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"61","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Ahlrichs","Maggie","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"62","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Johnson","Max","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"63","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Blackstone","Alyssa","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"64","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Carter","Lauren","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"65","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Starr","Tyler N","Basic Sciences and Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States",NA
"66","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Greaney","Allison J","Basic Sciences and Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States",NA
"67","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Lee","Kelly K","Department of Medicinal Chemistry, University of Washington, Seattle, WA, United States",NA
"68","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Veesler","David","Department of Biochemistry, University of Washington, Seattle, WA, United States",NA
"69","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","Bloom","Jesse D","Basic Sciences and Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States",NA
"70","34267764","10.3389/fimmu.2021.710263","Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.","The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generation vaccine candidates, as they feature robust manufacturing characteristics and have shown promising immunogenicity in preclinical models. Here, we us","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; antigen stabilization; computational protein design; deep mutational scanning; nanoparticle; receptor-binding domain; vaccine","King","Neil P","Institute for Protein Design, University of Washington, Seattle, WA, United States",NA
"71","34267735","10.3389/fmicb.2021.676314","Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.","The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late December 2019 in Wuhan, China, and is the causative agent for the worldwide COVID-19 pandemic. SARS-CoV-2 is a positive-sense single-stranded RNA virus belonging to the betacoronavirus genus. Due to the error-prone nature of the viral RNA-dependent polymerase complex, coronaviruses are known to acquire new mutations at each cycle of genome replication. This constitutes one of the main factors driving the evolu","2021","07","17","Front Microbiol","Frontiers in microbiology","B.1.1.7 variant; B1.351 variant; COVID-19; Coronavirus; P.1 variant; SARS-CoV-2; evolution; variants","Castonguay","Nicolas","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada",NA
"72","34267735","10.3389/fmicb.2021.676314","Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.","The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late December 2019 in Wuhan, China, and is the causative agent for the worldwide COVID-19 pandemic. SARS-CoV-2 is a positive-sense single-stranded RNA virus belonging to the betacoronavirus genus. Due to the error-prone nature of the viral RNA-dependent polymerase complex, coronaviruses are known to acquire new mutations at each cycle of genome replication. This constitutes one of the main factors driving the evolu","2021","07","17","Front Microbiol","Frontiers in microbiology","B.1.1.7 variant; B1.351 variant; COVID-19; Coronavirus; P.1 variant; SARS-CoV-2; evolution; variants","Zhang","Wandong","Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada",NA
"73","34267735","10.3389/fmicb.2021.676314","Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.","The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late December 2019 in Wuhan, China, and is the causative agent for the worldwide COVID-19 pandemic. SARS-CoV-2 is a positive-sense single-stranded RNA virus belonging to the betacoronavirus genus. Due to the error-prone nature of the viral RNA-dependent polymerase complex, coronaviruses are known to acquire new mutations at each cycle of genome replication. This constitutes one of the main factors driving the evolu","2021","07","17","Front Microbiol","Frontiers in microbiology","B.1.1.7 variant; B1.351 variant; COVID-19; Coronavirus; P.1 variant; SARS-CoV-2; evolution; variants","Langlois","Marc-André","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada",NA
"74","34267704","10.3389/fpsyg.2021.664399","What Explains Natives and Sojourners Preventive Health Behavior in a Pandemic: Role of Media and Scientific Self-Efficacy.","The COVID-19 pandemic triggered a severe global public health emergency. The current research investigated and compared ""Natives and Sojourners"" health-protective behavior in Mainland China during the pandemic. We adopted a unified view to propose our theoretical model by adapting the Health Belief Model (HBM) and Institutional Theory (IT). The data obtained through an online survey questionnaire from 435 respondents during the second and third quarters of were analyzed. Structural equation mode","2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; China; health belief model; media self-efficacy; scientific self-efficacy; sojourners","Keren","Fang","School of Journalism and Communication, Anhui University, Hefei, China",NA
"75","34267704","10.3389/fpsyg.2021.664399","What Explains Natives and Sojourners Preventive Health Behavior in a Pandemic: Role of Media and Scientific Self-Efficacy.","The COVID-19 pandemic triggered a severe global public health emergency. The current research investigated and compared ""Natives and Sojourners"" health-protective behavior in Mainland China during the pandemic. We adopted a unified view to propose our theoretical model by adapting the Health Belief Model (HBM) and Institutional Theory (IT). The data obtained through an online survey questionnaire from 435 respondents during the second and third quarters of were analyzed. Structural equation mode","2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; China; health belief model; media self-efficacy; scientific self-efficacy; sojourners","Siddiquei","Ahmad Nabeel","Bond Business School, Bond University, Gold Coast, QLD, Australia",NA
"76","34267704","10.3389/fpsyg.2021.664399","What Explains Natives and Sojourners Preventive Health Behavior in a Pandemic: Role of Media and Scientific Self-Efficacy.","The COVID-19 pandemic triggered a severe global public health emergency. The current research investigated and compared ""Natives and Sojourners"" health-protective behavior in Mainland China during the pandemic. We adopted a unified view to propose our theoretical model by adapting the Health Belief Model (HBM) and Institutional Theory (IT). The data obtained through an online survey questionnaire from 435 respondents during the second and third quarters of were analyzed. Structural equation mode","2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; China; health belief model; media self-efficacy; scientific self-efficacy; sojourners","Anwar","Muhammad Azfar","School of Management, University of Shenzhen, Shenzhen, China",NA
"77","34267704","10.3389/fpsyg.2021.664399","What Explains Natives and Sojourners Preventive Health Behavior in a Pandemic: Role of Media and Scientific Self-Efficacy.","The COVID-19 pandemic triggered a severe global public health emergency. The current research investigated and compared ""Natives and Sojourners"" health-protective behavior in Mainland China during the pandemic. We adopted a unified view to propose our theoretical model by adapting the Health Belief Model (HBM) and Institutional Theory (IT). The data obtained through an online survey questionnaire from 435 respondents during the second and third quarters of were analyzed. Structural equation mode","2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; China; health belief model; media self-efficacy; scientific self-efficacy; sojourners","Asmi","Fahad","Department of Science and Technology of Communication, University of Science and Technology of China, Hefei, China",NA
"78","34267704","10.3389/fpsyg.2021.664399","What Explains Natives and Sojourners Preventive Health Behavior in a Pandemic: Role of Media and Scientific Self-Efficacy.","The COVID-19 pandemic triggered a severe global public health emergency. The current research investigated and compared ""Natives and Sojourners"" health-protective behavior in Mainland China during the pandemic. We adopted a unified view to propose our theoretical model by adapting the Health Belief Model (HBM) and Institutional Theory (IT). The data obtained through an online survey questionnaire from 435 respondents during the second and third quarters of were analyzed. Structural equation mode","2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; China; health belief model; media self-efficacy; scientific self-efficacy; sojourners","Ye","Qing","Department of Science and Technology of Communication, University of Science and Technology of China, Hefei, China",NA
"79","34267693","10.3389/fpsyg.2021.628707","The Mental Health Impacts of COVID-19 on Pediatric Patients Following Recovery.",NA,"2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; PTSD; anxiety; children; depression","Liu","Dong","Department of Communication, Renmin University of China, Beijing, China",NA
"80","34267693","10.3389/fpsyg.2021.628707","The Mental Health Impacts of COVID-19 on Pediatric Patients Following Recovery.",NA,"2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; PTSD; anxiety; children; depression","Liu","Wenjun","Department of Communication, Renmin University of China, Beijing, China",NA
"81","34267693","10.3389/fpsyg.2021.628707","The Mental Health Impacts of COVID-19 on Pediatric Patients Following Recovery.",NA,"2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; PTSD; anxiety; children; depression","Rodriguez","Marcus","Pitzer College, Claremont, CA, United States",NA
"82","34267693","10.3389/fpsyg.2021.628707","The Mental Health Impacts of COVID-19 on Pediatric Patients Following Recovery.",NA,"2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; PTSD; anxiety; children; depression","Zhang","Jie","Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"83","34267693","10.3389/fpsyg.2021.628707","The Mental Health Impacts of COVID-19 on Pediatric Patients Following Recovery.",NA,"2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; PTSD; anxiety; children; depression","Zhang","Fuhai","School of Education, Hebei Normal University, Shijiazhuang, China",NA
"84","34267692","10.3389/fpsyg.2021.607309","A Game of Covid: Strategic Thoughts About a Ludified Pandemic.","Many aspects of handling the COVID-19 pandemic bear a resemblance to patterns found in games. We observe point displays and leader boards, the visible assumption of roles, classic archetypes, the collection of resources, and spatial awareness. We argue that these patterns manifest spontaneously as a form of analogical reasoning, because people lack cultural and individual norms as well as cognitive scripts for a pandemic. Trying to find systematic similarities between a novel and a familiar situ","2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; analogical reasoning; crisis; ludification; pandemic; strategic gamification","Raab","Marius Hans","Department of General Psychology and Methodology, University of Bamberg, Bamberg, Germany",NA
"85","34267692","10.3389/fpsyg.2021.607309","A Game of Covid: Strategic Thoughts About a Ludified Pandemic.","Many aspects of handling the COVID-19 pandemic bear a resemblance to patterns found in games. We observe point displays and leader boards, the visible assumption of roles, classic archetypes, the collection of resources, and spatial awareness. We argue that these patterns manifest spontaneously as a form of analogical reasoning, because people lack cultural and individual norms as well as cognitive scripts for a pandemic. Trying to find systematic similarities between a novel and a familiar situ","2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; analogical reasoning; crisis; ludification; pandemic; strategic gamification","Döbler","Niklas Alexander","Department of General Psychology and Methodology, University of Bamberg, Bamberg, Germany",NA
"86","34267692","10.3389/fpsyg.2021.607309","A Game of Covid: Strategic Thoughts About a Ludified Pandemic.","Many aspects of handling the COVID-19 pandemic bear a resemblance to patterns found in games. We observe point displays and leader boards, the visible assumption of roles, classic archetypes, the collection of resources, and spatial awareness. We argue that these patterns manifest spontaneously as a form of analogical reasoning, because people lack cultural and individual norms as well as cognitive scripts for a pandemic. Trying to find systematic similarities between a novel and a familiar situ","2021","07","17","Front Psychol","Frontiers in psychology","COVID-19; analogical reasoning; crisis; ludification; pandemic; strategic gamification","Carbon","Claus-Christian","Department of General Psychology and Methodology, University of Bamberg, Bamberg, Germany",NA
"87","34267681","10.3389/fpsyt.2021.644276","The Prevalence and Correlative Factors of Depression Among Chinese Teachers During the COVID-19 Outbreak.","Background: Epidemiological data on outbreak-associated depression of Chinese teachers are not available. This study aimed to investigate the prevalence and correlates of depression among teachers during the coronavirus disease 2019 (COVID-19) outbreak in mainland China. Methods: A large cross-sectional online survey was conducted during the COVID-19 outbreak. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). The Connor-Davidson Resilience Scale 25 (CD-RISC ","2021","07","17","Front Psychiatry","Frontiers in psychiatry","COVID-19; depression; factor; prevalence; teacher","Zhou","Jiaojiao","The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital and The Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China",NA
"88","34267681","10.3389/fpsyt.2021.644276","The Prevalence and Correlative Factors of Depression Among Chinese Teachers During the COVID-19 Outbreak.","Background: Epidemiological data on outbreak-associated depression of Chinese teachers are not available. This study aimed to investigate the prevalence and correlates of depression among teachers during the coronavirus disease 2019 (COVID-19) outbreak in mainland China. Methods: A large cross-sectional online survey was conducted during the COVID-19 outbreak. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). The Connor-Davidson Resilience Scale 25 (CD-RISC ","2021","07","17","Front Psychiatry","Frontiers in psychiatry","COVID-19; depression; factor; prevalence; teacher","Yuan","Xiaofei","The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital and The Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China",NA
"89","34267681","10.3389/fpsyt.2021.644276","The Prevalence and Correlative Factors of Depression Among Chinese Teachers During the COVID-19 Outbreak.","Background: Epidemiological data on outbreak-associated depression of Chinese teachers are not available. This study aimed to investigate the prevalence and correlates of depression among teachers during the coronavirus disease 2019 (COVID-19) outbreak in mainland China. Methods: A large cross-sectional online survey was conducted during the COVID-19 outbreak. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). The Connor-Davidson Resilience Scale 25 (CD-RISC ","2021","07","17","Front Psychiatry","Frontiers in psychiatry","COVID-19; depression; factor; prevalence; teacher","Huang","Huanhuan","The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital and The Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China",NA
"90","34267681","10.3389/fpsyt.2021.644276","The Prevalence and Correlative Factors of Depression Among Chinese Teachers During the COVID-19 Outbreak.","Background: Epidemiological data on outbreak-associated depression of Chinese teachers are not available. This study aimed to investigate the prevalence and correlates of depression among teachers during the coronavirus disease 2019 (COVID-19) outbreak in mainland China. Methods: A large cross-sectional online survey was conducted during the COVID-19 outbreak. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). The Connor-Davidson Resilience Scale 25 (CD-RISC ","2021","07","17","Front Psychiatry","Frontiers in psychiatry","COVID-19; depression; factor; prevalence; teacher","Li","Yaqiong","The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital and The Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China",NA
"91","34267681","10.3389/fpsyt.2021.644276","The Prevalence and Correlative Factors of Depression Among Chinese Teachers During the COVID-19 Outbreak.","Background: Epidemiological data on outbreak-associated depression of Chinese teachers are not available. This study aimed to investigate the prevalence and correlates of depression among teachers during the coronavirus disease 2019 (COVID-19) outbreak in mainland China. Methods: A large cross-sectional online survey was conducted during the COVID-19 outbreak. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). The Connor-Davidson Resilience Scale 25 (CD-RISC ","2021","07","17","Front Psychiatry","Frontiers in psychiatry","COVID-19; depression; factor; prevalence; teacher","Yu","HongYe","The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital and The Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China",NA
"92","34267681","10.3389/fpsyt.2021.644276","The Prevalence and Correlative Factors of Depression Among Chinese Teachers During the COVID-19 Outbreak.","Background: Epidemiological data on outbreak-associated depression of Chinese teachers are not available. This study aimed to investigate the prevalence and correlates of depression among teachers during the coronavirus disease 2019 (COVID-19) outbreak in mainland China. Methods: A large cross-sectional online survey was conducted during the COVID-19 outbreak. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). The Connor-Davidson Resilience Scale 25 (CD-RISC ","2021","07","17","Front Psychiatry","Frontiers in psychiatry","COVID-19; depression; factor; prevalence; teacher","Chen","Xu","The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital and The Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China",NA
"93","34267681","10.3389/fpsyt.2021.644276","The Prevalence and Correlative Factors of Depression Among Chinese Teachers During the COVID-19 Outbreak.","Background: Epidemiological data on outbreak-associated depression of Chinese teachers are not available. This study aimed to investigate the prevalence and correlates of depression among teachers during the coronavirus disease 2019 (COVID-19) outbreak in mainland China. Methods: A large cross-sectional online survey was conducted during the COVID-19 outbreak. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). The Connor-Davidson Resilience Scale 25 (CD-RISC ","2021","07","17","Front Psychiatry","Frontiers in psychiatry","COVID-19; depression; factor; prevalence; teacher","Luo","Jia","The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital and The Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China",NA
"94","34267671","10.3389/fphys.2021.628288","How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients.","COVID-19 is a disease caused by a new coronavirus SARS-CoV-2, primarily impacting the respiratory system. COVID-19 can result in mild illness or serious disease leading to critical illness and requires admission to ICU due to respiratory failure. There is intense discussion around potential factors predisposing to and protecting from COVID-19. The immune response and the abnormal respiratory function with a focus on respiratory function testing in COVID-19 patients will be at the center of this ","2021","07","17","Front Physiol","Frontiers in physiology","COVID-19; diffusing capacity for lung carbon monoxide; immune response; respiratory function testing; respiratory physiology","Laveneziana","Pierantonio","Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire APHP-Sorbonne Université, Sites Pitié-Salpêtrière, Saint-Antoine et Tenon, Service des Explorations Fonctionnelles de la Respiration, de l'Exercice et de la Dyspnée (Département R3S), Paris, France",NA
"95","34267671","10.3389/fphys.2021.628288","How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients.","COVID-19 is a disease caused by a new coronavirus SARS-CoV-2, primarily impacting the respiratory system. COVID-19 can result in mild illness or serious disease leading to critical illness and requires admission to ICU due to respiratory failure. There is intense discussion around potential factors predisposing to and protecting from COVID-19. The immune response and the abnormal respiratory function with a focus on respiratory function testing in COVID-19 patients will be at the center of this ","2021","07","17","Front Physiol","Frontiers in physiology","COVID-19; diffusing capacity for lung carbon monoxide; immune response; respiratory function testing; respiratory physiology","Straus","Christian","Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire APHP-Sorbonne Université, Sites Pitié-Salpêtrière, Saint-Antoine et Tenon, Service des Explorations Fonctionnelles de la Respiration, de l'Exercice et de la Dyspnée (Département R3S), Paris, France",NA
"96","34267671","10.3389/fphys.2021.628288","How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients.","COVID-19 is a disease caused by a new coronavirus SARS-CoV-2, primarily impacting the respiratory system. COVID-19 can result in mild illness or serious disease leading to critical illness and requires admission to ICU due to respiratory failure. There is intense discussion around potential factors predisposing to and protecting from COVID-19. The immune response and the abnormal respiratory function with a focus on respiratory function testing in COVID-19 patients will be at the center of this ","2021","07","17","Front Physiol","Frontiers in physiology","COVID-19; diffusing capacity for lung carbon monoxide; immune response; respiratory function testing; respiratory physiology","Meiners","Silke","Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany",NA
"97","34267664","10.3389/fphar.2021.698905","The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.","Lung alveolar type-II (AT-II) cells produce pulmonary surfactant (PS), consisting of proteins and lipids. The lipids in PS are primarily responsible for reducing the air-fluid surface tension inside the alveoli of the lungs and to prevent atelectasis. The proteins are of two types: hydrophilic and hydrophobic. Hydrophilic surfactants are primarily responsible for opsonisation, thereby protecting the lungs from microbial and environmental contaminants. Hydrophobic surfactants are primarily respon","2021","07","17","Front Pharmacol","Frontiers in pharmacology","ARDS; COVID-19; NRDS; SARS-cov-2; pulmonary surfactant","Wang","Shengguang","School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China",NA
"98","34267664","10.3389/fphar.2021.698905","The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.","Lung alveolar type-II (AT-II) cells produce pulmonary surfactant (PS), consisting of proteins and lipids. The lipids in PS are primarily responsible for reducing the air-fluid surface tension inside the alveoli of the lungs and to prevent atelectasis. The proteins are of two types: hydrophilic and hydrophobic. Hydrophilic surfactants are primarily responsible for opsonisation, thereby protecting the lungs from microbial and environmental contaminants. Hydrophobic surfactants are primarily respon","2021","07","17","Front Pharmacol","Frontiers in pharmacology","ARDS; COVID-19; NRDS; SARS-cov-2; pulmonary surfactant","Li","Zhen","School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China",NA
"99","34267664","10.3389/fphar.2021.698905","The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.","Lung alveolar type-II (AT-II) cells produce pulmonary surfactant (PS), consisting of proteins and lipids. The lipids in PS are primarily responsible for reducing the air-fluid surface tension inside the alveoli of the lungs and to prevent atelectasis. The proteins are of two types: hydrophilic and hydrophobic. Hydrophilic surfactants are primarily responsible for opsonisation, thereby protecting the lungs from microbial and environmental contaminants. Hydrophobic surfactants are primarily respon","2021","07","17","Front Pharmacol","Frontiers in pharmacology","ARDS; COVID-19; NRDS; SARS-cov-2; pulmonary surfactant","Wang","Xinyu","School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China",NA
"100","34267664","10.3389/fphar.2021.698905","The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.","Lung alveolar type-II (AT-II) cells produce pulmonary surfactant (PS), consisting of proteins and lipids. The lipids in PS are primarily responsible for reducing the air-fluid surface tension inside the alveoli of the lungs and to prevent atelectasis. The proteins are of two types: hydrophilic and hydrophobic. Hydrophilic surfactants are primarily responsible for opsonisation, thereby protecting the lungs from microbial and environmental contaminants. Hydrophobic surfactants are primarily respon","2021","07","17","Front Pharmacol","Frontiers in pharmacology","ARDS; COVID-19; NRDS; SARS-cov-2; pulmonary surfactant","Zhang","Shiming","School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China",NA
"101","34267664","10.3389/fphar.2021.698905","The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.","Lung alveolar type-II (AT-II) cells produce pulmonary surfactant (PS), consisting of proteins and lipids. The lipids in PS are primarily responsible for reducing the air-fluid surface tension inside the alveoli of the lungs and to prevent atelectasis. The proteins are of two types: hydrophilic and hydrophobic. Hydrophilic surfactants are primarily responsible for opsonisation, thereby protecting the lungs from microbial and environmental contaminants. Hydrophobic surfactants are primarily respon","2021","07","17","Front Pharmacol","Frontiers in pharmacology","ARDS; COVID-19; NRDS; SARS-cov-2; pulmonary surfactant","Gao","Peng","School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China",NA
"102","34267664","10.3389/fphar.2021.698905","The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.","Lung alveolar type-II (AT-II) cells produce pulmonary surfactant (PS), consisting of proteins and lipids. The lipids in PS are primarily responsible for reducing the air-fluid surface tension inside the alveoli of the lungs and to prevent atelectasis. The proteins are of two types: hydrophilic and hydrophobic. Hydrophilic surfactants are primarily responsible for opsonisation, thereby protecting the lungs from microbial and environmental contaminants. Hydrophobic surfactants are primarily respon","2021","07","17","Front Pharmacol","Frontiers in pharmacology","ARDS; COVID-19; NRDS; SARS-cov-2; pulmonary surfactant","Shi","Zuorong","School of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China",NA
"103","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Ayatollahi","Seyed Abdulmajid","Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"104","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Sharifi-Rad","Javad","Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"105","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Tsouh Fokou","Patrick Valere","Department of Biochemistry, Faculty of Science, University of Bamenda, Bamenda, Cameroon",NA
"106","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Mahady","Gail B","Department of Pharmacy Practice, PAHO/WHO Collaborating Centre for Traditional Medicine, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States",NA
"107","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Ansar Rasul Suleria","Hafiz","Department of Agriculture and Food Systems, University of Melbourne, Melbourne, VIC, Australia",NA
"108","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Krishna Kapuganti","Shivani","School of Basic Sciences, Indian Institute of Technology Mandi, Mandi, India",NA
"109","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Gadhave","Kundlik","School of Basic Sciences, Indian Institute of Technology Mandi, Mandi, India",NA
"110","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Giri","Rajanish","School of Basic Sciences, Indian Institute of Technology Mandi, Mandi, India",NA
"111","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Garg","Neha","Department of Medicinal Chemistry, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India",NA
"112","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Sharma","Rohit","Department of Rasa Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India",NA
"113","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Ribeiro","Daniel","Northern Superior Health School of the Portuguese Red Cross, Oliveira de Azeméis, Portugal",NA
"114","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Rodrigues","Célia F","LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Porto, Portugal",NA
"115","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Reiner","eljko","Department of Internal Medicine, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia",NA
"116","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Taheri","Yasaman","Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"117","34267652","10.3389/fphar.2021.575877","Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.","The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ~2.4 million ","2021","07","17","Front Pharmacol","Frontiers in pharmacology","COVID-19; Coronavirus; SARS-CoV-2; bioactive compounds; natural compounds","Cruz-Martins","Natália","Laboratory of Neuropsychophysiology, Faculty of Psychology and Education Sciences, University of Porto, Porto, Portugal",NA
"118","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Pisaturo","Mariantonietta","Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy",NA
"119","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Calò","Federica","Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy",NA
"120","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Russo","Antonio","Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy",NA
"121","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Camaioni","Clarissa","Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy",NA
"122","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Giaccone","Agnese","Infectious Diseases Unit, Federico II University, Naples, Italy",NA
"123","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Pinchera","Biagio","Infectious Diseases Unit, Federico II University, Naples, Italy",NA
"124","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Gentile","Ivan","Infectious Diseases Unit, Federico II University, Naples, Italy",NA
"125","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Simeone","Filomena","Infectious Disease Unit, AORN Caserta, Caserta, Italy",NA
"126","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Iodice","Angelo","Infectious Disease Unit, AORN Caserta, Caserta, Italy",NA
"127","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Maggi","Paolo","Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy",NA
"128","34267649","10.3389/fnagi.2021.698184","Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.","The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. In a multicenter, observational, 1:2 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (&lt;200, or","2021","07","17","Front Aging Neurosci","Frontiers in aging neuroscience","COVID-19; SARS-CoV-2; death; dementia; severity","Coppola","Nicola","Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy",NA
"129","34267641","10.1159/000517008","Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer.","We report on a 75-year old man who presented with metastatic, squamous-cell carcinoma (SCC) of the penis whose disease had progressed after radiotherapy (RT) and cisplatin-based chemotherapy (CT). A strong PD-L1 expression as well as a CDKN2A mutation was documented, and he was given cemiplimab every 3 weeks at time of disease progression. Complete response (CR) was demonstrated after 10 cycles, and no toxicity was reported. However, this treatment was stopped after 13 cycles when the patient de","2021","07","17","Case Rep Oncol","Case reports in oncology","Cemiplimab; Checkpoint inhibitor; Immunotherapy; Penile cancer","Denis","Chloé","Department of Medical Oncology, University Hospital of Liege, CHU Sart Tilman, Liège, Belgium",NA
"130","34267641","10.1159/000517008","Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer.","We report on a 75-year old man who presented with metastatic, squamous-cell carcinoma (SCC) of the penis whose disease had progressed after radiotherapy (RT) and cisplatin-based chemotherapy (CT). A strong PD-L1 expression as well as a CDKN2A mutation was documented, and he was given cemiplimab every 3 weeks at time of disease progression. Complete response (CR) was demonstrated after 10 cycles, and no toxicity was reported. However, this treatment was stopped after 13 cycles when the patient de","2021","07","17","Case Rep Oncol","Case reports in oncology","Cemiplimab; Checkpoint inhibitor; Immunotherapy; Penile cancer","Sakalihasan","Sarah","Department of Medical Oncology, University Hospital of Liege, CHU Sart Tilman, Liège, Belgium",NA
"131","34267641","10.1159/000517008","Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer.","We report on a 75-year old man who presented with metastatic, squamous-cell carcinoma (SCC) of the penis whose disease had progressed after radiotherapy (RT) and cisplatin-based chemotherapy (CT). A strong PD-L1 expression as well as a CDKN2A mutation was documented, and he was given cemiplimab every 3 weeks at time of disease progression. Complete response (CR) was demonstrated after 10 cycles, and no toxicity was reported. However, this treatment was stopped after 13 cycles when the patient de","2021","07","17","Case Rep Oncol","Case reports in oncology","Cemiplimab; Checkpoint inhibitor; Immunotherapy; Penile cancer","Frères","Pierre","Department of Medical Oncology, University Hospital of Liege, CHU Sart Tilman, Liège, Belgium",NA
"132","34267641","10.1159/000517008","Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer.","We report on a 75-year old man who presented with metastatic, squamous-cell carcinoma (SCC) of the penis whose disease had progressed after radiotherapy (RT) and cisplatin-based chemotherapy (CT). A strong PD-L1 expression as well as a CDKN2A mutation was documented, and he was given cemiplimab every 3 weeks at time of disease progression. Complete response (CR) was demonstrated after 10 cycles, and no toxicity was reported. However, this treatment was stopped after 13 cycles when the patient de","2021","07","17","Case Rep Oncol","Case reports in oncology","Cemiplimab; Checkpoint inhibitor; Immunotherapy; Penile cancer","Withofs","Nadia","Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, University Hospital of Liege, CHU Sart Tilman, Liège, Belgium",NA
"133","34267641","10.1159/000517008","Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer.","We report on a 75-year old man who presented with metastatic, squamous-cell carcinoma (SCC) of the penis whose disease had progressed after radiotherapy (RT) and cisplatin-based chemotherapy (CT). A strong PD-L1 expression as well as a CDKN2A mutation was documented, and he was given cemiplimab every 3 weeks at time of disease progression. Complete response (CR) was demonstrated after 10 cycles, and no toxicity was reported. However, this treatment was stopped after 13 cycles when the patient de","2021","07","17","Case Rep Oncol","Case reports in oncology","Cemiplimab; Checkpoint inhibitor; Immunotherapy; Penile cancer","Sautois","Brieuc","Department of Medical Oncology, University Hospital of Liege, CHU Sart Tilman, Liège, Belgium",NA
"134","34267612","10.17179/excli2021-3810","Is there a bidirectional interaction between periodontitis and the severity of SARS-CoV-2 infection?",NA,"2021","07","17","EXCLI J","EXCLI journal",NA,"Andrade","Rayle Monteiro","Graduate Program in Dentistry, Federal University of Sergipe, Aracaju, Sergipe, Brazil",NA
"135","34267612","10.17179/excli2021-3810","Is there a bidirectional interaction between periodontitis and the severity of SARS-CoV-2 infection?",NA,"2021","07","17","EXCLI J","EXCLI journal",NA,"Marques","Raquel Souza","Graduate Program in Dentistry, Federal University of Sergipe, Aracaju, Sergipe, Brazil",NA
"136","34267612","10.17179/excli2021-3810","Is there a bidirectional interaction between periodontitis and the severity of SARS-CoV-2 infection?",NA,"2021","07","17","EXCLI J","EXCLI journal",NA,"de Moura","Tatiana Rodrigues","Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil",NA
"137","34267612","10.17179/excli2021-3810","Is there a bidirectional interaction between periodontitis and the severity of SARS-CoV-2 infection?",NA,"2021","07","17","EXCLI J","EXCLI journal",NA,"de Paiva","Saul Martins","Graduate Program in Dentistry, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil",NA
"138","34267612","10.17179/excli2021-3810","Is there a bidirectional interaction between periodontitis and the severity of SARS-CoV-2 infection?",NA,"2021","07","17","EXCLI J","EXCLI journal",NA,"Gurgel","Ricardo Queiroz","Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil",NA
"139","34267612","10.17179/excli2021-3810","Is there a bidirectional interaction between periodontitis and the severity of SARS-CoV-2 infection?",NA,"2021","07","17","EXCLI J","EXCLI journal",NA,"Martins-Filho","Paulo Ricardo","Graduate Program in Dentistry, Federal University of Sergipe, Aracaju, Sergipe, Brazil",NA
"140","34267581","10.52082/jssm.2021.421","What Predicts the Mood of Athletes Involved in Preparations for Tokyo 2020/2021 Olympic Games During the Covid - 19 Pandemic? The Role of Sense of Coherence, Hope for Success and Coping Strategies.","The aim of the study was to identify coherence, hope for success and coping strategies as predictors of mood among this year's Olympians in the context of coronavirus events. The relationships between the above variables and the mood of athletes were analysed. The study group consisted of 57 athletes - women (29) and men (28) between 18 and 39 years of age - representing various sports disciplines who were preparing for the Tokyo Olympics. The research was conducted in the period of April 7-28, ","2021","07","19","J Sports Sci Med","Journal of sports science &amp; medicine","COVID-19; Salutogenesis; affective states; athletes; sense of coherence","Szczypinska","Marta","Jozef Pilsudski University of Physical Education, Warsaw, Poland",NA
"141","34267581","10.52082/jssm.2021.421","What Predicts the Mood of Athletes Involved in Preparations for Tokyo 2020/2021 Olympic Games During the Covid - 19 Pandemic? The Role of Sense of Coherence, Hope for Success and Coping Strategies.","The aim of the study was to identify coherence, hope for success and coping strategies as predictors of mood among this year's Olympians in the context of coronavirus events. The relationships between the above variables and the mood of athletes were analysed. The study group consisted of 57 athletes - women (29) and men (28) between 18 and 39 years of age - representing various sports disciplines who were preparing for the Tokyo Olympics. The research was conducted in the period of April 7-28, ","2021","07","19","J Sports Sci Med","Journal of sports science &amp; medicine","COVID-19; Salutogenesis; affective states; athletes; sense of coherence","Samelko","Aleksandra","Jozef Pilsudski University of Physical Education, Warsaw, Poland",NA
"142","34267581","10.52082/jssm.2021.421","What Predicts the Mood of Athletes Involved in Preparations for Tokyo 2020/2021 Olympic Games During the Covid - 19 Pandemic? The Role of Sense of Coherence, Hope for Success and Coping Strategies.","The aim of the study was to identify coherence, hope for success and coping strategies as predictors of mood among this year's Olympians in the context of coronavirus events. The relationships between the above variables and the mood of athletes were analysed. The study group consisted of 57 athletes - women (29) and men (28) between 18 and 39 years of age - representing various sports disciplines who were preparing for the Tokyo Olympics. The research was conducted in the period of April 7-28, ","2021","07","19","J Sports Sci Med","Journal of sports science &amp; medicine","COVID-19; Salutogenesis; affective states; athletes; sense of coherence","Guszkowska","Monika","Jozef Pilsudski University of Physical Education, Warsaw, Poland",NA
"143","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Cegan","Jeffrey C","US Army Engineer Research and Development Center, US Army Corps of Engineers, Vicksburg, MS, USA",NA
"144","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Trump","Benjamin D","US Army Engineer Research and Development Center, US Army Corps of Engineers, Vicksburg, MS, USA",NA
"145","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Cibulsky","Susan M","US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Boston, MA, USA",NA
"146","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Collier","Zachary A","Radford University, Davis College of Business and Economics, Department of Management, Radford, VA, USA",NA
"147","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Cummings","Christopher L","North Carolina State University, Genetic Engineering and Society Center, Raleigh, NC, USA",NA
"148","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Greer","Scott L","University of Michigan, School of Public Health, Department of Health Management and Policy, Ann Arbor, MI, USA",NA
"149","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Jarman","Holly","University of Michigan, School of Public Health, Department of Health Management and Policy, Ann Arbor, MI, USA",NA
"150","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Klasa","Kasia","US Army Engineer Research and Development Center, US Army Corps of Engineers, Vicksburg, MS, USA",NA
"151","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Kleinman","Gary","US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Boston, MA, USA",NA
"152","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Surette","Melissa A","Federal Emergency Management Agency, Region I, Boston, MA, USA",NA
"153","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Wells","Emily","US Army Engineer Research and Development Center, US Army Corps of Engineers, Vicksburg, MS, USA",NA
"154","34267565","10.2147/RMHP.S313312","Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?","Many efforts to predict the impact of COVID-19 on hospitalization, intensive care unit (ICU) utilization, and mortality rely on age and comorbidities. These predictions are foundational to learning, policymaking, and planning for the pandemic, and therefore understanding the relationship between age, comorbidities, and health outcomes is critical to assessing and managing public health risks. From a US government database of 1.4 million patient records collected in May 2020, we extracted the rel","2021","07","17","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; comorbidity; health outcomes; mortality rates","Linkov","Igor","US Army Engineer Research and Development Center, US Army Corps of Engineers, Vicksburg, MS, USA",NA
"155","34267564","10.2147/PRBM.S317961","Psychological Distress Among Ethiopian Pregnant Women During COVID-19: Negative Correlation with Self-Efficacy.","Since the onset of coronavirus disease 2019, the mental health of individuals has been negatively affected, especially among vulnerable groups. The aim of this study was to explore the association of psychological distress with self-efficacy and other correlates among Ethiopian pregnant women. A cross-sectional study was carried out among 384 pregnant women from August 1 to 15, 2020. Pandemic-related psychological distress was measured by the Impact of Event Scale Revised (IES-R). Hospital anxie","2021","07","17","Psychol Res Behav Manag","Psychology research and behavior management","COVID-19 fear; Ethiopia; anxiety; depression; mental well-beings","Dule","Aman","Department of Psychiatry, College of Health Sciences, Mettu University, Mettu, Ethiopia",NA
"156","34267561","10.2147/OAEM.S321218","The Effect of the COVID-19 on Corrosive Ingestion in Thailand.","Since January 2020, the outbreak of COVID-19 coronavirus has impacted global mental health, daily activities, and economies, including Thailand. The essential strategy is the disease-preventing measure of ""lockdown."" Corrosive ingestion is one of the most common forms of self-harm and problems worldwide. This study aimed to evaluate the effect of corrosive ingestion in the COVID-19 situation. This was a retrospective study of adult patients (=18y) who had ingested corrosives and been admitted to","2021","07","17","Open Access Emerg Med","Open access emergency medicine : OAEM","COVID-19; caustic injury; corrosive ingestion; esophagus; stomach","Thongchuam","Chatbadin","Department of Surgery, Faculty of Medicine, Thammasat University, Amphur Klongluang, Pathumthani, 12120, Thailand",NA
"157","34267561","10.2147/OAEM.S321218","The Effect of the COVID-19 on Corrosive Ingestion in Thailand.","Since January 2020, the outbreak of COVID-19 coronavirus has impacted global mental health, daily activities, and economies, including Thailand. The essential strategy is the disease-preventing measure of ""lockdown."" Corrosive ingestion is one of the most common forms of self-harm and problems worldwide. This study aimed to evaluate the effect of corrosive ingestion in the COVID-19 situation. This was a retrospective study of adult patients (=18y) who had ingested corrosives and been admitted to","2021","07","17","Open Access Emerg Med","Open access emergency medicine : OAEM","COVID-19; caustic injury; corrosive ingestion; esophagus; stomach","Mahawongkajit","Prasit","Department of Surgery, Faculty of Medicine, Thammasat University, Amphur Klongluang, Pathumthani, 12120, Thailand",NA
"158","34267561","10.2147/OAEM.S321218","The Effect of the COVID-19 on Corrosive Ingestion in Thailand.","Since January 2020, the outbreak of COVID-19 coronavirus has impacted global mental health, daily activities, and economies, including Thailand. The essential strategy is the disease-preventing measure of ""lockdown."" Corrosive ingestion is one of the most common forms of self-harm and problems worldwide. This study aimed to evaluate the effect of corrosive ingestion in the COVID-19 situation. This was a retrospective study of adult patients (=18y) who had ingested corrosives and been admitted to","2021","07","17","Open Access Emerg Med","Open access emergency medicine : OAEM","COVID-19; caustic injury; corrosive ingestion; esophagus; stomach","Kanlerd","Amonpon","Department of Surgery, Faculty of Medicine, Thammasat University, Amphur Klongluang, Pathumthani, 12120, Thailand",NA
"159","34267560","10.2147/OAEM.S316730","Perception of an Introductory Point-of-Care Ultrasound Course for Thai Medical Students on Emergency Medicine Rotation.","Point-of-care ultrasonography (POCUS) is increasingly utilized in emergency departments (EDs) throughout Thailand. Although emergency medicine (EM) residents are trained in POCUS, Thai medical students receive limited training. An introductory POCUS course was implemented for medical students to prepare them for internships. This study described the perception and use of POCUS by graduates of an introductory POCUS course. Medical students who completed the POCUS course were surveyed during their","2021","07","17","Open Access Emerg Med","Open access emergency medicine : OAEM","eFAST; intern; medical education; point-of-care ultrasound","Vanichkulbodee","Alissara","Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand",NA
"160","34267560","10.2147/OAEM.S316730","Perception of an Introductory Point-of-Care Ultrasound Course for Thai Medical Students on Emergency Medicine Rotation.","Point-of-care ultrasonography (POCUS) is increasingly utilized in emergency departments (EDs) throughout Thailand. Although emergency medicine (EM) residents are trained in POCUS, Thai medical students receive limited training. An introductory POCUS course was implemented for medical students to prepare them for internships. This study described the perception and use of POCUS by graduates of an introductory POCUS course. Medical students who completed the POCUS course were surveyed during their","2021","07","17","Open Access Emerg Med","Open access emergency medicine : OAEM","eFAST; intern; medical education; point-of-care ultrasound","Inboriboon","Pholaphat Charles","Department of Emergency Medicine, University of Illinois at Chicago College of Medicine, Chicago, IL, USA",NA
"161","34267560","10.2147/OAEM.S316730","Perception of an Introductory Point-of-Care Ultrasound Course for Thai Medical Students on Emergency Medicine Rotation.","Point-of-care ultrasonography (POCUS) is increasingly utilized in emergency departments (EDs) throughout Thailand. Although emergency medicine (EM) residents are trained in POCUS, Thai medical students receive limited training. An introductory POCUS course was implemented for medical students to prepare them for internships. This study described the perception and use of POCUS by graduates of an introductory POCUS course. Medical students who completed the POCUS course were surveyed during their","2021","07","17","Open Access Emerg Med","Open access emergency medicine : OAEM","eFAST; intern; medical education; point-of-care ultrasound","Balk","Andrew H","Department of Emergency Medicine, Truman Medical Center, University of Missouri-Kansas City (UMKC) School of Medicine, Kansas City, MO, USA",NA
"162","34267560","10.2147/OAEM.S316730","Perception of an Introductory Point-of-Care Ultrasound Course for Thai Medical Students on Emergency Medicine Rotation.","Point-of-care ultrasonography (POCUS) is increasingly utilized in emergency departments (EDs) throughout Thailand. Although emergency medicine (EM) residents are trained in POCUS, Thai medical students receive limited training. An introductory POCUS course was implemented for medical students to prepare them for internships. This study described the perception and use of POCUS by graduates of an introductory POCUS course. Medical students who completed the POCUS course were surveyed during their","2021","07","17","Open Access Emerg Med","Open access emergency medicine : OAEM","eFAST; intern; medical education; point-of-care ultrasound","Sri-On","Jiraporn","Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand",NA
"163","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Salem","Ayad Mohammed","Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"164","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Al Khathlan","Noor","Department of respiratory care, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"165","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Alharbi","Abdulelah Fawzi","College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"166","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Alghamdi","Turki","College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"167","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","AlDuilej","Saleh","College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"168","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Alghamdi","Mohammed","College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"169","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Alfudhaili","Majed","College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"170","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Alsunni","Ahmed","Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"171","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Yar","Talay","Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"172","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Latif","Rabia","Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"173","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Rafique","Nazish","Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"174","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Al Asoom","Lubna","Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"175","34267545","10.2147/IJGM.S319436","The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.","The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Fifty subjects (age 18-60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway re","2021","07","17","Int J Gen Med","International journal of general medicine","COVID-19; DLCO; FeNO; PFT; pneumonia","Sabit","Hussein","Department of Genetics, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"176","34267528","10.2147/IDR.S320658","Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan.","There is a concern that the spread of mutant strains of SARS-CoV-2 will increase the number of severe COVID-19 patients and weaken vaccine effectiveness in the world. The mutants of the spike region of SARS-CoV-2, such as N501Y, E484K, P681H, and deletion H69/V70 (del 69/70), were studied in 25 COVID-19 patients admitted from December 2020 to April 2021; there were no patients with N501Y and P681H, but nine patients had E484K alone. Their symptoms, laboratory data, and course of their disease we","2021","07","17","Infect Drug Resist","Infection and drug resistance","COVID-19; E484K; N501Y; P681H; PCR; remdesivir; vaccine","Takano","Kazuki","Division of Infectious Diseases and Infection Control",NA
"177","34267528","10.2147/IDR.S320658","Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan.","There is a concern that the spread of mutant strains of SARS-CoV-2 will increase the number of severe COVID-19 patients and weaken vaccine effectiveness in the world. The mutants of the spike region of SARS-CoV-2, such as N501Y, E484K, P681H, and deletion H69/V70 (del 69/70), were studied in 25 COVID-19 patients admitted from December 2020 to April 2021; there were no patients with N501Y and P681H, but nine patients had E484K alone. Their symptoms, laboratory data, and course of their disease we","2021","07","17","Infect Drug Resist","Infection and drug resistance","COVID-19; E484K; N501Y; P681H; PCR; remdesivir; vaccine","Watanabe","Yuji","Division of Infectious Diseases and Infection Control",NA
"178","34267528","10.2147/IDR.S320658","Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan.","There is a concern that the spread of mutant strains of SARS-CoV-2 will increase the number of severe COVID-19 patients and weaken vaccine effectiveness in the world. The mutants of the spike region of SARS-CoV-2, such as N501Y, E484K, P681H, and deletion H69/V70 (del 69/70), were studied in 25 COVID-19 patients admitted from December 2020 to April 2021; there were no patients with N501Y and P681H, but nine patients had E484K alone. Their symptoms, laboratory data, and course of their disease we","2021","07","17","Infect Drug Resist","Infection and drug resistance","COVID-19; E484K; N501Y; P681H; PCR; remdesivir; vaccine","Hariu","Maya","Division of Infectious Diseases and Infection Control",NA
"179","34267528","10.2147/IDR.S320658","Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan.","There is a concern that the spread of mutant strains of SARS-CoV-2 will increase the number of severe COVID-19 patients and weaken vaccine effectiveness in the world. The mutants of the spike region of SARS-CoV-2, such as N501Y, E484K, P681H, and deletion H69/V70 (del 69/70), were studied in 25 COVID-19 patients admitted from December 2020 to April 2021; there were no patients with N501Y and P681H, but nine patients had E484K alone. Their symptoms, laboratory data, and course of their disease we","2021","07","17","Infect Drug Resist","Infection and drug resistance","COVID-19; E484K; N501Y; P681H; PCR; remdesivir; vaccine","Seki","Masafumi","Division of Infectious Diseases and Infection Control",NA
"180","34267525","10.2147/JMDH.S308397","Identifying Patterns of Turnover Intention Among Alabama Frontline Nurses in Hospital Settings During the COVID-19 Pandemic.","Current research about frontline nurse stress and turnover intention lacks context related to rural communities' plight in providing organizational resources during the current COVID-19 pandemic. These implications have been particularly underexamined in the United States, whose regional differences may influence how frontline nurses perceive the access and utility of organizational resources. This study investigates if anxiety and stress while working during the current COVID-19 pandemic contri","2021","07","17","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; fear; job demand; nurse stress; organizational resources; pandemic; turnover intention","Cole","Astin","Public Administration, Auburn University, Auburn, AL, USA",NA
"181","34267525","10.2147/JMDH.S308397","Identifying Patterns of Turnover Intention Among Alabama Frontline Nurses in Hospital Settings During the COVID-19 Pandemic.","Current research about frontline nurse stress and turnover intention lacks context related to rural communities' plight in providing organizational resources during the current COVID-19 pandemic. These implications have been particularly underexamined in the United States, whose regional differences may influence how frontline nurses perceive the access and utility of organizational resources. This study investigates if anxiety and stress while working during the current COVID-19 pandemic contri","2021","07","17","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; fear; job demand; nurse stress; organizational resources; pandemic; turnover intention","Ali","Haneen","Health Services Administration Program, Auburn University, Auburn, AL, USA",NA
"182","34267525","10.2147/JMDH.S308397","Identifying Patterns of Turnover Intention Among Alabama Frontline Nurses in Hospital Settings During the COVID-19 Pandemic.","Current research about frontline nurse stress and turnover intention lacks context related to rural communities' plight in providing organizational resources during the current COVID-19 pandemic. These implications have been particularly underexamined in the United States, whose regional differences may influence how frontline nurses perceive the access and utility of organizational resources. This study investigates if anxiety and stress while working during the current COVID-19 pandemic contri","2021","07","17","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; fear; job demand; nurse stress; organizational resources; pandemic; turnover intention","Ahmed","Abdulaziz","Health Services Administration Program, University of Alabama at Birmingham, Birmingham, AL, USA",NA
"183","34267525","10.2147/JMDH.S308397","Identifying Patterns of Turnover Intention Among Alabama Frontline Nurses in Hospital Settings During the COVID-19 Pandemic.","Current research about frontline nurse stress and turnover intention lacks context related to rural communities' plight in providing organizational resources during the current COVID-19 pandemic. These implications have been particularly underexamined in the United States, whose regional differences may influence how frontline nurses perceive the access and utility of organizational resources. This study investigates if anxiety and stress while working during the current COVID-19 pandemic contri","2021","07","17","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; fear; job demand; nurse stress; organizational resources; pandemic; turnover intention","Hamasha","Mohammad","Department of Industrial and Systems Engineering, Hashemite University, Zarqa, Jordan",NA
"184","34267525","10.2147/JMDH.S308397","Identifying Patterns of Turnover Intention Among Alabama Frontline Nurses in Hospital Settings During the COVID-19 Pandemic.","Current research about frontline nurse stress and turnover intention lacks context related to rural communities' plight in providing organizational resources during the current COVID-19 pandemic. These implications have been particularly underexamined in the United States, whose regional differences may influence how frontline nurses perceive the access and utility of organizational resources. This study investigates if anxiety and stress while working during the current COVID-19 pandemic contri","2021","07","17","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; fear; job demand; nurse stress; organizational resources; pandemic; turnover intention","Jordan","Soren","Department of Political Science, Auburn University, Auburn, AL, USA",NA
"185","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Sil","Bijon Kumar","Gonoshasthaya-RNA Molecular Diagnostic and Research Center, Dhaka, 1205, Bangladesh",NA
"186","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Jamiruddin","Mohd Raeed","Department of Pharmacy, BRAC University, Dhaka, 1212, Bangladesh",NA
"187","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Haq","Md Ahsanul","Gonoshasthaya-RNA Molecular Diagnostic and Research Center, Dhaka, 1205, Bangladesh",NA
"188","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Khondoker","Mohib Ullah","Gonoshasthaya Samaj Vittik Medical College, Savar, Dhaka, 1344, Bangladesh",NA
"189","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Jahan","Nowshin","Gonoshasthaya-RNA Molecular Diagnostic and Research Center, Dhaka, 1205, Bangladesh",NA
"190","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Khandker","Shahad Saif","Gonoshasthaya-RNA Molecular Diagnostic and Research Center, Dhaka, 1205, Bangladesh",NA
"191","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Ali","Tamanna","Gonoshasthaya-RNA Molecular Diagnostic and Research Center, Dhaka, 1205, Bangladesh",NA
"192","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Oishee","Mumtarin Jannat","Gonoshasthaya-RNA Molecular Diagnostic and Research Center, Dhaka, 1205, Bangladesh",NA
"193","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Kaitsuka","Taku","School of Pharmacy, International University of Health and Welfare, Okawa, Fukuoka, 831-8501, Japan",NA
"194","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Mie","Masayasu","School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa, 226-8502, Japan",NA
"195","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Tomizawa","Kazuhito","Department of Molecular Physiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, 860-0811, Japan",NA
"196","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Kobatake","Eiry","School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa, 226-8502, Japan",NA
"197","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Haque","Mainul","The Unit of Pharmacology, Faculty of Medicine and Defence Health Universiti Pertahanan, Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, 57000, Malaysia",NA
"198","34267520","10.2147/IJN.S313140","AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.","Serological tests detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are widely used in seroprevalence studies and evaluating the efficacy of the vaccination program. Some of the widely used serological testing techniques are enzyme-linked immune-sorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow immunoassay (LFIA). However, these tests are plagued with low sensitivity or specificity, time-consuming, labor-intensive, and expensive. We developed a se","2021","07","21","Int J Nanomedicine","International journal of nanomedicine","AuNP; COVID-19; SARS-CoV-2; dot-blot immunoassay; gold nanoparticle; nucleocapsid; receptor binding domain; serosurveillance; Adult; Antibodies, Viral; Gold; Humans; Immunoblotting; Immunoglobulin G; Male; Metal Nanoparticles; Nucleocapsid; Predictive Value of Tests; SARS-CoV-2; Sensitivity and Specificity; Seroepidemiologic Studies","Adnan","Nihad","Department of Microbiology, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh",NA
"199","34267452","10.4103/ijn.IJN_276_20","COVID-19 Pandemic: A Perspective from Nephrology Resident.",NA,"2021","07","17","Indian J Nephrol","Indian journal of nephrology",NA,"Meena","Priti","Institute of Renal Science, Sir Gangaram Hospital, New Delhi, India",NA
"200","34267452","10.4103/ijn.IJN_276_20","COVID-19 Pandemic: A Perspective from Nephrology Resident.",NA,"2021","07","17","Indian J Nephrol","Indian journal of nephrology",NA,"Singh","Abhishek","Institute of Renal Science, Sir Gangaram Hospital, New Delhi, India",NA
"201","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Kute","Vivek B","Department of Nephrology, Institute of Kidney Diseases and Research Center and Dr. H L Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujarat, India",NA
"202","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Agarwal","Sanjay K","Department of Nephrology, All India Institute of Medical Sciences, Delhi, India",NA
"203","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Prakash","Jai","Department of Nephrology, Banaras Hindu University, Varanasi, Uttar Pradesh, India",NA
"204","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Guleria","Sandeep","Department of Transplantation Surgery, Apollo Hospital, Delhi, India",NA
"205","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Shroff","Sunil","Managing, Trustee, MOHAN Foundation, Chennai, Tamil Nadu, India",NA
"206","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Sharma","Ashish","Department of Transplant Surgery, The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India",NA
"207","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Varma","Prem","Department of Nephrology, Venkateshwar Hospital, Delhi, India",NA
"208","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Prasad","Narayan","Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India",NA
"209","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Sahay","Manisha","Department of Nephrology, Osmania Medical College, Hyderabad, Telangana, India",NA
"210","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Gupta","Subhash","Department of Liver Transplant Surgery, Max Center of Liver and Biliary Sciences at Max Hospital, Saket, Delhi, India",NA
"211","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Sudhindran","S","Clinical Professor in Transplantation and Gastrointestinal Surgery, Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala, India",NA
"212","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Krishan","Kewal","Department of Cardiovascular Surgery Max super specialty Hospital Saket, New Delhi, India",NA
"213","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Ramesh","Vasanthi","National Organ and Tissue Transplant Organization, New Delhi, India",NA
"214","34267426","10.4103/ijn.IJN_64_21","NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.","In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmiss","2021","07","17","Indian J Nephrol","Indian journal of nephrology","COVID-19 vaccine; NOTTO; guidelines; transplant recipients","Kumar","Sunil","Director General of Health Services, New Delhi, India",NA
"215","34267388","10.1038/d41586-021-01894-z","The US is boosting funding for research monkeys in the wake of COVID.",NA,"2021","07","16","Nature","Nature","Funding; Medical research; Policy; SARS-CoV-2","Subbaraman","Nidhi",NA,NA
"216","34267382","10.1038/d41591-021-00045-1","Another COVID-19 vaccine to boost rollout.",NA,"2021","07","16","Nat Med","Nature medicine","Infectious diseases; SARS-CoV-2; Vaccines","O'Leary","Karen",NA,NA
"217","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Sun","Shiyu","Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"218","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Cai","Yueqi","Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"219","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Song","Tian-Zhang","Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China",NA
"220","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Pu","Yang","Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China",NA
"221","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Cheng","Lin","Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China",NA
"222","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Xu","Hairong","Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"223","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Sun","Jing","State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",NA
"224","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Meng","Chaoyang","Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"225","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Lin","Yifan","Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"226","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Huang","Haibin","LivzonBio, Inc., Zhuhai, Guangdong, China",NA
"227","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Zhao","Fang","LivzonBio, Inc., Zhuhai, Guangdong, China",NA
"228","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Zhang","Silin","School of Pharmaceutical Sciences, Tsinghua University, Beijing, China",NA
"229","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Gao","Yu","University of Chinese Academy of Sciences, Beijing, China",NA
"230","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Han","Jian-Bao","Kunming National High-level Biosafety Research Center for Non-human Primates, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China",NA
"231","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Feng","Xiao-Li","Kunming National High-level Biosafety Research Center for Non-human Primates, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China",NA
"232","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Yu","Dan-Dan","Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China",NA
"233","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Zhu","Yalan","Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"234","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Gao","Pu","Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"235","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Tang","Haidong","School of Pharmaceutical Sciences, Tsinghua University, Beijing, China",NA
"236","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Zhao","Jincun","State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",NA
"237","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Zhang","Zheng","Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China",NA
"238","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Yang","Jiaming","LivzonBio, Inc., Zhuhai, Guangdong, China",NA
"239","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Hu","Zhenxiang","LivzonBio, Inc., Zhuhai, Guangdong, China",NA
"240","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Fu","Yang-Xin","Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Yang-Xin.Fu@UTSouthwestern","Xin.Fu@UTSouthwestern.edu"
"241","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Zheng","Yong-Tang","Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China. zhengyt@mail.kiz.ac","zhengyt@mail.kiz.ac.cn"
"242","34267349","10.1038/s41422-021-00531-8","Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used alone for vaccination. To enhance antigen processing and cross-presentation in draining lymph nodes (DLNs), we developed an interferon (IFN)-armed RBD dimerized by an i","2021","07","20","Cell Res","Cell research",NA,"Peng","Hua","Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. hpeng@moon.ibp.cas","hpeng@moon.ibp.cas.cn"
"243","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Wang","Wei","Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China",NA
"244","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Li","Sha-Sha","Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China",NA
"245","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Xu","Xin-Feng","Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China",NA
"246","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Yang","Chan","Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China",NA
"247","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Niu","Xiao-Ge","Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China",NA
"248","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Yin","Shu-Xian","Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China",NA
"249","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Pan","Xiao-Yan","State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China",NA
"250","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Xu","Wei","Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China",NA
"251","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Hu","Guo-Dong","Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China",NA
"252","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Wang","Chan","Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China. wangchan0308@163","wangchan0308@163.com"
"253","34267343","10.1038/s41401-021-00714-4","Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce acute inflammatory response like acute lung inflammation (ALI) or acute respiratory distress syndrome, leading to severe progression and mortality. Therapeutics for treatment of SARS-CoV-2-triggered respiratory inflammation are urgent to be discovered. Our previous study shows that Salvianolic acid C potently inhibits SARS-CoV-2 infection. In this study, we investigated the antiviral effects of a Salvia miltiorrhiza compound","2021","07","20","Acta Pharmacol Sin","Acta pharmacologica Sinica","Danshensu; SARS-CoV-2; acute lung inflammation; inflammatory cytokines; spike protein","Liu","Shu-Wen","Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China. liusw@smu.edu","liusw@smu.edu.cn"
"254","34267334","10.1038/s41423-021-00730-8","SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.",NA,"2021","07","20","Cell Mol Immunol","Cellular &amp; molecular immunology",NA,"Deng","Yao","NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China",NA
"255","34267334","10.1038/s41423-021-00730-8","SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.",NA,"2021","07","20","Cell Mol Immunol","Cellular &amp; molecular immunology",NA,"Li","Yu","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"256","34267334","10.1038/s41423-021-00730-8","SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.",NA,"2021","07","20","Cell Mol Immunol","Cellular &amp; molecular immunology",NA,"Yang","Ren","NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China",NA
"257","34267334","10.1038/s41423-021-00730-8","SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.",NA,"2021","07","20","Cell Mol Immunol","Cellular &amp; molecular immunology",NA,"Tan","Wenjie","NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. tanwj@ivdc.chinacdc","tanwj@ivdc.chinacdc.cn"
"258","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Recalde","Martina","Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain",NA
"259","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Roel","Elena","Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain",NA
"260","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Pistillo","Andrea","Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain",NA
"261","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Sena","Anthony G","Janssen Research &amp",NA
"262","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Prats-Uribe","Albert","Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK",NA
"263","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Ahmed","Waheed-Ul-Rahman","Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, UK",NA
"264","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Alghoul","Heba","Faculty of Medicine, Islamic University of Gaza, Gaza, Palestine",NA
"265","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Alshammari","Thamir M","College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia",NA
"266","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Alser","Osaid","Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA",NA
"267","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Areia","Carlos","Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK",NA
"268","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Burn","Edward","Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain",NA
"269","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Casajust","Paula","Real-World Evidence, Trial Form Support, Barcelona, Spain",NA
"270","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Dawoud","Dalia","Cairo University, Faculty of Pharmacy, Cairo, Egypt",NA
"271","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"DuVall","Scott L","VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA",NA
"272","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Falconer","Thomas","Department of Biomedical Informatics, Columbia University, New York, NY, USA",NA
"273","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Fernández-Bertolín","Sergio","Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain",NA
"274","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Golozar","Asieh","Department of Epidemiology, Johns Hopkins School of Public, Baltimore, MD, USA",NA
"275","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Gong","Mengchun","DHC Technologies co, Ltd, Beijing, China",NA
"276","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Lai","Lana Yin Hui","Division of Cancer Sciences, School of Medical Sciences, University of Manchester, Manchester, UK",NA
"277","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Lane","Jennifer C E","Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, UK",NA
"278","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Lynch","Kristine E","VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA",NA
"279","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Matheny","Michael E","Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA",NA
"280","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Mehta","Paras P","College of Medicine, The University of Arizona, Tucson, AZ, USA",NA
"281","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Morales","Daniel R","Division of Population Health and Genomics, University of Dundee, Dundee, UK",NA
"282","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Natarjan","Karthik","Department of Biomedical Informatics, Columbia University, New York, NY, USA",NA
"283","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Nyberg","Fredrik","School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden",NA
"284","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Posada","Jose D","Department of Medicine, Stanford University, Palo Alto, CA, USA",NA
"285","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Reich","Christian G","Real World Solutions, IQVIA, Cambridge, MA, USA",NA
"286","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Rijnbeek","Peter R","Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands",NA
"287","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Schilling","Lisa M","Data Science to Patient Value Program, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA",NA
"288","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Shah","Karishma","Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, UK",NA
"289","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Shah","Nigam H","Department of Medicine, Stanford University, Palo Alto, CA, USA",NA
"290","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Subbian","Vignesh","College of Engineering, The University of Arizona, Tucson, AZ, USA",NA
"291","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Zhang","Lin","School of Population Medicine and Public Health, Chinese Academy of Medical Sciences &amp",NA
"292","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Zhu","Hong","Institute of Health Management, Southern Medical University, Guangzhou, China",NA
"293","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Ryan","Patrick","Janssen Research &amp",NA
"294","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Prieto-Alhambra","Daniel","Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands",NA
"295","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Kostka","Kristin","Real World Solutions, IQVIA, Cambridge, MA, USA",NA
"296","34267326","10.1038/s41366-021-00893-4","Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.","A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two no","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Duarte-Salles","Talita","Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. tduarte@idiapjgol","tduarte@idiapjgol.org"
"297","34267325","10.1038/s41366-021-00912-4","Changes in weight and height among Chinese preschool children during COVID-19 school closures.","COVID-19-related school closures may increase the prevalence of childhood obesity, which has aroused public concerns. We aimed to analyze the weight and height changes in Chinese preschool children during the COVID-19-related school closures period. A total of 124,603 children from multi-city kindergartens in China were included in this study. We evaluated the prevalence of overweight and obese in preschool children experienced school closures, and compared the changes in BMI, weight, and height","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Wen","Juan","Nanjing Maternity and Child Health Care Institute, Women's Hospital of Nanjing Medical University (Nanjing Maternity and Child Health Care Hospital), Nanjing, China",NA
"298","34267325","10.1038/s41366-021-00912-4","Changes in weight and height among Chinese preschool children during COVID-19 school closures.","COVID-19-related school closures may increase the prevalence of childhood obesity, which has aroused public concerns. We aimed to analyze the weight and height changes in Chinese preschool children during the COVID-19-related school closures period. A total of 124,603 children from multi-city kindergartens in China were included in this study. We evaluated the prevalence of overweight and obese in preschool children experienced school closures, and compared the changes in BMI, weight, and height","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Zhu","Lijun","Nanjing Maternity and Child Health Care Institute, Women's Hospital of Nanjing Medical University (Nanjing Maternity and Child Health Care Hospital), Nanjing, China",NA
"299","34267325","10.1038/s41366-021-00912-4","Changes in weight and height among Chinese preschool children during COVID-19 school closures.","COVID-19-related school closures may increase the prevalence of childhood obesity, which has aroused public concerns. We aimed to analyze the weight and height changes in Chinese preschool children during the COVID-19-related school closures period. A total of 124,603 children from multi-city kindergartens in China were included in this study. We evaluated the prevalence of overweight and obese in preschool children experienced school closures, and compared the changes in BMI, weight, and height","2021","07","20","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Ji","Chenbo","Nanjing Maternity and Child Health Care Institute, Women's Hospital of Nanjing Medical University (Nanjing Maternity and Child Health Care Hospital), Nanjing, China. chenboji@njmu.edu","chenboji@njmu.edu.cn"
"300","34267318","10.1038/s42003-021-02410-9","Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.","COVID-19 pandemic has given rise to a collective scientific effort to study its viral causing agent SARS-CoV-2. Research is focusing in particular on its infection mechanisms and on the associated-disease symptoms. Interestingly, this environmental pathogen directly affects the human chemosensory systems leading to anosmia and ageusia. Evidence for the presence of the cellular entry sites of the virus, the ACE2/TMPRSS2 proteins, has been reported in non-chemosensory cells in the rodent's nose an","2021","07","21","Commun Biol","Communications biology","Age Factors; Ageusia; Animals; Anosmia; COVID-19; Female; Male; Mice; Olfactory Perception; SARS-CoV-2; Taste Perception","Brechbühl","Julien","Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland",NA
"301","34267318","10.1038/s42003-021-02410-9","Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.","COVID-19 pandemic has given rise to a collective scientific effort to study its viral causing agent SARS-CoV-2. Research is focusing in particular on its infection mechanisms and on the associated-disease symptoms. Interestingly, this environmental pathogen directly affects the human chemosensory systems leading to anosmia and ageusia. Evidence for the presence of the cellular entry sites of the virus, the ACE2/TMPRSS2 proteins, has been reported in non-chemosensory cells in the rodent's nose an","2021","07","21","Commun Biol","Communications biology","Age Factors; Ageusia; Animals; Anosmia; COVID-19; Female; Male; Mice; Olfactory Perception; SARS-CoV-2; Taste Perception","Lopes","Ana Catarina","Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland",NA
"302","34267318","10.1038/s42003-021-02410-9","Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.","COVID-19 pandemic has given rise to a collective scientific effort to study its viral causing agent SARS-CoV-2. Research is focusing in particular on its infection mechanisms and on the associated-disease symptoms. Interestingly, this environmental pathogen directly affects the human chemosensory systems leading to anosmia and ageusia. Evidence for the presence of the cellular entry sites of the virus, the ACE2/TMPRSS2 proteins, has been reported in non-chemosensory cells in the rodent's nose an","2021","07","21","Commun Biol","Communications biology","Age Factors; Ageusia; Animals; Anosmia; COVID-19; Female; Male; Mice; Olfactory Perception; SARS-CoV-2; Taste Perception","Wood","Dean","Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland",NA
"303","34267318","10.1038/s42003-021-02410-9","Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.","COVID-19 pandemic has given rise to a collective scientific effort to study its viral causing agent SARS-CoV-2. Research is focusing in particular on its infection mechanisms and on the associated-disease symptoms. Interestingly, this environmental pathogen directly affects the human chemosensory systems leading to anosmia and ageusia. Evidence for the presence of the cellular entry sites of the virus, the ACE2/TMPRSS2 proteins, has been reported in non-chemosensory cells in the rodent's nose an","2021","07","21","Commun Biol","Communications biology","Age Factors; Ageusia; Animals; Anosmia; COVID-19; Female; Male; Mice; Olfactory Perception; SARS-CoV-2; Taste Perception","Bouteiller","Sofiane","Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland",NA
"304","34267318","10.1038/s42003-021-02410-9","Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.","COVID-19 pandemic has given rise to a collective scientific effort to study its viral causing agent SARS-CoV-2. Research is focusing in particular on its infection mechanisms and on the associated-disease symptoms. Interestingly, this environmental pathogen directly affects the human chemosensory systems leading to anosmia and ageusia. Evidence for the presence of the cellular entry sites of the virus, the ACE2/TMPRSS2 proteins, has been reported in non-chemosensory cells in the rodent's nose an","2021","07","21","Commun Biol","Communications biology","Age Factors; Ageusia; Animals; Anosmia; COVID-19; Female; Male; Mice; Olfactory Perception; SARS-CoV-2; Taste Perception","de Vallière","Aurélie","Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland",NA
"305","34267318","10.1038/s42003-021-02410-9","Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.","COVID-19 pandemic has given rise to a collective scientific effort to study its viral causing agent SARS-CoV-2. Research is focusing in particular on its infection mechanisms and on the associated-disease symptoms. Interestingly, this environmental pathogen directly affects the human chemosensory systems leading to anosmia and ageusia. Evidence for the presence of the cellular entry sites of the virus, the ACE2/TMPRSS2 proteins, has been reported in non-chemosensory cells in the rodent's nose an","2021","07","21","Commun Biol","Communications biology","Age Factors; Ageusia; Animals; Anosmia; COVID-19; Female; Male; Mice; Olfactory Perception; SARS-CoV-2; Taste Perception","Verdumo","Chantal","Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland",NA
"306","34267318","10.1038/s42003-021-02410-9","Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.","COVID-19 pandemic has given rise to a collective scientific effort to study its viral causing agent SARS-CoV-2. Research is focusing in particular on its infection mechanisms and on the associated-disease symptoms. Interestingly, this environmental pathogen directly affects the human chemosensory systems leading to anosmia and ageusia. Evidence for the presence of the cellular entry sites of the virus, the ACE2/TMPRSS2 proteins, has been reported in non-chemosensory cells in the rodent's nose an","2021","07","21","Commun Biol","Communications biology","Age Factors; Ageusia; Animals; Anosmia; COVID-19; Female; Male; Mice; Olfactory Perception; SARS-CoV-2; Taste Perception","Broillet","Marie-Christine","Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. mbroille@unil","mbroille@unil.ch"
"307","34267316","10.1038/s42003-021-02399-1","DeepEMhancer: a deep learning solution for cryo-EM volume post-processing.","Cryo-EM maps are valuable sources of information for protein structure modeling. However, due to the loss of contrast at high frequencies, they generally need to be post-processed to improve their interpretability. Most popular approaches, based on global B-factor correction, suffer from limitations. For instance, they ignore the heterogeneity in the map local quality that reconstructions tend to exhibit. Aiming to overcome these problems, we present DeepEMhancer, a deep learning approach design","2021","07","21","Commun Biol","Communications biology","Cryoelectron Microscopy; DNA-Directed RNA Polymerases; Deep Learning; SARS-CoV-2; Viral Proteins","Sanchez-Garcia","Ruben","Biocomputing Unit, Centro Nacional de Biotecnología-CSIC, Madrid, Spain",NA
"308","34267316","10.1038/s42003-021-02399-1","DeepEMhancer: a deep learning solution for cryo-EM volume post-processing.","Cryo-EM maps are valuable sources of information for protein structure modeling. However, due to the loss of contrast at high frequencies, they generally need to be post-processed to improve their interpretability. Most popular approaches, based on global B-factor correction, suffer from limitations. For instance, they ignore the heterogeneity in the map local quality that reconstructions tend to exhibit. Aiming to overcome these problems, we present DeepEMhancer, a deep learning approach design","2021","07","21","Commun Biol","Communications biology","Cryoelectron Microscopy; DNA-Directed RNA Polymerases; Deep Learning; SARS-CoV-2; Viral Proteins","Gomez-Blanco","Josue","Department of Anatomy and Cell Biology, McGill University, Montréal, QC, Canada",NA
"309","34267316","10.1038/s42003-021-02399-1","DeepEMhancer: a deep learning solution for cryo-EM volume post-processing.","Cryo-EM maps are valuable sources of information for protein structure modeling. However, due to the loss of contrast at high frequencies, they generally need to be post-processed to improve their interpretability. Most popular approaches, based on global B-factor correction, suffer from limitations. For instance, they ignore the heterogeneity in the map local quality that reconstructions tend to exhibit. Aiming to overcome these problems, we present DeepEMhancer, a deep learning approach design","2021","07","21","Commun Biol","Communications biology","Cryoelectron Microscopy; DNA-Directed RNA Polymerases; Deep Learning; SARS-CoV-2; Viral Proteins","Cuervo","Ana","Biocomputing Unit, Centro Nacional de Biotecnología-CSIC, Madrid, Spain",NA
"310","34267316","10.1038/s42003-021-02399-1","DeepEMhancer: a deep learning solution for cryo-EM volume post-processing.","Cryo-EM maps are valuable sources of information for protein structure modeling. However, due to the loss of contrast at high frequencies, they generally need to be post-processed to improve their interpretability. Most popular approaches, based on global B-factor correction, suffer from limitations. For instance, they ignore the heterogeneity in the map local quality that reconstructions tend to exhibit. Aiming to overcome these problems, we present DeepEMhancer, a deep learning approach design","2021","07","21","Commun Biol","Communications biology","Cryoelectron Microscopy; DNA-Directed RNA Polymerases; Deep Learning; SARS-CoV-2; Viral Proteins","Carazo","Jose Maria","Biocomputing Unit, Centro Nacional de Biotecnología-CSIC, Madrid, Spain",NA
"311","34267316","10.1038/s42003-021-02399-1","DeepEMhancer: a deep learning solution for cryo-EM volume post-processing.","Cryo-EM maps are valuable sources of information for protein structure modeling. However, due to the loss of contrast at high frequencies, they generally need to be post-processed to improve their interpretability. Most popular approaches, based on global B-factor correction, suffer from limitations. For instance, they ignore the heterogeneity in the map local quality that reconstructions tend to exhibit. Aiming to overcome these problems, we present DeepEMhancer, a deep learning approach design","2021","07","21","Commun Biol","Communications biology","Cryoelectron Microscopy; DNA-Directed RNA Polymerases; Deep Learning; SARS-CoV-2; Viral Proteins","Sorzano","Carlos Oscar S","Biocomputing Unit, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. coss@cnb.csic","coss@cnb.csic.es"
"312","34267316","10.1038/s42003-021-02399-1","DeepEMhancer: a deep learning solution for cryo-EM volume post-processing.","Cryo-EM maps are valuable sources of information for protein structure modeling. However, due to the loss of contrast at high frequencies, they generally need to be post-processed to improve their interpretability. Most popular approaches, based on global B-factor correction, suffer from limitations. For instance, they ignore the heterogeneity in the map local quality that reconstructions tend to exhibit. Aiming to overcome these problems, we present DeepEMhancer, a deep learning approach design","2021","07","21","Commun Biol","Communications biology","Cryoelectron Microscopy; DNA-Directed RNA Polymerases; Deep Learning; SARS-CoV-2; Viral Proteins","Vargas","Javier","Department of Anatomy and Cell Biology, McGill University, Montréal, QC, Canada. jvargas@fis.ucm","jvargas@fis.ucm.es"
"313","34267295","10.1038/s41598-021-93932-z","Predictability of COVID-19-related morbidity and mortality based on model estimations to establish proactive protocols of countermeasures.","The COVID-19 pandemic (SARS-CoV-2) has revealed the need for proactive protocols to react and act, imposing preventive and restrictive countermeasures on time in any society. The extent to which confirmed cases can predict the morbidity and mortality in a society remains an unresolved issue. The research objective is therefore to test a generic model's predictability through time, based on percentage of confirmed cases on hospitalized patients, ICU patients and deceased. This study reports the e","2021","07","20","Sci Rep","Scientific reports",NA,"Svensson","Göran","Kristiania University College, Oslo, Norway. goran.svensson@kristiania","goran.svensson@kristiania.no"
"314","34267295","10.1038/s41598-021-93932-z","Predictability of COVID-19-related morbidity and mortality based on model estimations to establish proactive protocols of countermeasures.","The COVID-19 pandemic (SARS-CoV-2) has revealed the need for proactive protocols to react and act, imposing preventive and restrictive countermeasures on time in any society. The extent to which confirmed cases can predict the morbidity and mortality in a society remains an unresolved issue. The research objective is therefore to test a generic model's predictability through time, based on percentage of confirmed cases on hospitalized patients, ICU patients and deceased. This study reports the e","2021","07","20","Sci Rep","Scientific reports",NA,"Rodriguez","Rocio","Kristiania University College, Oslo, Norway",NA
"315","34267295","10.1038/s41598-021-93932-z","Predictability of COVID-19-related morbidity and mortality based on model estimations to establish proactive protocols of countermeasures.","The COVID-19 pandemic (SARS-CoV-2) has revealed the need for proactive protocols to react and act, imposing preventive and restrictive countermeasures on time in any society. The extent to which confirmed cases can predict the morbidity and mortality in a society remains an unresolved issue. The research objective is therefore to test a generic model's predictability through time, based on percentage of confirmed cases on hospitalized patients, ICU patients and deceased. This study reports the e","2021","07","20","Sci Rep","Scientific reports",NA,"Padin","Carmen","Kristiania University College, Oslo, Norway",NA
"316","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Ekpenyong","Moses Effiong","Department of Computer Science, University of Uyo, P.M.B. 1017, Uyo, 520003, Nigeria. mosesekpenyong@uniuyo.edu","mosesekpenyong@uniuyo.edu.ng"
"317","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Edoho","Mercy Ernest","Department of Computer Science, University of Uyo, P.M.B. 1017, Uyo, 520003, Nigeria",NA
"318","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Inyang","Udoinyang Godwin","Department of Computer Science, University of Uyo, P.M.B. 1017, Uyo, 520003, Nigeria",NA
"319","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Uzoka","Faith-Michael","Department of Mathematics and Computing, Mount Royal University, 4825 Mt Royal Gate SW, Calgary, AB, T3E 6K6, Canada",NA
"320","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Ekaidem","Itemobong Samuel","College of Health Sciences, University of Uyo, P.M.B. 1017, Uyo, 520003, Nigeria",NA
"321","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Moses","Anietie Effiong","College of Health Sciences, University of Uyo, P.M.B. 1017, Uyo, 520003, Nigeria",NA
"322","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Emeje","Martins Ochubiojo","National Institute for Pharmaceutical Research and Development (NIPRD), Plot 942, Cadastral Zone C16, Idu, Industrial District, Abuja, FCT, Nigeria",NA
"323","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Tatfeng","Youtchou Mirabeau","College of Health Sciences, Niger Delta University, Wilberforce Island, P.M.B. 071, Amassama, 560103, Nigeria",NA
"324","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Udo","Ifiok James","Department of Computer Science, University of Uyo, P.M.B. 1017, Uyo, 520003, Nigeria",NA
"325","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Anwana","EnoAbasi Deborah","Department of Botany and Ecological Studies, University of Uyo, P.M.B. 1017, Uyo, 520003, Nigeria",NA
"326","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Etim","Oboso Edem","Department of Biochemistry, University of Uyo, P.M.B. 1017, Uyo, 520003, Nigeria",NA
"327","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Geoffery","Joseph Ikim","Department of Computer Science, University of Uyo, P.M.B. 1017, Uyo, 520003, Nigeria",NA
"328","34267263","10.1038/s41598-021-93757-w","A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.","Whereas accelerated attention beclouded early stages of the coronavirus spread, knowledge of actual pathogenicity and origin of possible sub-strains remained unclear. By harvesting the Global initiative on Sharing All Influenza Data (GISAID) database ( https://www.gisaid.org/ ), between December 2019 and January 15, 2021, a total of 8864 human SARS-CoV-2 complete genome sequences processed by gender, across 6 continents (88 countries) of the world, Antarctica exempt, were analyzed. We hypothesiz","2021","07","20","Sci Rep","Scientific reports",NA,"Dan","Emmanuel Ambrose","Department of Computer Science, University of Uyo, P.M.B. 1017, Uyo, 520003, Nigeria",NA
"329","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Francis","Magen E","Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada",NA
"330","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Richardson","Brian","Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA",NA
"331","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Goncin","Una","Department of Medical Imaging, University of Saskatchewan, Saskatoon, SK, S7N 0W8, Canada",NA
"332","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"McNeil","Mara","Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada",NA
"333","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Rioux","Melissa","Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada",NA
"334","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Foley","Mary K","Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada",NA
"335","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Ge","Anni","Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada",NA
"336","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Pechous","Roger D","Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AK, 72205, USA",NA
"337","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Kindrachuk","Jason","Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, SK, S7N 5E3, Canada",NA
"338","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Cameron","Cheryl M","Department of Nutrition, Case Western Reserve University, Cleveland, OH, 44106, USA",NA
"339","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Richardson","Christopher","Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada",NA
"340","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Lew","Jocelyne","Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, SK, S7N 5E3, Canada",NA
"341","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Machtaler","Steven","Department of Medical Imaging, University of Saskatchewan, Saskatoon, SK, S7N 0W8, Canada",NA
"342","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Cameron","Mark J","Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA",NA
"343","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Gerdts","Volker","Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, SK, S7N 5E3, Canada",NA
"344","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Falzarano","Darryl","Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, SK, S7N 5E3, Canada",NA
"345","34267262","10.1038/s41598-021-93855-9","Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.","SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) hospitalizations and deaths disportionally affect males and older ages. Here we investigated the impact of male sex and age comparing sex-matched or age-matched ferrets infected with SARS-CoV-2. Differences in temperature regulation was identified for male ferrets which was accompanied by prolonged viral replication in the upper respiratory tract after infection. Gene expression analysis of the nasal turbinates indicated that 1-year-ol","2021","07","21","Sci Rep","Scientific reports",NA,"Kelvin","Alyson A","Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada. alyson.kelvin@usask","alyson.kelvin@usask.ca"
"346","34267238","10.1038/s41598-021-93533-w","Bayesian analysis of home advantage in North American professional sports before and during COVID-19.","Home advantage in professional sports is a widely accepted phenomenon despite the lack of any controlled experiments at the professional level. The return to play of professional sports during the COVID-19 pandemic presents a unique opportunity to analyze the hypothesized effect of home advantage in neutral settings. While recent work has examined the effect of COVID-19 restrictions on home advantage in European football, comparatively few studies have examined the effect of restrictions in the ","2021","07","20","Sci Rep","Scientific reports",NA,"Higgs","Nico","Computer Science, University of Saskatchewan, Saskatoon, S7N 5A2, Canada",NA
"347","34267238","10.1038/s41598-021-93533-w","Bayesian analysis of home advantage in North American professional sports before and during COVID-19.","Home advantage in professional sports is a widely accepted phenomenon despite the lack of any controlled experiments at the professional level. The return to play of professional sports during the COVID-19 pandemic presents a unique opportunity to analyze the hypothesized effect of home advantage in neutral settings. While recent work has examined the effect of COVID-19 restrictions on home advantage in European football, comparatively few studies have examined the effect of restrictions in the ","2021","07","20","Sci Rep","Scientific reports",NA,"Stavness","Ian","Computer Science, University of Saskatchewan, Saskatoon, S7N 5A2, Canada. ian.stavness@usask","ian.stavness@usask.ca"
"348","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Berry","Isha","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. isha.berry@mail.utoronto","isha.berry@mail.utoronto.ca"
"349","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"O'Neill","Meghan","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada",NA
"350","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Sturrock","Shelby L","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada",NA
"351","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Wright","James E","Centre for Global Child Health, The Hospital for Sick Children, Toronto, Ontario, Canada",NA
"352","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Acharya","Kamal","Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada",NA
"353","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Brankston","Gabrielle","Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada",NA
"354","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Harish","Vinyas","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada",NA
"355","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Kornas","Kathy","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada",NA
"356","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Maani","Nika","Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada",NA
"357","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Naganathan","Thivya","Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada",NA
"358","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Obress","Lindsay","Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada",NA
"359","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Rossi","Tanya","Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada",NA
"360","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Simmons","Alison E","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada",NA
"361","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Van Camp","Matthew","Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada",NA
"362","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Xie","Xiao","Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada",NA
"363","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Tuite","Ashleigh R","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada",NA
"364","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Greer","Amy L","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada",NA
"365","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Fisman","David N","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada",NA
"366","34267221","10.1038/s41597-021-00955-2","A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.","The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we","2021","07","24","Sci Data","Scientific data",NA,"Soucy","Jean-Paul R","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. jeanpaul.soucy@mail.utoronto","jeanpaul.soucy@mail.utoronto.ca"
"367","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Tanis","Charlotte C","University of Amsterdam, Department of Psychology, Amsterdam, 1018, WS, the Netherlands. c.c.tanis@uva","c.c.tanis@uva.nl"
"368","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Leach","Nina M","University of Amsterdam, Department of Psychology, Amsterdam, 1018, WS, the Netherlands",NA
"369","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Geiger","Sandra J","University of Amsterdam, Department of Psychology, Amsterdam, 1018, WS, the Netherlands",NA
"370","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Nauta","Floor H","University of Amsterdam, Department of Psychology, Amsterdam, 1018, WS, the Netherlands",NA
"371","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Dablander","Fabian","University of Amsterdam, Department of Psychology, Amsterdam, 1018, WS, the Netherlands",NA
"372","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"van Harreveld","Frenk","University of Amsterdam, Department of Psychology, Amsterdam, 1018, WS, the Netherlands",NA
"373","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"de Wit","Sanne","University of Amsterdam, Department of Psychology, Amsterdam, 1018, WS, the Netherlands",NA
"374","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Kanters","Gerard","Centillien B.V., Mierlo, 5731, SG, the Netherlands",NA
"375","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Knoppers","Jop","Centillien B.V., Mierlo, 5731, SG, the Netherlands",NA
"376","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Markus","Diederik A W","Centillien B.V., Mierlo, 5731, SG, the Netherlands",NA
"377","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Bouten","Rick R M","Focus Technologies B.V., Eindhoven, 5657, EW, the Netherlands",NA
"378","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Oostvogel","Quinten H","Focus Technologies B.V., Eindhoven, 5657, EW, the Netherlands",NA
"379","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Boersma","Meier J","Smart Distance Lab, Leiderdorp, 2353, NM, the Netherlands",NA
"380","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"van der Steenhoven","Maya V","Smart Distance Lab, Leiderdorp, 2353, NM, the Netherlands",NA
"381","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Borsboom","Denny","University of Amsterdam, Department of Psychology, Amsterdam, 1018, WS, the Netherlands",NA
"382","34267219","10.1038/s41597-021-00971-2","Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.","In the absence of a vaccine, social distancing behaviour is pivotal to mitigate COVID-19 virus spread. In this large-scale behavioural experiment, we gathered data during Smart Distance Lab: The Art Fair (n = 839) between August 28 and 30, 2020 in Amsterdam, the Netherlands. We varied walking directions (bidirectional, unidirectional, and no directions) and supplementary interventions (face mask and buzzer to alert visitors of 1.5 metres distance). We captured visitors' movements using cameras, ","2021","07","24","Sci Data","Scientific data",NA,"Blanken","Tessa F","University of Amsterdam, Department of Psychology, Amsterdam, 1018, WS, the Netherlands. t.f.blanken@uva","t.f.blanken@uva.nl"
"383","34267216","10.1038/s41597-021-00950-7","COVID-19 European regional tracker.","This Tracker presents data on daily COVID-19 cases at the sub-national level for 26 European countries from January 2020 till present. Country-level data sources are identified and processed to form a homogenized panel at the NUTS 3 or NUTS 2 level, the two lowest standardized administrative units in Europe. The strengths and weaknesses of each country dataset are discussed in detail. The raw data, spatial layers, the code, and the final homogenized files are provided in an online repository for","2021","07","24","Sci Data","Scientific data",NA,"Naqvi","Asjad","Advancing Systems Analysis (ASA), International Institute for Applied Systems Analysis (IIASA), Laxenburg, 2361, Austria. naqvi@iiasa.ac","naqvi@iiasa.ac.at"
"384","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Meng","Fan-Yue","NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China",NA
"385","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Gao","Fan","China National Institute for Food and Drug Control, Beijing, China",NA
"386","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Jia","Si-Yue","NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China",NA
"387","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Wu","Xiang-Hong","Sheyang County Center for Disease Control and Prevention, Yancheng, China",NA
"388","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Li","Jing-Xin","NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China",NA
"389","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Guo","Xi-Ling","NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China",NA
"390","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Zhang","Jia-Lu","China National Institute for Food and Drug Control, Beijing, China",NA
"391","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Cui","Bo-Pei","China National Institute for Food and Drug Control, Beijing, China",NA
"392","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Wu","Zhi-Ming","Jiangdu District Center for Disease Control and Prevention, Yangzhou, China",NA
"393","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Wei","Ming-Wei","NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China",NA
"394","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Ma","Zhi-Long","Taizhou Center for Disease Control and Prevention, Taizhou, China",NA
"395","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Peng","Hai-Lin","Jiangsu Taizhou People's Hospital, Taizhou, China",NA
"396","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Pan","Hong-Xing","NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China",NA
"397","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Fan","Lin","Jiangsu Taizhou People's Hospital, Taizhou, China",NA
"398","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Zhang","Jing","Sheyang County Center for Disease Control and Prevention, Yancheng, China",NA
"399","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Wan","Jiu-Qin","Jiangdu District Center for Disease Control and Prevention, Yangzhou, China",NA
"400","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Zhu","Zhong-Kui","Taizhou Center for Disease Control and Prevention, Taizhou, China",NA
"401","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Wang","Xue-Wen","Shanghai Canming Medical Technology Co., Ltd, Shanghai, China",NA
"402","34267185","10.1038/s41392-021-00692-3","Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.","COVID-19 vaccines from multiple manufacturers are needed to cope with the problem of insufficient supply. We did two single-center, randomised, double-blind, placebo-controlled phase 1 and phase 2 trials to assess the safety, tolerability and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older in China. Eligible participants were enrolled, the ratio of candidate vaccine and placebo within each dose group was 3:1 (phase 1) or 5:1 (phase 2). Fr","2021","07","20","Signal Transduct Target Ther","Signal transduction and targeted therapy",NA,"Zhu","Feng-Cai","NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China. jszfc@vip.sina","jszfc@vip.sina.com"
"403","34267176","","[Explanatory factors on the acceptance of SARS-CoV-2 vaccine from consumer's behaviour perspective.]","The success of policies to eradicate COVID-19 depends on the acceptance of vaccines among the population. This paper measures the influence on the intention to get vaccinated of three usual variables in studies on consumer behavior: the perception of the efficiency and risk of the vaccine and the social influence. It was used a survey of 600 residents in Spain that was answered during September 2020 has been used. That survey was conveniently stratified by age and monthly income. The impact of t","2021","07","19","Rev Esp Salud Publica","Revista espanola de salud publica","COVID-19; Risk acceptance; Social perception; Spain; Technologial acceptance models; Vaccination rejection; Vaccine concienciation; Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; Middle Aged; Patient Acceptance of Health Care; Spain; Surveys and Questionnaires; Vaccination; Young Adult","de Andrés Sánchez","Jorge","Laboratorio de Investigación en Sociedad y Empresa. Universidad Rovira i Virgili. Reus (Tarragona). España",NA
"404","34267176","","[Explanatory factors on the acceptance of SARS-CoV-2 vaccine from consumer's behaviour perspective.]","The success of policies to eradicate COVID-19 depends on the acceptance of vaccines among the population. This paper measures the influence on the intention to get vaccinated of three usual variables in studies on consumer behavior: the perception of the efficiency and risk of the vaccine and the social influence. It was used a survey of 600 residents in Spain that was answered during September 2020 has been used. That survey was conveniently stratified by age and monthly income. The impact of t","2021","07","19","Rev Esp Salud Publica","Revista espanola de salud publica","COVID-19; Risk acceptance; Social perception; Spain; Technologial acceptance models; Vaccination rejection; Vaccine concienciation; Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; Middle Aged; Patient Acceptance of Health Care; Spain; Surveys and Questionnaires; Vaccination; Young Adult","Arias-Oliva","Mario","Departamento de Organización de Empresas y Márqueting. Facultad de Economía y Empresa. Universidad Complutense. Madrid. España",NA
"405","34267176","","[Explanatory factors on the acceptance of SARS-CoV-2 vaccine from consumer's behaviour perspective.]","The success of policies to eradicate COVID-19 depends on the acceptance of vaccines among the population. This paper measures the influence on the intention to get vaccinated of three usual variables in studies on consumer behavior: the perception of the efficiency and risk of the vaccine and the social influence. It was used a survey of 600 residents in Spain that was answered during September 2020 has been used. That survey was conveniently stratified by age and monthly income. The impact of t","2021","07","19","Rev Esp Salud Publica","Revista espanola de salud publica","COVID-19; Risk acceptance; Social perception; Spain; Technologial acceptance models; Vaccination rejection; Vaccine concienciation; Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; Middle Aged; Patient Acceptance of Health Care; Spain; Surveys and Questionnaires; Vaccination; Young Adult","Pelegrín-Borondo","Jorge","Departamento de Economía y Empresa. Universidad de La Rioja. Logroño. España",NA
"406","34267176","","[Explanatory factors on the acceptance of SARS-CoV-2 vaccine from consumer's behaviour perspective.]","The success of policies to eradicate COVID-19 depends on the acceptance of vaccines among the population. This paper measures the influence on the intention to get vaccinated of three usual variables in studies on consumer behavior: the perception of the efficiency and risk of the vaccine and the social influence. It was used a survey of 600 residents in Spain that was answered during September 2020 has been used. That survey was conveniently stratified by age and monthly income. The impact of t","2021","07","19","Rev Esp Salud Publica","Revista espanola de salud publica","COVID-19; Risk acceptance; Social perception; Spain; Technologial acceptance models; Vaccination rejection; Vaccine concienciation; Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; Middle Aged; Patient Acceptance of Health Care; Spain; Surveys and Questionnaires; Vaccination; Young Adult","Lima Rua","Orlando","Departamento de Administración. Escuela de Contabilidad y Negocios de Oporto. Politécnico de Oporto. Oporto. Portugal",NA
"407","34267138","10.1097/SCS.0000000000007991","The Risk of Osseointegration in the Coronavirus Disease 19 Pandemic.","Coronavirus disease 19 (COVID-19) is associated with respiratory complications but also with alterations on bone metabolism. Coronavirus disease 19, therefore, might be a risk factor for osseointegration. Recent studies suggest that severe acute respiratory syndrome coronavirus 2 is related with bone abnormalities mainly for act via renin-angiotensin system. This report aims to list the bone alterations caused by coronavirus disease 19 and the possible consequences on the peri-implant bone heali","2021","07","16","J Craniofac Surg","The Journal of craniofacial surgery",NA,"Mulinari-Santos","Gabriel","State University of Northern Paraná, Jacarezinho São Paulo State University (Unesp), School of Dentistry, Araçatuba, São Paulo, Brazil",NA
"408","34267138","10.1097/SCS.0000000000007991","The Risk of Osseointegration in the Coronavirus Disease 19 Pandemic.","Coronavirus disease 19 (COVID-19) is associated with respiratory complications but also with alterations on bone metabolism. Coronavirus disease 19, therefore, might be a risk factor for osseointegration. Recent studies suggest that severe acute respiratory syndrome coronavirus 2 is related with bone abnormalities mainly for act via renin-angiotensin system. This report aims to list the bone alterations caused by coronavirus disease 19 and the possible consequences on the peri-implant bone heali","2021","07","16","J Craniofac Surg","The Journal of craniofacial surgery",NA,"Paino-Sant'Ana","Amanda","State University of Northern Paraná, Jacarezinho São Paulo State University (Unesp), School of Dentistry, Araçatuba, São Paulo, Brazil",NA
"409","34267138","10.1097/SCS.0000000000007991","The Risk of Osseointegration in the Coronavirus Disease 19 Pandemic.","Coronavirus disease 19 (COVID-19) is associated with respiratory complications but also with alterations on bone metabolism. Coronavirus disease 19, therefore, might be a risk factor for osseointegration. Recent studies suggest that severe acute respiratory syndrome coronavirus 2 is related with bone abnormalities mainly for act via renin-angiotensin system. This report aims to list the bone alterations caused by coronavirus disease 19 and the possible consequences on the peri-implant bone heali","2021","07","16","J Craniofac Surg","The Journal of craniofacial surgery",NA,"Okamoto","Roberta","State University of Northern Paraná, Jacarezinho São Paulo State University (Unesp), School of Dentistry, Araçatuba, São Paulo, Brazil",NA
"410","34267138","10.1097/SCS.0000000000007991","The Risk of Osseointegration in the Coronavirus Disease 19 Pandemic.","Coronavirus disease 19 (COVID-19) is associated with respiratory complications but also with alterations on bone metabolism. Coronavirus disease 19, therefore, might be a risk factor for osseointegration. Recent studies suggest that severe acute respiratory syndrome coronavirus 2 is related with bone abnormalities mainly for act via renin-angiotensin system. This report aims to list the bone alterations caused by coronavirus disease 19 and the possible consequences on the peri-implant bone heali","2021","07","16","J Craniofac Surg","The Journal of craniofacial surgery",NA,"Coléte","Juliana Zorzi","State University of Northern Paraná, Jacarezinho São Paulo State University (Unesp), School of Dentistry, Araçatuba, São Paulo, Brazil",NA
"411","34267138","10.1097/SCS.0000000000007991","The Risk of Osseointegration in the Coronavirus Disease 19 Pandemic.","Coronavirus disease 19 (COVID-19) is associated with respiratory complications but also with alterations on bone metabolism. Coronavirus disease 19, therefore, might be a risk factor for osseointegration. Recent studies suggest that severe acute respiratory syndrome coronavirus 2 is related with bone abnormalities mainly for act via renin-angiotensin system. This report aims to list the bone alterations caused by coronavirus disease 19 and the possible consequences on the peri-implant bone heali","2021","07","16","J Craniofac Surg","The Journal of craniofacial surgery",NA,"Neto","João Lopes Toledo","State University of Northern Paraná, Jacarezinho São Paulo State University (Unesp), School of Dentistry, Araçatuba, São Paulo, Brazil",NA
"412","34267132","10.1097/SCS.0000000000007791","Review of The Relationship Between Surgeon Gender and Stress During the COVID-19 Pandemic by Mavroudis CL, Landau S, Brooks E, Bergmark R, et al. Annals of Surgery 2021; 273: 625-629.",NA,"2021","07","16","J Craniofac Surg","The Journal of craniofacial surgery",NA,"McCarter","Jacob","Houston, TX",NA
"413","34267132","10.1097/SCS.0000000000007791","Review of The Relationship Between Surgeon Gender and Stress During the COVID-19 Pandemic by Mavroudis CL, Landau S, Brooks E, Bergmark R, et al. Annals of Surgery 2021; 273: 625-629.",NA,"2021","07","16","J Craniofac Surg","The Journal of craniofacial surgery",NA,"Hollier","Larry H","Houston, TX",NA
"414","34267109","10.1097/CEJ.0000000000000686","The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal.","The coronavirus disease 2019 (COVID-19) pandemic has affected the availability of healthcare resources, and adjustments to cancer care have been necessary considering the risk of morbidity by COVID-19 and of cancer progression. This study aims to quantify the impact of the COVID-19 pandemic on the care of patients with cancer by comparing a period of 4 months after the outbreak began (2 March 2020) with an equal period from 2019. Cancer cases of the esophagus, stomach, colon and rectum, pancreas","2021","07","16","Eur J Cancer Prev","European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)",NA,"Morais","Samantha","EPIUnit, Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas nº135 Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro Grupo de Epidemiologia do Cancro, Centro de Investigação do Instituto Português de Oncologia do Porto, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Serviço de Imagem, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Departamento de Estudos de Populações, Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Rua Jorge de Viterbo Ferreira 228, Porto, Portugal",NA
"415","34267109","10.1097/CEJ.0000000000000686","The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal.","The coronavirus disease 2019 (COVID-19) pandemic has affected the availability of healthcare resources, and adjustments to cancer care have been necessary considering the risk of morbidity by COVID-19 and of cancer progression. This study aims to quantify the impact of the COVID-19 pandemic on the care of patients with cancer by comparing a period of 4 months after the outbreak began (2 March 2020) with an equal period from 2019. Cancer cases of the esophagus, stomach, colon and rectum, pancreas","2021","07","16","Eur J Cancer Prev","European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)",NA,"Antunes","Luís","EPIUnit, Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas nº135 Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro Grupo de Epidemiologia do Cancro, Centro de Investigação do Instituto Português de Oncologia do Porto, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Serviço de Imagem, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Departamento de Estudos de Populações, Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Rua Jorge de Viterbo Ferreira 228, Porto, Portugal",NA
"416","34267109","10.1097/CEJ.0000000000000686","The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal.","The coronavirus disease 2019 (COVID-19) pandemic has affected the availability of healthcare resources, and adjustments to cancer care have been necessary considering the risk of morbidity by COVID-19 and of cancer progression. This study aims to quantify the impact of the COVID-19 pandemic on the care of patients with cancer by comparing a period of 4 months after the outbreak began (2 March 2020) with an equal period from 2019. Cancer cases of the esophagus, stomach, colon and rectum, pancreas","2021","07","16","Eur J Cancer Prev","European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)",NA,"Rodrigues","Jéssica","EPIUnit, Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas nº135 Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro Grupo de Epidemiologia do Cancro, Centro de Investigação do Instituto Português de Oncologia do Porto, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Serviço de Imagem, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Departamento de Estudos de Populações, Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Rua Jorge de Viterbo Ferreira 228, Porto, Portugal",NA
"417","34267109","10.1097/CEJ.0000000000000686","The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal.","The coronavirus disease 2019 (COVID-19) pandemic has affected the availability of healthcare resources, and adjustments to cancer care have been necessary considering the risk of morbidity by COVID-19 and of cancer progression. This study aims to quantify the impact of the COVID-19 pandemic on the care of patients with cancer by comparing a period of 4 months after the outbreak began (2 March 2020) with an equal period from 2019. Cancer cases of the esophagus, stomach, colon and rectum, pancreas","2021","07","16","Eur J Cancer Prev","European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)",NA,"Fontes","Filipa","EPIUnit, Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas nº135 Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro Grupo de Epidemiologia do Cancro, Centro de Investigação do Instituto Português de Oncologia do Porto, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Serviço de Imagem, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Departamento de Estudos de Populações, Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Rua Jorge de Viterbo Ferreira 228, Porto, Portugal",NA
"418","34267109","10.1097/CEJ.0000000000000686","The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal.","The coronavirus disease 2019 (COVID-19) pandemic has affected the availability of healthcare resources, and adjustments to cancer care have been necessary considering the risk of morbidity by COVID-19 and of cancer progression. This study aims to quantify the impact of the COVID-19 pandemic on the care of patients with cancer by comparing a period of 4 months after the outbreak began (2 March 2020) with an equal period from 2019. Cancer cases of the esophagus, stomach, colon and rectum, pancreas","2021","07","16","Eur J Cancer Prev","European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)",NA,"Bento","Maria José","EPIUnit, Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas nº135 Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro Grupo de Epidemiologia do Cancro, Centro de Investigação do Instituto Português de Oncologia do Porto, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Serviço de Imagem, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Departamento de Estudos de Populações, Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Rua Jorge de Viterbo Ferreira 228, Porto, Portugal",NA
"419","34267109","10.1097/CEJ.0000000000000686","The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal.","The coronavirus disease 2019 (COVID-19) pandemic has affected the availability of healthcare resources, and adjustments to cancer care have been necessary considering the risk of morbidity by COVID-19 and of cancer progression. This study aims to quantify the impact of the COVID-19 pandemic on the care of patients with cancer by comparing a period of 4 months after the outbreak began (2 March 2020) with an equal period from 2019. Cancer cases of the esophagus, stomach, colon and rectum, pancreas","2021","07","16","Eur J Cancer Prev","European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)",NA,"Lunet","Nuno","EPIUnit, Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas nº135 Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro Grupo de Epidemiologia do Cancro, Centro de Investigação do Instituto Português de Oncologia do Porto, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Serviço de Imagem, Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida Departamento de Estudos de Populações, Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Rua Jorge de Viterbo Ferreira 228, Porto, Portugal",NA
"420","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Matthews","Timothy A","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"421","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Chen","Liwei","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"422","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Chen","Zhuo","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"423","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Han","Xuesong","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"424","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Shi","Lu","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"425","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Li","Yan","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"426","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Wen","Ming","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"427","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Zhang","Donglan","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"428","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Li","Hongmei","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"429","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Su","Dejun","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"430","34267107","10.1097/JOM.0000000000002325","Negative Employment Changes During the COVID-19 Pandemic and Psychological Distress: Evidence from a Nationally Representative Survey in the U.S.","We examined associations of negative employment changes during the COVID-19 pandemic with mental health in a national sample of U.S. workers, and whether the associations differed by race. Data were from the Health, Ethnicity, and Pandemic Study, a cross-sectional survey. The effects of negative employment changes on psychological distress in 1,510 workers were examined via linear regression, and stratified analyses were conducted across racial subgroups. After adjustment for covariates, compare","2021","07","16","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Li","Jian","Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States (Matthews, Li)",NA
"431","34267103","10.1097/MAO.0000000000003275","Otologic Manifestations After COVID-19 Vaccination: The House Ear Clinic Experience.","With the increasing numbers of COVID-19 vaccinations available there are some reports of new onset of otologic symptoms. We present our experience in recently vaccinated patients over a 30-day time frame. Retrospective chart review. Tertiary otology ambulatory practice. All patients with available diagnostic codes, COVID-19 questionnaires and clinical notes. Observational recordings. Within the same 30-day time period in 2019, 2020, and 2021, 1.6, 2.4, and 3.8% respectively, of all office visits","2021","07","16","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",NA,"Wichova","Helena","House Clinic, Los Angeles, California",NA
"432","34267103","10.1097/MAO.0000000000003275","Otologic Manifestations After COVID-19 Vaccination: The House Ear Clinic Experience.","With the increasing numbers of COVID-19 vaccinations available there are some reports of new onset of otologic symptoms. We present our experience in recently vaccinated patients over a 30-day time frame. Retrospective chart review. Tertiary otology ambulatory practice. All patients with available diagnostic codes, COVID-19 questionnaires and clinical notes. Observational recordings. Within the same 30-day time period in 2019, 2020, and 2021, 1.6, 2.4, and 3.8% respectively, of all office visits","2021","07","16","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",NA,"Miller","Mia E","House Clinic, Los Angeles, California",NA
"433","34267103","10.1097/MAO.0000000000003275","Otologic Manifestations After COVID-19 Vaccination: The House Ear Clinic Experience.","With the increasing numbers of COVID-19 vaccinations available there are some reports of new onset of otologic symptoms. We present our experience in recently vaccinated patients over a 30-day time frame. Retrospective chart review. Tertiary otology ambulatory practice. All patients with available diagnostic codes, COVID-19 questionnaires and clinical notes. Observational recordings. Within the same 30-day time period in 2019, 2020, and 2021, 1.6, 2.4, and 3.8% respectively, of all office visits","2021","07","16","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",NA,"Derebery","M Jennifer","House Clinic, Los Angeles, California",NA
"434","34267095","10.1097/MAO.0000000000003291","Cochlear Implant Outcomes in Elderly Recipients During the COVID-19 Pandemic.","To evaluate the potential significance of social distancing and quarantine precautions for COVID-19 on speech outcomes, missed appointments, wear time, and exposure to various sound environments in the first 6 months following activation for elderly cochlear implant (CI) recipients. Retrospective cohort. Tertiary private practice. Fifty cochlear implant recipients =65 years were evaluated. A Control Group consisted of 26 patients implanted between November 2, 2018 and February 18, 2019 while the","2021","07","16","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",NA,"Knickerbocker","Alissa","Ear &amp",NA
"435","34267095","10.1097/MAO.0000000000003291","Cochlear Implant Outcomes in Elderly Recipients During the COVID-19 Pandemic.","To evaluate the potential significance of social distancing and quarantine precautions for COVID-19 on speech outcomes, missed appointments, wear time, and exposure to various sound environments in the first 6 months following activation for elderly cochlear implant (CI) recipients. Retrospective cohort. Tertiary private practice. Fifty cochlear implant recipients =65 years were evaluated. A Control Group consisted of 26 patients implanted between November 2, 2018 and February 18, 2019 while the","2021","07","16","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",NA,"Bourn","Stephanie","Ear &amp",NA
"436","34267095","10.1097/MAO.0000000000003291","Cochlear Implant Outcomes in Elderly Recipients During the COVID-19 Pandemic.","To evaluate the potential significance of social distancing and quarantine precautions for COVID-19 on speech outcomes, missed appointments, wear time, and exposure to various sound environments in the first 6 months following activation for elderly cochlear implant (CI) recipients. Retrospective cohort. Tertiary private practice. Fifty cochlear implant recipients =65 years were evaluated. A Control Group consisted of 26 patients implanted between November 2, 2018 and February 18, 2019 while the","2021","07","16","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",NA,"Goldstein","Mary Rose","Ear &amp",NA
"437","34267095","10.1097/MAO.0000000000003291","Cochlear Implant Outcomes in Elderly Recipients During the COVID-19 Pandemic.","To evaluate the potential significance of social distancing and quarantine precautions for COVID-19 on speech outcomes, missed appointments, wear time, and exposure to various sound environments in the first 6 months following activation for elderly cochlear implant (CI) recipients. Retrospective cohort. Tertiary private practice. Fifty cochlear implant recipients =65 years were evaluated. A Control Group consisted of 26 patients implanted between November 2, 2018 and February 18, 2019 while the","2021","07","16","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",NA,"Jacob","Abraham","Ear &amp",NA
"438","34267076","10.1097/MCC.0000000000000856","Functional outcomes following critical illness: epidemiology, current management strategies and the future priorities.","Intensive care unit (ICU) survivorship has gained significant attention over the course of the COVID-19 pandemic. In this review, we summarize the contemporary literature in relation to the epidemiology and management of post-ICU problems. Survivors of critical illness can have complex physical, social, emotional and cognitive needs in the months following hospital discharge. Emerging evidence has shown that pre-ICU characteristics such as educational attainment, alongside in-ICU factors such as","2021","07","16","Curr Opin Crit Care","Current opinion in critical care",NA,"McPeake","Joanne","NHS Greater Glasgow and Clyde, University of Glasgow, School of Medicine, Dentistry and Nursing, THIS Institute (University of Cambridge), Cambridge, UK Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"439","34267076","10.1097/MCC.0000000000000856","Functional outcomes following critical illness: epidemiology, current management strategies and the future priorities.","Intensive care unit (ICU) survivorship has gained significant attention over the course of the COVID-19 pandemic. In this review, we summarize the contemporary literature in relation to the epidemiology and management of post-ICU problems. Survivors of critical illness can have complex physical, social, emotional and cognitive needs in the months following hospital discharge. Emerging evidence has shown that pre-ICU characteristics such as educational attainment, alongside in-ICU factors such as","2021","07","16","Curr Opin Crit Care","Current opinion in critical care",NA,"Sevin","Carla M","NHS Greater Glasgow and Clyde, University of Glasgow, School of Medicine, Dentistry and Nursing, THIS Institute (University of Cambridge), Cambridge, UK Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"440","34267076","10.1097/MCC.0000000000000856","Functional outcomes following critical illness: epidemiology, current management strategies and the future priorities.","Intensive care unit (ICU) survivorship has gained significant attention over the course of the COVID-19 pandemic. In this review, we summarize the contemporary literature in relation to the epidemiology and management of post-ICU problems. Survivors of critical illness can have complex physical, social, emotional and cognitive needs in the months following hospital discharge. Emerging evidence has shown that pre-ICU characteristics such as educational attainment, alongside in-ICU factors such as","2021","07","16","Curr Opin Crit Care","Current opinion in critical care",NA,"Mikkelsen","Mark E","NHS Greater Glasgow and Clyde, University of Glasgow, School of Medicine, Dentistry and Nursing, THIS Institute (University of Cambridge), Cambridge, UK Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"441","34267075","10.1097/MCC.0000000000000859","The impact of resource limitations on care delivery and outcomes: routine variation, the coronavirus disease 2019 pandemic, and persistent shortage.","Resource limitation, or capacity strain, has been associated with changes in care delivery, and in some cases, poorer outcomes among critically ill patients. This may result from normal variation in strain on available resources, chronic strain in persistently under-resourced settings, and less commonly because of acute surges in demand, as seen during the coronavirus disease 2019 (COVID-19) pandemic. Recent studies confirmed existing evidence that high ICU strain is associated with ICU triage d","2021","07","16","Curr Opin Crit Care","Current opinion in critical care",NA,"Anesi","George L","Division of Pulmonary, Allergy, and Critical Care Palliative and Advanced Illness Research (PAIR) Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA",NA
"442","34267075","10.1097/MCC.0000000000000859","The impact of resource limitations on care delivery and outcomes: routine variation, the coronavirus disease 2019 pandemic, and persistent shortage.","Resource limitation, or capacity strain, has been associated with changes in care delivery, and in some cases, poorer outcomes among critically ill patients. This may result from normal variation in strain on available resources, chronic strain in persistently under-resourced settings, and less commonly because of acute surges in demand, as seen during the coronavirus disease 2019 (COVID-19) pandemic. Recent studies confirmed existing evidence that high ICU strain is associated with ICU triage d","2021","07","16","Curr Opin Crit Care","Current opinion in critical care",NA,"Kerlin","Meeta Prasad","Division of Pulmonary, Allergy, and Critical Care Palliative and Advanced Illness Research (PAIR) Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA",NA
"443","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Qin","Xiao-Song","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"444","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Gao","Peng","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"445","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Zhang","Zhi-Jie","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"446","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Bo","Zhi-Jian","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"447","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Li","Shi-Jun","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"448","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Yang","Mei","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"449","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Liu","Jian-Hua","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"450","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Wu","Li-Na","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"451","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Li","Ting","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"452","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Zhao","Zuo-Wei","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"453","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Li","Yan","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"454","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Bian","Hao-Dong","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"455","34267070","10.1097/CM9.0000000000001627","A low-cost and high-efficiency 10-in-1 test for the polymerase chain reaction-based screening of severe acute respiratory syndrome coronavirus 2 infection in low-risk areas.",NA,"2021","07","16","Chin Med J (Engl)","Chinese medical journal",NA,"Liu","Yong","Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China Department of Laboratory Medicine, Dalian Sixth People's Hospital, Dalian, Liaoning 1160311, China Microbiological Laboratory, Dalian Municipal Center for Disease Control and Prevention, Dalian, Liaoning 116019, China Department of Laboratory Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China Committee of the Party Group, Health Commission of Dalian, Dalian, Liaoning 116006, China Clinical Laboratory and Medical Quality Control Center, Health Service Center of Liaoning Province, Shenyang, Liaoning 110005, China",NA
"456","34267055","10.1097/QAI.0000000000002763","HIV and HCV Screening in the Emergency Department and Linkage to Care during COVID-19: Challenges and Solutions.","The recent global pandemic of coronavirus disease-19, also known as COVID-19, has posed significant challenges to Emergency Department (ED) HIV and HCV screening programs as well as linkage to care efforts in those identified with HIV or HCV infections. The goal of this educational report was to describe challenges in the face of the COVID-19 pandemic and solutions, focusing on our HIV and HCV opt-out universal ED screening program at the University of California San Diego (UCSD) Medical Center,","2021","07","16","J Acquir Immune Defic Syndr","Journal of acquired immune deficiency syndromes (1999)",NA,"Lara-Paez","George","Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, United States Department of Emergency Medicine, University of California San Diego, San Diego, California, United States",NA
"457","34267055","10.1097/QAI.0000000000002763","HIV and HCV Screening in the Emergency Department and Linkage to Care during COVID-19: Challenges and Solutions.","The recent global pandemic of coronavirus disease-19, also known as COVID-19, has posed significant challenges to Emergency Department (ED) HIV and HCV screening programs as well as linkage to care efforts in those identified with HIV or HCV infections. The goal of this educational report was to describe challenges in the face of the COVID-19 pandemic and solutions, focusing on our HIV and HCV opt-out universal ED screening program at the University of California San Diego (UCSD) Medical Center,","2021","07","16","J Acquir Immune Defic Syndr","Journal of acquired immune deficiency syndromes (1999)",NA,"Zuazo","Miriam","Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, United States Department of Emergency Medicine, University of California San Diego, San Diego, California, United States",NA
"458","34267055","10.1097/QAI.0000000000002763","HIV and HCV Screening in the Emergency Department and Linkage to Care during COVID-19: Challenges and Solutions.","The recent global pandemic of coronavirus disease-19, also known as COVID-19, has posed significant challenges to Emergency Department (ED) HIV and HCV screening programs as well as linkage to care efforts in those identified with HIV or HCV infections. The goal of this educational report was to describe challenges in the face of the COVID-19 pandemic and solutions, focusing on our HIV and HCV opt-out universal ED screening program at the University of California San Diego (UCSD) Medical Center,","2021","07","16","J Acquir Immune Defic Syndr","Journal of acquired immune deficiency syndromes (1999)",NA,"Blumenthal","Jill","Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, United States Department of Emergency Medicine, University of California San Diego, San Diego, California, United States",NA
"459","34267055","10.1097/QAI.0000000000002763","HIV and HCV Screening in the Emergency Department and Linkage to Care during COVID-19: Challenges and Solutions.","The recent global pandemic of coronavirus disease-19, also known as COVID-19, has posed significant challenges to Emergency Department (ED) HIV and HCV screening programs as well as linkage to care efforts in those identified with HIV or HCV infections. The goal of this educational report was to describe challenges in the face of the COVID-19 pandemic and solutions, focusing on our HIV and HCV opt-out universal ED screening program at the University of California San Diego (UCSD) Medical Center,","2021","07","16","J Acquir Immune Defic Syndr","Journal of acquired immune deficiency syndromes (1999)",NA,"Coyne","Christopher J","Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, United States Department of Emergency Medicine, University of California San Diego, San Diego, California, United States",NA
"460","34267055","10.1097/QAI.0000000000002763","HIV and HCV Screening in the Emergency Department and Linkage to Care during COVID-19: Challenges and Solutions.","The recent global pandemic of coronavirus disease-19, also known as COVID-19, has posed significant challenges to Emergency Department (ED) HIV and HCV screening programs as well as linkage to care efforts in those identified with HIV or HCV infections. The goal of this educational report was to describe challenges in the face of the COVID-19 pandemic and solutions, focusing on our HIV and HCV opt-out universal ED screening program at the University of California San Diego (UCSD) Medical Center,","2021","07","16","J Acquir Immune Defic Syndr","Journal of acquired immune deficiency syndromes (1999)",NA,"Hoenigl","Martin","Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, United States Department of Emergency Medicine, University of California San Diego, San Diego, California, United States",NA
"461","34267050","10.1097/WCO.0000000000000977","Neuromuscular monitoring devices - where to go next?","This paper reviews the clinical applications, technology, and evidence supporting the use of telemedicine devices and telehealth in neuromuscular disease. The COVID-19 pandemic interrupted standard multidisciplinary care of patients with neuromuscular disease and created a need to adapt to remote care. Telemedicine applications were rapidly introduced and have rapidly proved an important tool in maintaining specialist care. This review presents the current data being gathered identifying the pat","2021","07","16","Curr Opin Neurol","Current opinion in neurology",NA,"Damian","Maxwell Simon","Consultant in Neurology and Neurocritical Care, Division of Anaesthesia, Box 93, Addenbrookes Hospital, Cambridge, UK",NA
"462","34267043","10.1097/QCO.0000000000000770","How coronavirus disease will change the face of travel medicine.","The current article will review how the coronavirus disease 2019 pandemic has changed travel and travel medicine. Travelers spread severe acute respiratory syndrome coronavirus 2 globally and continue to spread variants. The characteristics of the virus, the place, and time created a perfect storm that allowed the virus to quickly spread globally. The virus spread by every mode of travel with risk of transmission influenced by proximity to an infected person, duration of trip, physical character","2021","07","16","Curr Opin Infect Dis","Current opinion in infectious diseases",NA,"Wilson","Mary E","Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, San Francisco, California Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA",NA
"463","34267011","","Teledentistry-based Program to Improve Oral Hygiene Indicators in Rural Pakistan-A Protocol.","The primary aim of this research protocol is to secure funding to initiate a teledentistry pilot project in order to improve the oral hygiene conditions of the most vulnerable population of rural Sindh in Pakistan, through hands-on training of 1,000 lady health workers by dentists and community dentistry specialists of other colleges led by Jinnah Medical and Dental College. Training courses on digital health consultation would be given to participating healthcare workers. The trainees would be ","2021","07","19","J Contemp Dent Pract","The journal of contemporary dental practice","Dental caries; Oral hygiene Teledentistry.; COVID-19; Humans; Oral Hygiene; Pakistan; Pandemics; Pilot Projects; SARS-CoV-2; Telemedicine","Mahdi","Syed Sarosh","Department of Community Dentistry, Jinnah Medical and Dental College, Sohail University, Karachi, Pakistan","syedsarosh.mahdi@unicam.it"
"464","34267011","","Teledentistry-based Program to Improve Oral Hygiene Indicators in Rural Pakistan-A Protocol.","The primary aim of this research protocol is to secure funding to initiate a teledentistry pilot project in order to improve the oral hygiene conditions of the most vulnerable population of rural Sindh in Pakistan, through hands-on training of 1,000 lady health workers by dentists and community dentistry specialists of other colleges led by Jinnah Medical and Dental College. Training courses on digital health consultation would be given to participating healthcare workers. The trainees would be ","2021","07","19","J Contemp Dent Pract","The journal of contemporary dental practice","Dental caries; Oral hygiene Teledentistry.; COVID-19; Humans; Oral Hygiene; Pakistan; Pandemics; Pilot Projects; SARS-CoV-2; Telemedicine","Allana","Raheel","Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi, Pakistan",NA
"465","34267011","","Teledentistry-based Program to Improve Oral Hygiene Indicators in Rural Pakistan-A Protocol.","The primary aim of this research protocol is to secure funding to initiate a teledentistry pilot project in order to improve the oral hygiene conditions of the most vulnerable population of rural Sindh in Pakistan, through hands-on training of 1,000 lady health workers by dentists and community dentistry specialists of other colleges led by Jinnah Medical and Dental College. Training courses on digital health consultation would be given to participating healthcare workers. The trainees would be ","2021","07","19","J Contemp Dent Pract","The journal of contemporary dental practice","Dental caries; Oral hygiene Teledentistry.; COVID-19; Humans; Oral Hygiene; Pakistan; Pandemics; Pilot Projects; SARS-CoV-2; Telemedicine","Amenta","Francesco","Centre of Clinical Research, Telemedicine and Telepharmacy, School of Medicinal and Health Products Sciences, University of Camerino, Macerta, Italy",NA
"466","34266997","","Dentistry and the Pandemic: A Year of Reckoning.","In March 2020, the world that we know irrevocably changed forever. It feels like ""Groundhog Day"" all over again, and it seems that the nightmare is here to stay. It all began on the January 8, 2020, when China grimly announced that coronavirus disease-2019 (COVID-19) pandemic is caused by the ""severe acute respiratory syndrome coronavirus 2"" (SARS-CoV-2)<sup>1</sup> but it was not until March 2020 that the situation swiftly careened out of control and is unequivocally posing the greatest challen","2021","07","19","J Contemp Dent Pract","The journal of contemporary dental practice","COVID-19; Dentistry; Humans; Pandemics; SARS-CoV-2","Vijayan","Srinivas P","Department of Prosthodontics and Restorative Dentistry, School of Dentistry, College of Medicine and Health Sciences, University of Rwanda, Remera Campus, Kigali, Rwanda",NA
"467","34266997","","Dentistry and the Pandemic: A Year of Reckoning.","In March 2020, the world that we know irrevocably changed forever. It feels like ""Groundhog Day"" all over again, and it seems that the nightmare is here to stay. It all began on the January 8, 2020, when China grimly announced that coronavirus disease-2019 (COVID-19) pandemic is caused by the ""severe acute respiratory syndrome coronavirus 2"" (SARS-CoV-2)<sup>1</sup> but it was not until March 2020 that the situation swiftly careened out of control and is unequivocally posing the greatest challen","2021","07","19","J Contemp Dent Pract","The journal of contemporary dental practice","COVID-19; Dentistry; Humans; Pandemics; SARS-CoV-2","Pandarathodiyil","Anitha K","Faculty of Dentistry, SEGi University, Petaling Jaya, Selangor, Malaysia, Phone: +60 361451780, e-mail: anithakrishnan@segi.edu","anithakrishnan@segi.edu.my"
"468","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Pino","Maria","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U",NA
"469","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Abid","Talha","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U",NA
"470","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Pereira Ribeiro","Susan","Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, U",NA
"471","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Edara","Venkata Viswanadh","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U",NA
"472","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Floyd","Katharine","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U",NA
"473","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Smith","Justin C","Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, U",NA
"474","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Latif","Muhammad Bilal","Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, U",NA
"475","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Pacheco-Sanchez","Gabriela","Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, U",NA
"476","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Dutta","Debashis","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U",NA
"477","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Wang","Shelly","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U",NA
"478","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Gumber","Sanjeev","Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, U",NA
"479","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Kirejczyk","Shannon","Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, U",NA
"480","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Cohen","Joyce","Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA",NA
"481","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Stammen","Rachelle L","Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA",NA
"482","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Jean","Sherrie M","Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA",NA
"483","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Wood","Jennifer S","Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA",NA
"484","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Connor-Stroud","Fawn","Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA",NA
"485","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Pollet","Jeroen","Texas Children's Center for Vaccine Development, Houston, TX, U",NA
"486","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Chen","Wen-Hsiang","Texas Children's Center for Vaccine Development, Houston, TX, U",NA
"487","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Wei","Junfei","Texas Children's Center for Vaccine Development, Houston, TX, U",NA
"488","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Zhan","Bin","Texas Children's Center for Vaccine Development, Houston, TX, U",NA
"489","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Lee","Jungsoon","Texas Children's Center for Vaccine Development, Houston, TX, U",NA
"490","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Liu","Zhuyun","Texas Children's Center for Vaccine Development, Houston, TX, U",NA
"491","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Strych","Ulrich","Texas Children's Center for Vaccine Development, Houston, TX, U",NA
"492","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Shenvi","Neeta","Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, U",NA
"493","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Easley","Kirk","Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, U",NA
"494","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Weiskopf","Daniela","Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA",NA
"495","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Sette","Alessandro","Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA",NA
"496","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Pollara","Justin","Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, NC, USA",NA
"497","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Mielke","Dieter","Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, NC, USA",NA
"498","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Gao","Hongmei","Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, NC, USA",NA
"499","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Eisel","Nathan","Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, NC, USA",NA
"500","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"LaBranche","Celia C","Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, NC, USA",NA
"501","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Shen","Xiaoying","Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, NC, USA",NA
"502","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Ferrari","Guido","Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, NC, USA",NA
"503","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Tomaras","Georgia D","Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, NC, USA",NA
"504","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Montefiori","David C","Department of Pediatrics, Molecular Virology &amp",NA
"505","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Sekaly","Rafick P","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U",NA
"506","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Vanderford","Thomas H","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U",NA
"507","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Tomai","Mark A","M Corporate Research Materials Laboratory, St. Paul, MN, USA",NA
"508","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Fox","Christopher B","The Infectious Disease Research Institute, Seattle, WA, USA",NA
"509","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Suthar","Mehul S","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U",NA
"510","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Kozlowski","Pamela A","Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, U",NA
"511","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Hotez","Peter J","Texas Children's Center for Vaccine Development, Houston, TX, U",NA
"512","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Paiardini","Mirko","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U.S.A. skastur@emory.edu bottazzi@bcm.edu mirko.paiardini@emory","skastur@emory.edu"
"513","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Bottazzi","Maria Elena","Texas Children's Center for Vaccine Development, Houston, TX, U.S.A. skastur@emory.edu bottazzi@bcm.edu mirko.paiardini@emory","skastur@emory.edu"
"514","34266981","10.1126/sciimmunol.abh3634","A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.","Ongoing SARS-CoV-2 vaccine development is focused on identifying stable, cost-effective, and accessible candidates for global use, specifically in low and middle-income countries. Here, we report the efficacy of a rapidly scalable, novel yeast expressed SARS-CoV-2 specific receptor-binding domain (RBD) based vaccine in rhesus macaques. We formulated the RBD immunogen in alum, a licensed and an emerging alum adsorbed TLR-7/8 targeted, 3M-052-alum adjuvants. The RBD+3M-052-alum adjuvanted vaccine ","2021","07","19","Sci Immunol","Science immunology",NA,"Kasturi","Sudhir Pai","Division of Microbiology and Immunology, Yerkes National Primate Research Center at Emory University, 954 Gatewood Rd, Atlanta, GA, U.S.A. skastur@emory.edu bottazzi@bcm.edu mirko.paiardini@emory","skastur@emory.edu"
"515","34266980","10.1136/jech-2020-216129","Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational study.","Despite having a large indigenous population, little is known about the differences in COVID-19-related health outcomes between indigenous and non-indigenous patients in Mexico. The aim of this study is to analyse the variation in hospitalisation and death between indigenous and non-indigenous patients with COVID-19 to guide future policies and clinical practice. We used data from the Mexican Ministry of Health (MoH) to study the hospitalisation and death of adults with laboratory-confirmed SARS","2021","07","21","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; ethnic groups; inequalities; morbidity; mortality","Serván-Mori","Edson","Center for Health Systems Research, National Institute of Public Health Mexico, Cuernavaca, Morelos, Mexico",NA
"516","34266980","10.1136/jech-2020-216129","Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational study.","Despite having a large indigenous population, little is known about the differences in COVID-19-related health outcomes between indigenous and non-indigenous patients in Mexico. The aim of this study is to analyse the variation in hospitalisation and death between indigenous and non-indigenous patients with COVID-19 to guide future policies and clinical practice. We used data from the Mexican Ministry of Health (MoH) to study the hospitalisation and death of adults with laboratory-confirmed SARS","2021","07","21","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; ethnic groups; inequalities; morbidity; mortality","Seiglie","Jacqueline A","Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"517","34266980","10.1136/jech-2020-216129","Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational study.","Despite having a large indigenous population, little is known about the differences in COVID-19-related health outcomes between indigenous and non-indigenous patients in Mexico. The aim of this study is to analyse the variation in hospitalisation and death between indigenous and non-indigenous patients with COVID-19 to guide future policies and clinical practice. We used data from the Mexican Ministry of Health (MoH) to study the hospitalisation and death of adults with laboratory-confirmed SARS","2021","07","21","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; ethnic groups; inequalities; morbidity; mortality","Gómez-Dantés","Octavio","Center for Health Systems Research, National Institute of Public Health Mexico, Cuernavaca, Morelos, Mexico",NA
"518","34266980","10.1136/jech-2020-216129","Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational study.","Despite having a large indigenous population, little is known about the differences in COVID-19-related health outcomes between indigenous and non-indigenous patients in Mexico. The aim of this study is to analyse the variation in hospitalisation and death between indigenous and non-indigenous patients with COVID-19 to guide future policies and clinical practice. We used data from the Mexican Ministry of Health (MoH) to study the hospitalisation and death of adults with laboratory-confirmed SARS","2021","07","21","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; ethnic groups; inequalities; morbidity; mortality","Wirtz","Veronika J","Department of Global Health, Boston University, Boston, Massachusetts, USA vwirtz@bu",NA
"519","34266974","10.1136/bmjmilitary-2021-001874","A pilot study of the depression, anxiety and stress in Greek military personnel during the first year of the COVID-19 pandemic.","The ongoing SARS-CoV-2 pandemic is a global health crisis which poses many psychological research challenges. The objective of this study was to evaluate the responsiveness and validity of depression, anxiety and stress in a representative cohort of Hellenic military personnel using the short version of the Greek military version of the Depression-Anxiety-Stress Scales-21 (DASS-21) questionnaire. A total of 158 participants were voluntarily surveyed using an electronically developed structured q","2021","07","21","BMJ Mil Health","BMJ military health","COVID-19; anxiety disorders; depression &amp; mood disorders; psychiatry","Kotoulas","Athanasios S","Research &amp","athkot@gmail.com"
"520","34266974","10.1136/bmjmilitary-2021-001874","A pilot study of the depression, anxiety and stress in Greek military personnel during the first year of the COVID-19 pandemic.","The ongoing SARS-CoV-2 pandemic is a global health crisis which poses many psychological research challenges. The objective of this study was to evaluate the responsiveness and validity of depression, anxiety and stress in a representative cohort of Hellenic military personnel using the short version of the Greek military version of the Depression-Anxiety-Stress Scales-21 (DASS-21) questionnaire. A total of 158 participants were voluntarily surveyed using an electronically developed structured q","2021","07","21","BMJ Mil Health","BMJ military health","COVID-19; anxiety disorders; depression &amp; mood disorders; psychiatry","Karamanavis","D","Medical Department, Hellenic Tactical Air Force, Larissa, Greece",NA
"521","34266974","10.1136/bmjmilitary-2021-001874","A pilot study of the depression, anxiety and stress in Greek military personnel during the first year of the COVID-19 pandemic.","The ongoing SARS-CoV-2 pandemic is a global health crisis which poses many psychological research challenges. The objective of this study was to evaluate the responsiveness and validity of depression, anxiety and stress in a representative cohort of Hellenic military personnel using the short version of the Greek military version of the Depression-Anxiety-Stress Scales-21 (DASS-21) questionnaire. A total of 158 participants were voluntarily surveyed using an electronically developed structured q","2021","07","21","BMJ Mil Health","BMJ military health","COVID-19; anxiety disorders; depression &amp; mood disorders; psychiatry","Lambrou","G <U+0399>","First Department of Pediatrics, Choremeio Research Laboratory, National and Kapodistrian University of Athens, Athens, Greece",NA
"522","34266974","10.1136/bmjmilitary-2021-001874","A pilot study of the depression, anxiety and stress in Greek military personnel during the first year of the COVID-19 pandemic.","The ongoing SARS-CoV-2 pandemic is a global health crisis which poses many psychological research challenges. The objective of this study was to evaluate the responsiveness and validity of depression, anxiety and stress in a representative cohort of Hellenic military personnel using the short version of the Greek military version of the Depression-Anxiety-Stress Scales-21 (DASS-21) questionnaire. A total of 158 participants were voluntarily surveyed using an electronically developed structured q","2021","07","21","BMJ Mil Health","BMJ military health","COVID-19; anxiety disorders; depression &amp; mood disorders; psychiatry","Karanikas","P","Medical Department, 110CW/Hellenic Tactical Air Force, Larissa, Greece",NA
"523","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Perez-Nieto","Orlando R","Intensive Care Unit, Hospital General San Juan del Rio, Querétaro, Mexico",NA
"524","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Escarraman-Martinez","Diego","Department of Anaesthesia, Hospital de Especialidades Centro Médico Nacional ""LaRaza"", Mexico City, Mexico",NA
"525","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Guerrero-Gutierrez","Manuel A","Department of Critical Care Medicine, Instituto Nacional de Cancerología, Mexico City, Mexico",NA
"526","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Zamarron-Lopez","Eder I","Intensive Care Unit, Hospital CEMAIN Tampico, Tamaulipas, Mexico",NA
"527","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Mancilla-Galindo","Javier","Unidad de Investigación UNAM-INC, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico",NA
"528","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Kammar-García","Ashuin","Emergency Department, Instituto Nacional de Ciencias Médicas y Nutrición ""Salvador Zubirán"", Mexico City, Mexico",NA
"529","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Martinez-Camacho","Miguel A","Intensive Care Unit, Hospital General de México, Mexico City, Mexico",NA
"530","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Deloya-Tomás","Ernesto","Intensive Care Unit, Hospital General San Juan del Rio, Querétaro, Mexico",NA
"531","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Sanchez-Diaz","Jesús S","Intensive Care Unit, Hospital de Alta Especialidad IMSS ""Adolfo Ruiz Cortines"" Veracruz, Veracruz, Mexico",NA
"532","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Macías-García","Luis A","Intensive Care Unit, Hospital Regional ISSSTE ""Fernando Quiroz Gutiérrez"", Mexico City, Mexico",NA
"533","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Soriano-Orozco","Raúl","Intensive Care Unit, Hospital de Alta Especialidad T1 IMSS, León, Guanajuato, Mexico",NA
"534","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Cruz-Sánchez","Gabriel","Intensive Care Unit, Clínica Hospital Mérida ISSSTE, Yucatán, Mexico",NA
"535","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Salmeron-Gonzalez","José D","Intensive Care Unit, Hospital General ""Miguel Silva"", Morelia, Michoacán, Mexico",NA
"536","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Toledo-Rivera","Marco A","Intensive Care Unit, Hospital SEDNA, Mexico City, Mexico",NA
"537","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Mata-Maqueda","Ivette","Secretaría de Salud del Estado de Querétaro, Ethics and Research Committee, Mexico",NA
"538","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Morgado-Villaseñor","Luis A","Intensive Care Unit, Hospital General de Zona IMSS No.15 Reynosa, Tamaulipas, Mexico",NA
"539","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Martinez-Mazariegos","Jenner J","Intensive Care Unit, Hospital Vida Mejor ISSSTECH Tuxtla Gutiérrez, Chiapas, Mexico",NA
"540","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Ramirez","Raymundo Flores","Intensive Care Unit, Hospital de Especialidades ""5 de Mayo"" ISSSTEP, Puebla, Puebla, Mexico",NA
"541","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Medina-Estrada","Josue L","Intensive Care Unit, Hospital Regional No. 1 IMSS ""Vicente Guerrero"", Acapulco, Guerrero, Mexico",NA
"542","34266942","10.1183/13993003.00265-2021","Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study.","The awake prone position (AP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease (COVID-19) who underwent AP during hospitalisation.In this retrospective, multicentre observational study conducted between May 1 and June 12, 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with ","2021","07","16","Eur Respir J","The European respiratory journal",NA,"Ñamendys-Silva","Silvio A","Department of Critical Care Medicine, Instituto Nacional de Cancerología, Mexico City, Mexico",NA
"543","34266910","10.1136/bmjspcare-2020-002713","From COVID-19 adversity comes opportunity: teaching an online integrative medicine course.","We examine the impact of a 5-day online elective course in integrative medicine (IM) taking place during the COVID-19 pandemic, attended by 18 medical students from two faculties of medicine in Israel. The course curriculum addressed effectiveness and safety of IM practices highlighting supportive and palliative care, demonstrated the work of integrative physicians (IPs) in designing patient-tailored treatments and taught practical skills in communication regarding IM. Group discussions were con","2021","07","16","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","complementary therapy; education and training; supportive care; symptoms and symptom management","Ben-Arye","Eran","Integrative Oncology Program, Oncology Service, Clalit Health Services, Haifa, Israel eranben@netvision.net","eranben@netvision.net.il"
"544","34266910","10.1136/bmjspcare-2020-002713","From COVID-19 adversity comes opportunity: teaching an online integrative medicine course.","We examine the impact of a 5-day online elective course in integrative medicine (IM) taking place during the COVID-19 pandemic, attended by 18 medical students from two faculties of medicine in Israel. The course curriculum addressed effectiveness and safety of IM practices highlighting supportive and palliative care, demonstrated the work of integrative physicians (IPs) in designing patient-tailored treatments and taught practical skills in communication regarding IM. Group discussions were con","2021","07","16","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","complementary therapy; education and training; supportive care; symptoms and symptom management","Keshet","Yael","Department of Sociology and Anthropology, Western Galilee College, Akko, Israel",NA
"545","34266910","10.1136/bmjspcare-2020-002713","From COVID-19 adversity comes opportunity: teaching an online integrative medicine course.","We examine the impact of a 5-day online elective course in integrative medicine (IM) taking place during the COVID-19 pandemic, attended by 18 medical students from two faculties of medicine in Israel. The course curriculum addressed effectiveness and safety of IM practices highlighting supportive and palliative care, demonstrated the work of integrative physicians (IPs) in designing patient-tailored treatments and taught practical skills in communication regarding IM. Group discussions were con","2021","07","16","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","complementary therapy; education and training; supportive care; symptoms and symptom management","Schiff","Ariel","Ben-Gurion University of the Negev, Beer Sheba, Israel",NA
"546","34266910","10.1136/bmjspcare-2020-002713","From COVID-19 adversity comes opportunity: teaching an online integrative medicine course.","We examine the impact of a 5-day online elective course in integrative medicine (IM) taking place during the COVID-19 pandemic, attended by 18 medical students from two faculties of medicine in Israel. The course curriculum addressed effectiveness and safety of IM practices highlighting supportive and palliative care, demonstrated the work of integrative physicians (IPs) in designing patient-tailored treatments and taught practical skills in communication regarding IM. Group discussions were con","2021","07","16","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","complementary therapy; education and training; supportive care; symptoms and symptom management","Zollman","Catherine","Penny Brohn UK, Bristol, UK",NA
"547","34266910","10.1136/bmjspcare-2020-002713","From COVID-19 adversity comes opportunity: teaching an online integrative medicine course.","We examine the impact of a 5-day online elective course in integrative medicine (IM) taking place during the COVID-19 pandemic, attended by 18 medical students from two faculties of medicine in Israel. The course curriculum addressed effectiveness and safety of IM practices highlighting supportive and palliative care, demonstrated the work of integrative physicians (IPs) in designing patient-tailored treatments and taught practical skills in communication regarding IM. Group discussions were con","2021","07","16","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","complementary therapy; education and training; supportive care; symptoms and symptom management","Portalupi","Emanuela","Associazione Italiana di Ricerche e Studi per la Medicina Antroposofica (ARESMA), Milano, Italy",NA
"548","34266910","10.1136/bmjspcare-2020-002713","From COVID-19 adversity comes opportunity: teaching an online integrative medicine course.","We examine the impact of a 5-day online elective course in integrative medicine (IM) taking place during the COVID-19 pandemic, attended by 18 medical students from two faculties of medicine in Israel. The course curriculum addressed effectiveness and safety of IM practices highlighting supportive and palliative care, demonstrated the work of integrative physicians (IPs) in designing patient-tailored treatments and taught practical skills in communication regarding IM. Group discussions were con","2021","07","16","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","complementary therapy; education and training; supportive care; symptoms and symptom management","Nave","Rachel","Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel",NA
"549","34266910","10.1136/bmjspcare-2020-002713","From COVID-19 adversity comes opportunity: teaching an online integrative medicine course.","We examine the impact of a 5-day online elective course in integrative medicine (IM) taking place during the COVID-19 pandemic, attended by 18 medical students from two faculties of medicine in Israel. The course curriculum addressed effectiveness and safety of IM practices highlighting supportive and palliative care, demonstrated the work of integrative physicians (IPs) in designing patient-tailored treatments and taught practical skills in communication regarding IM. Group discussions were con","2021","07","16","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","complementary therapy; education and training; supportive care; symptoms and symptom management","Shaham","Dorith","Hadassah Medical Center and Hebrew University Faculty of Medicine, Jerusalem, Israel",NA
"550","34266910","10.1136/bmjspcare-2020-002713","From COVID-19 adversity comes opportunity: teaching an online integrative medicine course.","We examine the impact of a 5-day online elective course in integrative medicine (IM) taking place during the COVID-19 pandemic, attended by 18 medical students from two faculties of medicine in Israel. The course curriculum addressed effectiveness and safety of IM practices highlighting supportive and palliative care, demonstrated the work of integrative physicians (IPs) in designing patient-tailored treatments and taught practical skills in communication regarding IM. Group discussions were con","2021","07","16","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","complementary therapy; education and training; supportive care; symptoms and symptom management","Samuels","Noah","Center for Integrative Complementary Medicine, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel",NA
"551","34266910","10.1136/bmjspcare-2020-002713","From COVID-19 adversity comes opportunity: teaching an online integrative medicine course.","We examine the impact of a 5-day online elective course in integrative medicine (IM) taking place during the COVID-19 pandemic, attended by 18 medical students from two faculties of medicine in Israel. The course curriculum addressed effectiveness and safety of IM practices highlighting supportive and palliative care, demonstrated the work of integrative physicians (IPs) in designing patient-tailored treatments and taught practical skills in communication regarding IM. Group discussions were con","2021","07","16","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","complementary therapy; education and training; supportive care; symptoms and symptom management","Schiff","Elad","Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel",NA
"552","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Farooqi","Kanwal M","Divisions of Pediatric Cardiology, kf2549@cumc.columbia","kf2549@cumc.columbia.edu"
"553","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Chan","Angela","Pediatric Allergy, Immunology, and Rheumatology",NA
"554","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Weller","Rachel J","Divisions of Pediatric Cardiology",NA
"555","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Mi","Junhui","Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York",NA
"556","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Jiang","Pengfei","Divisions of Pediatric Cardiology",NA
"557","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Abrahams","Elizabeth","Divisions of Pediatric Cardiology",NA
"558","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Ferris","Anne","Divisions of Pediatric Cardiology",NA
"559","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Krishnan","Usha S","Divisions of Pediatric Cardiology",NA
"560","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Pasumarti","Nikhil","Divisions of Pediatric Cardiology",NA
"561","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Suh","Sanghee","Divisions of Pediatric Cardiology",NA
"562","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Shah","Amee M","Divisions of Pediatric Cardiology",NA
"563","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"DiLorenzo","Michael P","Divisions of Pediatric Cardiology",NA
"564","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Zachariah","Philip","Pediatric Infectious Disease, New York-Presbyterian/Columbia University Irving Medical Center, New York, New York",NA
"565","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Milner","Joshua D","Pediatric Allergy, Immunology, and Rheumatology",NA
"566","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Rosenzweig","Erika B","Divisions of Pediatric Cardiology",NA
"567","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Gorelik","Mark","Pediatric Allergy, Immunology, and Rheumatology",NA
"568","34266903","10.1542/peds.2021-051155","Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.","In spring 2020, a novel hyperinflammatory process associated with severe acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children (MIS-C) was described. The long-term impact remains unknown. We report longitudinal outcomes from a New York interdisciplinary follow-up program. All children &lt;21 years of age, admitted to NewYork-Presbyterian with MIS-C in 2020, were included. Children were followed at 1 to 4 weeks, 1 to 4 months, and 4 to 9 months postdischarge. In t","2021","07","16","Pediatrics","Pediatrics",NA,"Anderson","Brett R","Pediatric Allergy, Immunology, and Rheumatology",NA
"569","34266880","10.1136/bmj.n1794","Defining covid-19 elimination.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Skegg","David Cg","Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand david.skegg@otago.ac","david.skegg@otago.ac.nz"
"570","34266880","10.1136/bmj.n1794","Defining covid-19 elimination.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Hill","Philip C","Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand",NA
"571","34266879","10.1136/bmj.n1802","Winter pressure: RSV, flu, and covid-19 could push NHS to breaking point, report warns.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Mahase","Elisabeth","The BMJ",NA
"572","34266877","10.1136/archdischild-2020-321546","Paediatric headbox as aerosol and droplet barrier.","High-flow nasal oxygen (HFNO) is frequently used in hospitals, producing droplets and aerosols that could transmit SARS-CoV-2. To determine if a headbox could reduce droplet and aerosol transmission from patients requiring HFNO. The size and dispersion of propylene glycol (model for patient-derived infectious particles) was measured using a spectrometer and an infant mannequin receiving 10-50 L/min of HFNO using (1) no headbox, (2) open headbox, (3) headbox-blanket or (4) headbox with a high-eff","2021","07","16","Arch Dis Child","Archives of disease in childhood","COVID-19; paediatrics; respiratory medicine; technology","Sahih","Monica","Department of General Paediatrics, Perth Children's Hospital, Perth, Western Australia, Australia monica.sahih@health.wa.gov","monica.sahih@health.wa.gov.au"
"573","34266877","10.1136/archdischild-2020-321546","Paediatric headbox as aerosol and droplet barrier.","High-flow nasal oxygen (HFNO) is frequently used in hospitals, producing droplets and aerosols that could transmit SARS-CoV-2. To determine if a headbox could reduce droplet and aerosol transmission from patients requiring HFNO. The size and dispersion of propylene glycol (model for patient-derived infectious particles) was measured using a spectrometer and an infant mannequin receiving 10-50 L/min of HFNO using (1) no headbox, (2) open headbox, (3) headbox-blanket or (4) headbox with a high-eff","2021","07","16","Arch Dis Child","Archives of disease in childhood","COVID-19; paediatrics; respiratory medicine; technology","Schultz","André","Telethon Kids Institute, Wal-yan Respiratory Research Centre, Perth, Western Australia, Australia",NA
"574","34266877","10.1136/archdischild-2020-321546","Paediatric headbox as aerosol and droplet barrier.","High-flow nasal oxygen (HFNO) is frequently used in hospitals, producing droplets and aerosols that could transmit SARS-CoV-2. To determine if a headbox could reduce droplet and aerosol transmission from patients requiring HFNO. The size and dispersion of propylene glycol (model for patient-derived infectious particles) was measured using a spectrometer and an infant mannequin receiving 10-50 L/min of HFNO using (1) no headbox, (2) open headbox, (3) headbox-blanket or (4) headbox with a high-eff","2021","07","16","Arch Dis Child","Archives of disease in childhood","COVID-19; paediatrics; respiratory medicine; technology","Wilson","Andrew","Department of Respiratory Medicine, Perth Children's Hospital, Perth, Western Australia, Australia",NA
"575","34266877","10.1136/archdischild-2020-321546","Paediatric headbox as aerosol and droplet barrier.","High-flow nasal oxygen (HFNO) is frequently used in hospitals, producing droplets and aerosols that could transmit SARS-CoV-2. To determine if a headbox could reduce droplet and aerosol transmission from patients requiring HFNO. The size and dispersion of propylene glycol (model for patient-derived infectious particles) was measured using a spectrometer and an infant mannequin receiving 10-50 L/min of HFNO using (1) no headbox, (2) open headbox, (3) headbox-blanket or (4) headbox with a high-eff","2021","07","16","Arch Dis Child","Archives of disease in childhood","COVID-19; paediatrics; respiratory medicine; technology","Alakeson","Renuka","Department of Anaesthetics, Perth Children's Hospital, Perth, Western Australia, Australia",NA
"576","34266877","10.1136/archdischild-2020-321546","Paediatric headbox as aerosol and droplet barrier.","High-flow nasal oxygen (HFNO) is frequently used in hospitals, producing droplets and aerosols that could transmit SARS-CoV-2. To determine if a headbox could reduce droplet and aerosol transmission from patients requiring HFNO. The size and dispersion of propylene glycol (model for patient-derived infectious particles) was measured using a spectrometer and an infant mannequin receiving 10-50 L/min of HFNO using (1) no headbox, (2) open headbox, (3) headbox-blanket or (4) headbox with a high-eff","2021","07","16","Arch Dis Child","Archives of disease in childhood","COVID-19; paediatrics; respiratory medicine; technology","Taylor","Ellen","Department of General Paediatrics, Perth Children's Hospital, Perth, Western Australia, Australia",NA
"577","34266877","10.1136/archdischild-2020-321546","Paediatric headbox as aerosol and droplet barrier.","High-flow nasal oxygen (HFNO) is frequently used in hospitals, producing droplets and aerosols that could transmit SARS-CoV-2. To determine if a headbox could reduce droplet and aerosol transmission from patients requiring HFNO. The size and dispersion of propylene glycol (model for patient-derived infectious particles) was measured using a spectrometer and an infant mannequin receiving 10-50 L/min of HFNO using (1) no headbox, (2) open headbox, (3) headbox-blanket or (4) headbox with a high-eff","2021","07","16","Arch Dis Child","Archives of disease in childhood","COVID-19; paediatrics; respiratory medicine; technology","Mullins","Benjamin","Curtin Health Innovation Research Institute, Curtin University, Perth, Western Australia, Australia",NA
"578","34266877","10.1136/archdischild-2020-321546","Paediatric headbox as aerosol and droplet barrier.","High-flow nasal oxygen (HFNO) is frequently used in hospitals, producing droplets and aerosols that could transmit SARS-CoV-2. To determine if a headbox could reduce droplet and aerosol transmission from patients requiring HFNO. The size and dispersion of propylene glycol (model for patient-derived infectious particles) was measured using a spectrometer and an infant mannequin receiving 10-50 L/min of HFNO using (1) no headbox, (2) open headbox, (3) headbox-blanket or (4) headbox with a high-eff","2021","07","16","Arch Dis Child","Archives of disease in childhood","COVID-19; paediatrics; respiratory medicine; technology","Martin","Andrew C","Department of General Paediatrics, Perth Children's Hospital, Perth, Western Australia, Australia",NA
"579","34266875","10.1136/archdischild-2021-322298","Kids are back in town: the return of high demand for paediatric emergency care.",NA,"2021","07","16","Arch Dis Child","Archives of disease in childhood","COVID-19; data collection","Jenner","Rachel","Paediatric Emergency Department, Royal Manchester Children's Hospital, Manchester, UK",NA
"580","34266875","10.1136/archdischild-2021-322298","Kids are back in town: the return of high demand for paediatric emergency care.",NA,"2021","07","16","Arch Dis Child","Archives of disease in childhood","COVID-19; data collection","Walker","Alexandra","Lancaster Medical School, Lancaster University, Lancaster, UK",NA
"581","34266875","10.1136/archdischild-2021-322298","Kids are back in town: the return of high demand for paediatric emergency care.",NA,"2021","07","16","Arch Dis Child","Archives of disease in childhood","COVID-19; data collection","Isba","Rachel","Lancaster Medical School, Lancaster University, Lancaster, UK rachel.isba@nhs","rachel.isba@nhs.net"
"582","34266864","10.1136/bmj.n1810","Covid-19: Face coverings and social distancing rules will continue in all healthcare settings.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Iacobucci","Gareth","The BMJ",NA
"583","34266863","10.1136/bmj.n1808","Covid-19: Vaccine centres operating at 30% capacity as young people stay away.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Torjesen","Ingrid","London",NA
"584","34266862","10.1136/bmj.n1811","Covid-19 vaccination: GPs ruled out of booster campaign at practice level.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"O'Dowd","Adrian","London, UK",NA
"585","34266850","10.1136/bmjgh-2021-006720","Equity without human rights: a false COVID-19 narrative?",NA,"2021","07","21","BMJ Glob Health","BMJ global health","COVID-19; health policy; public health; COVID-19; Human Rights; Humans; SARS-CoV-2","Khosla","Rajat","Amnesty International, London, UK",NA
"586","34266850","10.1136/bmjgh-2021-006720","Equity without human rights: a false COVID-19 narrative?",NA,"2021","07","21","BMJ Glob Health","BMJ global health","COVID-19; health policy; public health; COVID-19; Human Rights; Humans; SARS-CoV-2","Gruskin","Sofia","Institute on Inequalities in Global Health, University of Southern California, Los Angeles, California, USA Gruskin@med.usc","Gruskin@med.usc.edu"
"587","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Beniczky","Sándor","Department of Clinical Neurophysiology, Neurology, Aarhus University Hospital, Aarhus and Danish Epilepsy Centre, Dianalund, Denmark",NA
"588","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Husain","Aatif","Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA and Neurodiagnostic Center, Veterans Affairs Medical Center, Durham, North Carolina, USA",NA
"589","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Ikeda","Akio","Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, Kyoto, Japan",NA
"590","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Alabri","Haifa","Neurology Unit, Department of Medicine, Sultan Qaboos University Hospital, Sultan Qaboos university, Sultanate of Oman",NA
"591","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Cross","J Helen","UCL NIHR BRC Great Ormond Street Institute of Child Health, Great Ormond Street Hospital for Children, London, member of ERN EpiCARE, and Young Epilepsy Lingfield, UK",NA
"592","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Wilmshurst","Jo","Department of Paediatric Neurology, Red Cross War Memorial Children's Hospital, Neuroscience Institute, University of Cape Town, South Africa",NA
"593","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Seeck","Margitta","EEG &amp",NA
"594","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Focke","Niels","Department of Neurology, University Medical Center, Göttingen, Germany",NA
"595","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Braga","Patricia","Institute of Neurology, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Uruguay",NA
"596","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Wiebe","Samuel","Department of Clinical Neurosciences, University of Calgary, Canada",NA
"597","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Schuele","Stephan","Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, USA",NA
"598","34266813","10.1684/epd.2021.1292","Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology.","Restructuring of healthcare services during the COVID-19 pandemic has led to lockdown of epilepsy monitoring units (EMUs) in many hospitals. The ad-hoc taskforce of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) highlights the detrimental effect of postponing video-EEG monitoring of patients with epilepsy and other paroxysmal events. The taskforce calls for action for continued functioning of EMUs during emergency situations, ","2021","07","16","Epileptic Disord","Epileptic disorders : international epilepsy journal with videotape","COVID-19 pandemic; IFCN; ILAE; epilepsy monitoring units (EMUs); video-EEG","Trinka","Eugen","Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University and Centre for Cognitive Neuroscience, Salzburg, Austria, Affiliated EpiCARE Partner",NA
"599","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Sotomayor-Castillo","Cristina","Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, University of Sydney, Camperdown, NSW, 2006, Australia",NA
"600","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Nahidi","Shizar","Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, University of Sydney, Camperdown, NSW, 2006, Australia",NA
"601","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Li","Cecilia","Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, University of Sydney, Camperdown, NSW, 2006, Australia",NA
"602","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Macbeth","Deborough","Infection Control Department, Infectious Diseases and Immunology, Gold Coast Hospital and Health Service, Southport, QLD, 4215, Australia",NA
"603","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Russo","Philip L","Department of Nursing Research, Cabrini Institute, VIC, 3144, Australia",NA
"604","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Mitchell","Brett G","School of Nursing and Midwifery, College of Health, Medicine and Wellbeing, Newcastle University, NSW, 2308, Australia",NA
"605","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Cruickshank","Marilyn","Nursing Research Unit, Sydney Children's Hospitals Network, Sydney, NSW, 2031, Australia",NA
"606","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Sorrell","Tania","Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Westmead, NSW, 2145, Australia",NA
"607","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Gilroy","Nicole","Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital, Westmead, NSW, 2145, Australia",NA
"608","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Ferguson","Patricia","Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital, Westmead, NSW, 2145, Australia",NA
"609","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Watts","Matthew R","Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Westmead, NSW, 2145, Australia",NA
"610","34266812","10.1016/j.idh.2021.05.002","Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings.","COVID-19 has placed unprecedented demands on infection control professionals (ICPs) and infectious disease (ID) physicians. This study examined their knowledge, preparedness, and experiences managing COVID-19 in the Australian healthcare settings. A cross-sectional study of ICPs and ID physician members of the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID) was conducted using an online survey. Descriptive statistics w","2021","07","18","Infect Dis Health","Infection, disease &amp; health","Attitudes; COVID-19; Health knowledge; Infection control; Outbreaks; Practice","Shaban","Ramon Z","Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, University of Sydney, Camperdown, NSW, 2006, Australia","ramon.shaban@sydney.edu.au"
"611","34266784","10.1016/j.nephro.2021.06.003","[SFNDT in the heart of the COVID-19 epidemy].",NA,"2021","07","18","Nephrol Ther","Nephrologie &amp; therapeutique","COVID-19 epidemy; Crisis management; Dialyse; Dialysis; Gestion de crise; Transplantation; Épidémie COVID-19","Hourmant","Maryvonne","Service de néphrologie et immunologie clinique, CHU de Nantes, Nantes, France. Electronic address: maryvonne.hourmant@chu-nantes",NA
"612","34266784","10.1016/j.nephro.2021.06.003","[SFNDT in the heart of the COVID-19 epidemy].",NA,"2021","07","18","Nephrol Ther","Nephrologie &amp; therapeutique","COVID-19 epidemy; Crisis management; Dialyse; Dialysis; Gestion de crise; Transplantation; Épidémie COVID-19","Frimat","Luc","Service de néphrologie, CHRU de Nancy, Université de Lorraine, France",NA
"613","34266784","10.1016/j.nephro.2021.06.003","[SFNDT in the heart of the COVID-19 epidemy].",NA,"2021","07","18","Nephrol Ther","Nephrologie &amp; therapeutique","COVID-19 epidemy; Crisis management; Dialyse; Dialysis; Gestion de crise; Transplantation; Épidémie COVID-19","Moulin","Bruno","Service de néphrologie et transplantation, Hôpitaux universitaires de Strasbourg, Strasbourg, France",NA
"614","34266784","10.1016/j.nephro.2021.06.003","[SFNDT in the heart of the COVID-19 epidemy].",NA,"2021","07","18","Nephrol Ther","Nephrologie &amp; therapeutique","COVID-19 epidemy; Crisis management; Dialyse; Dialysis; Gestion de crise; Transplantation; Épidémie COVID-19","Vrtovsnik","François","Service de néphrologie, Hôpital Bichat, Paris, France",NA
"615","34266783","10.1016/j.nephro.2021.06.002","[Kidney damage in COVID-19].","COVID-19 is a disease caused by the RNA virus SARS-CoV-2. It is characterised by an attack mainly affecting the respiratory system. There is renal involvement which is characterised by three main types of damage, acute tubular necrosis occurring in the most severe cases, proximal tubulopathy which is a prognostic marker of the disease and segmental and focal hyalinosis occurring in a genetically predisposed terrain. The pathophysiology of SARS-CoV-2 renal involvement is not yet defined. The dire","2021","07","18","Nephrol Ther","Nephrologie &amp; therapeutique","Acute tubular necrosis; COVID-19; Focal segmental glomerulosclerosis; Hyalinose segmentaire et focale; Nécrose tubulaire aiguë; Proximal tubulopathy; SARS-CoV-2; Tubulopathie proximale","Burtey","Stéphane","Aix Marseille Univ, Inserm, INRAE, C2VN, 13005 Marseille, France",NA
"616","34266783","10.1016/j.nephro.2021.06.002","[Kidney damage in COVID-19].","COVID-19 is a disease caused by the RNA virus SARS-CoV-2. It is characterised by an attack mainly affecting the respiratory system. There is renal involvement which is characterised by three main types of damage, acute tubular necrosis occurring in the most severe cases, proximal tubulopathy which is a prognostic marker of the disease and segmental and focal hyalinosis occurring in a genetically predisposed terrain. The pathophysiology of SARS-CoV-2 renal involvement is not yet defined. The dire","2021","07","18","Nephrol Ther","Nephrologie &amp; therapeutique","Acute tubular necrosis; COVID-19; Focal segmental glomerulosclerosis; Hyalinose segmentaire et focale; Nécrose tubulaire aiguë; Proximal tubulopathy; SARS-CoV-2; Tubulopathie proximale","Sallée","Marion","Aix Marseille Univ, Inserm, INRAE, C2VN, 13005 Marseille, France",NA
"617","34266752","10.1016/j.jagp.2021.05.026","COVID-19 Associated Suicidal Ideation in Older Adults: Two Case Reports With a Review of the Literature.","The COVID-19 pandemic may profoundly harm the mental health and emotional well- being of many older adults. Public health interventions to minimize the spread of the virus have had the unintended consequences of worsening social isolation, financial stress, and unemployment. Results of early research efforts assessing the impact of these interventions on the mental health of older adults have been mixed. Available findings suggest that a subset of community-dwelling older adults have been less n","2021","07","18","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","COVID-19; ECT; case report; mental health; older adults; social isolation; suicidal ideation","Asthana","Niraj K","University of California, San Diego",NA
"618","34266752","10.1016/j.jagp.2021.05.026","COVID-19 Associated Suicidal Ideation in Older Adults: Two Case Reports With a Review of the Literature.","The COVID-19 pandemic may profoundly harm the mental health and emotional well- being of many older adults. Public health interventions to minimize the spread of the virus have had the unintended consequences of worsening social isolation, financial stress, and unemployment. Results of early research efforts assessing the impact of these interventions on the mental health of older adults have been mixed. Available findings suggest that a subset of community-dwelling older adults have been less n","2021","07","18","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","COVID-19; ECT; case report; mental health; older adults; social isolation; suicidal ideation","Mehaffey","Eamonn","University of California, San Diego",NA
"619","34266752","10.1016/j.jagp.2021.05.026","COVID-19 Associated Suicidal Ideation in Older Adults: Two Case Reports With a Review of the Literature.","The COVID-19 pandemic may profoundly harm the mental health and emotional well- being of many older adults. Public health interventions to minimize the spread of the virus have had the unintended consequences of worsening social isolation, financial stress, and unemployment. Results of early research efforts assessing the impact of these interventions on the mental health of older adults have been mixed. Available findings suggest that a subset of community-dwelling older adults have been less n","2021","07","18","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","COVID-19; ECT; case report; mental health; older adults; social isolation; suicidal ideation","Sewell","Daniel D","University of California, San Diego. Electronic address: dsewell@health.ucsd","dsewell@health.ucsd.edu"
"620","34266739","10.1016/j.acra.2021.05.004","Impact of COVID-19 on Radiology Faculty - An Exacerbation of Gender Differences in Unpaid Home Duties and Professional Productivity.","The COVID-19 pandemic stresses the tenuous balance between domestic obligations and academic output for women across professions. Our investigation aims to evaluate the impact of the pandemic on the home duties and workplace productivity of academic radiologists with respect to gender. A 49-question survey was distributed to 926 members of Association of University Radiologists in October 2020. Several categories were addressed: demographics; workplace changes; stress levels and personal experie","2021","07","16","Acad Radiol","Academic radiology","COVID-19; Gender Differences During COVID-19; female; homecare; productivity","Plaunova","Anastasia","NYU Grossman School of Medicine, 160 East 34th St, 3rd Floor, New York, New York 10016",NA
"621","34266739","10.1016/j.acra.2021.05.004","Impact of COVID-19 on Radiology Faculty - An Exacerbation of Gender Differences in Unpaid Home Duties and Professional Productivity.","The COVID-19 pandemic stresses the tenuous balance between domestic obligations and academic output for women across professions. Our investigation aims to evaluate the impact of the pandemic on the home duties and workplace productivity of academic radiologists with respect to gender. A 49-question survey was distributed to 926 members of Association of University Radiologists in October 2020. Several categories were addressed: demographics; workplace changes; stress levels and personal experie","2021","07","16","Acad Radiol","Academic radiology","COVID-19; Gender Differences During COVID-19; female; homecare; productivity","Heller","Samantha L","NYU Grossman School of Medicine, 160 East 34th St, 3rd Floor, New York, New York 10016",NA
"622","34266739","10.1016/j.acra.2021.05.004","Impact of COVID-19 on Radiology Faculty - An Exacerbation of Gender Differences in Unpaid Home Duties and Professional Productivity.","The COVID-19 pandemic stresses the tenuous balance between domestic obligations and academic output for women across professions. Our investigation aims to evaluate the impact of the pandemic on the home duties and workplace productivity of academic radiologists with respect to gender. A 49-question survey was distributed to 926 members of Association of University Radiologists in October 2020. Several categories were addressed: demographics; workplace changes; stress levels and personal experie","2021","07","16","Acad Radiol","Academic radiology","COVID-19; Gender Differences During COVID-19; female; homecare; productivity","Babb","James S","NYU Grossman School of Medicine, 160 East 34th St, 3rd Floor, New York, New York 10016",NA
"623","34266739","10.1016/j.acra.2021.05.004","Impact of COVID-19 on Radiology Faculty - An Exacerbation of Gender Differences in Unpaid Home Duties and Professional Productivity.","The COVID-19 pandemic stresses the tenuous balance between domestic obligations and academic output for women across professions. Our investigation aims to evaluate the impact of the pandemic on the home duties and workplace productivity of academic radiologists with respect to gender. A 49-question survey was distributed to 926 members of Association of University Radiologists in October 2020. Several categories were addressed: demographics; workplace changes; stress levels and personal experie","2021","07","16","Acad Radiol","Academic radiology","COVID-19; Gender Differences During COVID-19; female; homecare; productivity","Heffernan","Cathleen C","NYU Grossman School of Medicine, 160 East 34th St, 3rd Floor, New York, New York 10016. Electronic address: Cathleen.Heffernan@nyulangone","Cathleen.Heffernan@nyulangone.org"
"624","34266733","10.1016/j.iccn.2021.103094","Understanding new nurses' learning experiences in intensive care.","Recruitment and retention of nurses in intensive care units (ICU) has been challenging over the last few years. Rising demand is now exacerbated by the ongoing Covid-19 pandemic. Transition to ICU from other clinical areas is stressful resulting in significant nurse retention issues. This study therefore aimed to illuminate and explore new nurses' learning experiences in one large intensive care unit in the United Kingdom. Exploratory qualitative case study utilising two data collection methods:","2021","07","16","Intensive Crit Care Nurs","Intensive &amp; critical care nursing","ICU education; ICU nursing; Learning in ICU; New nurses in ICU","Stewart","Carolyne","Kings College London, United Kingdom. Electronic address: carolyne.1.stewart@kcl.ac","carolyne.1.stewart@kcl.ac.uk"
"625","34266715","10.1016/j.jadohealth.2021.05.019","The Impact of the COVID-19 Pandemic on the Number of Adolescents/Young Adults Seeking Eating Disorder-Related Care.","The COVID-19 pandemic has led to the development and worsening of eating disorder (ED) symptoms in adolescents and young adults. In order to examine COVID-19-related trends in ED care-seeking at our institution. We used interrupted time series regression to examine pre- and postpandemic monthly summary data of the following: (1) ED-related inpatient admissions for medical stabilization; (2) ED-related hospital bed-days; (3) completed outpatient ED assessments; and (4) ED outpatient care-related ","2021","07","16","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Eating disorders; Young adults","Lin","Jessica A","Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts","Jessica.lin2@childrens.harvard.edu"
"626","34266715","10.1016/j.jadohealth.2021.05.019","The Impact of the COVID-19 Pandemic on the Number of Adolescents/Young Adults Seeking Eating Disorder-Related Care.","The COVID-19 pandemic has led to the development and worsening of eating disorder (ED) symptoms in adolescents and young adults. In order to examine COVID-19-related trends in ED care-seeking at our institution. We used interrupted time series regression to examine pre- and postpandemic monthly summary data of the following: (1) ED-related inpatient admissions for medical stabilization; (2) ED-related hospital bed-days; (3) completed outpatient ED assessments; and (4) ED outpatient care-related ","2021","07","16","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Eating disorders; Young adults","Hartman-Munick","Sydney M","Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts",NA
"627","34266715","10.1016/j.jadohealth.2021.05.019","The Impact of the COVID-19 Pandemic on the Number of Adolescents/Young Adults Seeking Eating Disorder-Related Care.","The COVID-19 pandemic has led to the development and worsening of eating disorder (ED) symptoms in adolescents and young adults. In order to examine COVID-19-related trends in ED care-seeking at our institution. We used interrupted time series regression to examine pre- and postpandemic monthly summary data of the following: (1) ED-related inpatient admissions for medical stabilization; (2) ED-related hospital bed-days; (3) completed outpatient ED assessments; and (4) ED outpatient care-related ","2021","07","16","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Eating disorders; Young adults","Kells","Meredith R","Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois",NA
"628","34266715","10.1016/j.jadohealth.2021.05.019","The Impact of the COVID-19 Pandemic on the Number of Adolescents/Young Adults Seeking Eating Disorder-Related Care.","The COVID-19 pandemic has led to the development and worsening of eating disorder (ED) symptoms in adolescents and young adults. In order to examine COVID-19-related trends in ED care-seeking at our institution. We used interrupted time series regression to examine pre- and postpandemic monthly summary data of the following: (1) ED-related inpatient admissions for medical stabilization; (2) ED-related hospital bed-days; (3) completed outpatient ED assessments; and (4) ED outpatient care-related ","2021","07","16","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Eating disorders; Young adults","Milliren","Carly E","Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts",NA
"629","34266715","10.1016/j.jadohealth.2021.05.019","The Impact of the COVID-19 Pandemic on the Number of Adolescents/Young Adults Seeking Eating Disorder-Related Care.","The COVID-19 pandemic has led to the development and worsening of eating disorder (ED) symptoms in adolescents and young adults. In order to examine COVID-19-related trends in ED care-seeking at our institution. We used interrupted time series regression to examine pre- and postpandemic monthly summary data of the following: (1) ED-related inpatient admissions for medical stabilization; (2) ED-related hospital bed-days; (3) completed outpatient ED assessments; and (4) ED outpatient care-related ","2021","07","16","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Eating disorders; Young adults","Slater","Wallis A","Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts",NA
"630","34266715","10.1016/j.jadohealth.2021.05.019","The Impact of the COVID-19 Pandemic on the Number of Adolescents/Young Adults Seeking Eating Disorder-Related Care.","The COVID-19 pandemic has led to the development and worsening of eating disorder (ED) symptoms in adolescents and young adults. In order to examine COVID-19-related trends in ED care-seeking at our institution. We used interrupted time series regression to examine pre- and postpandemic monthly summary data of the following: (1) ED-related inpatient admissions for medical stabilization; (2) ED-related hospital bed-days; (3) completed outpatient ED assessments; and (4) ED outpatient care-related ","2021","07","16","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Eating disorders; Young adults","Woods","Elizabeth R","Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts",NA
"631","34266715","10.1016/j.jadohealth.2021.05.019","The Impact of the COVID-19 Pandemic on the Number of Adolescents/Young Adults Seeking Eating Disorder-Related Care.","The COVID-19 pandemic has led to the development and worsening of eating disorder (ED) symptoms in adolescents and young adults. In order to examine COVID-19-related trends in ED care-seeking at our institution. We used interrupted time series regression to examine pre- and postpandemic monthly summary data of the following: (1) ED-related inpatient admissions for medical stabilization; (2) ED-related hospital bed-days; (3) completed outpatient ED assessments; and (4) ED outpatient care-related ","2021","07","16","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Eating disorders; Young adults","Forman","Sara F","Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts",NA
"632","34266715","10.1016/j.jadohealth.2021.05.019","The Impact of the COVID-19 Pandemic on the Number of Adolescents/Young Adults Seeking Eating Disorder-Related Care.","The COVID-19 pandemic has led to the development and worsening of eating disorder (ED) symptoms in adolescents and young adults. In order to examine COVID-19-related trends in ED care-seeking at our institution. We used interrupted time series regression to examine pre- and postpandemic monthly summary data of the following: (1) ED-related inpatient admissions for medical stabilization; (2) ED-related hospital bed-days; (3) completed outpatient ED assessments; and (4) ED outpatient care-related ","2021","07","16","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Eating disorders; Young adults","Richmond","Tracy K","Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts",NA
"633","34266698","10.1016/j.ijmmb.2021.06.013","Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis.",NA,"2021","07","21","Indian J Med Microbiol","Indian journal of medical microbiology","COVID-19 associated mucormycosis; India; Rhizopus homothallicus","Kaur","Harsimran","Department of Medical Microbiology PGIMER, Chandigarh, India. Electronic address: drharsimranpgi@gmail","drharsimranpgi@gmail.com"
"634","34266698","10.1016/j.ijmmb.2021.06.013","Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis.",NA,"2021","07","21","Indian J Med Microbiol","Indian journal of medical microbiology","COVID-19 associated mucormycosis; India; Rhizopus homothallicus","Kanaujia","Rimjhim","Department of Medical Microbiology PGIMER, Chandigarh, India",NA
"635","34266698","10.1016/j.ijmmb.2021.06.013","Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis.",NA,"2021","07","21","Indian J Med Microbiol","Indian journal of medical microbiology","COVID-19 associated mucormycosis; India; Rhizopus homothallicus","Rudramurthy","Shivaprakash M","Department of Medical Microbiology PGIMER, Chandigarh, India",NA
"636","34266660","10.1016/j.bja.2021.06.016","COVID-19: a novel risk factor for perioperative neurocognitive disorders.",NA,"2021","07","18","Br J Anaesth","British journal of anaesthesia","COVID-19; SARS-CoV-2; older patients; perioperative neurocognitive disorders; risk factor","Wei","Penghui","Department of Anesthesiology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, People's Republic of China",NA
"637","34266660","10.1016/j.bja.2021.06.016","COVID-19: a novel risk factor for perioperative neurocognitive disorders.",NA,"2021","07","18","Br J Anaesth","British journal of anaesthesia","COVID-19; SARS-CoV-2; older patients; perioperative neurocognitive disorders; risk factor","Lyu","Wenyuan","Department of Anesthesiology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, People's Republic of China",NA
"638","34266660","10.1016/j.bja.2021.06.016","COVID-19: a novel risk factor for perioperative neurocognitive disorders.",NA,"2021","07","18","Br J Anaesth","British journal of anaesthesia","COVID-19; SARS-CoV-2; older patients; perioperative neurocognitive disorders; risk factor","Wan","Tiantian","Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Shandong First Medical University Shandong Provincial Qianfoshan Hospital, Shandong, People's Republic of China",NA
"639","34266660","10.1016/j.bja.2021.06.016","COVID-19: a novel risk factor for perioperative neurocognitive disorders.",NA,"2021","07","18","Br J Anaesth","British journal of anaesthesia","COVID-19; SARS-CoV-2; older patients; perioperative neurocognitive disorders; risk factor","Zheng","Qiang","Department of Anesthesiology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, People's Republic of China",NA
"640","34266660","10.1016/j.bja.2021.06.016","COVID-19: a novel risk factor for perioperative neurocognitive disorders.",NA,"2021","07","18","Br J Anaesth","British journal of anaesthesia","COVID-19; SARS-CoV-2; older patients; perioperative neurocognitive disorders; risk factor","Tang","Wenxi","Department of Anesthesiology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, People's Republic of China",NA
"641","34266660","10.1016/j.bja.2021.06.016","COVID-19: a novel risk factor for perioperative neurocognitive disorders.",NA,"2021","07","18","Br J Anaesth","British journal of anaesthesia","COVID-19; SARS-CoV-2; older patients; perioperative neurocognitive disorders; risk factor","Li","Jianjun","Department of Anesthesiology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, People's Republic of China. Electronic address: ljj9573@163","ljj9573@163.com"
"642","34266660","10.1016/j.bja.2021.06.016","COVID-19: a novel risk factor for perioperative neurocognitive disorders.",NA,"2021","07","18","Br J Anaesth","British journal of anaesthesia","COVID-19; SARS-CoV-2; older patients; perioperative neurocognitive disorders; risk factor","Yang","Jian-Jun","Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China. Electronic address: yjyangjj@126","yjyangjj@126.com"
"643","34266646","10.1016/j.surg.2021.03.069","Perspectives on virtual interviews-A follow-up study of the Comprehensive Endocrine Surgery Fellowship interview process.","The American Association of Endocrine Surgeons Comprehensive Endocrine Surgery Fellowship interview stakeholders previously favored in-person interviews, despite time and expense. This study assessed perception changes given mandated virtual interviews because of coronavirus disease 2019. Immediately after the 2020 Match, anonymous surveys were distributed to applicants (n = 37) and program directors (n = 22). Mixed-methods analyses were used to evaluate responses. Results were compared to data ","2021","07","16","Surgery","Surgery",NA,"Geary","Alaina D","Boston University School of Medicine and Boston Medical Center, MA. Electronic address: https://twitter.com/GearyMD",NA
"644","34266646","10.1016/j.surg.2021.03.069","Perspectives on virtual interviews-A follow-up study of the Comprehensive Endocrine Surgery Fellowship interview process.","The American Association of Endocrine Surgeons Comprehensive Endocrine Surgery Fellowship interview stakeholders previously favored in-person interviews, despite time and expense. This study assessed perception changes given mandated virtual interviews because of coronavirus disease 2019. Immediately after the 2020 Match, anonymous surveys were distributed to applicants (n = 37) and program directors (n = 22). Mixed-methods analyses were used to evaluate responses. Results were compared to data ","2021","07","16","Surgery","Surgery",NA,"Wang","Tracy S","Medical College of Wisconsin, Milwaukee, WI. Electronic address: https://twitter.com/tracyswangNYMKE",NA
"645","34266646","10.1016/j.surg.2021.03.069","Perspectives on virtual interviews-A follow-up study of the Comprehensive Endocrine Surgery Fellowship interview process.","The American Association of Endocrine Surgeons Comprehensive Endocrine Surgery Fellowship interview stakeholders previously favored in-person interviews, despite time and expense. This study assessed perception changes given mandated virtual interviews because of coronavirus disease 2019. Immediately after the 2020 Match, anonymous surveys were distributed to applicants (n = 37) and program directors (n = 22). Mixed-methods analyses were used to evaluate responses. Results were compared to data ","2021","07","16","Surgery","Surgery",NA,"Lindeman","Brenessa","University of Alabama at Birmingham, AL. Electronic address: https://twitter.com/BrenessaL",NA
"646","34266646","10.1016/j.surg.2021.03.069","Perspectives on virtual interviews-A follow-up study of the Comprehensive Endocrine Surgery Fellowship interview process.","The American Association of Endocrine Surgeons Comprehensive Endocrine Surgery Fellowship interview stakeholders previously favored in-person interviews, despite time and expense. This study assessed perception changes given mandated virtual interviews because of coronavirus disease 2019. Immediately after the 2020 Match, anonymous surveys were distributed to applicants (n = 37) and program directors (n = 22). Mixed-methods analyses were used to evaluate responses. Results were compared to data ","2021","07","16","Surgery","Surgery",NA,"Kuo","Jennifer H","Columbia University Medical Center, New York, NY. Electronic address: https://twitter.com/JenniferKuo5",NA
"647","34266646","10.1016/j.surg.2021.03.069","Perspectives on virtual interviews-A follow-up study of the Comprehensive Endocrine Surgery Fellowship interview process.","The American Association of Endocrine Surgeons Comprehensive Endocrine Surgery Fellowship interview stakeholders previously favored in-person interviews, despite time and expense. This study assessed perception changes given mandated virtual interviews because of coronavirus disease 2019. Immediately after the 2020 Match, anonymous surveys were distributed to applicants (n = 37) and program directors (n = 22). Mixed-methods analyses were used to evaluate responses. Results were compared to data ","2021","07","16","Surgery","Surgery",NA,"Lyden","Melanie L","Mayo Clinic, Rochester, MN",NA
"648","34266646","10.1016/j.surg.2021.03.069","Perspectives on virtual interviews-A follow-up study of the Comprehensive Endocrine Surgery Fellowship interview process.","The American Association of Endocrine Surgeons Comprehensive Endocrine Surgery Fellowship interview stakeholders previously favored in-person interviews, despite time and expense. This study assessed perception changes given mandated virtual interviews because of coronavirus disease 2019. Immediately after the 2020 Match, anonymous surveys were distributed to applicants (n = 37) and program directors (n = 22). Mixed-methods analyses were used to evaluate responses. Results were compared to data ","2021","07","16","Surgery","Surgery",NA,"Shen","Wen T","University of California, San Francisco, CA. Electronic address: https://twitter.com/wshen16",NA
"649","34266646","10.1016/j.surg.2021.03.069","Perspectives on virtual interviews-A follow-up study of the Comprehensive Endocrine Surgery Fellowship interview process.","The American Association of Endocrine Surgeons Comprehensive Endocrine Surgery Fellowship interview stakeholders previously favored in-person interviews, despite time and expense. This study assessed perception changes given mandated virtual interviews because of coronavirus disease 2019. Immediately after the 2020 Match, anonymous surveys were distributed to applicants (n = 37) and program directors (n = 22). Mixed-methods analyses were used to evaluate responses. Results were compared to data ","2021","07","16","Surgery","Surgery",NA,"Morris-Wiseman","Lilah F","University of Arizona - Tucson, College of Medicine, AZ. Electronic address: https://twitter.com/lilahfran",NA
"650","34266646","10.1016/j.surg.2021.03.069","Perspectives on virtual interviews-A follow-up study of the Comprehensive Endocrine Surgery Fellowship interview process.","The American Association of Endocrine Surgeons Comprehensive Endocrine Surgery Fellowship interview stakeholders previously favored in-person interviews, despite time and expense. This study assessed perception changes given mandated virtual interviews because of coronavirus disease 2019. Immediately after the 2020 Match, anonymous surveys were distributed to applicants (n = 37) and program directors (n = 22). Mixed-methods analyses were used to evaluate responses. Results were compared to data ","2021","07","16","Surgery","Surgery",NA,"Carty","Sally E","University of Pittsburgh, PA",NA
"651","34266646","10.1016/j.surg.2021.03.069","Perspectives on virtual interviews-A follow-up study of the Comprehensive Endocrine Surgery Fellowship interview process.","The American Association of Endocrine Surgeons Comprehensive Endocrine Surgery Fellowship interview stakeholders previously favored in-person interviews, despite time and expense. This study assessed perception changes given mandated virtual interviews because of coronavirus disease 2019. Immediately after the 2020 Match, anonymous surveys were distributed to applicants (n = 37) and program directors (n = 22). Mixed-methods analyses were used to evaluate responses. Results were compared to data ","2021","07","16","Surgery","Surgery",NA,"Drake","Frederick Thurston","Boston University School of Medicine and Boston Medical Center, MA. Electronic address: frederick.drake@bmc","frederick.drake@bmc.org"
"652","34266569","10.1016/bs.acdb.2021.04.001","Social learning from media: The need for a culturally diachronic developmental psychology.","Since the proliferation of television sets into households began over half a century ago there has been widespread interest in the impact that viewing has on young children's development. Such interest has grown with the increasing availability of smart phones and tablets. In this review we examine the literature documenting human social learning and how this learning is impacted when the instructing agent appears on a screen instead of face-to-face. We then explore the shifting nature of screen","2021","07","23","Adv Child Dev Behav","Advances in child development and behavior","Overimitation; Social constructivism; Social learning; Video deficit; COVID-19; Child; Child Development; Humans; Psychology, Developmental; Screen Time; Social Learning; Television","Nielsen","Mark","School of Psychology, University of Queensland, St. Lucia, QLD, Australia","m.nielsen@psy.uq.edu.au"
"653","34266569","10.1016/bs.acdb.2021.04.001","Social learning from media: The need for a culturally diachronic developmental psychology.","Since the proliferation of television sets into households began over half a century ago there has been widespread interest in the impact that viewing has on young children's development. Such interest has grown with the increasing availability of smart phones and tablets. In this review we examine the literature documenting human social learning and how this learning is impacted when the instructing agent appears on a screen instead of face-to-face. We then explore the shifting nature of screen","2021","07","23","Adv Child Dev Behav","Advances in child development and behavior","Overimitation; Social constructivism; Social learning; Video deficit; COVID-19; Child; Child Development; Humans; Psychology, Developmental; Screen Time; Social Learning; Television","Fong","Frankie T K","School of Psychology, University of Queensland, St. Lucia, QLD, Australia",NA
"654","34266569","10.1016/bs.acdb.2021.04.001","Social learning from media: The need for a culturally diachronic developmental psychology.","Since the proliferation of television sets into households began over half a century ago there has been widespread interest in the impact that viewing has on young children's development. Such interest has grown with the increasing availability of smart phones and tablets. In this review we examine the literature documenting human social learning and how this learning is impacted when the instructing agent appears on a screen instead of face-to-face. We then explore the shifting nature of screen","2021","07","23","Adv Child Dev Behav","Advances in child development and behavior","Overimitation; Social constructivism; Social learning; Video deficit; COVID-19; Child; Child Development; Humans; Psychology, Developmental; Screen Time; Social Learning; Television","Whiten","Andrew","School of Psychology and Neuroscience, University of St Andrews, St Andrews, United Kingdom",NA
"655","34266550","10.1016/j.spsy.2021.05.010","[Development of a psychiatric care facility into a Covid unit].","Covid-19 did not spare the psychiatric care services. At the Sainte-Anne Hospital, as in the medicine-surgery-obstetrics departments, several care units had to be transformed and organised in order to accommodate positive patients who did not need to be admitted to intensive care. Feedback on the transformation of a care structure of the ""Clinique des maladies mentales et de l'encéphale"" for more than two months.","2021","07","19","Soins Psychiatr","Soins. Psychiatrie","Covid-19; healthcare organization; hygiene; hygiène; infection risk; organisation des soins; risque infectieux; COVID-19; Female; Hospitalization; Humans; Pregnancy; SARS-CoV-2","Kimmel","Étienne","Clinique des Maladies mentales et de l'encéphale, service du Pr Philip Gorwood, groupe hospitalier universitaire Paris psychiatrie et neurosciences, 100 rue de la Santé, 75014 Paris, France. Electronic address: e.kimmel@ghu-paris",NA
"656","34266550","10.1016/j.spsy.2021.05.010","[Development of a psychiatric care facility into a Covid unit].","Covid-19 did not spare the psychiatric care services. At the Sainte-Anne Hospital, as in the medicine-surgery-obstetrics departments, several care units had to be transformed and organised in order to accommodate positive patients who did not need to be admitted to intensive care. Feedback on the transformation of a care structure of the ""Clinique des maladies mentales et de l'encéphale"" for more than two months.","2021","07","19","Soins Psychiatr","Soins. Psychiatrie","Covid-19; healthcare organization; hygiene; hygiène; infection risk; organisation des soins; risque infectieux; COVID-19; Female; Hospitalization; Humans; Pregnancy; SARS-CoV-2","Satori","Nadine","Clinique des Maladies mentales et de l'encéphale, service du Pr Philip Gorwood, groupe hospitalier universitaire Paris psychiatrie et neurosciences, 100 rue de la Santé, 75014 Paris, France",NA
"657","34266550","10.1016/j.spsy.2021.05.010","[Development of a psychiatric care facility into a Covid unit].","Covid-19 did not spare the psychiatric care services. At the Sainte-Anne Hospital, as in the medicine-surgery-obstetrics departments, several care units had to be transformed and organised in order to accommodate positive patients who did not need to be admitted to intensive care. Feedback on the transformation of a care structure of the ""Clinique des maladies mentales et de l'encéphale"" for more than two months.","2021","07","19","Soins Psychiatr","Soins. Psychiatrie","Covid-19; healthcare organization; hygiene; hygiène; infection risk; organisation des soins; risque infectieux; COVID-19; Female; Hospitalization; Humans; Pregnancy; SARS-CoV-2","Ménage","Gilles","Clinique des Maladies mentales et de l'encéphale, service du Pr Philip Gorwood, groupe hospitalier universitaire Paris psychiatrie et neurosciences, 100 rue de la Santé, 75014 Paris, France",NA
"658","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Buising","Kristy L","Victorian Infectious Diseases Service Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"659","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Schofield","Robyn","Environmental Science Hub, University of Melbourne, Melbourne, Victoria, Australia",NA
"660","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Irving","Louis","Respiratory Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"661","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Keywood","Melita","Oceans and Atmosphere, Commonwealth Scientific and Industrial Research Organization, Melbourne, Victoria, Australia",NA
"662","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Stevens","Ashley","Hospital Engineering, Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"663","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Keogh","Nick","Hospital Engineering, Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"664","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Skidmore","Grant","Department of Mechanical Engineering, University of Melbourne, Melbourne, Victoria, Australia",NA
"665","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Wadlow","Imogen","University of Melbourne, Melbourne, Victoria, Australia",NA
"666","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Kevin","Kevin","University of Melbourne, Melbourne, Victoria, Australia",NA
"667","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Rismanchi","Behzad","Department of Infrastructure Engineering, University of Melbourne, Melbourne, Victoria, Australia",NA
"668","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Wheeler","Amanda J","Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia",NA
"669","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Humphries","Ruhi S","Oceans and Atmosphere, Commonwealth Scientific and Industrial Research Organization, Melbourne, Victoria, Australia",NA
"670","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Kainer","Marion","Infection Prevention Western Health, Melbourne, Victoria, Australia",NA
"671","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Monty","Jason","Department of Mechanical Engineering, University of Melbourne, Melbourne, Victoria, Australia",NA
"672","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"McGain","Forbes","Intensive Care, Western Health, Melbourne, Victoria, Australia",NA
"673","34266516","10.1017/ice.2021.284","Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward.","To study the airflow, transmission, and clearance of aerosols in the clinical spaces of a hospital ward that had been used to care for patients with coronavirus disease 2019 (COVID-19) and to examine the impact of portable air cleaners on aerosol clearance. Observational study. A single ward of a tertiary-care public hospital in Melbourne, Australia. Glycerin-based aerosol was used as a surrogate for respiratory aerosols. The transmission of aerosols from a single patient room into corridors and","2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Marshall","Caroline","Infection Prevention and Surveillance Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"674","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Mukadam","Naaheed","Division of Psychiatry, University College London, UK",NA
"675","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Sommerlad","Andrew","Division of Psychiatry, University College London, UK",NA
"676","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Wright","Jessica","Camden and Islington NHS Foundation Trust, UK",NA
"677","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Smith","Abigail","Camden and Islington NHS Foundation Trust, UK",NA
"678","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Szczap","Aleksandra","Camden and Islington NHS Foundation Trust, UK",NA
"679","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Solomou","Solomis","Camden and Islington NHS Foundation Trust, UK",NA
"680","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Bhome","Rohan","Camden and Islington NHS Foundation Trust, UK",NA
"681","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Thayalan","Roshan","Camden and Islington NHS Foundation Trust, UK",NA
"682","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Abrol","Esha","Camden and Islington NHS Foundation Trust, UK",NA
"683","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Aref-Adib","Golnar","Division of Psychiatry, University College London, UK",NA
"684","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Maconick","Lucy","Division of Psychiatry, University College London, UK",NA
"685","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Aubrey-Jones","Dominic","Camden and Islington NHS Foundation Trust, UK",NA
"686","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Tugrul","Senem","Camden and Islington NHS Foundation Trust, UK",NA
"687","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Knowles","Melanie","Camden and Islington NHS Foundation Trust, UK",NA
"688","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Menys","Helen","Camden and Islington NHS Foundation Trust, UK",NA
"689","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Sathanandan","Shivanthi","Camden and Islington NHS Foundation Trust, UK",NA
"690","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Moslehi","Sarah","Camden and Islington NHS Foundation Trust, UK",NA
"691","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Huntley","Jonathan","Division of Psychiatry, University College London, UK",NA
"692","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Liu","Kathy","Division of Psychiatry, University College London, UK",NA
"693","34266510","10.1192/bjo.2021.970","Acute mental health presentations before and during the COVID-19 pandemic.","A number of community based surveys have identified an increase in psychological symptoms and distress but there has been no examination of symptoms at the more severe end of the mental health spectrum. We aimed to analyse numbers and types of psychiatric presentations to inform planning for future demand on mental health services in light of the COVID-19 pandemic. We analysed electronic data between January and April 2020 for 2534 patients referred to acute psychiatric services, and tested for ","2021","07","16","BJPsych Open","BJPsych open","Suicide; community mental health teams; depressive disorders; self-harm","Carlos Bazo-Alvarez","Juan","Department of Primary Care and Population Health, University College London, UK",NA
"694","34266498","10.1186/s40359-021-00603-9","How have people been coping during the COVID-19 pandemic? Patterns and predictors of coping strategies amongst 26,016 UK adults.","Individuals face increased psychological distress during the COVID-19 pandemic. However, it's unknown whether choice of coping styles are influenced by COVID-19 in addition to known predictors. Data from 26,016 UK adults in the UCL COVID-19 Social Study were analysed from 12/4/2020 15/5/2020. Regression models were used to identify predictors of coping styles (problem-focused, emotion-focused, avoidant, and socially-supported): model 1 included sociodemographic variables, model 2 additionally in","2021","07","19","BMC Psychol","BMC psychology","Adversity; COVID-19; Coping; Adaptation, Psychological; Adult; COVID-19; Humans; Pandemics; SARS-CoV-2; Surveys and Questionnaires; United Kingdom","Fluharty","Meg","Department of Behavioural Science and Health, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK. m.fluharty@ucl.ac","m.fluharty@ucl.ac.uk"
"695","34266498","10.1186/s40359-021-00603-9","How have people been coping during the COVID-19 pandemic? Patterns and predictors of coping strategies amongst 26,016 UK adults.","Individuals face increased psychological distress during the COVID-19 pandemic. However, it's unknown whether choice of coping styles are influenced by COVID-19 in addition to known predictors. Data from 26,016 UK adults in the UCL COVID-19 Social Study were analysed from 12/4/2020 15/5/2020. Regression models were used to identify predictors of coping styles (problem-focused, emotion-focused, avoidant, and socially-supported): model 1 included sociodemographic variables, model 2 additionally in","2021","07","19","BMC Psychol","BMC psychology","Adversity; COVID-19; Coping; Adaptation, Psychological; Adult; COVID-19; Humans; Pandemics; SARS-CoV-2; Surveys and Questionnaires; United Kingdom","Fancourt","Daisy","Department of Behavioural Science and Health, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK",NA
"696","34266487","10.1186/s40164-021-00235-0","COVID-19 vaccination associated severe immune thrombocytopenia.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has emerged as a deadliest global pandemic after its identification in December 2019 in Wuhan, China resulting in more than three million deaths worldwide. Recently FDA issued emergency authorization for three vaccines for prevention of COVID-19. Here in, we report three cases of severe immune thrombocytopenia (ITP) following COVID-19 vaccination and their clinical course. Case #1: 53 year old male with","2021","07","18","Exp Hematol Oncol","Experimental hematology &amp; oncology","Coronavirus disease 2019; Immune thrombocytopenia; Johnson and Johnson COVID-19 vaccine; Pfizer-BioNTech COVID-19 vaccine","Shah","Syed Raza Ali","Departments of Hospital Medicine, St. Michael Medical Center, Virginia Mason Franciscan Health, Silverdale, WA, USA. syedrashah@gmail","syedrashah@gmail.com"
"697","34266487","10.1186/s40164-021-00235-0","COVID-19 vaccination associated severe immune thrombocytopenia.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has emerged as a deadliest global pandemic after its identification in December 2019 in Wuhan, China resulting in more than three million deaths worldwide. Recently FDA issued emergency authorization for three vaccines for prevention of COVID-19. Here in, we report three cases of severe immune thrombocytopenia (ITP) following COVID-19 vaccination and their clinical course. Case #1: 53 year old male with","2021","07","18","Exp Hematol Oncol","Experimental hematology &amp; oncology","Coronavirus disease 2019; Immune thrombocytopenia; Johnson and Johnson COVID-19 vaccine; Pfizer-BioNTech COVID-19 vaccine","Dolkar","Sherpa","Departments of Hospital Medicine, St. Michael Medical Center, Virginia Mason Franciscan Health, Silverdale, WA, USA",NA
"698","34266487","10.1186/s40164-021-00235-0","COVID-19 vaccination associated severe immune thrombocytopenia.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has emerged as a deadliest global pandemic after its identification in December 2019 in Wuhan, China resulting in more than three million deaths worldwide. Recently FDA issued emergency authorization for three vaccines for prevention of COVID-19. Here in, we report three cases of severe immune thrombocytopenia (ITP) following COVID-19 vaccination and their clinical course. Case #1: 53 year old male with","2021","07","18","Exp Hematol Oncol","Experimental hematology &amp; oncology","Coronavirus disease 2019; Immune thrombocytopenia; Johnson and Johnson COVID-19 vaccine; Pfizer-BioNTech COVID-19 vaccine","Mathew","Jacob","Departments of Hematology, St. Michael Medical Center, Virginia Mason Franciscan Health, Silverdale, WA, USA",NA
"699","34266487","10.1186/s40164-021-00235-0","COVID-19 vaccination associated severe immune thrombocytopenia.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has emerged as a deadliest global pandemic after its identification in December 2019 in Wuhan, China resulting in more than three million deaths worldwide. Recently FDA issued emergency authorization for three vaccines for prevention of COVID-19. Here in, we report three cases of severe immune thrombocytopenia (ITP) following COVID-19 vaccination and their clinical course. Case #1: 53 year old male with","2021","07","18","Exp Hematol Oncol","Experimental hematology &amp; oncology","Coronavirus disease 2019; Immune thrombocytopenia; Johnson and Johnson COVID-19 vaccine; Pfizer-BioNTech COVID-19 vaccine","Vishnu","Prakash","Departments of Hematology, St. Michael Medical Center, Virginia Mason Franciscan Health, Silverdale, WA, USA",NA
"700","34266486","10.1186/s13287-021-02482-8","Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction.","The recent COronaVIrus Disease (COVID)-19 pandemic has placed an unprecedented burden on the drug development opportunity to prevent the onset of multi-organ failure.Emerging experimental reports have highlighted the beneficial effects of mesenchymal stem cell (MSC) administration against COVID-19. MSCs and their derived exosomes may attenuate SARS-CoV-2-induced inflammatory response through managing the immune cell function and cytokine expression. Although these are promising results, the expo","2021","07","21","Stem Cell Res Ther","Stem cell research &amp; therapy","COVID-19; Mesenchymal stem cells; Nicorandil; COVID-19; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Multiple Organ Failure; Nicorandil; SARS-CoV-2","Safari","Anahid","Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran",NA
"701","34266486","10.1186/s13287-021-02482-8","Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction.","The recent COronaVIrus Disease (COVID)-19 pandemic has placed an unprecedented burden on the drug development opportunity to prevent the onset of multi-organ failure.Emerging experimental reports have highlighted the beneficial effects of mesenchymal stem cell (MSC) administration against COVID-19. MSCs and their derived exosomes may attenuate SARS-CoV-2-induced inflammatory response through managing the immune cell function and cytokine expression. Although these are promising results, the expo","2021","07","21","Stem Cell Res Ther","Stem cell research &amp; therapy","COVID-19; Mesenchymal stem cells; Nicorandil; COVID-19; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Multiple Organ Failure; Nicorandil; SARS-CoV-2","Lionetti","Vicenzo","Unit of Translational Critical Care Medicine, Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy",NA
"702","34266486","10.1186/s13287-021-02482-8","Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction.","The recent COronaVIrus Disease (COVID)-19 pandemic has placed an unprecedented burden on the drug development opportunity to prevent the onset of multi-organ failure.Emerging experimental reports have highlighted the beneficial effects of mesenchymal stem cell (MSC) administration against COVID-19. MSCs and their derived exosomes may attenuate SARS-CoV-2-induced inflammatory response through managing the immune cell function and cytokine expression. Although these are promising results, the expo","2021","07","21","Stem Cell Res Ther","Stem cell research &amp; therapy","COVID-19; Mesenchymal stem cells; Nicorandil; COVID-19; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Multiple Organ Failure; Nicorandil; SARS-CoV-2","Razeghian-Jahromi","Iman","Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. razejahromi@yahoo","razejahromi@yahoo.com"
"703","34266483","10.1186/s13098-021-00696-7","Correction to: Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.",NA,"2021","07","18","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome",NA,"Abdoli","Samereh","College of Nursing, University of Tennessee, 1200 Volunteer Blvd Rm 155, Knoxville, TN, 37996, USA. sabdoli@utk","sabdoli@utk.edu"
"704","34266483","10.1186/s13098-021-00696-7","Correction to: Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.",NA,"2021","07","18","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome",NA,"Silveira","Monica S V M","Faculty of Medical Sciences, University of Campi-nas, Rua Tessália Vieira de Camargo, 126. Cidade Universitária Zeferino Vaz, Campinas, São Paulo, 13083-887, Brazil",NA
"705","34266483","10.1186/s13098-021-00696-7","Correction to: Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.",NA,"2021","07","18","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome",NA,"Doosti-Irani","Mehri","School of Nursing and Midwifery, Shahrekourd University of Medical Sciences, Shahrekord, Iran",NA
"706","34266483","10.1186/s13098-021-00696-7","Correction to: Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.",NA,"2021","07","18","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome",NA,"Fanti","Paulo","Faculty of Medical Sciences, University of Campi-nas, Rua Tessália Vieira de Camargo, 126. Cidade Universitária Zeferino Vaz, Campinas, São Paulo, 13083-887, Brazil",NA
"707","34266483","10.1186/s13098-021-00696-7","Correction to: Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.",NA,"2021","07","18","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome",NA,"Miller-Bains","Katherine","Assessment and Evaluation, Oak Ridge Associated Universities, Oak Ridge, TN, 37831, USA",NA
"708","34266483","10.1186/s13098-021-00696-7","Correction to: Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.",NA,"2021","07","18","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome",NA,"Pavin","Elizabeth João","Endocrinology Division, Department of Internal Medicine, Faculty of Medical Sciences, University of Campinas, Rua Tessália Vieira de Camargo, 126. Cidade Universitária Zeferino Vaz, Campinas, São Paulo, 13083-887, Brazil",NA
"709","34266483","10.1186/s13098-021-00696-7","Correction to: Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.",NA,"2021","07","18","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome",NA,"Cardoso","Edimariz Buin","Clinical Psychologist, Faculty of Medical Sciences, University of Campinas, Rua Tessália Vieira de Camargo, 126. Cidade Universitária Zeferino Vaz, Campinas, São Paulo, 13083-887, Brazil",NA
"710","34266483","10.1186/s13098-021-00696-7","Correction to: Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.",NA,"2021","07","18","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome",NA,"Vardanjani","Leila Rafee","School of Nursing and Midwifery, Shahrekourd University of Medical Sciences, Shahrekord, Iran",NA
"711","34266483","10.1186/s13098-021-00696-7","Correction to: Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.",NA,"2021","07","18","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome",NA,"Noorian","Kobra","School of Nursing and Midwifery, Shahrekourd University of Medical Sciences, Shahrekord, Iran",NA
"712","34266483","10.1186/s13098-021-00696-7","Correction to: Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.",NA,"2021","07","18","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome",NA,"Hessler","Danielle","Department of Family and Community Medicine, University of California, 500 Parnassus Avenue, San Francisco, CA, 94117, USA",NA
"713","34266476","10.1186/s13584-021-00472-y","National and regional trends in MRI utilization in the face of the ongoing COVID-19 pandemic.","Marked reductions in imaging exams have been documented during the COVID-19 pandemic. The study aimed to examine the effect of the two waves of COVID-19 on magnetic resonance imaging (MRI) utilization at the national and regional level. A retrospective-archive study was conducted in Israel, comparing March-December 2020 with March-December 2018 and 2019. Data on MRI utilization were obtained from the national MRI registry, while data on confirmed COVID-19 cases, by place of residence, were obtai","2021","07","21","Isr J Health Policy Res","Israel journal of health policy research","COVID-19; Pandemic; Wave, Disparity, MRI exam; COVID-19; Humans; Israel; Magnetic Resonance Imaging; Pandemics; Procedures and Techniques Utilization; Retrospective Studies","Luxenburg","Osnat","Medical Technology, Health Information and Research Directorate, Ministry of Health, Jerusalem, Israel",NA
"714","34266476","10.1186/s13584-021-00472-y","National and regional trends in MRI utilization in the face of the ongoing COVID-19 pandemic.","Marked reductions in imaging exams have been documented during the COVID-19 pandemic. The study aimed to examine the effect of the two waves of COVID-19 on magnetic resonance imaging (MRI) utilization at the national and regional level. A retrospective-archive study was conducted in Israel, comparing March-December 2020 with March-December 2018 and 2019. Data on MRI utilization were obtained from the national MRI registry, while data on confirmed COVID-19 cases, by place of residence, were obtai","2021","07","21","Isr J Health Policy Res","Israel journal of health policy research","COVID-19; Pandemic; Wave, Disparity, MRI exam; COVID-19; Humans; Israel; Magnetic Resonance Imaging; Pandemics; Procedures and Techniques Utilization; Retrospective Studies","Saban","Mor","The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, 1 Emek dotan Street, 5262100, Ramat-Gan, Israel. morsab1608@gmail","morsab1608@gmail.com"
"715","34266476","10.1186/s13584-021-00472-y","National and regional trends in MRI utilization in the face of the ongoing COVID-19 pandemic.","Marked reductions in imaging exams have been documented during the COVID-19 pandemic. The study aimed to examine the effect of the two waves of COVID-19 on magnetic resonance imaging (MRI) utilization at the national and regional level. A retrospective-archive study was conducted in Israel, comparing March-December 2020 with March-December 2018 and 2019. Data on MRI utilization were obtained from the national MRI registry, while data on confirmed COVID-19 cases, by place of residence, were obtai","2021","07","21","Isr J Health Policy Res","Israel journal of health policy research","COVID-19; Pandemic; Wave, Disparity, MRI exam; COVID-19; Humans; Israel; Magnetic Resonance Imaging; Pandemics; Procedures and Techniques Utilization; Retrospective Studies","Myers","Vicki","The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, 1 Emek dotan Street, 5262100, Ramat-Gan, Israel",NA
"716","34266476","10.1186/s13584-021-00472-y","National and regional trends in MRI utilization in the face of the ongoing COVID-19 pandemic.","Marked reductions in imaging exams have been documented during the COVID-19 pandemic. The study aimed to examine the effect of the two waves of COVID-19 on magnetic resonance imaging (MRI) utilization at the national and regional level. A retrospective-archive study was conducted in Israel, comparing March-December 2020 with March-December 2018 and 2019. Data on MRI utilization were obtained from the national MRI registry, while data on confirmed COVID-19 cases, by place of residence, were obtai","2021","07","21","Isr J Health Policy Res","Israel journal of health policy research","COVID-19; Pandemic; Wave, Disparity, MRI exam; COVID-19; Humans; Israel; Magnetic Resonance Imaging; Pandemics; Procedures and Techniques Utilization; Retrospective Studies","Vaknin","Sharona","The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, 1 Emek dotan Street, 5262100, Ramat-Gan, Israel",NA
"717","34266476","10.1186/s13584-021-00472-y","National and regional trends in MRI utilization in the face of the ongoing COVID-19 pandemic.","Marked reductions in imaging exams have been documented during the COVID-19 pandemic. The study aimed to examine the effect of the two waves of COVID-19 on magnetic resonance imaging (MRI) utilization at the national and regional level. A retrospective-archive study was conducted in Israel, comparing March-December 2020 with March-December 2018 and 2019. Data on MRI utilization were obtained from the national MRI registry, while data on confirmed COVID-19 cases, by place of residence, were obtai","2021","07","21","Isr J Health Policy Res","Israel journal of health policy research","COVID-19; Pandemic; Wave, Disparity, MRI exam; COVID-19; Humans; Israel; Magnetic Resonance Imaging; Pandemics; Procedures and Techniques Utilization; Retrospective Studies","Boldor","Noga","The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, 1 Emek dotan Street, 5262100, Ramat-Gan, Israel",NA
"718","34266476","10.1186/s13584-021-00472-y","National and regional trends in MRI utilization in the face of the ongoing COVID-19 pandemic.","Marked reductions in imaging exams have been documented during the COVID-19 pandemic. The study aimed to examine the effect of the two waves of COVID-19 on magnetic resonance imaging (MRI) utilization at the national and regional level. A retrospective-archive study was conducted in Israel, comparing March-December 2020 with March-December 2018 and 2019. Data on MRI utilization were obtained from the national MRI registry, while data on confirmed COVID-19 cases, by place of residence, were obtai","2021","07","21","Isr J Health Policy Res","Israel journal of health policy research","COVID-19; Pandemic; Wave, Disparity, MRI exam; COVID-19; Humans; Israel; Magnetic Resonance Imaging; Pandemics; Procedures and Techniques Utilization; Retrospective Studies","Wilf-Miron","Rachel","The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, 1 Emek dotan Street, 5262100, Ramat-Gan, Israel",NA
"719","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Beloncle","François","Medical ICU, University Hospital of Angers, Vent'Lab, University of Angers, Angers, France. Francois.beloncle@univ-angers",NA
"720","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Studer","Antoine","Medical ICU, University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France",NA
"721","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Seegers","Valérie","Oncology Data Factory and Analytics, ICO Integrated Center for Oncology, Angers, France",NA
"722","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Richard","Jean-Christophe","Medical ICU, University Hospital of Angers, Vent'Lab, University of Angers, Angers, France",NA
"723","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Desprez","Christophe","Medical ICU, University Hospital of Angers, Vent'Lab, University of Angers, Angers, France",NA
"724","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Fage","Nicolas","Medical ICU, University Hospital of Angers, Vent'Lab, University of Angers, Angers, France",NA
"725","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Merdji","Hamid","Medical ICU, University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France",NA
"726","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Pavlovsky","Bertrand","Medical ICU, University Hospital of Angers, Vent'Lab, University of Angers, Angers, France",NA
"727","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Helms","Julie","Medical ICU, University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France",NA
"728","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Cunat","Sibylle","Medical ICU, University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France",NA
"729","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Mortaza","Satar","Medical ICU, University Hospital of Angers, Vent'Lab, University of Angers, Angers, France",NA
"730","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Demiselle","Julien","Medical ICU, University Hospital of Angers, Vent'Lab, University of Angers, Angers, France",NA
"731","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Brochard","Laurent","Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada",NA
"732","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Mercat","Alain","Medical ICU, University Hospital of Angers, Vent'Lab, University of Angers, Angers, France",NA
"733","34266454","10.1186/s13054-021-03665-8","Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.","Differences in physiology of ARDS have been described between COVID-19 and non-COVID-19 patients. This study aimed to compare initial values and longitudinal changes in respiratory system compliance (CRS), oxygenation parameters and ventilatory ratio (VR) in patients with COVID-19 and non-COVID-19 pulmonary ARDS matched on oxygenation. 135 patients with COVID-19 ARDS from two centers were included in a physiological study; 767 non-COVID-19 ARDS from a clinical trial were used for the purpose of ","2021","07","20","Crit Care","Critical care (London, England)","Acute Respiratory Distress Syndrome; Covid-19; Dead space; Mechanical ventilation; Respiratory failure; Respiratory mechanics; Aged; Blood Gas Analysis; Body Mass Index; COVID-19; Female; Humans; Intensive Care Units; Male; Middle Aged; Positive-Pressure Respiration; Propensity Score; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; SARS-CoV-2","Meziani","Ferhat","Medical ICU, University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France",NA
"734","34266452","10.1186/s13063-021-05361-y","A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.","The pathophysiology of SARS-Cov-2 is characterized by inflammation, immune dysregulation, coagulopathy, and endothelial dysfunction. No single therapeutic agent can target all these pathophysiologic substrates. Moreover, the current therapies are not fully effective in reducing mortality in moderate and severe disease. Hence, we aim to evaluate the combination of drugs (aspirin, atorvastatin, and nicorandil) with anti-inflammatory, antithrombotic, immunomodulatory, and vasodilator properties as ","2021","07","19","Trials","Trials","Aspirin; Atorvastatin; COVID-19; Hospitalised patients; Nicorandil; Protocol; Randomised control trial; Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Sharma","Ambudhar","Department of Cardiology, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh, 176001, India. ambudhar414@gmail","ambudhar414@gmail.com"
"735","34266452","10.1186/s13063-021-05361-y","A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.","The pathophysiology of SARS-Cov-2 is characterized by inflammation, immune dysregulation, coagulopathy, and endothelial dysfunction. No single therapeutic agent can target all these pathophysiologic substrates. Moreover, the current therapies are not fully effective in reducing mortality in moderate and severe disease. Hence, we aim to evaluate the combination of drugs (aspirin, atorvastatin, and nicorandil) with anti-inflammatory, antithrombotic, immunomodulatory, and vasodilator properties as ","2021","07","19","Trials","Trials","Aspirin; Atorvastatin; COVID-19; Hospitalised patients; Nicorandil; Protocol; Randomised control trial; Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Sharma","Charu","Department of Anaesthesia, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh, 176001, India",NA
"736","34266452","10.1186/s13063-021-05361-y","A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.","The pathophysiology of SARS-Cov-2 is characterized by inflammation, immune dysregulation, coagulopathy, and endothelial dysfunction. No single therapeutic agent can target all these pathophysiologic substrates. Moreover, the current therapies are not fully effective in reducing mortality in moderate and severe disease. Hence, we aim to evaluate the combination of drugs (aspirin, atorvastatin, and nicorandil) with anti-inflammatory, antithrombotic, immunomodulatory, and vasodilator properties as ","2021","07","19","Trials","Trials","Aspirin; Atorvastatin; COVID-19; Hospitalised patients; Nicorandil; Protocol; Randomised control trial; Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Raina","Sujeet","Department of Internal Medicine, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh, 176001, India",NA
"737","34266452","10.1186/s13063-021-05361-y","A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.","The pathophysiology of SARS-Cov-2 is characterized by inflammation, immune dysregulation, coagulopathy, and endothelial dysfunction. No single therapeutic agent can target all these pathophysiologic substrates. Moreover, the current therapies are not fully effective in reducing mortality in moderate and severe disease. Hence, we aim to evaluate the combination of drugs (aspirin, atorvastatin, and nicorandil) with anti-inflammatory, antithrombotic, immunomodulatory, and vasodilator properties as ","2021","07","19","Trials","Trials","Aspirin; Atorvastatin; COVID-19; Hospitalised patients; Nicorandil; Protocol; Randomised control trial; Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Singh","Balraj","Department of Preventive and Social Medicine, Indira Gandhi Medical College, Shimla, 171001, India",NA
"738","34266452","10.1186/s13063-021-05361-y","A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.","The pathophysiology of SARS-Cov-2 is characterized by inflammation, immune dysregulation, coagulopathy, and endothelial dysfunction. No single therapeutic agent can target all these pathophysiologic substrates. Moreover, the current therapies are not fully effective in reducing mortality in moderate and severe disease. Hence, we aim to evaluate the combination of drugs (aspirin, atorvastatin, and nicorandil) with anti-inflammatory, antithrombotic, immunomodulatory, and vasodilator properties as ","2021","07","19","Trials","Trials","Aspirin; Atorvastatin; COVID-19; Hospitalised patients; Nicorandil; Protocol; Randomised control trial; Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Dadhwal","Devendra Singh","Department of Pulmonary Medicine, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh, 176001, India",NA
"739","34266452","10.1186/s13063-021-05361-y","A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.","The pathophysiology of SARS-Cov-2 is characterized by inflammation, immune dysregulation, coagulopathy, and endothelial dysfunction. No single therapeutic agent can target all these pathophysiologic substrates. Moreover, the current therapies are not fully effective in reducing mortality in moderate and severe disease. Hence, we aim to evaluate the combination of drugs (aspirin, atorvastatin, and nicorandil) with anti-inflammatory, antithrombotic, immunomodulatory, and vasodilator properties as ","2021","07","19","Trials","Trials","Aspirin; Atorvastatin; COVID-19; Hospitalised patients; Nicorandil; Protocol; Randomised control trial; Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Dogra","Vinay","Department of Endocrinology, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh, 176001, India",NA
"740","34266452","10.1186/s13063-021-05361-y","A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.","The pathophysiology of SARS-Cov-2 is characterized by inflammation, immune dysregulation, coagulopathy, and endothelial dysfunction. No single therapeutic agent can target all these pathophysiologic substrates. Moreover, the current therapies are not fully effective in reducing mortality in moderate and severe disease. Hence, we aim to evaluate the combination of drugs (aspirin, atorvastatin, and nicorandil) with anti-inflammatory, antithrombotic, immunomodulatory, and vasodilator properties as ","2021","07","19","Trials","Trials","Aspirin; Atorvastatin; COVID-19; Hospitalised patients; Nicorandil; Protocol; Randomised control trial; Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Gupta","Swatantra","Department of Gastroenterology, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh, 176001, India",NA
"741","34266452","10.1186/s13063-021-05361-y","A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.","The pathophysiology of SARS-Cov-2 is characterized by inflammation, immune dysregulation, coagulopathy, and endothelial dysfunction. No single therapeutic agent can target all these pathophysiologic substrates. Moreover, the current therapies are not fully effective in reducing mortality in moderate and severe disease. Hence, we aim to evaluate the combination of drugs (aspirin, atorvastatin, and nicorandil) with anti-inflammatory, antithrombotic, immunomodulatory, and vasodilator properties as ","2021","07","19","Trials","Trials","Aspirin; Atorvastatin; COVID-19; Hospitalised patients; Nicorandil; Protocol; Randomised control trial; Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Bhandari","Shyam","Department of Anaesthesia, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh, 176001, India",NA
"742","34266452","10.1186/s13063-021-05361-y","A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.","The pathophysiology of SARS-Cov-2 is characterized by inflammation, immune dysregulation, coagulopathy, and endothelial dysfunction. No single therapeutic agent can target all these pathophysiologic substrates. Moreover, the current therapies are not fully effective in reducing mortality in moderate and severe disease. Hence, we aim to evaluate the combination of drugs (aspirin, atorvastatin, and nicorandil) with anti-inflammatory, antithrombotic, immunomodulatory, and vasodilator properties as ","2021","07","19","Trials","Trials","Aspirin; Atorvastatin; COVID-19; Hospitalised patients; Nicorandil; Protocol; Randomised control trial; Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Sood","Vivek","Department of Internal Medicine, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh, 176001, India",NA
"743","34266409","10.1186/s12889-021-11424-1","Demographics, politics, and health factors predict mask wearing during the COVID-19 pandemic: a cross-sectional study.","Wearing a protective face covering can reduce the spread of COVID-19, but Americans' compliance with wearing a mask is uneven. The purpose of this study is to examine the association between health determinants (Health Behaviors, Clinical Care, Social and Economic Conditions, and the Physical Environment) and mask wearing at the county level. Data were collected from publicly available sources, including the County Health Rankings and the New York Times. The dependent variable was the percent of","2021","07","21","BMC Public Health","BMC public health","COVID-19; Cross-Sectional Studies; Demography; Humans; Masks; New York; Pandemics; Politics; SARS-CoV-2","Cunningham","George B","Texas A&amp","gbcunningham@tamu.edu"
"744","34266409","10.1186/s12889-021-11424-1","Demographics, politics, and health factors predict mask wearing during the COVID-19 pandemic: a cross-sectional study.","Wearing a protective face covering can reduce the spread of COVID-19, but Americans' compliance with wearing a mask is uneven. The purpose of this study is to examine the association between health determinants (Health Behaviors, Clinical Care, Social and Economic Conditions, and the Physical Environment) and mask wearing at the county level. Data were collected from publicly available sources, including the County Health Rankings and the New York Times. The dependent variable was the percent of","2021","07","21","BMC Public Health","BMC public health","COVID-19; Cross-Sectional Studies; Demography; Humans; Masks; New York; Pandemics; Politics; SARS-CoV-2","Nite","Calvin","Texas A&amp",NA
"745","34266403","10.1186/s12889-021-11468-3","Health authorities' health risk communication with the public during pandemics: a rapid scoping review.","Responses from the H1N1 swine flu pandemic and the recent COVID-19 coronavirus pandemic provide an opportunity for insight into the role of health authorities' ways of communicating health risk information to the public. We aimed to synthesise the existing evidence regarding different modes of communication used by health authorities in health risk communication with the public during a pandemic. We conducted a rapid scoping review. MEDLINE and EMBASE were searched for publications in English fr","2021","07","21","BMC Public Health","BMC public health","COVID-19; H1N1; Health communication; Media communication; Pandemic; Risk communication; Animals; COVID-19; Communication; Health Communication; Humans; Influenza A Virus, H1N1 Subtype; Pandemics; Public Health; SARS-CoV-2; Social Media; Swine","Berg","Siv Hilde","Centre for Resilience in Healthcare, Faculty of Health Sciences, University of Stavanger, Kjell Arholmsgate 43, 4021, Stavanger, Norway. Siv.h.berg@uis","Siv.h.berg@uis.no"
"746","34266403","10.1186/s12889-021-11468-3","Health authorities' health risk communication with the public during pandemics: a rapid scoping review.","Responses from the H1N1 swine flu pandemic and the recent COVID-19 coronavirus pandemic provide an opportunity for insight into the role of health authorities' ways of communicating health risk information to the public. We aimed to synthesise the existing evidence regarding different modes of communication used by health authorities in health risk communication with the public during a pandemic. We conducted a rapid scoping review. MEDLINE and EMBASE were searched for publications in English fr","2021","07","21","BMC Public Health","BMC public health","COVID-19; H1N1; Health communication; Media communication; Pandemic; Risk communication; Animals; COVID-19; Communication; Health Communication; Humans; Influenza A Virus, H1N1 Subtype; Pandemics; Public Health; SARS-CoV-2; Social Media; Swine","O'Hara","Jane K","Faculty of Medicine &amp",NA
"747","34266403","10.1186/s12889-021-11468-3","Health authorities' health risk communication with the public during pandemics: a rapid scoping review.","Responses from the H1N1 swine flu pandemic and the recent COVID-19 coronavirus pandemic provide an opportunity for insight into the role of health authorities' ways of communicating health risk information to the public. We aimed to synthesise the existing evidence regarding different modes of communication used by health authorities in health risk communication with the public during a pandemic. We conducted a rapid scoping review. MEDLINE and EMBASE were searched for publications in English fr","2021","07","21","BMC Public Health","BMC public health","COVID-19; H1N1; Health communication; Media communication; Pandemic; Risk communication; Animals; COVID-19; Communication; Health Communication; Humans; Influenza A Virus, H1N1 Subtype; Pandemics; Public Health; SARS-CoV-2; Social Media; Swine","Shortt","Marie Therese","Centre for Resilience in Healthcare, Faculty of Health Sciences, University of Stavanger, Kjell Arholmsgate 43, 4021, Stavanger, Norway",NA
"748","34266403","10.1186/s12889-021-11468-3","Health authorities' health risk communication with the public during pandemics: a rapid scoping review.","Responses from the H1N1 swine flu pandemic and the recent COVID-19 coronavirus pandemic provide an opportunity for insight into the role of health authorities' ways of communicating health risk information to the public. We aimed to synthesise the existing evidence regarding different modes of communication used by health authorities in health risk communication with the public during a pandemic. We conducted a rapid scoping review. MEDLINE and EMBASE were searched for publications in English fr","2021","07","21","BMC Public Health","BMC public health","COVID-19; H1N1; Health communication; Media communication; Pandemic; Risk communication; Animals; COVID-19; Communication; Health Communication; Humans; Influenza A Virus, H1N1 Subtype; Pandemics; Public Health; SARS-CoV-2; Social Media; Swine","Thune","Henriette","Centre for Resilience in Healthcare, Faculty of Health Sciences, University of Stavanger, Kjell Arholmsgate 43, 4021, Stavanger, Norway",NA
"749","34266403","10.1186/s12889-021-11468-3","Health authorities' health risk communication with the public during pandemics: a rapid scoping review.","Responses from the H1N1 swine flu pandemic and the recent COVID-19 coronavirus pandemic provide an opportunity for insight into the role of health authorities' ways of communicating health risk information to the public. We aimed to synthesise the existing evidence regarding different modes of communication used by health authorities in health risk communication with the public during a pandemic. We conducted a rapid scoping review. MEDLINE and EMBASE were searched for publications in English fr","2021","07","21","BMC Public Health","BMC public health","COVID-19; H1N1; Health communication; Media communication; Pandemic; Risk communication; Animals; COVID-19; Communication; Health Communication; Humans; Influenza A Virus, H1N1 Subtype; Pandemics; Public Health; SARS-CoV-2; Social Media; Swine","Brønnick","Kolbjørn Kallesten","Centre for Resilience in Healthcare, Faculty of Health Sciences, University of Stavanger, Kjell Arholmsgate 43, 4021, Stavanger, Norway",NA
"750","34266403","10.1186/s12889-021-11468-3","Health authorities' health risk communication with the public during pandemics: a rapid scoping review.","Responses from the H1N1 swine flu pandemic and the recent COVID-19 coronavirus pandemic provide an opportunity for insight into the role of health authorities' ways of communicating health risk information to the public. We aimed to synthesise the existing evidence regarding different modes of communication used by health authorities in health risk communication with the public during a pandemic. We conducted a rapid scoping review. MEDLINE and EMBASE were searched for publications in English fr","2021","07","21","BMC Public Health","BMC public health","COVID-19; H1N1; Health communication; Media communication; Pandemic; Risk communication; Animals; COVID-19; Communication; Health Communication; Humans; Influenza A Virus, H1N1 Subtype; Pandemics; Public Health; SARS-CoV-2; Social Media; Swine","Lungu","Daniel Adrian","Centre for Resilience in Healthcare, Faculty of Health Sciences, University of Stavanger, Kjell Arholmsgate 43, 4021, Stavanger, Norway",NA
"751","34266403","10.1186/s12889-021-11468-3","Health authorities' health risk communication with the public during pandemics: a rapid scoping review.","Responses from the H1N1 swine flu pandemic and the recent COVID-19 coronavirus pandemic provide an opportunity for insight into the role of health authorities' ways of communicating health risk information to the public. We aimed to synthesise the existing evidence regarding different modes of communication used by health authorities in health risk communication with the public during a pandemic. We conducted a rapid scoping review. MEDLINE and EMBASE were searched for publications in English fr","2021","07","21","BMC Public Health","BMC public health","COVID-19; H1N1; Health communication; Media communication; Pandemic; Risk communication; Animals; COVID-19; Communication; Health Communication; Humans; Influenza A Virus, H1N1 Subtype; Pandemics; Public Health; SARS-CoV-2; Social Media; Swine","Røislien","Jo","Centre for Resilience in Healthcare, Faculty of Health Sciences, University of Stavanger, Kjell Arholmsgate 43, 4021, Stavanger, Norway",NA
"752","34266403","10.1186/s12889-021-11468-3","Health authorities' health risk communication with the public during pandemics: a rapid scoping review.","Responses from the H1N1 swine flu pandemic and the recent COVID-19 coronavirus pandemic provide an opportunity for insight into the role of health authorities' ways of communicating health risk information to the public. We aimed to synthesise the existing evidence regarding different modes of communication used by health authorities in health risk communication with the public during a pandemic. We conducted a rapid scoping review. MEDLINE and EMBASE were searched for publications in English fr","2021","07","21","BMC Public Health","BMC public health","COVID-19; H1N1; Health communication; Media communication; Pandemic; Risk communication; Animals; COVID-19; Communication; Health Communication; Humans; Influenza A Virus, H1N1 Subtype; Pandemics; Public Health; SARS-CoV-2; Social Media; Swine","Wiig","Siri","Centre for Resilience in Healthcare, Faculty of Health Sciences, University of Stavanger, Kjell Arholmsgate 43, 4021, Stavanger, Norway",NA
"753","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Siewe Fodjo","Joseph Nelson","Global Health Institute, University of Antwerp, Antwerp, Belgium",NA
"754","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Ngarka","Leonard","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"755","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Njamnshi","Wepnyu Y","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"756","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Nfor","Leonard N","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"757","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Mengnjo","Michel K","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"758","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Mendo","Edwige Laure","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"759","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Angwafor","Samuel A","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"760","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Atchou Basseguin","Jonas Guy","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"761","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Nkouonlack","Cyrille","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"762","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Njit","Edith N","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"763","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Ahidjo","Nene","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"764","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Chokote","Eric S","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"765","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Dema","Fidèle","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"766","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Fonsah","Julius Y","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"767","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Tatah","Godwin Y","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"768","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Palmer","Nancy","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"769","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Seke Etet","Paul F","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"770","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Palmer","Dennis","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"771","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Nsagha","Dickson S","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"772","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Etya'ale","Daniel E","Brain Research Africa Initiative (BRAIN), Geneva, Switzerland",NA
"773","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Perrig","Stephen","Brain Research Africa Initiative (BRAIN), Geneva, Switzerland",NA
"774","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Sztajzel","Roman","Brain Research Africa Initiative (BRAIN), Geneva, Switzerland",NA
"775","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Annoni","Jean-Marie","Brain Research Africa Initiative (BRAIN), Geneva, Switzerland",NA
"776","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Zoung-Kanyi Bissek","Anne-Cécile","Division of Health Operations Research, Ministry of Public Health, Yaoundé, Cameroon",NA
"777","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Leke","Rose G F","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"778","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Abena Ondoa Obama","Marie-Thérèse","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon",NA
"779","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Nkengasong","John N","CDC Africa, African Union, Addis Ababa, Ethiopia",NA
"780","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Colebunders","Robert","Global Health Institute, University of Antwerp, Antwerp, Belgium",NA
"781","34266400","10.1186/s12888-021-03323-x","Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.","The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient H","2021","07","21","BMC Psychiatry","BMC psychiatry","COVID-19; Cameroon; Depression; FCV-19S; Fear; PHQ-9; Adult; COVID-19; Cameroon; Depression; Fear; Female; Humans; Male; Pandemics; SARS-CoV-2","Njamnshi","Alfred K","Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon. alfred.njamnshi@brainafrica","alfred.njamnshi@brainafrica.org"
"782","34266396","10.1186/s12879-021-06378-z","High risk groups for severe COVID-19 in a whole of population cohort in Australia.","Increasing age is the strongest known risk factor for severe COVID-19 disease but information on other factors is more limited. All cases of COVID-19 diagnosed from January-October 2020 in New South Wales Australia were followed for COVID-19-related hospitalisations, intensive care unit (ICU) admissions and deaths through record linkage. Adjusted hazard ratios (aHR) for severe COVID-19 disease, measured by hospitalisation or death, or very severe COVID-19, measured by ICU admission or death acco","2021","07","19","BMC Infect Dis","BMC infectious diseases","Adult; Aged; Aged, 80 and over; Aging; COVID-19; Cohort Studies; Comorbidity; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; New South Wales; Proportional Hazards Models; Risk Factors; SARS-CoV-2; Sex Characteristics; Survival Analysis","Liu","Bette","School of Population Health, UNSW, Sydney, Australia. bette.liu@unsw.edu","bette.liu@unsw.edu.au"
"783","34266396","10.1186/s12879-021-06378-z","High risk groups for severe COVID-19 in a whole of population cohort in Australia.","Increasing age is the strongest known risk factor for severe COVID-19 disease but information on other factors is more limited. All cases of COVID-19 diagnosed from January-October 2020 in New South Wales Australia were followed for COVID-19-related hospitalisations, intensive care unit (ICU) admissions and deaths through record linkage. Adjusted hazard ratios (aHR) for severe COVID-19 disease, measured by hospitalisation or death, or very severe COVID-19, measured by ICU admission or death acco","2021","07","19","BMC Infect Dis","BMC infectious diseases","Adult; Aged; Aged, 80 and over; Aging; COVID-19; Cohort Studies; Comorbidity; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; New South Wales; Proportional Hazards Models; Risk Factors; SARS-CoV-2; Sex Characteristics; Survival Analysis","Spokes","Paula","Public Health Response Branch, NSW Ministry of Health, St. Leonards, Australia",NA
"784","34266396","10.1186/s12879-021-06378-z","High risk groups for severe COVID-19 in a whole of population cohort in Australia.","Increasing age is the strongest known risk factor for severe COVID-19 disease but information on other factors is more limited. All cases of COVID-19 diagnosed from January-October 2020 in New South Wales Australia were followed for COVID-19-related hospitalisations, intensive care unit (ICU) admissions and deaths through record linkage. Adjusted hazard ratios (aHR) for severe COVID-19 disease, measured by hospitalisation or death, or very severe COVID-19, measured by ICU admission or death acco","2021","07","19","BMC Infect Dis","BMC infectious diseases","Adult; Aged; Aged, 80 and over; Aging; COVID-19; Cohort Studies; Comorbidity; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; New South Wales; Proportional Hazards Models; Risk Factors; SARS-CoV-2; Sex Characteristics; Survival Analysis","He","Wenqiang","School of Population Health, UNSW, Sydney, Australia",NA
"785","34266396","10.1186/s12879-021-06378-z","High risk groups for severe COVID-19 in a whole of population cohort in Australia.","Increasing age is the strongest known risk factor for severe COVID-19 disease but information on other factors is more limited. All cases of COVID-19 diagnosed from January-October 2020 in New South Wales Australia were followed for COVID-19-related hospitalisations, intensive care unit (ICU) admissions and deaths through record linkage. Adjusted hazard ratios (aHR) for severe COVID-19 disease, measured by hospitalisation or death, or very severe COVID-19, measured by ICU admission or death acco","2021","07","19","BMC Infect Dis","BMC infectious diseases","Adult; Aged; Aged, 80 and over; Aging; COVID-19; Cohort Studies; Comorbidity; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; New South Wales; Proportional Hazards Models; Risk Factors; SARS-CoV-2; Sex Characteristics; Survival Analysis","Kaldor","John","Kirby Institute, UNSW, Sydney, Australia",NA
"786","34266339","10.1177/00912174211033710","Perceived stress in different countries at the beginning of the coronavirus pandemic.","The coronavirus has spread around the world, causing an ongoing pandemic. After the lockdown and quarantine protocols, an evaluation of the population's current emotional state was made through a web-based survey available in both English and Spanish. The objective was to observe how respondents perceived stress and worry as a result of COVID-19. The survey gathered data across three sections: socio-demographic data, the Perceived Stress Scale (PSS-10) by Cohen, and additional queries on current","2021","07","16","Int J Psychiatry Med","International journal of psychiatry in medicine","COVID-19; PSS-10; coronavirus; pandemic; stress; worry","Gamonal-Limcaoco","Sinta","Department of Psychiatry, University of Salamanca Health Care Complex, Salamanca, Spain",NA
"787","34266339","10.1177/00912174211033710","Perceived stress in different countries at the beginning of the coronavirus pandemic.","The coronavirus has spread around the world, causing an ongoing pandemic. After the lockdown and quarantine protocols, an evaluation of the population's current emotional state was made through a web-based survey available in both English and Spanish. The objective was to observe how respondents perceived stress and worry as a result of COVID-19. The survey gathered data across three sections: socio-demographic data, the Perceived Stress Scale (PSS-10) by Cohen, and additional queries on current","2021","07","16","Int J Psychiatry Med","International journal of psychiatry in medicine","COVID-19; PSS-10; coronavirus; pandemic; stress; worry","Montero-Mateos","Enrique","Department of Pathology, University of Salamanca Health Care Complex, Salamanca, Spain",NA
"788","34266339","10.1177/00912174211033710","Perceived stress in different countries at the beginning of the coronavirus pandemic.","The coronavirus has spread around the world, causing an ongoing pandemic. After the lockdown and quarantine protocols, an evaluation of the population's current emotional state was made through a web-based survey available in both English and Spanish. The objective was to observe how respondents perceived stress and worry as a result of COVID-19. The survey gathered data across three sections: socio-demographic data, the Perceived Stress Scale (PSS-10) by Cohen, and additional queries on current","2021","07","16","Int J Psychiatry Med","International journal of psychiatry in medicine","COVID-19; PSS-10; coronavirus; pandemic; stress; worry","Lozano-López","Maria Teresa","Department of Psychiatry, University of Salamanca Health Care Complex, Salamanca, Spain",NA
"789","34266339","10.1177/00912174211033710","Perceived stress in different countries at the beginning of the coronavirus pandemic.","The coronavirus has spread around the world, causing an ongoing pandemic. After the lockdown and quarantine protocols, an evaluation of the population's current emotional state was made through a web-based survey available in both English and Spanish. The objective was to observe how respondents perceived stress and worry as a result of COVID-19. The survey gathered data across three sections: socio-demographic data, the Perceived Stress Scale (PSS-10) by Cohen, and additional queries on current","2021","07","16","Int J Psychiatry Med","International journal of psychiatry in medicine","COVID-19; PSS-10; coronavirus; pandemic; stress; worry","Maciá-Casas","Ana","Department of Psychiatry, University of Salamanca Health Care Complex, Salamanca, Spain",NA
"790","34266339","10.1177/00912174211033710","Perceived stress in different countries at the beginning of the coronavirus pandemic.","The coronavirus has spread around the world, causing an ongoing pandemic. After the lockdown and quarantine protocols, an evaluation of the population's current emotional state was made through a web-based survey available in both English and Spanish. The objective was to observe how respondents perceived stress and worry as a result of COVID-19. The survey gathered data across three sections: socio-demographic data, the Perceived Stress Scale (PSS-10) by Cohen, and additional queries on current","2021","07","16","Int J Psychiatry Med","International journal of psychiatry in medicine","COVID-19; PSS-10; coronavirus; pandemic; stress; worry","Matías-Fernández","Juan","Department of Psychiatry, University of Salamanca Health Care Complex, Salamanca, Spain",NA
"791","34266339","10.1177/00912174211033710","Perceived stress in different countries at the beginning of the coronavirus pandemic.","The coronavirus has spread around the world, causing an ongoing pandemic. After the lockdown and quarantine protocols, an evaluation of the population's current emotional state was made through a web-based survey available in both English and Spanish. The objective was to observe how respondents perceived stress and worry as a result of COVID-19. The survey gathered data across three sections: socio-demographic data, the Perceived Stress Scale (PSS-10) by Cohen, and additional queries on current","2021","07","16","Int J Psychiatry Med","International journal of psychiatry in medicine","COVID-19; PSS-10; coronavirus; pandemic; stress; worry","Roncero","Carlos","Department of Psychiatry, University of Salamanca Health Care Complex, Salamanca, Spain",NA
"792","34266230","10.37201/req/151.2020","[Pneumonia in patients with SARS-CoV-2 infection: series of 17 cases in the region of Murcia].","Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. Retrospective data collection from August to October 2020 in two hospitals in the Murcia region. Eighteen patients had COVID-19 diagnosed by PCR and pneumococcal infection confirmed by antigenuria, which represented a prevalence of 2%. A total of 88% had radiological alterations upon admission (two patients had an X-ray within n","2021","07","16","Rev Esp Quimioter","Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","SARS-CoV-2; Streptococcus pneumoniae; pneumonia","Moral Escudero","E","Encarnación Moral Escudero, Medicina Interna-Infecciosas. Hospital Virgen de la Arrixaca, Murcia, Spain. emoralescudero@hotmail","emoralescudero@hotmail.com"
"793","34266230","10.37201/req/151.2020","[Pneumonia in patients with SARS-CoV-2 infection: series of 17 cases in the region of Murcia].","Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. Retrospective data collection from August to October 2020 in two hospitals in the Murcia region. Eighteen patients had COVID-19 diagnosed by PCR and pneumococcal infection confirmed by antigenuria, which represented a prevalence of 2%. A total of 88% had radiological alterations upon admission (two patients had an X-ray within n","2021","07","16","Rev Esp Quimioter","Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","SARS-CoV-2; Streptococcus pneumoniae; pneumonia","Hernández Torres","A","Encarnación Moral Escudero, Medicina Interna-Infecciosas. Hospital Virgen de la Arrixaca, Murcia, Spain. emoralescudero@hotmail",NA
"794","34266230","10.37201/req/151.2020","[Pneumonia in patients with SARS-CoV-2 infection: series of 17 cases in the region of Murcia].","Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. Retrospective data collection from August to October 2020 in two hospitals in the Murcia region. Eighteen patients had COVID-19 diagnosed by PCR and pneumococcal infection confirmed by antigenuria, which represented a prevalence of 2%. A total of 88% had radiological alterations upon admission (two patients had an X-ray within n","2021","07","16","Rev Esp Quimioter","Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","SARS-CoV-2; Streptococcus pneumoniae; pneumonia","Roura Piloto","A E","Encarnación Moral Escudero, Medicina Interna-Infecciosas. Hospital Virgen de la Arrixaca, Murcia, Spain. emoralescudero@hotmail",NA
"795","34266230","10.37201/req/151.2020","[Pneumonia in patients with SARS-CoV-2 infection: series of 17 cases in the region of Murcia].","Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. Retrospective data collection from August to October 2020 in two hospitals in the Murcia region. Eighteen patients had COVID-19 diagnosed by PCR and pneumococcal infection confirmed by antigenuria, which represented a prevalence of 2%. A total of 88% had radiological alterations upon admission (two patients had an X-ray within n","2021","07","16","Rev Esp Quimioter","Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","SARS-CoV-2; Streptococcus pneumoniae; pneumonia","Albendín Iglesias","H","Encarnación Moral Escudero, Medicina Interna-Infecciosas. Hospital Virgen de la Arrixaca, Murcia, Spain. emoralescudero@hotmail",NA
"796","34266230","10.37201/req/151.2020","[Pneumonia in patients with SARS-CoV-2 infection: series of 17 cases in the region of Murcia].","Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. Retrospective data collection from August to October 2020 in two hospitals in the Murcia region. Eighteen patients had COVID-19 diagnosed by PCR and pneumococcal infection confirmed by antigenuria, which represented a prevalence of 2%. A total of 88% had radiological alterations upon admission (two patients had an X-ray within n","2021","07","16","Rev Esp Quimioter","Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","SARS-CoV-2; Streptococcus pneumoniae; pneumonia","Peláez Ballesta","A","Encarnación Moral Escudero, Medicina Interna-Infecciosas. Hospital Virgen de la Arrixaca, Murcia, Spain. emoralescudero@hotmail",NA
"797","34266230","10.37201/req/151.2020","[Pneumonia in patients with SARS-CoV-2 infection: series of 17 cases in the region of Murcia].","Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. Retrospective data collection from August to October 2020 in two hospitals in the Murcia region. Eighteen patients had COVID-19 diagnosed by PCR and pneumococcal infection confirmed by antigenuria, which represented a prevalence of 2%. A total of 88% had radiological alterations upon admission (two patients had an X-ray within n","2021","07","16","Rev Esp Quimioter","Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","SARS-CoV-2; Streptococcus pneumoniae; pneumonia","García Vázquez","E","Encarnación Moral Escudero, Medicina Interna-Infecciosas. Hospital Virgen de la Arrixaca, Murcia, Spain. emoralescudero@hotmail",NA
"798","34266228","10.6859/aja.202107/PP.0001","All Is Not Well in COVID-19 Recovered Patients: Anesthesiologist Viewpoint.",NA,"2021","07","19","Asian J Anesthesiol","Asian journal of anesthesiology",NA,"Dubey","Prakash K","Department of Anesthesiology and Critical Care Medicine, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India",NA
"799","34266228","10.6859/aja.202107/PP.0001","All Is Not Well in COVID-19 Recovered Patients: Anesthesiologist Viewpoint.",NA,"2021","07","19","Asian J Anesthesiol","Asian journal of anesthesiology",NA,"Singh","Kunal","Department of Anesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"800","34266227","10.6859/aja.202107/PP.0002","Point of Care Supraglottic Airway Devices for Safe Percutaneous Tracheostomy in Patients With Coronavirus Disease 2019.",NA,"2021","07","19","Asian J Anesthesiol","Asian journal of anesthesiology",NA,"Kotani","Taichi","Department of Anesthesiology and Division of Intensive Care, Nara Medical University, Kashihara, Nara, Japan",NA
"801","34266227","10.6859/aja.202107/PP.0002","Point of Care Supraglottic Airway Devices for Safe Percutaneous Tracheostomy in Patients With Coronavirus Disease 2019.",NA,"2021","07","19","Asian J Anesthesiol","Asian journal of anesthesiology",NA,"Inoue","Satoki","Department of Anesthesiology and Division of Intensive Care, Nara Medical University, Kashihara, Nara, Japan",NA
"802","34266227","10.6859/aja.202107/PP.0002","Point of Care Supraglottic Airway Devices for Safe Percutaneous Tracheostomy in Patients With Coronavirus Disease 2019.",NA,"2021","07","19","Asian J Anesthesiol","Asian journal of anesthesiology",NA,"Uemura","Keiko","Department of Anesthesiology and Division of Intensive Care, Nara Medical University, Kashihara, Nara, Japan",NA
"803","34266227","10.6859/aja.202107/PP.0002","Point of Care Supraglottic Airway Devices for Safe Percutaneous Tracheostomy in Patients With Coronavirus Disease 2019.",NA,"2021","07","19","Asian J Anesthesiol","Asian journal of anesthesiology",NA,"Kawaguchi","Masahiko","Department of Anesthesiology and Division of Intensive Care, Nara Medical University, Kashihara, Nara, Japan",NA
"804","34265893","10.4178/epih.e2021045","A closer look to the high burden of the psychiatric disorders among health care workers (HCWs) in Egypt during COVID-19 outbreak: A meta-analysis of 3137 HCWs.","To study the prevalence of psychiatric disorders among Egyptian health care workers (HCWs) during the Coronavirus Disease 2019 (COVID-19) outbreak. We searched six databases for relevant papers. The quality of the included articles was measured by The National Institute of Health quality assessment tool. We used the fixed-effect model if there is no heterogeneity and the random model if heterogeneity exists. After the screening of 197 records, we included 10 studies. Among all psychiatric disord","2021","07","15","Epidemiol Health","Epidemiology and health","COVID-19; Egypt; Health care workers; Mental health; Psychiatry","El-Qushayri","Amr Ehab","Faculty of Medicine, Minia University, Minia, Egypt, Minia, Egypt",NA
"805","34265893","10.4178/epih.e2021045","A closer look to the high burden of the psychiatric disorders among health care workers (HCWs) in Egypt during COVID-19 outbreak: A meta-analysis of 3137 HCWs.","To study the prevalence of psychiatric disorders among Egyptian health care workers (HCWs) during the Coronavirus Disease 2019 (COVID-19) outbreak. We searched six databases for relevant papers. The quality of the included articles was measured by The National Institute of Health quality assessment tool. We used the fixed-effect model if there is no heterogeneity and the random model if heterogeneity exists. After the screening of 197 records, we included 10 studies. Among all psychiatric disord","2021","07","15","Epidemiol Health","Epidemiology and health","COVID-19; Egypt; Health care workers; Mental health; Psychiatry","Dahy","Abdullah","Faculty of Medicine, Minia University, Minia, Egypt, Minia, Egypt",NA
"806","34265893","10.4178/epih.e2021045","A closer look to the high burden of the psychiatric disorders among health care workers (HCWs) in Egypt during COVID-19 outbreak: A meta-analysis of 3137 HCWs.","To study the prevalence of psychiatric disorders among Egyptian health care workers (HCWs) during the Coronavirus Disease 2019 (COVID-19) outbreak. We searched six databases for relevant papers. The quality of the included articles was measured by The National Institute of Health quality assessment tool. We used the fixed-effect model if there is no heterogeneity and the random model if heterogeneity exists. After the screening of 197 records, we included 10 studies. Among all psychiatric disord","2021","07","15","Epidemiol Health","Epidemiology and health","COVID-19; Egypt; Health care workers; Mental health; Psychiatry","Reda","Abdullah","Faculty of Medicine, Al-Azhar University, Cairo, Egypt, Cairo, Egypt",NA
"807","34265893","10.4178/epih.e2021045","A closer look to the high burden of the psychiatric disorders among health care workers (HCWs) in Egypt during COVID-19 outbreak: A meta-analysis of 3137 HCWs.","To study the prevalence of psychiatric disorders among Egyptian health care workers (HCWs) during the Coronavirus Disease 2019 (COVID-19) outbreak. We searched six databases for relevant papers. The quality of the included articles was measured by The National Institute of Health quality assessment tool. We used the fixed-effect model if there is no heterogeneity and the random model if heterogeneity exists. After the screening of 197 records, we included 10 studies. Among all psychiatric disord","2021","07","15","Epidemiol Health","Epidemiology and health","COVID-19; Egypt; Health care workers; Mental health; Psychiatry","Mahmoud","Mariam Abdelmageed","Faculty of Medicine, Tanta University, Tanta, Egypt, Tanta, Egypt",NA
"808","34265893","10.4178/epih.e2021045","A closer look to the high burden of the psychiatric disorders among health care workers (HCWs) in Egypt during COVID-19 outbreak: A meta-analysis of 3137 HCWs.","To study the prevalence of psychiatric disorders among Egyptian health care workers (HCWs) during the Coronavirus Disease 2019 (COVID-19) outbreak. We searched six databases for relevant papers. The quality of the included articles was measured by The National Institute of Health quality assessment tool. We used the fixed-effect model if there is no heterogeneity and the random model if heterogeneity exists. After the screening of 197 records, we included 10 studies. Among all psychiatric disord","2021","07","15","Epidemiol Health","Epidemiology and health","COVID-19; Egypt; Health care workers; Mental health; Psychiatry","Abdel Mageed","Sarah","Faculty of Medicine, Tanta University, Tanta, Egypt, Tanta, Egypt",NA
"809","34265893","10.4178/epih.e2021045","A closer look to the high burden of the psychiatric disorders among health care workers (HCWs) in Egypt during COVID-19 outbreak: A meta-analysis of 3137 HCWs.","To study the prevalence of psychiatric disorders among Egyptian health care workers (HCWs) during the Coronavirus Disease 2019 (COVID-19) outbreak. We searched six databases for relevant papers. The quality of the included articles was measured by The National Institute of Health quality assessment tool. We used the fixed-effect model if there is no heterogeneity and the random model if heterogeneity exists. After the screening of 197 records, we included 10 studies. Among all psychiatric disord","2021","07","15","Epidemiol Health","Epidemiology and health","COVID-19; Egypt; Health care workers; Mental health; Psychiatry","Kamel","Ahmed Mostafa Ahmed","Faculty of Pharmacy, Minia University, Minia 61519, Egypt, Minia, Egypt",NA
"810","34265893","10.4178/epih.e2021045","A closer look to the high burden of the psychiatric disorders among health care workers (HCWs) in Egypt during COVID-19 outbreak: A meta-analysis of 3137 HCWs.","To study the prevalence of psychiatric disorders among Egyptian health care workers (HCWs) during the Coronavirus Disease 2019 (COVID-19) outbreak. We searched six databases for relevant papers. The quality of the included articles was measured by The National Institute of Health quality assessment tool. We used the fixed-effect model if there is no heterogeneity and the random model if heterogeneity exists. After the screening of 197 records, we included 10 studies. Among all psychiatric disord","2021","07","15","Epidemiol Health","Epidemiology and health","COVID-19; Egypt; Health care workers; Mental health; Psychiatry","Ghozy","Sherief","Faculty of Medicine, Mansoura University, Mansoura, Egypt, Mansoura, Egypt",NA
"811","34265888","10.1515/jbcpp-2020-0369","Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.","The new Coronavirus (SARS-CoV-2) created a pandemic in the world in late 2019 and early 2020. Unfortunately, despite the increasing prevalence of the disease, there is no effective drug for the treatment. A computational drug repurposing study would be an appropriate and rapid way to provide an effective drug in the treatment of the coronavirus disease of 2019 (COVID-19) pandemic. In this study, the inhibitory potential of more than 50 antiviral drugs on three important proteins of SARS-CoV-2, w","2021","07","15","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","Covid-19; drug repositioning; lopinavir; molecular docking; saquinavir","Jalalvand","Alireza","Department of Influenza and Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran",NA
"812","34265888","10.1515/jbcpp-2020-0369","Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.","The new Coronavirus (SARS-CoV-2) created a pandemic in the world in late 2019 and early 2020. Unfortunately, despite the increasing prevalence of the disease, there is no effective drug for the treatment. A computational drug repurposing study would be an appropriate and rapid way to provide an effective drug in the treatment of the coronavirus disease of 2019 (COVID-19) pandemic. In this study, the inhibitory potential of more than 50 antiviral drugs on three important proteins of SARS-CoV-2, w","2021","07","15","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","Covid-19; drug repositioning; lopinavir; molecular docking; saquinavir","Khatouni","Somayeh Behjat","Department of Influenza and Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran",NA
"813","34265888","10.1515/jbcpp-2020-0369","Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.","The new Coronavirus (SARS-CoV-2) created a pandemic in the world in late 2019 and early 2020. Unfortunately, despite the increasing prevalence of the disease, there is no effective drug for the treatment. A computational drug repurposing study would be an appropriate and rapid way to provide an effective drug in the treatment of the coronavirus disease of 2019 (COVID-19) pandemic. In this study, the inhibitory potential of more than 50 antiviral drugs on three important proteins of SARS-CoV-2, w","2021","07","15","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","Covid-19; drug repositioning; lopinavir; molecular docking; saquinavir","Najafi","Zahra Bahri","Department of Influenza and Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran",NA
"814","34265888","10.1515/jbcpp-2020-0369","Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.","The new Coronavirus (SARS-CoV-2) created a pandemic in the world in late 2019 and early 2020. Unfortunately, despite the increasing prevalence of the disease, there is no effective drug for the treatment. A computational drug repurposing study would be an appropriate and rapid way to provide an effective drug in the treatment of the coronavirus disease of 2019 (COVID-19) pandemic. In this study, the inhibitory potential of more than 50 antiviral drugs on three important proteins of SARS-CoV-2, w","2021","07","15","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","Covid-19; drug repositioning; lopinavir; molecular docking; saquinavir","Fatahinia","Foroozan","Department of Influenza and Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran",NA
"815","34265888","10.1515/jbcpp-2020-0369","Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.","The new Coronavirus (SARS-CoV-2) created a pandemic in the world in late 2019 and early 2020. Unfortunately, despite the increasing prevalence of the disease, there is no effective drug for the treatment. A computational drug repurposing study would be an appropriate and rapid way to provide an effective drug in the treatment of the coronavirus disease of 2019 (COVID-19) pandemic. In this study, the inhibitory potential of more than 50 antiviral drugs on three important proteins of SARS-CoV-2, w","2021","07","15","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","Covid-19; drug repositioning; lopinavir; molecular docking; saquinavir","Ismailzadeh","Narges","Department of Influenza and Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran",NA
"816","34265888","10.1515/jbcpp-2020-0369","Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.","The new Coronavirus (SARS-CoV-2) created a pandemic in the world in late 2019 and early 2020. Unfortunately, despite the increasing prevalence of the disease, there is no effective drug for the treatment. A computational drug repurposing study would be an appropriate and rapid way to provide an effective drug in the treatment of the coronavirus disease of 2019 (COVID-19) pandemic. In this study, the inhibitory potential of more than 50 antiviral drugs on three important proteins of SARS-CoV-2, w","2021","07","15","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","Covid-19; drug repositioning; lopinavir; molecular docking; saquinavir","Farahmand","Behrokh","Department of Influenza and Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran",NA
"817","34265874","10.4088/PCC.21m02977","Mental Health Effects of COVID-19 Within the Socioeconomic Crisis and After the Beirut Blast Among Health Care Workers and Medical Students in Lebanon.","Objective: To measure the mental health effects (perceived stress, anxiety, and depression) among health care workers and medical students in Lebanon during the coronavirus disease 2019 (COVID-19) pandemic and subsequent to the Beirut blast. Methods: In this cross-sectional study, a self-administered online questionnaire was developed and distributed between late December 2020 and early February 2021 among health care workers and medical students via social media. The 10-item Perceived Stress Sc","2021","07","22","Prim Care Companion CNS Disord","The primary care companion for CNS disorders","Adult; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Disasters; Economic Recession; Female; Health Personnel; Humans; Lebanon; Male; Mental Health; Middle Aged; Pandemics; Prevalence; Resilience, Psychological; Sex Factors; Students, Medical; Surveys and Questionnaires; Young Adult","Abed","Ahed El","Faculty of Medical Sciences, Lebanese University, Hadath, Beirut, Lebanon",NA
"818","34265874","10.4088/PCC.21m02977","Mental Health Effects of COVID-19 Within the Socioeconomic Crisis and After the Beirut Blast Among Health Care Workers and Medical Students in Lebanon.","Objective: To measure the mental health effects (perceived stress, anxiety, and depression) among health care workers and medical students in Lebanon during the coronavirus disease 2019 (COVID-19) pandemic and subsequent to the Beirut blast. Methods: In this cross-sectional study, a self-administered online questionnaire was developed and distributed between late December 2020 and early February 2021 among health care workers and medical students via social media. The 10-item Perceived Stress Sc","2021","07","22","Prim Care Companion CNS Disord","The primary care companion for CNS disorders","Adult; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Disasters; Economic Recession; Female; Health Personnel; Humans; Lebanon; Male; Mental Health; Middle Aged; Pandemics; Prevalence; Resilience, Psychological; Sex Factors; Students, Medical; Surveys and Questionnaires; Young Adult","Razzak","Rawane Abdul","Faculty of Medical Sciences, Lebanese University, Hadath, Beirut, Lebanon",NA
"819","34265874","10.4088/PCC.21m02977","Mental Health Effects of COVID-19 Within the Socioeconomic Crisis and After the Beirut Blast Among Health Care Workers and Medical Students in Lebanon.","Objective: To measure the mental health effects (perceived stress, anxiety, and depression) among health care workers and medical students in Lebanon during the coronavirus disease 2019 (COVID-19) pandemic and subsequent to the Beirut blast. Methods: In this cross-sectional study, a self-administered online questionnaire was developed and distributed between late December 2020 and early February 2021 among health care workers and medical students via social media. The 10-item Perceived Stress Sc","2021","07","22","Prim Care Companion CNS Disord","The primary care companion for CNS disorders","Adult; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Disasters; Economic Recession; Female; Health Personnel; Humans; Lebanon; Male; Mental Health; Middle Aged; Pandemics; Prevalence; Resilience, Psychological; Sex Factors; Students, Medical; Surveys and Questionnaires; Young Adult","Hashim","Hashim Talib","University of Baghdad, College of Medicine, Nasiriyah, Thi-Qar, Iraq","hashim.h.t.h@gmail.com"
"820","34265848","10.1093/pubmed/fdab284","Discussing data security and telehealth during the COVID-19 pandemic.",NA,"2021","07","15","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Camarines","Teresa M","De La Salle University Integrated School, 2401 Taft Ave, Malate, Manila, 1004, Philippines",NA
"821","34265848","10.1093/pubmed/fdab284","Discussing data security and telehealth during the COVID-19 pandemic.",NA,"2021","07","15","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Camarines","John Christopher M","De La Salle University, 2401 Taft Ave, Malate, Manila, 1004, Philippines",NA
"822","34265771","10.1159/000517276","Does COVID-19 Worsen the Semen Parameters? Early Results of a Tertiary Healthcare Center.","The coronavirus disease 2019 (COVID-19) is a global pandemic which may affect multiple organs and systems including testes and disrupt the gonadal functions. The current study aimed to evaluate the effect of COVID-19 on the semen parameters and sex-related hormone levels in infertile men. The study included 21 patients who were evaluated in Ankara City Hospital, Andrology Clinic, for male infertility and have had the diagnosis of COVID-19. All the patients were evaluated in terms of semen parame","2021","07","15","Urol Int","Urologia internationalis","Coronavirus disease 2019; Infertility; Semen analyses; Severe acute respiratory syndrome coronavirus 2; Testosterone","Koç","Erdem","Department of Urology, Ankara Yildirim Beyazit University, School of Medicine, Ankara State Hospital, Ankara, Turkey",NA
"823","34265771","10.1159/000517276","Does COVID-19 Worsen the Semen Parameters? Early Results of a Tertiary Healthcare Center.","The coronavirus disease 2019 (COVID-19) is a global pandemic which may affect multiple organs and systems including testes and disrupt the gonadal functions. The current study aimed to evaluate the effect of COVID-19 on the semen parameters and sex-related hormone levels in infertile men. The study included 21 patients who were evaluated in Ankara City Hospital, Andrology Clinic, for male infertility and have had the diagnosis of COVID-19. All the patients were evaluated in terms of semen parame","2021","07","15","Urol Int","Urologia internationalis","Coronavirus disease 2019; Infertility; Semen analyses; Severe acute respiratory syndrome coronavirus 2; Testosterone","Keseroglu","Bugra Bilge","Department of Urology, Ankara State Hospital, Ankara, Turkey",NA
"824","34265748","10.1088/1361-6498/ac14d3","Prevention and management of infections after exposure to ionizing radiation.","Ionizing radiation impacts many organ systems, each of which comprises a level of immunity to infectious disease. Bone marrow toxicity after radiation results in a predisposition to leukopenia and subsequent susceptibility to bacterial, viral, and fungal infections. Radiation-induced damage to mucosal, integumentary, and solid organ structures disrupts additional lines of innate defense. Over the past three decades, much progress has been made in effective antimicrobial prophylaxis, resulting in","2021","07","15","J Radiol Prot","Journal of radiological protection : official journal of the Society for Radiological Protection","covid 19; neutropenic fever; prophylaxis; vaccination","Maher","Keri","Hematology/Oncology, Virginia Commonwealth University, 1250 E Marshall St, Richmond, Virginia, 23219, UNITED STATES",NA
"825","34265748","10.1088/1361-6498/ac14d3","Prevention and management of infections after exposure to ionizing radiation.","Ionizing radiation impacts many organ systems, each of which comprises a level of immunity to infectious disease. Bone marrow toxicity after radiation results in a predisposition to leukopenia and subsequent susceptibility to bacterial, viral, and fungal infections. Radiation-induced damage to mucosal, integumentary, and solid organ structures disrupts additional lines of innate defense. Over the past three decades, much progress has been made in effective antimicrobial prophylaxis, resulting in","2021","07","15","J Radiol Prot","Journal of radiological protection : official journal of the Society for Radiological Protection","covid 19; neutropenic fever; prophylaxis; vaccination","Bouligny","Ian Michael","Hematology &amp",NA
"826","34265748","10.1088/1361-6498/ac14d3","Prevention and management of infections after exposure to ionizing radiation.","Ionizing radiation impacts many organ systems, each of which comprises a level of immunity to infectious disease. Bone marrow toxicity after radiation results in a predisposition to leukopenia and subsequent susceptibility to bacterial, viral, and fungal infections. Radiation-induced damage to mucosal, integumentary, and solid organ structures disrupts additional lines of innate defense. Over the past three decades, much progress has been made in effective antimicrobial prophylaxis, resulting in","2021","07","15","J Radiol Prot","Journal of radiological protection : official journal of the Society for Radiological Protection","covid 19; neutropenic fever; prophylaxis; vaccination","Yeager","Andrew M","Medicine, The University of Arizona College of Medicine Tucson, Tucson, Arizona, UNITED STATES",NA
"827","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Glampson","Ben","NIHR Imperial Biomedical Research Centre, Imperial College Healthcare NHS Trust, Praed Street, W2 1NY, London, UK, London, GB",NA
"828","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Brittain","James","Department of Surgery &amp",NA
"829","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Kaura","Amit","Department of Surgery &amp",NA
"830","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Mulla","Abdulrahim","Department of Surgery &amp",NA
"831","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Mercuri","Luca","Department of Surgery &amp",NA
"832","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Brett","Stephen J","Department of Surgery &amp",NA
"833","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Aylin","Paul","School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, W2 1PG, London, UK, London, GB",NA
"834","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Sandall","Tessa","North West London Collaboration of Clinical Commissioning Groups, 15 Marylebone Road, NW1 5JD, London, UK",NA
"835","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Goodman","Ian","North West London Collaboration of Clinical Commissioning Groups, 15 Marylebone Road, NW1 5JD, London, UK",NA
"836","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Redhead","Julian","NIHR Imperial Biomedical Research Centre, Imperial College Healthcare NHS Trust, Praed Street, W2 1NY, London, UK, London, GB",NA
"837","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Saravanakumar","Kavitha","North West London Collaboration of Clinical Commissioning Groups, 15 Marylebone Road, NW1 5JD, London, UK",NA
"838","34265740","10.2196/30010","North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness: Retrospective Cohort Study.","On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) syndrome, as a pandemic. The UK mass vaccination programme commenced on December 08, 2020 vaccinating groups of the population deemed to be most vulnerable to severe COVID-19 infection. To assess the early vaccine administration coverage and outcome data across an integrated care system in North West London (NWL), leveraging a uniqu","2021","07","15","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Mayer","Erik K","Department of Surgery &amp",NA
"839","34265737","10.1016/j.copsyc.2021.05.004","Autonomy-connection tensions, stress, and attachment: The case of COVID-19.","The COVID pandemic, and actions taken by governments worldwide to deal with it, have placed stress on couple relationships. Reports from many countries have documented substantial increases in relationship difficulties, conflict, and violence. We propose that issues concerning autonomy and connection are central to these problems, particularly as couples face changing situations with regard to lockdowns, social distancing, and border closures. We further propose that a fruitful approach to under","2021","07","23","Curr Opin Psychol","Current opinion in psychology","Attachment; Autonomyconnection; Couple dynamics; Emotionally focused couples therapy.; Stress","Feeney","Judith A","School of Psychology, University of Queensland, St. Lucia, Queensland, 4072, Australia. Electronic address: j.feeney@psy.uq.edu","j.feeney@psy.uq.edu.au"
"840","34265737","10.1016/j.copsyc.2021.05.004","Autonomy-connection tensions, stress, and attachment: The case of COVID-19.","The COVID pandemic, and actions taken by governments worldwide to deal with it, have placed stress on couple relationships. Reports from many countries have documented substantial increases in relationship difficulties, conflict, and violence. We propose that issues concerning autonomy and connection are central to these problems, particularly as couples face changing situations with regard to lockdowns, social distancing, and border closures. We further propose that a fruitful approach to under","2021","07","23","Curr Opin Psychol","Current opinion in psychology","Attachment; Autonomyconnection; Couple dynamics; Emotionally focused couples therapy.; Stress","Fitzgerald","Jennifer","Discipline of Psychiatry, University of Queensland, Royal Brisbane and Women's Hospital, Herston, 4006, Australia",NA
"841","34265672","10.1016/j.jcis.2021.06.170","Porous Au@Pt nanoparticles with superior peroxidase-like activity for colorimetric detection of spike protein of SARS-CoV-2.","The development of colorimetric assays for rapid and accurate diagnosis of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of practical importance for point-of-care (POC) testing. Here we report the colorimetric detection of spike (S1) protein of SARS-CoV-2 based on excellent peroxidase-like activity of Au@Pt nanoparticles, with merits of rapidness, easy operation, and high sensitivity. The Au@Pt NPs were fabricated by a facile seed","2021","07","23","J Colloid Interface Sci","Journal of colloid and interface science","Catalysis; Colorimetric Detection; Mechanism; Nanozyme; SARS-CoV-2 spike protein","Fu","Zhao","CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China",NA
"842","34265672","10.1016/j.jcis.2021.06.170","Porous Au@Pt nanoparticles with superior peroxidase-like activity for colorimetric detection of spike protein of SARS-CoV-2.","The development of colorimetric assays for rapid and accurate diagnosis of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of practical importance for point-of-care (POC) testing. Here we report the colorimetric detection of spike (S1) protein of SARS-CoV-2 based on excellent peroxidase-like activity of Au@Pt nanoparticles, with merits of rapidness, easy operation, and high sensitivity. The Au@Pt NPs were fabricated by a facile seed","2021","07","23","J Colloid Interface Sci","Journal of colloid and interface science","Catalysis; Colorimetric Detection; Mechanism; Nanozyme; SARS-CoV-2 spike protein","Zeng","Weilun","CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China",NA
"843","34265672","10.1016/j.jcis.2021.06.170","Porous Au@Pt nanoparticles with superior peroxidase-like activity for colorimetric detection of spike protein of SARS-CoV-2.","The development of colorimetric assays for rapid and accurate diagnosis of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of practical importance for point-of-care (POC) testing. Here we report the colorimetric detection of spike (S1) protein of SARS-CoV-2 based on excellent peroxidase-like activity of Au@Pt nanoparticles, with merits of rapidness, easy operation, and high sensitivity. The Au@Pt NPs were fabricated by a facile seed","2021","07","23","J Colloid Interface Sci","Journal of colloid and interface science","Catalysis; Colorimetric Detection; Mechanism; Nanozyme; SARS-CoV-2 spike protein","Cai","Shuangfei","CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China. Electronic address: caisf@nanoctr","caisf@nanoctr.cn"
"844","34265672","10.1016/j.jcis.2021.06.170","Porous Au@Pt nanoparticles with superior peroxidase-like activity for colorimetric detection of spike protein of SARS-CoV-2.","The development of colorimetric assays for rapid and accurate diagnosis of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of practical importance for point-of-care (POC) testing. Here we report the colorimetric detection of spike (S1) protein of SARS-CoV-2 based on excellent peroxidase-like activity of Au@Pt nanoparticles, with merits of rapidness, easy operation, and high sensitivity. The Au@Pt NPs were fabricated by a facile seed","2021","07","23","J Colloid Interface Sci","Journal of colloid and interface science","Catalysis; Colorimetric Detection; Mechanism; Nanozyme; SARS-CoV-2 spike protein","Li","Haolin","CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China",NA
"845","34265672","10.1016/j.jcis.2021.06.170","Porous Au@Pt nanoparticles with superior peroxidase-like activity for colorimetric detection of spike protein of SARS-CoV-2.","The development of colorimetric assays for rapid and accurate diagnosis of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of practical importance for point-of-care (POC) testing. Here we report the colorimetric detection of spike (S1) protein of SARS-CoV-2 based on excellent peroxidase-like activity of Au@Pt nanoparticles, with merits of rapidness, easy operation, and high sensitivity. The Au@Pt NPs were fabricated by a facile seed","2021","07","23","J Colloid Interface Sci","Journal of colloid and interface science","Catalysis; Colorimetric Detection; Mechanism; Nanozyme; SARS-CoV-2 spike protein","Ding","Jianwei","CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China",NA
"846","34265672","10.1016/j.jcis.2021.06.170","Porous Au@Pt nanoparticles with superior peroxidase-like activity for colorimetric detection of spike protein of SARS-CoV-2.","The development of colorimetric assays for rapid and accurate diagnosis of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of practical importance for point-of-care (POC) testing. Here we report the colorimetric detection of spike (S1) protein of SARS-CoV-2 based on excellent peroxidase-like activity of Au@Pt nanoparticles, with merits of rapidness, easy operation, and high sensitivity. The Au@Pt NPs were fabricated by a facile seed","2021","07","23","J Colloid Interface Sci","Journal of colloid and interface science","Catalysis; Colorimetric Detection; Mechanism; Nanozyme; SARS-CoV-2 spike protein","Wang","Chen","CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China",NA
"847","34265672","10.1016/j.jcis.2021.06.170","Porous Au@Pt nanoparticles with superior peroxidase-like activity for colorimetric detection of spike protein of SARS-CoV-2.","The development of colorimetric assays for rapid and accurate diagnosis of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of practical importance for point-of-care (POC) testing. Here we report the colorimetric detection of spike (S1) protein of SARS-CoV-2 based on excellent peroxidase-like activity of Au@Pt nanoparticles, with merits of rapidness, easy operation, and high sensitivity. The Au@Pt NPs were fabricated by a facile seed","2021","07","23","J Colloid Interface Sci","Journal of colloid and interface science","Catalysis; Colorimetric Detection; Mechanism; Nanozyme; SARS-CoV-2 spike protein","Chen","Yunfa","State Key Laboratory of Multiphase Complex Systems, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China",NA
"848","34265672","10.1016/j.jcis.2021.06.170","Porous Au@Pt nanoparticles with superior peroxidase-like activity for colorimetric detection of spike protein of SARS-CoV-2.","The development of colorimetric assays for rapid and accurate diagnosis of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of practical importance for point-of-care (POC) testing. Here we report the colorimetric detection of spike (S1) protein of SARS-CoV-2 based on excellent peroxidase-like activity of Au@Pt nanoparticles, with merits of rapidness, easy operation, and high sensitivity. The Au@Pt NPs were fabricated by a facile seed","2021","07","23","J Colloid Interface Sci","Journal of colloid and interface science","Catalysis; Colorimetric Detection; Mechanism; Nanozyme; SARS-CoV-2 spike protein","Han","Ning","State Key Laboratory of Multiphase Complex Systems, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China",NA
"849","34265672","10.1016/j.jcis.2021.06.170","Porous Au@Pt nanoparticles with superior peroxidase-like activity for colorimetric detection of spike protein of SARS-CoV-2.","The development of colorimetric assays for rapid and accurate diagnosis of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of practical importance for point-of-care (POC) testing. Here we report the colorimetric detection of spike (S1) protein of SARS-CoV-2 based on excellent peroxidase-like activity of Au@Pt nanoparticles, with merits of rapidness, easy operation, and high sensitivity. The Au@Pt NPs were fabricated by a facile seed","2021","07","23","J Colloid Interface Sci","Journal of colloid and interface science","Catalysis; Colorimetric Detection; Mechanism; Nanozyme; SARS-CoV-2 spike protein","Yang","Rong","CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China","yangr@nanoctr.cn"
"850","34265658","10.1016/j.socscimed.2021.114218","Thoughts of social distancing experiences affect food intake and hypothetical binge eating: Implications for people in home quarantine during COVID-19.","Social distance regulations have been suggested as one of the best ways to control and prevent the spread of COVID-19. Social connection and food are intertwined because both have played critical evolutionary roles in human survival. We tested whether the substitutability hypothesis in human motivation applies here in that cues signaling scarcity in one domain (e.g., social connection) might enhance the desire to acquire resources in another domain (e.g., food). We recruited 140 adults from Kaoh","2021","07","23","Soc Sci Med","Social science &amp; medicine (1982)","COVID-19; Desire for food; Obesity; Social disconnection; Social distancing; Substitutability","Yi-Chi Chang","Yevvon","Department of Hospitality Management, Tunghai University, Taichung, 407224, Taiwan. Electronic address: yevvon@thu.edu","yevvon@thu.edu.tw"
"851","34265658","10.1016/j.socscimed.2021.114218","Thoughts of social distancing experiences affect food intake and hypothetical binge eating: Implications for people in home quarantine during COVID-19.","Social distance regulations have been suggested as one of the best ways to control and prevent the spread of COVID-19. Social connection and food are intertwined because both have played critical evolutionary roles in human survival. We tested whether the substitutability hypothesis in human motivation applies here in that cues signaling scarcity in one domain (e.g., social connection) might enhance the desire to acquire resources in another domain (e.g., food). We recruited 140 adults from Kaoh","2021","07","23","Soc Sci Med","Social science &amp; medicine (1982)","COVID-19; Desire for food; Obesity; Social disconnection; Social distancing; Substitutability","Wu","Pai-Lu","Center for Teacher Education, Cheng Shiu University, Kaohsiung, 83347, Taiwan. Electronic address: pailu@gcloud.csu.edu","pailu@gcloud.csu.edu.tw"
"852","34265658","10.1016/j.socscimed.2021.114218","Thoughts of social distancing experiences affect food intake and hypothetical binge eating: Implications for people in home quarantine during COVID-19.","Social distance regulations have been suggested as one of the best ways to control and prevent the spread of COVID-19. Social connection and food are intertwined because both have played critical evolutionary roles in human survival. We tested whether the substitutability hypothesis in human motivation applies here in that cues signaling scarcity in one domain (e.g., social connection) might enhance the desire to acquire resources in another domain (e.g., food). We recruited 140 adults from Kaoh","2021","07","23","Soc Sci Med","Social science &amp; medicine (1982)","COVID-19; Desire for food; Obesity; Social disconnection; Social distancing; Substitutability","Chiou","Wen-Bin","Institute of Education, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan. Electronic address: wbchiou@mail.nsysu.edu","wbchiou@mail.nsysu.edu.tw"
"853","34265650","10.1016/j.jhazmat.2021.126570","High-value utilization of mask and heavy fraction of bio-oil: From hazardous waste to biochar, bio-oil, and graphene films.","At present, it is very common to wear mask outdoors in order to avoid coronavirus disease 19 (COVID-19) infection. However, this leads to the formation of numerous plastic wastes that threaten humans and ecosystem. Against this major background, a novel co-pyrolysis coupled chemical vapor deposition (CVD) strategy is proposed to systematically convert mask and heavy fraction of bio-oil (HB) into biochar, bio-oil, and three-dimensional graphene films (3DGFs) is proposed. The biochar exhibits high","2021","07","23","J Hazard Mater","Journal of hazardous materials","Bio-oil; Biochar; Heavy fraction of bio-oil; Mask; Three-dimensional graphene films","Luo","Zejun","School of Engineering Science, University of Science and Technology of China, 96 Jinzhai Road, Hefei, Anhui 230026, PR China",NA
"854","34265650","10.1016/j.jhazmat.2021.126570","High-value utilization of mask and heavy fraction of bio-oil: From hazardous waste to biochar, bio-oil, and graphene films.","At present, it is very common to wear mask outdoors in order to avoid coronavirus disease 19 (COVID-19) infection. However, this leads to the formation of numerous plastic wastes that threaten humans and ecosystem. Against this major background, a novel co-pyrolysis coupled chemical vapor deposition (CVD) strategy is proposed to systematically convert mask and heavy fraction of bio-oil (HB) into biochar, bio-oil, and three-dimensional graphene films (3DGFs) is proposed. The biochar exhibits high","2021","07","23","J Hazard Mater","Journal of hazardous materials","Bio-oil; Biochar; Heavy fraction of bio-oil; Mask; Three-dimensional graphene films","Zhu","Xiefei","School of Engineering Science, University of Science and Technology of China, 96 Jinzhai Road, Hefei, Anhui 230026, PR China",NA
"855","34265650","10.1016/j.jhazmat.2021.126570","High-value utilization of mask and heavy fraction of bio-oil: From hazardous waste to biochar, bio-oil, and graphene films.","At present, it is very common to wear mask outdoors in order to avoid coronavirus disease 19 (COVID-19) infection. However, this leads to the formation of numerous plastic wastes that threaten humans and ecosystem. Against this major background, a novel co-pyrolysis coupled chemical vapor deposition (CVD) strategy is proposed to systematically convert mask and heavy fraction of bio-oil (HB) into biochar, bio-oil, and three-dimensional graphene films (3DGFs) is proposed. The biochar exhibits high","2021","07","23","J Hazard Mater","Journal of hazardous materials","Bio-oil; Biochar; Heavy fraction of bio-oil; Mask; Three-dimensional graphene films","Deng","Jingjing","School of Engineering Science, University of Science and Technology of China, 96 Jinzhai Road, Hefei, Anhui 230026, PR China",NA
"856","34265650","10.1016/j.jhazmat.2021.126570","High-value utilization of mask and heavy fraction of bio-oil: From hazardous waste to biochar, bio-oil, and graphene films.","At present, it is very common to wear mask outdoors in order to avoid coronavirus disease 19 (COVID-19) infection. However, this leads to the formation of numerous plastic wastes that threaten humans and ecosystem. Against this major background, a novel co-pyrolysis coupled chemical vapor deposition (CVD) strategy is proposed to systematically convert mask and heavy fraction of bio-oil (HB) into biochar, bio-oil, and three-dimensional graphene films (3DGFs) is proposed. The biochar exhibits high","2021","07","23","J Hazard Mater","Journal of hazardous materials","Bio-oil; Biochar; Heavy fraction of bio-oil; Mask; Three-dimensional graphene films","Gong","Ke","Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Technology of China, 96 Jinzhai Road, Hefei, Anhui 230026, PR China",NA
"857","34265650","10.1016/j.jhazmat.2021.126570","High-value utilization of mask and heavy fraction of bio-oil: From hazardous waste to biochar, bio-oil, and graphene films.","At present, it is very common to wear mask outdoors in order to avoid coronavirus disease 19 (COVID-19) infection. However, this leads to the formation of numerous plastic wastes that threaten humans and ecosystem. Against this major background, a novel co-pyrolysis coupled chemical vapor deposition (CVD) strategy is proposed to systematically convert mask and heavy fraction of bio-oil (HB) into biochar, bio-oil, and three-dimensional graphene films (3DGFs) is proposed. The biochar exhibits high","2021","07","23","J Hazard Mater","Journal of hazardous materials","Bio-oil; Biochar; Heavy fraction of bio-oil; Mask; Three-dimensional graphene films","Zhu","Xifeng","School of Engineering Science, University of Science and Technology of China, 96 Jinzhai Road, Hefei, Anhui 230026, PR China. Electronic address: xfzhu@ustc.edu","xfzhu@ustc.edu.cn"
"858","34265636","10.1016/j.sleep.2021.06.035","Validation of the Japanese version of Stress and Anxiety to Viral Epidemics-9 (SAVE-9) and relationship among stress, insomnia, anxiety, and depression in healthcare workers exposed to coronavirus disease 2019.","This study aimed to validate the Japanese version of the 9-item Stress and Anxiety to Viral Epidemics scale (SAVE-9) and the relationships among the stress related to viral epidemics, insomnia, anxiety, and depression. A cross-sectional questionnaire-based study was conducted online. In total, 1000 healthcare workers (579 men, 421 women; mean age: 43.11 ± 11.69 years) were asked to complete the SAVE-9, Athens Insomnia Scale, Generalized Anxiety Disorder-7 Scale, and Center for Epidemiological St","2021","07","21","Sleep Med","Sleep medicine","Anxiety; COVID-19; Cross-sectional survey; Depression; Insomnia; Stress and Anxiety to Viral Epidemics","Okajima","Isa","Department of Psychological Counseling, Faculty of Humanities, Tokyo Kasei University, Tokyo, Japan. Electronic address: okajima-i@tokyo-kasei.ac",NA
"859","34265636","10.1016/j.sleep.2021.06.035","Validation of the Japanese version of Stress and Anxiety to Viral Epidemics-9 (SAVE-9) and relationship among stress, insomnia, anxiety, and depression in healthcare workers exposed to coronavirus disease 2019.","This study aimed to validate the Japanese version of the 9-item Stress and Anxiety to Viral Epidemics scale (SAVE-9) and the relationships among the stress related to viral epidemics, insomnia, anxiety, and depression. A cross-sectional questionnaire-based study was conducted online. In total, 1000 healthcare workers (579 men, 421 women; mean age: 43.11 ± 11.69 years) were asked to complete the SAVE-9, Athens Insomnia Scale, Generalized Anxiety Disorder-7 Scale, and Center for Epidemiological St","2021","07","21","Sleep Med","Sleep medicine","Anxiety; COVID-19; Cross-sectional survey; Depression; Insomnia; Stress and Anxiety to Viral Epidemics","Chung","Seockhoon","Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea",NA
"860","34265636","10.1016/j.sleep.2021.06.035","Validation of the Japanese version of Stress and Anxiety to Viral Epidemics-9 (SAVE-9) and relationship among stress, insomnia, anxiety, and depression in healthcare workers exposed to coronavirus disease 2019.","This study aimed to validate the Japanese version of the 9-item Stress and Anxiety to Viral Epidemics scale (SAVE-9) and the relationships among the stress related to viral epidemics, insomnia, anxiety, and depression. A cross-sectional questionnaire-based study was conducted online. In total, 1000 healthcare workers (579 men, 421 women; mean age: 43.11 ± 11.69 years) were asked to complete the SAVE-9, Athens Insomnia Scale, Generalized Anxiety Disorder-7 Scale, and Center for Epidemiological St","2021","07","21","Sleep Med","Sleep medicine","Anxiety; COVID-19; Cross-sectional survey; Depression; Insomnia; Stress and Anxiety to Viral Epidemics","Suh","Sooyeon","Department of Psychology, Sungshin Women's University, Seoul, South Korea",NA
"861","34265632","10.1016/j.ijheh.2021.113807","Detection of SARS-CoV-2 RNA on contact surfaces within shared sanitation facilities.","Contamination of contact surfaces with SARS-CoV-2 has been reported as a potential route for the transmission of COVID-19. This could be a major issue in developing countries where access to basic sanitation is poor, leading to the sharing of toilet facilities. In this study, we report SARS-CoV-2 contamination of key contact surfaces in shared toilets and the probabilistic risks of COVID-19 infections based on detection and quantification of the nucleic acid on the surfaces. We observed that 54-","2021","07","24","Int J Hyg Environ Health","International journal of hygiene and environmental health","COVID-19; Contact surface contamination; Digital droplet PCR; Risk assessment; SARS-CoV-2; Shared sanitation","Amoah","Isaac Dennis","Institute for Water and Wastewater Technology, Durban University of Technology, P.O. Box 1334, Durban, 4000, South Africa",NA
"862","34265632","10.1016/j.ijheh.2021.113807","Detection of SARS-CoV-2 RNA on contact surfaces within shared sanitation facilities.","Contamination of contact surfaces with SARS-CoV-2 has been reported as a potential route for the transmission of COVID-19. This could be a major issue in developing countries where access to basic sanitation is poor, leading to the sharing of toilet facilities. In this study, we report SARS-CoV-2 contamination of key contact surfaces in shared toilets and the probabilistic risks of COVID-19 infections based on detection and quantification of the nucleic acid on the surfaces. We observed that 54-","2021","07","24","Int J Hyg Environ Health","International journal of hygiene and environmental health","COVID-19; Contact surface contamination; Digital droplet PCR; Risk assessment; SARS-CoV-2; Shared sanitation","Pillay","Leanne","Institute for Water and Wastewater Technology, Durban University of Technology, P.O. Box 1334, Durban, 4000, South Africa",NA
"863","34265632","10.1016/j.ijheh.2021.113807","Detection of SARS-CoV-2 RNA on contact surfaces within shared sanitation facilities.","Contamination of contact surfaces with SARS-CoV-2 has been reported as a potential route for the transmission of COVID-19. This could be a major issue in developing countries where access to basic sanitation is poor, leading to the sharing of toilet facilities. In this study, we report SARS-CoV-2 contamination of key contact surfaces in shared toilets and the probabilistic risks of COVID-19 infections based on detection and quantification of the nucleic acid on the surfaces. We observed that 54-","2021","07","24","Int J Hyg Environ Health","International journal of hygiene and environmental health","COVID-19; Contact surface contamination; Digital droplet PCR; Risk assessment; SARS-CoV-2; Shared sanitation","Deepnarian","Nashia","Institute for Water and Wastewater Technology, Durban University of Technology, P.O. Box 1334, Durban, 4000, South Africa",NA
"864","34265632","10.1016/j.ijheh.2021.113807","Detection of SARS-CoV-2 RNA on contact surfaces within shared sanitation facilities.","Contamination of contact surfaces with SARS-CoV-2 has been reported as a potential route for the transmission of COVID-19. This could be a major issue in developing countries where access to basic sanitation is poor, leading to the sharing of toilet facilities. In this study, we report SARS-CoV-2 contamination of key contact surfaces in shared toilets and the probabilistic risks of COVID-19 infections based on detection and quantification of the nucleic acid on the surfaces. We observed that 54-","2021","07","24","Int J Hyg Environ Health","International journal of hygiene and environmental health","COVID-19; Contact surface contamination; Digital droplet PCR; Risk assessment; SARS-CoV-2; Shared sanitation","Awolusi","Oluyemi","Institute for Water and Wastewater Technology, Durban University of Technology, P.O. Box 1334, Durban, 4000, South Africa",NA
"865","34265632","10.1016/j.ijheh.2021.113807","Detection of SARS-CoV-2 RNA on contact surfaces within shared sanitation facilities.","Contamination of contact surfaces with SARS-CoV-2 has been reported as a potential route for the transmission of COVID-19. This could be a major issue in developing countries where access to basic sanitation is poor, leading to the sharing of toilet facilities. In this study, we report SARS-CoV-2 contamination of key contact surfaces in shared toilets and the probabilistic risks of COVID-19 infections based on detection and quantification of the nucleic acid on the surfaces. We observed that 54-","2021","07","24","Int J Hyg Environ Health","International journal of hygiene and environmental health","COVID-19; Contact surface contamination; Digital droplet PCR; Risk assessment; SARS-CoV-2; Shared sanitation","Pillay","Kriveshin","Institute for Water and Wastewater Technology, Durban University of Technology, P.O. Box 1334, Durban, 4000, South Africa",NA
"866","34265632","10.1016/j.ijheh.2021.113807","Detection of SARS-CoV-2 RNA on contact surfaces within shared sanitation facilities.","Contamination of contact surfaces with SARS-CoV-2 has been reported as a potential route for the transmission of COVID-19. This could be a major issue in developing countries where access to basic sanitation is poor, leading to the sharing of toilet facilities. In this study, we report SARS-CoV-2 contamination of key contact surfaces in shared toilets and the probabilistic risks of COVID-19 infections based on detection and quantification of the nucleic acid on the surfaces. We observed that 54-","2021","07","24","Int J Hyg Environ Health","International journal of hygiene and environmental health","COVID-19; Contact surface contamination; Digital droplet PCR; Risk assessment; SARS-CoV-2; Shared sanitation","Ramlal","Preshod","School of Life Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, 4001, South Africa",NA
"867","34265632","10.1016/j.ijheh.2021.113807","Detection of SARS-CoV-2 RNA on contact surfaces within shared sanitation facilities.","Contamination of contact surfaces with SARS-CoV-2 has been reported as a potential route for the transmission of COVID-19. This could be a major issue in developing countries where access to basic sanitation is poor, leading to the sharing of toilet facilities. In this study, we report SARS-CoV-2 contamination of key contact surfaces in shared toilets and the probabilistic risks of COVID-19 infections based on detection and quantification of the nucleic acid on the surfaces. We observed that 54-","2021","07","24","Int J Hyg Environ Health","International journal of hygiene and environmental health","COVID-19; Contact surface contamination; Digital droplet PCR; Risk assessment; SARS-CoV-2; Shared sanitation","Kumari","Sheena","Institute for Water and Wastewater Technology, Durban University of Technology, P.O. Box 1334, Durban, 4000, South Africa",NA
"868","34265632","10.1016/j.ijheh.2021.113807","Detection of SARS-CoV-2 RNA on contact surfaces within shared sanitation facilities.","Contamination of contact surfaces with SARS-CoV-2 has been reported as a potential route for the transmission of COVID-19. This could be a major issue in developing countries where access to basic sanitation is poor, leading to the sharing of toilet facilities. In this study, we report SARS-CoV-2 contamination of key contact surfaces in shared toilets and the probabilistic risks of COVID-19 infections based on detection and quantification of the nucleic acid on the surfaces. We observed that 54-","2021","07","24","Int J Hyg Environ Health","International journal of hygiene and environmental health","COVID-19; Contact surface contamination; Digital droplet PCR; Risk assessment; SARS-CoV-2; Shared sanitation","Bux","Faizal","Institute for Water and Wastewater Technology, Durban University of Technology, P.O. Box 1334, Durban, 4000, South Africa. Electronic address: faizalb@dut.ac","faizalb@dut.ac.za"
"869","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Taghizadeh","Peyman","School of Biology, University College of Science, University of Tehran, Tehran, Iran",NA
"870","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Salehi","Sadegh","Cell and Molecular Biology Department, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran",NA
"871","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Heshmati","Ali","School of Biology, University College of Science, University of Tehran, Tehran, Iran",NA
"872","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Houshmand","Seyed Massoud","Department of Medical Biotechnology, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran",NA
"873","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","InanlooRahatloo","Kolsoum","School of Biology, University College of Science, University of Tehran, Tehran, Iran",NA
"874","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Mahjoubi","Forouzandeh","Department of Medical Biotechnology, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran",NA
"875","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Sanati","Mohammad Hossein","Department of Medical Biotechnology, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran",NA
"876","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Yari","Hadi","Human Genetics Division, Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology, Tehran, Iran",NA
"877","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Alavi","Afagh","Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran",NA
"878","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Jamehdar","Saeid Amel","Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"879","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Dabiri","Soroosh","Department of Laboratory Sciences, Zahedan University of Medical Sciences, Zahedan, Iran",NA
"880","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Galehdari","Hamid","Department of Genetics, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran",NA
"881","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Haghshenas","Mohammad Reza","Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran",NA
"882","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Hashemian","Amir Masoud","Department of Emergency Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"883","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Heidarzadeh","Abtin","Faculty of Medicine, Guilan University of Medical Sciences, Guilan, Iran",NA
"884","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Jahanzad","Issa","Pars Hospital Laboratory, Rasht, Iran",NA
"885","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Kheyrani","Elham","Taban Genetics Laboratory, Tehran, Iran",NA
"886","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Piroozmand","Ahmad","Department of Microbiology and Immunology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran",NA
"887","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Mojtahedi","Ali","Microbiology Department, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran",NA
"888","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Nikoo","Hadi Razavi","Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran",NA
"889","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Rahimi Bidgoli","Mohammad Masoud","Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran",NA
"890","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Rezvani","Nayebali","Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran",NA
"891","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Sepehrnejad","Mehdi","COVID-19 Diagnosis Laboratory, Kashan University of Medical Sciences, Kashan, Iran",NA
"892","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Shakibzadeh","Arash","Department of Medical Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran",NA
"893","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Shariati","Gholamreza","Department of Medical Genetics, Faculty of Medicine, Jundishapur University of Medical Sciences, Ahvaz, Iran",NA
"894","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Seyyedi","Noorossadat","Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran",NA
"895","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","MohammadSaleh Zahraei","Seyed","Department of Genetics, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran",NA
"896","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Safari","Iman","School of Biology, University College of Science, University of Tehran, Tehran, Iran. Electronic address: imansafari@ut.ac","imansafari@ut.ac.ir"
"897","34265628","10.1016/j.virol.2021.06.004","Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.","We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating","2021","07","21","Virology","Virology","Co-infection; Haplotypes; Iran; Recombinant genomes; SARS-CoV-2; Tag nucleotide genotyping","Elahi","Elahe","School of Biology, University College of Science, University of Tehran, Tehran, Iran. Electronic address: elaheelahi@ut.ac","elaheelahi@ut.ac.ir"
"898","34265625","10.1016/j.jneuroim.2021.577655","Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis.","Movement disorders are extremely rare in acute disseminated encephalomyelitis (ADEM) and in the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection. We herein report a 34-years-old previously healthy woman who presented with a febrile illness and a constellation of movement disorders (predominantly myoclonus) followed by encephalopathy. After exclusion of common infectious, autoimmune and paraneoplastic etiologies, she was diagnosed to have COVID-19 induced ADEM, which res","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","ADEM; Acute disseminated encephalomyelitis; COVID-19; Movement disorders; Myoclonus; SARS-CoV-2","Ghosh","Ritwik","Department of General Medicine, Burdwan Medical College &amp",NA
"899","34265625","10.1016/j.jneuroim.2021.577655","Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis.","Movement disorders are extremely rare in acute disseminated encephalomyelitis (ADEM) and in the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection. We herein report a 34-years-old previously healthy woman who presented with a febrile illness and a constellation of movement disorders (predominantly myoclonus) followed by encephalopathy. After exclusion of common infectious, autoimmune and paraneoplastic etiologies, she was diagnosed to have COVID-19 induced ADEM, which res","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","ADEM; Acute disseminated encephalomyelitis; COVID-19; Movement disorders; Myoclonus; SARS-CoV-2","Dubey","Souvik","Department of Neuromedicine, Bangur Institute of Neurosciences, Kolkata, India",NA
"900","34265625","10.1016/j.jneuroim.2021.577655","Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis.","Movement disorders are extremely rare in acute disseminated encephalomyelitis (ADEM) and in the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection. We herein report a 34-years-old previously healthy woman who presented with a febrile illness and a constellation of movement disorders (predominantly myoclonus) followed by encephalopathy. After exclusion of common infectious, autoimmune and paraneoplastic etiologies, she was diagnosed to have COVID-19 induced ADEM, which res","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","ADEM; Acute disseminated encephalomyelitis; COVID-19; Movement disorders; Myoclonus; SARS-CoV-2","Mandal","Arpan","Department of General Medicine, Burdwan Medical College &amp",NA
"901","34265625","10.1016/j.jneuroim.2021.577655","Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis.","Movement disorders are extremely rare in acute disseminated encephalomyelitis (ADEM) and in the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection. We herein report a 34-years-old previously healthy woman who presented with a febrile illness and a constellation of movement disorders (predominantly myoclonus) followed by encephalopathy. After exclusion of common infectious, autoimmune and paraneoplastic etiologies, she was diagnosed to have COVID-19 induced ADEM, which res","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","ADEM; Acute disseminated encephalomyelitis; COVID-19; Movement disorders; Myoclonus; SARS-CoV-2","Ray","Biman Kanti","Department of Neuromedicine, Bangur Institute of Neurosciences, Kolkata, India",NA
"902","34265625","10.1016/j.jneuroim.2021.577655","Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis.","Movement disorders are extremely rare in acute disseminated encephalomyelitis (ADEM) and in the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection. We herein report a 34-years-old previously healthy woman who presented with a febrile illness and a constellation of movement disorders (predominantly myoclonus) followed by encephalopathy. After exclusion of common infectious, autoimmune and paraneoplastic etiologies, she was diagnosed to have COVID-19 induced ADEM, which res","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","ADEM; Acute disseminated encephalomyelitis; COVID-19; Movement disorders; Myoclonus; SARS-CoV-2","Benito-León","Julián","Department of Neurology, University Hospital ""12 de Octubre"", Madrid, Spain","jbenitol67@gmail.com"
"903","34265624","10.1016/j.jneuroim.2021.577654","N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARa.","Increasing evidence suggests that SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is associated with increased risk of developing neurological or psychiatric conditions such as depression, anxiety or dementia. While the precise mechanism underlying this association is unknown, aberrant activation of toll-like receptor (TLR)3, a viral recognizing pattern recognition receptor, may play a key role. Synthetic cannabinoids and enhancing cannabinoid tone via inhibition of fatty acid amide","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Anandamide; Cannabinoid; Hypothalamus; Neuroinflammation; OEA; PEA; PPAR; Temperature; Viral infection","Flannery","Lisa E","Physiology, National University of Ireland, Galway, Ireland",NA
"904","34265624","10.1016/j.jneuroim.2021.577654","N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARa.","Increasing evidence suggests that SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is associated with increased risk of developing neurological or psychiatric conditions such as depression, anxiety or dementia. While the precise mechanism underlying this association is unknown, aberrant activation of toll-like receptor (TLR)3, a viral recognizing pattern recognition receptor, may play a key role. Synthetic cannabinoids and enhancing cannabinoid tone via inhibition of fatty acid amide","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Anandamide; Cannabinoid; Hypothalamus; Neuroinflammation; OEA; PEA; PPAR; Temperature; Viral infection","Kerr","Daniel M","Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland",NA
"905","34265624","10.1016/j.jneuroim.2021.577654","N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARa.","Increasing evidence suggests that SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is associated with increased risk of developing neurological or psychiatric conditions such as depression, anxiety or dementia. While the precise mechanism underlying this association is unknown, aberrant activation of toll-like receptor (TLR)3, a viral recognizing pattern recognition receptor, may play a key role. Synthetic cannabinoids and enhancing cannabinoid tone via inhibition of fatty acid amide","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Anandamide; Cannabinoid; Hypothalamus; Neuroinflammation; OEA; PEA; PPAR; Temperature; Viral infection","Hughes","Edel M","Physiology, National University of Ireland, Galway, Ireland",NA
"906","34265624","10.1016/j.jneuroim.2021.577654","N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARa.","Increasing evidence suggests that SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is associated with increased risk of developing neurological or psychiatric conditions such as depression, anxiety or dementia. While the precise mechanism underlying this association is unknown, aberrant activation of toll-like receptor (TLR)3, a viral recognizing pattern recognition receptor, may play a key role. Synthetic cannabinoids and enhancing cannabinoid tone via inhibition of fatty acid amide","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Anandamide; Cannabinoid; Hypothalamus; Neuroinflammation; OEA; PEA; PPAR; Temperature; Viral infection","Kelly","Colm","Physiology, National University of Ireland, Galway, Ireland",NA
"907","34265624","10.1016/j.jneuroim.2021.577654","N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARa.","Increasing evidence suggests that SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is associated with increased risk of developing neurological or psychiatric conditions such as depression, anxiety or dementia. While the precise mechanism underlying this association is unknown, aberrant activation of toll-like receptor (TLR)3, a viral recognizing pattern recognition receptor, may play a key role. Synthetic cannabinoids and enhancing cannabinoid tone via inhibition of fatty acid amide","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Anandamide; Cannabinoid; Hypothalamus; Neuroinflammation; OEA; PEA; PPAR; Temperature; Viral infection","Costello","Jonathan","Physiology, National University of Ireland, Galway, Ireland",NA
"908","34265624","10.1016/j.jneuroim.2021.577654","N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARa.","Increasing evidence suggests that SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is associated with increased risk of developing neurological or psychiatric conditions such as depression, anxiety or dementia. While the precise mechanism underlying this association is unknown, aberrant activation of toll-like receptor (TLR)3, a viral recognizing pattern recognition receptor, may play a key role. Synthetic cannabinoids and enhancing cannabinoid tone via inhibition of fatty acid amide","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Anandamide; Cannabinoid; Hypothalamus; Neuroinflammation; OEA; PEA; PPAR; Temperature; Viral infection","Thornton","Aoife M","Physiology, National University of Ireland, Galway, Ireland",NA
"909","34265624","10.1016/j.jneuroim.2021.577654","N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARa.","Increasing evidence suggests that SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is associated with increased risk of developing neurological or psychiatric conditions such as depression, anxiety or dementia. While the precise mechanism underlying this association is unknown, aberrant activation of toll-like receptor (TLR)3, a viral recognizing pattern recognition receptor, may play a key role. Synthetic cannabinoids and enhancing cannabinoid tone via inhibition of fatty acid amide","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Anandamide; Cannabinoid; Hypothalamus; Neuroinflammation; OEA; PEA; PPAR; Temperature; Viral infection","Humphrey","Rachel M","Physiology, National University of Ireland, Galway, Ireland",NA
"910","34265624","10.1016/j.jneuroim.2021.577654","N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARa.","Increasing evidence suggests that SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is associated with increased risk of developing neurological or psychiatric conditions such as depression, anxiety or dementia. While the precise mechanism underlying this association is unknown, aberrant activation of toll-like receptor (TLR)3, a viral recognizing pattern recognition receptor, may play a key role. Synthetic cannabinoids and enhancing cannabinoid tone via inhibition of fatty acid amide","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Anandamide; Cannabinoid; Hypothalamus; Neuroinflammation; OEA; PEA; PPAR; Temperature; Viral infection","Finn","David P","Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland",NA
"911","34265624","10.1016/j.jneuroim.2021.577654","N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARa.","Increasing evidence suggests that SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is associated with increased risk of developing neurological or psychiatric conditions such as depression, anxiety or dementia. While the precise mechanism underlying this association is unknown, aberrant activation of toll-like receptor (TLR)3, a viral recognizing pattern recognition receptor, may play a key role. Synthetic cannabinoids and enhancing cannabinoid tone via inhibition of fatty acid amide","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Anandamide; Cannabinoid; Hypothalamus; Neuroinflammation; OEA; PEA; PPAR; Temperature; Viral infection","Roche","Michelle","Physiology, National University of Ireland, Galway, Ireland","Michelle.roche@nuigalway.ie"
"912","34265606","10.1016/j.thromres.2021.07.006","Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.",NA,"2021","07","23","Thromb Res","Thrombosis research","COVID-19; Oral anticoagulation; Remote warfarin management; Warfarin","Machado","Kendra Lys Calixto","Universidade da Região de Joinville (UNIVILLE), Brazil",NA
"913","34265606","10.1016/j.thromres.2021.07.006","Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.",NA,"2021","07","23","Thromb Res","Thrombosis research","COVID-19; Oral anticoagulation; Remote warfarin management; Warfarin","Rosa","Suzana Tanquella da","Centro de Hematologia e Hemoterapia de Santa Catarina (HEMOSC), Brazil",NA
"914","34265606","10.1016/j.thromres.2021.07.006","Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.",NA,"2021","07","23","Thromb Res","Thrombosis research","COVID-19; Oral anticoagulation; Remote warfarin management; Warfarin","Dobner","Soraya","Centro de Hematologia e Hemoterapia de Santa Catarina (HEMOSC), Brazil",NA
"915","34265606","10.1016/j.thromres.2021.07.006","Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.",NA,"2021","07","23","Thromb Res","Thrombosis research","COVID-19; Oral anticoagulation; Remote warfarin management; Warfarin","Boettcher","Ivan Schneider","Centro de Hematologia e Hemoterapia de Santa Catarina (HEMOSC), Brazil",NA
"916","34265606","10.1016/j.thromres.2021.07.006","Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.",NA,"2021","07","23","Thromb Res","Thrombosis research","COVID-19; Oral anticoagulation; Remote warfarin management; Warfarin","Pasqualotto","Gilberto Comaru","Centro de Hematologia e Hemoterapia de Santa Catarina (HEMOSC), Brazil",NA
"917","34265606","10.1016/j.thromres.2021.07.006","Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.",NA,"2021","07","23","Thromb Res","Thrombosis research","COVID-19; Oral anticoagulation; Remote warfarin management; Warfarin","Lopes","Adelina Elisabeth Lehmkuhl","Centro de Hematologia e Hemoterapia de Santa Catarina (HEMOSC), Brazil",NA
"918","34265606","10.1016/j.thromres.2021.07.006","Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.",NA,"2021","07","23","Thromb Res","Thrombosis research","COVID-19; Oral anticoagulation; Remote warfarin management; Warfarin","Araújo","Tainá de","Universidade da Região de Joinville (UNIVILLE), Brazil",NA
"919","34265606","10.1016/j.thromres.2021.07.006","Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.",NA,"2021","07","23","Thromb Res","Thrombosis research","COVID-19; Oral anticoagulation; Remote warfarin management; Warfarin","Bolduan","Lysandra Patricia Luchtenberg","Centro de Hematologia e Hemoterapia de Santa Catarina (HEMOSC), Brazil",NA
"920","34265606","10.1016/j.thromres.2021.07.006","Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.",NA,"2021","07","23","Thromb Res","Thrombosis research","COVID-19; Oral anticoagulation; Remote warfarin management; Warfarin","Colombo","Maria Daniela Holthausen Perico","Centro de Hematologia e Hemoterapia de Santa Catarina (HEMOSC), Brazil",NA
"921","34265606","10.1016/j.thromres.2021.07.006","Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil.",NA,"2021","07","23","Thromb Res","Thrombosis research","COVID-19; Oral anticoagulation; Remote warfarin management; Warfarin","Lacerda","Marcelo Pitombeira de","Universidade da Região de Joinville (UNIVILLE), Brazil","marcelolacerda001@gmail.com"
"922","34265603","10.1016/j.jss.2021.06.038","Mentorship: a millennia-old remedy for learner success amidst the COVID-19 pandemic.",NA,"2021","07","19","J Surg Res","The Journal of surgical research","COVID-19 Pandemic; Career Development; Medical Education; Medical Training; Mentorship","Santiesteban","Luis","Department of Surgery, Division of Trauma and Surgical Critical Care, Kendall Regional Medical Center, Miami, FL, USA",NA
"923","34265603","10.1016/j.jss.2021.06.038","Mentorship: a millennia-old remedy for learner success amidst the COVID-19 pandemic.",NA,"2021","07","19","J Surg Res","The Journal of surgical research","COVID-19 Pandemic; Career Development; Medical Education; Medical Training; Mentorship","McKenney","Mark","Department of Surgery, Division of Trauma and Surgical Critical Care, Kendall Regional Medical Center, Miami, FL, USA",NA
"924","34265603","10.1016/j.jss.2021.06.038","Mentorship: a millennia-old remedy for learner success amidst the COVID-19 pandemic.",NA,"2021","07","19","J Surg Res","The Journal of surgical research","COVID-19 Pandemic; Career Development; Medical Education; Medical Training; Mentorship","Elkbuli","Adel","Department of Surgery, Division of Trauma and Surgical Critical Care, Kendall Regional Medical Center, Miami, FL, USA. Electronic address: Adel.Elkbulli@HCAHealthcare","Adel.Elkbulli@HCAHealthcare.com"
"925","34265597","10.1016/j.comppsych.2021.152260","Media use before, during and after COVID-19 lockdown according to parents in a clinically referred sample in child and adolescent psychiatry: Results of an online survey in Switzerland.","To investigate the consequences of COVID-19 lockdown on screen media use in children and adolescents with mental health problems, an online survey was conducted on leisure media use before, during and after the lockdown of spring 2020. Parents of patients (10-18 yrs) referred to child and adolescent psychiatry participated in an anonymous online survey, approximately six weeks after the first easing of lockdown measures. Parents rated the amount, the content and the psychological impact of their","2021","07","19","Compr Psychiatry","Comprehensive psychiatry","COVID-19; Child and adolescent psychiatry; Lockdown; Pandemic; Problematic use of the internet; Screen media use","Werling","Anna Maria","Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: anna.werling@pukzh","anna.werling@pukzh.ch"
"926","34265597","10.1016/j.comppsych.2021.152260","Media use before, during and after COVID-19 lockdown according to parents in a clinically referred sample in child and adolescent psychiatry: Results of an online survey in Switzerland.","To investigate the consequences of COVID-19 lockdown on screen media use in children and adolescents with mental health problems, an online survey was conducted on leisure media use before, during and after the lockdown of spring 2020. Parents of patients (10-18 yrs) referred to child and adolescent psychiatry participated in an anonymous online survey, approximately six weeks after the first easing of lockdown measures. Parents rated the amount, the content and the psychological impact of their","2021","07","19","Compr Psychiatry","Comprehensive psychiatry","COVID-19; Child and adolescent psychiatry; Lockdown; Pandemic; Problematic use of the internet; Screen media use","Walitza","Susanne","Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland",NA
"927","34265597","10.1016/j.comppsych.2021.152260","Media use before, during and after COVID-19 lockdown according to parents in a clinically referred sample in child and adolescent psychiatry: Results of an online survey in Switzerland.","To investigate the consequences of COVID-19 lockdown on screen media use in children and adolescents with mental health problems, an online survey was conducted on leisure media use before, during and after the lockdown of spring 2020. Parents of patients (10-18 yrs) referred to child and adolescent psychiatry participated in an anonymous online survey, approximately six weeks after the first easing of lockdown measures. Parents rated the amount, the content and the psychological impact of their","2021","07","19","Compr Psychiatry","Comprehensive psychiatry","COVID-19; Child and adolescent psychiatry; Lockdown; Pandemic; Problematic use of the internet; Screen media use","Grünblatt","Edna","Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland",NA
"928","34265597","10.1016/j.comppsych.2021.152260","Media use before, during and after COVID-19 lockdown according to parents in a clinically referred sample in child and adolescent psychiatry: Results of an online survey in Switzerland.","To investigate the consequences of COVID-19 lockdown on screen media use in children and adolescents with mental health problems, an online survey was conducted on leisure media use before, during and after the lockdown of spring 2020. Parents of patients (10-18 yrs) referred to child and adolescent psychiatry participated in an anonymous online survey, approximately six weeks after the first easing of lockdown measures. Parents rated the amount, the content and the psychological impact of their","2021","07","19","Compr Psychiatry","Comprehensive psychiatry","COVID-19; Child and adolescent psychiatry; Lockdown; Pandemic; Problematic use of the internet; Screen media use","Drechsler","Renate","Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland",NA
"929","34265589","10.1016/j.coi.2021.06.013","Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation.","The study of monogenic autoimmune diseases has provided key insights into molecular mechanisms involved in development of autoimmunity and immune tolerance. It has also become clear that such inborn errors of immunity (IEIs) frequently present clinically not only with autoimmune diseases, but also frequently have increased susceptibility to infection. The genes associated with monogenic autoimmunity influence diverse functional pathways, and the resulting immune dysregulation also impacts the co","2021","07","21","Curr Opin Immunol","Current opinion in immunology",NA,"Bigley","Tarin M","Department of Pediatrics, Division of Rheumatology/Immunology, Washington University in St. Louis, St. Louis, MO, 63110, United States",NA
"930","34265589","10.1016/j.coi.2021.06.013","Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation.","The study of monogenic autoimmune diseases has provided key insights into molecular mechanisms involved in development of autoimmunity and immune tolerance. It has also become clear that such inborn errors of immunity (IEIs) frequently present clinically not only with autoimmune diseases, but also frequently have increased susceptibility to infection. The genes associated with monogenic autoimmunity influence diverse functional pathways, and the resulting immune dysregulation also impacts the co","2021","07","21","Curr Opin Immunol","Current opinion in immunology",NA,"Cooper","Megan A","Department of Pediatrics, Division of Rheumatology/Immunology, Washington University in St. Louis, St. Louis, MO, 63110, United States. Electronic address: Cooper_m@wustl",NA
"931","34265560","10.1016/j.envpol.2021.117748","Face masks as a source of nanoplastics and microplastics in the environment: Quantification, characterization, and potential for bioaccumulation.","Billions of disposable face masks are consumed daily due to the COVID-19 pandemic. The role of these masks as a source of nanoplastics (NPs) and microplastics (MPs) in the environment has not been studied in previous studies. We quantified and characterized face mask released particles and evaluated their potential for accumulation in humans and marine organisms. More than one billion of NPs and MPs were released from each surgical or N95 face mask. These irregularly-shaped particles sized from ","2021","07","21","Environ Pollut","Environmental pollution (Barking, Essex : 1987)","COVID-19; Face mask; Microplastics; Nanoplastics; Personal protective equipment (PPE); Plastic pollution","Ma","Jie","Shenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen University, Shenzhen, 518060, China",NA
"932","34265560","10.1016/j.envpol.2021.117748","Face masks as a source of nanoplastics and microplastics in the environment: Quantification, characterization, and potential for bioaccumulation.","Billions of disposable face masks are consumed daily due to the COVID-19 pandemic. The role of these masks as a source of nanoplastics (NPs) and microplastics (MPs) in the environment has not been studied in previous studies. We quantified and characterized face mask released particles and evaluated their potential for accumulation in humans and marine organisms. More than one billion of NPs and MPs were released from each surgical or N95 face mask. These irregularly-shaped particles sized from ","2021","07","21","Environ Pollut","Environmental pollution (Barking, Essex : 1987)","COVID-19; Face mask; Microplastics; Nanoplastics; Personal protective equipment (PPE); Plastic pollution","Chen","Fengyuan","Shenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen University, Shenzhen, 518060, China",NA
"933","34265560","10.1016/j.envpol.2021.117748","Face masks as a source of nanoplastics and microplastics in the environment: Quantification, characterization, and potential for bioaccumulation.","Billions of disposable face masks are consumed daily due to the COVID-19 pandemic. The role of these masks as a source of nanoplastics (NPs) and microplastics (MPs) in the environment has not been studied in previous studies. We quantified and characterized face mask released particles and evaluated their potential for accumulation in humans and marine organisms. More than one billion of NPs and MPs were released from each surgical or N95 face mask. These irregularly-shaped particles sized from ","2021","07","21","Environ Pollut","Environmental pollution (Barking, Essex : 1987)","COVID-19; Face mask; Microplastics; Nanoplastics; Personal protective equipment (PPE); Plastic pollution","Xu","Huo","Shenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen University, Shenzhen, 518060, China",NA
"934","34265560","10.1016/j.envpol.2021.117748","Face masks as a source of nanoplastics and microplastics in the environment: Quantification, characterization, and potential for bioaccumulation.","Billions of disposable face masks are consumed daily due to the COVID-19 pandemic. The role of these masks as a source of nanoplastics (NPs) and microplastics (MPs) in the environment has not been studied in previous studies. We quantified and characterized face mask released particles and evaluated their potential for accumulation in humans and marine organisms. More than one billion of NPs and MPs were released from each surgical or N95 face mask. These irregularly-shaped particles sized from ","2021","07","21","Environ Pollut","Environmental pollution (Barking, Essex : 1987)","COVID-19; Face mask; Microplastics; Nanoplastics; Personal protective equipment (PPE); Plastic pollution","Jiang","Hao","Shenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen University, Shenzhen, 518060, China",NA
"935","34265560","10.1016/j.envpol.2021.117748","Face masks as a source of nanoplastics and microplastics in the environment: Quantification, characterization, and potential for bioaccumulation.","Billions of disposable face masks are consumed daily due to the COVID-19 pandemic. The role of these masks as a source of nanoplastics (NPs) and microplastics (MPs) in the environment has not been studied in previous studies. We quantified and characterized face mask released particles and evaluated their potential for accumulation in humans and marine organisms. More than one billion of NPs and MPs were released from each surgical or N95 face mask. These irregularly-shaped particles sized from ","2021","07","21","Environ Pollut","Environmental pollution (Barking, Essex : 1987)","COVID-19; Face mask; Microplastics; Nanoplastics; Personal protective equipment (PPE); Plastic pollution","Liu","Jingli","Shenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen University, Shenzhen, 518060, China",NA
"936","34265560","10.1016/j.envpol.2021.117748","Face masks as a source of nanoplastics and microplastics in the environment: Quantification, characterization, and potential for bioaccumulation.","Billions of disposable face masks are consumed daily due to the COVID-19 pandemic. The role of these masks as a source of nanoplastics (NPs) and microplastics (MPs) in the environment has not been studied in previous studies. We quantified and characterized face mask released particles and evaluated their potential for accumulation in humans and marine organisms. More than one billion of NPs and MPs were released from each surgical or N95 face mask. These irregularly-shaped particles sized from ","2021","07","21","Environ Pollut","Environmental pollution (Barking, Essex : 1987)","COVID-19; Face mask; Microplastics; Nanoplastics; Personal protective equipment (PPE); Plastic pollution","Li","Ping","Shenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen University, Shenzhen, 518060, China",NA
"937","34265560","10.1016/j.envpol.2021.117748","Face masks as a source of nanoplastics and microplastics in the environment: Quantification, characterization, and potential for bioaccumulation.","Billions of disposable face masks are consumed daily due to the COVID-19 pandemic. The role of these masks as a source of nanoplastics (NPs) and microplastics (MPs) in the environment has not been studied in previous studies. We quantified and characterized face mask released particles and evaluated their potential for accumulation in humans and marine organisms. More than one billion of NPs and MPs were released from each surgical or N95 face mask. These irregularly-shaped particles sized from ","2021","07","21","Environ Pollut","Environmental pollution (Barking, Essex : 1987)","COVID-19; Face mask; Microplastics; Nanoplastics; Personal protective equipment (PPE); Plastic pollution","Chen","Ciara Chun","Shenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen University, Shenzhen, 518060, China",NA
"938","34265560","10.1016/j.envpol.2021.117748","Face masks as a source of nanoplastics and microplastics in the environment: Quantification, characterization, and potential for bioaccumulation.","Billions of disposable face masks are consumed daily due to the COVID-19 pandemic. The role of these masks as a source of nanoplastics (NPs) and microplastics (MPs) in the environment has not been studied in previous studies. We quantified and characterized face mask released particles and evaluated their potential for accumulation in humans and marine organisms. More than one billion of NPs and MPs were released from each surgical or N95 face mask. These irregularly-shaped particles sized from ","2021","07","21","Environ Pollut","Environmental pollution (Barking, Essex : 1987)","COVID-19; Face mask; Microplastics; Nanoplastics; Personal protective equipment (PPE); Plastic pollution","Pan","Ke","Shenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen University, Shenzhen, 518060, China. Electronic address: panke@szu.edu","panke@szu.edu.cn"
"939","34265539","10.1016/j.autneu.2021.102841","Preparing for the long-haul: Autonomic complications of COVID-19.","As global numbers of COVID-19 grow, chronic neurological symptoms, including those of autonomic dysfunction, are being reported with increasing frequency. Mounting evidence suggests that many patients experience chronic and sometimes debilitating symptoms long after their acute infectious period, leading to the new diagnostic category of post-acute COVID syndrome. Many symptoms of post-acute COVID syndrome appear autonomic in nature, suggesting that autonomic impairment may play a central role i","2021","07","23","Auton Neurosci","Autonomic neuroscience : basic &amp; clinical","Autonomic; COVID; Chronic; Dysautonomia; Long-haul COVID; POTS; Post-COVID; Post-acute COVID","Larsen","Nicholas W","Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, USA",NA
"940","34265539","10.1016/j.autneu.2021.102841","Preparing for the long-haul: Autonomic complications of COVID-19.","As global numbers of COVID-19 grow, chronic neurological symptoms, including those of autonomic dysfunction, are being reported with increasing frequency. Mounting evidence suggests that many patients experience chronic and sometimes debilitating symptoms long after their acute infectious period, leading to the new diagnostic category of post-acute COVID syndrome. Many symptoms of post-acute COVID syndrome appear autonomic in nature, suggesting that autonomic impairment may play a central role i","2021","07","23","Auton Neurosci","Autonomic neuroscience : basic &amp; clinical","Autonomic; COVID; Chronic; Dysautonomia; Long-haul COVID; POTS; Post-COVID; Post-acute COVID","Stiles","Lauren E","Department of Neurology, Stony Brook University Renaissance School of Medicine, Stony Brook, NY, USA",NA
"941","34265539","10.1016/j.autneu.2021.102841","Preparing for the long-haul: Autonomic complications of COVID-19.","As global numbers of COVID-19 grow, chronic neurological symptoms, including those of autonomic dysfunction, are being reported with increasing frequency. Mounting evidence suggests that many patients experience chronic and sometimes debilitating symptoms long after their acute infectious period, leading to the new diagnostic category of post-acute COVID syndrome. Many symptoms of post-acute COVID syndrome appear autonomic in nature, suggesting that autonomic impairment may play a central role i","2021","07","23","Auton Neurosci","Autonomic neuroscience : basic &amp; clinical","Autonomic; COVID; Chronic; Dysautonomia; Long-haul COVID; POTS; Post-COVID; Post-acute COVID","Miglis","Mitchell G","Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, USA. Electronic address: mmiglis@stanford","mmiglis@stanford.edu"
"942","34265494","10.1016/j.dsx.2021.102203","Lack of vaccination and associated comorbidities predispose to the need for intensive care in individuals infected with the delta variant - A case cohort study from a tertiary care hospital in New Delhi, India.",NA,"2021","07","15","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Disease; SARS-CoV-2; Variant; Virus","Vaishya","Raju","Indraprastha Apollo Hospitals, New Delhi, India. Electronic address: raju_vaishya@apollohospitalsdelhi","vaishya@apollohospitalsdelhi.com"
"943","34265494","10.1016/j.dsx.2021.102203","Lack of vaccination and associated comorbidities predispose to the need for intensive care in individuals infected with the delta variant - A case cohort study from a tertiary care hospital in New Delhi, India.",NA,"2021","07","15","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Disease; SARS-CoV-2; Variant; Virus","Sibal","Anupam","Group Medical Director, Apollo Hospital Group, Indraprastha Apollo Hospitals, New Delhi, India. Electronic address: anupamsibal@apollohospitals","anupamsibal@apollohospitals.com"
"944","34265494","10.1016/j.dsx.2021.102203","Lack of vaccination and associated comorbidities predispose to the need for intensive care in individuals infected with the delta variant - A case cohort study from a tertiary care hospital in New Delhi, India.",NA,"2021","07","15","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Disease; SARS-CoV-2; Variant; Virus","Sharma","Himani","Indraprastha Apollo Hospitals, New Delhi, India. Electronic address: himani_sa@apollohospitalsdelhi",NA
"945","34265494","10.1016/j.dsx.2021.102203","Lack of vaccination and associated comorbidities predispose to the need for intensive care in individuals infected with the delta variant - A case cohort study from a tertiary care hospital in New Delhi, India.",NA,"2021","07","15","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Disease; SARS-CoV-2; Variant; Virus","Singh","Sujeet Kumar","National Centre for Disease Control, Shamnath Marg, 110054, New Delhi, India. Electronic address: sujeet647@gmail","sujeet647@gmail.com"
"946","34265488","10.1016/j.gerinurse.2021.06.008","Psychological distress among older adults during COVID-19 pandemic: Prevalence and associated factors.",NA,"2021","07","21","Geriatr Nurs","Geriatric nursing (New York, N.Y.)",NA,"Fadila","Doaa El Sayed","Gerontological Nursing Department, Faculty of Nursing, Mansoura University, Egypt. Electronic address: doaa2005@mans.edu","doaa2005@mans.edu.eg"
"947","34265488","10.1016/j.gerinurse.2021.06.008","Psychological distress among older adults during COVID-19 pandemic: Prevalence and associated factors.",NA,"2021","07","21","Geriatr Nurs","Geriatric nursing (New York, N.Y.)",NA,"Ibrahim","Fatma Magdy","Gerontological Nursing Department, Faculty of Nursing, Mansoura University, Egypt",NA
"948","34265488","10.1016/j.gerinurse.2021.06.008","Psychological distress among older adults during COVID-19 pandemic: Prevalence and associated factors.",NA,"2021","07","21","Geriatr Nurs","Geriatric nursing (New York, N.Y.)",NA,"El-Gilany","Abdel-Hady","Public Health Department, Faculty of Medicine, Mansoura University, Egypt",NA
"949","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Paris","Christophe","Service de Santé au Travail, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, France, INSERM U1085 IRSET, 35033, Rennes. Electronic address: Christophe.paris@inserm","Christophe.paris@inserm.fr"
"950","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Perrin","Sophie","Service de Santé au Travail, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, France, INSERM U1085 IRSET, 35033, Rennes",NA
"951","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Hamonic","Stephanie","Service d'Epidémiologie et de Santé Publique, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, 35033, Rennes, France",NA
"952","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Bourget","Baptiste","Service de Santé au Travail, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, France, INSERM U1085 IRSET, 35033, Rennes",NA
"953","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Roué","Clémence","Service de Santé au Travail, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, France, INSERM U1085 IRSET, 35033, Rennes",NA
"954","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Brassard","Olivier","Service de Santé au Travail, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, France, INSERM U1085 IRSET, 35033, Rennes",NA
"955","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Tadié","Emilie","Service de Santé au Travail, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, France, INSERM U1085 IRSET, 35033, Rennes",NA
"956","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Gicquel","Vincent","Pharmacie centrale, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, 35033, Rennes, France",NA
"957","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Bénézit","François","Maladies Infectieuses et Réanimation Médicale, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, 35033, Rennes, France",NA
"958","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Thibault","Vincent","Laboratoire de virologie, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, 35033, Rennes, France",NA
"959","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Garlantézec","Ronan","Service d'Epidémiologie et de Santé Publique, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, 35033, Rennes, France",NA
"960","34265462","10.1016/j.cmi.2021.06.043","Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data.","Health care workers (HCWs), at increased risk of COVID-19, were among the primary targets for vaccine campaigns. We aimed to estimate the effectiveness of the 3 first COVID-19 vaccines available in Western Europe for their protection. We merged two prospective databases that systematically recorded, in our institution: i) HCWs positive for SARS-CoV-2 by RT-PCR on nasopharyngeal sample; ii) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during ","2021","07","18","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; ChAdOx1 nCoV-19; Effectiveness; Health care workers; mRNA-1273; mRNABNT162b2; vaccine","Tattevin","Pierre","Maladies Infectieuses et Réanimation Médicale, Hôpital Pontchaillou, Centre Hospitalo-Universitaire, 35033, Rennes, France",NA
"961","34265448","10.1016/j.jaip.2021.06.036","Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia.",NA,"2021","07","24","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; SARS-CoV-2; asthma; minority populations","Margolis","Rachel H F","Center for Translational Research, Children's National Research Institute, Washington, DC",NA
"962","34265448","10.1016/j.jaip.2021.06.036","Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia.",NA,"2021","07","24","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; SARS-CoV-2; asthma; minority populations","Patel","Shilpa J","Center for Translational Research, Children's National Research Institute, Washington, DC",NA
"963","34265448","10.1016/j.jaip.2021.06.036","Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia.",NA,"2021","07","24","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; SARS-CoV-2; asthma; minority populations","Sheehan","William J","Center for Translational Research, Children's National Research Institute, Washington, DC",NA
"964","34265448","10.1016/j.jaip.2021.06.036","Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia.",NA,"2021","07","24","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; SARS-CoV-2; asthma; minority populations","Simpson","Joelle N","Center for Translational Research, Children's National Research Institute, Washington, DC",NA
"965","34265448","10.1016/j.jaip.2021.06.036","Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia.",NA,"2021","07","24","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; SARS-CoV-2; asthma; minority populations","Kachroo","Nikita","Center for Translational Research, Children's National Research Institute, Washington, DC",NA
"966","34265448","10.1016/j.jaip.2021.06.036","Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia.",NA,"2021","07","24","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; SARS-CoV-2; asthma; minority populations","Bahar","Burak","Division of Pathology and Laboratory Medicine, Children's National Hospital, Washington, DC",NA
"967","34265448","10.1016/j.jaip.2021.06.036","Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia.",NA,"2021","07","24","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; SARS-CoV-2; asthma; minority populations","Teach","Stephen J","Center for Translational Research, Children's National Research Institute, Washington, DC","steach@childrensnational.org"
"968","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Chivese","Tawanda","Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar. Electronic address: tchivese@qu.edu","tchivese@qu.edu.qa"
"969","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Musa","Omran A H","Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar",NA
"970","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Hindy","George","Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar",NA
"971","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Al-Wattary","Noor","Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar",NA
"972","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Badran","Saif","Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar",NA
"973","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Soliman","Nada","College of Medicine, QU Health, Qatar University, Doha, Qatar",NA
"974","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Aboughalia","Ahmed T M","College of Medicine, QU Health, Qatar University, Doha, Qatar",NA
"975","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Matizanadzo","Joshua T","Brighton and Sussex Medical School, United Kingdom",NA
"976","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Emara","Mohamed M","Basic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar",NA
"977","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Thalib","Lukman","Department of Biostatistics, Faculty of Medicine, Istanbul Aydin University, Istanbul, Turkey",NA
"978","34265436","10.1016/j.tmaid.2021.102135","Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.","To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis. A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews wer","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","Adverse events; COVID-19; Chloroquine; Disease worsening; Efficacy; Hydroxychloroquine; ICU; Mortality; Virological cure","Doi","Suhail A R","Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar",NA
"979","34265387","10.1016/j.aanat.2021.151792","Anatomy in times of pandemia - impact on teaching and body donations.",NA,"2021","07","15","Ann Anat","Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","SARS-CoV-2; anatomy; body donations; dissection courses; teaching","Tschernig","Thomas","Institute of Anatomy and Cell Biology, Saarland University, Kirrberger Straße, 66421 Homburg/Saar, Germany. Electronic address: Thomas.Tschernig@uks","Thomas.Tschernig@uks.eu"
"980","34265387","10.1016/j.aanat.2021.151792","Anatomy in times of pandemia - impact on teaching and body donations.",NA,"2021","07","15","Ann Anat","Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","SARS-CoV-2; anatomy; body donations; dissection courses; teaching","Bechmann","Ingo","Board members of the Anatomische Gesellschaft, https://anatomische-gesellschaft",NA
"981","34265387","10.1016/j.aanat.2021.151792","Anatomy in times of pandemia - impact on teaching and body donations.",NA,"2021","07","15","Ann Anat","Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","SARS-CoV-2; anatomy; body donations; dissection courses; teaching","Meier","Carola","Board members of the Anatomische Gesellschaft, https://anatomische-gesellschaft",NA
"982","34265387","10.1016/j.aanat.2021.151792","Anatomy in times of pandemia - impact on teaching and body donations.",NA,"2021","07","15","Ann Anat","Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","SARS-CoV-2; anatomy; body donations; dissection courses; teaching","Paulsen","Friedrich","Board members of the Anatomische Gesellschaft, https://anatomische-gesellschaft.de/",NA
"983","34265387","10.1016/j.aanat.2021.151792","Anatomy in times of pandemia - impact on teaching and body donations.",NA,"2021","07","15","Ann Anat","Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","SARS-CoV-2; anatomy; body donations; dissection courses; teaching","Waschke","Jens","Board members of the Anatomische Gesellschaft, https://anatomische-gesellschaft",NA
"984","34265387","10.1016/j.aanat.2021.151792","Anatomy in times of pandemia - impact on teaching and body donations.",NA,"2021","07","15","Ann Anat","Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","SARS-CoV-2; anatomy; body donations; dissection courses; teaching","Westermann","Jürgen","Board members of the Anatomische Gesellschaft, https://anatomische-gesellschaft",NA
"985","34265387","10.1016/j.aanat.2021.151792","Anatomy in times of pandemia - impact on teaching and body donations.",NA,"2021","07","15","Ann Anat","Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","SARS-CoV-2; anatomy; body donations; dissection courses; teaching","Bräuer","Lars","Institute of Anatomy, Functional and Clinical Anatomy, University of Erlangen, Erlangen, Germany",NA
"986","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Michot","J M","Hematology Department, Gustave Roussy, Paris-Saclay University, Paris, France. Electronic address: jean-marie.michot@gustaveroussy","marie.michot@gustaveroussy.fr"
"987","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Hueso","T","Hematology Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"988","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Ibrahimi","N","Biostatistics Department, Gustave Roussy, Paris-Saclay University",NA
"989","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Pommeret","F","Cancer Medicine Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"990","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Willekens","C","Hematology Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"991","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Colomba","E","Cancer Medicine Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"992","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Francis","S","Biopathology Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"993","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Bayle","A","Cancer Medicine Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"994","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Cournède","P H","Lab MICS, CentraleSupélec, Paris-Saclay University, Paris, France",NA
"995","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Merad","M","Interdisciplinary Cancer Course Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"996","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Foulon","S","Biostatistics Department, Gustave Roussy, Paris-Saclay University",NA
"997","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Albiges","L","Cancer Medicine Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"998","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Gachot","B","Interdisciplinary Cancer Course Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"999","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Barlesi","F","Gustave Roussy, Paris-Saclay University, Paris, France",NA
"1000","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Soria","J C","Gustave Roussy, Paris-Saclay University, Paris, France",NA
"1001","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Ribrag","V","Hematology Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"1002","34265373","10.1016/j.annonc.2021.07.002","Severe COVID-19 in patients with hematological cancers presenting with viremia.",NA,"2021","07","18","Ann Oncol","Annals of oncology : official journal of the European Society for Medical Oncology",NA,"Griscelli","F","Biopathology Department, Gustave Roussy, Paris-Saclay University, Paris, France",NA
"1003","34265364","10.1016/j.jdent.2021.103746","The effect of high-speed dental handpiece coolant delivery and design on aerosol and droplet production.","High-speed dental instruments produce aerosol and droplets. The objective of this study was to evaluate aerosol and droplet production from a novel electric micromotor handpiece (without compressed air coolant) in real world clinical settings. 10-minute upper incisor crown preparations were performed in triplicate in an open-plan clinic with mechanical ventilation providing 3.45 air changes per hour. A 1:5 ratio electric micromotor handpiece which allows water coolant without compressed air (Ti-","2021","07","23","J Dent","Journal of dentistry","Aerosol generating procedures; Bioaerosols; Dental equipment; Dental infection control; SARS-CoV-2","Allison","James R","School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, United Kingdom",NA
"1004","34265364","10.1016/j.jdent.2021.103746","The effect of high-speed dental handpiece coolant delivery and design on aerosol and droplet production.","High-speed dental instruments produce aerosol and droplets. The objective of this study was to evaluate aerosol and droplet production from a novel electric micromotor handpiece (without compressed air coolant) in real world clinical settings. 10-minute upper incisor crown preparations were performed in triplicate in an open-plan clinic with mechanical ventilation providing 3.45 air changes per hour. A 1:5 ratio electric micromotor handpiece which allows water coolant without compressed air (Ti-","2021","07","23","J Dent","Journal of dentistry","Aerosol generating procedures; Bioaerosols; Dental equipment; Dental infection control; SARS-CoV-2","Edwards","David C","School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, United Kingdom",NA
"1005","34265364","10.1016/j.jdent.2021.103746","The effect of high-speed dental handpiece coolant delivery and design on aerosol and droplet production.","High-speed dental instruments produce aerosol and droplets. The objective of this study was to evaluate aerosol and droplet production from a novel electric micromotor handpiece (without compressed air coolant) in real world clinical settings. 10-minute upper incisor crown preparations were performed in triplicate in an open-plan clinic with mechanical ventilation providing 3.45 air changes per hour. A 1:5 ratio electric micromotor handpiece which allows water coolant without compressed air (Ti-","2021","07","23","J Dent","Journal of dentistry","Aerosol generating procedures; Bioaerosols; Dental equipment; Dental infection control; SARS-CoV-2","Bowes","Charlotte","School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, United Kingdom",NA
"1006","34265364","10.1016/j.jdent.2021.103746","The effect of high-speed dental handpiece coolant delivery and design on aerosol and droplet production.","High-speed dental instruments produce aerosol and droplets. The objective of this study was to evaluate aerosol and droplet production from a novel electric micromotor handpiece (without compressed air coolant) in real world clinical settings. 10-minute upper incisor crown preparations were performed in triplicate in an open-plan clinic with mechanical ventilation providing 3.45 air changes per hour. A 1:5 ratio electric micromotor handpiece which allows water coolant without compressed air (Ti-","2021","07","23","J Dent","Journal of dentistry","Aerosol generating procedures; Bioaerosols; Dental equipment; Dental infection control; SARS-CoV-2","Pickering","Kimberley","Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom",NA
"1007","34265364","10.1016/j.jdent.2021.103746","The effect of high-speed dental handpiece coolant delivery and design on aerosol and droplet production.","High-speed dental instruments produce aerosol and droplets. The objective of this study was to evaluate aerosol and droplet production from a novel electric micromotor handpiece (without compressed air coolant) in real world clinical settings. 10-minute upper incisor crown preparations were performed in triplicate in an open-plan clinic with mechanical ventilation providing 3.45 air changes per hour. A 1:5 ratio electric micromotor handpiece which allows water coolant without compressed air (Ti-","2021","07","23","J Dent","Journal of dentistry","Aerosol generating procedures; Bioaerosols; Dental equipment; Dental infection control; SARS-CoV-2","Dowson","Christopher","School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, United Kingdom",NA
"1008","34265364","10.1016/j.jdent.2021.103746","The effect of high-speed dental handpiece coolant delivery and design on aerosol and droplet production.","High-speed dental instruments produce aerosol and droplets. The objective of this study was to evaluate aerosol and droplet production from a novel electric micromotor handpiece (without compressed air coolant) in real world clinical settings. 10-minute upper incisor crown preparations were performed in triplicate in an open-plan clinic with mechanical ventilation providing 3.45 air changes per hour. A 1:5 ratio electric micromotor handpiece which allows water coolant without compressed air (Ti-","2021","07","23","J Dent","Journal of dentistry","Aerosol generating procedures; Bioaerosols; Dental equipment; Dental infection control; SARS-CoV-2","Stone","Simon J","School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, United Kingdom",NA
"1009","34265364","10.1016/j.jdent.2021.103746","The effect of high-speed dental handpiece coolant delivery and design on aerosol and droplet production.","High-speed dental instruments produce aerosol and droplets. The objective of this study was to evaluate aerosol and droplet production from a novel electric micromotor handpiece (without compressed air coolant) in real world clinical settings. 10-minute upper incisor crown preparations were performed in triplicate in an open-plan clinic with mechanical ventilation providing 3.45 air changes per hour. A 1:5 ratio electric micromotor handpiece which allows water coolant without compressed air (Ti-","2021","07","23","J Dent","Journal of dentistry","Aerosol generating procedures; Bioaerosols; Dental equipment; Dental infection control; SARS-CoV-2","Lumb","Joanna","Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom",NA
"1010","34265364","10.1016/j.jdent.2021.103746","The effect of high-speed dental handpiece coolant delivery and design on aerosol and droplet production.","High-speed dental instruments produce aerosol and droplets. The objective of this study was to evaluate aerosol and droplet production from a novel electric micromotor handpiece (without compressed air coolant) in real world clinical settings. 10-minute upper incisor crown preparations were performed in triplicate in an open-plan clinic with mechanical ventilation providing 3.45 air changes per hour. A 1:5 ratio electric micromotor handpiece which allows water coolant without compressed air (Ti-","2021","07","23","J Dent","Journal of dentistry","Aerosol generating procedures; Bioaerosols; Dental equipment; Dental infection control; SARS-CoV-2","Durham","Justin","School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, United Kingdom",NA
"1011","34265364","10.1016/j.jdent.2021.103746","The effect of high-speed dental handpiece coolant delivery and design on aerosol and droplet production.","High-speed dental instruments produce aerosol and droplets. The objective of this study was to evaluate aerosol and droplet production from a novel electric micromotor handpiece (without compressed air coolant) in real world clinical settings. 10-minute upper incisor crown preparations were performed in triplicate in an open-plan clinic with mechanical ventilation providing 3.45 air changes per hour. A 1:5 ratio electric micromotor handpiece which allows water coolant without compressed air (Ti-","2021","07","23","J Dent","Journal of dentistry","Aerosol generating procedures; Bioaerosols; Dental equipment; Dental infection control; SARS-CoV-2","Jakubovics","Nicholas","School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, United Kingdom",NA
"1012","34265364","10.1016/j.jdent.2021.103746","The effect of high-speed dental handpiece coolant delivery and design on aerosol and droplet production.","High-speed dental instruments produce aerosol and droplets. The objective of this study was to evaluate aerosol and droplet production from a novel electric micromotor handpiece (without compressed air coolant) in real world clinical settings. 10-minute upper incisor crown preparations were performed in triplicate in an open-plan clinic with mechanical ventilation providing 3.45 air changes per hour. A 1:5 ratio electric micromotor handpiece which allows water coolant without compressed air (Ti-","2021","07","23","J Dent","Journal of dentistry","Aerosol generating procedures; Bioaerosols; Dental equipment; Dental infection control; SARS-CoV-2","Holliday","Richard","School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, United Kingdom","Richard.holliday@newcastle.ac.uk"
"1013","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Touret","Franck","Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France. Electronic address: franck.touret@univ-amu",NA
"1014","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Driouich","Jean-Sélim","Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France",NA
"1015","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Cochin","Maxime","Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France",NA
"1016","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Petit","Paul Rémi","Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France",NA
"1017","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Gilles","Magali","Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France",NA
"1018","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Barthélémy","Karine","Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France",NA
"1019","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Moureau","Grégory","Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France",NA
"1020","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Mahon","Francois-Xavier","Cancer Center of Bordeaux, Institut Bergonié, INSERM U1218, University of Bordeaux, Bordeaux, France",NA
"1021","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Malvy","Denis","Department for Infectious and Tropical Diseases, University Hospital Center of Bordeaux, Bordeaux, France",NA
"1022","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Solas","Caroline","APHM, Unité des Virus Émergents (UVE: Aix Marseille University IRD 190-Inserm 1207-IHU Méditerranée Infection), Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, Marseille, France",NA
"1023","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","de Lamballerie","Xavier","Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France",NA
"1024","34265358","10.1016/j.antiviral.2021.105137","Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.","Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses. Imatinib, one of them, has more than twenty years of safe utilization for the treatment of hematological malignancies. In this context, Imatinib was rapidly evaluated in clinic","2021","07","23","Antiviral Res","Antiviral research","Antivirals; Coronavirus; Covid-19; Imatinib; SARS-CoV-2; Tyrosine kinase inhibitor","Nougairède","Antoine","Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France",NA
"1025","34265349","10.1016/j.envres.2021.111679","Transmission risks of respiratory infectious diseases in various confined spaces: A meta-analysis for future pandemics.","If the different transmission risks of respiratory infectious diseases according to the type of confined space and associated factors could be discovered, this kind of information will be an important basis for devising future quarantine policies. However, no comprehensive systematic review or meta-analysis for this topic exists. The objective of this study is to analyze different transmission risks of respiratory infectious diseases according to the type of confined space. This information will","2021","07","15","Environ Res","Environmental research","COVID-19; Confined space; Meta-analysis; Respiratory infectious disease; SARS-CoV-2; Transmission risk","Moon","Jinyoung","Department of Environmental Health Science, Graduate School of Public Health, Seoul National University, 1, Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea","pollux@snu.ac.kr"
"1026","34265349","10.1016/j.envres.2021.111679","Transmission risks of respiratory infectious diseases in various confined spaces: A meta-analysis for future pandemics.","If the different transmission risks of respiratory infectious diseases according to the type of confined space and associated factors could be discovered, this kind of information will be an important basis for devising future quarantine policies. However, no comprehensive systematic review or meta-analysis for this topic exists. The objective of this study is to analyze different transmission risks of respiratory infectious diseases according to the type of confined space. This information will","2021","07","15","Environ Res","Environmental research","COVID-19; Confined space; Meta-analysis; Respiratory infectious disease; SARS-CoV-2; Transmission risk","Ryu","Byung-Han","Department of Internal Medicine, Gyeongsang National University Changwon Hospital, 11, Samjeongja-ro, Seongsan-gu, Changwon-si, Gyeongsangnam-do, Republic of Korea. Electronic address: qudhany@naver","qudhany@naver.com"
"1027","34265315","10.1016/j.ophtha.2021.07.008","Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data.","To compare the rate of postoperative endophthalmitis following immediately sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) using the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry database. Retrospective cohort study. IRIS Registry patients who underwent cataract surgery during 2013-2018. Patients who underwent cataract surgery were divided into two groups: (1) ISBCS and (2) DSBCS (second eye surgery =1 day ","2021","07","15","Ophthalmology","Ophthalmology","COVID-19; Complications; Delayed Sequential Bilateral Cataract Surgery (DSBCS); Immediately Sequential Bilateral Cataract Surgery (ISBCS); Intelligent Research in Sight Registry (IRIS Registry); Outcomes; Postoperative Endophthalmitis; SARS-CoV-2; Same-day Bilateral Cataract Surgery; Simultaneous Bilateral Cataract Surgery","Lacy","Megan","Department of Ophthalmology, University of Washington, Seattle, Washington, United States",NA
"1028","34265315","10.1016/j.ophtha.2021.07.008","Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data.","To compare the rate of postoperative endophthalmitis following immediately sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) using the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry database. Retrospective cohort study. IRIS Registry patients who underwent cataract surgery during 2013-2018. Patients who underwent cataract surgery were divided into two groups: (1) ISBCS and (2) DSBCS (second eye surgery =1 day ","2021","07","15","Ophthalmology","Ophthalmology","COVID-19; Complications; Delayed Sequential Bilateral Cataract Surgery (DSBCS); Immediately Sequential Bilateral Cataract Surgery (ISBCS); Intelligent Research in Sight Registry (IRIS Registry); Outcomes; Postoperative Endophthalmitis; SARS-CoV-2; Same-day Bilateral Cataract Surgery; Simultaneous Bilateral Cataract Surgery","Kung","Timothy-Paul H","Department of Ophthalmology, University of Washington, Seattle, Washington, United States",NA
"1029","34265315","10.1016/j.ophtha.2021.07.008","Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data.","To compare the rate of postoperative endophthalmitis following immediately sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) using the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry database. Retrospective cohort study. IRIS Registry patients who underwent cataract surgery during 2013-2018. Patients who underwent cataract surgery were divided into two groups: (1) ISBCS and (2) DSBCS (second eye surgery =1 day ","2021","07","15","Ophthalmology","Ophthalmology","COVID-19; Complications; Delayed Sequential Bilateral Cataract Surgery (DSBCS); Immediately Sequential Bilateral Cataract Surgery (ISBCS); Intelligent Research in Sight Registry (IRIS Registry); Outcomes; Postoperative Endophthalmitis; SARS-CoV-2; Same-day Bilateral Cataract Surgery; Simultaneous Bilateral Cataract Surgery","Owen","Julia P","Department of Ophthalmology, University of Washington, Seattle, Washington, United States",NA
"1030","34265315","10.1016/j.ophtha.2021.07.008","Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data.","To compare the rate of postoperative endophthalmitis following immediately sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) using the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry database. Retrospective cohort study. IRIS Registry patients who underwent cataract surgery during 2013-2018. Patients who underwent cataract surgery were divided into two groups: (1) ISBCS and (2) DSBCS (second eye surgery =1 day ","2021","07","15","Ophthalmology","Ophthalmology","COVID-19; Complications; Delayed Sequential Bilateral Cataract Surgery (DSBCS); Immediately Sequential Bilateral Cataract Surgery (ISBCS); Intelligent Research in Sight Registry (IRIS Registry); Outcomes; Postoperative Endophthalmitis; SARS-CoV-2; Same-day Bilateral Cataract Surgery; Simultaneous Bilateral Cataract Surgery","Yanagihara","Ryan T","Department of Ophthalmology, University of Washington, Seattle, Washington, United States",NA
"1031","34265315","10.1016/j.ophtha.2021.07.008","Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data.","To compare the rate of postoperative endophthalmitis following immediately sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) using the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry database. Retrospective cohort study. IRIS Registry patients who underwent cataract surgery during 2013-2018. Patients who underwent cataract surgery were divided into two groups: (1) ISBCS and (2) DSBCS (second eye surgery =1 day ","2021","07","15","Ophthalmology","Ophthalmology","COVID-19; Complications; Delayed Sequential Bilateral Cataract Surgery (DSBCS); Immediately Sequential Bilateral Cataract Surgery (ISBCS); Intelligent Research in Sight Registry (IRIS Registry); Outcomes; Postoperative Endophthalmitis; SARS-CoV-2; Same-day Bilateral Cataract Surgery; Simultaneous Bilateral Cataract Surgery","Blazes","Marian","Department of Ophthalmology, University of Washington, Seattle, Washington, United States",NA
"1032","34265315","10.1016/j.ophtha.2021.07.008","Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data.","To compare the rate of postoperative endophthalmitis following immediately sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) using the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry database. Retrospective cohort study. IRIS Registry patients who underwent cataract surgery during 2013-2018. Patients who underwent cataract surgery were divided into two groups: (1) ISBCS and (2) DSBCS (second eye surgery =1 day ","2021","07","15","Ophthalmology","Ophthalmology","COVID-19; Complications; Delayed Sequential Bilateral Cataract Surgery (DSBCS); Immediately Sequential Bilateral Cataract Surgery (ISBCS); Intelligent Research in Sight Registry (IRIS Registry); Outcomes; Postoperative Endophthalmitis; SARS-CoV-2; Same-day Bilateral Cataract Surgery; Simultaneous Bilateral Cataract Surgery","Pershing","Suzann","Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California, United States",NA
"1033","34265315","10.1016/j.ophtha.2021.07.008","Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data.","To compare the rate of postoperative endophthalmitis following immediately sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) using the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry database. Retrospective cohort study. IRIS Registry patients who underwent cataract surgery during 2013-2018. Patients who underwent cataract surgery were divided into two groups: (1) ISBCS and (2) DSBCS (second eye surgery =1 day ","2021","07","15","Ophthalmology","Ophthalmology","COVID-19; Complications; Delayed Sequential Bilateral Cataract Surgery (DSBCS); Immediately Sequential Bilateral Cataract Surgery (ISBCS); Intelligent Research in Sight Registry (IRIS Registry); Outcomes; Postoperative Endophthalmitis; SARS-CoV-2; Same-day Bilateral Cataract Surgery; Simultaneous Bilateral Cataract Surgery","Hyman","Leslie G","Veterans Affairs Palo Alto Health California System, Palo Alto, California, United States",NA
"1034","34265315","10.1016/j.ophtha.2021.07.008","Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data.","To compare the rate of postoperative endophthalmitis following immediately sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) using the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry database. Retrospective cohort study. IRIS Registry patients who underwent cataract surgery during 2013-2018. Patients who underwent cataract surgery were divided into two groups: (1) ISBCS and (2) DSBCS (second eye surgery =1 day ","2021","07","15","Ophthalmology","Ophthalmology","COVID-19; Complications; Delayed Sequential Bilateral Cataract Surgery (DSBCS); Immediately Sequential Bilateral Cataract Surgery (ISBCS); Intelligent Research in Sight Registry (IRIS Registry); Outcomes; Postoperative Endophthalmitis; SARS-CoV-2; Same-day Bilateral Cataract Surgery; Simultaneous Bilateral Cataract Surgery","Van Gelder","Russell N","Department of Ophthalmology, University of Washington, Seattle, Washington, United States",NA
"1035","34265315","10.1016/j.ophtha.2021.07.008","Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data.","To compare the rate of postoperative endophthalmitis following immediately sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) using the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry database. Retrospective cohort study. IRIS Registry patients who underwent cataract surgery during 2013-2018. Patients who underwent cataract surgery were divided into two groups: (1) ISBCS and (2) DSBCS (second eye surgery =1 day ","2021","07","15","Ophthalmology","Ophthalmology","COVID-19; Complications; Delayed Sequential Bilateral Cataract Surgery (DSBCS); Immediately Sequential Bilateral Cataract Surgery (ISBCS); Intelligent Research in Sight Registry (IRIS Registry); Outcomes; Postoperative Endophthalmitis; SARS-CoV-2; Same-day Bilateral Cataract Surgery; Simultaneous Bilateral Cataract Surgery","Lee","Aaron Y","Department of Ophthalmology, University of Washington, Seattle, Washington, United States",NA
"1036","34265315","10.1016/j.ophtha.2021.07.008","Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data.","To compare the rate of postoperative endophthalmitis following immediately sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) using the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry database. Retrospective cohort study. IRIS Registry patients who underwent cataract surgery during 2013-2018. Patients who underwent cataract surgery were divided into two groups: (1) ISBCS and (2) DSBCS (second eye surgery =1 day ","2021","07","15","Ophthalmology","Ophthalmology","COVID-19; Complications; Delayed Sequential Bilateral Cataract Surgery (DSBCS); Immediately Sequential Bilateral Cataract Surgery (ISBCS); Intelligent Research in Sight Registry (IRIS Registry); Outcomes; Postoperative Endophthalmitis; SARS-CoV-2; Same-day Bilateral Cataract Surgery; Simultaneous Bilateral Cataract Surgery","Lee","Cecilia S","Department of Ophthalmology, University of Washington, Seattle, Washington, United States",NA
"1037","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Schaefer","Robin","Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland. Electronic address: schaeferr@who","schaeferr@who.int"
"1038","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Schmidt","Heather-Marie A","Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland",NA
"1039","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Ravasi","Giovanni","Pan-American Health Organization, Washington, DC, USA",NA
"1040","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Mozalevskis","Antons","World Health Organization Regional Office for Europe, Copenhagen, Denmark",NA
"1041","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Rewari","Bharat B","World Health Organization Regional Office for South-East Asia, New Delhi, India",NA
"1042","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Lule","Frank","World Health Organization Regional Office for Africa, Brazzaville, Republic of the Congo",NA
"1043","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Yeboue","Kouadio","World Health Organization Regional Office for Africa, Inter-Country Support Team, Ouagadougou, Burkina Faso",NA
"1044","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Brink","Anne","World Health Organization Regional Office for the Western Pacific, Manila, Philippines",NA
"1045","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Mangadan Konath","Nabeel","World Health Organization Regional Office for South-East Asia, New Delhi, India",NA
"1046","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Sharma","Mukta","World Health Organization Regional Office for South-East Asia, New Delhi, India",NA
"1047","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Seguy","Nicole","World Health Organization Regional Office for Europe, Copenhagen, Denmark",NA
"1048","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Hermez","Joumana","World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt",NA
"1049","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Alaama","Ahmed S","World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt",NA
"1050","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Ishikawa","Naoko","World Health Organization Regional Office for the Western Pacific, Manila, Philippines",NA
"1051","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Dongmo Nguimfack","Boniface","Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland",NA
"1052","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Low-Beer","Daniel","Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland",NA
"1053","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Baggaley","Rachel","Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland",NA
"1054","34265283","10.1016/S2352-3018(21)00127-2","Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this target at an end, we aimed to assess global trends in the adoption of WHO PrEP recommendations into national guidelines and numbers of PrEP users, defined as people who received oral PrEP at least once in a given year, and to estimate future trajectories of PrEP use. In this global summary and forecasting study, data on adoption of WHO PrEP recommendations and numbers o","2021","07","15","Lancet HIV","The lancet. HIV",NA,"Dalal","Shona","Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland",NA
"1055","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Nathan","Anusha","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1056","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Rossin","Elizabeth J","The Broad Institute, Cambridge, MA 02142, USA",NA
"1057","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Kaseke","Clarety","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1058","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Park","Ryan J","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1059","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Khatri","Ashok","Massachusetts General Hospital Endocrine Division and Department of Medicine, Harvard Medical School, Boston, MA 02114, USA",NA
"1060","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Koundakjian","Dylan","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1061","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Urbach","Jonathan M","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1062","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Singh","Nishant K","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1063","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Bashirova","Arman","Basic Science Program, Frederick National Laboratory for Cancer Research in the Laboratory of Integrative Cancer Immunology, National Cancer Institute, Bethesda, MD 20892, USA",NA
"1064","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Tano-Menka","Rhoda","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1065","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Senjobe","Fernando","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1066","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Waring","Michael T","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1067","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Piechocka-Trocha","Alicja","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1068","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Garcia-Beltran","Wilfredo F","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1069","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Iafrate","A John","Department of Pathology, Massachusetts General Hospital, MA 02115, USA",NA
"1070","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Naranbhai","Vivek","Department of Medicine, Massachusetts General Hospital, Boston, MA 02115, USA",NA
"1071","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Carrington","Mary","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1072","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Walker","Bruce D","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA",NA
"1073","34265281","10.1016/j.cell.2021.06.029","Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8<sup>+</sup> T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating va","2021","07","18","Cell","Cell","CD8(+) T cells; COVID-19; SARS-CoV-2; epitopes; protection; sarbecovirus; vaccine; variants","Gaiha","Gaurav D","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA","ggaiha@mgh.harvard.edu"
"1074","34265270","10.1016/j.ajog.2021.06.088","Association between COVID-19 infection at the time of admission for birth and adverse pregnancy outcomes: evolving evidence to aid decision-making.",NA,"2021","07","18","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"VAN DER Meulen","Jan","Department of Health Services Research, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH UK",NA
"1075","34265270","10.1016/j.ajog.2021.06.088","Association between COVID-19 infection at the time of admission for birth and adverse pregnancy outcomes: evolving evidence to aid decision-making.",NA,"2021","07","18","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"Khalil","Asma","Fetal Medicine Unit, St George's Hospital, Blackshaw Road London SW17 0QT, UK","akhalil@sgul.ac.uk"
"1076","34265251","10.1016/j.ccell.2021.06.019","Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.",NA,"2021","07","18","Cancer Cell","Cancer cell",NA,"Labaki","Chris","Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA",NA
"1077","34265251","10.1016/j.ccell.2021.06.019","Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.",NA,"2021","07","18","Cancer Cell","Cancer cell",NA,"Bakouny","Ziad","Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA",NA
"1078","34265251","10.1016/j.ccell.2021.06.019","Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.",NA,"2021","07","18","Cancer Cell","Cancer cell",NA,"Schmidt","Andrew","Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA",NA
"1079","34265251","10.1016/j.ccell.2021.06.019","Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.",NA,"2021","07","18","Cancer Cell","Cancer cell",NA,"Lipsitz","Stuart R","Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA",NA
"1080","34265251","10.1016/j.ccell.2021.06.019","Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.",NA,"2021","07","18","Cancer Cell","Cancer cell",NA,"Rebbeck","Timothy R","Division of Population Science, Dana-Farber Cancer Institute and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA",NA
"1081","34265251","10.1016/j.ccell.2021.06.019","Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.",NA,"2021","07","18","Cancer Cell","Cancer cell",NA,"Trinh","Quoc-Dien","Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA","qtrinh@bwh.harvard.edu"
"1082","34265251","10.1016/j.ccell.2021.06.019","Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.",NA,"2021","07","18","Cancer Cell","Cancer cell",NA,"Choueiri","Toni K","Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Electronic address: toni_choueiri@dfci.harvard","choueiri@dfci.harvard.edu"
"1083","34265250","10.1016/j.bpj.2021.06.019","Biophysicists' continued outstanding response to COVID-19.",NA,"2021","07","23","Biophys J","Biophysical journal",NA,"Schlick","Tamar","Department of Chemistry and Courant Institute of Mathematical Sciences, New York University, New York, New York. Electronic address: schlick@nyu","schlick@nyu.edu"
"1084","34265250","10.1016/j.bpj.2021.06.019","Biophysicists' continued outstanding response to COVID-19.",NA,"2021","07","23","Biophys J","Biophysical journal",NA,"Sundberg","Eric J","Department of Biochemistry, Emory University, Atlanta, Georgia",NA
"1085","34265250","10.1016/j.bpj.2021.06.019","Biophysicists' continued outstanding response to COVID-19.",NA,"2021","07","23","Biophys J","Biophysical journal",NA,"Schroeder","Susan J","Department of Chemistry and Biochemistry, and Department of Microbiology and Plant Biology, University of Oklahoma, Norman, Oklahoma",NA
"1086","34265250","10.1016/j.bpj.2021.06.019","Biophysicists' continued outstanding response to COVID-19.",NA,"2021","07","23","Biophys J","Biophysical journal",NA,"Babu","M Madan","Department of Structural Biology and Center for Data Driven Discovery, St. Jude Children's Research Hospital, Memphis, Tennessee",NA
"1087","34265246","10.1016/j.chom.2021.06.005","SnapShot: SARS-CoV-2 antibodies.",NA,"2021","07","21","Cell Host Microbe","Cell host &amp; microbe",NA,"Montefiori","David C","Department of Surgery, Duke University Medical Center, Durham, NC 27707, USA",NA
"1088","34265246","10.1016/j.chom.2021.06.005","SnapShot: SARS-CoV-2 antibodies.",NA,"2021","07","21","Cell Host Microbe","Cell host &amp; microbe",NA,"Acharya","Priyamvada","Department of Surgery, Duke University Medical Center, Durham, NC 27707, USA",NA
"1089","34265245","10.1016/j.chom.2021.06.016","The success of SARS-CoV-2 vaccines and challenges ahead.","The rapid and remarkably successful development, manufacture, and deployment of several effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is now tempered by three key challenges. First, reducing virus transmission will require prevention of asymptomatic and mild infections in addition to severe symptomatic infections. Second, the emergence of variants of concern with mutations in the S protein's receptor binding domain increases the likelihood that vaccines will hav","2021","07","21","Cell Host Microbe","Cell host &amp; microbe",NA,"Subbarao","Kanta","WHO Collaborating Centre for Reference and Research on Influenza","kanta.subbarao@influenzacentre.org"
"1090","34265244","10.1016/j.chom.2021.06.017","The devil in the details: Herd immunity and pandemic response.","If enough individuals in a population are immune to a pathogen, it cannot cause an outbreak. Deliberately seeking such herd immunity through infection during a potentially lethal pandemic is contrary to all principles of public health, given the potential for uncontrolled outbreaks and risks to vulnerable populations.","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; herd immunity; overdispersion; pandemic; transmission; waning immunity","Schaeffer","Beau","Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA",NA
"1091","34265244","10.1016/j.chom.2021.06.017","The devil in the details: Herd immunity and pandemic response.","If enough individuals in a population are immune to a pathogen, it cannot cause an outbreak. Deliberately seeking such herd immunity through infection during a potentially lethal pandemic is contrary to all principles of public health, given the potential for uncontrolled outbreaks and risks to vulnerable populations.","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; herd immunity; overdispersion; pandemic; transmission; waning immunity","Taylor","Bradford","Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA",NA
"1092","34265244","10.1016/j.chom.2021.06.017","The devil in the details: Herd immunity and pandemic response.","If enough individuals in a population are immune to a pathogen, it cannot cause an outbreak. Deliberately seeking such herd immunity through infection during a potentially lethal pandemic is contrary to all principles of public health, given the potential for uncontrolled outbreaks and risks to vulnerable populations.","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; herd immunity; overdispersion; pandemic; transmission; waning immunity","Bushman","Mary","Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA",NA
"1093","34265244","10.1016/j.chom.2021.06.017","The devil in the details: Herd immunity and pandemic response.","If enough individuals in a population are immune to a pathogen, it cannot cause an outbreak. Deliberately seeking such herd immunity through infection during a potentially lethal pandemic is contrary to all principles of public health, given the potential for uncontrolled outbreaks and risks to vulnerable populations.","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; herd immunity; overdispersion; pandemic; transmission; waning immunity","Hanage","William P","Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. Electronic address: whanage@hsph.harvard","whanage@hsph.harvard.edu"
"1094","34265243","10.1016/j.chom.2021.06.018","An aberrant inflammatory response in severe COVID-19.","Severe COVID-19 arises from the convergence of inadequate pre-existing immunity and a host response that damages, rather than repairs, tissues. We outline clinical presentations of COVID-19 that are likely driven by dysregulated host immunity, discuss potential mechanisms underlying pathological responses, and highlight important areas for basic research on this topic.","2021","07","22","Cell Host Microbe","Cell host &amp; microbe",NA,"Merad","Miriam","The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1095","34265243","10.1016/j.chom.2021.06.018","An aberrant inflammatory response in severe COVID-19.","Severe COVID-19 arises from the convergence of inadequate pre-existing immunity and a host response that damages, rather than repairs, tissues. We outline clinical presentations of COVID-19 that are likely driven by dysregulated host immunity, discuss potential mechanisms underlying pathological responses, and highlight important areas for basic research on this topic.","2021","07","22","Cell Host Microbe","Cell host &amp; microbe",NA,"Subramanian","Aruna","Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA",NA
"1096","34265243","10.1016/j.chom.2021.06.018","An aberrant inflammatory response in severe COVID-19.","Severe COVID-19 arises from the convergence of inadequate pre-existing immunity and a host response that damages, rather than repairs, tissues. We outline clinical presentations of COVID-19 that are likely driven by dysregulated host immunity, discuss potential mechanisms underlying pathological responses, and highlight important areas for basic research on this topic.","2021","07","22","Cell Host Microbe","Cell host &amp; microbe",NA,"Wang","Taia T","Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA","taiawang@stanford.edu"
"1097","34265242","10.1016/j.chom.2021.06.015","Children and SARS-CoV-2.","A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss what remains unknown.","2021","07","21","Cell Host Microbe","Cell host &amp; microbe",NA,"Bogunovic","Dusan","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA","dusan.bogunovic@mssm.edu"
"1098","34265242","10.1016/j.chom.2021.06.015","Children and SARS-CoV-2.","A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss what remains unknown.","2021","07","21","Cell Host Microbe","Cell host &amp; microbe",NA,"Merad","Miriam","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA","miram.merad@mssm.edu"
"1099","34265241","10.1016/j.chom.2021.06.007","Global COVID-19 vaccine inequity: The scope, the impact, and the challenges.","Global vaccine inequity is prolonging the COVID-19 pandemic. Here, we outline the scope and impact of inequitable vaccine distribution and identify challenges in vaccine development, manufacturing, and distribution as well as potential solutions to address this crisis.","2021","07","21","Cell Host Microbe","Cell host &amp; microbe",NA,"Asundi","Archana","Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA",NA
"1100","34265241","10.1016/j.chom.2021.06.007","Global COVID-19 vaccine inequity: The scope, the impact, and the challenges.","Global vaccine inequity is prolonging the COVID-19 pandemic. Here, we outline the scope and impact of inequitable vaccine distribution and identify challenges in vaccine development, manufacturing, and distribution as well as potential solutions to address this crisis.","2021","07","21","Cell Host Microbe","Cell host &amp; microbe",NA,"O'Leary","Colin","Program in Virology, Harvard Medical School, Boston, MA 02115, USA",NA
"1101","34265241","10.1016/j.chom.2021.06.007","Global COVID-19 vaccine inequity: The scope, the impact, and the challenges.","Global vaccine inequity is prolonging the COVID-19 pandemic. Here, we outline the scope and impact of inequitable vaccine distribution and identify challenges in vaccine development, manufacturing, and distribution as well as potential solutions to address this crisis.","2021","07","21","Cell Host Microbe","Cell host &amp; microbe",NA,"Bhadelia","Nahid","Section of Infectious Diseases, Boston Medical Center, Boston, MA 02118, USA",NA
"1102","34265240","10.1016/j.chom.2021.06.013","Beyond neutralization for BNT162b2 mRNA vaccination.","Mounting a robust immune response against SARS-CoV-2 requires neutralization as well as effector T cell functions. In this issue of Cell Host Microbe, Tauzin et al. characterize the humoral and T cell responses after a single dose of BNT162b2 mRNA vaccine in individuals with or without previous exposure to SARS-CoV-2.","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","COVID-19; COVID-19 Vaccines; Humans; RNA, Messenger; SARS-CoV-2; Vaccination","Damani-Yokota","Payal","Department of Microbiology, New York University Langone Health, New York, NY, USA",NA
"1103","34265240","10.1016/j.chom.2021.06.013","Beyond neutralization for BNT162b2 mRNA vaccination.","Mounting a robust immune response against SARS-CoV-2 requires neutralization as well as effector T cell functions. In this issue of Cell Host Microbe, Tauzin et al. characterize the humoral and T cell responses after a single dose of BNT162b2 mRNA vaccine in individuals with or without previous exposure to SARS-CoV-2.","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","COVID-19; COVID-19 Vaccines; Humans; RNA, Messenger; SARS-CoV-2; Vaccination","Yeung","Stephen T","Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA",NA
"1104","34265240","10.1016/j.chom.2021.06.013","Beyond neutralization for BNT162b2 mRNA vaccination.","Mounting a robust immune response against SARS-CoV-2 requires neutralization as well as effector T cell functions. In this issue of Cell Host Microbe, Tauzin et al. characterize the humoral and T cell responses after a single dose of BNT162b2 mRNA vaccine in individuals with or without previous exposure to SARS-CoV-2.","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","COVID-19; COVID-19 Vaccines; Humans; RNA, Messenger; SARS-CoV-2; Vaccination","Khanna","Kamal M","Department of Microbiology, New York University Langone Health, New York, NY, USA","kamal.khanna@nyulangone.org"
"1105","34265239","10.1016/j.chom.2021.06.012","Virus hunters: Discovering the evolutionary origins of SARS-CoV-2.","The likely animal source of SARS-CoV-2 remains speculative. A recent study published in Cell by Zhou et al. reported the detection of novel alpha- and betacoronaviruses, including SARS-CoV-2-related viruses in bats.","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","Animals; COVID-19; Chiroptera; Genome, Viral; Humans; Phylogeny; SARS-CoV-2","Banerjee","Arinjay","Vaccine and Infectious Disease Organization, Department of Veterinary Microbiology, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada","arinjay.banerjee@usask.ca"
"1106","34265238","10.1016/S2213-2600(21)00328-3","Lifting of COVID-19 restrictions in the UK and the Delta variant.",NA,"2021","07","21","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Burki","Talha Khan",NA,NA
"1107","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Ravikirti","Additional Professor and Head, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India","Postgraduate Trainee, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India","34265236"
"1108","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Roy","Ranjini","Postgraduate Trainee, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"1109","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Pattadar","Chandrima","Postgraduate Trainee, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"1110","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Raj","Rishav","Postgraduate Trainee, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"1111","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Agarwal","Neeraj","Professor and Head, Department of Community and Family Medicine, All India Institute of Medical Sciences, Bibinagar, Telangana, India",NA
"1112","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Biswas","Bijit","Senior Resident, Department of Community and Family Medicine, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"1113","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Manjhi","Pramod Kumar","Assistant Professor and Head, Department of Pharmacology, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"1114","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Rai","Deependra Kumar","Additional Professor and Head, Department of Pulmonary Medicine, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"1115","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Shyama","Assistant Professor, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India","Additional Professor and Head, Department of Pulmonary Medicine, All India Institute of Medical Sciences, Patna, Bihar, India","34265236"
"1116","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Kumar","Anjani","Assistant Professor, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"1117","34265236","10.18433/jpps32105","Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.","There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern Ind","2021","07","19","J Pharm Pharm Sci","Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",NA,"Sarfaraz","Asim","Assistant Professor, Department of Microbiology, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"1118","34265234","10.1164/rccm.202105-1137LE","The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study.",NA,"2021","07","15","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","Bronchiectasis; COVID-19; Exacerbations; Symptoms","Crichton","Megan L","University of Dundee, 3042, Dundee, United Kingdom of Great Britain and Northern Ireland",NA
"1119","34265234","10.1164/rccm.202105-1137LE","The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study.",NA,"2021","07","15","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","Bronchiectasis; COVID-19; Exacerbations; Symptoms","Shoemark","Amelia","Royal Brompton Hospital, 156726, EM Unit, London, United Kingdom of Great Britain and Northern Ireland",NA
"1120","34265234","10.1164/rccm.202105-1137LE","The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study.",NA,"2021","07","15","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","Bronchiectasis; COVID-19; Exacerbations; Symptoms","Chalmers","James D","University of Dundee, 3042, Dundee, United Kingdom of Great Britain and Northern Ireland","j.chalmers@dundee.ac.uk"
"1121","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Aiyegbusi","Olalekan Lee","Institute of Applied Health Research, 1724University of Birmingham, Birmingham, UK",NA
"1122","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Hughes","Sarah E","Institute of Applied Health Research, 1724University of Birmingham, Birmingham, UK",NA
"1123","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Turner","Grace","Institute of Applied Health Research, 1724University of Birmingham, Birmingham, UK",NA
"1124","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Rivera","Samantha Cruz","Institute of Applied Health Research, 1724University of Birmingham, Birmingham, UK",NA
"1125","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","McMullan","Christel","Institute of Applied Health Research, 1724University of Birmingham, Birmingham, UK",NA
"1126","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Chandan","Joht Singh","Institute of Applied Health Research, 1724University of Birmingham, Birmingham, UK",NA
"1127","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Haroon","Shamil","Institute of Applied Health Research, 1724University of Birmingham, Birmingham, UK",NA
"1128","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Price","Gary","Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, 1724University of Birmingham, Birmingham, UK",NA
"1129","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Davies","Elin Haf","0911Aparito Limited, Wrexham, UK",NA
"1130","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Nirantharakumar","Krishnarajah","Institute of Applied Health Research, 1724University of Birmingham, Birmingham, UK",NA
"1131","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Sapey","Elizabeth","Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, 1724University of Birmingham, Birmingham, UK",NA
"1132","34265229","10.1177/01410768211032850","Symptoms, complications and management of long COVID: a review.","Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness. Patients with 'long COVID' experience a wide range of physical and mental/psychological symptoms. Pooled prevalence data showed the 10 most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, ","2021","07","15","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; epidemiology; health service research; infectious diseases; long COVID; persistent COVID-19 symptoms; post-COVID-19 syndrome; public health; respiratory medicine","Calvert","Melanie J","Institute of Applied Health Research, 1724University of Birmingham, Birmingham, UK",NA
"1133","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","Sevilis","Theresa","TeleSpecialists, LLC, Fort Myers, Florida, USA",NA
"1134","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","McDonald","Mark","TeleSpecialists, LLC, Fort Myers, Florida, USA",NA
"1135","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","Avila","Amanda","TeleSpecialists, LLC, Fort Myers, Florida, USA",NA
"1136","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","Heath","Gregory","Public Health Department and University of Tennessee-Chattanooga, Chattanooga, Tennessee, USA",NA
"1137","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","Gao","Lan","Mathematics Department, University of Tennessee-Chattanooga, Chattanooga, Tennessee, USA",NA
"1138","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","O'Brien","Gayle","TeleSpecialists, LLC, Fort Myers, Florida, USA",NA
"1139","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","Zaman","Mohammed","TeleSpecialists, LLC, Fort Myers, Florida, USA",NA
"1140","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","Heller","Adam","TeleSpecialists, LLC, Fort Myers, Florida, USA",NA
"1141","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","Masud","Muhammad","TeleSpecialists, LLC, Fort Myers, Florida, USA",NA
"1142","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","Mowzoon","Nima","TeleSpecialists, LLC, Fort Myers, Florida, USA",NA
"1143","34265222","10.1089/tmj.2021.0149","Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic.","Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with thrombolytics at hospitals utilizing telestroke acute stroke services. Methods: Acute stroke consultations seen in 171 hospitals (19 states) via telestroke from Dec","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; quality; telehealth; telemedicine; telestroke","Devlin","Thomas","Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA",NA
"1144","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","VanderWerf","Mark","Telehealth Consultants, Worcester, Massachusetts, USA",NA
"1145","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Bernard","Jordana","Consultant, North Potomac, Maryland, USA",NA
"1146","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Barta","Doris T","National Telehealth Technology Assessment Center, Anchorage, Alaska, USA",NA
"1147","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Berg","Jordan","National Telehealth Technology Assessment Center, Anchorage, Alaska, USA",NA
"1148","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Collins","Tim","Alaska Native Epidemiology Center, Anchorage, Alaska, USA",NA
"1149","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Dowdy","Mike","Consultant, Lewistown, Montana, USA",NA
"1150","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Feiler","Kenneth","Velocity Healthcare Consultants, Denver, Colorado, USA",NA
"1151","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Moore","Douglas L","Consultant, Meridian, Idaho, USA",NA
"1152","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Sifri","Costi","University of Virginia School of Medicine, Charlottesville, Virginia, USA",NA
"1153","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Spargo","Garret","Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA",NA
"1154","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Taylor","Carl W","Consultant, Fort Lauderdale, Florida, USA",NA
"1155","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Towle","Cara B","University of Washington, Seattle Washington, USA",NA
"1156","34265217","10.1089/tmj.2021.0215","Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.","Background: The Covid-19 pandemic created critical challenges for hospitals and healthcare providers. Suddenly clinics were forced to close; scheduled visits were cancelled; emergency rooms were overcrowded; hospital beds, equipment and personal protective equipment (PPE) was in short supply; and staff were faced with rapidly changing circumstances, care protocols, trauma and personal risk. In order to better address the ongoing the Covid-19 pandemic and prepare for future pande","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Covid-19; assessment; pandemic; policy; telemedicine","Wibberly","Kathy Hsu","Mid-Atlantic Telehealth Resource Center, Charlottesville, Virginia, USA",NA
"1157","34265215","10.1089/tmj.2021.0135","Patient and Visit Characteristics of Families Accessing Pediatric Urgent Care Telemedicine During the COVID-19 Pandemic.","Background: Telemedicine expansion during the coronavirus pandemic improved health care access for some. However, studies show disparate uptake among marginalized communities, where minority patients experience higher infection rates. We examined changes in pediatric telemedicine utilization as related to social determinants of health and characteristics of families accessing care. Materials and Methods: This IRB-approved study is a retrospective, cross-sect","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID; pediatric; telehealth; telemedicine","Solo-Josephson","Patricia","Nemours Children's Hospital, Center for Health Delivery Innovation, Orlando, Florida, USA",NA
"1158","34265215","10.1089/tmj.2021.0135","Patient and Visit Characteristics of Families Accessing Pediatric Urgent Care Telemedicine During the COVID-19 Pandemic.","Background: Telemedicine expansion during the coronavirus pandemic improved health care access for some. However, studies show disparate uptake among marginalized communities, where minority patients experience higher infection rates. We examined changes in pediatric telemedicine utilization as related to social determinants of health and characteristics of families accessing care. Materials and Methods: This IRB-approved study is a retrospective, cross-sect","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID; pediatric; telehealth; telemedicine","Murren-Boezem","Joanne","Nemours Children's Hospital, Center for Health Delivery Innovation, Orlando, Florida, USA",NA
"1159","34265215","10.1089/tmj.2021.0135","Patient and Visit Characteristics of Families Accessing Pediatric Urgent Care Telemedicine During the COVID-19 Pandemic.","Background: Telemedicine expansion during the coronavirus pandemic improved health care access for some. However, studies show disparate uptake among marginalized communities, where minority patients experience higher infection rates. We examined changes in pediatric telemedicine utilization as related to social determinants of health and characteristics of families accessing care. Materials and Methods: This IRB-approved study is a retrospective, cross-sect","2021","07","15","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID; pediatric; telehealth; telemedicine","Zettler-Greeley","Cynthia M","Center for Health Delivery Innovation, Nemours Children's Health, Jacksonville, Florida, USA",NA
"1160","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Friedrich","Frederico","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1161","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","E Garcia","Laura de Castro","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1162","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Petry","Lucas Montiel","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1163","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Pieta","Marina Puerari","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1164","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Carvalho","Gustavo Eggers","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1165","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Zocche","Giovani","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1166","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Ongaratto","Renata","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1167","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Lumertz","Magali Santos","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1168","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Brum","Marcos","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1169","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Stein","Renato T","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1170","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Scotta","Marcelo C","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1171","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Jones","Marcus Herbert","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1172","34265188","10.1002/ppul.25570","Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil.","The knowledge about the impact of the nonpharmacological measures to control the COVID-19 pandemic can give insight into ways in which they can also be applied for other respiratory diseases. To assess the impact of containment measures of the COVID-19 pandemic on pneumonia hospitalizations in children from 0 to 14 years of age in Brazil. Data from hospital admissions for pneumonia were obtained from the Department of Informatics of Brazilian Public Health System database in the period of 2015-2","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; hospitalization; pediatrics; pneumonia","Pinto","Leonardo Araújo","Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Avenida Ipiranga 6690, Porto Alegre, Brazil",NA
"1173","34265187","10.1002/ppul.25560","Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting.","The coronavirus 2019 (COVID-19) pandemic has demanded care changes for patients with chronic disease. Patients with cystic fibrosis (CF) are considered at higher risk of developing severe manifestations in the case of SARS-CoV-2 infection, and a need for new ways of safer care delivery has been required to avoid transmission. To assess the impact of the lockdown during the first wave of the COVID-19 pandemic and remote monitoring on patient's health status and daily maintenance therapy in a midd","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; cystic fibrosis; monitoring; telemedicine; telephone visits","Hatziagorou","Elpis","Paediatric Pulmonology and Cystic Fibrosis Unit, 3rd Paediatric Department, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1174","34265187","10.1002/ppul.25560","Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting.","The coronavirus 2019 (COVID-19) pandemic has demanded care changes for patients with chronic disease. Patients with cystic fibrosis (CF) are considered at higher risk of developing severe manifestations in the case of SARS-CoV-2 infection, and a need for new ways of safer care delivery has been required to avoid transmission. To assess the impact of the lockdown during the first wave of the COVID-19 pandemic and remote monitoring on patient's health status and daily maintenance therapy in a midd","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; cystic fibrosis; monitoring; telemedicine; telephone visits","Toulia","Ilektra","Paediatric Pulmonology and Cystic Fibrosis Unit, 3rd Paediatric Department, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1175","34265187","10.1002/ppul.25560","Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting.","The coronavirus 2019 (COVID-19) pandemic has demanded care changes for patients with chronic disease. Patients with cystic fibrosis (CF) are considered at higher risk of developing severe manifestations in the case of SARS-CoV-2 infection, and a need for new ways of safer care delivery has been required to avoid transmission. To assess the impact of the lockdown during the first wave of the COVID-19 pandemic and remote monitoring on patient's health status and daily maintenance therapy in a midd","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; cystic fibrosis; monitoring; telemedicine; telephone visits","Avramidou","Vasiliki","Paediatric Pulmonology and Cystic Fibrosis Unit, 3rd Paediatric Department, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1176","34265187","10.1002/ppul.25560","Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting.","The coronavirus 2019 (COVID-19) pandemic has demanded care changes for patients with chronic disease. Patients with cystic fibrosis (CF) are considered at higher risk of developing severe manifestations in the case of SARS-CoV-2 infection, and a need for new ways of safer care delivery has been required to avoid transmission. To assess the impact of the lockdown during the first wave of the COVID-19 pandemic and remote monitoring on patient's health status and daily maintenance therapy in a midd","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; cystic fibrosis; monitoring; telemedicine; telephone visits","Kampouras","Asterios","Paediatric Pulmonology and Cystic Fibrosis Unit, 3rd Paediatric Department, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1177","34265187","10.1002/ppul.25560","Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting.","The coronavirus 2019 (COVID-19) pandemic has demanded care changes for patients with chronic disease. Patients with cystic fibrosis (CF) are considered at higher risk of developing severe manifestations in the case of SARS-CoV-2 infection, and a need for new ways of safer care delivery has been required to avoid transmission. To assess the impact of the lockdown during the first wave of the COVID-19 pandemic and remote monitoring on patient's health status and daily maintenance therapy in a midd","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; cystic fibrosis; monitoring; telemedicine; telephone visits","Tsara","Venetia","Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece",NA
"1178","34265187","10.1002/ppul.25560","Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting.","The coronavirus 2019 (COVID-19) pandemic has demanded care changes for patients with chronic disease. Patients with cystic fibrosis (CF) are considered at higher risk of developing severe manifestations in the case of SARS-CoV-2 infection, and a need for new ways of safer care delivery has been required to avoid transmission. To assess the impact of the lockdown during the first wave of the COVID-19 pandemic and remote monitoring on patient's health status and daily maintenance therapy in a midd","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; cystic fibrosis; monitoring; telemedicine; telephone visits","Tsanakas","John","Paediatric Pulmonology and Cystic Fibrosis Unit, 3rd Paediatric Department, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1179","34265185","10.1002/ppul.25557","Impact of COVID-19 on pediatric pulmonology healthcare practice.","Coronavirus 2019 (COVID-19) is typically spread by droplets and has had a remarkable effect on pediatric pulmonology healthcare practice. Here, we aimed to evaluate the effect of the COVID-19 pandemic on the clinical follow-up and hospital visits of patients followed up at a pediatric pulmonology unit at a tertiary care center. This study was an observational descriptive study performed at a tertiary care center pediatric pulmonology unit between January 2019 and December 2020. We analyzed the o","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; children; flexible fiberoptic bronchoscopy; pulmonary function testing","Nayir Buyuksahin","Halime","Department of Pediatric Pulmonology, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey",NA
"1180","34265185","10.1002/ppul.25557","Impact of COVID-19 on pediatric pulmonology healthcare practice.","Coronavirus 2019 (COVID-19) is typically spread by droplets and has had a remarkable effect on pediatric pulmonology healthcare practice. Here, we aimed to evaluate the effect of the COVID-19 pandemic on the clinical follow-up and hospital visits of patients followed up at a pediatric pulmonology unit at a tertiary care center. This study was an observational descriptive study performed at a tertiary care center pediatric pulmonology unit between January 2019 and December 2020. We analyzed the o","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; children; flexible fiberoptic bronchoscopy; pulmonary function testing","Emiralioglu","Nagehan","Department of Pediatric Pulmonology, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey",NA
"1181","34265185","10.1002/ppul.25557","Impact of COVID-19 on pediatric pulmonology healthcare practice.","Coronavirus 2019 (COVID-19) is typically spread by droplets and has had a remarkable effect on pediatric pulmonology healthcare practice. Here, we aimed to evaluate the effect of the COVID-19 pandemic on the clinical follow-up and hospital visits of patients followed up at a pediatric pulmonology unit at a tertiary care center. This study was an observational descriptive study performed at a tertiary care center pediatric pulmonology unit between January 2019 and December 2020. We analyzed the o","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; children; flexible fiberoptic bronchoscopy; pulmonary function testing","Ademhan Tural","Dilber","Department of Pediatric Pulmonology, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey",NA
"1182","34265185","10.1002/ppul.25557","Impact of COVID-19 on pediatric pulmonology healthcare practice.","Coronavirus 2019 (COVID-19) is typically spread by droplets and has had a remarkable effect on pediatric pulmonology healthcare practice. Here, we aimed to evaluate the effect of the COVID-19 pandemic on the clinical follow-up and hospital visits of patients followed up at a pediatric pulmonology unit at a tertiary care center. This study was an observational descriptive study performed at a tertiary care center pediatric pulmonology unit between January 2019 and December 2020. We analyzed the o","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; children; flexible fiberoptic bronchoscopy; pulmonary function testing","Ozsezen","Beste","Department of Pediatric Pulmonology, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey",NA
"1183","34265185","10.1002/ppul.25557","Impact of COVID-19 on pediatric pulmonology healthcare practice.","Coronavirus 2019 (COVID-19) is typically spread by droplets and has had a remarkable effect on pediatric pulmonology healthcare practice. Here, we aimed to evaluate the effect of the COVID-19 pandemic on the clinical follow-up and hospital visits of patients followed up at a pediatric pulmonology unit at a tertiary care center. This study was an observational descriptive study performed at a tertiary care center pediatric pulmonology unit between January 2019 and December 2020. We analyzed the o","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; children; flexible fiberoptic bronchoscopy; pulmonary function testing","Sunman","Birce","Department of Pediatric Pulmonology, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey",NA
"1184","34265185","10.1002/ppul.25557","Impact of COVID-19 on pediatric pulmonology healthcare practice.","Coronavirus 2019 (COVID-19) is typically spread by droplets and has had a remarkable effect on pediatric pulmonology healthcare practice. Here, we aimed to evaluate the effect of the COVID-19 pandemic on the clinical follow-up and hospital visits of patients followed up at a pediatric pulmonology unit at a tertiary care center. This study was an observational descriptive study performed at a tertiary care center pediatric pulmonology unit between January 2019 and December 2020. We analyzed the o","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; children; flexible fiberoptic bronchoscopy; pulmonary function testing","Guzelkas","Ismail","Department of Pediatric Pulmonology, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey",NA
"1185","34265185","10.1002/ppul.25557","Impact of COVID-19 on pediatric pulmonology healthcare practice.","Coronavirus 2019 (COVID-19) is typically spread by droplets and has had a remarkable effect on pediatric pulmonology healthcare practice. Here, we aimed to evaluate the effect of the COVID-19 pandemic on the clinical follow-up and hospital visits of patients followed up at a pediatric pulmonology unit at a tertiary care center. This study was an observational descriptive study performed at a tertiary care center pediatric pulmonology unit between January 2019 and December 2020. We analyzed the o","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; children; flexible fiberoptic bronchoscopy; pulmonary function testing","Yalcin","Ebru","Department of Pediatric Pulmonology, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey",NA
"1186","34265185","10.1002/ppul.25557","Impact of COVID-19 on pediatric pulmonology healthcare practice.","Coronavirus 2019 (COVID-19) is typically spread by droplets and has had a remarkable effect on pediatric pulmonology healthcare practice. Here, we aimed to evaluate the effect of the COVID-19 pandemic on the clinical follow-up and hospital visits of patients followed up at a pediatric pulmonology unit at a tertiary care center. This study was an observational descriptive study performed at a tertiary care center pediatric pulmonology unit between January 2019 and December 2020. We analyzed the o","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; children; flexible fiberoptic bronchoscopy; pulmonary function testing","Dogru","Deniz","Department of Pediatric Pulmonology, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey",NA
"1187","34265185","10.1002/ppul.25557","Impact of COVID-19 on pediatric pulmonology healthcare practice.","Coronavirus 2019 (COVID-19) is typically spread by droplets and has had a remarkable effect on pediatric pulmonology healthcare practice. Here, we aimed to evaluate the effect of the COVID-19 pandemic on the clinical follow-up and hospital visits of patients followed up at a pediatric pulmonology unit at a tertiary care center. This study was an observational descriptive study performed at a tertiary care center pediatric pulmonology unit between January 2019 and December 2020. We analyzed the o","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; children; flexible fiberoptic bronchoscopy; pulmonary function testing","Ozcelik","Ugur","Department of Pediatric Pulmonology, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey",NA
"1188","34265185","10.1002/ppul.25557","Impact of COVID-19 on pediatric pulmonology healthcare practice.","Coronavirus 2019 (COVID-19) is typically spread by droplets and has had a remarkable effect on pediatric pulmonology healthcare practice. Here, we aimed to evaluate the effect of the COVID-19 pandemic on the clinical follow-up and hospital visits of patients followed up at a pediatric pulmonology unit at a tertiary care center. This study was an observational descriptive study performed at a tertiary care center pediatric pulmonology unit between January 2019 and December 2020. We analyzed the o","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; children; flexible fiberoptic bronchoscopy; pulmonary function testing","Kiper","Nural","Department of Pediatric Pulmonology, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey",NA
"1189","34265183","10.1002/ppul.25567","Unaffected asthma control in children with mild asthma after COVID-19.",NA,"2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; asthma; asthma control; children","Tosca","Maria A","Allergy Center, Istituto Giannina Gaslini, Genoa, Italy",NA
"1190","34265183","10.1002/ppul.25567","Unaffected asthma control in children with mild asthma after COVID-19.",NA,"2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; asthma; asthma control; children","Crocco","Marco","Allergy Center, Istituto Giannina Gaslini, Genoa, Italy",NA
"1191","34265183","10.1002/ppul.25567","Unaffected asthma control in children with mild asthma after COVID-19.",NA,"2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; asthma; asthma control; children","Girosi","Donata","Pediatric Pulmonology and Respiratory Endoscopy, Istituto Giannina Gaslini, Genoa, Italy",NA
"1192","34265183","10.1002/ppul.25567","Unaffected asthma control in children with mild asthma after COVID-19.",NA,"2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; asthma; asthma control; children","Olcese","Roberta","Allergy Center, Istituto Giannina Gaslini, Genoa, Italy",NA
"1193","34265183","10.1002/ppul.25567","Unaffected asthma control in children with mild asthma after COVID-19.",NA,"2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; asthma; asthma control; children","Schiavetti","Irene","Health Science Department, University of Genoa, Genoa, Italy",NA
"1194","34265183","10.1002/ppul.25567","Unaffected asthma control in children with mild asthma after COVID-19.",NA,"2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; asthma; asthma control; children","Ciprandi","Giorgio","Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy",NA
"1195","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Aykac","Kubra","Department of Pediatric Infectious Diseases, Ankara Training and Research Hospital, University of Health Science, Ankara, Turkey",NA
"1196","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Ozsurekci","Yasemin","Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"1197","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Yayla","Burcu Ceylan Cura","Department of Pediatric Infectious Diseases, Ankara Training and Research Hospital, University of Health Science, Ankara, Turkey",NA
"1198","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Gurlevik","Sibel Lacinel","Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"1199","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Oygar","Pembe Derin","Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"1200","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Bolu","Nuriye Boduc","Department of Pediatric Diseases, Ankara Training and Research Hospital, University of Health Science, Ankara, Turkey",NA
"1201","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Tasar","Medine Aysin","Department of Pediatric Diseases, Ankara Training and Research Hospital, University of Health Science, Ankara, Turkey",NA
"1202","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Erdinc","Fatma Sebnem","Department of Infectious Diseases, Ankara Training and Research Hospital, University of Health Science, Ankara, Turkey",NA
"1203","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Ertem","Gulay Tuncer","Department of Infectious Diseases, Ankara Training and Research Hospital, University of Health Science, Ankara, Turkey",NA
"1204","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Neselioglu","Salim","Department of Clinical Biochemistry, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey",NA
"1205","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Erel","Ozcan","Department of Clinical Biochemistry, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey",NA
"1206","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Cengiz","Ali Bülent","Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"1207","34265172","10.1002/ppul.25549","Oxidant and antioxidant balance in patients with COVID-19.","A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection. We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID-19 and compared them against the values of healthy controls. Serum native thiol (NT),","2021","07","15","Pediatr Pulmonol","Pediatric pulmonology","COVID-19; oxidative stress; pediatrics; severity; thiols","Ceyhan","Mehmet","Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"1208","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","Gao","Yuan","Faculty of Psychology, Southwest University, Chongqing, China",NA
"1209","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","Ao","Hua","Faculty of Psychology, Southwest University, Chongqing, China",NA
"1210","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","Hu","Xiaoyong","Faculty of Psychology, Southwest University, Chongqing, China",NA
"1211","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","Wang","Xinyu","Faculty of Psychology, Southwest University, Chongqing, China",NA
"1212","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","Huang","Duo","Faculty of Psychology, Southwest University, Chongqing, China",NA
"1213","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","Huang","Wanjun","Faculty of Psychology, Southwest University, Chongqing, China",NA
"1214","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","Han","Yan","Graduate School, Army Medical University, Chongqing, China",NA
"1215","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","Zhou","Chao","Ideological and Political Department, Xi'an Vocational and Technical College, Xi'an City, Shanxi Province, China",NA
"1216","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","He","Ling","Faculty of Psychology, Southwest University, Chongqing, China",NA
"1217","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","Lei","Xu","Faculty of Psychology, Southwest University, Chongqing, China",NA
"1218","34265167","10.1111/aphw.12291","Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism.","China was a major hotspot during the beginning of the COVID-19 pandemic. Several studies have reported changes in residents' eating behaviors and appetite during city wide lockdowns and home confinements. However, few have investigated how neuroticism interacts with the impact of COVID-19 to influence eating behaviors during city lockdowns. Thus, the current study aims to establish a pathway model to understand social media exposure, negative affect, neuroticism, and their interaction with eatin","2021","07","15","Appl Psychol Health Well Being","Applied psychology. Health and well-being","COVID-19; anxiety; emotional eating; neuroticism; social media exposure","Gao","Xiao","Faculty of Psychology, Southwest University, Chongqing, China",NA
"1220","34265143","10.1002/jgc4.1470","Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.","The COVID-19 pandemic rapidly changed genetic counseling services across the United States. At the University of Pennsylvania (UPenn), a large academic hospital in an urban setting, nearly all genetic counseling (GC) visits for adult-onset disorders within the Department of Neurology were conducted via secure videoconferencing (telegenetics) or telephone between March and December 2020. Although telemedicine services have been steadily emerging, many clinical programs, including the neurogenetic","2021","07","15","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; neurogenetics; telegenetics; telehealth; telemedicine","Dratch","Laynie","Department of Neurology, Neurogenetics Translational Center of Excellence, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"1221","34265143","10.1002/jgc4.1470","Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.","The COVID-19 pandemic rapidly changed genetic counseling services across the United States. At the University of Pennsylvania (UPenn), a large academic hospital in an urban setting, nearly all genetic counseling (GC) visits for adult-onset disorders within the Department of Neurology were conducted via secure videoconferencing (telegenetics) or telephone between March and December 2020. Although telemedicine services have been steadily emerging, many clinical programs, including the neurogenetic","2021","07","15","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; neurogenetics; telegenetics; telehealth; telemedicine","Paul","Rachel A","Department of Neurology, Neurogenetics Translational Center of Excellence, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"1222","34265143","10.1002/jgc4.1470","Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.","The COVID-19 pandemic rapidly changed genetic counseling services across the United States. At the University of Pennsylvania (UPenn), a large academic hospital in an urban setting, nearly all genetic counseling (GC) visits for adult-onset disorders within the Department of Neurology were conducted via secure videoconferencing (telegenetics) or telephone between March and December 2020. Although telemedicine services have been steadily emerging, many clinical programs, including the neurogenetic","2021","07","15","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; neurogenetics; telegenetics; telehealth; telemedicine","Baldwin","Aaron","Department of Neurology, Neurogenetics Translational Center of Excellence, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"1223","34265143","10.1002/jgc4.1470","Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.","The COVID-19 pandemic rapidly changed genetic counseling services across the United States. At the University of Pennsylvania (UPenn), a large academic hospital in an urban setting, nearly all genetic counseling (GC) visits for adult-onset disorders within the Department of Neurology were conducted via secure videoconferencing (telegenetics) or telephone between March and December 2020. Although telemedicine services have been steadily emerging, many clinical programs, including the neurogenetic","2021","07","15","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; neurogenetics; telegenetics; telehealth; telemedicine","Brzozowski","Morgan","Department of Neurology, Neurogenetics Translational Center of Excellence, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"1224","34265143","10.1002/jgc4.1470","Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.","The COVID-19 pandemic rapidly changed genetic counseling services across the United States. At the University of Pennsylvania (UPenn), a large academic hospital in an urban setting, nearly all genetic counseling (GC) visits for adult-onset disorders within the Department of Neurology were conducted via secure videoconferencing (telegenetics) or telephone between March and December 2020. Although telemedicine services have been steadily emerging, many clinical programs, including the neurogenetic","2021","07","15","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; neurogenetics; telegenetics; telehealth; telemedicine","Gonzalez-Alegre","Pedro","Department of Neurology, Neurogenetics Translational Center of Excellence, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"1225","34265143","10.1002/jgc4.1470","Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.","The COVID-19 pandemic rapidly changed genetic counseling services across the United States. At the University of Pennsylvania (UPenn), a large academic hospital in an urban setting, nearly all genetic counseling (GC) visits for adult-onset disorders within the Department of Neurology were conducted via secure videoconferencing (telegenetics) or telephone between March and December 2020. Although telemedicine services have been steadily emerging, many clinical programs, including the neurogenetic","2021","07","15","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; neurogenetics; telegenetics; telehealth; telemedicine","Tropea","Thomas F","Department of Neurology, Neurogenetics Translational Center of Excellence, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"1226","34265143","10.1002/jgc4.1470","Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.","The COVID-19 pandemic rapidly changed genetic counseling services across the United States. At the University of Pennsylvania (UPenn), a large academic hospital in an urban setting, nearly all genetic counseling (GC) visits for adult-onset disorders within the Department of Neurology were conducted via secure videoconferencing (telegenetics) or telephone between March and December 2020. Although telemedicine services have been steadily emerging, many clinical programs, including the neurogenetic","2021","07","15","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; neurogenetics; telegenetics; telehealth; telemedicine","Raper","Anna","Department of Neurology, Neurogenetics Translational Center of Excellence, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"1227","34265143","10.1002/jgc4.1470","Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.","The COVID-19 pandemic rapidly changed genetic counseling services across the United States. At the University of Pennsylvania (UPenn), a large academic hospital in an urban setting, nearly all genetic counseling (GC) visits for adult-onset disorders within the Department of Neurology were conducted via secure videoconferencing (telegenetics) or telephone between March and December 2020. Although telemedicine services have been steadily emerging, many clinical programs, including the neurogenetic","2021","07","15","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; neurogenetics; telegenetics; telehealth; telemedicine","Bardakjian","Tanya","Department of Neurology, Neurogenetics Translational Center of Excellence, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"1228","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Breuer","Adin","Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1229","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Raphael","Allon","Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1230","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Stern","Hagay","Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1231","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Odeh","Ma'aran","Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1232","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Fiszlinski","Judith","Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1233","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Algur","Nurit","Clinical Endocrinology Laboratory, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1234","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Magen","Sophie","Clinical Endocrinology Laboratory, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1235","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Megged","Orli","Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1236","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Schlesinger","Yechiel","Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1237","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Barak-Corren","Yuval","Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1238","34265136","10.1111/apa.16031","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.","We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood test","2021","07","23","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","antibody levels; asymptomatic infection; coronavirus; immunity; school closures","Heiman","Eyal","Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"1239","34265068","10.4315/JFP-21-201","Food Safety and Employee Health Implications of COVID-19.","The COVID-19 pandemic has greatly impacted the US food supply and consumer behavior. Food production and processing are being disrupted as illnesses, proactive quarantines, and government-mandated movement restrictions cause labor shortages. In this environment, the food industry has been required to adopt new, additional practices to minimize the risk of COVID-19 cases and outbreaks among its workforce. Successfully overcoming these challenges requires a comprehensive approach that addresses CO","2021","07","15","J Food Prot","Journal of food protection","COVID-19; Food Industry; Food Safety; SARS-CoV-2","Trmcic","Aljosa","Department of Food Science, Cornell University, Ithaca, New York 14850, USA",NA
"1240","34265068","10.4315/JFP-21-201","Food Safety and Employee Health Implications of COVID-19.","The COVID-19 pandemic has greatly impacted the US food supply and consumer behavior. Food production and processing are being disrupted as illnesses, proactive quarantines, and government-mandated movement restrictions cause labor shortages. In this environment, the food industry has been required to adopt new, additional practices to minimize the risk of COVID-19 cases and outbreaks among its workforce. Successfully overcoming these challenges requires a comprehensive approach that addresses CO","2021","07","15","J Food Prot","Journal of food protection","COVID-19; Food Industry; Food Safety; SARS-CoV-2","Demmings","Elizabeth","Department of Food Science, Cornell University, Geneva, New York 14456, USA",NA
"1241","34265068","10.4315/JFP-21-201","Food Safety and Employee Health Implications of COVID-19.","The COVID-19 pandemic has greatly impacted the US food supply and consumer behavior. Food production and processing are being disrupted as illnesses, proactive quarantines, and government-mandated movement restrictions cause labor shortages. In this environment, the food industry has been required to adopt new, additional practices to minimize the risk of COVID-19 cases and outbreaks among its workforce. Successfully overcoming these challenges requires a comprehensive approach that addresses CO","2021","07","15","J Food Prot","Journal of food protection","COVID-19; Food Industry; Food Safety; SARS-CoV-2","Kniel","Kalmia","Department of Animal and Food Sciences, University of Delaware, Newark, Delaware 19716, USA",NA
"1242","34265068","10.4315/JFP-21-201","Food Safety and Employee Health Implications of COVID-19.","The COVID-19 pandemic has greatly impacted the US food supply and consumer behavior. Food production and processing are being disrupted as illnesses, proactive quarantines, and government-mandated movement restrictions cause labor shortages. In this environment, the food industry has been required to adopt new, additional practices to minimize the risk of COVID-19 cases and outbreaks among its workforce. Successfully overcoming these challenges requires a comprehensive approach that addresses CO","2021","07","15","J Food Prot","Journal of food protection","COVID-19; Food Industry; Food Safety; SARS-CoV-2","Wiedmann","Martin","Department of Food Science, Cornell University, Ithaca, New York 14850, USA",NA
"1243","34265068","10.4315/JFP-21-201","Food Safety and Employee Health Implications of COVID-19.","The COVID-19 pandemic has greatly impacted the US food supply and consumer behavior. Food production and processing are being disrupted as illnesses, proactive quarantines, and government-mandated movement restrictions cause labor shortages. In this environment, the food industry has been required to adopt new, additional practices to minimize the risk of COVID-19 cases and outbreaks among its workforce. Successfully overcoming these challenges requires a comprehensive approach that addresses CO","2021","07","15","J Food Prot","Journal of food protection","COVID-19; Food Industry; Food Safety; SARS-CoV-2","Alcaine","Samuel David","Cornell University Assistant Professor 411 Tower Rd 362 Stocking Hall UNITED STATES Ithaca NY 14853",NA
"1244","34265057","10.1093/cid/ciab635","Candidemia and Severe COVID-19 - Which Risk Factors are Modifiable?",NA,"2021","07","15","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"McCarty","Todd","University of Alabama at Birmingham, Birmingham, Alabama, United States",NA
"1245","34265054","10.1093/cid/ciab631","Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.","Evidence remains inconclusive on any significant benefits of remdesivir in mild-to-moderate COVID-19 patients. This study explored the disease progression, various clinical outcomes, changes in viral load, and costs associated with early remdesivir treatment among COVID-19 patients. A territory-wide retrospective cohort of 10,419 patients with COVID-19 hospitalized from 21st January 2020 to 31st January 2021 in Hong Kong were identified. Early remdesivir users were matched with controls using pr","2021","07","15","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; antiviral activity; clinical improvement; cost; remdesivir","Wong","Carlos K H","Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China",NA
"1246","34265054","10.1093/cid/ciab631","Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.","Evidence remains inconclusive on any significant benefits of remdesivir in mild-to-moderate COVID-19 patients. This study explored the disease progression, various clinical outcomes, changes in viral load, and costs associated with early remdesivir treatment among COVID-19 patients. A territory-wide retrospective cohort of 10,419 patients with COVID-19 hospitalized from 21st January 2020 to 31st January 2021 in Hong Kong were identified. Early remdesivir users were matched with controls using pr","2021","07","15","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; antiviral activity; clinical improvement; cost; remdesivir","Lau","Kristy T K","Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China",NA
"1247","34265054","10.1093/cid/ciab631","Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.","Evidence remains inconclusive on any significant benefits of remdesivir in mild-to-moderate COVID-19 patients. This study explored the disease progression, various clinical outcomes, changes in viral load, and costs associated with early remdesivir treatment among COVID-19 patients. A territory-wide retrospective cohort of 10,419 patients with COVID-19 hospitalized from 21st January 2020 to 31st January 2021 in Hong Kong were identified. Early remdesivir users were matched with controls using pr","2021","07","15","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; antiviral activity; clinical improvement; cost; remdesivir","Au","Ivan C H","Department of Family Medicine and Primary Care, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China",NA
"1248","34265054","10.1093/cid/ciab631","Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.","Evidence remains inconclusive on any significant benefits of remdesivir in mild-to-moderate COVID-19 patients. This study explored the disease progression, various clinical outcomes, changes in viral load, and costs associated with early remdesivir treatment among COVID-19 patients. A territory-wide retrospective cohort of 10,419 patients with COVID-19 hospitalized from 21st January 2020 to 31st January 2021 in Hong Kong were identified. Early remdesivir users were matched with controls using pr","2021","07","15","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; antiviral activity; clinical improvement; cost; remdesivir","Xiong","Xi","Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China",NA
"1249","34265054","10.1093/cid/ciab631","Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.","Evidence remains inconclusive on any significant benefits of remdesivir in mild-to-moderate COVID-19 patients. This study explored the disease progression, various clinical outcomes, changes in viral load, and costs associated with early remdesivir treatment among COVID-19 patients. A territory-wide retrospective cohort of 10,419 patients with COVID-19 hospitalized from 21st January 2020 to 31st January 2021 in Hong Kong were identified. Early remdesivir users were matched with controls using pr","2021","07","15","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; antiviral activity; clinical improvement; cost; remdesivir","Lau","Eric H Y","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China",NA
"1250","34265054","10.1093/cid/ciab631","Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.","Evidence remains inconclusive on any significant benefits of remdesivir in mild-to-moderate COVID-19 patients. This study explored the disease progression, various clinical outcomes, changes in viral load, and costs associated with early remdesivir treatment among COVID-19 patients. A territory-wide retrospective cohort of 10,419 patients with COVID-19 hospitalized from 21st January 2020 to 31st January 2021 in Hong Kong were identified. Early remdesivir users were matched with controls using pr","2021","07","15","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; antiviral activity; clinical improvement; cost; remdesivir","Cowling","Benjamin J","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China",NA
"1251","34265044","10.1093/ajh/hpab111","Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.","The role of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) has been addressed in some studies related to the current coronavirus disease-2019 (COVID-19) pandemic with possible higher severity and mortality in patients with hypertension. A triple-blind randomized controlled trial was designed to evaluate the effects of these medications on the COVID-19 progression. Patients were enrolled in this trial between April and September 2020. They were randomize","2021","07","15","Am J Hypertens","American journal of hypertension","Adverse Outcome; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronavirus Disease-2019; Hypertension","Najmeddin","Farhad","Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran",NA
"1252","34265044","10.1093/ajh/hpab111","Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.","The role of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) has been addressed in some studies related to the current coronavirus disease-2019 (COVID-19) pandemic with possible higher severity and mortality in patients with hypertension. A triple-blind randomized controlled trial was designed to evaluate the effects of these medications on the COVID-19 progression. Patients were enrolled in this trial between April and September 2020. They were randomize","2021","07","15","Am J Hypertens","American journal of hypertension","Adverse Outcome; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronavirus Disease-2019; Hypertension","Solhjoo","Maedeh","Pharmacy student, Tehran University of Medical Sciences, Tehran, Iran",NA
"1253","34265044","10.1093/ajh/hpab111","Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.","The role of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) has been addressed in some studies related to the current coronavirus disease-2019 (COVID-19) pandemic with possible higher severity and mortality in patients with hypertension. A triple-blind randomized controlled trial was designed to evaluate the effects of these medications on the COVID-19 progression. Patients were enrolled in this trial between April and September 2020. They were randomize","2021","07","15","Am J Hypertens","American journal of hypertension","Adverse Outcome; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronavirus Disease-2019; Hypertension","Ashraf","Haleh","Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran, Cardiac Primary Prevention Research Center (CPPRC), Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran, Research Development Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran",NA
"1254","34265044","10.1093/ajh/hpab111","Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.","The role of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) has been addressed in some studies related to the current coronavirus disease-2019 (COVID-19) pandemic with possible higher severity and mortality in patients with hypertension. A triple-blind randomized controlled trial was designed to evaluate the effects of these medications on the COVID-19 progression. Patients were enrolled in this trial between April and September 2020. They were randomize","2021","07","15","Am J Hypertens","American journal of hypertension","Adverse Outcome; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronavirus Disease-2019; Hypertension","Salehi","Mohammadreza","Department of Infectious Disease, Tehran University of Medical Sciences, Tehran, Iran",NA
"1255","34265044","10.1093/ajh/hpab111","Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.","The role of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) has been addressed in some studies related to the current coronavirus disease-2019 (COVID-19) pandemic with possible higher severity and mortality in patients with hypertension. A triple-blind randomized controlled trial was designed to evaluate the effects of these medications on the COVID-19 progression. Patients were enrolled in this trial between April and September 2020. They were randomize","2021","07","15","Am J Hypertens","American journal of hypertension","Adverse Outcome; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronavirus Disease-2019; Hypertension","Rasooli","Fatemeh","Department of Emergency Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran",NA
"1256","34265044","10.1093/ajh/hpab111","Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.","The role of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) has been addressed in some studies related to the current coronavirus disease-2019 (COVID-19) pandemic with possible higher severity and mortality in patients with hypertension. A triple-blind randomized controlled trial was designed to evaluate the effects of these medications on the COVID-19 progression. Patients were enrolled in this trial between April and September 2020. They were randomize","2021","07","15","Am J Hypertens","American journal of hypertension","Adverse Outcome; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronavirus Disease-2019; Hypertension","Ghoghaei","Morteza","Department of Internal Medicine, Sina Hospital, Tehran, Iran",NA
"1257","34265044","10.1093/ajh/hpab111","Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.","The role of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) has been addressed in some studies related to the current coronavirus disease-2019 (COVID-19) pandemic with possible higher severity and mortality in patients with hypertension. A triple-blind randomized controlled trial was designed to evaluate the effects of these medications on the COVID-19 progression. Patients were enrolled in this trial between April and September 2020. They were randomize","2021","07","15","Am J Hypertens","American journal of hypertension","Adverse Outcome; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronavirus Disease-2019; Hypertension","Soleimani","Abbas","Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran",NA
"1258","34265044","10.1093/ajh/hpab111","Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.","The role of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) has been addressed in some studies related to the current coronavirus disease-2019 (COVID-19) pandemic with possible higher severity and mortality in patients with hypertension. A triple-blind randomized controlled trial was designed to evaluate the effects of these medications on the COVID-19 progression. Patients were enrolled in this trial between April and September 2020. They were randomize","2021","07","15","Am J Hypertens","American journal of hypertension","Adverse Outcome; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronavirus Disease-2019; Hypertension","Bahreini","Maryam","Department of Emergency Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran Prehospital and Hospital Emergency Research Center, Tehran University of Medical Sciences, Tehran, Iran",NA
"1259","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Francis","Magen Ellen","Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1260","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Goncin","Una","Department of Medical Imaging, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1261","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Kroeker","Andrea","Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1262","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Swan","Cynthia","Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1263","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Ralph","Robyn","Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1264","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Lu","Yao","Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1265","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Etzioni","Athema Louise","Department of Pathobiology, Tuskegee University College of Veterinary Medicine, Tuskegee Institute, Tuskegee, Alabama, United States of America",NA
"1266","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Falzarano","Darryl","Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1267","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Gerdts","Volker","Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1268","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Machtaler","Steven","Department of Medical Imaging, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1269","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Kindrachuk","Jason","Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1270","34265022","10.1371/journal.ppat.1009705","SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.","COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in infla","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Kelvin","Alyson Ann","Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1271","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Girgis","Samia A","Professor of Clinical Pathology, Faculty of Medicine Director of Infection Control Unit and Vice Director of Ain Shams University Hospitals, Cairo, Egypt",NA
"1272","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Hafez","Hala M","Professor of Clinical Pathology, Faculty of Medicine, Head of Clinical Microbiology Unit, Ain Shams University Hospitals, Cairo, Egypt",NA
"1273","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Elarab","Hoda Ezz","Department of Clinical Pathology, Ain Shams University Hospitals, Cairo, Egypt",NA
"1274","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Sherif","Basma","Department of Clinical Pathology, Ain Shams University Hospitals, Cairo, Egypt",NA
"1275","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Sabry","Moshira H","Infection Control Unit, Ain Shams University Hospitals, Cairo, Egypt",NA
"1276","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Afifi","Iman","Infection Control Unit, Ain Shams University Hospitals, Cairo, Egypt",NA
"1277","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Hassan","Fatma Elzahraa","Infection Control Unit, Ain Shams University Hospitals, Cairo, Egypt",NA
"1278","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Reda","Amira","Infection Control Unit, Ain Shams University Hospitals, Cairo, Egypt",NA
"1279","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Elsayed","Shaimaa","Infection Control Unit, Ain Shams University Hospitals, Cairo, Egypt",NA
"1280","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Mahmoud","Asmaa","Infection Control Unit, Ain Shams University Hospitals, Cairo, Egypt",NA
"1281","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Habeb","Petra","Infection Control Unit, Ain Shams University Hospitals, Cairo, Egypt",NA
"1282","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Habil","Ihab S","Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"1283","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Hussein","Rasha S","Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"1284","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Mossad","Isis M","Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"1285","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Mansour","Ossama","Vice Dean of Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"1286","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Omar","Ashraf","Dean of Faculty of Medicine and chairman of board of Ain Shams University Hospitals, Ain Shams University, Cairo, Egypt",NA
"1287","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"Saleh","Ayman M","Vice President of Ain Shams University, Cairo, Egypt",NA
"1288","34265021","10.1371/journal.pone.0254581","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.","Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. Our study was carried out between May 5 and ","2021","07","19","PLoS One","PloS one",NA,"El-Meteini","Mahmoud","President of Ain-Shams University, Cairo, Egypt",NA
"1289","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Sims","Joshua J","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1290","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Greig","Jenny A","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1291","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Michalson","Kristofer T","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1292","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Lian","Sharon","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1293","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Martino","R Alexander","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1294","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Meggersee","Rosemary","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1295","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Turner","Kevin B","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1296","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Nambiar","Kalyani","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1297","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Dyer","Cecilia","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1298","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Hinderer","Christian","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1299","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Horiuchi","Makoto","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1300","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Yan","Hanying","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1301","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Huang","Xin","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1302","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Chen","Shu-Jen","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1303","34265018","10.1371/journal.ppat.1009544","Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.","SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achieving 1000-fold binding improvements that extend across a wide range of SARS-CoV-2 variants and dist","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Wilson","James M","Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America",NA
"1304","34264974","10.1371/journal.pone.0254635","Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.","Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used data from 10,541 patients hospitalized with COVID-19 through September 2020 at 104 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease (CVD) Registry to evaluate t","2021","07","19","PLoS One","PloS one",NA,"Daniels","Lori B","Division of Cardiovascular Medicine, Department of Medicine, UC San Diego, La Jolla, California, United States of America",NA
"1305","34264974","10.1371/journal.pone.0254635","Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.","Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used data from 10,541 patients hospitalized with COVID-19 through September 2020 at 104 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease (CVD) Registry to evaluate t","2021","07","19","PLoS One","PloS one",NA,"Ren","Junting","Division of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, UC San Diego, La Jolla, California, United States of America",NA
"1306","34264974","10.1371/journal.pone.0254635","Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.","Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used data from 10,541 patients hospitalized with COVID-19 through September 2020 at 104 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease (CVD) Registry to evaluate t","2021","07","19","PLoS One","PloS one",NA,"Kumar","Kris","Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, United States of America",NA
"1307","34264974","10.1371/journal.pone.0254635","Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.","Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used data from 10,541 patients hospitalized with COVID-19 through September 2020 at 104 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease (CVD) Registry to evaluate t","2021","07","19","PLoS One","PloS one",NA,"Bui","Quan M","Division of Cardiovascular Medicine, Department of Medicine, UC San Diego, La Jolla, California, United States of America",NA
"1308","34264974","10.1371/journal.pone.0254635","Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.","Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used data from 10,541 patients hospitalized with COVID-19 through September 2020 at 104 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease (CVD) Registry to evaluate t","2021","07","19","PLoS One","PloS one",NA,"Zhang","Jing","UCSD Moores Cancer Center, UC San Diego, La Jolla, California, United States of America",NA
"1309","34264974","10.1371/journal.pone.0254635","Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.","Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used data from 10,541 patients hospitalized with COVID-19 through September 2020 at 104 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease (CVD) Registry to evaluate t","2021","07","19","PLoS One","PloS one",NA,"Zhang","Xinlian","Division of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, UC San Diego, La Jolla, California, United States of America",NA
"1310","34264974","10.1371/journal.pone.0254635","Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.","Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used data from 10,541 patients hospitalized with COVID-19 through September 2020 at 104 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease (CVD) Registry to evaluate t","2021","07","19","PLoS One","PloS one",NA,"Sawan","Mariem A","Department of Medicine, Emory University School of Medicine, Atlanta, Georgia",NA
"1311","34264974","10.1371/journal.pone.0254635","Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.","Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used data from 10,541 patients hospitalized with COVID-19 through September 2020 at 104 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease (CVD) Registry to evaluate t","2021","07","19","PLoS One","PloS one",NA,"Eisen","Howard","Pennsylvania State Health, Hershey, Pennsylvania, United States of America",NA
"1312","34264974","10.1371/journal.pone.0254635","Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.","Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used data from 10,541 patients hospitalized with COVID-19 through September 2020 at 104 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease (CVD) Registry to evaluate t","2021","07","19","PLoS One","PloS one",NA,"Longhurst","Christopher A","Department of Medicine, UC San Diego, La Jolla, California, United States of America",NA
"1313","34264974","10.1371/journal.pone.0254635","Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.","Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used data from 10,541 patients hospitalized with COVID-19 through September 2020 at 104 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease (CVD) Registry to evaluate t","2021","07","19","PLoS One","PloS one",NA,"Messer","Karen","Division of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, UC San Diego, La Jolla, California, United States of America",NA
"1314","34264973","10.1371/journal.pone.0253664","Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.","The COVID-19 pandemic has had a profound worldwide impact. Vietnam, a lower middle-income country with limited resources, has successfully slowed this pandemic. The objectives of this report are to explore the impact of the COVID-19 pandemic on the research activities of an ongoing hypertension trial using a storytelling intervention in Vietnam. Data were collected in a mixed-methods study among 86 patients and 10 health care workers participating in a clinical trial designed to improve hyperten","2021","07","19","PLoS One","PloS one",NA,"Nguyen","Hoa L","Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America",NA
"1315","34264973","10.1371/journal.pone.0253664","Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.","The COVID-19 pandemic has had a profound worldwide impact. Vietnam, a lower middle-income country with limited resources, has successfully slowed this pandemic. The objectives of this report are to explore the impact of the COVID-19 pandemic on the research activities of an ongoing hypertension trial using a storytelling intervention in Vietnam. Data were collected in a mixed-methods study among 86 patients and 10 health care workers participating in a clinical trial designed to improve hyperten","2021","07","19","PLoS One","PloS one",NA,"Tran","Oanh T","HealthStrategy and Policy Institute, Hanoi, Vietnam",NA
"1316","34264973","10.1371/journal.pone.0253664","Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.","The COVID-19 pandemic has had a profound worldwide impact. Vietnam, a lower middle-income country with limited resources, has successfully slowed this pandemic. The objectives of this report are to explore the impact of the COVID-19 pandemic on the research activities of an ongoing hypertension trial using a storytelling intervention in Vietnam. Data were collected in a mixed-methods study among 86 patients and 10 health care workers participating in a clinical trial designed to improve hyperten","2021","07","19","PLoS One","PloS one",NA,"Ha","Duc A","HealthStrategy and Policy Institute, Hanoi, Vietnam",NA
"1317","34264973","10.1371/journal.pone.0253664","Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.","The COVID-19 pandemic has had a profound worldwide impact. Vietnam, a lower middle-income country with limited resources, has successfully slowed this pandemic. The objectives of this report are to explore the impact of the COVID-19 pandemic on the research activities of an ongoing hypertension trial using a storytelling intervention in Vietnam. Data were collected in a mixed-methods study among 86 patients and 10 health care workers participating in a clinical trial designed to improve hyperten","2021","07","19","PLoS One","PloS one",NA,"Phan","Van H","HealthStrategy and Policy Institute, Hanoi, Vietnam",NA
"1318","34264973","10.1371/journal.pone.0253664","Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.","The COVID-19 pandemic has had a profound worldwide impact. Vietnam, a lower middle-income country with limited resources, has successfully slowed this pandemic. The objectives of this report are to explore the impact of the COVID-19 pandemic on the research activities of an ongoing hypertension trial using a storytelling intervention in Vietnam. Data were collected in a mixed-methods study among 86 patients and 10 health care workers participating in a clinical trial designed to improve hyperten","2021","07","19","PLoS One","PloS one",NA,"Nguyen","Cuc T","HealthStrategy and Policy Institute, Hanoi, Vietnam",NA
"1319","34264973","10.1371/journal.pone.0253664","Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.","The COVID-19 pandemic has had a profound worldwide impact. Vietnam, a lower middle-income country with limited resources, has successfully slowed this pandemic. The objectives of this report are to explore the impact of the COVID-19 pandemic on the research activities of an ongoing hypertension trial using a storytelling intervention in Vietnam. Data were collected in a mixed-methods study among 86 patients and 10 health care workers participating in a clinical trial designed to improve hyperten","2021","07","19","PLoS One","PloS one",NA,"Nguyen","Giang H","HealthStrategy and Policy Institute, Hanoi, Vietnam",NA
"1320","34264973","10.1371/journal.pone.0253664","Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.","The COVID-19 pandemic has had a profound worldwide impact. Vietnam, a lower middle-income country with limited resources, has successfully slowed this pandemic. The objectives of this report are to explore the impact of the COVID-19 pandemic on the research activities of an ongoing hypertension trial using a storytelling intervention in Vietnam. Data were collected in a mixed-methods study among 86 patients and 10 health care workers participating in a clinical trial designed to improve hyperten","2021","07","19","PLoS One","PloS one",NA,"Nguyen","Thang T","HealthStrategy and Policy Institute, Hanoi, Vietnam",NA
"1321","34264973","10.1371/journal.pone.0253664","Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.","The COVID-19 pandemic has had a profound worldwide impact. Vietnam, a lower middle-income country with limited resources, has successfully slowed this pandemic. The objectives of this report are to explore the impact of the COVID-19 pandemic on the research activities of an ongoing hypertension trial using a storytelling intervention in Vietnam. Data were collected in a mixed-methods study among 86 patients and 10 health care workers participating in a clinical trial designed to improve hyperten","2021","07","19","PLoS One","PloS one",NA,"Chiriboga","Germán","Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America",NA
"1322","34264973","10.1371/journal.pone.0253664","Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.","The COVID-19 pandemic has had a profound worldwide impact. Vietnam, a lower middle-income country with limited resources, has successfully slowed this pandemic. The objectives of this report are to explore the impact of the COVID-19 pandemic on the research activities of an ongoing hypertension trial using a storytelling intervention in Vietnam. Data were collected in a mixed-methods study among 86 patients and 10 health care workers participating in a clinical trial designed to improve hyperten","2021","07","19","PLoS One","PloS one",NA,"Goldberg","Robert J","Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America",NA
"1323","34264973","10.1371/journal.pone.0253664","Impact of the COVID-19 pandemic on clinical research activities: Survey of study participants and health care workers participating in a hypertension trial in Vietnam.","The COVID-19 pandemic has had a profound worldwide impact. Vietnam, a lower middle-income country with limited resources, has successfully slowed this pandemic. The objectives of this report are to explore the impact of the COVID-19 pandemic on the research activities of an ongoing hypertension trial using a storytelling intervention in Vietnam. Data were collected in a mixed-methods study among 86 patients and 10 health care workers participating in a clinical trial designed to improve hyperten","2021","07","19","PLoS One","PloS one",NA,"Allison","Jeroan J","Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America",NA
"1324","34264972","10.1371/journal.pone.0254313","Predicting COVID-19 cases with unknown homogeneous or heterogeneous resistance to infectivity.","We present a restricted infection rate inverse binomial-based approach to better predict COVID-19 cases after a family gathering. The traditional inverse binomial (IB) model is inappropriate to match the reality of COVID-19, because the collected data contradicts the model's requirement that variance should be larger than the expected value. Our version of an IB model is more appropriate, as it can accommodate all potential data scenarios in which the variance is smaller, equal, or larger than t","2021","07","19","PLoS One","PloS one",NA,"Shanmugam","Ramalingam","School of Health Administration, Texas State University, San Marcos, Texas, United States of America",NA
"1325","34264972","10.1371/journal.pone.0254313","Predicting COVID-19 cases with unknown homogeneous or heterogeneous resistance to infectivity.","We present a restricted infection rate inverse binomial-based approach to better predict COVID-19 cases after a family gathering. The traditional inverse binomial (IB) model is inappropriate to match the reality of COVID-19, because the collected data contradicts the model's requirement that variance should be larger than the expected value. Our version of an IB model is more appropriate, as it can accommodate all potential data scenarios in which the variance is smaller, equal, or larger than t","2021","07","19","PLoS One","PloS one",NA,"Ledlow","Gerald","Department of Healthcare Policy, Economics and Management, School of Community and Rural Health, The University of Texas Health Sciences Center at Tyler, Tyler, Texas, United States of America",NA
"1326","34264972","10.1371/journal.pone.0254313","Predicting COVID-19 cases with unknown homogeneous or heterogeneous resistance to infectivity.","We present a restricted infection rate inverse binomial-based approach to better predict COVID-19 cases after a family gathering. The traditional inverse binomial (IB) model is inappropriate to match the reality of COVID-19, because the collected data contradicts the model's requirement that variance should be larger than the expected value. Our version of an IB model is more appropriate, as it can accommodate all potential data scenarios in which the variance is smaller, equal, or larger than t","2021","07","19","PLoS One","PloS one",NA,"Singh","Karan P","Department of Epidemiology and Biostatistics, School of Community and Rural Health, The University of Texas Health Sciences Center at Tyler, Tyler, Texas, United States of America",NA
"1327","34264968","10.1371/journal.pone.0253662","Introducing the 4Ps Model of Transitioning to Distance Learning: A convergent mixed methods study conducted during the COVID-19 pandemic.","Significant concern has been raised regarding the effect of COVID-19 on medical education. This study aimed to shed light on the distance learning experiences of medical students and their instructors at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) in Dubai, United Arab Emirates. A convergent mixed methods approach was utilized. Qualitative and quantitative data was collected using a survey of closed-ended followed by open-ended questions. The percentage of the total","2021","07","19","PLoS One","PloS one",NA,"Otaki","Farah","Strategy and Institutional Excellence, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates",NA
"1328","34264968","10.1371/journal.pone.0253662","Introducing the 4Ps Model of Transitioning to Distance Learning: A convergent mixed methods study conducted during the COVID-19 pandemic.","Significant concern has been raised regarding the effect of COVID-19 on medical education. This study aimed to shed light on the distance learning experiences of medical students and their instructors at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) in Dubai, United Arab Emirates. A convergent mixed methods approach was utilized. Qualitative and quantitative data was collected using a survey of closed-ended followed by open-ended questions. The percentage of the total","2021","07","19","PLoS One","PloS one",NA,"Zaher","Shroque","College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates",NA
"1329","34264968","10.1371/journal.pone.0253662","Introducing the 4Ps Model of Transitioning to Distance Learning: A convergent mixed methods study conducted during the COVID-19 pandemic.","Significant concern has been raised regarding the effect of COVID-19 on medical education. This study aimed to shed light on the distance learning experiences of medical students and their instructors at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) in Dubai, United Arab Emirates. A convergent mixed methods approach was utilized. Qualitative and quantitative data was collected using a survey of closed-ended followed by open-ended questions. The percentage of the total","2021","07","19","PLoS One","PloS one",NA,"Du Plessis","Stefan","College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates",NA
"1330","34264968","10.1371/journal.pone.0253662","Introducing the 4Ps Model of Transitioning to Distance Learning: A convergent mixed methods study conducted during the COVID-19 pandemic.","Significant concern has been raised regarding the effect of COVID-19 on medical education. This study aimed to shed light on the distance learning experiences of medical students and their instructors at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) in Dubai, United Arab Emirates. A convergent mixed methods approach was utilized. Qualitative and quantitative data was collected using a survey of closed-ended followed by open-ended questions. The percentage of the total","2021","07","19","PLoS One","PloS one",NA,"Lakhtakia","Ritu","College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates",NA
"1331","34264968","10.1371/journal.pone.0253662","Introducing the 4Ps Model of Transitioning to Distance Learning: A convergent mixed methods study conducted during the COVID-19 pandemic.","Significant concern has been raised regarding the effect of COVID-19 on medical education. This study aimed to shed light on the distance learning experiences of medical students and their instructors at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) in Dubai, United Arab Emirates. A convergent mixed methods approach was utilized. Qualitative and quantitative data was collected using a survey of closed-ended followed by open-ended questions. The percentage of the total","2021","07","19","PLoS One","PloS one",NA,"Zary","Nabil","Institute for Excellence in Health Professions Education, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates",NA
"1332","34264968","10.1371/journal.pone.0253662","Introducing the 4Ps Model of Transitioning to Distance Learning: A convergent mixed methods study conducted during the COVID-19 pandemic.","Significant concern has been raised regarding the effect of COVID-19 on medical education. This study aimed to shed light on the distance learning experiences of medical students and their instructors at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) in Dubai, United Arab Emirates. A convergent mixed methods approach was utilized. Qualitative and quantitative data was collected using a survey of closed-ended followed by open-ended questions. The percentage of the total","2021","07","19","PLoS One","PloS one",NA,"Inuwa","Ibrahim M","College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates",NA
"1333","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Nam","Nguyen Hai","Graduate School of Medicine, Kyoto University, Kyoto, Japan",NA
"1334","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Tien","Phan Thi My","Online Research Club, Nagasaki, Japan",NA
"1335","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Truong","Le Van","Online Research Club, Nagasaki, Japan",NA
"1336","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"El-Ramly","Toka Aziz","Online Research Club, Nagasaki, Japan",NA
"1337","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Anh","Pham Gia","Online Research Club, Nagasaki, Japan",NA
"1338","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Hien","Nguyen Thi","Online Research Club, Nagasaki, Japan",NA
"1339","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Mahmoud","El Marabea","Online Research Club, Nagasaki, Japan",NA
"1340","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Eltaras","Mennatullah Mohamed","Online Research Club, Nagasaki, Japan",NA
"1341","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Khader","Sarah Abd Elaziz","Online Research Club, Nagasaki, Japan",NA
"1342","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Desokey","Mohammed Salah","Online Research Club, Nagasaki, Japan",NA
"1343","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Gayed","Ramy Magdy","Online Research Club, Nagasaki, Japan",NA
"1344","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Alhady","Shamael Thabit Mohammed","Online Research Club, Nagasaki, Japan",NA
"1345","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Le","Bao-Tran Do","Online Research Club, Nagasaki, Japan",NA
"1346","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Nguyen","Do Phuc Nhu","Online Research Club, Nagasaki, Japan",NA
"1347","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Tiwari","Ranjit","Online Research Club, Nagasaki, Japan",NA
"1348","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Eldoadoa","Mohammed","Online Research Club, Nagasaki, Japan",NA
"1349","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Howard","Britney","Online Research Club, Nagasaki, Japan",NA
"1350","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Trung","Tran Thanh","Online Research Club, Nagasaki, Japan",NA
"1351","34264966","10.1371/journal.pone.0254012","Early centralized isolation strategy for all confirmed cases of COVID-19 remains a core intervention to disrupt the pandemic spreading significantly.","In response to the spread of the coronavirus disease 2019 (COVID-19), plenty of control measures were proposed. To assess the impact of current control measures on the number of new case indices 14 countries with the highest confirmed cases, highest mortality rate, and having a close relationship with the outbreak's origin; were selected and analyzed. In the study, we analyzed the impact of five control measures, including centralized isolation of all confirmed cases, closure of schools, closure","2021","07","19","PLoS One","PloS one",NA,"Huy","Nguyen Tien","School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan",NA
"1352","34264960","10.1371/journal.pone.0254397","Cure and death play a role in understanding dynamics for COVID-19: Data-driven competing risk compartmental models, with and without vaccination.","Several factors have played a strong role in influencing the dynamics of COVID-19 in the U.S. One being the economy, where a tug of war has existed between lockdown measures to control disease versus loosening of restrictions to address economic hardship. A more recent effect has been availability of vaccines and the mass vaccination efforts of 2021. In order to address the challenges in analyzing this complex process, we developed a competing risk compartmental model framework with and without ","2021","07","19","PLoS One","PloS one",NA,"Lu","Min","Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, United States of America",NA
"1353","34264960","10.1371/journal.pone.0254397","Cure and death play a role in understanding dynamics for COVID-19: Data-driven competing risk compartmental models, with and without vaccination.","Several factors have played a strong role in influencing the dynamics of COVID-19 in the U.S. One being the economy, where a tug of war has existed between lockdown measures to control disease versus loosening of restrictions to address economic hardship. A more recent effect has been availability of vaccines and the mass vaccination efforts of 2021. In order to address the challenges in analyzing this complex process, we developed a competing risk compartmental model framework with and without ","2021","07","19","PLoS One","PloS one",NA,"Ishwaran","Hemant","Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, United States of America",NA
"1354","34264957","10.1371/journal.pgen.1009620","Global variation in sequencing impedes SARS-CoV-2 surveillance.",NA,"2021","07","20","PLoS Genet","PLoS genetics","DNA Mutational Analysis; Epidemiological Monitoring; Humans; Internationality; SARS-CoV-2; United States","Crawford","Dana C","Departments of Population and Quantitative Health Sciences and Genetics and Genome Sciences, Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio, United States of America",NA
"1355","34264957","10.1371/journal.pgen.1009620","Global variation in sequencing impedes SARS-CoV-2 surveillance.",NA,"2021","07","20","PLoS Genet","PLoS genetics","DNA Mutational Analysis; Epidemiological Monitoring; Humans; Internationality; SARS-CoV-2; United States","Williams","Scott M","Departments of Population and Quantitative Health Sciences and Genetics and Genome Sciences, Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio, United States of America",NA
"1356","34264954","10.1371/journal.pone.0253036","Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia.","Although COVID-19 is an acute disease that usually resolves rapidly in most cases, the disease can be fatal and has a mortality rate of about 1% to 56%. Alveolar injury and respiratory failure are the main causes of death in patients with COVID 19. In addition, the effect of the disease on other organs is not fully understood. Renal system affection has been reported in patients with COVID 19 and is associated with a higher rate of diverse outcomes, including mortality. Therefore, in the present","2021","07","19","PLoS One","PloS one",NA,"Allemailem","Khaled S","Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia",NA
"1357","34264954","10.1371/journal.pone.0253036","Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia.","Although COVID-19 is an acute disease that usually resolves rapidly in most cases, the disease can be fatal and has a mortality rate of about 1% to 56%. Alveolar injury and respiratory failure are the main causes of death in patients with COVID 19. In addition, the effect of the disease on other organs is not fully understood. Renal system affection has been reported in patients with COVID 19 and is associated with a higher rate of diverse outcomes, including mortality. Therefore, in the present","2021","07","19","PLoS One","PloS one",NA,"Almatroudi","Ahmad","Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia",NA
"1358","34264954","10.1371/journal.pone.0253036","Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia.","Although COVID-19 is an acute disease that usually resolves rapidly in most cases, the disease can be fatal and has a mortality rate of about 1% to 56%. Alveolar injury and respiratory failure are the main causes of death in patients with COVID 19. In addition, the effect of the disease on other organs is not fully understood. Renal system affection has been reported in patients with COVID 19 and is associated with a higher rate of diverse outcomes, including mortality. Therefore, in the present","2021","07","19","PLoS One","PloS one",NA,"Khan","Amjad Ali","Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia",NA
"1359","34264954","10.1371/journal.pone.0253036","Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia.","Although COVID-19 is an acute disease that usually resolves rapidly in most cases, the disease can be fatal and has a mortality rate of about 1% to 56%. Alveolar injury and respiratory failure are the main causes of death in patients with COVID 19. In addition, the effect of the disease on other organs is not fully understood. Renal system affection has been reported in patients with COVID 19 and is associated with a higher rate of diverse outcomes, including mortality. Therefore, in the present","2021","07","19","PLoS One","PloS one",NA,"Rahmani","Arshad H","Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia",NA
"1360","34264954","10.1371/journal.pone.0253036","Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia.","Although COVID-19 is an acute disease that usually resolves rapidly in most cases, the disease can be fatal and has a mortality rate of about 1% to 56%. Alveolar injury and respiratory failure are the main causes of death in patients with COVID 19. In addition, the effect of the disease on other organs is not fully understood. Renal system affection has been reported in patients with COVID 19 and is associated with a higher rate of diverse outcomes, including mortality. Therefore, in the present","2021","07","19","PLoS One","PloS one",NA,"Almarshad","Ibrahim S","Department of Laboratory and Blood Bank, King Fahd Specialist Hospital, Buraydah, Saudi Arabia",NA
"1361","34264954","10.1371/journal.pone.0253036","Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia.","Although COVID-19 is an acute disease that usually resolves rapidly in most cases, the disease can be fatal and has a mortality rate of about 1% to 56%. Alveolar injury and respiratory failure are the main causes of death in patients with COVID 19. In addition, the effect of the disease on other organs is not fully understood. Renal system affection has been reported in patients with COVID 19 and is associated with a higher rate of diverse outcomes, including mortality. Therefore, in the present","2021","07","19","PLoS One","PloS one",NA,"Alekezem","Fahad S","Department of Laboratory and Blood Bank, King Fahd Specialist Hospital, Buraydah, Saudi Arabia",NA
"1362","34264954","10.1371/journal.pone.0253036","Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia.","Although COVID-19 is an acute disease that usually resolves rapidly in most cases, the disease can be fatal and has a mortality rate of about 1% to 56%. Alveolar injury and respiratory failure are the main causes of death in patients with COVID 19. In addition, the effect of the disease on other organs is not fully understood. Renal system affection has been reported in patients with COVID 19 and is associated with a higher rate of diverse outcomes, including mortality. Therefore, in the present","2021","07","19","PLoS One","PloS one",NA,"Hassanein","Nagwa","Department of Clinical Pathology, Faculty of Medicine (Girls Branch), Al-Azhar University, Cairo, Egypt",NA
"1363","34264954","10.1371/journal.pone.0253036","Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia.","Although COVID-19 is an acute disease that usually resolves rapidly in most cases, the disease can be fatal and has a mortality rate of about 1% to 56%. Alveolar injury and respiratory failure are the main causes of death in patients with COVID 19. In addition, the effect of the disease on other organs is not fully understood. Renal system affection has been reported in patients with COVID 19 and is associated with a higher rate of diverse outcomes, including mortality. Therefore, in the present","2021","07","19","PLoS One","PloS one",NA,"El-Kady","Asmaa M","Department of Medical Parasitology, Faculty of Medicine, South Valley University, Qena, Egypt",NA
"1364","34264940","10.1371/journal.pone.0251708","Knowledge, attitude and preventive practice towards COVID-19 and associated factors among outpatient service visitors at Debre Markos compressive specialized hospital, north-west Ethiopia, 2020.","COVID-19 is an emerging infectious disease which is a major public health problem worldwide. Given the serious threats imposed by COVID-19 and the absence of vaccines until August 2020, preventive measures play an essential role in reducing infection rates and controlling its spread. This shows the necessity of public adherence for preventive and control measures, which is affected by their knowledge, attitudes, and practices. This study aimed to determine knowledge, attitude, and practice (KAP)","2021","07","20","PLoS One","PloS one",NA,"Feleke","Bekele Taye","Department of Medicine, School of Medicine, Debre Markos University, Debre Markos, Ethiopia",NA
"1365","34264940","10.1371/journal.pone.0251708","Knowledge, attitude and preventive practice towards COVID-19 and associated factors among outpatient service visitors at Debre Markos compressive specialized hospital, north-west Ethiopia, 2020.","COVID-19 is an emerging infectious disease which is a major public health problem worldwide. Given the serious threats imposed by COVID-19 and the absence of vaccines until August 2020, preventive measures play an essential role in reducing infection rates and controlling its spread. This shows the necessity of public adherence for preventive and control measures, which is affected by their knowledge, attitudes, and practices. This study aimed to determine knowledge, attitude, and practice (KAP)","2021","07","20","PLoS One","PloS one",NA,"Wale","Mengistu Zelalem","Department of Biomedical Sciences, School of Medicine, Debre Markos University, Debre Markos, Ethiopia",NA
"1366","34264940","10.1371/journal.pone.0251708","Knowledge, attitude and preventive practice towards COVID-19 and associated factors among outpatient service visitors at Debre Markos compressive specialized hospital, north-west Ethiopia, 2020.","COVID-19 is an emerging infectious disease which is a major public health problem worldwide. Given the serious threats imposed by COVID-19 and the absence of vaccines until August 2020, preventive measures play an essential role in reducing infection rates and controlling its spread. This shows the necessity of public adherence for preventive and control measures, which is affected by their knowledge, attitudes, and practices. This study aimed to determine knowledge, attitude, and practice (KAP)","2021","07","20","PLoS One","PloS one",NA,"Yirsaw","Mesenbet Terefe","Department of Biomedical Sciences, School of Medicine, Debre Markos University, Debre Markos, Ethiopia",NA
"1367","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Pingali","Cassandra",NA,NA
"1368","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Meghani","Mehreen",NA,NA
"1369","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Razzaghi","Hilda",NA,NA
"1370","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Lamias","Mark J",NA,NA
"1371","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Weintraub","Eric",NA,NA
"1372","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Kenigsberg","Tat'Yana A",NA,NA
"1373","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Klein","Nicola P",NA,NA
"1374","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Lewis","Ned",NA,NA
"1375","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Fireman","Bruce",NA,NA
"1376","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Zerbo","Ousseny",NA,NA
"1377","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Bartlett","Joan",NA,NA
"1378","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Goddard","Kristin",NA,NA
"1379","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Donahue","James",NA,NA
"1380","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Hanson","Kayla",NA,NA
"1381","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Naleway","Allison",NA,NA
"1382","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Kharbanda","Elyse O",NA,NA
"1383","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Yih","W Katherine",NA,NA
"1384","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Nelson","Jennifer Clark",NA,NA
"1385","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Lewin","Bruno J",NA,NA
"1386","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Williams","Joshua T B",NA,NA
"1387","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Glanz","Jason M",NA,NA
"1388","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Singleton","James A",NA,NA
"1389","34264911","10.15585/mmwr.mm7028a1","COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.","COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19-associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower in these groups (2). CDC used data from CDC's Vaccine Safety Datalink (VSD)* to assess disparities in vaccination coverage among persons aged =16 years by race and ethnicity during December 14, 2020-May 15, 2021. Measures of coverage included receipt of =1 C","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Delivery of Health Care, Integrated; Ethnic Groups; Female; Health Status Disparities; Humans; Insurance, Health; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Patel","Suchita A",NA,NA
"1390","34264910","10.15585/mmwr.mm7028e2","SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.","The B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, was identified in India in late 2020 and has subsequently been detected in approximately 60 countries (1). The B.1.617.2 variant has a potentially higher rate of transmission than other variants (2). During May 12-18, 2021, the Oklahoma State Department of Health (OSDH) Acute Disease Service (ADS) was notified by the OSDH Public Health Laboratory (PHL) of 21 SARS-CoV-2 B.1.617.2 specimens temporally and geographically c","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; Child; Child, Preschool; Cohort Studies; Contact Tracing; Disease Outbreaks; Female; Gymnastics; Humans; Male; Middle Aged; Oklahoma; SARS-CoV-2; Sports and Recreational Facilities; Young Adult","Dougherty","Kendra","Oklahoma State Department of Health",NA
"1391","34264910","10.15585/mmwr.mm7028e2","SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.","The B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, was identified in India in late 2020 and has subsequently been detected in approximately 60 countries (1). The B.1.617.2 variant has a potentially higher rate of transmission than other variants (2). During May 12-18, 2021, the Oklahoma State Department of Health (OSDH) Acute Disease Service (ADS) was notified by the OSDH Public Health Laboratory (PHL) of 21 SARS-CoV-2 B.1.617.2 specimens temporally and geographically c","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; Child; Child, Preschool; Cohort Studies; Contact Tracing; Disease Outbreaks; Female; Gymnastics; Humans; Male; Middle Aged; Oklahoma; SARS-CoV-2; Sports and Recreational Facilities; Young Adult","Mannell","Mike","Oklahoma State Department of Health",NA
"1392","34264910","10.15585/mmwr.mm7028e2","SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.","The B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, was identified in India in late 2020 and has subsequently been detected in approximately 60 countries (1). The B.1.617.2 variant has a potentially higher rate of transmission than other variants (2). During May 12-18, 2021, the Oklahoma State Department of Health (OSDH) Acute Disease Service (ADS) was notified by the OSDH Public Health Laboratory (PHL) of 21 SARS-CoV-2 B.1.617.2 specimens temporally and geographically c","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; Child; Child, Preschool; Cohort Studies; Contact Tracing; Disease Outbreaks; Female; Gymnastics; Humans; Male; Middle Aged; Oklahoma; SARS-CoV-2; Sports and Recreational Facilities; Young Adult","Naqvi","Ozair","Oklahoma State Department of Health",NA
"1393","34264910","10.15585/mmwr.mm7028e2","SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.","The B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, was identified in India in late 2020 and has subsequently been detected in approximately 60 countries (1). The B.1.617.2 variant has a potentially higher rate of transmission than other variants (2). During May 12-18, 2021, the Oklahoma State Department of Health (OSDH) Acute Disease Service (ADS) was notified by the OSDH Public Health Laboratory (PHL) of 21 SARS-CoV-2 B.1.617.2 specimens temporally and geographically c","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; Child; Child, Preschool; Cohort Studies; Contact Tracing; Disease Outbreaks; Female; Gymnastics; Humans; Male; Middle Aged; Oklahoma; SARS-CoV-2; Sports and Recreational Facilities; Young Adult","Matson","Dakota","Oklahoma State Department of Health",NA
"1394","34264910","10.15585/mmwr.mm7028e2","SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.","The B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, was identified in India in late 2020 and has subsequently been detected in approximately 60 countries (1). The B.1.617.2 variant has a potentially higher rate of transmission than other variants (2). During May 12-18, 2021, the Oklahoma State Department of Health (OSDH) Acute Disease Service (ADS) was notified by the OSDH Public Health Laboratory (PHL) of 21 SARS-CoV-2 B.1.617.2 specimens temporally and geographically c","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; Child; Child, Preschool; Cohort Studies; Contact Tracing; Disease Outbreaks; Female; Gymnastics; Humans; Male; Middle Aged; Oklahoma; SARS-CoV-2; Sports and Recreational Facilities; Young Adult","Stone","Jolianne","Oklahoma State Department of Health",NA
"1395","34264909","10.15585/mmwr.mm7028a2","COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.","COVID-19 has disproportionately affected non-Hispanic Black or African American (Black) and Hispanic persons in the United States (1,2). In North Carolina during January-September 2020, deaths from COVID-19 were 1.6 times higher among Black persons than among non-Hispanic White persons (3), and the rate of COVID-19 cases among Hispanic persons was 2.3 times higher than that among non-Hispanic persons (4). During December 14, 2020-April 6, 2021, the North Carolina Department of Health and Human S","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Ethnic Groups; Health Care Rationing; Health Status Disparities; Humans; Middle Aged; North Carolina; Vaccination Coverage; Young Adult","Wong","Charlene A",NA,NA
"1396","34264909","10.15585/mmwr.mm7028a2","COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.","COVID-19 has disproportionately affected non-Hispanic Black or African American (Black) and Hispanic persons in the United States (1,2). In North Carolina during January-September 2020, deaths from COVID-19 were 1.6 times higher among Black persons than among non-Hispanic White persons (3), and the rate of COVID-19 cases among Hispanic persons was 2.3 times higher than that among non-Hispanic persons (4). During December 14, 2020-April 6, 2021, the North Carolina Department of Health and Human S","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Ethnic Groups; Health Care Rationing; Health Status Disparities; Humans; Middle Aged; North Carolina; Vaccination Coverage; Young Adult","Dowler","Shannon",NA,NA
"1397","34264909","10.15585/mmwr.mm7028a2","COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.","COVID-19 has disproportionately affected non-Hispanic Black or African American (Black) and Hispanic persons in the United States (1,2). In North Carolina during January-September 2020, deaths from COVID-19 were 1.6 times higher among Black persons than among non-Hispanic White persons (3), and the rate of COVID-19 cases among Hispanic persons was 2.3 times higher than that among non-Hispanic persons (4). During December 14, 2020-April 6, 2021, the North Carolina Department of Health and Human S","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Ethnic Groups; Health Care Rationing; Health Status Disparities; Humans; Middle Aged; North Carolina; Vaccination Coverage; Young Adult","Moore","Amanda Fuller",NA,NA
"1398","34264909","10.15585/mmwr.mm7028a2","COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.","COVID-19 has disproportionately affected non-Hispanic Black or African American (Black) and Hispanic persons in the United States (1,2). In North Carolina during January-September 2020, deaths from COVID-19 were 1.6 times higher among Black persons than among non-Hispanic White persons (3), and the rate of COVID-19 cases among Hispanic persons was 2.3 times higher than that among non-Hispanic persons (4). During December 14, 2020-April 6, 2021, the North Carolina Department of Health and Human S","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Ethnic Groups; Health Care Rationing; Health Status Disparities; Humans; Middle Aged; North Carolina; Vaccination Coverage; Young Adult","Sosne","Erin Fry",NA,NA
"1399","34264909","10.15585/mmwr.mm7028a2","COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.","COVID-19 has disproportionately affected non-Hispanic Black or African American (Black) and Hispanic persons in the United States (1,2). In North Carolina during January-September 2020, deaths from COVID-19 were 1.6 times higher among Black persons than among non-Hispanic White persons (3), and the rate of COVID-19 cases among Hispanic persons was 2.3 times higher than that among non-Hispanic persons (4). During December 14, 2020-April 6, 2021, the North Carolina Department of Health and Human S","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Ethnic Groups; Health Care Rationing; Health Status Disparities; Humans; Middle Aged; North Carolina; Vaccination Coverage; Young Adult","Young","Hayley",NA,NA
"1400","34264909","10.15585/mmwr.mm7028a2","COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.","COVID-19 has disproportionately affected non-Hispanic Black or African American (Black) and Hispanic persons in the United States (1,2). In North Carolina during January-September 2020, deaths from COVID-19 were 1.6 times higher among Black persons than among non-Hispanic White persons (3), and the rate of COVID-19 cases among Hispanic persons was 2.3 times higher than that among non-Hispanic persons (4). During December 14, 2020-April 6, 2021, the North Carolina Department of Health and Human S","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Ethnic Groups; Health Care Rationing; Health Status Disparities; Humans; Middle Aged; North Carolina; Vaccination Coverage; Young Adult","Tenenbaum","Jessica D",NA,NA
"1401","34264909","10.15585/mmwr.mm7028a2","COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.","COVID-19 has disproportionately affected non-Hispanic Black or African American (Black) and Hispanic persons in the United States (1,2). In North Carolina during January-September 2020, deaths from COVID-19 were 1.6 times higher among Black persons than among non-Hispanic White persons (3), and the rate of COVID-19 cases among Hispanic persons was 2.3 times higher than that among non-Hispanic persons (4). During December 14, 2020-April 6, 2021, the North Carolina Department of Health and Human S","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Ethnic Groups; Health Care Rationing; Health Status Disparities; Humans; Middle Aged; North Carolina; Vaccination Coverage; Young Adult","Burns","Cardra E",NA,NA
"1402","34264909","10.15585/mmwr.mm7028a2","COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.","COVID-19 has disproportionately affected non-Hispanic Black or African American (Black) and Hispanic persons in the United States (1,2). In North Carolina during January-September 2020, deaths from COVID-19 were 1.6 times higher among Black persons than among non-Hispanic White persons (3), and the rate of COVID-19 cases among Hispanic persons was 2.3 times higher than that among non-Hispanic persons (4). During December 14, 2020-April 6, 2021, the North Carolina Department of Health and Human S","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Ethnic Groups; Health Care Rationing; Health Status Disparities; Humans; Middle Aged; North Carolina; Vaccination Coverage; Young Adult","Jones","Sydney",NA,NA
"1403","34264909","10.15585/mmwr.mm7028a2","COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.","COVID-19 has disproportionately affected non-Hispanic Black or African American (Black) and Hispanic persons in the United States (1,2). In North Carolina during January-September 2020, deaths from COVID-19 were 1.6 times higher among Black persons than among non-Hispanic White persons (3), and the rate of COVID-19 cases among Hispanic persons was 2.3 times higher than that among non-Hispanic persons (4). During December 14, 2020-April 6, 2021, the North Carolina Department of Health and Human S","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Ethnic Groups; Health Care Rationing; Health Status Disparities; Humans; Middle Aged; North Carolina; Vaccination Coverage; Young Adult","Smelyanskaya","Marina",NA,NA
"1404","34264909","10.15585/mmwr.mm7028a2","COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.","COVID-19 has disproportionately affected non-Hispanic Black or African American (Black) and Hispanic persons in the United States (1,2). In North Carolina during January-September 2020, deaths from COVID-19 were 1.6 times higher among Black persons than among non-Hispanic White persons (3), and the rate of COVID-19 cases among Hispanic persons was 2.3 times higher than that among non-Hispanic persons (4). During December 14, 2020-April 6, 2021, the North Carolina Department of Health and Human S","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Continental Population Groups; Ethnic Groups; Health Care Rationing; Health Status Disparities; Humans; Middle Aged; North Carolina; Vaccination Coverage; Young Adult","Kinsley","Kody H",NA,NA
"1405","34264908","10.15585/mmwr.mm7028e1","Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.","On May 10, 2021, the Food and Drug Administration (FDA) expanded its Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12-15 years; this authorization was followed by interim recommendations from the Advisory Committee on Immunization Practices (ACIP) for the vaccine among this age group (1). Using data from nonprobability-based Internet panel surveys administered by the Healthcare and Public Perceptions of Immunizations (HaPPI) Survey Collaborative","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; COVID-19; COVID-19 Vaccines; Child; Consumer Health Information; Female; Humans; Intention; Male; Parents; Patient Acceptance of Health Care; United States; Vaccination","Scherer","Aaron M",NA,NA
"1406","34264908","10.15585/mmwr.mm7028e1","Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.","On May 10, 2021, the Food and Drug Administration (FDA) expanded its Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12-15 years; this authorization was followed by interim recommendations from the Advisory Committee on Immunization Practices (ACIP) for the vaccine among this age group (1). Using data from nonprobability-based Internet panel surveys administered by the Healthcare and Public Perceptions of Immunizations (HaPPI) Survey Collaborative","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; COVID-19; COVID-19 Vaccines; Child; Consumer Health Information; Female; Humans; Intention; Male; Parents; Patient Acceptance of Health Care; United States; Vaccination","Gedlinske","Amber M",NA,NA
"1407","34264908","10.15585/mmwr.mm7028e1","Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.","On May 10, 2021, the Food and Drug Administration (FDA) expanded its Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12-15 years; this authorization was followed by interim recommendations from the Advisory Committee on Immunization Practices (ACIP) for the vaccine among this age group (1). Using data from nonprobability-based Internet panel surveys administered by the Healthcare and Public Perceptions of Immunizations (HaPPI) Survey Collaborative","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; COVID-19; COVID-19 Vaccines; Child; Consumer Health Information; Female; Humans; Intention; Male; Parents; Patient Acceptance of Health Care; United States; Vaccination","Parker","Andrew M",NA,NA
"1408","34264908","10.15585/mmwr.mm7028e1","Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.","On May 10, 2021, the Food and Drug Administration (FDA) expanded its Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12-15 years; this authorization was followed by interim recommendations from the Advisory Committee on Immunization Practices (ACIP) for the vaccine among this age group (1). Using data from nonprobability-based Internet panel surveys administered by the Healthcare and Public Perceptions of Immunizations (HaPPI) Survey Collaborative","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; COVID-19; COVID-19 Vaccines; Child; Consumer Health Information; Female; Humans; Intention; Male; Parents; Patient Acceptance of Health Care; United States; Vaccination","Gidengil","Courtney A",NA,NA
"1409","34264908","10.15585/mmwr.mm7028e1","Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.","On May 10, 2021, the Food and Drug Administration (FDA) expanded its Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12-15 years; this authorization was followed by interim recommendations from the Advisory Committee on Immunization Practices (ACIP) for the vaccine among this age group (1). Using data from nonprobability-based Internet panel surveys administered by the Healthcare and Public Perceptions of Immunizations (HaPPI) Survey Collaborative","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; COVID-19; COVID-19 Vaccines; Child; Consumer Health Information; Female; Humans; Intention; Male; Parents; Patient Acceptance of Health Care; United States; Vaccination","Askelson","Natoshia M",NA,NA
"1410","34264908","10.15585/mmwr.mm7028e1","Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.","On May 10, 2021, the Food and Drug Administration (FDA) expanded its Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12-15 years; this authorization was followed by interim recommendations from the Advisory Committee on Immunization Practices (ACIP) for the vaccine among this age group (1). Using data from nonprobability-based Internet panel surveys administered by the Healthcare and Public Perceptions of Immunizations (HaPPI) Survey Collaborative","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; COVID-19; COVID-19 Vaccines; Child; Consumer Health Information; Female; Humans; Intention; Male; Parents; Patient Acceptance of Health Care; United States; Vaccination","Petersen","Christine A",NA,NA
"1411","34264908","10.15585/mmwr.mm7028e1","Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.","On May 10, 2021, the Food and Drug Administration (FDA) expanded its Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12-15 years; this authorization was followed by interim recommendations from the Advisory Committee on Immunization Practices (ACIP) for the vaccine among this age group (1). Using data from nonprobability-based Internet panel surveys administered by the Healthcare and Public Perceptions of Immunizations (HaPPI) Survey Collaborative","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; COVID-19; COVID-19 Vaccines; Child; Consumer Health Information; Female; Humans; Intention; Male; Parents; Patient Acceptance of Health Care; United States; Vaccination","Woodworth","Kate R",NA,NA
"1412","34264908","10.15585/mmwr.mm7028e1","Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.","On May 10, 2021, the Food and Drug Administration (FDA) expanded its Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12-15 years; this authorization was followed by interim recommendations from the Advisory Committee on Immunization Practices (ACIP) for the vaccine among this age group (1). Using data from nonprobability-based Internet panel surveys administered by the Healthcare and Public Perceptions of Immunizations (HaPPI) Survey Collaborative","2021","07","16","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; COVID-19; COVID-19 Vaccines; Child; Consumer Health Information; Female; Humans; Intention; Male; Parents; Patient Acceptance of Health Care; United States; Vaccination","Lindley","Megan C",NA,NA
"1413","34264890","10.1097/MJT.0000000000001412","Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients.",NA,"2021","07","23","Am J Ther","American journal of therapeutics",NA,"Morin","Scott J","Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA Department of Infectious Diseases, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA",NA
"1414","34264890","10.1097/MJT.0000000000001412","Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients.",NA,"2021","07","23","Am J Ther","American journal of therapeutics",NA,"Jani","Chinmay","Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA Department of Infectious Diseases, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA",NA
"1415","34264890","10.1097/MJT.0000000000001412","Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients.",NA,"2021","07","23","Am J Ther","American journal of therapeutics",NA,"Rupal","Arashdeep","Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA Department of Infectious Diseases, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA",NA
"1416","34264890","10.1097/MJT.0000000000001412","Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients.",NA,"2021","07","23","Am J Ther","American journal of therapeutics",NA,"Singh","Harpreet","Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA Department of Infectious Diseases, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA",NA
"1417","34264890","10.1097/MJT.0000000000001412","Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients.",NA,"2021","07","23","Am J Ther","American journal of therapeutics",NA,"Bourque","Daniel","Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA Department of Infectious Diseases, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA",NA
"1418","34264890","10.1097/MJT.0000000000001412","Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients.",NA,"2021","07","23","Am J Ther","American journal of therapeutics",NA,"Colgrove","Robert C","Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA Department of Infectious Diseases, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA",NA
"1419","34264880","10.1097/BOR.0000000000000822","Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate.","The COVID-19 pandemic is a global public health crisis with considerable mortality and morbidity. A role for cytokine storm and therapeutic immunomodulation in a subgroup of patients with severe COVID-19 was proposed early in the pandemic. The concept of cytokine storm in COVID-19 has been criticised, given the lack of clear definition and relatively modest cytokinaemia (which may be necessary for viral clearance) compared with acute respiratory distress syndrome and bacterial sepsis. Here we co","2021","07","16","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Mehta","Puja","Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London Department of Rheumatology, University College London Hospital (UCLH), London, UK Department of Medicine, Division of Translational Medicine and Human Genetics, Center for Cytokine Storm Treatment and Laboratory, Philadelphia, Pennsylvania, USA",NA
"1420","34264880","10.1097/BOR.0000000000000822","Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate.","The COVID-19 pandemic is a global public health crisis with considerable mortality and morbidity. A role for cytokine storm and therapeutic immunomodulation in a subgroup of patients with severe COVID-19 was proposed early in the pandemic. The concept of cytokine storm in COVID-19 has been criticised, given the lack of clear definition and relatively modest cytokinaemia (which may be necessary for viral clearance) compared with acute respiratory distress syndrome and bacterial sepsis. Here we co","2021","07","16","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Fajgenbaum","David C","Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London Department of Rheumatology, University College London Hospital (UCLH), London, UK Department of Medicine, Division of Translational Medicine and Human Genetics, Center for Cytokine Storm Treatment and Laboratory, Philadelphia, Pennsylvania, USA",NA
"1421","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Shi","Hui","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"1422","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Gandhi","Alex A","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"1423","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Smith","Stephanie A","Department of Biological Chemistry, University of Michigan, Ann Arbor, United States of America",NA
"1424","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Wang","Qiuyu","Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States of America",NA
"1425","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Chiang","Diane","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"1426","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Yalavarthi","Srilakshmi","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"1427","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Ali","Ramadan A","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"1428","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Liu","Chao","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"1429","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Sule","Gautam","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"1430","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Tsou","Pei-Suen","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"1431","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Zuo","Yu","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"1432","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Kanthi","Yogendra","Division of Intramural Research National Heart, Lung and Blood Institute, Bethesda, United States of America",NA
"1433","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Farkash","Evan A","Department of Pathology, University of Michigan, Ann Arbor, United States of America",NA
"1434","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Lin","Jiandie D","University of Michigan, Ann Arbor, United States of America",NA
"1435","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Morrissey","James H","Department of Biological Chemistry, University of Michigan, Ann Arbor, United States of America",NA
"1436","34264868","10.1172/jci.insight.149149","Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.","Neutrophil-mediated activation and injury of the endothelium play a role in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap/NET-derived histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the FDA-approved polyanionic agent defibrotide (a pleotropic mixture of oligonucleotides) dire","2021","07","20","JCI Insight","JCI insight","Endothelial cells; Inflammation; Neutrophils; Thrombosis; Vascular Biology","Knight","Jason S","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"1437","34264847","10.1370/afm.2721","FAMILY MEDICINE EDUCATORS AS EXEMPLARS OF MASTER ADAPTIVE LEARNING IN RESPONSE TO THE COVID-19 PANDEMIC.",NA,"2021","07","19","Ann Fam Med","Annals of family medicine",NA,"Keister","Drew",NA,NA
"1438","34264847","10.1370/afm.2721","FAMILY MEDICINE EDUCATORS AS EXEMPLARS OF MASTER ADAPTIVE LEARNING IN RESPONSE TO THE COVID-19 PANDEMIC.",NA,"2021","07","19","Ann Fam Med","Annals of family medicine",NA,"Omole","Folashade",NA,NA
"1439","34264847","10.1370/afm.2721","FAMILY MEDICINE EDUCATORS AS EXEMPLARS OF MASTER ADAPTIVE LEARNING IN RESPONSE TO THE COVID-19 PANDEMIC.",NA,"2021","07","19","Ann Fam Med","Annals of family medicine",NA,"Sepdham","Dan",NA,NA
"1440","34264847","10.1370/afm.2721","FAMILY MEDICINE EDUCATORS AS EXEMPLARS OF MASTER ADAPTIVE LEARNING IN RESPONSE TO THE COVID-19 PANDEMIC.",NA,"2021","07","19","Ann Fam Med","Annals of family medicine",NA,"Anderson","Susan",NA,NA
"1441","34264845","10.1370/afm.2694","Sandwiches, 6 Feet Apart: Reflections on Community (and Medical School) During COVID-19.","During the COVID-19 pandemic, medical students were removed from clinical clerkships. During this time of uncertainty, 4 clinical medical students at the University of Michigan returned to the community to support their neighbors experiencing homelessness. They did so by making brown bag lunches for people sleeping on the streets and acting as community volunteers in temporary shelters. Though formal education was stalled, they reconnected with the initial desire that led them to pursue medical ","2021","07","19","Ann Fam Med","Annals of family medicine","COVID-19; community; homelessness; medical education; medical humanities; racism","Fessler","M Margaret","University of Michigan Medical School, Ann Arbor, Michigan mfessler@med.umich","mfessler@med.umich.edu"
"1442","34264845","10.1370/afm.2694","Sandwiches, 6 Feet Apart: Reflections on Community (and Medical School) During COVID-19.","During the COVID-19 pandemic, medical students were removed from clinical clerkships. During this time of uncertainty, 4 clinical medical students at the University of Michigan returned to the community to support their neighbors experiencing homelessness. They did so by making brown bag lunches for people sleeping on the streets and acting as community volunteers in temporary shelters. Though formal education was stalled, they reconnected with the initial desire that led them to pursue medical ","2021","07","19","Ann Fam Med","Annals of family medicine","COVID-19; community; homelessness; medical education; medical humanities; racism","Bishop","Ruth A","University of Michigan Medical School, Ann Arbor, Michigan",NA
"1443","34264845","10.1370/afm.2694","Sandwiches, 6 Feet Apart: Reflections on Community (and Medical School) During COVID-19.","During the COVID-19 pandemic, medical students were removed from clinical clerkships. During this time of uncertainty, 4 clinical medical students at the University of Michigan returned to the community to support their neighbors experiencing homelessness. They did so by making brown bag lunches for people sleeping on the streets and acting as community volunteers in temporary shelters. Though formal education was stalled, they reconnected with the initial desire that led them to pursue medical ","2021","07","19","Ann Fam Med","Annals of family medicine","COVID-19; community; homelessness; medical education; medical humanities; racism","Jabour","Sarah M","University of Michigan Medical School, Ann Arbor, Michigan",NA
"1444","34264845","10.1370/afm.2694","Sandwiches, 6 Feet Apart: Reflections on Community (and Medical School) During COVID-19.","During the COVID-19 pandemic, medical students were removed from clinical clerkships. During this time of uncertainty, 4 clinical medical students at the University of Michigan returned to the community to support their neighbors experiencing homelessness. They did so by making brown bag lunches for people sleeping on the streets and acting as community volunteers in temporary shelters. Though formal education was stalled, they reconnected with the initial desire that led them to pursue medical ","2021","07","19","Ann Fam Med","Annals of family medicine","COVID-19; community; homelessness; medical education; medical humanities; racism","Vasudevan","Anita","University of Michigan Medical School, Ann Arbor, Michigan",NA
"1445","34264842","10.1370/afm.2693","Virtual Care: Choosing the Right Tool, at the Right Time.","When the immediate threat of COVID-19 subsides, the future of health care will involve more virtual care. Before the pandemic, patient choice rather than clinician guidance determined which medium (telephone visits, video visits, electronic messaging) was used to receive care. Two media synchronicity theory principles-conveyance and convergence-can create a framework for determining how to choose the right medium of care for the patient. The author describes how it changed their practice and dec","2021","07","19","Ann Fam Med","Annals of family medicine","judgement; office visits; primary health care; telemedicine","Sundar","Kumara Raja","Kaiser Permanente of Washington, Burien, Washington raja.sundar825@gmail","raja.sundar825@gmail.com"
"1446","34264800","10.3928/19382359-20210613-01","Ear, Nose, and Throat Manifestations of COVID-19 in Children.","The article reviews and analyzes the different ear, nose, and throat (ENT)-related manifestations reported in coronavirus disease 2019 (COVID-19)-positive pediatric patients (age &lt;18 years) in peer-reviewed and published literature. We searched the PubMed database using medical subject headings and associated key words, focusing on ENT symptoms in children with COVID-19. We included relevant published and peer-reviewed articles in English and excluded case reports and articles in press. There","2021","07","15","Pediatr Ann","Pediatric annals",NA,"Kumar","Banu",NA,NA
"1447","34264800","10.3928/19382359-20210613-01","Ear, Nose, and Throat Manifestations of COVID-19 in Children.","The article reviews and analyzes the different ear, nose, and throat (ENT)-related manifestations reported in coronavirus disease 2019 (COVID-19)-positive pediatric patients (age &lt;18 years) in peer-reviewed and published literature. We searched the PubMed database using medical subject headings and associated key words, focusing on ENT symptoms in children with COVID-19. We included relevant published and peer-reviewed articles in English and excluded case reports and articles in press. There","2021","07","15","Pediatr Ann","Pediatric annals",NA,"Scheffler","Patrick",NA,NA
"1448","34264798","10.3928/19382359-20210520-01","Reply: Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.",NA,"2021","07","21","Pediatr Ann","Pediatric annals","Adrenal Cortex Hormones; COVID-19; Child; Humans; Methylprednisolone; SARS-CoV-2","Khan","Leah","Chanhassen, MN",NA
"1449","34264793","10.3928/19382359-20210701-01","Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.",NA,"2021","07","21","Pediatr Ann","Pediatric annals","Adrenal Cortex Hormones; COVID-19; Child; Humans; Methylprednisolone; SARS-CoV-2","Prutsky","Gabriela J","Mankato, MN",NA
"1450","34264793","10.3928/19382359-20210701-01","Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.",NA,"2021","07","21","Pediatr Ann","Pediatric annals","Adrenal Cortex Hormones; COVID-19; Child; Humans; Methylprednisolone; SARS-CoV-2","Kamat","Deepak","San Antonio, TX",NA
"1451","34264772","10.1089/cyber.2020.0669","Jealousy and Electronic Intrusion Mediated by Relationship Uncertainty in Married and Cohabiting Couples During COVID-19.","The COVID-19 pandemic poses unique threats to romantic relationships as couples were issued to stay at home by a mandatory order, limiting social interactions with others. Although technology allows for social interactions, the privacy of interactions through technology may be compromised. Electronic intrusion (EI) occurs when individuals covertly gain access of their partner's mobile device to go through content (e.g., text messages, private messages on social media sites), and previous study i","2021","07","21","Cyberpsychol Behav Soc Netw","Cyberpsychology, behavior and social networking","couples; cyberdating abuse; pandemic; smartphones; surveillance; Adult; Aged; COVID-19; Family Characteristics; Humans; Interpersonal Relations; Intimate Partner Violence; Jealousy; Male; Marriage; Sexual Partners; Social Interaction; Social Media; Uncertainty","Ligman","Kaitlyn","Department of Psychology, University of South Florida, Tampa, Florida, USA",NA
"1452","34264772","10.1089/cyber.2020.0669","Jealousy and Electronic Intrusion Mediated by Relationship Uncertainty in Married and Cohabiting Couples During COVID-19.","The COVID-19 pandemic poses unique threats to romantic relationships as couples were issued to stay at home by a mandatory order, limiting social interactions with others. Although technology allows for social interactions, the privacy of interactions through technology may be compromised. Electronic intrusion (EI) occurs when individuals covertly gain access of their partner's mobile device to go through content (e.g., text messages, private messages on social media sites), and previous study i","2021","07","21","Cyberpsychol Behav Soc Netw","Cyberpsychology, behavior and social networking","couples; cyberdating abuse; pandemic; smartphones; surveillance; Adult; Aged; COVID-19; Family Characteristics; Humans; Interpersonal Relations; Intimate Partner Violence; Jealousy; Male; Marriage; Sexual Partners; Social Interaction; Social Media; Uncertainty","Rodriguez","Lindsey M","Department of Psychology, University of South Florida, Tampa, Florida, USA",NA
"1453","34264772","10.1089/cyber.2020.0669","Jealousy and Electronic Intrusion Mediated by Relationship Uncertainty in Married and Cohabiting Couples During COVID-19.","The COVID-19 pandemic poses unique threats to romantic relationships as couples were issued to stay at home by a mandatory order, limiting social interactions with others. Although technology allows for social interactions, the privacy of interactions through technology may be compromised. Electronic intrusion (EI) occurs when individuals covertly gain access of their partner's mobile device to go through content (e.g., text messages, private messages on social media sites), and previous study i","2021","07","21","Cyberpsychol Behav Soc Netw","Cyberpsychology, behavior and social networking","couples; cyberdating abuse; pandemic; smartphones; surveillance; Adult; Aged; COVID-19; Family Characteristics; Humans; Interpersonal Relations; Intimate Partner Violence; Jealousy; Male; Marriage; Sexual Partners; Social Interaction; Social Media; Uncertainty","Rocek","George","Department of Psychology, University of South Florida, Tampa, Florida, USA",NA
"1454","34264769","10.1089/cyber.2020.0729","Moderation of Technology Use in the Association Between Self-Isolation During COVID-19 Pandemic and Adolescents' Romantic Relationship Quality.","The purpose of this study was to examine the moderating effects of technology use for relationship maintenance on the longitudinal associations among self-isolation during the coronavirus-19 (COVID-19) pandemic and romantic relationship quality among adolescents. Participants were 239 (120 female; M age = 16.69, standard deviation [SD] = 0.61; 60 percent Caucasian) 11th and 12th graders from three midwestern high schools. To qualify for this study, adolescents had to be in the same","2021","07","21","Cyberpsychol Behav Soc Netw","Cyberpsychology, behavior and social networking","COVID-19; adolescent; coronavirus; romantic relationship; romantic relationship quality; technology; Adolescent; Adolescent Behavior; COVID-19; Courtship; Female; Friends; Humans; Male; Psychology, Adolescent; Social Isolation; Technology","Wright","Michelle F","Department of Psychology, Pennsylvania State University, State College, Pennsylvania, USA",NA
"1455","34264769","10.1089/cyber.2020.0729","Moderation of Technology Use in the Association Between Self-Isolation During COVID-19 Pandemic and Adolescents' Romantic Relationship Quality.","The purpose of this study was to examine the moderating effects of technology use for relationship maintenance on the longitudinal associations among self-isolation during the coronavirus-19 (COVID-19) pandemic and romantic relationship quality among adolescents. Participants were 239 (120 female; M age = 16.69, standard deviation [SD] = 0.61; 60 percent Caucasian) 11th and 12th graders from three midwestern high schools. To qualify for this study, adolescents had to be in the same","2021","07","21","Cyberpsychol Behav Soc Netw","Cyberpsychology, behavior and social networking","COVID-19; adolescent; coronavirus; romantic relationship; romantic relationship quality; technology; Adolescent; Adolescent Behavior; COVID-19; Courtship; Female; Friends; Humans; Male; Psychology, Adolescent; Social Isolation; Technology","Wachs","Sebastian","Department of Educational Studies, University of Potsdam, Potsdam, Germany",NA
"1456","34264764","10.1089/photob.2021.0018","Ultraviolet C Supported Novel Phototherapy Units at the Crossroads of the COVID-19 Pandemic.","The numerous dermatology clinics have decreased or stopped phototherapy sessions due to the increased risk of getting COVID-19 during the current pandemic. In this context, poorly ventilated phototherapy units (PUs) should be redesigned in order to continue UV-based therapies and to protect our patients from getting COVID-19. Recently, it has been reported that ultraviolet C (UVC)-related dose and virus concentration may play a decisive role in the virucidal activity. Considering air changes per","2021","07","22","Photobiomodul Photomed Laser Surg","Photobiomodulation, photomedicine, and laser surgery","COVID-19; phototherapy; ultraviolet C; COVID-19; Equipment Design; Humans; Infection Control; Pandemics; Phototherapy; SARS-CoV-2; Ultraviolet Rays; Ventilation; Virus Inactivation","Kutlu","Ömer","Department of Dermatology and Venereology, School of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey",NA
"1457","34264753","10.1089/pop.2021.0140","<i>Letter to the Editor:</i> Impact of COVID-19 Prevention Methods on Influenza and Other Respiratory Infections in Taiwan.",NA,"2021","07","15","Popul Health Manag","Population health management",NA,"Clinciu","Daniel L","Department of Basic Medical Science, Graduate Institute of Biomedical Sciences, China Medical University, Taichung City, Taiwan",NA
"1458","34264753","10.1089/pop.2021.0140","<i>Letter to the Editor:</i> Impact of COVID-19 Prevention Methods on Influenza and Other Respiratory Infections in Taiwan.",NA,"2021","07","15","Popul Health Manag","Population health management",NA,"Chen","Cheng-Shien","Department of Optics and Photonics, National Central University, Taoyuan City, Taiwan",NA
"1459","34264753","10.1089/pop.2021.0140","<i>Letter to the Editor:</i> Impact of COVID-19 Prevention Methods on Influenza and Other Respiratory Infections in Taiwan.",NA,"2021","07","15","Popul Health Manag","Population health management",NA,"Wang","Jong-Yi","Department of Health Services Administration, China Medical University, Taichung City, Taiwan",NA
"1460","34264753","10.1089/pop.2021.0140","<i>Letter to the Editor:</i> Impact of COVID-19 Prevention Methods on Influenza and Other Respiratory Infections in Taiwan.",NA,"2021","07","15","Popul Health Manag","Population health management",NA,"Huang","Garry","Department of Health Care Administration, College of Management, Taipei Medical University, Taipei City, Taiwan",NA
"1461","34264741","10.1200/OP.21.00195","Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.","The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's present and future roles (both phone and video) for patients with cancer. The National Comprehensive Cancer Network (NCCN) Electronic Health Record (EHR) Oncology Advisory Group formed a Workgroup to assess the state of oncology telemedicine and created a 20-question survey. NCCN EHR Oncology Advisory Group members e-mailed the survey to provi","2021","07","15","JCO Oncol Pract","JCO oncology practice",NA,"Tevaarwerk","Amye J","University of Wisconsin, Madison, WI",NA
"1462","34264741","10.1200/OP.21.00195","Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.","The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's present and future roles (both phone and video) for patients with cancer. The National Comprehensive Cancer Network (NCCN) Electronic Health Record (EHR) Oncology Advisory Group formed a Workgroup to assess the state of oncology telemedicine and created a 20-question survey. NCCN EHR Oncology Advisory Group members e-mailed the survey to provi","2021","07","15","JCO Oncol Pract","JCO oncology practice",NA,"Chandereng","Thevaa","Columbia University, New York, NY",NA
"1463","34264741","10.1200/OP.21.00195","Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.","The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's present and future roles (both phone and video) for patients with cancer. The National Comprehensive Cancer Network (NCCN) Electronic Health Record (EHR) Oncology Advisory Group formed a Workgroup to assess the state of oncology telemedicine and created a 20-question survey. NCCN EHR Oncology Advisory Group members e-mailed the survey to provi","2021","07","15","JCO Oncol Pract","JCO oncology practice",NA,"Osterman","Travis","Vanderbilt-Ingram Cancer Center, Nashville, TN",NA
"1464","34264741","10.1200/OP.21.00195","Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.","The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's present and future roles (both phone and video) for patients with cancer. The National Comprehensive Cancer Network (NCCN) Electronic Health Record (EHR) Oncology Advisory Group formed a Workgroup to assess the state of oncology telemedicine and created a 20-question survey. NCCN EHR Oncology Advisory Group members e-mailed the survey to provi","2021","07","15","JCO Oncol Pract","JCO oncology practice",NA,"Arafat","Waddah","Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX",NA
"1465","34264741","10.1200/OP.21.00195","Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.","The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's present and future roles (both phone and video) for patients with cancer. The National Comprehensive Cancer Network (NCCN) Electronic Health Record (EHR) Oncology Advisory Group formed a Workgroup to assess the state of oncology telemedicine and created a 20-question survey. NCCN EHR Oncology Advisory Group members e-mailed the survey to provi","2021","07","15","JCO Oncol Pract","JCO oncology practice",NA,"Smerage","Jeffrey","Rogel Comprehensive Cancer Center, University of Michigan",NA
"1466","34264741","10.1200/OP.21.00195","Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.","The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's present and future roles (both phone and video) for patients with cancer. The National Comprehensive Cancer Network (NCCN) Electronic Health Record (EHR) Oncology Advisory Group formed a Workgroup to assess the state of oncology telemedicine and created a 20-question survey. NCCN EHR Oncology Advisory Group members e-mailed the survey to provi","2021","07","15","JCO Oncol Pract","JCO oncology practice",NA,"Polubriaginof","Fernanda C G","Memorial Sloan Kettering Cancer Center, New York, NY",NA
"1467","34264741","10.1200/OP.21.00195","Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.","The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's present and future roles (both phone and video) for patients with cancer. The National Comprehensive Cancer Network (NCCN) Electronic Health Record (EHR) Oncology Advisory Group formed a Workgroup to assess the state of oncology telemedicine and created a 20-question survey. NCCN EHR Oncology Advisory Group members e-mailed the survey to provi","2021","07","15","JCO Oncol Pract","JCO oncology practice",NA,"Heinrichs","Tricia","National Comprehensive Cancer Network, Plymouth Meeting, PA",NA
"1468","34264741","10.1200/OP.21.00195","Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.","The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's present and future roles (both phone and video) for patients with cancer. The National Comprehensive Cancer Network (NCCN) Electronic Health Record (EHR) Oncology Advisory Group formed a Workgroup to assess the state of oncology telemedicine and created a 20-question survey. NCCN EHR Oncology Advisory Group members e-mailed the survey to provi","2021","07","15","JCO Oncol Pract","JCO oncology practice",NA,"Sugalski","Jessica","National Comprehensive Cancer Network, Plymouth Meeting, PA",NA
"1469","34264741","10.1200/OP.21.00195","Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.","The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's present and future roles (both phone and video) for patients with cancer. The National Comprehensive Cancer Network (NCCN) Electronic Health Record (EHR) Oncology Advisory Group formed a Workgroup to assess the state of oncology telemedicine and created a 20-question survey. NCCN EHR Oncology Advisory Group members e-mailed the survey to provi","2021","07","15","JCO Oncol Pract","JCO oncology practice",NA,"Martin","Daniel B","University of Washington Medical Center, Seattle, WA",NA
"1470","34264696","10.1037/cou0000568","A mindfulness-based mobile health (mHealth) intervention among psychologically distressed university students in quarantine during the COVID-19 pandemic: A randomized controlled trial.","This randomized controlled trial evaluated the effect of a mindfulness-based mobile health (mHealth) intervention, tailored to the pandemic context, among young adult students (N = 114) with elevated anxiety and/or depressive symptoms during quarantine in China, compared to a time- and attention-matched social support-based mHealth control. At baseline, postintervention (1 month), and 2-month follow-up, participants completed self-reports of primary outcomes (anxiety and depression), secondary o","2021","07","15","J Couns Psychol","Journal of counseling psychology",NA,"Sun","Shufang","Department of Behavioral and Social Sciences, Brown University School of Public Health",NA
"1471","34264696","10.1037/cou0000568","A mindfulness-based mobile health (mHealth) intervention among psychologically distressed university students in quarantine during the COVID-19 pandemic: A randomized controlled trial.","This randomized controlled trial evaluated the effect of a mindfulness-based mobile health (mHealth) intervention, tailored to the pandemic context, among young adult students (N = 114) with elevated anxiety and/or depressive symptoms during quarantine in China, compared to a time- and attention-matched social support-based mHealth control. At baseline, postintervention (1 month), and 2-month follow-up, participants completed self-reports of primary outcomes (anxiety and depression), secondary o","2021","07","15","J Couns Psychol","Journal of counseling psychology",NA,"Lin","Danhua","Institute of Developmental Psychology, Department of Psychology, Beijing Normal University",NA
"1472","34264696","10.1037/cou0000568","A mindfulness-based mobile health (mHealth) intervention among psychologically distressed university students in quarantine during the COVID-19 pandemic: A randomized controlled trial.","This randomized controlled trial evaluated the effect of a mindfulness-based mobile health (mHealth) intervention, tailored to the pandemic context, among young adult students (N = 114) with elevated anxiety and/or depressive symptoms during quarantine in China, compared to a time- and attention-matched social support-based mHealth control. At baseline, postintervention (1 month), and 2-month follow-up, participants completed self-reports of primary outcomes (anxiety and depression), secondary o","2021","07","15","J Couns Psychol","Journal of counseling psychology",NA,"Goldberg","Simon","Department of Counseling Psychology, University of Wisconsin-Madison College of Education",NA
"1473","34264696","10.1037/cou0000568","A mindfulness-based mobile health (mHealth) intervention among psychologically distressed university students in quarantine during the COVID-19 pandemic: A randomized controlled trial.","This randomized controlled trial evaluated the effect of a mindfulness-based mobile health (mHealth) intervention, tailored to the pandemic context, among young adult students (N = 114) with elevated anxiety and/or depressive symptoms during quarantine in China, compared to a time- and attention-matched social support-based mHealth control. At baseline, postintervention (1 month), and 2-month follow-up, participants completed self-reports of primary outcomes (anxiety and depression), secondary o","2021","07","15","J Couns Psychol","Journal of counseling psychology",NA,"Shen","Zijiao","Institute of Developmental Psychology, Department of Psychology, Beijing Normal University",NA
"1474","34264696","10.1037/cou0000568","A mindfulness-based mobile health (mHealth) intervention among psychologically distressed university students in quarantine during the COVID-19 pandemic: A randomized controlled trial.","This randomized controlled trial evaluated the effect of a mindfulness-based mobile health (mHealth) intervention, tailored to the pandemic context, among young adult students (N = 114) with elevated anxiety and/or depressive symptoms during quarantine in China, compared to a time- and attention-matched social support-based mHealth control. At baseline, postintervention (1 month), and 2-month follow-up, participants completed self-reports of primary outcomes (anxiety and depression), secondary o","2021","07","15","J Couns Psychol","Journal of counseling psychology",NA,"Chen","Pujing","Institute of Developmental Psychology, Department of Psychology, Beijing Normal University",NA
"1475","34264696","10.1037/cou0000568","A mindfulness-based mobile health (mHealth) intervention among psychologically distressed university students in quarantine during the COVID-19 pandemic: A randomized controlled trial.","This randomized controlled trial evaluated the effect of a mindfulness-based mobile health (mHealth) intervention, tailored to the pandemic context, among young adult students (N = 114) with elevated anxiety and/or depressive symptoms during quarantine in China, compared to a time- and attention-matched social support-based mHealth control. At baseline, postintervention (1 month), and 2-month follow-up, participants completed self-reports of primary outcomes (anxiety and depression), secondary o","2021","07","15","J Couns Psychol","Journal of counseling psychology",NA,"Qiao","Shan","Department of Health Promotion, Education, and Behavior, University of South Carolina Arnold School of Public Health",NA
"1476","34264696","10.1037/cou0000568","A mindfulness-based mobile health (mHealth) intervention among psychologically distressed university students in quarantine during the COVID-19 pandemic: A randomized controlled trial.","This randomized controlled trial evaluated the effect of a mindfulness-based mobile health (mHealth) intervention, tailored to the pandemic context, among young adult students (N = 114) with elevated anxiety and/or depressive symptoms during quarantine in China, compared to a time- and attention-matched social support-based mHealth control. At baseline, postintervention (1 month), and 2-month follow-up, participants completed self-reports of primary outcomes (anxiety and depression), secondary o","2021","07","15","J Couns Psychol","Journal of counseling psychology",NA,"Brewer","Judson","Department of Behavioral and Social Sciences, Brown University School of Public Health",NA
"1477","34264696","10.1037/cou0000568","A mindfulness-based mobile health (mHealth) intervention among psychologically distressed university students in quarantine during the COVID-19 pandemic: A randomized controlled trial.","This randomized controlled trial evaluated the effect of a mindfulness-based mobile health (mHealth) intervention, tailored to the pandemic context, among young adult students (N = 114) with elevated anxiety and/or depressive symptoms during quarantine in China, compared to a time- and attention-matched social support-based mHealth control. At baseline, postintervention (1 month), and 2-month follow-up, participants completed self-reports of primary outcomes (anxiety and depression), secondary o","2021","07","15","J Couns Psychol","Journal of counseling psychology",NA,"Loucks","Eric","Department of Behavioral and Social Sciences, Brown University School of Public Health",NA
"1478","34264696","10.1037/cou0000568","A mindfulness-based mobile health (mHealth) intervention among psychologically distressed university students in quarantine during the COVID-19 pandemic: A randomized controlled trial.","This randomized controlled trial evaluated the effect of a mindfulness-based mobile health (mHealth) intervention, tailored to the pandemic context, among young adult students (N = 114) with elevated anxiety and/or depressive symptoms during quarantine in China, compared to a time- and attention-matched social support-based mHealth control. At baseline, postintervention (1 month), and 2-month follow-up, participants completed self-reports of primary outcomes (anxiety and depression), secondary o","2021","07","15","J Couns Psychol","Journal of counseling psychology",NA,"Operario","Don","Department of Behavioral and Social Sciences, Brown University School of Public Health",NA
"1479","34264684","10.1021/acs.molpharmaceut.1c00447","Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.","Despite the many advances that have occurred in the field of vaccine adjuvants, there are still unmet needs that may enable the development of vaccines suitable for more challenging pathogens (e.g., HIV and tuberculosis) and for cancer vaccines. Liposomes have already been shown to be highly effective as adjuvant/delivery systems due to their versatility and likely will find further uses in this space. The broad potential of lipid-based delivery systems is highlighted by the recent approval of C","2021","07","15","Mol Pharm","Molecular pharmaceutics","COVID-19; adjuvants; delivery systems; lipid nanoparticles; vaccines","Chatzikleanthous","Despo","Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, G4 0RE Glasgow, U",NA
"1480","34264684","10.1021/acs.molpharmaceut.1c00447","Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.","Despite the many advances that have occurred in the field of vaccine adjuvants, there are still unmet needs that may enable the development of vaccines suitable for more challenging pathogens (e.g., HIV and tuberculosis) and for cancer vaccines. Liposomes have already been shown to be highly effective as adjuvant/delivery systems due to their versatility and likely will find further uses in this space. The broad potential of lipid-based delivery systems is highlighted by the recent approval of C","2021","07","15","Mol Pharm","Molecular pharmaceutics","COVID-19; adjuvants; delivery systems; lipid nanoparticles; vaccines","O'Hagan","Derek T","GSK, Rockville, Maryland 20850, United States",NA
"1481","34264684","10.1021/acs.molpharmaceut.1c00447","Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.","Despite the many advances that have occurred in the field of vaccine adjuvants, there are still unmet needs that may enable the development of vaccines suitable for more challenging pathogens (e.g., HIV and tuberculosis) and for cancer vaccines. Liposomes have already been shown to be highly effective as adjuvant/delivery systems due to their versatility and likely will find further uses in this space. The broad potential of lipid-based delivery systems is highlighted by the recent approval of C","2021","07","15","Mol Pharm","Molecular pharmaceutics","COVID-19; adjuvants; delivery systems; lipid nanoparticles; vaccines","Adamo","Roberto","GSK, Via Fiorentina 1, 53100 Siena, Italy",NA
"1482","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Schang","Christelle","Environmental and Public Health Microbiology Lab (EPHM Lab), Department of Civil Engineering, Monash University, Clayton, Victoria 3800, Australia",NA
"1483","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Crosbie","Nicolas D","Melbourne Water Corp., 990 La Trobe St., Docklands, Victoria 3001, Australia",NA
"1484","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Nolan","Monica","Department of Health, Victoria Department of Health and Human Services, 50 Lonsdale St., Melbourne, Victoria 3000, Australia",NA
"1485","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Poon","Rachael","Department of Health, Victoria Department of Health and Human Services, 50 Lonsdale St., Melbourne, Victoria 3000, Australia",NA
"1486","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Wang","Miao","Environmental and Public Health Microbiology Lab (EPHM Lab), Department of Civil Engineering, Monash University, Clayton, Victoria 3800, Australia",NA
"1487","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Jex","Aaron","The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia",NA
"1488","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","John","Nijoy","The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia",NA
"1489","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Baker","Louise","The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia",NA
"1490","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Scales","Peter","The University of Melbourne, Parkville, Victoria 3010, Australia",NA
"1491","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Schmidt","Jonathan","South East Water, Frankston, Victoria 3199 Australia",NA
"1492","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Thorley","Bruce R","Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia",NA
"1493","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Hill","Kelly","Water Research Australia, Adelaide Office, Level 2, 250 Victoria Square, Adelaide 5000, South Australia",NA
"1494","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Zamyadi","Arash","Water Research Australia, Melbourne Office, 990 La Trobe St., Docklands, Victoria 3001, Australia",NA
"1495","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Tseng","Chi-Wen","Environmental and Public Health Microbiology Lab (EPHM Lab), Department of Civil Engineering, Monash University, Clayton, Victoria 3800, Australia",NA
"1496","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Henry","Rebekah","Environmental and Public Health Microbiology Lab (EPHM Lab), Department of Civil Engineering, Monash University, Clayton, Victoria 3800, Australia",NA
"1497","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Kolotelo","Peter","Environmental and Public Health Microbiology Lab (EPHM Lab), Department of Civil Engineering, Monash University, Clayton, Victoria 3800, Australia",NA
"1498","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Langeveld","Jeroen","Department of Water Management, TU Delft, Delft, CN 2628, The Netherlands",NA
"1499","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Schilperoort","Remy","Partners4UrbanWater, Nijmegen 6532 ZV, The Netherlands",NA
"1500","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Shi","Baiqian","Environmental and Public Health Microbiology Lab (EPHM Lab), Department of Civil Engineering, Monash University, Clayton, Victoria 3800, Australia",NA
"1501","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Einsiedel","Steve","ALS Hydrographics, 22 Dalmore Drive, Scoresby, Victoria 3179, Australia",NA
"1502","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Thomas","Michael","Barwon Water, 55-67 Ryrie St., Geelong, Victoria 3220, Australia",NA
"1503","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Black","James","Department of Health, Victoria Department of Health and Human Services, 50 Lonsdale St., Melbourne, Victoria 3000, Australia",NA
"1504","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","Wilson","Simon","Melbourne Water Corp., 990 La Trobe St., Docklands, Victoria 3001, Australia",NA
"1505","34264643","10.1021/acs.est.1c01530","Passive Sampling of SARS-CoV-2 for Wastewater Surveillance.","The shedding of pathogens by infected humans enables the use of sewage monitoring to conduct wastewater-based epidemiology (WBE). Although most WBE studies use data from large sewage treatment plants, timely data from smaller catchments are needed for targeted public health action. Traditional sampling methods, like autosamplers or grab sampling, are not conducive to quick ad hoc deployments and high-resolution monitoring at these smaller scales. This study develops and validates a cheap ","2021","07","21","Environ Sci Technol","Environmental science &amp; technology","COVID-19; SARS-CoV-2; coronavirus; pathogens; sampling methods; surveillance; wastewater surveillance; wastewater-based epidemiology (WBE); water","McCarthy","David T","Environmental and Public Health Microbiology Lab (EPHM Lab), Department of Civil Engineering, Monash University, Clayton, Victoria 3800, Australia",NA
"1506","34264614","","Top 20 Research Studies of 2020 for Primary Care Physicians.","This article summarizes the top 20 research studies of 2020 identified as POEMs (patient-oriented evidence that matters), including the two most highly rated guidelines of the year on gout and chronic obstructive pulmonary disease (COPD). Regarding COVID-19, handwashing and social distancing through stay-at-home orders or quarantine measures are effective at slowing the spread of illness. Use of proper face masks (not gaiters or bandanas) is also effective at preventing trans- mission. This is i","2021","07","21","Am Fam Physician","American family physician","Adult; Biomedical Research; COVID-19; Family Practice; Female; Humans; Male; Middle Aged; Musculoskeletal Diseases; Patient-Centered Care; Physicians, Primary Care; Practice Guidelines as Topic; Primary Health Care; Research Report","Grad","Roland","McGill University, Montreal, Quebec, Canada",NA
"1507","34264614","","Top 20 Research Studies of 2020 for Primary Care Physicians.","This article summarizes the top 20 research studies of 2020 identified as POEMs (patient-oriented evidence that matters), including the two most highly rated guidelines of the year on gout and chronic obstructive pulmonary disease (COPD). Regarding COVID-19, handwashing and social distancing through stay-at-home orders or quarantine measures are effective at slowing the spread of illness. Use of proper face masks (not gaiters or bandanas) is also effective at preventing trans- mission. This is i","2021","07","21","Am Fam Physician","American family physician","Adult; Biomedical Research; COVID-19; Family Practice; Female; Humans; Male; Middle Aged; Musculoskeletal Diseases; Patient-Centered Care; Physicians, Primary Care; Practice Guidelines as Topic; Primary Health Care; Research Report","Ebell","Mark H","University of Georgia, Athens, GA, USA",NA
"1508","34264600","","Rapid Point-of-Care Antigen and Molecular Tests for Diagnosis of SARS-CoV-2 Infection.",NA,"2021","07","21","Am Fam Physician","American family physician","Antigens; COVID-19; Humans; Molecular Diagnostic Techniques; Point-of-Care Systems; Practice Guidelines as Topic; Sensitivity and Specificity","Simmons","Sean","Navy Medicine Readiness and Training Command, Portsmouth, VA, USA",NA
"1509","34264600","","Rapid Point-of-Care Antigen and Molecular Tests for Diagnosis of SARS-CoV-2 Infection.",NA,"2021","07","21","Am Fam Physician","American family physician","Antigens; COVID-19; Humans; Molecular Diagnostic Techniques; Point-of-Care Systems; Practice Guidelines as Topic; Sensitivity and Specificity","Saguil","Aaron","Uniformed Services University of the Health Sciences, San Antonio, TX, USA",NA
"1510","34264546","10.1002/pbc.29240","SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.","This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged =16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged =18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief reg","2021","07","15","Pediatr Blood Cancer","Pediatric blood &amp; cancer","COVID-19; SARS-CoV-2; adolescents; cancer; coronavirus; pediatric oncology; refusal; vaccination; young adults","Nigro","Olga","Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"1511","34264546","10.1002/pbc.29240","SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.","This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged =16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged =18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief reg","2021","07","15","Pediatr Blood Cancer","Pediatric blood &amp; cancer","COVID-19; SARS-CoV-2; adolescents; cancer; coronavirus; pediatric oncology; refusal; vaccination; young adults","Sironi","Giovanna","Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"1512","34264546","10.1002/pbc.29240","SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.","This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged =16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged =18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief reg","2021","07","15","Pediatr Blood Cancer","Pediatric blood &amp; cancer","COVID-19; SARS-CoV-2; adolescents; cancer; coronavirus; pediatric oncology; refusal; vaccination; young adults","Bergamaschi","Luca","Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"1513","34264546","10.1002/pbc.29240","SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.","This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged =16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged =18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief reg","2021","07","15","Pediatr Blood Cancer","Pediatric blood &amp; cancer","COVID-19; SARS-CoV-2; adolescents; cancer; coronavirus; pediatric oncology; refusal; vaccination; young adults","Gattuso","Giovanna","Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"1514","34264546","10.1002/pbc.29240","SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.","This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged =16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged =18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief reg","2021","07","15","Pediatr Blood Cancer","Pediatric blood &amp; cancer","COVID-19; SARS-CoV-2; adolescents; cancer; coronavirus; pediatric oncology; refusal; vaccination; young adults","Puma","Nadia","Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"1515","34264546","10.1002/pbc.29240","SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.","This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged =16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged =18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief reg","2021","07","15","Pediatr Blood Cancer","Pediatric blood &amp; cancer","COVID-19; SARS-CoV-2; adolescents; cancer; coronavirus; pediatric oncology; refusal; vaccination; young adults","Livellara","Virginia","Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"1516","34264546","10.1002/pbc.29240","SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.","This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged =16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged =18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief reg","2021","07","15","Pediatr Blood Cancer","Pediatric blood &amp; cancer","COVID-19; SARS-CoV-2; adolescents; cancer; coronavirus; pediatric oncology; refusal; vaccination; young adults","Chiaravalli","Stefano","Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"1517","34264546","10.1002/pbc.29240","SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.","This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged =16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged =18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief reg","2021","07","15","Pediatr Blood Cancer","Pediatric blood &amp; cancer","COVID-19; SARS-CoV-2; adolescents; cancer; coronavirus; pediatric oncology; refusal; vaccination; young adults","Ferrari","Andrea","Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"1518","34264546","10.1002/pbc.29240","SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.","This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged =16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged =18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief reg","2021","07","15","Pediatr Blood Cancer","Pediatric blood &amp; cancer","COVID-19; SARS-CoV-2; adolescents; cancer; coronavirus; pediatric oncology; refusal; vaccination; young adults","Massimino","Maura","Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"1519","34264528","10.1002/jmv.27203","Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis.","To systematically evaluate the effectiveness and safety of the SARS-CoV-2 vaccines currently undergoing clinical trials. Search PubMed, EMBASE, Cochrane Library database, collect open human COVID-19 vaccines randomized controlled trials (RCT), without limiting the search time and language. The researches collected in the above-mentioned databases were merged, repeated researches were removed, and the researches were initially screened according to the title and abstract content. After reading th","2021","07","15","J Med Virol","Journal of medical virology","Effectiveness; Meta-Analysis; SARS-CoV-2 Vaccines; Safety; Systematic Review","Ling","Yunzhi","Center Lab of Longhua Branch and Department of Infectious Disease, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, 518020, PR China",NA
"1520","34264528","10.1002/jmv.27203","Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis.","To systematically evaluate the effectiveness and safety of the SARS-CoV-2 vaccines currently undergoing clinical trials. Search PubMed, EMBASE, Cochrane Library database, collect open human COVID-19 vaccines randomized controlled trials (RCT), without limiting the search time and language. The researches collected in the above-mentioned databases were merged, repeated researches were removed, and the researches were initially screened according to the title and abstract content. After reading th","2021","07","15","J Med Virol","Journal of medical virology","Effectiveness; Meta-Analysis; SARS-CoV-2 Vaccines; Safety; Systematic Review","Zhong","Jiaying","Research center of Algae company, Guangzhou, China, 510720",NA
"1521","34264528","10.1002/jmv.27203","Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis.","To systematically evaluate the effectiveness and safety of the SARS-CoV-2 vaccines currently undergoing clinical trials. Search PubMed, EMBASE, Cochrane Library database, collect open human COVID-19 vaccines randomized controlled trials (RCT), without limiting the search time and language. The researches collected in the above-mentioned databases were merged, repeated researches were removed, and the researches were initially screened according to the title and abstract content. After reading th","2021","07","15","J Med Virol","Journal of medical virology","Effectiveness; Meta-Analysis; SARS-CoV-2 Vaccines; Safety; Systematic Review","Luo","Jiaru","Research center of Algae company, Guangzhou, China, 510720",NA
"1522","34264527","10.1002/jmv.27206","Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients.","Severe acute respiratory syndrome coronavirus (SARS-CoV-2) has affected all inhabited continents, and India is currently experiencing a devastating second wave of coronavirus disease-2019 (COVID-19). Here, we examined the duration of clearance of SARS-CoV-2 in respiratory samples from 207 infected cases by real-time reverse-transcription polymerase chain reaction (RT-PCR). A substantial proportion of COVID-19 positive cases with cycle threshold (Ct) values more than or equal to 31 (45.7%) were s","2021","07","23","J Med Virol","Journal of medical virology","COVID 19; RT-PCR; SARS-CoV-2; cycle threshold value; isolation","Aranha","Clara","Department of Molecular Immunology and Microbiology, ICMR- National Institute for Research in Reproductive Health, Mumbai, India",NA
"1523","34264527","10.1002/jmv.27206","Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients.","Severe acute respiratory syndrome coronavirus (SARS-CoV-2) has affected all inhabited continents, and India is currently experiencing a devastating second wave of coronavirus disease-2019 (COVID-19). Here, we examined the duration of clearance of SARS-CoV-2 in respiratory samples from 207 infected cases by real-time reverse-transcription polymerase chain reaction (RT-PCR). A substantial proportion of COVID-19 positive cases with cycle threshold (Ct) values more than or equal to 31 (45.7%) were s","2021","07","23","J Med Virol","Journal of medical virology","COVID 19; RT-PCR; SARS-CoV-2; cycle threshold value; isolation","Patel","Vainav","Department of Biochemistry &amp",NA
"1524","34264527","10.1002/jmv.27206","Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients.","Severe acute respiratory syndrome coronavirus (SARS-CoV-2) has affected all inhabited continents, and India is currently experiencing a devastating second wave of coronavirus disease-2019 (COVID-19). Here, we examined the duration of clearance of SARS-CoV-2 in respiratory samples from 207 infected cases by real-time reverse-transcription polymerase chain reaction (RT-PCR). A substantial proportion of COVID-19 positive cases with cycle threshold (Ct) values more than or equal to 31 (45.7%) were s","2021","07","23","J Med Virol","Journal of medical virology","COVID 19; RT-PCR; SARS-CoV-2; cycle threshold value; isolation","Bhor","Vikrant","Department of Molecular Immunology and Microbiology, ICMR- National Institute for Research in Reproductive Health, Mumbai, India",NA
"1525","34264527","10.1002/jmv.27206","Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients.","Severe acute respiratory syndrome coronavirus (SARS-CoV-2) has affected all inhabited continents, and India is currently experiencing a devastating second wave of coronavirus disease-2019 (COVID-19). Here, we examined the duration of clearance of SARS-CoV-2 in respiratory samples from 207 infected cases by real-time reverse-transcription polymerase chain reaction (RT-PCR). A substantial proportion of COVID-19 positive cases with cycle threshold (Ct) values more than or equal to 31 (45.7%) were s","2021","07","23","J Med Virol","Journal of medical virology","COVID 19; RT-PCR; SARS-CoV-2; cycle threshold value; isolation","Gogoi","Dimpu","Department of Biochemistry &amp",NA
"1526","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Smith","Ignacio","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnologia, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1527","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Mc Callum","Gregorio Juan","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnologia, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1528","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Sabljic","Adriana Victoria","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1529","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Marfia","Juan Ignacio","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1530","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Bombicino","Silvina Sonia","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1531","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Trabucchi","Aldana","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1532","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Iacono","Ruben Francisco","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1533","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Birenbaum","Joaquín Manuel","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnologia, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1534","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Vazquez","Susana Claudia","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnologia, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1535","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Minoia","Juan Mauricio","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnologia, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1536","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Cascone","Osvaldo","Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Universidad de Buenos Aires, Instituto de Nanobiotecnología (NANOBIOTEC), Buenos Aires, Argentina",NA
"1537","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","López","María Gabriela","Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina",NA
"1538","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Taboga","Oscar","Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina",NA
"1539","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Targovnik","Alexandra Marisa","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnologia, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1540","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Wolman","Federico Javier","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnologia, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1541","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Fingermann","Matías","Instituto Nacional de Producción de Biológicos (INPB), ANLIS ""Dr. Carlos G. Malbrán"", Buenos Aires, Argentina",NA
"1542","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Alonso","Leonardo Gabriel","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnologia, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1543","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Valdez","Silvina Noemí","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1544","34264519","10.1002/bit.27889","Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.","Serology testing for COVID-19 is important in evaluating active immune response against SARS-CoV-2, studying the antibody kinetics, and monitoring reinfections with genetic variants and new virus strains, in particular, the duration of antibodies in virus-exposed individuals and vaccine-mediated immunity. In this study, recombinant S protein of SARS-CoV-2 was expressed in Rachiplusia nu, an important agronomic plague. One gram of insect larvae produces an amount of S protein sufficient for 150 d","2021","07","23","Biotechnol Bioeng","Biotechnology and bioengineering","ELISA; SARS-CoV-2 coronavirus; antibodies; insect larvae; trimeric spike","Miranda","María Victoria","Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnologia, Universidad de Buenos Aires, Buenos Aires, Argentina",NA
"1545","34264514","10.1007/s12185-021-03190-y","Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.","Thrombotic thrombocytopenic purpura (TTP) is a known menace in hematology and is quite rare in practice with known triggers. Lately, in the COVID-19 pandemic, hematology has seen a new pathology amongst which TTP associated with COVID-19 messenger RNA (mRNA) vaccine is unique. We report a case of a 69-year-old male with multiple comorbidities who presented to the hospital with severe fatigue and shortness of breath. Labs were significant for thrombocytopenia, anemia, and hemolysis with schistocy","2021","07","20","Int J Hematol","International journal of hematology","COVID-19; TTP; Thrombocytopenia; Thrombosis; Vaccine","Waqar","Syed Hamza Bin","Department of Internal Medicine, Downstate Medical Center, State University of New York (SUNY), 186 Lenox Rd, Apartment 1H, NYC, Brooklyn, NY, 11226, USA. Syed.waqar@downstate","Syed.waqar@downstate.edu"
"1546","34264514","10.1007/s12185-021-03190-y","Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.","Thrombotic thrombocytopenic purpura (TTP) is a known menace in hematology and is quite rare in practice with known triggers. Lately, in the COVID-19 pandemic, hematology has seen a new pathology amongst which TTP associated with COVID-19 messenger RNA (mRNA) vaccine is unique. We report a case of a 69-year-old male with multiple comorbidities who presented to the hospital with severe fatigue and shortness of breath. Labs were significant for thrombocytopenia, anemia, and hemolysis with schistocy","2021","07","20","Int J Hematol","International journal of hematology","COVID-19; TTP; Thrombocytopenia; Thrombosis; Vaccine","Khan","Anosh Aslam","Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan",NA
"1547","34264514","10.1007/s12185-021-03190-y","Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.","Thrombotic thrombocytopenic purpura (TTP) is a known menace in hematology and is quite rare in practice with known triggers. Lately, in the COVID-19 pandemic, hematology has seen a new pathology amongst which TTP associated with COVID-19 messenger RNA (mRNA) vaccine is unique. We report a case of a 69-year-old male with multiple comorbidities who presented to the hospital with severe fatigue and shortness of breath. Labs were significant for thrombocytopenia, anemia, and hemolysis with schistocy","2021","07","20","Int J Hematol","International journal of hematology","COVID-19; TTP; Thrombocytopenia; Thrombosis; Vaccine","Memon","Shehzeen","Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan",NA
"1548","34264507","10.1007/s43678-021-00146-3","Professional development during a pandemic: a live virtual conference for emergency medicine chief residents.","Limited professional development training exists for chief residents. The available training uses in-person lectures and workshops at annual national conferences. The COVID-19 pandemic prevented most in-person gatherings in 2020, including pivotal onboarding and training events for new chief residents. However, for the last five years, Academic Life in Emergency Medicine's Chief Resident Incubator conducted year-long remote training programs, creating virtual communities of practice for chief re","2021","07","20","CJEM","CJEM","Chief resident; Professional development; Virtual learning","Zaver","Fareen","Department of Emergency Medicine, University of Calgary, Foothills Medical Center, C231, 1403-29th Street NW, Calgary, AB, T2N 2T9, Canada. fzaver@gmail","fzaver@gmail.com"
"1549","34264507","10.1007/s43678-021-00146-3","Professional development during a pandemic: a live virtual conference for emergency medicine chief residents.","Limited professional development training exists for chief residents. The available training uses in-person lectures and workshops at annual national conferences. The COVID-19 pandemic prevented most in-person gatherings in 2020, including pivotal onboarding and training events for new chief residents. However, for the last five years, Academic Life in Emergency Medicine's Chief Resident Incubator conducted year-long remote training programs, creating virtual communities of practice for chief re","2021","07","20","CJEM","CJEM","Chief resident; Professional development; Virtual learning","Battaglioli","Nicole","Department of Emergency Medicine, Emory University, Atlanta, GA, USA",NA
"1550","34264507","10.1007/s43678-021-00146-3","Professional development during a pandemic: a live virtual conference for emergency medicine chief residents.","Limited professional development training exists for chief residents. The available training uses in-person lectures and workshops at annual national conferences. The COVID-19 pandemic prevented most in-person gatherings in 2020, including pivotal onboarding and training events for new chief residents. However, for the last five years, Academic Life in Emergency Medicine's Chief Resident Incubator conducted year-long remote training programs, creating virtual communities of practice for chief re","2021","07","20","CJEM","CJEM","Chief resident; Professional development; Virtual learning","Rose","Christian C","Center for Health Policy, Freeman Spogli Institute for International Studies and Center for Primary Care &amp",NA
"1551","34264507","10.1007/s43678-021-00146-3","Professional development during a pandemic: a live virtual conference for emergency medicine chief residents.","Limited professional development training exists for chief residents. The available training uses in-person lectures and workshops at annual national conferences. The COVID-19 pandemic prevented most in-person gatherings in 2020, including pivotal onboarding and training events for new chief residents. However, for the last five years, Academic Life in Emergency Medicine's Chief Resident Incubator conducted year-long remote training programs, creating virtual communities of practice for chief re","2021","07","20","CJEM","CJEM","Chief resident; Professional development; Virtual learning","Montrief","Tim","Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA",NA
"1552","34264507","10.1007/s43678-021-00146-3","Professional development during a pandemic: a live virtual conference for emergency medicine chief residents.","Limited professional development training exists for chief residents. The available training uses in-person lectures and workshops at annual national conferences. The COVID-19 pandemic prevented most in-person gatherings in 2020, including pivotal onboarding and training events for new chief residents. However, for the last five years, Academic Life in Emergency Medicine's Chief Resident Incubator conducted year-long remote training programs, creating virtual communities of practice for chief re","2021","07","20","CJEM","CJEM","Chief resident; Professional development; Virtual learning","Alvarez","Al'ai","Department of Emergency Medicine, Stanford University School of Medicine, Stanford, CA, USA",NA
"1553","34264507","10.1007/s43678-021-00146-3","Professional development during a pandemic: a live virtual conference for emergency medicine chief residents.","Limited professional development training exists for chief residents. The available training uses in-person lectures and workshops at annual national conferences. The COVID-19 pandemic prevented most in-person gatherings in 2020, including pivotal onboarding and training events for new chief residents. However, for the last five years, Academic Life in Emergency Medicine's Chief Resident Incubator conducted year-long remote training programs, creating virtual communities of practice for chief re","2021","07","20","CJEM","CJEM","Chief resident; Professional development; Virtual learning","Lin","Michelle","Department of Emergency Medicine, University of California San Francisco, San Francisco, CA, USA",NA
"1554","34264506","10.1007/s40615-021-01093-6","COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfizer-BioNTech and Moderna Vaccines Among Community Healthcare Workers.","The health and economic ramifications of the coronavirus pandemic have prompted the need for a timely and effective vaccine development. While the rollout of the COVID-19 vaccine in record time is being hailed as a scientific feat, skepticism about the safety, side effects, and even its long-term effects remain. Acceptance of the vaccine may therefore be a challenge among healthcare workers (HCWs), whose role is considered a proxy to determining the COVID-19 vaccine uptake response by the genera","2021","07","20","J Racial Ethn Health Disparities","Journal of racial and ethnic health disparities","COVID-19; COVID-19 vaccine; Healthcare workers; Vaccine hesitance; Vaccine uptake","Famuyiro","Tolulope B","Department of Family and Community Medicine, The University of Texas McGovern Medical School, Houston, TX, USA. Tolulope.b.akintide@uth.tmc","Tolulope.b.akintide@uth.tmc.edu"
"1555","34264506","10.1007/s40615-021-01093-6","COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfizer-BioNTech and Moderna Vaccines Among Community Healthcare Workers.","The health and economic ramifications of the coronavirus pandemic have prompted the need for a timely and effective vaccine development. While the rollout of the COVID-19 vaccine in record time is being hailed as a scientific feat, skepticism about the safety, side effects, and even its long-term effects remain. Acceptance of the vaccine may therefore be a challenge among healthcare workers (HCWs), whose role is considered a proxy to determining the COVID-19 vaccine uptake response by the genera","2021","07","20","J Racial Ethn Health Disparities","Journal of racial and ethnic health disparities","COVID-19; COVID-19 vaccine; Healthcare workers; Vaccine hesitance; Vaccine uptake","Ogunwale","Abayomi","Department of Family and Community Medicine, The University of Texas McGovern Medical School, Houston, TX, USA",NA
"1556","34264506","10.1007/s40615-021-01093-6","COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfizer-BioNTech and Moderna Vaccines Among Community Healthcare Workers.","The health and economic ramifications of the coronavirus pandemic have prompted the need for a timely and effective vaccine development. While the rollout of the COVID-19 vaccine in record time is being hailed as a scientific feat, skepticism about the safety, side effects, and even its long-term effects remain. Acceptance of the vaccine may therefore be a challenge among healthcare workers (HCWs), whose role is considered a proxy to determining the COVID-19 vaccine uptake response by the genera","2021","07","20","J Racial Ethn Health Disparities","Journal of racial and ethnic health disparities","COVID-19; COVID-19 vaccine; Healthcare workers; Vaccine hesitance; Vaccine uptake","des Bordes","Jude","Department of Family and Community Medicine, The University of Texas McGovern Medical School, Houston, TX, USA",NA
"1557","34264506","10.1007/s40615-021-01093-6","COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfizer-BioNTech and Moderna Vaccines Among Community Healthcare Workers.","The health and economic ramifications of the coronavirus pandemic have prompted the need for a timely and effective vaccine development. While the rollout of the COVID-19 vaccine in record time is being hailed as a scientific feat, skepticism about the safety, side effects, and even its long-term effects remain. Acceptance of the vaccine may therefore be a challenge among healthcare workers (HCWs), whose role is considered a proxy to determining the COVID-19 vaccine uptake response by the genera","2021","07","20","J Racial Ethn Health Disparities","Journal of racial and ethnic health disparities","COVID-19; COVID-19 vaccine; Healthcare workers; Vaccine hesitance; Vaccine uptake","Raji","Mukaila","Division of Geriatrics and Palliative Medicine Department of Internal Medicine Department of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston, TX, USA",NA
"1558","34264498","10.1007/s11356-021-15374-4","SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater.","The current outbreak of coronavirus disease (COVID-19) has led to creating a public health emergency conditions since 2019. COVID-19, which is caused by SARS-CoV-2, is spread via human-to-human transmission by direct contact or droplets. Through conducting this study, we were looking for detecting SARS-CoV-2 in wastewater produced in Iran country (Ardabil, Nir, Khalkhal, and Kowsar) (wastewater collection network, wastewater treatment plant, and hospital wastewater). In this research, samples (n","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international","Collection network; Coronavirus; Hospital wastewater; Municipal wastewater; SARS-CoV-2; Wastewater treatment plant","Karami","Chiman","Department of Microbiology, Parasitology and Immunology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran",NA
"1559","34264498","10.1007/s11356-021-15374-4","SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater.","The current outbreak of coronavirus disease (COVID-19) has led to creating a public health emergency conditions since 2019. COVID-19, which is caused by SARS-CoV-2, is spread via human-to-human transmission by direct contact or droplets. Through conducting this study, we were looking for detecting SARS-CoV-2 in wastewater produced in Iran country (Ardabil, Nir, Khalkhal, and Kowsar) (wastewater collection network, wastewater treatment plant, and hospital wastewater). In this research, samples (n","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international","Collection network; Coronavirus; Hospital wastewater; Municipal wastewater; SARS-CoV-2; Wastewater treatment plant","Dargahi","Abdollah","Social Determinants of Health Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. a.dargahi29@yahoo","a.dargahi29@yahoo.com"
"1560","34264498","10.1007/s11356-021-15374-4","SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater.","The current outbreak of coronavirus disease (COVID-19) has led to creating a public health emergency conditions since 2019. COVID-19, which is caused by SARS-CoV-2, is spread via human-to-human transmission by direct contact or droplets. Through conducting this study, we were looking for detecting SARS-CoV-2 in wastewater produced in Iran country (Ardabil, Nir, Khalkhal, and Kowsar) (wastewater collection network, wastewater treatment plant, and hospital wastewater). In this research, samples (n","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international","Collection network; Coronavirus; Hospital wastewater; Municipal wastewater; SARS-CoV-2; Wastewater treatment plant","Vosoughi","Mehdi","Social Determinants of Health Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. mvn_20@yahoo",NA
"1561","34264498","10.1007/s11356-021-15374-4","SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater.","The current outbreak of coronavirus disease (COVID-19) has led to creating a public health emergency conditions since 2019. COVID-19, which is caused by SARS-CoV-2, is spread via human-to-human transmission by direct contact or droplets. Through conducting this study, we were looking for detecting SARS-CoV-2 in wastewater produced in Iran country (Ardabil, Nir, Khalkhal, and Kowsar) (wastewater collection network, wastewater treatment plant, and hospital wastewater). In this research, samples (n","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international","Collection network; Coronavirus; Hospital wastewater; Municipal wastewater; SARS-CoV-2; Wastewater treatment plant","Normohammadi","Ali","Department of Environmental Health Engineering, School of Public Health, Ardabil University of Medical Sciences, Ardabil, Iran",NA
"1562","34264498","10.1007/s11356-021-15374-4","SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater.","The current outbreak of coronavirus disease (COVID-19) has led to creating a public health emergency conditions since 2019. COVID-19, which is caused by SARS-CoV-2, is spread via human-to-human transmission by direct contact or droplets. Through conducting this study, we were looking for detecting SARS-CoV-2 in wastewater produced in Iran country (Ardabil, Nir, Khalkhal, and Kowsar) (wastewater collection network, wastewater treatment plant, and hospital wastewater). In this research, samples (n","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international","Collection network; Coronavirus; Hospital wastewater; Municipal wastewater; SARS-CoV-2; Wastewater treatment plant","Jeddi","Farhad","Department of Genetics and Pathology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran",NA
"1563","34264498","10.1007/s11356-021-15374-4","SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater.","The current outbreak of coronavirus disease (COVID-19) has led to creating a public health emergency conditions since 2019. COVID-19, which is caused by SARS-CoV-2, is spread via human-to-human transmission by direct contact or droplets. Through conducting this study, we were looking for detecting SARS-CoV-2 in wastewater produced in Iran country (Ardabil, Nir, Khalkhal, and Kowsar) (wastewater collection network, wastewater treatment plant, and hospital wastewater). In this research, samples (n","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international","Collection network; Coronavirus; Hospital wastewater; Municipal wastewater; SARS-CoV-2; Wastewater treatment plant","Asghariazar","Vahid","Immunology Research Center, Ardabil University of Medical Sciences, Ardabil, Iran",NA
"1564","34264498","10.1007/s11356-021-15374-4","SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater.","The current outbreak of coronavirus disease (COVID-19) has led to creating a public health emergency conditions since 2019. COVID-19, which is caused by SARS-CoV-2, is spread via human-to-human transmission by direct contact or droplets. Through conducting this study, we were looking for detecting SARS-CoV-2 in wastewater produced in Iran country (Ardabil, Nir, Khalkhal, and Kowsar) (wastewater collection network, wastewater treatment plant, and hospital wastewater). In this research, samples (n","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international","Collection network; Coronavirus; Hospital wastewater; Municipal wastewater; SARS-CoV-2; Wastewater treatment plant","Mokhtari","Ahamad","Department of Environmental Health Engineering, School of Public Health, Ardabil University of Medical Sciences, Ardabil, Iran",NA
"1565","34264498","10.1007/s11356-021-15374-4","SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater.","The current outbreak of coronavirus disease (COVID-19) has led to creating a public health emergency conditions since 2019. COVID-19, which is caused by SARS-CoV-2, is spread via human-to-human transmission by direct contact or droplets. Through conducting this study, we were looking for detecting SARS-CoV-2 in wastewater produced in Iran country (Ardabil, Nir, Khalkhal, and Kowsar) (wastewater collection network, wastewater treatment plant, and hospital wastewater). In this research, samples (n","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international","Collection network; Coronavirus; Hospital wastewater; Municipal wastewater; SARS-CoV-2; Wastewater treatment plant","Sedigh","Anoshirvan","Department of Environmental Health Engineering, School of Public Health, Ardabil University of Medical Sciences, Ardabil, Iran",NA
"1566","34264498","10.1007/s11356-021-15374-4","SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater.","The current outbreak of coronavirus disease (COVID-19) has led to creating a public health emergency conditions since 2019. COVID-19, which is caused by SARS-CoV-2, is spread via human-to-human transmission by direct contact or droplets. Through conducting this study, we were looking for detecting SARS-CoV-2 in wastewater produced in Iran country (Ardabil, Nir, Khalkhal, and Kowsar) (wastewater collection network, wastewater treatment plant, and hospital wastewater). In this research, samples (n","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international","Collection network; Coronavirus; Hospital wastewater; Municipal wastewater; SARS-CoV-2; Wastewater treatment plant","Zandian","Hamed","Social Determinants of Health Research Center, Ardabil University of Medical Sciences, Ardabil, Iran",NA
"1567","34264498","10.1007/s11356-021-15374-4","SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater.","The current outbreak of coronavirus disease (COVID-19) has led to creating a public health emergency conditions since 2019. COVID-19, which is caused by SARS-CoV-2, is spread via human-to-human transmission by direct contact or droplets. Through conducting this study, we were looking for detecting SARS-CoV-2 in wastewater produced in Iran country (Ardabil, Nir, Khalkhal, and Kowsar) (wastewater collection network, wastewater treatment plant, and hospital wastewater). In this research, samples (n","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international","Collection network; Coronavirus; Hospital wastewater; Municipal wastewater; SARS-CoV-2; Wastewater treatment plant","Alighadri","Morteza","Department of Environmental Health Engineering, School of Public Health, Ardabil University of Medical Sciences, Ardabil, Iran",NA
"1568","34264495","10.1007/s11356-021-15004-z","Environmental concerns and pollution control in the context of developing countries.","In the developing countries, the pace of change-in vital technologies, in scientific research, in economic fundamentals, in the living environment, and in pursuing quality of life-is accelerating every day, propelled by continuous changes in technology innovation, human activities, and the rapidly evolving demands of the COVID-19 pandemic. This special issue (SI) of Environmental Science and Pollution Research (ESPR) collected 17 peer-reviewed articles relating to green buildings research, the i","2021","07","20","Environ Sci Pollut Res Int","Environmental science and pollution research international",NA,"Weng","Chih-Huang","Department of Civil Engineering, I-Shou University, Kaohsiung, Taiwan. chweng@isu.edu","chweng@isu.edu.tw"
"1569","34264472","10.1007/s10877-021-00744-7","Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests.","Abnormal coagulation parameters are often observed in patients with coronavirus disease 2019 (COVID-19) and the severity of derangement has been associated with a poor prognosis. The COVID-19 associated coagulopathy (CAC) displays unique features that include a high risk of developing thromboembolic complications. Viscoelastic tests (VETs), such as thromboelastometry (ROTEM), thromboelastography (TEG) and Quantra Hemostasis Analyzer (Quantra), provide ""dynamic"" data on clot formation and dissolu","2021","07","20","J Clin Monit Comput","Journal of clinical monitoring and computing","COVID-19; Coagulopathy; Thromboembolic events; Viscoelastic tests","Pavoni","Vittorio","Emergency Department and Critical Care Area, Anesthesia and Intensive Care Unit, Santa Maria Annunziata Hospital, Bagno a Ripoli, Florence, Italy",NA
"1570","34264472","10.1007/s10877-021-00744-7","Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests.","Abnormal coagulation parameters are often observed in patients with coronavirus disease 2019 (COVID-19) and the severity of derangement has been associated with a poor prognosis. The COVID-19 associated coagulopathy (CAC) displays unique features that include a high risk of developing thromboembolic complications. Viscoelastic tests (VETs), such as thromboelastometry (ROTEM), thromboelastography (TEG) and Quantra Hemostasis Analyzer (Quantra), provide ""dynamic"" data on clot formation and dissolu","2021","07","20","J Clin Monit Comput","Journal of clinical monitoring and computing","COVID-19; Coagulopathy; Thromboembolic events; Viscoelastic tests","Gianesello","Lara","Department of Anesthesia and Intensive Care, Orthopedic Anesthesia, University-Hospital Careggi, Largo Palagi, 1, 50139, Florence, Italy. gianesello.lara@libero","gianesello.lara@libero.it"
"1571","34264472","10.1007/s10877-021-00744-7","Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests.","Abnormal coagulation parameters are often observed in patients with coronavirus disease 2019 (COVID-19) and the severity of derangement has been associated with a poor prognosis. The COVID-19 associated coagulopathy (CAC) displays unique features that include a high risk of developing thromboembolic complications. Viscoelastic tests (VETs), such as thromboelastometry (ROTEM), thromboelastography (TEG) and Quantra Hemostasis Analyzer (Quantra), provide ""dynamic"" data on clot formation and dissolu","2021","07","20","J Clin Monit Comput","Journal of clinical monitoring and computing","COVID-19; Coagulopathy; Thromboembolic events; Viscoelastic tests","Pazzi","Maddalena","Emergency Department and Critical Care Area, Anesthesia and Intensive Care Unit, Santa Maria Annunziata Hospital, Bagno a Ripoli, Florence, Italy",NA
"1572","34264472","10.1007/s10877-021-00744-7","Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests.","Abnormal coagulation parameters are often observed in patients with coronavirus disease 2019 (COVID-19) and the severity of derangement has been associated with a poor prognosis. The COVID-19 associated coagulopathy (CAC) displays unique features that include a high risk of developing thromboembolic complications. Viscoelastic tests (VETs), such as thromboelastometry (ROTEM), thromboelastography (TEG) and Quantra Hemostasis Analyzer (Quantra), provide ""dynamic"" data on clot formation and dissolu","2021","07","20","J Clin Monit Comput","Journal of clinical monitoring and computing","COVID-19; Coagulopathy; Thromboembolic events; Viscoelastic tests","Dattolo","Pietro","Nephrology Unit Florence 1, Santa Maria Annunziata Hospital, Bagno a Ripoli, Florence, Italy",NA
"1573","34264472","10.1007/s10877-021-00744-7","Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests.","Abnormal coagulation parameters are often observed in patients with coronavirus disease 2019 (COVID-19) and the severity of derangement has been associated with a poor prognosis. The COVID-19 associated coagulopathy (CAC) displays unique features that include a high risk of developing thromboembolic complications. Viscoelastic tests (VETs), such as thromboelastometry (ROTEM), thromboelastography (TEG) and Quantra Hemostasis Analyzer (Quantra), provide ""dynamic"" data on clot formation and dissolu","2021","07","20","J Clin Monit Comput","Journal of clinical monitoring and computing","COVID-19; Coagulopathy; Thromboembolic events; Viscoelastic tests","Prisco","Domenico","Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy",NA
"1574","34264419","10.1007/s11604-021-01170-0","Letter to the Editor concerning: pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19.",NA,"2021","07","20","Jpn J Radiol","Japanese journal of radiology",NA,"Lozano-Carrillo","Luis Carlos","School of Medicine, Human Anatomy Department, Universidad Autonoma de Nuevo Leon, Ave. Madero y Dr. Eduardo Aguirre Pequeño s/n, Col. Mitras Centro, 64460, Monterrey, Nuevo León, México",NA
"1575","34264419","10.1007/s11604-021-01170-0","Letter to the Editor concerning: pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19.",NA,"2021","07","20","Jpn J Radiol","Japanese journal of radiology",NA,"Hernández-Garate","Yenitzeh Ana Karen","School of Medicine, Human Anatomy Department, Universidad Autonoma de Nuevo Leon, Ave. Madero y Dr. Eduardo Aguirre Pequeño s/n, Col. Mitras Centro, 64460, Monterrey, Nuevo León, México",NA
"1576","34264419","10.1007/s11604-021-01170-0","Letter to the Editor concerning: pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19.",NA,"2021","07","20","Jpn J Radiol","Japanese journal of radiology",NA,"Quiroga-Garza","Alejandro","School of Medicine, Human Anatomy Department, Universidad Autonoma de Nuevo Leon, Ave. Madero y Dr. Eduardo Aguirre Pequeño s/n, Col. Mitras Centro, 64460, Monterrey, Nuevo León, México",NA
"1577","34264419","10.1007/s11604-021-01170-0","Letter to the Editor concerning: pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19.",NA,"2021","07","20","Jpn J Radiol","Japanese journal of radiology",NA,"Elizondo-Omaña","Rodrigo Enrique","School of Medicine, Human Anatomy Department, Universidad Autonoma de Nuevo Leon, Ave. Madero y Dr. Eduardo Aguirre Pequeño s/n, Col. Mitras Centro, 64460, Monterrey, Nuevo León, México",NA
"1578","34264419","10.1007/s11604-021-01170-0","Letter to the Editor concerning: pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19.",NA,"2021","07","20","Jpn J Radiol","Japanese journal of radiology",NA,"Guzman-Lopez","Santos","School of Medicine, Human Anatomy Department, Universidad Autonoma de Nuevo Leon, Ave. Madero y Dr. Eduardo Aguirre Pequeño s/n, Col. Mitras Centro, 64460, Monterrey, Nuevo León, México. dr.santos.anato@gmail","dr.santos.anato@gmail.com"
"1579","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Dono","Fedele","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy. fedele.dono@unich","fedele.dono@unich.it"
"1580","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Consoli","Stefano","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy",NA
"1581","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Evangelista","Giacomo","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy",NA
"1582","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","D'Apolito","Maria","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy",NA
"1583","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Russo","Mirella","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy",NA
"1584","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Carrarini","Claudia","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy",NA
"1585","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Calisi","Dario","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy",NA
"1586","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","De Rosa","Matteo","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy",NA
"1587","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Di Pietro","Martina","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy",NA
"1588","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","De Angelis","Maria Vittoria","Department of Neurology, Stroke Unit, SS Annunziata Hospital, Chieti, Italy",NA
"1589","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Travaglini","Daniela","Department of Neurology, Headache Center, SS Annunziata Hospital, Chieti, Italy",NA
"1590","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Sensi","Stefano L","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy",NA
"1591","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Onofrj","Marco","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy",NA
"1592","34264414","10.1007/s10072-021-05444-3","New daily persistent headache after SARS-CoV-2 infection: a report of two cases.","The 2019 Coronavirus (SARS-CoV-2) is a novel respiratory virus which causes Coronavirus Disease19 (COVID-19). Although the predominant clinical picture of COVID-19 is represented by respiratory symptoms, neurological manifestations are being increasingly recognized. Headache, in particular migraine-like and tension types, has been largely reported in patients suffering from COVID-19 both in the acute and the healing phase of the infection. New daily persistent headache (NDPH) is a primary headac","2021","07","20","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Headache; Immunotherapy; Neuroinflammation; Pandemic; Steroid","Bonanni","Laura","Department of Neuroscience, Imaging and Clinical Science, ""G. d'Annunzio"" University of Chieti-Pescara, Chieti, Italy. l.bonanni@unich","l.bonanni@unich.it"
"1593","34264411","10.1007/s10198-021-01346-5","How the COVID-19 pandemic can distort risk adjustment of health plan payment.","The COVID-19 pandemic has led to disruptions in healthcare utilization and spending. While some changes might persist (e.g. substitution of specialist visits by online consultations), others will be transitory (e.g. fewer surgical procedures due to cancellation of treatments). This paper discusses the implications of transitory changes in healthcare utilization and spending for risk adjustment of health plan payment. In practice, risk adjustment methodologies typically consist of two steps: (1) ","2021","07","20","Eur J Health Econ","The European journal of health economics : HEPAC : health economics in prevention and care","COVID-19; Health insurance; Risk adjustment","van Kleef","Richard C","Erasmus School of Health Policy &amp","vankleef@eshpm.eur.nl"
"1594","34264411","10.1007/s10198-021-01346-5","How the COVID-19 pandemic can distort risk adjustment of health plan payment.","The COVID-19 pandemic has led to disruptions in healthcare utilization and spending. While some changes might persist (e.g. substitution of specialist visits by online consultations), others will be transitory (e.g. fewer surgical procedures due to cancellation of treatments). This paper discusses the implications of transitory changes in healthcare utilization and spending for risk adjustment of health plan payment. In practice, risk adjustment methodologies typically consist of two steps: (1) ","2021","07","20","Eur J Health Econ","The European journal of health economics : HEPAC : health economics in prevention and care","COVID-19; Health insurance; Risk adjustment","Reuser","Mieke","Erasmus School of Health Policy &amp",NA
"1595","34264384","10.1007/s00540-021-02974-0","Tocilizumab in patients with COVID-19: which patient, time, and dose?","Tocilizumab (TCZ) is a recombinant anti-interleukin-6 monoclonal antibody which showed uprising evidence as an anti-inflammatory agent which modulates the cytokine storm in patients with COVID-19. However, proper use of the drug requires selection of the appropriate patient and timing. The two main factors which might improve patient selection are the degree of respiratory failure and systemic inflammation. TCZ can decrease the mortality and progression to invasive mechanical ventilation in pati","2021","07","20","J Anesth","Journal of anesthesia","COVID-19; SARS-CoV-2; Tocilizumab","Hasanin","Ahmed","Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, 01 elsarayah street, Elmanyal, Cairo, Egypt. ahmedmohamedhasanin@gmail","ahmedmohamedhasanin@gmail.com"
"1596","34264384","10.1007/s00540-021-02974-0","Tocilizumab in patients with COVID-19: which patient, time, and dose?","Tocilizumab (TCZ) is a recombinant anti-interleukin-6 monoclonal antibody which showed uprising evidence as an anti-inflammatory agent which modulates the cytokine storm in patients with COVID-19. However, proper use of the drug requires selection of the appropriate patient and timing. The two main factors which might improve patient selection are the degree of respiratory failure and systemic inflammation. TCZ can decrease the mortality and progression to invasive mechanical ventilation in pati","2021","07","20","J Anesth","Journal of anesthesia","COVID-19; SARS-CoV-2; Tocilizumab","Mostafa","Maha","Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, 01 elsarayah street, Elmanyal, Cairo, Egypt",NA
"1597","34264357","10.1007/s00383-021-04962-7","Impact of the COVID-19 pandemic on trauma activations at a pediatric level 1 trauma center in New York.","The disruptive effects on society and medical systems due to the coronavirus disease 2019 (COVID-19) pandemic are substantial and far-reaching. The effect of the pandemic on the quantity and quality of pediatric traumas is unclear and has a direct bearing on how scarce hospital resources should be allocated in a pandemic situation. A retrospective review of the trauma registry was performed for trauma activations in the years 2018 through 2020 during the months of March, April, and May. Demograp","2021","07","20","Pediatr Surg Int","Pediatric surgery international","COVID; Pediatrics; Trauma","Shi","Yan","Division of Pediatric Surgery, Cohen Children's Medical Center, 1111 Marcus Avenue, Suite M15, New Hyde Park, NY, 11042, USA. yan.shi@uhhospitals","yan.shi@uhhospitals.org"
"1598","34264357","10.1007/s00383-021-04962-7","Impact of the COVID-19 pandemic on trauma activations at a pediatric level 1 trauma center in New York.","The disruptive effects on society and medical systems due to the coronavirus disease 2019 (COVID-19) pandemic are substantial and far-reaching. The effect of the pandemic on the quantity and quality of pediatric traumas is unclear and has a direct bearing on how scarce hospital resources should be allocated in a pandemic situation. A retrospective review of the trauma registry was performed for trauma activations in the years 2018 through 2020 during the months of March, April, and May. Demograp","2021","07","20","Pediatr Surg Int","Pediatric surgery international","COVID; Pediatrics; Trauma","Kvasnovsky","Charlotte","Division of Pediatric Surgery, Cohen Children's Medical Center, 1111 Marcus Avenue, Suite M15, New Hyde Park, NY, 11042, USA",NA
"1599","34264357","10.1007/s00383-021-04962-7","Impact of the COVID-19 pandemic on trauma activations at a pediatric level 1 trauma center in New York.","The disruptive effects on society and medical systems due to the coronavirus disease 2019 (COVID-19) pandemic are substantial and far-reaching. The effect of the pandemic on the quantity and quality of pediatric traumas is unclear and has a direct bearing on how scarce hospital resources should be allocated in a pandemic situation. A retrospective review of the trauma registry was performed for trauma activations in the years 2018 through 2020 during the months of March, April, and May. Demograp","2021","07","20","Pediatr Surg Int","Pediatric surgery international","COVID; Pediatrics; Trauma","Khan","Saira","Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA",NA
"1600","34264357","10.1007/s00383-021-04962-7","Impact of the COVID-19 pandemic on trauma activations at a pediatric level 1 trauma center in New York.","The disruptive effects on society and medical systems due to the coronavirus disease 2019 (COVID-19) pandemic are substantial and far-reaching. The effect of the pandemic on the quantity and quality of pediatric traumas is unclear and has a direct bearing on how scarce hospital resources should be allocated in a pandemic situation. A retrospective review of the trauma registry was performed for trauma activations in the years 2018 through 2020 during the months of March, April, and May. Demograp","2021","07","20","Pediatr Surg Int","Pediatric surgery international","COVID; Pediatrics; Trauma","Jain","Shelley","Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA",NA
"1601","34264357","10.1007/s00383-021-04962-7","Impact of the COVID-19 pandemic on trauma activations at a pediatric level 1 trauma center in New York.","The disruptive effects on society and medical systems due to the coronavirus disease 2019 (COVID-19) pandemic are substantial and far-reaching. The effect of the pandemic on the quantity and quality of pediatric traumas is unclear and has a direct bearing on how scarce hospital resources should be allocated in a pandemic situation. A retrospective review of the trauma registry was performed for trauma activations in the years 2018 through 2020 during the months of March, April, and May. Demograp","2021","07","20","Pediatr Surg Int","Pediatric surgery international","COVID; Pediatrics; Trauma","Sargeant","Danielle","Division of Pediatric Surgery, Gambino Pediatric Trauma and Imaging Center, Cohen Children's Medical Center, New Hyde Park, NY, USA",NA
"1602","34264357","10.1007/s00383-021-04962-7","Impact of the COVID-19 pandemic on trauma activations at a pediatric level 1 trauma center in New York.","The disruptive effects on society and medical systems due to the coronavirus disease 2019 (COVID-19) pandemic are substantial and far-reaching. The effect of the pandemic on the quantity and quality of pediatric traumas is unclear and has a direct bearing on how scarce hospital resources should be allocated in a pandemic situation. A retrospective review of the trauma registry was performed for trauma activations in the years 2018 through 2020 during the months of March, April, and May. Demograp","2021","07","20","Pediatr Surg Int","Pediatric surgery international","COVID; Pediatrics; Trauma","Lamoshi","Abdulraouf","Division of Pediatric Surgery, Cohen Children's Medical Center, 1111 Marcus Avenue, Suite M15, New Hyde Park, NY, 11042, USA",NA
"1603","34264357","10.1007/s00383-021-04962-7","Impact of the COVID-19 pandemic on trauma activations at a pediatric level 1 trauma center in New York.","The disruptive effects on society and medical systems due to the coronavirus disease 2019 (COVID-19) pandemic are substantial and far-reaching. The effect of the pandemic on the quantity and quality of pediatric traumas is unclear and has a direct bearing on how scarce hospital resources should be allocated in a pandemic situation. A retrospective review of the trauma registry was performed for trauma activations in the years 2018 through 2020 during the months of March, April, and May. Demograp","2021","07","20","Pediatr Surg Int","Pediatric surgery international","COVID; Pediatrics; Trauma","Prince","Jose","Division of Pediatric Surgery, Cohen Children's Medical Center, 1111 Marcus Avenue, Suite M15, New Hyde Park, NY, 11042, USA",NA
"1604","34264357","10.1007/s00383-021-04962-7","Impact of the COVID-19 pandemic on trauma activations at a pediatric level 1 trauma center in New York.","The disruptive effects on society and medical systems due to the coronavirus disease 2019 (COVID-19) pandemic are substantial and far-reaching. The effect of the pandemic on the quantity and quality of pediatric traumas is unclear and has a direct bearing on how scarce hospital resources should be allocated in a pandemic situation. A retrospective review of the trauma registry was performed for trauma activations in the years 2018 through 2020 during the months of March, April, and May. Demograp","2021","07","20","Pediatr Surg Int","Pediatric surgery international","COVID; Pediatrics; Trauma","Sathya","Chethan","Division of Pediatric Surgery, Cohen Children's Medical Center, 1111 Marcus Avenue, Suite M15, New Hyde Park, NY, 11042, USA",NA
"1605","34264350","10.1093/qjmed/hcab195","COVID-19 associated mucormycosis-elucidating the etiology of this emerging entity.",NA,"2021","07","15","QJM","QJM : monthly journal of the Association of Physicians",NA,"Sakthivel","Pirabu","Department of Otorhinolaryngology and Head-Neck Surgery, Teaching block, All India Institute of Medical Sciences, New Delhi",NA
"1606","34264350","10.1093/qjmed/hcab195","COVID-19 associated mucormycosis-elucidating the etiology of this emerging entity.",NA,"2021","07","15","QJM","QJM : monthly journal of the Association of Physicians",NA,"Ish","Pranav","Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, Delhi",NA
"1607","34264346","10.1093/qjmed/hcab191","COVID-19 associated Mucormycosis and evolving evidence.",NA,"2021","07","15","QJM","QJM : monthly journal of the Association of Physicians",NA,"Sarda","Radhika","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1608","34264346","10.1093/qjmed/hcab191","COVID-19 associated Mucormycosis and evolving evidence.",NA,"2021","07","15","QJM","QJM : monthly journal of the Association of Physicians",NA,"Swain","Satish","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1609","34264346","10.1093/qjmed/hcab191","COVID-19 associated Mucormycosis and evolving evidence.",NA,"2021","07","15","QJM","QJM : monthly journal of the Association of Physicians",NA,"Ray","Animesh","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1610","34264346","10.1093/qjmed/hcab191","COVID-19 associated Mucormycosis and evolving evidence.",NA,"2021","07","15","QJM","QJM : monthly journal of the Association of Physicians",NA,"Wig","Naveet","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1611","34264330","10.1001/jamanetworkopen.2021.17267","Sociodemographic Characteristics and Inequities Associated With Access to In-Person and Remote Elementary Schooling During the COVID-19 Pandemic in New York State.",NA,"2021","07","23","JAMA Netw Open","JAMA network open","COVID-19; Child; Child Welfare; Continental Population Groups; Cross-Sectional Studies; Disabled Children; Education, Distance; Ethnic Groups; Female; Homeopathy; Humans; Male; New York; Pandemics; Physical Distancing; Poverty; Residence Characteristics; Schools; Social Justice; Socioeconomic Factors","Fox","Ashley M","Department of Public Administration and Policy, University at Albany, Albany, New York",NA
"1612","34264330","10.1001/jamanetworkopen.2021.17267","Sociodemographic Characteristics and Inequities Associated With Access to In-Person and Remote Elementary Schooling During the COVID-19 Pandemic in New York State.",NA,"2021","07","23","JAMA Netw Open","JAMA network open","COVID-19; Child; Child Welfare; Continental Population Groups; Cross-Sectional Studies; Disabled Children; Education, Distance; Ethnic Groups; Female; Homeopathy; Humans; Male; New York; Pandemics; Physical Distancing; Poverty; Residence Characteristics; Schools; Social Justice; Socioeconomic Factors","Lee","Jun Soo","Department of Economics, University at Albany, Albany, New York",NA
"1613","34264330","10.1001/jamanetworkopen.2021.17267","Sociodemographic Characteristics and Inequities Associated With Access to In-Person and Remote Elementary Schooling During the COVID-19 Pandemic in New York State.",NA,"2021","07","23","JAMA Netw Open","JAMA network open","COVID-19; Child; Child Welfare; Continental Population Groups; Cross-Sectional Studies; Disabled Children; Education, Distance; Ethnic Groups; Female; Homeopathy; Humans; Male; New York; Pandemics; Physical Distancing; Poverty; Residence Characteristics; Schools; Social Justice; Socioeconomic Factors","Sorensen","Lucy C","Department of Public Administration and Policy, University at Albany, Albany, New York",NA
"1614","34264330","10.1001/jamanetworkopen.2021.17267","Sociodemographic Characteristics and Inequities Associated With Access to In-Person and Remote Elementary Schooling During the COVID-19 Pandemic in New York State.",NA,"2021","07","23","JAMA Netw Open","JAMA network open","COVID-19; Child; Child Welfare; Continental Population Groups; Cross-Sectional Studies; Disabled Children; Education, Distance; Ethnic Groups; Female; Homeopathy; Humans; Male; New York; Pandemics; Physical Distancing; Poverty; Residence Characteristics; Schools; Social Justice; Socioeconomic Factors","Martin","Erika G","Department of Public Administration and Policy, University at Albany, Albany, New York",NA
"1615","34264329","10.1001/jamanetworkopen.2021.14741","Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.","Randomized clinical trials have yielded conflicting results about the effects of remdesivir therapy on survival and length of hospital stay among people with COVID-19. To examine associations between remdesivir treatment and survival and length of hospital stay among people hospitalized with COVID-19 in routine care settings. This retrospective cohort study used data from the Veterans Health Administration (VHA) to identify adult patients in 123 VHA hospitals who had a first hospitalization with","2021","07","23","JAMA Netw Open","JAMA network open","Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; United States; Veterans; Veterans Health Services","Ohl","Michael E","Center for Access &amp",NA
"1616","34264329","10.1001/jamanetworkopen.2021.14741","Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.","Randomized clinical trials have yielded conflicting results about the effects of remdesivir therapy on survival and length of hospital stay among people with COVID-19. To examine associations between remdesivir treatment and survival and length of hospital stay among people hospitalized with COVID-19 in routine care settings. This retrospective cohort study used data from the Veterans Health Administration (VHA) to identify adult patients in 123 VHA hospitals who had a first hospitalization with","2021","07","23","JAMA Netw Open","JAMA network open","Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; United States; Veterans; Veterans Health Services","Miller","Donald R","Center for Healthcare Organization &amp",NA
"1617","34264329","10.1001/jamanetworkopen.2021.14741","Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.","Randomized clinical trials have yielded conflicting results about the effects of remdesivir therapy on survival and length of hospital stay among people with COVID-19. To examine associations between remdesivir treatment and survival and length of hospital stay among people hospitalized with COVID-19 in routine care settings. This retrospective cohort study used data from the Veterans Health Administration (VHA) to identify adult patients in 123 VHA hospitals who had a first hospitalization with","2021","07","23","JAMA Netw Open","JAMA network open","Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; United States; Veterans; Veterans Health Services","Lund","Brian C","Center for Access &amp",NA
"1618","34264329","10.1001/jamanetworkopen.2021.14741","Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.","Randomized clinical trials have yielded conflicting results about the effects of remdesivir therapy on survival and length of hospital stay among people with COVID-19. To examine associations between remdesivir treatment and survival and length of hospital stay among people hospitalized with COVID-19 in routine care settings. This retrospective cohort study used data from the Veterans Health Administration (VHA) to identify adult patients in 123 VHA hospitals who had a first hospitalization with","2021","07","23","JAMA Netw Open","JAMA network open","Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; United States; Veterans; Veterans Health Services","Kobayashi","Takaaki","Center for Access &amp",NA
"1619","34264329","10.1001/jamanetworkopen.2021.14741","Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.","Randomized clinical trials have yielded conflicting results about the effects of remdesivir therapy on survival and length of hospital stay among people with COVID-19. To examine associations between remdesivir treatment and survival and length of hospital stay among people hospitalized with COVID-19 in routine care settings. This retrospective cohort study used data from the Veterans Health Administration (VHA) to identify adult patients in 123 VHA hospitals who had a first hospitalization with","2021","07","23","JAMA Netw Open","JAMA network open","Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; United States; Veterans; Veterans Health Services","Richardson Miell","Kelly","Center for Access &amp",NA
"1620","34264329","10.1001/jamanetworkopen.2021.14741","Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.","Randomized clinical trials have yielded conflicting results about the effects of remdesivir therapy on survival and length of hospital stay among people with COVID-19. To examine associations between remdesivir treatment and survival and length of hospital stay among people hospitalized with COVID-19 in routine care settings. This retrospective cohort study used data from the Veterans Health Administration (VHA) to identify adult patients in 123 VHA hospitals who had a first hospitalization with","2021","07","23","JAMA Netw Open","JAMA network open","Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; United States; Veterans; Veterans Health Services","Beck","Brice F","Center for Access &amp",NA
"1621","34264329","10.1001/jamanetworkopen.2021.14741","Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.","Randomized clinical trials have yielded conflicting results about the effects of remdesivir therapy on survival and length of hospital stay among people with COVID-19. To examine associations between remdesivir treatment and survival and length of hospital stay among people hospitalized with COVID-19 in routine care settings. This retrospective cohort study used data from the Veterans Health Administration (VHA) to identify adult patients in 123 VHA hospitals who had a first hospitalization with","2021","07","23","JAMA Netw Open","JAMA network open","Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; United States; Veterans; Veterans Health Services","Alexander","Bruce","Center for Access &amp",NA
"1622","34264329","10.1001/jamanetworkopen.2021.14741","Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.","Randomized clinical trials have yielded conflicting results about the effects of remdesivir therapy on survival and length of hospital stay among people with COVID-19. To examine associations between remdesivir treatment and survival and length of hospital stay among people hospitalized with COVID-19 in routine care settings. This retrospective cohort study used data from the Veterans Health Administration (VHA) to identify adult patients in 123 VHA hospitals who had a first hospitalization with","2021","07","23","JAMA Netw Open","JAMA network open","Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; United States; Veterans; Veterans Health Services","Crothers","Kristina","VA Puget Sound Health Care System, Seattle, Washington",NA
"1623","34264329","10.1001/jamanetworkopen.2021.14741","Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.","Randomized clinical trials have yielded conflicting results about the effects of remdesivir therapy on survival and length of hospital stay among people with COVID-19. To examine associations between remdesivir treatment and survival and length of hospital stay among people hospitalized with COVID-19 in routine care settings. This retrospective cohort study used data from the Veterans Health Administration (VHA) to identify adult patients in 123 VHA hospitals who had a first hospitalization with","2021","07","23","JAMA Netw Open","JAMA network open","Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; United States; Veterans; Veterans Health Services","Vaughan Sarrazin","Mary S","Center for Access &amp",NA
"1624","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Jimenez","Manuel E","Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey",NA
"1625","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Rivera-Núñez","Zorimar","Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Rutgers Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey",NA
"1626","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Crabtree","Benjamin F","Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey",NA
"1627","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Hill","Diane","Rutgers School of Public Affairs and Administration, University-Community Partnerships, Newark, New Jersey",NA
"1628","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Pellerano","Maria B","Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey",NA
"1629","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Devance","Donita","Rutgers, the State University of New Jersey, University-Community Partnerships, Newark",NA
"1630","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Macenat","Myneka","Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey",NA
"1631","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Lima","Daniel","Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey",NA
"1632","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Martinez Alcaraz","Emmanuel","Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey",NA
"1633","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Ferrante","Jeanne M","Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey",NA
"1634","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Barrett","Emily S","Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Rutgers Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey",NA
"1635","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Blaser","Martin J","Department of Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers Center for Advance Biotechnology and Medicine, New Brunswick, New Jersey",NA
"1636","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Panettieri","Reynold A","Rutgers Institute for Translational Medicine and Science, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey",NA
"1637","34264327","10.1001/jamanetworkopen.2021.17074","Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.","Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. To explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines. In this community-engaged qualitative study conducted with 18 community-based organizations and 4 health care organizations between November 19, 2020, ","2021","07","23","JAMA Netw Open","JAMA network open","Adolescent; Adult; African Americans; Aged; Aged, 80 and over; Attitude; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Female; Hispanic Americans; Humans; Information Seeking Behavior; Male; Mass Screening; Middle Aged; New Jersey; Pandemics; Research; SARS-CoV-2; Trust; Young Adult","Hudson","Shawna V","Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey",NA
"1638","34264277","10.1182/blood.2021011149","Thrombosis with COVID-19: kids get it too.",NA,"2021","07","20","Blood","Blood","COVID-19; Humans; SARS-CoV-2; Thrombosis; Vaccination","Takemoto","Cliff","St Jude Children's Research Hospital",NA
"1639","34264269","10.1001/jamaoto.2021.1456","A Rapid Olfactory Test as a Potential Screening Tool for COVID-19.",NA,"2021","07","20","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Said","Mena","Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California, San Diego",NA
"1640","34264269","10.1001/jamaoto.2021.1456","A Rapid Olfactory Test as a Potential Screening Tool for COVID-19.",NA,"2021","07","20","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Davis","Peter","Southern Methodist University Health Center, Southern Methodist University, Dallas, Texas",NA
"1641","34264269","10.1001/jamaoto.2021.1456","A Rapid Olfactory Test as a Potential Screening Tool for COVID-19.",NA,"2021","07","20","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Davis","Stephanie","Southern Methodist University Health Center, Southern Methodist University, Dallas, Texas",NA
"1642","34264269","10.1001/jamaoto.2021.1456","A Rapid Olfactory Test as a Potential Screening Tool for COVID-19.",NA,"2021","07","20","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Smart","Kristin","Southern Methodist University Health Center, Southern Methodist University, Dallas, Texas",NA
"1643","34264269","10.1001/jamaoto.2021.1456","A Rapid Olfactory Test as a Potential Screening Tool for COVID-19.",NA,"2021","07","20","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Davis","Sarah","Park Cities Personal Physicians, Dallas, Texas",NA
"1644","34264269","10.1001/jamaoto.2021.1456","A Rapid Olfactory Test as a Potential Screening Tool for COVID-19.",NA,"2021","07","20","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Yan","Carol H","Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California, San Diego",NA
"1645","34264266","10.1001/jama.2021.11880","Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents.",NA,"2021","07","20","JAMA","JAMA",NA,"Radtke","Thomas","Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland",NA
"1646","34264266","10.1001/jama.2021.11880","Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents.",NA,"2021","07","20","JAMA","JAMA",NA,"Ulyte","Agne","Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland",NA
"1647","34264266","10.1001/jama.2021.11880","Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents.",NA,"2021","07","20","JAMA","JAMA",NA,"Puhan","Milo A","Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland",NA
"1648","34264266","10.1001/jama.2021.11880","Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents.",NA,"2021","07","20","JAMA","JAMA",NA,"Kriemler","Susi","Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland",NA
"1649","34264262","10.1001/jama.2021.11211","Potential Benefits of Expanded COVID-19 Surveillance in the US.",NA,"2021","07","15","JAMA","JAMA",NA,"Holtgrave","David R","University at Albany School of Public Health, State University of New York, New York",NA
"1650","34264262","10.1001/jama.2021.11211","Potential Benefits of Expanded COVID-19 Surveillance in the US.",NA,"2021","07","15","JAMA","JAMA",NA,"Vermund","Sten H","Yale School of Public Health, New Haven, Connecticut",NA
"1651","34264262","10.1001/jama.2021.11211","Potential Benefits of Expanded COVID-19 Surveillance in the US.",NA,"2021","07","15","JAMA","JAMA",NA,"Wen","Leana S","Fitzhugh Mullan Institute for Health Workforce Equity, George Washington University, Washington, DC",NA
"1652","34264250","10.1039/d1ob00827g","1,10/1,11-Cyclization catalyzed by diverged plant sesquiterpene synthases is dependent on a single residue.","The exquisite chemodiversity of terpenoids is the product of the large diverse terpene synthase (TPS) superfamily. Here, by using structural and phylogenetic analyses and site-directed mutagenesis, we identified a residue (Cys440 in Nicotiana tabacum 5-epi-aristolochene synthase) proximal to an ion-binding motif common to all TPSs and named the preNSE/DTE residue, which determines the product specificity of sesquiterpene synthases from different plant species. In sesquiterpene synthases catalyzi","2021","07","17","Org Biomol Chem","Organic &amp; biomolecular chemistry",NA,"Huang","Jin-Quan","Yunnan University, Kunming, PR China and National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology/CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, PR China",NA
"1653","34264250","10.1039/d1ob00827g","1,10/1,11-Cyclization catalyzed by diverged plant sesquiterpene synthases is dependent on a single residue.","The exquisite chemodiversity of terpenoids is the product of the large diverse terpene synthase (TPS) superfamily. Here, by using structural and phylogenetic analyses and site-directed mutagenesis, we identified a residue (Cys440 in Nicotiana tabacum 5-epi-aristolochene synthase) proximal to an ion-binding motif common to all TPSs and named the preNSE/DTE residue, which determines the product specificity of sesquiterpene synthases from different plant species. In sesquiterpene synthases catalyzi","2021","07","17","Org Biomol Chem","Organic &amp; biomolecular chemistry",NA,"Li","Dong-Mei","Yunnan University, Kunming, PR China and State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, Yunnan, PR China. xinfang@mail.kib.ac","xinfang@mail.kib.ac.cn"
"1654","34264250","10.1039/d1ob00827g","1,10/1,11-Cyclization catalyzed by diverged plant sesquiterpene synthases is dependent on a single residue.","The exquisite chemodiversity of terpenoids is the product of the large diverse terpene synthase (TPS) superfamily. Here, by using structural and phylogenetic analyses and site-directed mutagenesis, we identified a residue (Cys440 in Nicotiana tabacum 5-epi-aristolochene synthase) proximal to an ion-binding motif common to all TPSs and named the preNSE/DTE residue, which determines the product specificity of sesquiterpene synthases from different plant species. In sesquiterpene synthases catalyzi","2021","07","17","Org Biomol Chem","Organic &amp; biomolecular chemistry",NA,"Li","Jian-Xu","National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology/CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, PR China",NA
"1655","34264250","10.1039/d1ob00827g","1,10/1,11-Cyclization catalyzed by diverged plant sesquiterpene synthases is dependent on a single residue.","The exquisite chemodiversity of terpenoids is the product of the large diverse terpene synthase (TPS) superfamily. Here, by using structural and phylogenetic analyses and site-directed mutagenesis, we identified a residue (Cys440 in Nicotiana tabacum 5-epi-aristolochene synthase) proximal to an ion-binding motif common to all TPSs and named the preNSE/DTE residue, which determines the product specificity of sesquiterpene synthases from different plant species. In sesquiterpene synthases catalyzi","2021","07","17","Org Biomol Chem","Organic &amp; biomolecular chemistry",NA,"Lin","Jia-Ling","National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology/CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, PR China and School of Life Science and Technology, ShanghaiTech University, Shanghai, PR China",NA
"1656","34264250","10.1039/d1ob00827g","1,10/1,11-Cyclization catalyzed by diverged plant sesquiterpene synthases is dependent on a single residue.","The exquisite chemodiversity of terpenoids is the product of the large diverse terpene synthase (TPS) superfamily. Here, by using structural and phylogenetic analyses and site-directed mutagenesis, we identified a residue (Cys440 in Nicotiana tabacum 5-epi-aristolochene synthase) proximal to an ion-binding motif common to all TPSs and named the preNSE/DTE residue, which determines the product specificity of sesquiterpene synthases from different plant species. In sesquiterpene synthases catalyzi","2021","07","17","Org Biomol Chem","Organic &amp; biomolecular chemistry",NA,"Tian","Xiu","National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology/CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, PR China",NA
"1657","34264250","10.1039/d1ob00827g","1,10/1,11-Cyclization catalyzed by diverged plant sesquiterpene synthases is dependent on a single residue.","The exquisite chemodiversity of terpenoids is the product of the large diverse terpene synthase (TPS) superfamily. Here, by using structural and phylogenetic analyses and site-directed mutagenesis, we identified a residue (Cys440 in Nicotiana tabacum 5-epi-aristolochene synthase) proximal to an ion-binding motif common to all TPSs and named the preNSE/DTE residue, which determines the product specificity of sesquiterpene synthases from different plant species. In sesquiterpene synthases catalyzi","2021","07","17","Org Biomol Chem","Organic &amp; biomolecular chemistry",NA,"Wang","Ling-Jian","National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology/CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, PR China",NA
"1658","34264250","10.1039/d1ob00827g","1,10/1,11-Cyclization catalyzed by diverged plant sesquiterpene synthases is dependent on a single residue.","The exquisite chemodiversity of terpenoids is the product of the large diverse terpene synthase (TPS) superfamily. Here, by using structural and phylogenetic analyses and site-directed mutagenesis, we identified a residue (Cys440 in Nicotiana tabacum 5-epi-aristolochene synthase) proximal to an ion-binding motif common to all TPSs and named the preNSE/DTE residue, which determines the product specificity of sesquiterpene synthases from different plant species. In sesquiterpene synthases catalyzi","2021","07","17","Org Biomol Chem","Organic &amp; biomolecular chemistry",NA,"Chen","Xiao-Ya","National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology/CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, PR China",NA
"1659","34264250","10.1039/d1ob00827g","1,10/1,11-Cyclization catalyzed by diverged plant sesquiterpene synthases is dependent on a single residue.","The exquisite chemodiversity of terpenoids is the product of the large diverse terpene synthase (TPS) superfamily. Here, by using structural and phylogenetic analyses and site-directed mutagenesis, we identified a residue (Cys440 in Nicotiana tabacum 5-epi-aristolochene synthase) proximal to an ion-binding motif common to all TPSs and named the preNSE/DTE residue, which determines the product specificity of sesquiterpene synthases from different plant species. In sesquiterpene synthases catalyzi","2021","07","17","Org Biomol Chem","Organic &amp; biomolecular chemistry",NA,"Fang","Xin","State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, Yunnan, PR China. xinfang@mail.kib.ac","xinfang@mail.kib.ac.cn"
"1660","34264179","10.1080/19338244.2021.1952152","The effect of type D personality on anxiety, depression and fear of COVID-19 disease in healthcare workers.","During the pandemic, healthcare workers are at the top of the risky groups regarding mental stress. This study aimed to evaluate the relationship of type D personality traits with anxiety, depression, and fear of the SARS-CoV-2 related illness and SARS-CoV-2 virus in healthcare workers during the pandemic period. One hundred ninety-four healthcare workers (53 physicians, 19 dentists, 76 nurses, and 46 auxiliary health personnel) were included in the present study. Sociodemographic Data Form, Typ","2021","07","15","Arch Environ Occup Health","Archives of environmental &amp; occupational health"," COVID-19; Anxiety; cognitive disorders; depression; healthcare workers; occupational diseases; risk assessment; type D personality","Tuman","Taha Can","Medical Faculty, Department of Psychiatry, Istanbul Medipol University, Istanbul, Turkey",NA
"1661","34264177","10.1080/0361073X.2021.1943794","Elderly People with Dementia Admitted for COVID-19: How Different are They?","Patients with a dementia diagnosis and COVID-19 sometimes manifest an atypical clinical picture. However, differences between elderly COVID-19 patients having dementia and those not having dementia have not been described yet. The in-hospital mortality and out-of-hospital mortality from both groups has not been reported. The primary aim of this study is to determine if there is a significant difference in-hospital and out-of-hospital mortality in the elderly patients admitted for COVID-19, compa","2021","07","15","Exp Aging Res","Experimental aging research",NA,"Roig-Marín","Noel","UMH, Universidad Miguel Hernández, Campus De San Juan De Alicante, Spain",NA
"1662","34264177","10.1080/0361073X.2021.1943794","Elderly People with Dementia Admitted for COVID-19: How Different are They?","Patients with a dementia diagnosis and COVID-19 sometimes manifest an atypical clinical picture. However, differences between elderly COVID-19 patients having dementia and those not having dementia have not been described yet. The in-hospital mortality and out-of-hospital mortality from both groups has not been reported. The primary aim of this study is to determine if there is a significant difference in-hospital and out-of-hospital mortality in the elderly patients admitted for COVID-19, compa","2021","07","15","Exp Aging Res","Experimental aging research",NA,"Roig-Rico","Pablo","UMH, Universidad Miguel Hernández, Campus De San Juan De Alicante, Spain",NA
"1663","34264174","10.1080/21645515.2021.1947101","Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis.","The COVID-19 pandemic will subside only through the emergence and distribution of an efficacious vaccine. The two main aspects that should be maintained in equilibrium: the dire necessity for speedy vaccine research and the need for safeguarding the research subjects, which is of utmost concern in research ethics. This opens up a discussion of what norms to follow during the clinical trials while developing the vaccine. As of now, various companies like Moderna, Pfizer, University of Oxford, Ast","2021","07","15","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19 vaccines; India; ethics; principles","Kumar","Vaibhav","Department of Public Health Dentistry, TPCT'S Terna Dental College, Navi Mumbai, Maharashtra, India",NA
"1664","34264174","10.1080/21645515.2021.1947101","Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis.","The COVID-19 pandemic will subside only through the emergence and distribution of an efficacious vaccine. The two main aspects that should be maintained in equilibrium: the dire necessity for speedy vaccine research and the need for safeguarding the research subjects, which is of utmost concern in research ethics. This opens up a discussion of what norms to follow during the clinical trials while developing the vaccine. As of now, various companies like Moderna, Pfizer, University of Oxford, Ast","2021","07","15","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19 vaccines; India; ethics; principles","Aranha","Venetia","TPCT's Terna Dental College, Navi Mumbai, Maharashtra, India",NA
"1665","34264174","10.1080/21645515.2021.1947101","Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis.","The COVID-19 pandemic will subside only through the emergence and distribution of an efficacious vaccine. The two main aspects that should be maintained in equilibrium: the dire necessity for speedy vaccine research and the need for safeguarding the research subjects, which is of utmost concern in research ethics. This opens up a discussion of what norms to follow during the clinical trials while developing the vaccine. As of now, various companies like Moderna, Pfizer, University of Oxford, Ast","2021","07","15","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19 vaccines; India; ethics; principles","Rajgarhia","Rajni","Dental Profiles, Bellandur, Bengaluru, India",NA
"1666","34264174","10.1080/21645515.2021.1947101","Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis.","The COVID-19 pandemic will subside only through the emergence and distribution of an efficacious vaccine. The two main aspects that should be maintained in equilibrium: the dire necessity for speedy vaccine research and the need for safeguarding the research subjects, which is of utmost concern in research ethics. This opens up a discussion of what norms to follow during the clinical trials while developing the vaccine. As of now, various companies like Moderna, Pfizer, University of Oxford, Ast","2021","07","15","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19 vaccines; India; ethics; principles","Royal","Abhishek","Department of Public Health, Faculty of Medicine, Public Health &amp",NA
"1667","34264174","10.1080/21645515.2021.1947101","Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis.","The COVID-19 pandemic will subside only through the emergence and distribution of an efficacious vaccine. The two main aspects that should be maintained in equilibrium: the dire necessity for speedy vaccine research and the need for safeguarding the research subjects, which is of utmost concern in research ethics. This opens up a discussion of what norms to follow during the clinical trials while developing the vaccine. As of now, various companies like Moderna, Pfizer, University of Oxford, Ast","2021","07","15","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19 vaccines; India; ethics; principles","Mehta","Kedar","Community Medicine Department, GMERS Medical College, Gotri, Vadodara, Gujarat, India",NA
"1668","34264162","10.2989/16085906.2021.1948877","AIDS and COVID-19 in southern Africa.","By the end of the first year of the COVID-19 pandemic, in February 2021, the numbers of cases and deaths in southern Africa were low in absolute and relative numbers. The BBC ran a story (which was later retracted) headlined ""Coronavirus in Africa: Could poverty explain mystery of low death rate?"". A heading in the New York Post said: ""Scientists can't explain puzzling lack of coronavirus outbreaks in Africa"". Journalist Karen Attiah concluded: ""It's almost as if they are disappointed tha","2021","07","22","Afr J AIDS Res","African journal of AIDS research : AJAR","HIV; SARS-CoV-2; TB; co-infection; Acquired Immunodeficiency Syndrome; Africa, Southern; COVID-19; HIV Infections; Humans; SARS-CoV-2","van Wyngaard","Arnau","Shiselweni Home-Based Care, Department of Science of Religion and Missiology, University of Pretoria, Piet Retief, South Africa",NA
"1669","34264162","10.2989/16085906.2021.1948877","AIDS and COVID-19 in southern Africa.","By the end of the first year of the COVID-19 pandemic, in February 2021, the numbers of cases and deaths in southern Africa were low in absolute and relative numbers. The BBC ran a story (which was later retracted) headlined ""Coronavirus in Africa: Could poverty explain mystery of low death rate?"". A heading in the New York Post said: ""Scientists can't explain puzzling lack of coronavirus outbreaks in Africa"". Journalist Karen Attiah concluded: ""It's almost as if they are disappointed tha","2021","07","22","Afr J AIDS Res","African journal of AIDS research : AJAR","HIV; SARS-CoV-2; TB; co-infection; Acquired Immunodeficiency Syndrome; Africa, Southern; COVID-19; HIV Infections; Humans; SARS-CoV-2","Whiteside","Alan","Balsillie School of International Affairs, Waterloo, Canada",NA
"1670","34264151","10.1080/14740338.2021.1955101","Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines.","Concerns about the increased risk of blood clots associated with the VAXZEVRIA (previously named Oxford-AstraZeneca COVID-19 vaccine) and Johnson &amp; Johnson (Janssen) COVID-19 vaccines raises the question of the thrombotic safety of other COVID-19 vaccines such as Pfizer-BioNTech or Moderna, especially in younger women, who at the early stage of the pandemic was a priority group for vaccination. Using the US-based Vaccine Adverse Event Reporting System (VAERS) and the FDA Event Reporting Syst","2021","07","15","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; FAERS; VAERS; thrombosis; vaccine","Sessa","Maurizio","Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark",NA
"1671","34264151","10.1080/14740338.2021.1955101","Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines.","Concerns about the increased risk of blood clots associated with the VAXZEVRIA (previously named Oxford-AstraZeneca COVID-19 vaccine) and Johnson &amp; Johnson (Janssen) COVID-19 vaccines raises the question of the thrombotic safety of other COVID-19 vaccines such as Pfizer-BioNTech or Moderna, especially in younger women, who at the early stage of the pandemic was a priority group for vaccination. Using the US-based Vaccine Adverse Event Reporting System (VAERS) and the FDA Event Reporting Syst","2021","07","15","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; FAERS; VAERS; thrombosis; vaccine","Kragholm","Kristian","Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark",NA
"1672","34264151","10.1080/14740338.2021.1955101","Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines.","Concerns about the increased risk of blood clots associated with the VAXZEVRIA (previously named Oxford-AstraZeneca COVID-19 vaccine) and Johnson &amp; Johnson (Janssen) COVID-19 vaccines raises the question of the thrombotic safety of other COVID-19 vaccines such as Pfizer-BioNTech or Moderna, especially in younger women, who at the early stage of the pandemic was a priority group for vaccination. Using the US-based Vaccine Adverse Event Reporting System (VAERS) and the FDA Event Reporting Syst","2021","07","15","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; FAERS; VAERS; thrombosis; vaccine","Hviid","Anders","Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark",NA
"1673","34264151","10.1080/14740338.2021.1955101","Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines.","Concerns about the increased risk of blood clots associated with the VAXZEVRIA (previously named Oxford-AstraZeneca COVID-19 vaccine) and Johnson &amp; Johnson (Janssen) COVID-19 vaccines raises the question of the thrombotic safety of other COVID-19 vaccines such as Pfizer-BioNTech or Moderna, especially in younger women, who at the early stage of the pandemic was a priority group for vaccination. Using the US-based Vaccine Adverse Event Reporting System (VAERS) and the FDA Event Reporting Syst","2021","07","15","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; FAERS; VAERS; thrombosis; vaccine","Andersen","Morten","Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark",NA
"1674","34264140","10.1177/0272684X211031106","Community Health Education for Health Crisis Management: The Case of COVID-19 in Cameroon.","The current coronavirus disease 2019 (COVID-19) pandemic has led Cameroon's government to implement public health measures aimed at preventing its spread. This paper investigates how community health education on the virus was being carried out, what gaps exist and what further action could be taken. A survey instrument was used to gather data among a total of 179 Cameroonians recruited via opportunistic and snowball sampling methods. According to our findings, gaps exist. These include the need","2021","07","15","Int Q Community Health Educ","International quarterly of community health education","COVID-19; Cameroon; community health education; integrated approach","Mbah","Marcellus","Institute of Education, Nottingham Trent University, UK",NA
"1675","34264140","10.1177/0272684X211031106","Community Health Education for Health Crisis Management: The Case of COVID-19 in Cameroon.","The current coronavirus disease 2019 (COVID-19) pandemic has led Cameroon's government to implement public health measures aimed at preventing its spread. This paper investigates how community health education on the virus was being carried out, what gaps exist and what further action could be taken. A survey instrument was used to gather data among a total of 179 Cameroonians recruited via opportunistic and snowball sampling methods. According to our findings, gaps exist. These include the need","2021","07","15","Int Q Community Health Educ","International quarterly of community health education","COVID-19; Cameroon; community health education; integrated approach","Bang","Henry","Centre for Disaster Management, Bournemouth University, UK",NA
"1676","34264140","10.1177/0272684X211031106","Community Health Education for Health Crisis Management: The Case of COVID-19 in Cameroon.","The current coronavirus disease 2019 (COVID-19) pandemic has led Cameroon's government to implement public health measures aimed at preventing its spread. This paper investigates how community health education on the virus was being carried out, what gaps exist and what further action could be taken. A survey instrument was used to gather data among a total of 179 Cameroonians recruited via opportunistic and snowball sampling methods. According to our findings, gaps exist. These include the need","2021","07","15","Int Q Community Health Educ","International quarterly of community health education","COVID-19; Cameroon; community health education; integrated approach","Ndi","Humphrey","Department of Geography, Higher Teacher Training College, University of Yaounde I, Cameroon",NA
"1677","34264140","10.1177/0272684X211031106","Community Health Education for Health Crisis Management: The Case of COVID-19 in Cameroon.","The current coronavirus disease 2019 (COVID-19) pandemic has led Cameroon's government to implement public health measures aimed at preventing its spread. This paper investigates how community health education on the virus was being carried out, what gaps exist and what further action could be taken. A survey instrument was used to gather data among a total of 179 Cameroonians recruited via opportunistic and snowball sampling methods. According to our findings, gaps exist. These include the need","2021","07","15","Int Q Community Health Educ","International quarterly of community health education","COVID-19; Cameroon; community health education; integrated approach","Ndzo","Judwin Alieh","Queen's Medical Centre, Nottingham University Hospital NHS Trust, Nottingham, UK",NA
"1678","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Velasco","John Mark","U.S. Army Medical Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"1679","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Chinnawirotpisan","Piyawan","U.S. Army Medical Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"1680","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Valderama","Maria Theresa","U.S. Army Medical Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"1681","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Joonlasak","Khajohn","U.S. Army Medical Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"1682","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Manasatienkij","Wudtichai","U.S. Army Medical Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"1683","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Huang","Angkana","U.S. Army Medical Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"1684","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Diones","Paula Corazon","U.S. Army Medical Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"1685","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Navarro","Fatima Claire","V. Luna Medical Center, Armed Forces of the Philippines Health Service Command, Quezon City, Philippines",NA
"1686","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Vila","Vicente","V. Luna Medical Center, Armed Forces of the Philippines Health Service Command, Quezon City, Philippines",NA
"1687","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Tabinas","Henry","V. Luna Medical Center, Armed Forces of the Philippines Health Service Command, Quezon City, Philippines",NA
"1688","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Chua","Domingo","V. Luna Medical Center, Armed Forces of the Philippines Health Service Command, Quezon City, Philippines",NA
"1689","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Fernandez","Stefan","U.S. Army Medical Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"1690","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Jones","Anthony","U.S. Army Medical Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"1691","34264104","10.1128/MRA.00498-21","Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.","Here, we report the complete genome sequences of 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from the Philippines. Lineage analysis showed 3 B.1.1.7 and 8 B.1.351 sequences. One B.1.1.7 sequence contained two additional mutations, F318N and V320F, with V320F located in the receptor binding domain of the S1 subunit.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Klungthong","Chonticha","U.S. Army Medical Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"1692","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Afrad","Mokibul Hassan","International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh",NA
"1693","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Khan","Manjur Hossain","Institute of Epidemiology, Disease Control, and Research, Dhaka, Bangladesh",NA
"1694","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Rahman","Sadia Isfat Ara","International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh",NA
"1695","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Bin Manjur","Omar Hamza","Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh",NA
"1696","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Hossain","Mohabbat","Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh",NA
"1697","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Alam","Ahmed Nawsher","Institute of Epidemiology, Disease Control, and Research, Dhaka, Bangladesh",NA
"1698","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Khan","Farzana Islam","Institute of Epidemiology, Disease Control, and Research, Dhaka, Bangladesh",NA
"1699","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Afreen","Nawroz","Institute of Epidemiology, Disease Control, and Research, Dhaka, Bangladesh",NA
"1700","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Haque","Farsim Tarannum","Institute of Epidemiology, Disease Control, and Research, Dhaka, Bangladesh",NA
"1701","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Thomson","Nicholas R","Wellcome Sanger Institute, Hinxton, Cambridgeshire, United Kingdom",NA
"1702","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Shirin","Tahmina","Institute of Epidemiology, Disease Control, and Research, Dhaka, Bangladesh",NA
"1703","34264100","10.1128/MRA.00560-21","Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.","We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.","2021","07","16","Microbiol Resour Announc","Microbiology resource announcements",NA,"Qadri","Firdausi","International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh",NA
"1704","34264067","10.1021/acs.analchem.1c01657","Amplification-Free SARS-CoV-2 Detection Using Nanoyeast-scFv and Ultrasensitive Plasmonic Nanobox-Integrated Nanomixing Microassay.","The implementation of accurate and sensitive molecular detection for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to effectively control the ongoing coronavirus disease 2019 (COVID-19) pandemic. In this regard, we herein propose the specific and highly sensitive SARS-CoV-2 detection based on nanoyeast single-chain-variable fragment (scFv) and ultrasensitive plasmonic nanobox-integrated nanomixing microassay. Importantly, this designed platform showcases the utili","2021","07","21","Anal Chem","Analytical chemistry",NA,"Li","Junrong","Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia",NA
"1705","34264067","10.1021/acs.analchem.1c01657","Amplification-Free SARS-CoV-2 Detection Using Nanoyeast-scFv and Ultrasensitive Plasmonic Nanobox-Integrated Nanomixing Microassay.","The implementation of accurate and sensitive molecular detection for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to effectively control the ongoing coronavirus disease 2019 (COVID-19) pandemic. In this regard, we herein propose the specific and highly sensitive SARS-CoV-2 detection based on nanoyeast single-chain-variable fragment (scFv) and ultrasensitive plasmonic nanobox-integrated nanomixing microassay. Importantly, this designed platform showcases the utili","2021","07","21","Anal Chem","Analytical chemistry",NA,"Wuethrich","Alain","Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia",NA
"1706","34264067","10.1021/acs.analchem.1c01657","Amplification-Free SARS-CoV-2 Detection Using Nanoyeast-scFv and Ultrasensitive Plasmonic Nanobox-Integrated Nanomixing Microassay.","The implementation of accurate and sensitive molecular detection for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to effectively control the ongoing coronavirus disease 2019 (COVID-19) pandemic. In this regard, we herein propose the specific and highly sensitive SARS-CoV-2 detection based on nanoyeast single-chain-variable fragment (scFv) and ultrasensitive plasmonic nanobox-integrated nanomixing microassay. Importantly, this designed platform showcases the utili","2021","07","21","Anal Chem","Analytical chemistry",NA,"Edwardraja","Selvakumar","Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia",NA
"1707","34264067","10.1021/acs.analchem.1c01657","Amplification-Free SARS-CoV-2 Detection Using Nanoyeast-scFv and Ultrasensitive Plasmonic Nanobox-Integrated Nanomixing Microassay.","The implementation of accurate and sensitive molecular detection for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to effectively control the ongoing coronavirus disease 2019 (COVID-19) pandemic. In this regard, we herein propose the specific and highly sensitive SARS-CoV-2 detection based on nanoyeast single-chain-variable fragment (scFv) and ultrasensitive plasmonic nanobox-integrated nanomixing microassay. Importantly, this designed platform showcases the utili","2021","07","21","Anal Chem","Analytical chemistry",NA,"Lobb","Richard J","Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia",NA
"1708","34264067","10.1021/acs.analchem.1c01657","Amplification-Free SARS-CoV-2 Detection Using Nanoyeast-scFv and Ultrasensitive Plasmonic Nanobox-Integrated Nanomixing Microassay.","The implementation of accurate and sensitive molecular detection for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to effectively control the ongoing coronavirus disease 2019 (COVID-19) pandemic. In this regard, we herein propose the specific and highly sensitive SARS-CoV-2 detection based on nanoyeast single-chain-variable fragment (scFv) and ultrasensitive plasmonic nanobox-integrated nanomixing microassay. Importantly, this designed platform showcases the utili","2021","07","21","Anal Chem","Analytical chemistry",NA,"Puttick","Simon","Probing Biosystems Future Science Platform, Commonwealth Scientific and Industrial Research Organization, Brisbane, QLD 4029, Australia",NA
"1709","34264067","10.1021/acs.analchem.1c01657","Amplification-Free SARS-CoV-2 Detection Using Nanoyeast-scFv and Ultrasensitive Plasmonic Nanobox-Integrated Nanomixing Microassay.","The implementation of accurate and sensitive molecular detection for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to effectively control the ongoing coronavirus disease 2019 (COVID-19) pandemic. In this regard, we herein propose the specific and highly sensitive SARS-CoV-2 detection based on nanoyeast single-chain-variable fragment (scFv) and ultrasensitive plasmonic nanobox-integrated nanomixing microassay. Importantly, this designed platform showcases the utili","2021","07","21","Anal Chem","Analytical chemistry",NA,"Rose","Stephen","Probing Biosystems Future Science Platform, Commonwealth Scientific and Industrial Research Organization, Brisbane, QLD 4029, Australia",NA
"1710","34264067","10.1021/acs.analchem.1c01657","Amplification-Free SARS-CoV-2 Detection Using Nanoyeast-scFv and Ultrasensitive Plasmonic Nanobox-Integrated Nanomixing Microassay.","The implementation of accurate and sensitive molecular detection for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to effectively control the ongoing coronavirus disease 2019 (COVID-19) pandemic. In this regard, we herein propose the specific and highly sensitive SARS-CoV-2 detection based on nanoyeast single-chain-variable fragment (scFv) and ultrasensitive plasmonic nanobox-integrated nanomixing microassay. Importantly, this designed platform showcases the utili","2021","07","21","Anal Chem","Analytical chemistry",NA,"Howard","Christopher B","Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia",NA
"1711","34264067","10.1021/acs.analchem.1c01657","Amplification-Free SARS-CoV-2 Detection Using Nanoyeast-scFv and Ultrasensitive Plasmonic Nanobox-Integrated Nanomixing Microassay.","The implementation of accurate and sensitive molecular detection for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to effectively control the ongoing coronavirus disease 2019 (COVID-19) pandemic. In this regard, we herein propose the specific and highly sensitive SARS-CoV-2 detection based on nanoyeast single-chain-variable fragment (scFv) and ultrasensitive plasmonic nanobox-integrated nanomixing microassay. Importantly, this designed platform showcases the utili","2021","07","21","Anal Chem","Analytical chemistry",NA,"Trau","Matt","Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia",NA
"1712","34264042","",NA,NA,"2021","07","19","Rev Med Suisse","Revue medicale suisse","COVID-19; Humans; Immunization Programs; SARS-CoV-2; Vaccination","Meylan","Pascal","Professeur honoraire, Faculté de biologie et de médecine, Université de Lausanne, 1015 Lausanne",NA
"1713","34264036","","[The ""vulnerable person"" and the role of the treating physician].","One major concern in the management of the COVID-19 pandemic has been to ensure the protection of certain categories of population considered to be at especially high risk in the event of an infection. This article gives an overview of the legal status of the «vulnerable» person in Switzerland and explores the role of the treating physician in this context, particularly with regard to labour law. The physician will have to assess the status of «vulnerable person» and, where applicable, issue a v","2021","07","16","Rev Med Suisse","Revue medicale suisse","COVID-19; Humans; Pandemics; Physicians; SARS-CoV-2; Switzerland","Martin-Achard","Pierre","Avocat·e, PMA Pedrazzini Martin-Achard Avocats, 11 rue De-Candolle, 1205 Genève",NA
"1714","34264036","","[The ""vulnerable person"" and the role of the treating physician].","One major concern in the management of the COVID-19 pandemic has been to ensure the protection of certain categories of population considered to be at especially high risk in the event of an infection. This article gives an overview of the legal status of the «vulnerable» person in Switzerland and explores the role of the treating physician in this context, particularly with regard to labour law. The physician will have to assess the status of «vulnerable person» and, where applicable, issue a v","2021","07","16","Rev Med Suisse","Revue medicale suisse","COVID-19; Humans; Pandemics; Physicians; SARS-CoV-2; Switzerland","Viret","Marjolaine","Avocat·e, PMA Pedrazzini Martin-Achard Avocats, 11 rue De-Candolle, 1205 Genève",NA
"1715","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","El Rifay","Amira S","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1716","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","Mahmoud","Sara H","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1717","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","Marouf","Mohamed A","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1718","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","Gomaa","Mokhtar R","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1719","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","El Taweel","Ahmed","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1720","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","Abo Shama","Noura M","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1721","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","GabAllah","Mohamed","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1722","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","Abd El Dayem","Soha M","Paediatrics Department, National Research Centre, Giza, Egypt",NA
"1723","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","Kandeil","Ahmed","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1724","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","Mostafa","Ahmed","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1725","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","El-Shesheny","Rabeh","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1726","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","Kayali","Ghazi","Department of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas, Houston, Texas, USA",NA
"1727","34264010","10.1111/irv.12889","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings. We conducted a cross-sectional serolog","2021","07","15","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; Egypt; SARS-CoV-2; covariates; neutralizing antibodies; seroprevalence","Ali","Mohamed A","Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt",NA
"1728","34264006","10.1111/apha.13717","Post-COVID-19 neuropsychiatric syndrome: Is maladaptive glial recovery to blame?",NA,"2021","07","22","Acta Physiol (Oxf)","Acta physiologica (Oxford, England)",NA,"Steardo","Luca","Psychiatric Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy",NA
"1729","34264006","10.1111/apha.13717","Post-COVID-19 neuropsychiatric syndrome: Is maladaptive glial recovery to blame?",NA,"2021","07","22","Acta Physiol (Oxf)","Acta physiologica (Oxford, England)",NA,"Steardo","Luca","Department of Physiology and Pharmacology ""Vittorio Erspamer"", SAPIENZA University of Rome, Rome, Italy",NA
"1730","34264006","10.1111/apha.13717","Post-COVID-19 neuropsychiatric syndrome: Is maladaptive glial recovery to blame?",NA,"2021","07","22","Acta Physiol (Oxf)","Acta physiologica (Oxford, England)",NA,"Verkhratsky","Alexei","Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK",NA
"1731","34264006","10.1111/apha.13717","Post-COVID-19 neuropsychiatric syndrome: Is maladaptive glial recovery to blame?",NA,"2021","07","22","Acta Physiol (Oxf)","Acta physiologica (Oxford, England)",NA,"Scuderi","Caterina","Department of Physiology and Pharmacology ""Vittorio Erspamer"", SAPIENZA University of Rome, Rome, Italy",NA
"1732","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Nguyen","Phuong Hong","Poverty Health and Nutrition Division, International Food Policy Research Institute, Washington, District of Columbia, USA",NA
"1733","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Sununtnasuk","Celeste","Poverty Health and Nutrition Division, International Food Policy Research Institute, Washington, District of Columbia, USA",NA
"1734","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Pant","Anjali","Poverty Health and Nutrition Division, International Food Policy Research Institute, Washington, District of Columbia, USA",NA
"1735","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Tran Mai","Lan","FHI Solutions, Washington, District of Columbia, USA",NA
"1736","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Kachwaha","Shivani","Poverty Health and Nutrition Division, International Food Policy Research Institute, Washington, District of Columbia, USA",NA
"1737","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Ash","Deborah","FHI Solutions, Washington, District of Columbia, USA",NA
"1738","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Ali","Mohsin","FHI Solutions, Washington, District of Columbia, USA",NA
"1739","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Ireen","Santhia","FHI Solutions, Washington, District of Columbia, USA",NA
"1740","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Kappos","Kristen","FHI Solutions, Washington, District of Columbia, USA",NA
"1741","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Escobar-Alegria","Jessica","FHI Solutions, Washington, District of Columbia, USA",NA
"1742","34264002","10.1111/mcn.13218","Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh.","The COVID-19 pandemic is expected to have profound effects on healthcare systems, but little evidence exists on service provision, utilisation, or adaptations. This study aimed to (1) examine the changes to health and nutrition service delivery and utilisation in urban Bangladesh during and after enforcement of COVID-19 restrictions and (2) identify adaptations and potential solutions to strengthen delivery and uptake. We conducted longitudinal surveys with health care providers (n = 45), pregna","2021","07","15","Matern Child Nutr","Maternal &amp; child nutrition","Bangladesh; COVID-19; service delivery; service utilisation","Menon","Purnima","Poverty Health and Nutrition Division, International Food Policy Research Institute, Washington, District of Columbia, USA",NA
"1743","34263996","10.1002/ejhf.2305","HFpEF and COVID-19: which comes first, the chicken or the egg? REPLY.",NA,"2021","07","15","Eur J Heart Fail","European journal of heart failure","COVID-19; HFA-PEFF; diastolic dysfunction","Anker","Markus S","Department of Cardiology Charité - Universitätsmedizin Berlin, Campus Benjamin-Franklin, Berlin, Germany",NA
"1744","34263996","10.1002/ejhf.2305","HFpEF and COVID-19: which comes first, the chicken or the egg? REPLY.",NA,"2021","07","15","Eur J Heart Fail","European journal of heart failure","COVID-19; HFA-PEFF; diastolic dysfunction","Tschöpe","Carsten","Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany",NA
"1745","34263984","10.1002/ejhf.2302","EFFICACY OF THE COVID-19 VACCINE IN HEART TRANSPLANT RECIPIENTS: WHAT DO WE KNOW AND WHAT IGNORE?",NA,"2021","07","15","Eur J Heart Fail","European journal of heart failure",NA,"Crespo-Leiro","Maria Generosa","Department of Cardiology, Complexo Hospitalario Universitario a Coruña (Chuac). Instituto De Investigación Biomedica a Coruña (Inibic). Centro de Investigacion Biomedica en Red Cardiovascular (Cibercv), A Coruña, Spain",NA
"1746","34263984","10.1002/ejhf.2302","EFFICACY OF THE COVID-19 VACCINE IN HEART TRANSPLANT RECIPIENTS: WHAT DO WE KNOW AND WHAT IGNORE?",NA,"2021","07","15","Eur J Heart Fail","European journal of heart failure",NA,"Barge-Caballero","Eduardo","Department of Cardiology, Complexo Hospitalario Universitario a Coruña (Chuac). Instituto De Investigación Biomedica a Coruña (Inibic). Centro de Investigacion Biomedica en Red Cardiovascular (Cibercv), A Coruña, Spain",NA
"1747","34263984","10.1002/ejhf.2302","EFFICACY OF THE COVID-19 VACCINE IN HEART TRANSPLANT RECIPIENTS: WHAT DO WE KNOW AND WHAT IGNORE?",NA,"2021","07","15","Eur J Heart Fail","European journal of heart failure",NA,"Gustafsson","Finn","Department of Cardiology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark",NA
"1748","34263951","10.1002/hpm.3280","Resuming outpatient services during COVID times: Our approach and experience at India's apex institute.","Healthcare services have been severely strained and stressed coping with the rising burden of COVID-19 patients. With the situation gradually worsening and the growing need to cater to Non-COVID patients, we ventured to reopen the OPDs. This was to be implemented in a staggered manner. The backbone to this endeavour was the specialised screening and sampling OPD for healthcare workers which had been earlier established. We would like to share our two-pronged approach in this unprecedented situat","2021","07","15","Int J Health Plann Manage","The International journal of health planning and management","infection control; outpatient department; pandemic; screening","Sarda","Radhika","Departments of Medicine, All India Institute of Medical Sciences, New Delhi, Delhi, India",NA
"1749","34263951","10.1002/hpm.3280","Resuming outpatient services during COVID times: Our approach and experience at India's apex institute.","Healthcare services have been severely strained and stressed coping with the rising burden of COVID-19 patients. With the situation gradually worsening and the growing need to cater to Non-COVID patients, we ventured to reopen the OPDs. This was to be implemented in a staggered manner. The backbone to this endeavour was the specialised screening and sampling OPD for healthcare workers which had been earlier established. We would like to share our two-pronged approach in this unprecedented situat","2021","07","15","Int J Health Plann Manage","The International journal of health planning and management","infection control; outpatient department; pandemic; screening","Mattoo","Bhawna","Departments of Physiology, All India Institute of Medical Sciences, New Delhi, Delhi, India",NA
"1750","34263951","10.1002/hpm.3280","Resuming outpatient services during COVID times: Our approach and experience at India's apex institute.","Healthcare services have been severely strained and stressed coping with the rising burden of COVID-19 patients. With the situation gradually worsening and the growing need to cater to Non-COVID patients, we ventured to reopen the OPDs. This was to be implemented in a staggered manner. The backbone to this endeavour was the specialised screening and sampling OPD for healthcare workers which had been earlier established. We would like to share our two-pronged approach in this unprecedented situat","2021","07","15","Int J Health Plann Manage","The International journal of health planning and management","infection control; outpatient department; pandemic; screening","Kumar","Arvind","Departments of Medicine, All India Institute of Medical Sciences, New Delhi, Delhi, India",NA
"1751","34263951","10.1002/hpm.3280","Resuming outpatient services during COVID times: Our approach and experience at India's apex institute.","Healthcare services have been severely strained and stressed coping with the rising burden of COVID-19 patients. With the situation gradually worsening and the growing need to cater to Non-COVID patients, we ventured to reopen the OPDs. This was to be implemented in a staggered manner. The backbone to this endeavour was the specialised screening and sampling OPD for healthcare workers which had been earlier established. We would like to share our two-pronged approach in this unprecedented situat","2021","07","15","Int J Health Plann Manage","The International journal of health planning and management","infection control; outpatient department; pandemic; screening","H","Vikas","Departments of Hospital Administration, All India Institute of Medical Sciences, New Delhi, Delhi, India",NA
"1752","34263951","10.1002/hpm.3280","Resuming outpatient services during COVID times: Our approach and experience at India's apex institute.","Healthcare services have been severely strained and stressed coping with the rising burden of COVID-19 patients. With the situation gradually worsening and the growing need to cater to Non-COVID patients, we ventured to reopen the OPDs. This was to be implemented in a staggered manner. The backbone to this endeavour was the specialised screening and sampling OPD for healthcare workers which had been earlier established. We would like to share our two-pronged approach in this unprecedented situat","2021","07","15","Int J Health Plann Manage","The International journal of health planning and management","infection control; outpatient department; pandemic; screening","Madaan","Nirupam","Departments of Hospital Administration, All India Institute of Medical Sciences, New Delhi, Delhi, India",NA
"1753","34263951","10.1002/hpm.3280","Resuming outpatient services during COVID times: Our approach and experience at India's apex institute.","Healthcare services have been severely strained and stressed coping with the rising burden of COVID-19 patients. With the situation gradually worsening and the growing need to cater to Non-COVID patients, we ventured to reopen the OPDs. This was to be implemented in a staggered manner. The backbone to this endeavour was the specialised screening and sampling OPD for healthcare workers which had been earlier established. We would like to share our two-pronged approach in this unprecedented situat","2021","07","15","Int J Health Plann Manage","The International journal of health planning and management","infection control; outpatient department; pandemic; screening","Wig","Naveet","Departments of Medicine, All India Institute of Medical Sciences, New Delhi, Delhi, India",NA
"1754","34263921","10.5603/GP.a2021.0118","COVID-19 infection in pregnancy: a single center experience with 75 cases.","This study aimed to summarize the clinical features, maternal, fetal, and perinatal outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proven infections of pregnancies. This retrospective single center study was conducted on 75 pregnant patients diagnosed of coronavirus disease 2019 (COVID-19). Demographic characteristics, clinical courses, laboratory and radiological findings, and maternal and perinatal outcomes were analyzed using medical records. Of the 75 pregnant women","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; SARS-CoV-2; perinatal outcome; pregnancy; vertical transmission","Damar Çakirca","Tuba","Department of Infectious Diseases and Clinical Microbiology, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey. dr.tubadamar@gmail","dr.tubadamar@gmail.com"
"1755","34263921","10.5603/GP.a2021.0118","COVID-19 infection in pregnancy: a single center experience with 75 cases.","This study aimed to summarize the clinical features, maternal, fetal, and perinatal outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proven infections of pregnancies. This retrospective single center study was conducted on 75 pregnant patients diagnosed of coronavirus disease 2019 (COVID-19). Demographic characteristics, clinical courses, laboratory and radiological findings, and maternal and perinatal outcomes were analyzed using medical records. Of the 75 pregnant women","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; SARS-CoV-2; perinatal outcome; pregnancy; vertical transmission","Torun","Ayse","Department of Infectious Diseases and Clinical Microbiology, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey",NA
"1756","34263921","10.5603/GP.a2021.0118","COVID-19 infection in pregnancy: a single center experience with 75 cases.","This study aimed to summarize the clinical features, maternal, fetal, and perinatal outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proven infections of pregnancies. This retrospective single center study was conducted on 75 pregnant patients diagnosed of coronavirus disease 2019 (COVID-19). Demographic characteristics, clinical courses, laboratory and radiological findings, and maternal and perinatal outcomes were analyzed using medical records. Of the 75 pregnant women","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; SARS-CoV-2; perinatal outcome; pregnancy; vertical transmission","Hamidanoglu","Melek","Department of Infectious Diseases and Clinical Microbiology, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey",NA
"1757","34263921","10.5603/GP.a2021.0118","COVID-19 infection in pregnancy: a single center experience with 75 cases.","This study aimed to summarize the clinical features, maternal, fetal, and perinatal outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proven infections of pregnancies. This retrospective single center study was conducted on 75 pregnant patients diagnosed of coronavirus disease 2019 (COVID-19). Demographic characteristics, clinical courses, laboratory and radiological findings, and maternal and perinatal outcomes were analyzed using medical records. Of the 75 pregnant women","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; SARS-CoV-2; perinatal outcome; pregnancy; vertical transmission","Portakal","Reyhan Derya","Department of Chest Diseases, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey",NA
"1758","34263921","10.5603/GP.a2021.0118","COVID-19 infection in pregnancy: a single center experience with 75 cases.","This study aimed to summarize the clinical features, maternal, fetal, and perinatal outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proven infections of pregnancies. This retrospective single center study was conducted on 75 pregnant patients diagnosed of coronavirus disease 2019 (COVID-19). Demographic characteristics, clinical courses, laboratory and radiological findings, and maternal and perinatal outcomes were analyzed using medical records. Of the 75 pregnant women","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; SARS-CoV-2; perinatal outcome; pregnancy; vertical transmission","Ölçen","Merhamet","Department of Chest Diseases, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey",NA
"1759","34263921","10.5603/GP.a2021.0118","COVID-19 infection in pregnancy: a single center experience with 75 cases.","This study aimed to summarize the clinical features, maternal, fetal, and perinatal outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proven infections of pregnancies. This retrospective single center study was conducted on 75 pregnant patients diagnosed of coronavirus disease 2019 (COVID-19). Demographic characteristics, clinical courses, laboratory and radiological findings, and maternal and perinatal outcomes were analyzed using medical records. Of the 75 pregnant women","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; SARS-CoV-2; perinatal outcome; pregnancy; vertical transmission","Çakirca","Gökhan","Department of Biochemistry, Sanliurfa Mehmet Akif Inan Training and Research Hospital, Sanliurfa, Turkey",NA
"1760","34263921","10.5603/GP.a2021.0118","COVID-19 infection in pregnancy: a single center experience with 75 cases.","This study aimed to summarize the clinical features, maternal, fetal, and perinatal outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proven infections of pregnancies. This retrospective single center study was conducted on 75 pregnant patients diagnosed of coronavirus disease 2019 (COVID-19). Demographic characteristics, clinical courses, laboratory and radiological findings, and maternal and perinatal outcomes were analyzed using medical records. Of the 75 pregnant women","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; SARS-CoV-2; perinatal outcome; pregnancy; vertical transmission","Haksever","Murat","Department of Obstetrics and Gynecology, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey",NA
"1761","34263917","10.5603/GP.a2021.0135","The impact of COVID-19 pandemic on reproductive intentions among the Polish population.","The study was conducted in order to determine the impact of the COVID-19 pandemic on the fertility intentions among the Polish population. A cross-sectional, questionnaire-based online study was carried out among Polish adults in order to determine the impact of the COVID-19 pandemic on the reproductive plans of the Polish society. A total of 984 participants correctly completed the survey. The pandemic has affected the reproductive intentions of 22% (n = 216) of the respondents, most of them wa","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; pandemic; reproduction; reproductive health","Sienicka","Agnieszka","Students' Scientific Group affiliated to II Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland",NA
"1762","34263917","10.5603/GP.a2021.0135","The impact of COVID-19 pandemic on reproductive intentions among the Polish population.","The study was conducted in order to determine the impact of the COVID-19 pandemic on the fertility intentions among the Polish population. A cross-sectional, questionnaire-based online study was carried out among Polish adults in order to determine the impact of the COVID-19 pandemic on the reproductive plans of the Polish society. A total of 984 participants correctly completed the survey. The pandemic has affected the reproductive intentions of 22% (n = 216) of the respondents, most of them wa","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; pandemic; reproduction; reproductive health","Pisula","Agata","Students' Scientific Group affiliated to II Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland",NA
"1763","34263917","10.5603/GP.a2021.0135","The impact of COVID-19 pandemic on reproductive intentions among the Polish population.","The study was conducted in order to determine the impact of the COVID-19 pandemic on the fertility intentions among the Polish population. A cross-sectional, questionnaire-based online study was carried out among Polish adults in order to determine the impact of the COVID-19 pandemic on the reproductive plans of the Polish society. A total of 984 participants correctly completed the survey. The pandemic has affected the reproductive intentions of 22% (n = 216) of the respondents, most of them wa","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; pandemic; reproduction; reproductive health","Pawlik","Katarzyna Karina","Students' Scientific Group affiliated to II Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland",NA
"1764","34263917","10.5603/GP.a2021.0135","The impact of COVID-19 pandemic on reproductive intentions among the Polish population.","The study was conducted in order to determine the impact of the COVID-19 pandemic on the fertility intentions among the Polish population. A cross-sectional, questionnaire-based online study was carried out among Polish adults in order to determine the impact of the COVID-19 pandemic on the reproductive plans of the Polish society. A total of 984 participants correctly completed the survey. The pandemic has affected the reproductive intentions of 22% (n = 216) of the respondents, most of them wa","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; pandemic; reproduction; reproductive health","Kacperczyk-Bartnik","Joanna","II Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland. asiakacperczyk@gmail","asiakacperczyk@gmail.com"
"1765","34263917","10.5603/GP.a2021.0135","The impact of COVID-19 pandemic on reproductive intentions among the Polish population.","The study was conducted in order to determine the impact of the COVID-19 pandemic on the fertility intentions among the Polish population. A cross-sectional, questionnaire-based online study was carried out among Polish adults in order to determine the impact of the COVID-19 pandemic on the reproductive plans of the Polish society. A total of 984 participants correctly completed the survey. The pandemic has affected the reproductive intentions of 22% (n = 216) of the respondents, most of them wa","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; pandemic; reproduction; reproductive health","Bartnik","Pawel","II Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland",NA
"1766","34263917","10.5603/GP.a2021.0135","The impact of COVID-19 pandemic on reproductive intentions among the Polish population.","The study was conducted in order to determine the impact of the COVID-19 pandemic on the fertility intentions among the Polish population. A cross-sectional, questionnaire-based online study was carried out among Polish adults in order to determine the impact of the COVID-19 pandemic on the reproductive plans of the Polish society. A total of 984 participants correctly completed the survey. The pandemic has affected the reproductive intentions of 22% (n = 216) of the respondents, most of them wa","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; pandemic; reproduction; reproductive health","Dobrowolska-Redo","Agnieszka","II Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland",NA
"1767","34263917","10.5603/GP.a2021.0135","The impact of COVID-19 pandemic on reproductive intentions among the Polish population.","The study was conducted in order to determine the impact of the COVID-19 pandemic on the fertility intentions among the Polish population. A cross-sectional, questionnaire-based online study was carried out among Polish adults in order to determine the impact of the COVID-19 pandemic on the reproductive plans of the Polish society. A total of 984 participants correctly completed the survey. The pandemic has affected the reproductive intentions of 22% (n = 216) of the respondents, most of them wa","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; pandemic; reproduction; reproductive health","Romejko-Wolniewicz","Ewa","II Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland",NA
"1768","34263916","10.5603/GP.a2021.0134","Did the SARS-CoV-2 effect pregnancy complications?","This study aimed to evaluate the effect of SARS-CoV-2 on pregnancy complications, which increased compared to the same period before the pandemic. This prospective study was conducted at Etlik Zübeyde HanimWomen'sHealthPractices &amp;Research Center between June 2020 and July 2020. The asymptomatic term PROM and miscarriage pregnant women were screened for SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) positivity by using IgM and IgG antibody tests. All the positive cases were conf","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; asymptomatic; miscarriage; pregnancy; term prelabor rupture of membranes","Yucel Celik","Ozge","University of Health Sciences Etlik Zübeyde Hanim Women's Health Care, Training and Research Hospital, Ankara, Turkey. ozgeyucel86@hotmail","ozgeyucel86@hotmail.com"
"1769","34263916","10.5603/GP.a2021.0134","Did the SARS-CoV-2 effect pregnancy complications?","This study aimed to evaluate the effect of SARS-CoV-2 on pregnancy complications, which increased compared to the same period before the pandemic. This prospective study was conducted at Etlik Zübeyde HanimWomen'sHealthPractices &amp;Research Center between June 2020 and July 2020. The asymptomatic term PROM and miscarriage pregnant women were screened for SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) positivity by using IgM and IgG antibody tests. All the positive cases were conf","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; asymptomatic; miscarriage; pregnancy; term prelabor rupture of membranes","Çelen","Sevki","University of Health Sciences Etlik Zübeyde Hanim Women's Health Care, Training and Research Hospital, Ankara, Turkey",NA
"1770","34263916","10.5603/GP.a2021.0134","Did the SARS-CoV-2 effect pregnancy complications?","This study aimed to evaluate the effect of SARS-CoV-2 on pregnancy complications, which increased compared to the same period before the pandemic. This prospective study was conducted at Etlik Zübeyde HanimWomen'sHealthPractices &amp;Research Center between June 2020 and July 2020. The asymptomatic term PROM and miscarriage pregnant women were screened for SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) positivity by using IgM and IgG antibody tests. All the positive cases were conf","2021","07","15","Ginekol Pol","Ginekologia polska","COVID-19; asymptomatic; miscarriage; pregnancy; term prelabor rupture of membranes","Engin Üstün","Yaprak","University of Health Sciences Etlik Zübeyde Hanim Women's Health Care, Training and Research Hospital, Ankara, Turkey",NA
"1771","34263876","10.1701/3638.36184","[Access to anti-covid vaccines: research, development and role of patents.]","Access to vaccines against covid-19 is a very topical issue. On the one hand, we are suffering from supply problems and inadequate availability of doses both nationally and internationally. On the other hand, public health needs do not coincide with those of the market economy: the need to vaccinate the entire world population to overcome the pandemic cannot be satisfied due to market rules and limits in production processes. The result is a radical inequality in access to vaccines. We are aware","2021","07","22","Recenti Prog Med","Recenti progressi in medicina","Biomedical Research; COVID-19; COVID-19 Vaccines; Diffusion of Innovation; Drug Development; Global Health; Healthcare Disparities; Humans; Intellectual Property; Italy; Needs Assessment; Patents as Topic; Public Health; Research Support as Topic; Vaccination Coverage","Formoso","Giulio","Struttura Governo Clinico, Azienda USL - IRCCS di Reggio Emilia - Associazione Alessandro Liberati, Perugia",NA
"1772","34263876","10.1701/3638.36184","[Access to anti-covid vaccines: research, development and role of patents.]","Access to vaccines against covid-19 is a very topical issue. On the one hand, we are suffering from supply problems and inadequate availability of doses both nationally and internationally. On the other hand, public health needs do not coincide with those of the market economy: the need to vaccinate the entire world population to overcome the pandemic cannot be satisfied due to market rules and limits in production processes. The result is a radical inequality in access to vaccines. We are aware","2021","07","22","Recenti Prog Med","Recenti progressi in medicina","Biomedical Research; COVID-19; COVID-19 Vaccines; Diffusion of Innovation; Drug Development; Global Health; Healthcare Disparities; Humans; Intellectual Property; Italy; Needs Assessment; Patents as Topic; Public Health; Research Support as Topic; Vaccination Coverage","Mancini","Silvia","Medici Senza Frontiere, Roma",NA
"1773","34263736","10.1172/JCI149412","Distinctive features of severe SARS-CoV-2 pneumonia.","The coronavirus disease 2019 (COVID-19) pandemic is among the most important public health crises of our generation. Despite the promise of prevention offered by effective vaccines, patients with severe COVID-19 will continue to populate hospitals and intensive care units for the foreseeable future. The most common clinical presentation of severe COVID-19 is hypoxemia and respiratory failure, typical of the acute respiratory distress syndrome (ARDS). Whether the clinical features and pathobiolog","2021","07","22","J Clin Invest","The Journal of clinical investigation","Angiotensin-Converting Enzyme 2; Autopsy; COVID-19; Cytokines; Humans; Lung; Macrophages, Alveolar; Models, Biological; Pandemics; Pneumonia, Viral; Receptors, Virus; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index","Budinger","G R Scott",NA,NA
"1774","34263736","10.1172/JCI149412","Distinctive features of severe SARS-CoV-2 pneumonia.","The coronavirus disease 2019 (COVID-19) pandemic is among the most important public health crises of our generation. Despite the promise of prevention offered by effective vaccines, patients with severe COVID-19 will continue to populate hospitals and intensive care units for the foreseeable future. The most common clinical presentation of severe COVID-19 is hypoxemia and respiratory failure, typical of the acute respiratory distress syndrome (ARDS). Whether the clinical features and pathobiolog","2021","07","22","J Clin Invest","The Journal of clinical investigation","Angiotensin-Converting Enzyme 2; Autopsy; COVID-19; Cytokines; Humans; Lung; Macrophages, Alveolar; Models, Biological; Pandemics; Pneumonia, Viral; Receptors, Virus; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index","Misharin","Alexander V",NA,NA
"1775","34263736","10.1172/JCI149412","Distinctive features of severe SARS-CoV-2 pneumonia.","The coronavirus disease 2019 (COVID-19) pandemic is among the most important public health crises of our generation. Despite the promise of prevention offered by effective vaccines, patients with severe COVID-19 will continue to populate hospitals and intensive care units for the foreseeable future. The most common clinical presentation of severe COVID-19 is hypoxemia and respiratory failure, typical of the acute respiratory distress syndrome (ARDS). Whether the clinical features and pathobiolog","2021","07","22","J Clin Invest","The Journal of clinical investigation","Angiotensin-Converting Enzyme 2; Autopsy; COVID-19; Cytokines; Humans; Lung; Macrophages, Alveolar; Models, Biological; Pandemics; Pneumonia, Viral; Receptors, Virus; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index","Ridge","Karen M",NA,NA
"1776","34263736","10.1172/JCI149412","Distinctive features of severe SARS-CoV-2 pneumonia.","The coronavirus disease 2019 (COVID-19) pandemic is among the most important public health crises of our generation. Despite the promise of prevention offered by effective vaccines, patients with severe COVID-19 will continue to populate hospitals and intensive care units for the foreseeable future. The most common clinical presentation of severe COVID-19 is hypoxemia and respiratory failure, typical of the acute respiratory distress syndrome (ARDS). Whether the clinical features and pathobiolog","2021","07","22","J Clin Invest","The Journal of clinical investigation","Angiotensin-Converting Enzyme 2; Autopsy; COVID-19; Cytokines; Humans; Lung; Macrophages, Alveolar; Models, Biological; Pandemics; Pneumonia, Viral; Receptors, Virus; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index","Singer","Benjamin D",NA,NA
"1777","34263736","10.1172/JCI149412","Distinctive features of severe SARS-CoV-2 pneumonia.","The coronavirus disease 2019 (COVID-19) pandemic is among the most important public health crises of our generation. Despite the promise of prevention offered by effective vaccines, patients with severe COVID-19 will continue to populate hospitals and intensive care units for the foreseeable future. The most common clinical presentation of severe COVID-19 is hypoxemia and respiratory failure, typical of the acute respiratory distress syndrome (ARDS). Whether the clinical features and pathobiolog","2021","07","22","J Clin Invest","The Journal of clinical investigation","Angiotensin-Converting Enzyme 2; Autopsy; COVID-19; Cytokines; Humans; Lung; Macrophages, Alveolar; Models, Biological; Pandemics; Pneumonia, Viral; Receptors, Virus; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index","Wunderink","Richard G",NA,NA
"1778","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Guo","Hua","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1779","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Hu","Ben","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1780","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Si","Hao-Rui","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1781","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Zhu","Yan","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1782","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Zhang","Wei","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1783","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Li","Bei","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1784","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Li","Ang","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1785","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Geng","Rong","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1786","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Lin","Hao-Feng","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1787","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Yang","Xing-Lou","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1788","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Zhou","Peng","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1789","34263709","10.1080/22221751.2021.1956373","Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.","Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbor highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2","2021","07","15","Emerg Microbes Infect","Emerging microbes &amp; infections","ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host","Shi","Zheng-Li","CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China",NA
"1790","34263708","10.1080/15257770.2021.1950759","Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic of the coronavirus disease in 2019. RNA-dependent RNA polymerase (RdRp) plays an essential role in RNA replication and transcription in SARS-CoV-2. In this study, we focused on the RNA template component of viral RdRp structure and analyzed human microRNAs (miRNAs) targeting specific sequences in this RNA. By examining miRNA databases and using an in vitro RNA-RNA interaction assay, we observed hsa-miR-15b-5p i","2021","07","15","Nucleosides Nucleotides Nucleic Acids","Nucleosides, nucleotides &amp; nucleic acids","Hsa-miR-15b-5p; RNA template component; RdRp; SARS-CoV-2; miRNA","Sato","Akira","Department of Biochemistry and Molecular Biology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan",NA
"1791","34263708","10.1080/15257770.2021.1950759","Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic of the coronavirus disease in 2019. RNA-dependent RNA polymerase (RdRp) plays an essential role in RNA replication and transcription in SARS-CoV-2. In this study, we focused on the RNA template component of viral RdRp structure and analyzed human microRNAs (miRNAs) targeting specific sequences in this RNA. By examining miRNA databases and using an in vitro RNA-RNA interaction assay, we observed hsa-miR-15b-5p i","2021","07","15","Nucleosides Nucleotides Nucleic Acids","Nucleosides, nucleotides &amp; nucleic acids","Hsa-miR-15b-5p; RNA template component; RdRp; SARS-CoV-2; miRNA","Ogino","Yoko","Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan",NA
"1792","34263708","10.1080/15257770.2021.1950759","Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic of the coronavirus disease in 2019. RNA-dependent RNA polymerase (RdRp) plays an essential role in RNA replication and transcription in SARS-CoV-2. In this study, we focused on the RNA template component of viral RdRp structure and analyzed human microRNAs (miRNAs) targeting specific sequences in this RNA. By examining miRNA databases and using an in vitro RNA-RNA interaction assay, we observed hsa-miR-15b-5p i","2021","07","15","Nucleosides Nucleotides Nucleic Acids","Nucleosides, nucleotides &amp; nucleic acids","Hsa-miR-15b-5p; RNA template component; RdRp; SARS-CoV-2; miRNA","Tanuma","Sei-Ichi","Department of Genomic Medicinal Science, Research Institute for Science and Technology, Organization for Research Advancement, Tokyo University of Science, Noda, Japan",NA
"1793","34263708","10.1080/15257770.2021.1950759","Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic of the coronavirus disease in 2019. RNA-dependent RNA polymerase (RdRp) plays an essential role in RNA replication and transcription in SARS-CoV-2. In this study, we focused on the RNA template component of viral RdRp structure and analyzed human microRNAs (miRNAs) targeting specific sequences in this RNA. By examining miRNA databases and using an in vitro RNA-RNA interaction assay, we observed hsa-miR-15b-5p i","2021","07","15","Nucleosides Nucleotides Nucleic Acids","Nucleosides, nucleotides &amp; nucleic acids","Hsa-miR-15b-5p; RNA template component; RdRp; SARS-CoV-2; miRNA","Uchiumi","Fumiaki","Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan",NA
"1794","34263682","10.1080/13548506.2021.1954669","Sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19).","To investigate the sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19) in order to promote timely intervention and treatment. An Questionnaire Star of WeChat online survey was conducted at Hwamei Hospital, University of Chinese Academy of Sciences, NingBo, China. The questionnaire consisted of two parts including sociodemographic characteristics, and the Pittsburgh Sleep Quality Index (PSQI), the Generalized Anxiety Disord","2021","07","15","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; anxiety; depression; healthcare professionals; sleep quality","Jiang","Ya-Fen","Department of Neurology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejing, China",NA
"1795","34263682","10.1080/13548506.2021.1954669","Sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19).","To investigate the sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19) in order to promote timely intervention and treatment. An Questionnaire Star of WeChat online survey was conducted at Hwamei Hospital, University of Chinese Academy of Sciences, NingBo, China. The questionnaire consisted of two parts including sociodemographic characteristics, and the Pittsburgh Sleep Quality Index (PSQI), the Generalized Anxiety Disord","2021","07","15","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; anxiety; depression; healthcare professionals; sleep quality","Chen","Jia-Qi","Department of Neurology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejing, China",NA
"1796","34263682","10.1080/13548506.2021.1954669","Sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19).","To investigate the sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19) in order to promote timely intervention and treatment. An Questionnaire Star of WeChat online survey was conducted at Hwamei Hospital, University of Chinese Academy of Sciences, NingBo, China. The questionnaire consisted of two parts including sociodemographic characteristics, and the Pittsburgh Sleep Quality Index (PSQI), the Generalized Anxiety Disord","2021","07","15","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; anxiety; depression; healthcare professionals; sleep quality","Wang","Yang-Gang","Department of Rehabilitation, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejing, China",NA
"1797","34263682","10.1080/13548506.2021.1954669","Sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19).","To investigate the sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19) in order to promote timely intervention and treatment. An Questionnaire Star of WeChat online survey was conducted at Hwamei Hospital, University of Chinese Academy of Sciences, NingBo, China. The questionnaire consisted of two parts including sociodemographic characteristics, and the Pittsburgh Sleep Quality Index (PSQI), the Generalized Anxiety Disord","2021","07","15","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; anxiety; depression; healthcare professionals; sleep quality","Zhang","Xiao-Dan","Department of Neurology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejing, China",NA
"1798","34263682","10.1080/13548506.2021.1954669","Sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19).","To investigate the sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19) in order to promote timely intervention and treatment. An Questionnaire Star of WeChat online survey was conducted at Hwamei Hospital, University of Chinese Academy of Sciences, NingBo, China. The questionnaire consisted of two parts including sociodemographic characteristics, and the Pittsburgh Sleep Quality Index (PSQI), the Generalized Anxiety Disord","2021","07","15","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; anxiety; depression; healthcare professionals; sleep quality","Hong","Wen-Ke","Department of Neurology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejing, China",NA
"1799","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Aboueshia","Mohamed","Department of Surgery, Division of Endocrine &amp",NA
"1800","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Hussein","Mohammad Hosny","Department of Surgery, Division of Endocrine &amp",NA
"1801","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Attia","Abdallah S","Department of Surgery, Division of Endocrine &amp",NA
"1802","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Swinford","Aubrey","Tulane University, School of Medicine, New Orleans, LA 70112, USA",NA
"1803","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Miller","Peter","Tulane University, School of Medicine, New Orleans, LA 70112, USA",NA
"1804","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Omar","Mahmoud","Department of Surgery, Division of Endocrine &amp",NA
"1805","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Toraih","Eman Ali","Department of Surgery, Division of Endocrine &amp",NA
"1806","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Saba","Nakhle","Section of Hematology &amp",NA
"1807","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Safah","Hana","Section of Hematology &amp",NA
"1808","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Duchesne","Juan","Trauma/Acute Care &amp",NA
"1809","34263660","10.2217/fon-2021-0121","Cancer and COVID-19: analysis of patient outcomes.","Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p &lt; 0.049), and required longer hospital s","2021","07","20","Future Oncol","Future oncology (London, England)","COVID-19; active cancer and remission; breast cancer; cancer; comorbidities; delayed management; lung cancer; outcomes; prostate cancer","Kandil","Emad","Department of Surgery, Tulane University School of Medicine, New Orleans, LA 70112 USA",NA
"1810","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Cheung","Christabel K","University of Maryland School of Social Work, 525 West Redwood St., Baltimore, MD 21201, USA",NA
"1811","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Tucker-Seeley","Reginald","University of Southern California, Leonard Davis School of Gerontology, Los Angeles, CA 90089, USA",NA
"1812","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Davies","Simon","Teen Cancer America, Los Angeles, CA 90064, USA",NA
"1813","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Gilman","Megan","AYA Psychiatry, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA",NA
"1814","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Miller","Kimberly A","Department of Preventive Medicine, USC Center for Young Adult Cancer Survivorship Research, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA",NA
"1815","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Lopes","Gilberto","Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA",NA
"1816","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Betz","Gail D","University of Maryland Health Sciences and Human Services Library, Baltimore, MD 21201, USA",NA
"1817","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Katerere-Virima","Thuli","University of Maryland Health Sciences and Human Services Library, Baltimore, MD 21201, USA",NA
"1818","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Helbling","Laura E","University of Maryland Health Sciences and Human Services Library, Baltimore, MD 21201, USA",NA
"1819","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Thomas","Bria N","Loyola University Maryland, Baltimore, MD 21210, USA",NA
"1820","34263658","10.2217/fon-2020-1213","A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.","Amidst the concurrent global crises of coronavirus disease 2019 (COVID-19), uprisings against Anti-Black racism and police brutality, as well as anti-Asian racism and violence, the field of medicine found itself simultaneously called upon to respond as essential workers in the public health devastation of COVID-19, and as representatives of healthcare institutions wrought with the impacts of systemic racism. Clinicians, researchers, and advocates in adolescent and young adult (AYA) oncology, mus","2021","07","15","Future Oncol","Future oncology (London, England)","AYA; COVID-19; PCORI; adolescent and young adult oncology; antiracist; patient advocacy; patient engagement; psychosocial; racial/ethnic minority; research methods","Lewis","Mark A","Department of Gastrointestinal Oncology, Intermountain Healthcare, Murray, UT 84107, USA",NA
"1821","34263633","10.21037/apm-21-393","Clinical features and survival analysis of 97 coronavirus disease 2019 (COVID-19) patients.","We aim to investigate the clinical characteristics and survival rate of coronavirus disease 2019 (COVID-19) patients. Ninety-seven COVID-19 patients were enrolled. The laboratory results, lung imaging and medical treatment were compared. Patients were followed up after 1 year, and the Kaplan-Meier test was used for survival analysis. Compared with the non-severe group, the age of the severe group was older, and the proportion of concomitant diseases were higher. As fever was the primary clinical","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Coronavirus disease 2019 (COVID-19); age; concomitant diseases; survival analysis","Li","Aixin","Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China",NA
"1822","34263633","10.21037/apm-21-393","Clinical features and survival analysis of 97 coronavirus disease 2019 (COVID-19) patients.","We aim to investigate the clinical characteristics and survival rate of coronavirus disease 2019 (COVID-19) patients. Ninety-seven COVID-19 patients were enrolled. The laboratory results, lung imaging and medical treatment were compared. Patients were followed up after 1 year, and the Kaplan-Meier test was used for survival analysis. Compared with the non-severe group, the age of the severe group was older, and the proportion of concomitant diseases were higher. As fever was the primary clinical","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Coronavirus disease 2019 (COVID-19); age; concomitant diseases; survival analysis","Chen","Feng","Department of Radiology, Beijing Youan Hospital, Capital Medical University, Beijing, China",NA
"1823","34263633","10.21037/apm-21-393","Clinical features and survival analysis of 97 coronavirus disease 2019 (COVID-19) patients.","We aim to investigate the clinical characteristics and survival rate of coronavirus disease 2019 (COVID-19) patients. Ninety-seven COVID-19 patients were enrolled. The laboratory results, lung imaging and medical treatment were compared. Patients were followed up after 1 year, and the Kaplan-Meier test was used for survival analysis. Compared with the non-severe group, the age of the severe group was older, and the proportion of concomitant diseases were higher. As fever was the primary clinical","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Coronavirus disease 2019 (COVID-19); age; concomitant diseases; survival analysis","Gao","Yue","Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China",NA
"1824","34263633","10.21037/apm-21-393","Clinical features and survival analysis of 97 coronavirus disease 2019 (COVID-19) patients.","We aim to investigate the clinical characteristics and survival rate of coronavirus disease 2019 (COVID-19) patients. Ninety-seven COVID-19 patients were enrolled. The laboratory results, lung imaging and medical treatment were compared. Patients were followed up after 1 year, and the Kaplan-Meier test was used for survival analysis. Compared with the non-severe group, the age of the severe group was older, and the proportion of concomitant diseases were higher. As fever was the primary clinical","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Coronavirus disease 2019 (COVID-19); age; concomitant diseases; survival analysis","Huang","Xiaojie","Department of Infection and Immunological Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, China",NA
"1825","34263633","10.21037/apm-21-393","Clinical features and survival analysis of 97 coronavirus disease 2019 (COVID-19) patients.","We aim to investigate the clinical characteristics and survival rate of coronavirus disease 2019 (COVID-19) patients. Ninety-seven COVID-19 patients were enrolled. The laboratory results, lung imaging and medical treatment were compared. Patients were followed up after 1 year, and the Kaplan-Meier test was used for survival analysis. Compared with the non-severe group, the age of the severe group was older, and the proportion of concomitant diseases were higher. As fever was the primary clinical","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Coronavirus disease 2019 (COVID-19); age; concomitant diseases; survival analysis","Li","Tongzeng","Department of Respiratory and Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China",NA
"1826","34263633","10.21037/apm-21-393","Clinical features and survival analysis of 97 coronavirus disease 2019 (COVID-19) patients.","We aim to investigate the clinical characteristics and survival rate of coronavirus disease 2019 (COVID-19) patients. Ninety-seven COVID-19 patients were enrolled. The laboratory results, lung imaging and medical treatment were compared. Patients were followed up after 1 year, and the Kaplan-Meier test was used for survival analysis. Compared with the non-severe group, the age of the severe group was older, and the proportion of concomitant diseases were higher. As fever was the primary clinical","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Coronavirus disease 2019 (COVID-19); age; concomitant diseases; survival analysis","Zhang","Jiaying","Department of Respiratory and Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China",NA
"1827","34263633","10.21037/apm-21-393","Clinical features and survival analysis of 97 coronavirus disease 2019 (COVID-19) patients.","We aim to investigate the clinical characteristics and survival rate of coronavirus disease 2019 (COVID-19) patients. Ninety-seven COVID-19 patients were enrolled. The laboratory results, lung imaging and medical treatment were compared. Patients were followed up after 1 year, and the Kaplan-Meier test was used for survival analysis. Compared with the non-severe group, the age of the severe group was older, and the proportion of concomitant diseases were higher. As fever was the primary clinical","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Coronavirus disease 2019 (COVID-19); age; concomitant diseases; survival analysis","Liang","Lianchun","Department of Respiratory and Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China",NA
"1828","34263633","10.21037/apm-21-393","Clinical features and survival analysis of 97 coronavirus disease 2019 (COVID-19) patients.","We aim to investigate the clinical characteristics and survival rate of coronavirus disease 2019 (COVID-19) patients. Ninety-seven COVID-19 patients were enrolled. The laboratory results, lung imaging and medical treatment were compared. Patients were followed up after 1 year, and the Kaplan-Meier test was used for survival analysis. Compared with the non-severe group, the age of the severe group was older, and the proportion of concomitant diseases were higher. As fever was the primary clinical","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Coronavirus disease 2019 (COVID-19); age; concomitant diseases; survival analysis","Li","Xuemei","Department of Chronic Disease Management Center, Beijing Youan Hospital, Capital Medical University, Beijing, China",NA
"1829","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Xin","Xiaoyan","Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"1830","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Mo","Ran","Department of Burns and Plastic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"1831","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Shao","Mingran","Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"1832","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Yang","Wen","Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"1833","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Li","Daixin","Department of Radiology, the Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China",NA
"1834","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Zhang","Yanqiu","Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"1835","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Wang","Han","Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"1836","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Liu","Baiyun","Beijing Infervision Technology Co. Ltd., Beijing, China",NA
"1837","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Tian","Song","Beijing Infervision Technology Co. Ltd., Beijing, China",NA
"1838","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Chen","Weidao","Beijing Infervision Technology Co. Ltd., Beijing, China",NA
"1839","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Wu","Jiangfen","Beijing Infervision Technology Co. Ltd., Beijing, China",NA
"1840","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Zhu","Bin","Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"1841","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Zhou","Kefeng","Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"1842","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Du","Chao","Department of Radiology, the Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China",NA
"1843","34263624","10.21037/apm-20-2625","A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.","This study aimed to build a radiomics model with deep learning (DL) and human auditing and examine its diagnostic value in differentiating between coronavirus disease 2019 (COVID-19) and community-acquired pneumonia (CAP). Forty-three COVID-19 patients, whose diagnoses had been confirmed with reverse-transcriptase polymerase-chain-reaction (RT-PCR) tests, and 60 CAP patients, whose diagnoses had been confirmed with sputum cultures, were enrolled in this retrospective study. The candidate regions","2021","07","15","Ann Palliat Med","Annals of palliative medicine","classification; coronavirus disease 2019 (COVID-19); deep learning (DL); human audit; radiomics","Zhang","Bing","Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"1844","34263609","10.21037/apm-20-1176","Management of a COVID-19-infected critically ill patient treated by extracorporeal membrane oxygenation: a case report.","Coronavirus disease 2019 (COVID-19) is a new type of respiratory infectious disease that spreads among humans. People infected with COVID-19 present with severe acute respiratory symptoms, fever, cough, breathlessness and dyspnea, impaired physical conditions, kidney failure, and even death. Chest radiographs suggest diffuse inflammation in both lungs and show ""white lung"" changes. Patients may even experience multiple organ failures within a short period. The effects of general ventilator-assis","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Case report; coronavirus disease 2019 (COVID-19); extracorporeal membrane oxygenation technology; management","Fu","Qingpin","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China",NA
"1845","34263609","10.21037/apm-20-1176","Management of a COVID-19-infected critically ill patient treated by extracorporeal membrane oxygenation: a case report.","Coronavirus disease 2019 (COVID-19) is a new type of respiratory infectious disease that spreads among humans. People infected with COVID-19 present with severe acute respiratory symptoms, fever, cough, breathlessness and dyspnea, impaired physical conditions, kidney failure, and even death. Chest radiographs suggest diffuse inflammation in both lungs and show ""white lung"" changes. Patients may even experience multiple organ failures within a short period. The effects of general ventilator-assis","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Case report; coronavirus disease 2019 (COVID-19); extracorporeal membrane oxygenation technology; management","Li","Difei","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China",NA
"1846","34263609","10.21037/apm-20-1176","Management of a COVID-19-infected critically ill patient treated by extracorporeal membrane oxygenation: a case report.","Coronavirus disease 2019 (COVID-19) is a new type of respiratory infectious disease that spreads among humans. People infected with COVID-19 present with severe acute respiratory symptoms, fever, cough, breathlessness and dyspnea, impaired physical conditions, kidney failure, and even death. Chest radiographs suggest diffuse inflammation in both lungs and show ""white lung"" changes. Patients may even experience multiple organ failures within a short period. The effects of general ventilator-assis","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Case report; coronavirus disease 2019 (COVID-19); extracorporeal membrane oxygenation technology; management","He","Wei","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China",NA
"1847","34263609","10.21037/apm-20-1176","Management of a COVID-19-infected critically ill patient treated by extracorporeal membrane oxygenation: a case report.","Coronavirus disease 2019 (COVID-19) is a new type of respiratory infectious disease that spreads among humans. People infected with COVID-19 present with severe acute respiratory symptoms, fever, cough, breathlessness and dyspnea, impaired physical conditions, kidney failure, and even death. Chest radiographs suggest diffuse inflammation in both lungs and show ""white lung"" changes. Patients may even experience multiple organ failures within a short period. The effects of general ventilator-assis","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Case report; coronavirus disease 2019 (COVID-19); extracorporeal membrane oxygenation technology; management","Zeng","Qiuxuan","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China",NA
"1848","34263609","10.21037/apm-20-1176","Management of a COVID-19-infected critically ill patient treated by extracorporeal membrane oxygenation: a case report.","Coronavirus disease 2019 (COVID-19) is a new type of respiratory infectious disease that spreads among humans. People infected with COVID-19 present with severe acute respiratory symptoms, fever, cough, breathlessness and dyspnea, impaired physical conditions, kidney failure, and even death. Chest radiographs suggest diffuse inflammation in both lungs and show ""white lung"" changes. Patients may even experience multiple organ failures within a short period. The effects of general ventilator-assis","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Case report; coronavirus disease 2019 (COVID-19); extracorporeal membrane oxygenation technology; management","Chen","Jieya","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China",NA
"1849","34263609","10.21037/apm-20-1176","Management of a COVID-19-infected critically ill patient treated by extracorporeal membrane oxygenation: a case report.","Coronavirus disease 2019 (COVID-19) is a new type of respiratory infectious disease that spreads among humans. People infected with COVID-19 present with severe acute respiratory symptoms, fever, cough, breathlessness and dyspnea, impaired physical conditions, kidney failure, and even death. Chest radiographs suggest diffuse inflammation in both lungs and show ""white lung"" changes. Patients may even experience multiple organ failures within a short period. The effects of general ventilator-assis","2021","07","15","Ann Palliat Med","Annals of palliative medicine","Case report; coronavirus disease 2019 (COVID-19); extracorporeal membrane oxygenation technology; management","Zhang","Guolong","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China",NA
"1850","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Gong","Fanwu","Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1851","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Wei","Hua-Xing","Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1852","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Qi","Ji","CAS Key Laboratory of Coastal Environmental Processes and Ecological Remediation, Research Center for Coastal Environmental Engineering and Technology, Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, China",NA
"1853","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Ma","Huan","Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1854","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Liu","Lianxin","Department of Hepatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China",NA
"1855","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Weng","Jianping","Department of Endocrinology and Metabolism, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China",NA
"1856","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Zheng","Xucai","Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1857","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Li","Qiangsheng","Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1858","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Zhao","Dan","Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1859","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Fang","Haopeng","Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1860","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Liu","Liu","Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1861","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","He","Hongliang","Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1862","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Ma","Cuichen","Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1863","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Han","Jinglong","School of Environment and Materials Engineering, Yantai University, Yantai 264005, China",NA
"1864","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Sun","Anyuan","Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1865","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Wang","Baolong","Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1866","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Jin","Tengchuan","Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1867","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Li","Bowei","CAS Key Laboratory of Coastal Environmental Processes and Ecological Remediation, Research Center for Coastal Environmental Engineering and Technology, Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, China",NA
"1868","34263598","10.1021/acssensors.1c00773","Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis.","The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by","2021","07","23","ACS Sens","ACS sensors","COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation","Li","Bofeng","Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China",NA
"1869","34263591","10.23736/S0375-9393.21.15924-3","Hypercoagulable state complications in SARS-CoV-2 pneumonia.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Linassi","Federico","Department of Anesthesiology and Critical Care, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy - federico.linassi@gmail","federico.linassi@gmail.com"
"1870","34263591","10.23736/S0375-9393.21.15924-3","Hypercoagulable state complications in SARS-CoV-2 pneumonia.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Campagnolo","Matteo","Department of Anesthesiology and Critical Care, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy",NA
"1871","34263591","10.23736/S0375-9393.21.15924-3","Hypercoagulable state complications in SARS-CoV-2 pneumonia.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Minniti","Giuseppe","Department of Cardiac-Surgery, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy",NA
"1872","34263591","10.23736/S0375-9393.21.15924-3","Hypercoagulable state complications in SARS-CoV-2 pneumonia.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Farnia","Antonio","Department of Anesthesiology and Critical Care, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy",NA
"1873","34263591","10.23736/S0375-9393.21.15924-3","Hypercoagulable state complications in SARS-CoV-2 pneumonia.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Peta","Mario","Department of Anesthesiology and Critical Care, Treviso Regional Hospital AULSS 2 Marca Trevigiana, Treviso, Italy",NA
"1874","34263589","10.23736/S0375-9393.21.15865-1","Cervical plexus block and carotid endarterectomy in the COVID-19 pandemic: regional anesthesia is the key.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Sepolvere","Giuseppe","Department of Anesthesia and Cardiac Surgery Intensive Care Unit, San Michele Hospital, Maddaloni, Caserta, Italy - gsepolvere@inwind","gsepolvere@inwind.it"
"1875","34263589","10.23736/S0375-9393.21.15865-1","Cervical plexus block and carotid endarterectomy in the COVID-19 pandemic: regional anesthesia is the key.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Scialdone","Valeria R","Department of Anesthesia and Cardiac Surgery Intensive Care Unit, San Michele Hospital, Maddaloni, Caserta, Italy",NA
"1876","34263589","10.23736/S0375-9393.21.15865-1","Cervical plexus block and carotid endarterectomy in the COVID-19 pandemic: regional anesthesia is the key.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Tedesco","Mario","Department of Anesthesia and Intensive Care Unit and Pain Therapy, Mater Dei Hospital, Bari, Italy",NA
"1877","34263589","10.23736/S0375-9393.21.15865-1","Cervical plexus block and carotid endarterectomy in the COVID-19 pandemic: regional anesthesia is the key.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Cristiano","Loredana","Department of Anesthesia and Cardiac Surgery Intensive Care Unit, San Michele Hospital, Maddaloni, Caserta, Italy",NA
"1878","34263588","10.23736/S0375-9393.21.15864-X","Difference between prolonged versus standard duration of prone position in COVID-19 patients: a retrospective study.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Rezoagli","Emanuele","Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy",NA
"1879","34263588","10.23736/S0375-9393.21.15864-X","Difference between prolonged versus standard duration of prone position in COVID-19 patients: a retrospective study.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Mariani","Ilaria","Department of Emergency and Intensive Care, San Gerardo Hospital, Monza, Italy",NA
"1880","34263588","10.23736/S0375-9393.21.15864-X","Difference between prolonged versus standard duration of prone position in COVID-19 patients: a retrospective study.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Rona","Roberto","Department of Emergency and Intensive Care, San Gerardo Hospital, Monza, Italy",NA
"1881","34263588","10.23736/S0375-9393.21.15864-X","Difference between prolonged versus standard duration of prone position in COVID-19 patients: a retrospective study.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Foti","Giuseppe","Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy",NA
"1882","34263588","10.23736/S0375-9393.21.15864-X","Difference between prolonged versus standard duration of prone position in COVID-19 patients: a retrospective study.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Bellani","Giacomo","Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy - giacomo.bellani1@unimib","giacomo.bellani1@unimib.it"
"1883","34263584","10.23736/S0375-9393.21.15750-5","Blood pressure augmentation to supra normal levels to improve oxygenation in COVID-19.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Okkerse","Pieter","Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands - p.okkerse@lumc","p.okkerse@lumc.nl"
"1884","34263584","10.23736/S0375-9393.21.15750-5","Blood pressure augmentation to supra normal levels to improve oxygenation in COVID-19.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Berendsen","Remco R","Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands",NA
"1885","34263584","10.23736/S0375-9393.21.15750-5","Blood pressure augmentation to supra normal levels to improve oxygenation in COVID-19.",NA,"2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Schoe","Abraham","Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands",NA
"1886","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Jansen","Gerrit","Department of Anesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine, and Pain Therapy, Protestant Hospital of the Bethel Foundation, University Hospital of Bielefeld, Bielefeld, Germany - Gerrit.Jansen@evkb","Gerrit.Jansen@evkb.de"
"1887","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Ebeling","Nicole","Department of Anesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine, and Pain Therapy, Protestant Hospital of the Bethel Foundation, University Hospital of Bielefeld, Bielefeld, Germany",NA
"1888","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Latka","Eugen","Department of Medical and Emergency Services, Study Institute Westfalen-Lippe, Bielefeld, Germany",NA
"1889","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Krüger","Stefan","Department of Anesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine, and Pain Therapy, Protestant Hospital of the Bethel Foundation, University Hospital of Bielefeld, Bielefeld, Germany",NA
"1890","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Scholz","Sean S","Department of Anesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine, and Pain Therapy, Protestant Hospital of the Bethel Foundation, University Hospital of Bielefeld, Bielefeld, Germany",NA
"1891","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Trapp","Simon","Department of Anesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine, and Pain Therapy, Protestant Hospital of the Bethel Foundation, University Hospital of Bielefeld, Bielefeld, Germany",NA
"1892","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Granneman","Julia J","Department of Anesthesiology, Operative Intensive Care Medicine, Emergency Medicine and Pain therapy, Bielefeld Municipal Hospital, Bielefeld, Germany",NA
"1893","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Thaemel","Daniel","Department of Anesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine, and Pain Therapy, Protestant Hospital of the Bethel Foundation, University Hospital of Bielefeld, Bielefeld, Germany",NA
"1894","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Chandwani","Suraj","Clinic for Internal Medicine and Gastroenterology, Protestant Hospital of the Bethel Foundation, University Hospital of Bielefeld, Bielefeld, Germany",NA
"1895","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Sauzet","Odile","Epidemiology and International Public Health, Bielefeld School of Public Health &amp",NA
"1896","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Rehberg","Sebastian W","Department of Anesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine, and Pain Therapy, Protestant Hospital of the Bethel Foundation, University Hospital of Bielefeld, Bielefeld, Germany",NA
"1897","34263582","10.23736/S0375-9393.21.15621-4","Impact of COVID-19 adapted guidelines on resuscitation quality in out-of-hospital-cardiac-arrest: a manikin study.","To evaluate the effects of European Resuscitation Council (ERC) COVID-19-guidelines on resuscitation quality emphasizing advanced airway management in out-of-hospital-cardiacarrest. In a manikin study paramedics and emergency physicians performed Advanced-Cardiac-Life-Support in three settings: ERC guidelines 2015 (Control), COVID-19-guidelines as suggested with minimum staff (COVID-19-minimal-personnel); COVID-19-guidelines with paramedics and an emergency physician (COVID-19-advanced-airway-ma","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Borgstedt","Rainer","Department of Anesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine, and Pain Therapy, Protestant Hospital of the Bethel Foundation, University Hospital of Bielefeld, Bielefeld, Germany",NA
"1898","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Biasucci","Daniele G","Intensive Care Unit, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy - danieleguerino.biasucci@policlinicogemelli","danieleguerino.biasucci@policlinicogemelli.it"
"1899","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Buonsenso","Danilo","Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1900","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Piano","Alfonso","Emergency Room, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1901","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Bonadia","Nicola","Emergency Medicine, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1902","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Vargas","Joel","Intensive Care Unit, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1903","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Settanni","Donatella","Intensive Care Unit, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1904","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Bocci","Maria Grazia","Intensive Care Unit, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1905","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Grieco","Domenico L","Intensive Care Unit, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1906","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Carnicelli","Annamaria","Emergency Medicine, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1907","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Scoppettuolo","Giancarlo","Infectious Diseases Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1908","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Eleuteri","Davide","Intensive Care Unit, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1909","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"DE Pascale","Gennaro","Intensive Care Unit, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1910","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Pennisi","Mariano A","Shock and Trauma Unit, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1911","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Franceschi","Francesco","Emergency Medicine, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1912","34263580","10.23736/S0375-9393.21.15188-0","Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.","To determine relationships between lung aeration assessed by lung ultrasound (LUS) with Non-Invasive Ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure. A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS sco","2021","07","15","Minerva Anestesiol","Minerva anestesiologica",NA,"Antonelli","Massimo","Intensive Care Unit, Department of Emergency, Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1913","34263541","10.1111/eip.13193","The effects of the COVID-19 lockdown on adolescents with an eating disorder and identifying factors predicting disordered eating behaviour.","To evaluate the impact of the COVID-19 lockdown on adolescents with eating disorders (ED) and identify factors predicting ED behaviour. This study took place during an age-stratified lockdown for those under 20 years in Turkey. Participants completed a survey developed to evaluate the effects of the lockdown on ED behaviour, well-being and quality of life (QoL) and additionally the eating disorder examination questionnaire (EDE-Q), and scales for depression, anxiety and obsessive-compulsive beha","2021","07","15","Early Interv Psychiatry","Early intervention in psychiatry","COVID-19; adolescent; eating disorder; lockdown; quarantine","Akgül","Sinem","Ihsan Dogramaci Children's Hospital, Department of Pediatrics, Division of Adolescent Medicine, Hacettepe University, Ankara, Turkey",NA
"1914","34263541","10.1111/eip.13193","The effects of the COVID-19 lockdown on adolescents with an eating disorder and identifying factors predicting disordered eating behaviour.","To evaluate the impact of the COVID-19 lockdown on adolescents with eating disorders (ED) and identify factors predicting ED behaviour. This study took place during an age-stratified lockdown for those under 20 years in Turkey. Participants completed a survey developed to evaluate the effects of the lockdown on ED behaviour, well-being and quality of life (QoL) and additionally the eating disorder examination questionnaire (EDE-Q), and scales for depression, anxiety and obsessive-compulsive beha","2021","07","15","Early Interv Psychiatry","Early intervention in psychiatry","COVID-19; adolescent; eating disorder; lockdown; quarantine","Akdemir","Devrim","Department of Child and Adolescent Psychiatry, Hacettepe University, Ankara, Turkey",NA
"1915","34263541","10.1111/eip.13193","The effects of the COVID-19 lockdown on adolescents with an eating disorder and identifying factors predicting disordered eating behaviour.","To evaluate the impact of the COVID-19 lockdown on adolescents with eating disorders (ED) and identify factors predicting ED behaviour. This study took place during an age-stratified lockdown for those under 20 years in Turkey. Participants completed a survey developed to evaluate the effects of the lockdown on ED behaviour, well-being and quality of life (QoL) and additionally the eating disorder examination questionnaire (EDE-Q), and scales for depression, anxiety and obsessive-compulsive beha","2021","07","15","Early Interv Psychiatry","Early intervention in psychiatry","COVID-19; adolescent; eating disorder; lockdown; quarantine","Nalbant","Kevser","Department of Child and Adolescent Psychiatry, Hacettepe University, Ankara, Turkey",NA
"1916","34263541","10.1111/eip.13193","The effects of the COVID-19 lockdown on adolescents with an eating disorder and identifying factors predicting disordered eating behaviour.","To evaluate the impact of the COVID-19 lockdown on adolescents with eating disorders (ED) and identify factors predicting ED behaviour. This study took place during an age-stratified lockdown for those under 20 years in Turkey. Participants completed a survey developed to evaluate the effects of the lockdown on ED behaviour, well-being and quality of life (QoL) and additionally the eating disorder examination questionnaire (EDE-Q), and scales for depression, anxiety and obsessive-compulsive beha","2021","07","15","Early Interv Psychiatry","Early intervention in psychiatry","COVID-19; adolescent; eating disorder; lockdown; quarantine","Derman","Orhan","Ihsan Dogramaci Children's Hospital, Department of Pediatrics, Division of Adolescent Medicine, Hacettepe University, Ankara, Turkey",NA
"1917","34263541","10.1111/eip.13193","The effects of the COVID-19 lockdown on adolescents with an eating disorder and identifying factors predicting disordered eating behaviour.","To evaluate the impact of the COVID-19 lockdown on adolescents with eating disorders (ED) and identify factors predicting ED behaviour. This study took place during an age-stratified lockdown for those under 20 years in Turkey. Participants completed a survey developed to evaluate the effects of the lockdown on ED behaviour, well-being and quality of life (QoL) and additionally the eating disorder examination questionnaire (EDE-Q), and scales for depression, anxiety and obsessive-compulsive beha","2021","07","15","Early Interv Psychiatry","Early intervention in psychiatry","COVID-19; adolescent; eating disorder; lockdown; quarantine","Ersöz Alan","Burcu","Department of Child and Adolescent Psychiatry, Hacettepe University, Ankara, Turkey",NA
"1918","34263541","10.1111/eip.13193","The effects of the COVID-19 lockdown on adolescents with an eating disorder and identifying factors predicting disordered eating behaviour.","To evaluate the impact of the COVID-19 lockdown on adolescents with eating disorders (ED) and identify factors predicting ED behaviour. This study took place during an age-stratified lockdown for those under 20 years in Turkey. Participants completed a survey developed to evaluate the effects of the lockdown on ED behaviour, well-being and quality of life (QoL) and additionally the eating disorder examination questionnaire (EDE-Q), and scales for depression, anxiety and obsessive-compulsive beha","2021","07","15","Early Interv Psychiatry","Early intervention in psychiatry","COVID-19; adolescent; eating disorder; lockdown; quarantine","Tüzün","Zeynep","Ihsan Dogramaci Children's Hospital, Department of Pediatrics, Division of Adolescent Medicine, Hacettepe University, Ankara, Turkey",NA
"1919","34263541","10.1111/eip.13193","The effects of the COVID-19 lockdown on adolescents with an eating disorder and identifying factors predicting disordered eating behaviour.","To evaluate the impact of the COVID-19 lockdown on adolescents with eating disorders (ED) and identify factors predicting ED behaviour. This study took place during an age-stratified lockdown for those under 20 years in Turkey. Participants completed a survey developed to evaluate the effects of the lockdown on ED behaviour, well-being and quality of life (QoL) and additionally the eating disorder examination questionnaire (EDE-Q), and scales for depression, anxiety and obsessive-compulsive beha","2021","07","15","Early Interv Psychiatry","Early intervention in psychiatry","COVID-19; adolescent; eating disorder; lockdown; quarantine","Kanbur","Nuray","Ihsan Dogramaci Children's Hospital, Department of Pediatrics, Division of Adolescent Medicine, Hacettepe University, Ankara, Turkey",NA
"1920","34263522","10.1111/codi.15794","The impact of the first peak of the COVID-19 pandemic on colorectal cancer services in England and Wales: A national survey, by Boyle et al.",NA,"2021","07","19","Colorectal Dis","Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland","COVID-19; Colorectal Neoplasms; England; Humans; Pandemics; SARS-CoV-2; Wales","Burns","Elaine",NA,NA
"1921","34263423","10.1007/s11239-021-02499-z","Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.","Coronavirus disease (COVID-19)-related systemic cytokine response induces the production of procoagulant factors, which predisposes patients to a prothrombotic state. Viscoelastic testing can identify the degree of hypercoagulability, which is related to outcomes. We aimed to study the changes in clot waveform analysis (CWA) parameters in COVID-19 patients on hospital admission compared to those in a group of healthy individuals. We conducted a retrospective study of COVID-19 patients admitted t","2021","07","20","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","COVID-19; Clot wave analysis; Fibrinogen; General ward; Hypercoagulability","Ichikawa","Junko","Department of Anesthesiology, Tokyo Women's Medical University Medical Centre, East, Tokyo, Japan. htwfx872@yahoo.co","htwfx872@yahoo.co.jp"
"1922","34263423","10.1007/s11239-021-02499-z","Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.","Coronavirus disease (COVID-19)-related systemic cytokine response induces the production of procoagulant factors, which predisposes patients to a prothrombotic state. Viscoelastic testing can identify the degree of hypercoagulability, which is related to outcomes. We aimed to study the changes in clot waveform analysis (CWA) parameters in COVID-19 patients on hospital admission compared to those in a group of healthy individuals. We conducted a retrospective study of COVID-19 patients admitted t","2021","07","20","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","COVID-19; Clot wave analysis; Fibrinogen; General ward; Hypercoagulability","Okazaki","Ryouta","Department of Anesthesiology, Tokyo Women's Medical University Medical Centre, East, Tokyo, Japan",NA
"1923","34263423","10.1007/s11239-021-02499-z","Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.","Coronavirus disease (COVID-19)-related systemic cytokine response induces the production of procoagulant factors, which predisposes patients to a prothrombotic state. Viscoelastic testing can identify the degree of hypercoagulability, which is related to outcomes. We aimed to study the changes in clot waveform analysis (CWA) parameters in COVID-19 patients on hospital admission compared to those in a group of healthy individuals. We conducted a retrospective study of COVID-19 patients admitted t","2021","07","20","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","COVID-19; Clot wave analysis; Fibrinogen; General ward; Hypercoagulability","Fukuda","Tomoki","Department of Anesthesiology, Tokyo Women's Medical University Medical Centre, East, Tokyo, Japan",NA
"1924","34263423","10.1007/s11239-021-02499-z","Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.","Coronavirus disease (COVID-19)-related systemic cytokine response induces the production of procoagulant factors, which predisposes patients to a prothrombotic state. Viscoelastic testing can identify the degree of hypercoagulability, which is related to outcomes. We aimed to study the changes in clot waveform analysis (CWA) parameters in COVID-19 patients on hospital admission compared to those in a group of healthy individuals. We conducted a retrospective study of COVID-19 patients admitted t","2021","07","20","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","COVID-19; Clot wave analysis; Fibrinogen; General ward; Hypercoagulability","Ono","Takuya","Department of Internal Medicine, Tokyo Women's Medical University Medical Centre, East, Tokyo, Japan",NA
"1925","34263423","10.1007/s11239-021-02499-z","Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.","Coronavirus disease (COVID-19)-related systemic cytokine response induces the production of procoagulant factors, which predisposes patients to a prothrombotic state. Viscoelastic testing can identify the degree of hypercoagulability, which is related to outcomes. We aimed to study the changes in clot waveform analysis (CWA) parameters in COVID-19 patients on hospital admission compared to those in a group of healthy individuals. We conducted a retrospective study of COVID-19 patients admitted t","2021","07","20","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","COVID-19; Clot wave analysis; Fibrinogen; General ward; Hypercoagulability","Ishikawa","Motonao","Department of Internal Medicine, Tokyo Women's Medical University Medical Centre, East, Tokyo, Japan",NA
"1926","34263423","10.1007/s11239-021-02499-z","Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.","Coronavirus disease (COVID-19)-related systemic cytokine response induces the production of procoagulant factors, which predisposes patients to a prothrombotic state. Viscoelastic testing can identify the degree of hypercoagulability, which is related to outcomes. We aimed to study the changes in clot waveform analysis (CWA) parameters in COVID-19 patients on hospital admission compared to those in a group of healthy individuals. We conducted a retrospective study of COVID-19 patients admitted t","2021","07","20","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","COVID-19; Clot wave analysis; Fibrinogen; General ward; Hypercoagulability","Komori","Makiko","Department of Anesthesiology, Tokyo Women's Medical University Medical Centre, East, Tokyo, Japan",NA
"1927","34263422","10.1007/s40273-021-01054-1","Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review.","Diagnostic testing for respiratory tract infections is a tool to manage the current COVID-19 pandemic, as well as the rising incidence of antimicrobial resistance. At the same time, new European regulations for market entry of in vitro diagnostics, in the form of the in vitro diagnostic regulation, may lead to more clinical evidence supporting health-economic analyses. The objective of this systematic review was to review the methods used in economic evaluations of applied diagnostic techniques,","2021","07","20","Pharmacoeconomics","PharmacoEconomics",NA,"van der Pol","Simon","Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. s.van.der.pol@umcg","s.van.der.pol@umcg.nl"
"1928","34263422","10.1007/s40273-021-01054-1","Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review.","Diagnostic testing for respiratory tract infections is a tool to manage the current COVID-19 pandemic, as well as the rising incidence of antimicrobial resistance. At the same time, new European regulations for market entry of in vitro diagnostics, in the form of the in vitro diagnostic regulation, may lead to more clinical evidence supporting health-economic analyses. The objective of this systematic review was to review the methods used in economic evaluations of applied diagnostic techniques,","2021","07","20","Pharmacoeconomics","PharmacoEconomics",NA,"Garcia","Paula Rojas","Department of Economics and Business, University of La Rioja, Rioja, Spain",NA
"1929","34263422","10.1007/s40273-021-01054-1","Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review.","Diagnostic testing for respiratory tract infections is a tool to manage the current COVID-19 pandemic, as well as the rising incidence of antimicrobial resistance. At the same time, new European regulations for market entry of in vitro diagnostics, in the form of the in vitro diagnostic regulation, may lead to more clinical evidence supporting health-economic analyses. The objective of this systematic review was to review the methods used in economic evaluations of applied diagnostic techniques,","2021","07","20","Pharmacoeconomics","PharmacoEconomics",NA,"Postma","Maarten J","Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands",NA
"1930","34263422","10.1007/s40273-021-01054-1","Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review.","Diagnostic testing for respiratory tract infections is a tool to manage the current COVID-19 pandemic, as well as the rising incidence of antimicrobial resistance. At the same time, new European regulations for market entry of in vitro diagnostics, in the form of the in vitro diagnostic regulation, may lead to more clinical evidence supporting health-economic analyses. The objective of this systematic review was to review the methods used in economic evaluations of applied diagnostic techniques,","2021","07","20","Pharmacoeconomics","PharmacoEconomics",NA,"Villar","Fernando Antoñanzas","Department of Economics and Business, University of La Rioja, Rioja, Spain",NA
"1931","34263422","10.1007/s40273-021-01054-1","Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review.","Diagnostic testing for respiratory tract infections is a tool to manage the current COVID-19 pandemic, as well as the rising incidence of antimicrobial resistance. At the same time, new European regulations for market entry of in vitro diagnostics, in the form of the in vitro diagnostic regulation, may lead to more clinical evidence supporting health-economic analyses. The objective of this systematic review was to review the methods used in economic evaluations of applied diagnostic techniques,","2021","07","20","Pharmacoeconomics","PharmacoEconomics",NA,"van Asselt","Antoinette D I","Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands",NA
"1932","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Ouederni","Monia","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia. ouederni.moni@gmail","ouederni.moni@gmail.com"
"1933","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Rekaya","Samia","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1934","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Bouabdallah","Oussema","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1935","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Ben Fradj","Ilhem","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1936","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Kouki","Ridha","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1937","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Chebbi","Yosr","Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia",NA
"1938","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Ammar","Sahar Ben","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1939","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Lamouchi","Takwa","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1940","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Lachiheb","Asma","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1941","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Zekri","Nessrine","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1942","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Laajili","Siwar","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1943","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Zaiter","Ikram","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1944","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Hamzaoui","Agnes","Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia",NA
"1945","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Bejaoui","Mohamed","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1946","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Mellouli","Fethi","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1947","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Achour","Wafa","Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia",NA
"1948","34263394","10.1007/s10875-021-01094-4","Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit.",NA,"2021","07","20","J Clin Immunol","Journal of clinical immunology",NA,"Ben Khaled","Monia","Department of Pediatrics: Immuno-Hematology and Stem Cell Transplantation, Bone Marrow Transplant Center, Tunis, Tunisia",NA
"1949","34263390","10.1007/s10943-021-01347-x","Spiritual Health and the COVID-19 Pandemic: Impacts on Orthodox Christianity Devotion Practices, Rituals, and Religious Pilgrimages.","The impact of the COVID-19 pandemic on multiple aspects of physical and social health, including spiritual and religious dimensions, has been discussed not only by numerous theologians, scientists, and politicians, but also by millions of believers of all faiths worldwide. The pandemic seems to have exerted a significant impact on religious practices. Massive gatherings of devoted and faithful people have been strongly discouraged and even openly banned. Prominent religious festivals and pilgrim","2021","07","20","J Relig Health","Journal of religion and health","COVID-19; Orthodox Christianity; Pilgrimages; Spiritual health","Papazoglou","Andreas S","First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kiriakidi 1, 54636, Thessaloniki, Greece. anpapazoglou@yahoo","anpapazoglou@yahoo.com"
"1950","34263390","10.1007/s10943-021-01347-x","Spiritual Health and the COVID-19 Pandemic: Impacts on Orthodox Christianity Devotion Practices, Rituals, and Religious Pilgrimages.","The impact of the COVID-19 pandemic on multiple aspects of physical and social health, including spiritual and religious dimensions, has been discussed not only by numerous theologians, scientists, and politicians, but also by millions of believers of all faiths worldwide. The pandemic seems to have exerted a significant impact on religious practices. Massive gatherings of devoted and faithful people have been strongly discouraged and even openly banned. Prominent religious festivals and pilgrim","2021","07","20","J Relig Health","Journal of religion and health","COVID-19; Orthodox Christianity; Pilgrimages; Spiritual health","Moysidis","Dimitrios V","First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kiriakidi 1, 54636, Thessaloniki, Greece",NA
"1951","34263390","10.1007/s10943-021-01347-x","Spiritual Health and the COVID-19 Pandemic: Impacts on Orthodox Christianity Devotion Practices, Rituals, and Religious Pilgrimages.","The impact of the COVID-19 pandemic on multiple aspects of physical and social health, including spiritual and religious dimensions, has been discussed not only by numerous theologians, scientists, and politicians, but also by millions of believers of all faiths worldwide. The pandemic seems to have exerted a significant impact on religious practices. Massive gatherings of devoted and faithful people have been strongly discouraged and even openly banned. Prominent religious festivals and pilgrim","2021","07","20","J Relig Health","Journal of religion and health","COVID-19; Orthodox Christianity; Pilgrimages; Spiritual health","Tsagkaris","Christos","Faculty of Medicine, University of Crete, Heraklion, Greece",NA
"1952","34263390","10.1007/s10943-021-01347-x","Spiritual Health and the COVID-19 Pandemic: Impacts on Orthodox Christianity Devotion Practices, Rituals, and Religious Pilgrimages.","The impact of the COVID-19 pandemic on multiple aspects of physical and social health, including spiritual and religious dimensions, has been discussed not only by numerous theologians, scientists, and politicians, but also by millions of believers of all faiths worldwide. The pandemic seems to have exerted a significant impact on religious practices. Massive gatherings of devoted and faithful people have been strongly discouraged and even openly banned. Prominent religious festivals and pilgrim","2021","07","20","J Relig Health","Journal of religion and health","COVID-19; Orthodox Christianity; Pilgrimages; Spiritual health","Dorosh","Marko","Bukovinian State Medical University, Chernivtsi, Ukraine",NA
"1953","34263390","10.1007/s10943-021-01347-x","Spiritual Health and the COVID-19 Pandemic: Impacts on Orthodox Christianity Devotion Practices, Rituals, and Religious Pilgrimages.","The impact of the COVID-19 pandemic on multiple aspects of physical and social health, including spiritual and religious dimensions, has been discussed not only by numerous theologians, scientists, and politicians, but also by millions of believers of all faiths worldwide. The pandemic seems to have exerted a significant impact on religious practices. Massive gatherings of devoted and faithful people have been strongly discouraged and even openly banned. Prominent religious festivals and pilgrim","2021","07","20","J Relig Health","Journal of religion and health","COVID-19; Orthodox Christianity; Pilgrimages; Spiritual health","Karagiannidis","Efstratios","First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kiriakidi 1, 54636, Thessaloniki, Greece",NA
"1954","34263390","10.1007/s10943-021-01347-x","Spiritual Health and the COVID-19 Pandemic: Impacts on Orthodox Christianity Devotion Practices, Rituals, and Religious Pilgrimages.","The impact of the COVID-19 pandemic on multiple aspects of physical and social health, including spiritual and religious dimensions, has been discussed not only by numerous theologians, scientists, and politicians, but also by millions of believers of all faiths worldwide. The pandemic seems to have exerted a significant impact on religious practices. Massive gatherings of devoted and faithful people have been strongly discouraged and even openly banned. Prominent religious festivals and pilgrim","2021","07","20","J Relig Health","Journal of religion and health","COVID-19; Orthodox Christianity; Pilgrimages; Spiritual health","Mazin","Rafael","Independent Consultant on Public Health and Sexual Health and Rights, Washington, USA",NA
"1955","34263389","10.1007/s10943-021-01326-2","The Orthodox Church and the Mental Health Burden of a Pandemic: A Narrative Mini-Review.","The mental health burden of the recent COVID19 pandemic will be extensive and pervasive likely for many years to come. The stress and anxiety of this event will undoubtedly impact Orthodox communities regardless of location after the world has met the crisis and resumed some sense of normalcy. The assessment of mental health needs among Orthodox Christians remains a largely unstudied phenomenon. A small narrative review was conducted to ascertain ways in which other faith-based organizations hav","2021","07","20","J Relig Health","Journal of religion and health","Anxiety; COVID-19; Clergy training; Depression; Pandemic","Schieffler","Danny A","Sacred Heart University, 5151 Park Avenue, Fairfield, CT, 06825, USA. schiefflerd@sacredheart","schiefflerd@sacredheart.edu"
"1956","34263389","10.1007/s10943-021-01326-2","The Orthodox Church and the Mental Health Burden of a Pandemic: A Narrative Mini-Review.","The mental health burden of the recent COVID19 pandemic will be extensive and pervasive likely for many years to come. The stress and anxiety of this event will undoubtedly impact Orthodox communities regardless of location after the world has met the crisis and resumed some sense of normalcy. The assessment of mental health needs among Orthodox Christians remains a largely unstudied phenomenon. A small narrative review was conducted to ascertain ways in which other faith-based organizations hav","2021","07","20","J Relig Health","Journal of religion and health","Anxiety; COVID-19; Clergy training; Depression; Pandemic","Genig","Joshua","St. Joseph Mercy Hospital, Ann Arbor, MI, USA",NA
"1957","34263248","10.1002/emp2.12482","In support of ""Toxicity of herbal medications suggested as treatment for COVID-19: A narrative review"".",NA,"2021","07","16","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open",NA,"DiPietro","Michael A","Department of Emergency Medicine Newark Beth Israel Medical Center Newark New Jersey USA",NA
"1958","34263248","10.1002/emp2.12482","In support of ""Toxicity of herbal medications suggested as treatment for COVID-19: A narrative review"".",NA,"2021","07","16","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open",NA,"Mondie","Christopher","Department of Emergency Medicine Newark Beth Israel Medical Center Newark New Jersey USA",NA
"1959","34263230","10.5152/FNJN.2021.20090","Transitioning Nursing Students' Education from Traditional Classroom to Online Education during the COVID-19 Pandemic: A Case Study Applied to the Meleis Trial.","Theories can be used to determine the factors that affect a situation and the most appropriate ways to reach a goal. The coronavirus disease 2019 pandemic has deeply affected nursing education in which had considered a critical factor in the transition of teaching methods that is being and will be experienced. Transition is a process of changing from a known to an unknown state. Personal, community, and social factors can facilitate or prevent a transition. In this study, nursing education as we","2021","07","24","Florence Nightingale J Nurs","Florence Nightingale journal of nursing","COVID-19; meleis theory; nursing education; nursing student; online education","Jallad","Samar Thabet","Department of Nursing, Near East University Faculty of Health Sciences Institute, Nicosia, Cyprus",NA
"1960","34263230","10.5152/FNJN.2021.20090","Transitioning Nursing Students' Education from Traditional Classroom to Online Education during the COVID-19 Pandemic: A Case Study Applied to the Meleis Trial.","Theories can be used to determine the factors that affect a situation and the most appropriate ways to reach a goal. The coronavirus disease 2019 pandemic has deeply affected nursing education in which had considered a critical factor in the transition of teaching methods that is being and will be experienced. Transition is a process of changing from a known to an unknown state. Personal, community, and social factors can facilitate or prevent a transition. In this study, nursing education as we","2021","07","24","Florence Nightingale J Nurs","Florence Nightingale journal of nursing","COVID-19; meleis theory; nursing education; nursing student; online education","Isik","Burçin","Department of Nursing, Gaziantep Islam Science and Technology University Faculty of Health Sciences, Gaziantep, Turkey",NA
"1961","34263216","10.5152/FNJN.2020.20102","The Nursing Now Campaign in the Fight Against COVID-19: Possibilities for Nurses.",NA,"2021","07","23","Florence Nightingale J Nurs","Florence Nightingale journal of nursing",NA,"Lira Neto","Jose Claudio Garcia","Department of Nursing, Federal University of Piauí, Floriano, Piauí, Brazil",NA
"1962","34263164","10.1177/2632010X211025308","COVID-19 Impact on Medical Practice in Sub-Saharan Africa; The Need to Guard Against Medical Negligence: A Case Report in a Health Care Facility in Kumasi, Ghana.","With the novel coronavirus disease 2019 (COVID-19) still in pandemic mode, according to the World Health Organization (WHO), the African continent has experienced continued growth in the total tally. According to the Africa Centers for Disease Control and Prevention (CDC), the virus has spread to almost all 54 recognized African countries. Figures from the CDC indicate that the highly affected countries include South Africa, Egypt, Nigeria, Algeria, Morocco, and Ghana (with more than 55 000 case","2021","07","16","Clin Pathol","Clinical pathology (Thousand Oaks, Ventura County, Calif.)","COVID-19; Coronavirus; autopsy; bilateral lung congestion; cardiomegaly; cardiopulmonary failure; interstitial pneumonia; liver cirrhosis; medical negligence; subcapsular granulation","Ossei","Paul Poku Sampene","Department of Pathology, School of Medicine and Dentistry, Kwame Nkrumah University of Science &amp",NA
"1963","34263164","10.1177/2632010X211025308","COVID-19 Impact on Medical Practice in Sub-Saharan Africa; The Need to Guard Against Medical Negligence: A Case Report in a Health Care Facility in Kumasi, Ghana.","With the novel coronavirus disease 2019 (COVID-19) still in pandemic mode, according to the World Health Organization (WHO), the African continent has experienced continued growth in the total tally. According to the Africa Centers for Disease Control and Prevention (CDC), the virus has spread to almost all 54 recognized African countries. Figures from the CDC indicate that the highly affected countries include South Africa, Egypt, Nigeria, Algeria, Morocco, and Ghana (with more than 55 000 case","2021","07","16","Clin Pathol","Clinical pathology (Thousand Oaks, Ventura County, Calif.)","COVID-19; Coronavirus; autopsy; bilateral lung congestion; cardiomegaly; cardiopulmonary failure; interstitial pneumonia; liver cirrhosis; medical negligence; subcapsular granulation","Ayibor","William Gilbert","Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science &amp",NA
"1964","34263164","10.1177/2632010X211025308","COVID-19 Impact on Medical Practice in Sub-Saharan Africa; The Need to Guard Against Medical Negligence: A Case Report in a Health Care Facility in Kumasi, Ghana.","With the novel coronavirus disease 2019 (COVID-19) still in pandemic mode, according to the World Health Organization (WHO), the African continent has experienced continued growth in the total tally. According to the Africa Centers for Disease Control and Prevention (CDC), the virus has spread to almost all 54 recognized African countries. Figures from the CDC indicate that the highly affected countries include South Africa, Egypt, Nigeria, Algeria, Morocco, and Ghana (with more than 55 000 case","2021","07","16","Clin Pathol","Clinical pathology (Thousand Oaks, Ventura County, Calif.)","COVID-19; Coronavirus; autopsy; bilateral lung congestion; cardiomegaly; cardiopulmonary failure; interstitial pneumonia; liver cirrhosis; medical negligence; subcapsular granulation","Taylor","John","Department of Pathology, School of Medicine and Dentistry, Kwame Nkrumah University of Science &amp",NA
"1965","34263164","10.1177/2632010X211025308","COVID-19 Impact on Medical Practice in Sub-Saharan Africa; The Need to Guard Against Medical Negligence: A Case Report in a Health Care Facility in Kumasi, Ghana.","With the novel coronavirus disease 2019 (COVID-19) still in pandemic mode, according to the World Health Organization (WHO), the African continent has experienced continued growth in the total tally. According to the Africa Centers for Disease Control and Prevention (CDC), the virus has spread to almost all 54 recognized African countries. Figures from the CDC indicate that the highly affected countries include South Africa, Egypt, Nigeria, Algeria, Morocco, and Ghana (with more than 55 000 case","2021","07","16","Clin Pathol","Clinical pathology (Thousand Oaks, Ventura County, Calif.)","COVID-19; Coronavirus; autopsy; bilateral lung congestion; cardiomegaly; cardiopulmonary failure; interstitial pneumonia; liver cirrhosis; medical negligence; subcapsular granulation","Agyemang","Lawrence","Pathology Unit, Komfo Anokye Teaching Hospital, Kumasi, Ghana",NA
"1966","34263164","10.1177/2632010X211025308","COVID-19 Impact on Medical Practice in Sub-Saharan Africa; The Need to Guard Against Medical Negligence: A Case Report in a Health Care Facility in Kumasi, Ghana.","With the novel coronavirus disease 2019 (COVID-19) still in pandemic mode, according to the World Health Organization (WHO), the African continent has experienced continued growth in the total tally. According to the Africa Centers for Disease Control and Prevention (CDC), the virus has spread to almost all 54 recognized African countries. Figures from the CDC indicate that the highly affected countries include South Africa, Egypt, Nigeria, Algeria, Morocco, and Ghana (with more than 55 000 case","2021","07","16","Clin Pathol","Clinical pathology (Thousand Oaks, Ventura County, Calif.)","COVID-19; Coronavirus; autopsy; bilateral lung congestion; cardiomegaly; cardiopulmonary failure; interstitial pneumonia; liver cirrhosis; medical negligence; subcapsular granulation","Aninkora","Kwabena Owusu","Pathology Unit, Komfo Anokye Teaching Hospital, Kumasi, Ghana",NA
"1967","34263164","10.1177/2632010X211025308","COVID-19 Impact on Medical Practice in Sub-Saharan Africa; The Need to Guard Against Medical Negligence: A Case Report in a Health Care Facility in Kumasi, Ghana.","With the novel coronavirus disease 2019 (COVID-19) still in pandemic mode, according to the World Health Organization (WHO), the African continent has experienced continued growth in the total tally. According to the Africa Centers for Disease Control and Prevention (CDC), the virus has spread to almost all 54 recognized African countries. Figures from the CDC indicate that the highly affected countries include South Africa, Egypt, Nigeria, Algeria, Morocco, and Ghana (with more than 55 000 case","2021","07","16","Clin Pathol","Clinical pathology (Thousand Oaks, Ventura County, Calif.)","COVID-19; Coronavirus; autopsy; bilateral lung congestion; cardiomegaly; cardiopulmonary failure; interstitial pneumonia; liver cirrhosis; medical negligence; subcapsular granulation","Asante","Bright Opoku","Department of Pathology, School of Medicine and Dentistry, Kwame Nkrumah University of Science &amp",NA
"1968","34263153","10.4274/ejbh.galenos.2021.6161","How Do Breast Cancer Patients Present Following COVID-19 Early Peak in a Breast Cancer Center in Turkey?","Coronavirus disease 2019 (COVID-19) has placed an unprecedented burden on healthcare systems and restricted resources for non-COVID patients worldwide. Treatment approaches and follow-up plans have been modified to prevent the risk of infection for patients and healthcare workers. Patients prefer to delay or cancel their treatments during the peak period of infection. We retrospectively reviewed the characteristics of patients with breast cancer who were consulted at our outpatient clinic right ","2021","07","16","Eur J Breast Health","European journal of breast health","Breast cancer; COVID-19; early peak","Dauti Isiklar","Aysun","Breast Health Center, Acibadem Altunizade Hospital, Istanbul, Turkey",NA
"1969","34263153","10.4274/ejbh.galenos.2021.6161","How Do Breast Cancer Patients Present Following COVID-19 Early Peak in a Breast Cancer Center in Turkey?","Coronavirus disease 2019 (COVID-19) has placed an unprecedented burden on healthcare systems and restricted resources for non-COVID patients worldwide. Treatment approaches and follow-up plans have been modified to prevent the risk of infection for patients and healthcare workers. Patients prefer to delay or cancel their treatments during the peak period of infection. We retrospectively reviewed the characteristics of patients with breast cancer who were consulted at our outpatient clinic right ","2021","07","16","Eur J Breast Health","European journal of breast health","Breast cancer; COVID-19; early peak","Deniz","Cem","Acibadem University School of Medicine, Istanbul, Turkey",NA
"1970","34263153","10.4274/ejbh.galenos.2021.6161","How Do Breast Cancer Patients Present Following COVID-19 Early Peak in a Breast Cancer Center in Turkey?","Coronavirus disease 2019 (COVID-19) has placed an unprecedented burden on healthcare systems and restricted resources for non-COVID patients worldwide. Treatment approaches and follow-up plans have been modified to prevent the risk of infection for patients and healthcare workers. Patients prefer to delay or cancel their treatments during the peak period of infection. We retrospectively reviewed the characteristics of patients with breast cancer who were consulted at our outpatient clinic right ","2021","07","16","Eur J Breast Health","European journal of breast health","Breast cancer; COVID-19; early peak","Soyder","Aykut","Breast Health Center, Acibadem Altunizade Hospital, Istanbul, Turkey",NA
"1971","34263153","10.4274/ejbh.galenos.2021.6161","How Do Breast Cancer Patients Present Following COVID-19 Early Peak in a Breast Cancer Center in Turkey?","Coronavirus disease 2019 (COVID-19) has placed an unprecedented burden on healthcare systems and restricted resources for non-COVID patients worldwide. Treatment approaches and follow-up plans have been modified to prevent the risk of infection for patients and healthcare workers. Patients prefer to delay or cancel their treatments during the peak period of infection. We retrospectively reviewed the characteristics of patients with breast cancer who were consulted at our outpatient clinic right ","2021","07","16","Eur J Breast Health","European journal of breast health","Breast cancer; COVID-19; early peak","Güldogan","Nilgün","Breast Health Center, Acibadem Altunizade Hospital, Istanbul, Turkey",NA
"1972","34263153","10.4274/ejbh.galenos.2021.6161","How Do Breast Cancer Patients Present Following COVID-19 Early Peak in a Breast Cancer Center in Turkey?","Coronavirus disease 2019 (COVID-19) has placed an unprecedented burden on healthcare systems and restricted resources for non-COVID patients worldwide. Treatment approaches and follow-up plans have been modified to prevent the risk of infection for patients and healthcare workers. Patients prefer to delay or cancel their treatments during the peak period of infection. We retrospectively reviewed the characteristics of patients with breast cancer who were consulted at our outpatient clinic right ","2021","07","16","Eur J Breast Health","European journal of breast health","Breast cancer; COVID-19; early peak","Yilmaz","Ebru","Breast Health Center, Acibadem Altunizade Hospital, Istanbul, Turkey",NA
"1973","34263153","10.4274/ejbh.galenos.2021.6161","How Do Breast Cancer Patients Present Following COVID-19 Early Peak in a Breast Cancer Center in Turkey?","Coronavirus disease 2019 (COVID-19) has placed an unprecedented burden on healthcare systems and restricted resources for non-COVID patients worldwide. Treatment approaches and follow-up plans have been modified to prevent the risk of infection for patients and healthcare workers. Patients prefer to delay or cancel their treatments during the peak period of infection. We retrospectively reviewed the characteristics of patients with breast cancer who were consulted at our outpatient clinic right ","2021","07","16","Eur J Breast Health","European journal of breast health","Breast cancer; COVID-19; early peak","Basaran","Gül","Breast Health Center, Acibadem Altunizade Hospital, Istanbul, Turkey",NA
"1974","34263143","10.1097/HS9.0000000000000618","Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine.",NA,"2021","07","16","Hemasphere","HemaSphere",NA,"Gaignard","Marie-Estelle","Department of Internal Medicine, Kantonsspital Muensterlingen, Switzerland",NA
"1975","34263143","10.1097/HS9.0000000000000618","Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine.",NA,"2021","07","16","Hemasphere","HemaSphere",NA,"Lieberherr","Sven","Department of Internal Medicine, Kantonsspital Muensterlingen, Switzerland",NA
"1976","34263143","10.1097/HS9.0000000000000618","Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine.",NA,"2021","07","16","Hemasphere","HemaSphere",NA,"Schoenenberger","Andreas","Department of Internal Medicine, Kantonsspital Muensterlingen, Switzerland",NA
"1977","34263143","10.1097/HS9.0000000000000618","Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine.",NA,"2021","07","16","Hemasphere","HemaSphere",NA,"Benz","Rudolf","Department of Hematology and Oncology, Kantonsspital Muensterlingen, Switzerland",NA
"1978","34263128","10.1093/ehjcr/ytab239","Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series.","Cardiovascular and thromboembolic complications have been reported in patients with Coronavirus disease-2019 (COVID-19)-related severe respiratory distress syndrome. Although myocarditis associated with COVID-19 pneumonia has been described, evidence of left ventricular (LV) mural thrombi with other multisystem events has not been reported. We report two cases with severe COVID-19 pneumonia and myocardial injury with large LV thrombi and other multisystem thrombotic events. The first patient rep","2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports","COVID-19; Case series; Left ventricular thrombi; Myocardial injury; ST-elevation myocardial infarction","Garg","Aakash","Division of Cardiology, Newark Beth Israel Medical Center, 201 Lyons Ave, Newark, NJ 07112, USA",NA
"1979","34263128","10.1093/ehjcr/ytab239","Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series.","Cardiovascular and thromboembolic complications have been reported in patients with Coronavirus disease-2019 (COVID-19)-related severe respiratory distress syndrome. Although myocarditis associated with COVID-19 pneumonia has been described, evidence of left ventricular (LV) mural thrombi with other multisystem events has not been reported. We report two cases with severe COVID-19 pneumonia and myocardial injury with large LV thrombi and other multisystem thrombotic events. The first patient rep","2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports","COVID-19; Case series; Left ventricular thrombi; Myocardial injury; ST-elevation myocardial infarction","Hakeem","Hisham","Division of Cardiology, Newark Beth Israel Medical Center, 201 Lyons Ave, Newark, NJ 07112, USA",NA
"1980","34263128","10.1093/ehjcr/ytab239","Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series.","Cardiovascular and thromboembolic complications have been reported in patients with Coronavirus disease-2019 (COVID-19)-related severe respiratory distress syndrome. Although myocarditis associated with COVID-19 pneumonia has been described, evidence of left ventricular (LV) mural thrombi with other multisystem events has not been reported. We report two cases with severe COVID-19 pneumonia and myocardial injury with large LV thrombi and other multisystem thrombotic events. The first patient rep","2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports","COVID-19; Case series; Left ventricular thrombi; Myocardial injury; ST-elevation myocardial infarction","Chennu","Gouthami","Division of Cardiology, Newark Beth Israel Medical Center, 201 Lyons Ave, Newark, NJ 07112, USA",NA
"1981","34263128","10.1093/ehjcr/ytab239","Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series.","Cardiovascular and thromboembolic complications have been reported in patients with Coronavirus disease-2019 (COVID-19)-related severe respiratory distress syndrome. Although myocarditis associated with COVID-19 pneumonia has been described, evidence of left ventricular (LV) mural thrombi with other multisystem events has not been reported. We report two cases with severe COVID-19 pneumonia and myocardial injury with large LV thrombi and other multisystem thrombotic events. The first patient rep","2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports","COVID-19; Case series; Left ventricular thrombi; Myocardial injury; ST-elevation myocardial infarction","Saeed","Qaisra","Division of Cardiology, Newark Beth Israel Medical Center, 201 Lyons Ave, Newark, NJ 07112, USA",NA
"1982","34263128","10.1093/ehjcr/ytab239","Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series.","Cardiovascular and thromboembolic complications have been reported in patients with Coronavirus disease-2019 (COVID-19)-related severe respiratory distress syndrome. Although myocarditis associated with COVID-19 pneumonia has been described, evidence of left ventricular (LV) mural thrombi with other multisystem events has not been reported. We report two cases with severe COVID-19 pneumonia and myocardial injury with large LV thrombi and other multisystem thrombotic events. The first patient rep","2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports","COVID-19; Case series; Left ventricular thrombi; Myocardial injury; ST-elevation myocardial infarction","Vucic","Esad","Division of Cardiology, Newark Beth Israel Medical Center, 201 Lyons Ave, Newark, NJ 07112, USA",NA
"1983","34263128","10.1093/ehjcr/ytab239","Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series.","Cardiovascular and thromboembolic complications have been reported in patients with Coronavirus disease-2019 (COVID-19)-related severe respiratory distress syndrome. Although myocarditis associated with COVID-19 pneumonia has been described, evidence of left ventricular (LV) mural thrombi with other multisystem events has not been reported. We report two cases with severe COVID-19 pneumonia and myocardial injury with large LV thrombi and other multisystem thrombotic events. The first patient rep","2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports","COVID-19; Case series; Left ventricular thrombi; Myocardial injury; ST-elevation myocardial infarction","Kats","Yuliya","Division of Cardiology, Newark Beth Israel Medical Center, 201 Lyons Ave, Newark, NJ 07112, USA",NA
"1984","34263128","10.1093/ehjcr/ytab239","Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series.","Cardiovascular and thromboembolic complications have been reported in patients with Coronavirus disease-2019 (COVID-19)-related severe respiratory distress syndrome. Although myocarditis associated with COVID-19 pneumonia has been described, evidence of left ventricular (LV) mural thrombi with other multisystem events has not been reported. We report two cases with severe COVID-19 pneumonia and myocardial injury with large LV thrombi and other multisystem thrombotic events. The first patient rep","2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports","COVID-19; Case series; Left ventricular thrombi; Myocardial injury; ST-elevation myocardial infarction","Waxman","Sergio","Division of Cardiology, Newark Beth Israel Medical Center, 201 Lyons Ave, Newark, NJ 07112, USA",NA
"1985","34263123","10.1093/ehjcr/ytab222","Subacute left main stem thrombus in COVID-19: a case report.",NA,"2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports",NA,"Akhtar","Zaki","Department of Cardiology, Ashford and St Peter's Hospitals NHS trust, Guildford road, Surrey, KT16 0PZ, UK",NA
"1986","34263123","10.1093/ehjcr/ytab222","Subacute left main stem thrombus in COVID-19: a case report.",NA,"2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports",NA,"Leung","Lisa W M","Department of Cardiology, St George's University Hospital, Blackshaw road, London, SW17 0RE, UK",NA
"1987","34263123","10.1093/ehjcr/ytab222","Subacute left main stem thrombus in COVID-19: a case report.",NA,"2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports",NA,"Gallagher","Mark M","Department of Cardiology, Ashford and St Peter's Hospitals NHS trust, Guildford road, Surrey, KT16 0PZ, UK",NA
"1988","34263123","10.1093/ehjcr/ytab222","Subacute left main stem thrombus in COVID-19: a case report.",NA,"2021","07","16","Eur Heart J Case Rep","European heart journal. Case reports",NA,"Sharma","Sumeet","Department of Cardiology, Ashford and St Peter's Hospitals NHS trust, Guildford road, Surrey, KT16 0PZ, UK",NA
"1989","34263101","10.1002/rth2.12547","Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors.",NA,"2021","07","16","Res Pract Thromb Haemost","Research and practice in thrombosis and haemostasis",NA,"Spyropoulos","Alex C","Feinstein Institutes for Medical Research Northwell Health Manhasset NY USA",NA
"1990","34263101","10.1002/rth2.12547","Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors.",NA,"2021","07","16","Res Pract Thromb Haemost","Research and practice in thrombosis and haemostasis",NA,"Giannis","Dimitrios","Feinstein Institutes for Medical Research Northwell Health Manhasset NY USA",NA
"1991","34263101","10.1002/rth2.12547","Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors.",NA,"2021","07","16","Res Pract Thromb Haemost","Research and practice in thrombosis and haemostasis",NA,"Goldin","Mark","Feinstein Institutes for Medical Research Northwell Health Manhasset NY USA",NA
"1992","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Killackey","Tieghan","The Hospital for Sick Children, Child Health Evaluative Sciences, Toronto, Ontario, Canada",NA
"1993","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Noel","Melanie","Alberta Children's Hospital, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada",NA
"1994","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Birnie","Kathryn A","Department of Anesthesiology, Perioperative, and Pain Medicine, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada",NA
"1995","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Choinière","Manon","Department of Anesthesiology and Pain Medicine, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada",NA
"1996","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Pagé","M Gabrielle","Research Center of the Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada",NA
"1997","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Dassieu","Lise","Research Center of the Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada",NA
"1998","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Lacasse","Anaïs","Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, Quebec, Canada",NA
"1999","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Lalloo","Chitra","The Hospital for Sick Children, Child Health Evaluative Sciences, Toronto, Ontario, Canada",NA
"2000","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Brennenstuhl","Sarah","Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada",NA
"2001","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Poulin","Patricia","Department of Anesthesiology &amp",NA
"2002","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Ingelmo","Pablo","Chronic Pain Service, Montreal Children's Hospital, McGill University Health Center, Montreal, Quebec, Canada",NA
"2003","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Ali","Samina","Departments of Pediatrics &amp",NA
"2004","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Battaglia","Marco","Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada",NA
"2005","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Campbell","Fiona","Department of Anesthesia and Pain Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada",NA
"2006","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Smith","Andrew","Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada",NA
"2007","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Harris","Lauren","The Hospital for Sick Children, Child Health Evaluative Sciences, Toronto, Ontario, Canada",NA
"2008","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Mohabir","Vina","The Hospital for Sick Children, Child Health Evaluative Sciences, Toronto, Ontario, Canada",NA
"2009","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Benayon","Myles","Department of Medicine, McMaster University, Hamilton, Ontario, Canada",NA
"2010","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Jordan","Isabel","British Columbia, Canada",NA
"2011","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Marianayagam","Justina","Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada",NA
"2012","34263096","10.1080/24740527.2021.1931069","COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals.","Background: The COVID-19 pandemic presents one of the greatest threats to pediatric pain care seen in generations. Due to public health restrictions, many pediatric pain clinics halted in-person appointments, delaying and disrupting access to care. There is no existing research on the impacts of COVID-19 on pediatric chronic pain care in Canada or the challenges experienced by health care professionals and pain clinics. Aims: The aim of this study was to evaluate the impact of COVID-19 on Canadi","2021","07","16","Can J Pain","Canadian journal of pain = Revue canadienne de la douleur","COVID-19; distance treatments; e-health; pain clinics; pediatric pain; telehealth","Stinson","Jennifer","The Hospital for Sick Children, Child Health Evaluative Sciences, Toronto, Ontario, Canada",NA
"2013","34263079","10.1002/jgh3.12595","Verification of negative pressure box for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during upper gastrointestinal endoscopy.","During the COVID-19 pandemic era, multiple infection prevention and control measures to reduce the risk of SARS-CoV-2 transmission may be required in upper gastrointestinal endoscopy (UGI). We herein studied the verification tests of Endo barrier, which is one of the protective barrier enclosures. Endo barrier may be an alternative for minimizing SARS-CoV-2 transmission during UGI.","2021","07","16","JGH Open","JGH open : an open access journal of gastroenterology and hepatology","endoscopy: upper gastrointestinal; gastroenterology; gastrointestinal infections; protective barrier enclosures; virus transmission","Kobara","Hideki","Department of Gastroenterology and Neurology, Faculty of Medicine Kagawa University Kita Japan",NA
"2014","34263079","10.1002/jgh3.12595","Verification of negative pressure box for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during upper gastrointestinal endoscopy.","During the COVID-19 pandemic era, multiple infection prevention and control measures to reduce the risk of SARS-CoV-2 transmission may be required in upper gastrointestinal endoscopy (UGI). We herein studied the verification tests of Endo barrier, which is one of the protective barrier enclosures. Endo barrier may be an alternative for minimizing SARS-CoV-2 transmission during UGI.","2021","07","16","JGH Open","JGH open : an open access journal of gastroenterology and hepatology","endoscopy: upper gastrointestinal; gastroenterology; gastrointestinal infections; protective barrier enclosures; virus transmission","Nishiyama","Noriko","Department of Gastroenterology and Neurology, Faculty of Medicine Kagawa University Kita Japan",NA
"2015","34263079","10.1002/jgh3.12595","Verification of negative pressure box for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during upper gastrointestinal endoscopy.","During the COVID-19 pandemic era, multiple infection prevention and control measures to reduce the risk of SARS-CoV-2 transmission may be required in upper gastrointestinal endoscopy (UGI). We herein studied the verification tests of Endo barrier, which is one of the protective barrier enclosures. Endo barrier may be an alternative for minimizing SARS-CoV-2 transmission during UGI.","2021","07","16","JGH Open","JGH open : an open access journal of gastroenterology and hepatology","endoscopy: upper gastrointestinal; gastroenterology; gastrointestinal infections; protective barrier enclosures; virus transmission","Oba","Haruo","Department of Engineering and Design Kagawa University Kita Japan",NA
"2016","34263079","10.1002/jgh3.12595","Verification of negative pressure box for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during upper gastrointestinal endoscopy.","During the COVID-19 pandemic era, multiple infection prevention and control measures to reduce the risk of SARS-CoV-2 transmission may be required in upper gastrointestinal endoscopy (UGI). We herein studied the verification tests of Endo barrier, which is one of the protective barrier enclosures. Endo barrier may be an alternative for minimizing SARS-CoV-2 transmission during UGI.","2021","07","16","JGH Open","JGH open : an open access journal of gastroenterology and hepatology","endoscopy: upper gastrointestinal; gastroenterology; gastrointestinal infections; protective barrier enclosures; virus transmission","Nagatomi","Taichi","Center for Industrial-Academic Partnership and Intellectual Property Kagawa University Kita Japan",NA
"2017","34263079","10.1002/jgh3.12595","Verification of negative pressure box for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during upper gastrointestinal endoscopy.","During the COVID-19 pandemic era, multiple infection prevention and control measures to reduce the risk of SARS-CoV-2 transmission may be required in upper gastrointestinal endoscopy (UGI). We herein studied the verification tests of Endo barrier, which is one of the protective barrier enclosures. Endo barrier may be an alternative for minimizing SARS-CoV-2 transmission during UGI.","2021","07","16","JGH Open","JGH open : an open access journal of gastroenterology and hepatology","endoscopy: upper gastrointestinal; gastroenterology; gastrointestinal infections; protective barrier enclosures; virus transmission","Tada","Naoya","Department of Gastroenterology and Neurology, Faculty of Medicine Kagawa University Kita Japan",NA
"2018","34263079","10.1002/jgh3.12595","Verification of negative pressure box for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during upper gastrointestinal endoscopy.","During the COVID-19 pandemic era, multiple infection prevention and control measures to reduce the risk of SARS-CoV-2 transmission may be required in upper gastrointestinal endoscopy (UGI). We herein studied the verification tests of Endo barrier, which is one of the protective barrier enclosures. Endo barrier may be an alternative for minimizing SARS-CoV-2 transmission during UGI.","2021","07","16","JGH Open","JGH open : an open access journal of gastroenterology and hepatology","endoscopy: upper gastrointestinal; gastroenterology; gastrointestinal infections; protective barrier enclosures; virus transmission","Fujihara","Shintaro","Department of Gastroenterology and Neurology, Faculty of Medicine Kagawa University Kita Japan",NA
"2019","34263079","10.1002/jgh3.12595","Verification of negative pressure box for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during upper gastrointestinal endoscopy.","During the COVID-19 pandemic era, multiple infection prevention and control measures to reduce the risk of SARS-CoV-2 transmission may be required in upper gastrointestinal endoscopy (UGI). We herein studied the verification tests of Endo barrier, which is one of the protective barrier enclosures. Endo barrier may be an alternative for minimizing SARS-CoV-2 transmission during UGI.","2021","07","16","JGH Open","JGH open : an open access journal of gastroenterology and hepatology","endoscopy: upper gastrointestinal; gastroenterology; gastrointestinal infections; protective barrier enclosures; virus transmission","Masaki","Tsutomu","Department of Gastroenterology and Neurology, Faculty of Medicine Kagawa University Kita Japan",NA
"2020","34263056","10.1177/23821205211024055","Lessons Learnt from the COVID-19 Pandemic: Starting Residency in a Foster Institution.","In Singapore, the Ministry of Health (MOH) raised the public health response level from DORSCON (Disease Outbreak Response System Condition) 'Yellow' to 'Orange' on 7 February 2020. This instituted strict movement restrictions for all healthcare workers to minimise cross-institutional transmission of COVID-19, creating a unique scenario where many residents physically located in different healthcare institutions at the start of DORSCON Orange were unable to return to their matched Sponsoring Ins","2021","07","16","J Med Educ Curric Dev","Journal of medical education and curricular development","Coronavirus; Singapore; education; graduate; internship and residency; medical; public health","Tan","Jiekai","National Healthcare Group Residency, Singapore, Singapore",NA
"2021","34263056","10.1177/23821205211024055","Lessons Learnt from the COVID-19 Pandemic: Starting Residency in a Foster Institution.","In Singapore, the Ministry of Health (MOH) raised the public health response level from DORSCON (Disease Outbreak Response System Condition) 'Yellow' to 'Orange' on 7 February 2020. This instituted strict movement restrictions for all healthcare workers to minimise cross-institutional transmission of COVID-19, creating a unique scenario where many residents physically located in different healthcare institutions at the start of DORSCON Orange were unable to return to their matched Sponsoring Ins","2021","07","16","J Med Educ Curric Dev","Journal of medical education and curricular development","Coronavirus; Singapore; education; graduate; internship and residency; medical; public health","Wee","Lin","National Healthcare Group Residency, Singapore, Singapore",NA
"2022","34263056","10.1177/23821205211024055","Lessons Learnt from the COVID-19 Pandemic: Starting Residency in a Foster Institution.","In Singapore, the Ministry of Health (MOH) raised the public health response level from DORSCON (Disease Outbreak Response System Condition) 'Yellow' to 'Orange' on 7 February 2020. This instituted strict movement restrictions for all healthcare workers to minimise cross-institutional transmission of COVID-19, creating a unique scenario where many residents physically located in different healthcare institutions at the start of DORSCON Orange were unable to return to their matched Sponsoring Ins","2021","07","16","J Med Educ Curric Dev","Journal of medical education and curricular development","Coronavirus; Singapore; education; graduate; internship and residency; medical; public health","Li-Ann Chia","Faith","National Healthcare Group Residency, Singapore, Singapore",NA
"2023","34263056","10.1177/23821205211024055","Lessons Learnt from the COVID-19 Pandemic: Starting Residency in a Foster Institution.","In Singapore, the Ministry of Health (MOH) raised the public health response level from DORSCON (Disease Outbreak Response System Condition) 'Yellow' to 'Orange' on 7 February 2020. This instituted strict movement restrictions for all healthcare workers to minimise cross-institutional transmission of COVID-19, creating a unique scenario where many residents physically located in different healthcare institutions at the start of DORSCON Orange were unable to return to their matched Sponsoring Ins","2021","07","16","J Med Educ Curric Dev","Journal of medical education and curricular development","Coronavirus; Singapore; education; graduate; internship and residency; medical; public health","Khoon Ng","Wee","National Healthcare Group Residency, Singapore, Singapore",NA
"2024","34263055","10.1177/23821205211020760","Optimizing Remote Learning: Leveraging Zoom to Develop and Implement Successful Education Sessions.","Virtual meeting platforms, such as Zoom, have become essential to medical education during the SARS-CoV-2 pandemic. However, many medical educators do not have experience planning or leading these sessions. Despite the prevalence of Zoom learning, there has been little published on best practices. In this article we describe best practices for using Zoom for remote learning, acknowledging technical considerations, and recommending workflows for designing and implementing virtual sessions. Furthe","2021","07","16","J Med Educ Curric Dev","Journal of medical education and curricular development","Medical Education; Remote learning; Virtual learning; Zoom","Ohnigian","Sarah","Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA",NA
"2025","34263055","10.1177/23821205211020760","Optimizing Remote Learning: Leveraging Zoom to Develop and Implement Successful Education Sessions.","Virtual meeting platforms, such as Zoom, have become essential to medical education during the SARS-CoV-2 pandemic. However, many medical educators do not have experience planning or leading these sessions. Despite the prevalence of Zoom learning, there has been little published on best practices. In this article we describe best practices for using Zoom for remote learning, acknowledging technical considerations, and recommending workflows for designing and implementing virtual sessions. Furthe","2021","07","16","J Med Educ Curric Dev","Journal of medical education and curricular development","Medical Education; Remote learning; Virtual learning; Zoom","Richards","Jeremy B","Division of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA",NA
"2026","34263055","10.1177/23821205211020760","Optimizing Remote Learning: Leveraging Zoom to Develop and Implement Successful Education Sessions.","Virtual meeting platforms, such as Zoom, have become essential to medical education during the SARS-CoV-2 pandemic. However, many medical educators do not have experience planning or leading these sessions. Despite the prevalence of Zoom learning, there has been little published on best practices. In this article we describe best practices for using Zoom for remote learning, acknowledging technical considerations, and recommending workflows for designing and implementing virtual sessions. Furthe","2021","07","16","J Med Educ Curric Dev","Journal of medical education and curricular development","Medical Education; Remote learning; Virtual learning; Zoom","Monette","Derek L","Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA",NA
"2027","34263055","10.1177/23821205211020760","Optimizing Remote Learning: Leveraging Zoom to Develop and Implement Successful Education Sessions.","Virtual meeting platforms, such as Zoom, have become essential to medical education during the SARS-CoV-2 pandemic. However, many medical educators do not have experience planning or leading these sessions. Despite the prevalence of Zoom learning, there has been little published on best practices. In this article we describe best practices for using Zoom for remote learning, acknowledging technical considerations, and recommending workflows for designing and implementing virtual sessions. Furthe","2021","07","16","J Med Educ Curric Dev","Journal of medical education and curricular development","Medical Education; Remote learning; Virtual learning; Zoom","Roberts","David H","Division of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA",NA
"2028","34263028","10.1177/23779608211025117","Actual Frailty Conditions and Lifestyle Changes in Community-Dwelling Older Adults Affected by Coronavirus Disease 2019 Countermeasures in Japan: A Cross-Sectional Study.","Because of the countermeasures to prevent the spread of coronavirus disease 2019 (COVID-19) in Japan, it is easy to predict that the suspension of local activities and changes in lifestyle that lead to decreased activity will result in increased frailty and prefrailty rates in older adults. To clarify the actual frailty conditions and lifestyle changes among community-dwelling older adults affected by COVID-19 countermeasures in Japan. This cross-sectional study was conducted between May 8 and J","2021","07","16","SAGE Open Nurs","SAGE open nursing","COVID-19; frailty; lifestyle; older adult","Shinohara","Tomoyuki","Department of Physical Therapy, Faculty of Health Care, Takasaki University of Health and Welfare, Takasaki-shi, Japan",NA
"2029","34263028","10.1177/23779608211025117","Actual Frailty Conditions and Lifestyle Changes in Community-Dwelling Older Adults Affected by Coronavirus Disease 2019 Countermeasures in Japan: A Cross-Sectional Study.","Because of the countermeasures to prevent the spread of coronavirus disease 2019 (COVID-19) in Japan, it is easy to predict that the suspension of local activities and changes in lifestyle that lead to decreased activity will result in increased frailty and prefrailty rates in older adults. To clarify the actual frailty conditions and lifestyle changes among community-dwelling older adults affected by COVID-19 countermeasures in Japan. This cross-sectional study was conducted between May 8 and J","2021","07","16","SAGE Open Nurs","SAGE open nursing","COVID-19; frailty; lifestyle; older adult","Saida","Kosuke","Department of Physical Therapy, Faculty of Health Care, Takasaki University of Health and Welfare, Takasaki-shi, Japan",NA
"2030","34263028","10.1177/23779608211025117","Actual Frailty Conditions and Lifestyle Changes in Community-Dwelling Older Adults Affected by Coronavirus Disease 2019 Countermeasures in Japan: A Cross-Sectional Study.","Because of the countermeasures to prevent the spread of coronavirus disease 2019 (COVID-19) in Japan, it is easy to predict that the suspension of local activities and changes in lifestyle that lead to decreased activity will result in increased frailty and prefrailty rates in older adults. To clarify the actual frailty conditions and lifestyle changes among community-dwelling older adults affected by COVID-19 countermeasures in Japan. This cross-sectional study was conducted between May 8 and J","2021","07","16","SAGE Open Nurs","SAGE open nursing","COVID-19; frailty; lifestyle; older adult","Tanaka","Shigeya","Department of Physical Therapy, Faculty of Health Care, Takasaki University of Health and Welfare, Takasaki-shi, Japan",NA
"2031","34263028","10.1177/23779608211025117","Actual Frailty Conditions and Lifestyle Changes in Community-Dwelling Older Adults Affected by Coronavirus Disease 2019 Countermeasures in Japan: A Cross-Sectional Study.","Because of the countermeasures to prevent the spread of coronavirus disease 2019 (COVID-19) in Japan, it is easy to predict that the suspension of local activities and changes in lifestyle that lead to decreased activity will result in increased frailty and prefrailty rates in older adults. To clarify the actual frailty conditions and lifestyle changes among community-dwelling older adults affected by COVID-19 countermeasures in Japan. This cross-sectional study was conducted between May 8 and J","2021","07","16","SAGE Open Nurs","SAGE open nursing","COVID-19; frailty; lifestyle; older adult","Murayama","Akihiko","Department of Physical Therapy, Faculty of Rehabilitation, Gunma University of Health and Welfare, Maebashi-shi, Japan",NA
"2032","34263025","10.1177/23742895211023948","Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic.","The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular workflow as they adapted to new diagnostic tests and sample volumes. Herein, we summarize the modifications/adaptation the laboratory had to exercise to cope with rapidly evolving situations in the current pandemic. In the first phase of the pandemic, the laboratory validate","2021","07","16","Acad Pathol","Academic pathology","COVID-19; clinical laboratory; pandemic; pooling strategy; testing","Sahajpal","Nikhil S","Department of Pathology, Medical College of Georgia, Augusta University, GA, USA",NA
"2033","34263025","10.1177/23742895211023948","Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic.","The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular workflow as they adapted to new diagnostic tests and sample volumes. Herein, we summarize the modifications/adaptation the laboratory had to exercise to cope with rapidly evolving situations in the current pandemic. In the first phase of the pandemic, the laboratory validate","2021","07","16","Acad Pathol","Academic pathology","COVID-19; clinical laboratory; pandemic; pooling strategy; testing","Mondal","Ashis K","Department of Pathology, Medical College of Georgia, Augusta University, GA, USA",NA
"2034","34263025","10.1177/23742895211023948","Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic.","The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular workflow as they adapted to new diagnostic tests and sample volumes. Herein, we summarize the modifications/adaptation the laboratory had to exercise to cope with rapidly evolving situations in the current pandemic. In the first phase of the pandemic, the laboratory validate","2021","07","16","Acad Pathol","Academic pathology","COVID-19; clinical laboratory; pandemic; pooling strategy; testing","Ananth","Sudha","Department of Pathology, Medical College of Georgia, Augusta University, GA, USA",NA
"2035","34263025","10.1177/23742895211023948","Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic.","The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular workflow as they adapted to new diagnostic tests and sample volumes. Herein, we summarize the modifications/adaptation the laboratory had to exercise to cope with rapidly evolving situations in the current pandemic. In the first phase of the pandemic, the laboratory validate","2021","07","16","Acad Pathol","Academic pathology","COVID-19; clinical laboratory; pandemic; pooling strategy; testing","Njau","Allan","Department of Pathology, Aga Khan University Hospital, Nairobi, Kenya",NA
"2036","34263025","10.1177/23742895211023948","Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic.","The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular workflow as they adapted to new diagnostic tests and sample volumes. Herein, we summarize the modifications/adaptation the laboratory had to exercise to cope with rapidly evolving situations in the current pandemic. In the first phase of the pandemic, the laboratory validate","2021","07","16","Acad Pathol","Academic pathology","COVID-19; clinical laboratory; pandemic; pooling strategy; testing","Fulzele","Sadanand","Center for Healthy Aging, Medical College of Georgia, Augusta University, GA, USA",NA
"2037","34263025","10.1177/23742895211023948","Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic.","The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular workflow as they adapted to new diagnostic tests and sample volumes. Herein, we summarize the modifications/adaptation the laboratory had to exercise to cope with rapidly evolving situations in the current pandemic. In the first phase of the pandemic, the laboratory validate","2021","07","16","Acad Pathol","Academic pathology","COVID-19; clinical laboratory; pandemic; pooling strategy; testing","Ahaluwalia","Pankaj","Department of Pathology, Medical College of Georgia, Augusta University, GA, USA",NA
"2038","34263025","10.1177/23742895211023948","Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic.","The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular workflow as they adapted to new diagnostic tests and sample volumes. Herein, we summarize the modifications/adaptation the laboratory had to exercise to cope with rapidly evolving situations in the current pandemic. In the first phase of the pandemic, the laboratory validate","2021","07","16","Acad Pathol","Academic pathology","COVID-19; clinical laboratory; pandemic; pooling strategy; testing","Chaubey","Alka","Department of Pathology, Medical College of Georgia, Augusta University, GA, USA",NA
"2039","34263025","10.1177/23742895211023948","Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic.","The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular workflow as they adapted to new diagnostic tests and sample volumes. Herein, we summarize the modifications/adaptation the laboratory had to exercise to cope with rapidly evolving situations in the current pandemic. In the first phase of the pandemic, the laboratory validate","2021","07","16","Acad Pathol","Academic pathology","COVID-19; clinical laboratory; pandemic; pooling strategy; testing","Hegde","Madhuri","Global Laboratory Services, PerkinElmer Inc, Waltham, GA, USA",NA
"2040","34263025","10.1177/23742895211023948","Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic.","The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular workflow as they adapted to new diagnostic tests and sample volumes. Herein, we summarize the modifications/adaptation the laboratory had to exercise to cope with rapidly evolving situations in the current pandemic. In the first phase of the pandemic, the laboratory validate","2021","07","16","Acad Pathol","Academic pathology","COVID-19; clinical laboratory; pandemic; pooling strategy; testing","Rojiani","Amyn M","Department of Pathology, Medical College of Georgia, Augusta University, GA, USA",NA
"2041","34263025","10.1177/23742895211023948","Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic.","The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular workflow as they adapted to new diagnostic tests and sample volumes. Herein, we summarize the modifications/adaptation the laboratory had to exercise to cope with rapidly evolving situations in the current pandemic. In the first phase of the pandemic, the laboratory validate","2021","07","16","Acad Pathol","Academic pathology","COVID-19; clinical laboratory; pandemic; pooling strategy; testing","Kolhe","Ravindra","Department of Pathology, Medical College of Georgia, Augusta University, GA, USA",NA
"2042","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Patel","Robin","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2043","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Hoppman","Nicole Lynn","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2044","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Gosse","Cindy M","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2045","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Hagen-Moe","Deborah J","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2046","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Dunemann","Susan K","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2047","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Kreuter","Justin D","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2048","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Preuss","Sharon A","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2049","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Winters","Jeffrey L","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2050","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Sturgis","Charles D","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2051","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Maleszewski","Joseph J","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2052","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Solanki","Malvika H","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2053","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Pritt","Bobbi S","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2054","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Rivera","Michael","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2055","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Mairose","Ann M","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2056","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Nelsen","Michelle A","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2057","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Hansing","Kara L","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2058","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Lehman","Susan M","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2059","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Gruhlke","Randy C","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2060","34263023","10.1177/23742895211020487","Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned.","The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology education","2021","07","16","Acad Pathol","Academic pathology","COVID-19; education; laboratory medicine; pathology; virtual","Boland","Jennifer M","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA",NA
"2061","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Walker","Alexis","Berman Institute of Bioethics, Johns Hopkins University, 1809 Ashland Avenue, Baltimore MD 21205 USA",NA
"2062","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Bonham","Vence L","Social and Behavioral Research Branch, National Human Genome Research Institute, 31 Center Drive, Bethesda MD 20894 USA",NA
"2063","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Boyce","Angie","Berman Institute of Bioethics, Johns Hopkins University, 1809 Ashland Avenue, Baltimore MD 21205 USA",NA
"2064","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Clayton","Ellen Wright","Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville TN 37232 USA",NA
"2065","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Garcia","Debra","International Society for Biological and Environmental Repositories, 750 W Pender St #301, Vancouver BC V6C 1G8 Canada",NA
"2066","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Johnson","Stephanie","Wellcome Centre for Ethics and the Humanities and Ethox Centre, University of Oxford, Oxford OX1 2JD UK",NA
"2067","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Laeyendecker","Oliver","Johns Hopkins University School of Medicine, 733 N Broadway, Baltimore MD 21205 USA",NA
"2068","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Lewis","Michelle","Berman Institute of Bioethics, Johns Hopkins University, 1809 Ashland Avenue, Baltimore MD 21205 USA",NA
"2069","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Margolick","Joseph B","Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore MD 21205 USA",NA
"2070","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Mathews","Debra","Berman Institute of Bioethics, Johns Hopkins University, 1809 Ashland Avenue, Baltimore MD 21205 USA",NA
"2071","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Parker","Michael J","Wellcome Centre for Ethics and the Humanities and Ethox Centre, University of Oxford, Oxford OX1 2JD UK",NA
"2072","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Spicer","Paul","Department of Anthropology and the Center for Applied Social Research, University of Oklahoma, 455 W Lindsey St, Norman OK 73069 USA",NA
"2073","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Thio","Chloe L","Johns Hopkins University School of Medicine, 733 N Broadway, Baltimore MD 21205 USA",NA
"2074","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Geller","Gail","Berman Institute of Bioethics, Johns Hopkins University, 1809 Ashland Avenue, Baltimore MD 21205 USA",NA
"2075","34263019","10.1016/j.jemep.2021.100684","Ethical Issues in Genetics and Infectious Diseases Research: An Interdisciplinary Expert Review.","Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review. This paper presents res","2021","07","16","Ethics Med Public Health","Ethics, medicine, and public health","Genetics; Infectious diseases; Justice; Privacy; Resource allocation; Return of research results","Kahn","Jeffrey","Berman Institute of Bioethics, Johns Hopkins University, 1809 Ashland Avenue, Baltimore MD 21205 USA",NA
"2076","34262960","10.3389/fvets.2021.627894","Factors Affecting the Development of Bovine Respiratory Disease: A Cross-Sectional Study in Beef Steers Shipped From France to Italy.","Bovine respiratory disease (BRD) is a complex, multifactorial syndrome and one of the major welfare and economical concerns for the cattle industry. This 1-year cross-sectional study was aimed at documenting the prevalence of BRD-related pathogens and clinical signs before and after a long journey and at identifying possible predisposition factors. Male Limousine beef steers (n = 169) traveling from France to Italy were health checked and sampled with Deep Nasopharyngeal Swabs (DNS) at lo","2021","07","16","Front Vet Sci","Frontiers in veterinary science","bacteria; cattle; health; transport; virus; welfare","Padalino","Barbara","Department of Agricultural and Food Science, University of Bologna, Bologna, Italy",NA
"2077","34262960","10.3389/fvets.2021.627894","Factors Affecting the Development of Bovine Respiratory Disease: A Cross-Sectional Study in Beef Steers Shipped From France to Italy.","Bovine respiratory disease (BRD) is a complex, multifactorial syndrome and one of the major welfare and economical concerns for the cattle industry. This 1-year cross-sectional study was aimed at documenting the prevalence of BRD-related pathogens and clinical signs before and after a long journey and at identifying possible predisposition factors. Male Limousine beef steers (n = 169) traveling from France to Italy were health checked and sampled with Deep Nasopharyngeal Swabs (DNS) at lo","2021","07","16","Front Vet Sci","Frontiers in veterinary science","bacteria; cattle; health; transport; virus; welfare","Cirone","Francesco","Department of Veterinary Medicine, University of Bari, Bari, Italy",NA
"2078","34262960","10.3389/fvets.2021.627894","Factors Affecting the Development of Bovine Respiratory Disease: A Cross-Sectional Study in Beef Steers Shipped From France to Italy.","Bovine respiratory disease (BRD) is a complex, multifactorial syndrome and one of the major welfare and economical concerns for the cattle industry. This 1-year cross-sectional study was aimed at documenting the prevalence of BRD-related pathogens and clinical signs before and after a long journey and at identifying possible predisposition factors. Male Limousine beef steers (n = 169) traveling from France to Italy were health checked and sampled with Deep Nasopharyngeal Swabs (DNS) at lo","2021","07","16","Front Vet Sci","Frontiers in veterinary science","bacteria; cattle; health; transport; virus; welfare","Zappaterra","Martina","Department of Agricultural and Food Science, University of Bologna, Bologna, Italy",NA
"2079","34262960","10.3389/fvets.2021.627894","Factors Affecting the Development of Bovine Respiratory Disease: A Cross-Sectional Study in Beef Steers Shipped From France to Italy.","Bovine respiratory disease (BRD) is a complex, multifactorial syndrome and one of the major welfare and economical concerns for the cattle industry. This 1-year cross-sectional study was aimed at documenting the prevalence of BRD-related pathogens and clinical signs before and after a long journey and at identifying possible predisposition factors. Male Limousine beef steers (n = 169) traveling from France to Italy were health checked and sampled with Deep Nasopharyngeal Swabs (DNS) at lo","2021","07","16","Front Vet Sci","Frontiers in veterinary science","bacteria; cattle; health; transport; virus; welfare","Tullio","Daniele","Azienda Sanitaria Locale della Provincia di Bari (ASL BA) - Local Health Authority Veterinary Service, Bari, Italy",NA
"2080","34262960","10.3389/fvets.2021.627894","Factors Affecting the Development of Bovine Respiratory Disease: A Cross-Sectional Study in Beef Steers Shipped From France to Italy.","Bovine respiratory disease (BRD) is a complex, multifactorial syndrome and one of the major welfare and economical concerns for the cattle industry. This 1-year cross-sectional study was aimed at documenting the prevalence of BRD-related pathogens and clinical signs before and after a long journey and at identifying possible predisposition factors. Male Limousine beef steers (n = 169) traveling from France to Italy were health checked and sampled with Deep Nasopharyngeal Swabs (DNS) at lo","2021","07","16","Front Vet Sci","Frontiers in veterinary science","bacteria; cattle; health; transport; virus; welfare","Ficco","Gigliola","Siciliani S.p.A. Industria Lavorazione Carne, Bari, Italy",NA
"2081","34262960","10.3389/fvets.2021.627894","Factors Affecting the Development of Bovine Respiratory Disease: A Cross-Sectional Study in Beef Steers Shipped From France to Italy.","Bovine respiratory disease (BRD) is a complex, multifactorial syndrome and one of the major welfare and economical concerns for the cattle industry. This 1-year cross-sectional study was aimed at documenting the prevalence of BRD-related pathogens and clinical signs before and after a long journey and at identifying possible predisposition factors. Male Limousine beef steers (n = 169) traveling from France to Italy were health checked and sampled with Deep Nasopharyngeal Swabs (DNS) at lo","2021","07","16","Front Vet Sci","Frontiers in veterinary science","bacteria; cattle; health; transport; virus; welfare","Giustino","Antonio","Self Employed Veterinarian, Bari, Italy",NA
"2082","34262960","10.3389/fvets.2021.627894","Factors Affecting the Development of Bovine Respiratory Disease: A Cross-Sectional Study in Beef Steers Shipped From France to Italy.","Bovine respiratory disease (BRD) is a complex, multifactorial syndrome and one of the major welfare and economical concerns for the cattle industry. This 1-year cross-sectional study was aimed at documenting the prevalence of BRD-related pathogens and clinical signs before and after a long journey and at identifying possible predisposition factors. Male Limousine beef steers (n = 169) traveling from France to Italy were health checked and sampled with Deep Nasopharyngeal Swabs (DNS) at lo","2021","07","16","Front Vet Sci","Frontiers in veterinary science","bacteria; cattle; health; transport; virus; welfare","Ndiana","Linda Amarachi","Department of Veterinary Medicine, University of Bari, Bari, Italy",NA
"2083","34262960","10.3389/fvets.2021.627894","Factors Affecting the Development of Bovine Respiratory Disease: A Cross-Sectional Study in Beef Steers Shipped From France to Italy.","Bovine respiratory disease (BRD) is a complex, multifactorial syndrome and one of the major welfare and economical concerns for the cattle industry. This 1-year cross-sectional study was aimed at documenting the prevalence of BRD-related pathogens and clinical signs before and after a long journey and at identifying possible predisposition factors. Male Limousine beef steers (n = 169) traveling from France to Italy were health checked and sampled with Deep Nasopharyngeal Swabs (DNS) at lo","2021","07","16","Front Vet Sci","Frontiers in veterinary science","bacteria; cattle; health; transport; virus; welfare","Pratelli","Annamaria","Department of Veterinary Medicine, University of Bari, Bari, Italy",NA
"2084","34262944","10.3389/frobt.2021.612855","A COVID-19 Emergency Response for Remote Control of a Dialysis Machine with Mobile HRI.","Healthcare workers face a high risk of contagion during a pandemic due to their close proximity to patients. The situation is further exacerbated in the case of a shortage of personal protective equipment that can increase the risk of exposure for the healthcare workers and even non-pandemic related patients, such as those on dialysis. In this study, we propose an emergency, non-invasive remote monitoring and control response system to retrofit dialysis machines with robotic manipulators for saf","2021","07","16","Front Robot AI","Frontiers in robotics and AI","COVID-19; human-robot interaction; interface; manipulation; remote interaction; robotics","Wazir","Hassam Khan","Mechatronics, Controls, and Robotics Laboratory, Mechanical and Aerospace Engineering Department, NYU Tandon School of Engineering, Brooklyn, NY, United States",NA
"2085","34262944","10.3389/frobt.2021.612855","A COVID-19 Emergency Response for Remote Control of a Dialysis Machine with Mobile HRI.","Healthcare workers face a high risk of contagion during a pandemic due to their close proximity to patients. The situation is further exacerbated in the case of a shortage of personal protective equipment that can increase the risk of exposure for the healthcare workers and even non-pandemic related patients, such as those on dialysis. In this study, we propose an emergency, non-invasive remote monitoring and control response system to retrofit dialysis machines with robotic manipulators for saf","2021","07","16","Front Robot AI","Frontiers in robotics and AI","COVID-19; human-robot interaction; interface; manipulation; remote interaction; robotics","Lourido","Christian","Mechatronics, Controls, and Robotics Laboratory, Mechanical and Aerospace Engineering Department, NYU Tandon School of Engineering, Brooklyn, NY, United States",NA
"2086","34262944","10.3389/frobt.2021.612855","A COVID-19 Emergency Response for Remote Control of a Dialysis Machine with Mobile HRI.","Healthcare workers face a high risk of contagion during a pandemic due to their close proximity to patients. The situation is further exacerbated in the case of a shortage of personal protective equipment that can increase the risk of exposure for the healthcare workers and even non-pandemic related patients, such as those on dialysis. In this study, we propose an emergency, non-invasive remote monitoring and control response system to retrofit dialysis machines with robotic manipulators for saf","2021","07","16","Front Robot AI","Frontiers in robotics and AI","COVID-19; human-robot interaction; interface; manipulation; remote interaction; robotics","Chacko","Sonia Mary","Mechatronics, Controls, and Robotics Laboratory, Mechanical and Aerospace Engineering Department, NYU Tandon School of Engineering, Brooklyn, NY, United States",NA
"2087","34262944","10.3389/frobt.2021.612855","A COVID-19 Emergency Response for Remote Control of a Dialysis Machine with Mobile HRI.","Healthcare workers face a high risk of contagion during a pandemic due to their close proximity to patients. The situation is further exacerbated in the case of a shortage of personal protective equipment that can increase the risk of exposure for the healthcare workers and even non-pandemic related patients, such as those on dialysis. In this study, we propose an emergency, non-invasive remote monitoring and control response system to retrofit dialysis machines with robotic manipulators for saf","2021","07","16","Front Robot AI","Frontiers in robotics and AI","COVID-19; human-robot interaction; interface; manipulation; remote interaction; robotics","Kapila","Vikram","Mechatronics, Controls, and Robotics Laboratory, Mechanical and Aerospace Engineering Department, NYU Tandon School of Engineering, Brooklyn, NY, United States",NA
"2088","34262922","10.3389/fnut.2021.646988","Therapeutic and Industrial Applications of Curdlan With Overview on Its Recent Patents.","Curdlan is an exopolysaccharide, which is composed of glucose linked with ß-(1,3)-glycosidic bond and is produced by bacteria, such as Alcaligenes spp., Agrobacterium spp., Paenibacillus spp., Rhizobium spp., Saccharomyces cerevisiae, Candida spp., and fungal sources like Aureobasidium pullulan, Poria cocos, etc. Curdlan has been utilized in the food and pharmaceutical industries for its prebiotic, viscosifying, and water-holding properties for decades. ","2021","07","16","Front Nutr","Frontiers in nutrition","anti-cancer; anti-malaria; anti-viral; curdlan sulfate; functional food; immunomodulatory activity; succinoglucan; ß-(1,3)-glucan oligosaccharides","Chaudhari","Vinay","Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies, Mumbai, India",NA
"2089","34262922","10.3389/fnut.2021.646988","Therapeutic and Industrial Applications of Curdlan With Overview on Its Recent Patents.","Curdlan is an exopolysaccharide, which is composed of glucose linked with ß-(1,3)-glycosidic bond and is produced by bacteria, such as Alcaligenes spp., Agrobacterium spp., Paenibacillus spp., Rhizobium spp., Saccharomyces cerevisiae, Candida spp., and fungal sources like Aureobasidium pullulan, Poria cocos, etc. Curdlan has been utilized in the food and pharmaceutical industries for its prebiotic, viscosifying, and water-holding properties for decades. ","2021","07","16","Front Nutr","Frontiers in nutrition","anti-cancer; anti-malaria; anti-viral; curdlan sulfate; functional food; immunomodulatory activity; succinoglucan; ß-(1,3)-glucan oligosaccharides","Buttar","Harpal Singh","Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada",NA
"2090","34262922","10.3389/fnut.2021.646988","Therapeutic and Industrial Applications of Curdlan With Overview on Its Recent Patents.","Curdlan is an exopolysaccharide, which is composed of glucose linked with ß-(1,3)-glycosidic bond and is produced by bacteria, such as Alcaligenes spp., Agrobacterium spp., Paenibacillus spp., Rhizobium spp., Saccharomyces cerevisiae, Candida spp., and fungal sources like Aureobasidium pullulan, Poria cocos, etc. Curdlan has been utilized in the food and pharmaceutical industries for its prebiotic, viscosifying, and water-holding properties for decades. ","2021","07","16","Front Nutr","Frontiers in nutrition","anti-cancer; anti-malaria; anti-viral; curdlan sulfate; functional food; immunomodulatory activity; succinoglucan; ß-(1,3)-glucan oligosaccharides","Bagwe-Parab","Siddhi","Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies, Mumbai, India",NA
"2091","34262922","10.3389/fnut.2021.646988","Therapeutic and Industrial Applications of Curdlan With Overview on Its Recent Patents.","Curdlan is an exopolysaccharide, which is composed of glucose linked with ß-(1,3)-glycosidic bond and is produced by bacteria, such as Alcaligenes spp., Agrobacterium spp., Paenibacillus spp., Rhizobium spp., Saccharomyces cerevisiae, Candida spp., and fungal sources like Aureobasidium pullulan, Poria cocos, etc. Curdlan has been utilized in the food and pharmaceutical industries for its prebiotic, viscosifying, and water-holding properties for decades. ","2021","07","16","Front Nutr","Frontiers in nutrition","anti-cancer; anti-malaria; anti-viral; curdlan sulfate; functional food; immunomodulatory activity; succinoglucan; ß-(1,3)-glucan oligosaccharides","Tuli","Hardeep Singh","Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana, India",NA
"2092","34262922","10.3389/fnut.2021.646988","Therapeutic and Industrial Applications of Curdlan With Overview on Its Recent Patents.","Curdlan is an exopolysaccharide, which is composed of glucose linked with ß-(1,3)-glycosidic bond and is produced by bacteria, such as Alcaligenes spp., Agrobacterium spp., Paenibacillus spp., Rhizobium spp., Saccharomyces cerevisiae, Candida spp., and fungal sources like Aureobasidium pullulan, Poria cocos, etc. Curdlan has been utilized in the food and pharmaceutical industries for its prebiotic, viscosifying, and water-holding properties for decades. ","2021","07","16","Front Nutr","Frontiers in nutrition","anti-cancer; anti-malaria; anti-viral; curdlan sulfate; functional food; immunomodulatory activity; succinoglucan; ß-(1,3)-glucan oligosaccharides","Vora","Amisha","Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies, Mumbai, India",NA
"2093","34262922","10.3389/fnut.2021.646988","Therapeutic and Industrial Applications of Curdlan With Overview on Its Recent Patents.","Curdlan is an exopolysaccharide, which is composed of glucose linked with ß-(1,3)-glycosidic bond and is produced by bacteria, such as Alcaligenes spp., Agrobacterium spp., Paenibacillus spp., Rhizobium spp., Saccharomyces cerevisiae, Candida spp., and fungal sources like Aureobasidium pullulan, Poria cocos, etc. Curdlan has been utilized in the food and pharmaceutical industries for its prebiotic, viscosifying, and water-holding properties for decades. ","2021","07","16","Front Nutr","Frontiers in nutrition","anti-cancer; anti-malaria; anti-viral; curdlan sulfate; functional food; immunomodulatory activity; succinoglucan; ß-(1,3)-glucan oligosaccharides","Kaur","Ginpreet","Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies, Mumbai, India",NA
"2094","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Laiton-Donato","Katherine","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2095","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Usme-Ciro","Jose A","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2096","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Franco-Muñoz","Carlos","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2097","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Álvarez-Díaz","Diego A","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2098","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Ruiz-Moreno","Hector Alejandro","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2099","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Reales-González","Jhonnatan","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2100","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Prada","Diego Andrés","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2101","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Corchuelo","Sheryll","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2102","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Herrera-Sepúlveda","Maria T","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2103","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Naizaque","Julian","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2104","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Santamaría","Gerardo","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2105","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Wiesner","Magdalena","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2106","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Walteros","Diana Marcela","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2107","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Ospina Martínez","Martha Lucia","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2108","34262921","10.3389/fmed.2021.697605","Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.","COVID-19 pandemics has led to genetic diversification of SARS-CoV-2 and the appearance of variants with potential impact in transmissibility and viral escape from acquired immunity. We report a new and highly divergent lineage containing 21 distinctive mutations (10 non-synonymous, eight synonymous, and three substitutions in non-coding regions). The amino acid changes L249S and E484K located at the CTD and RBD of the Spike protein could be of special interest due to their potential biological r","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; lineage; spike; variant of interest","Mercado-Reyes","Marcela","Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia",NA
"2109","34262919","10.3389/fmed.2021.692898","Case Report: A Rehabilitation Practice Report During ICU Management for a Patient With Multiple Disabilities Due to COVID-19 Pneumonia and COPD.","Patients with severe coronavirus disease (COVID-19) and admitted to the intensive care unit (ICU) are at high risk of developing ICU-acquired weakness and disuse syndrome. Although their medical management may include prolonged deep sedation for pulmonary protection and ventilator management, we aim for early mobilization of these patients with COVID-19. We present the case of a 71-year-old man with chronic obstructive pulmonary disease (COPD) and COVID-19 pneumonia. Passive range of motion trai","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; case report; early ambulation; rehabilitation; supplemental oxygen therapy","Kinoshita","Tokio","Department of Rehabilitation Medicine, Wakayama Medical University, Wakayama, Japan",NA
"2110","34262919","10.3389/fmed.2021.692898","Case Report: A Rehabilitation Practice Report During ICU Management for a Patient With Multiple Disabilities Due to COVID-19 Pneumonia and COPD.","Patients with severe coronavirus disease (COVID-19) and admitted to the intensive care unit (ICU) are at high risk of developing ICU-acquired weakness and disuse syndrome. Although their medical management may include prolonged deep sedation for pulmonary protection and ventilator management, we aim for early mobilization of these patients with COVID-19. We present the case of a 71-year-old man with chronic obstructive pulmonary disease (COPD) and COVID-19 pneumonia. Passive range of motion trai","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; case report; early ambulation; rehabilitation; supplemental oxygen therapy","Kouda","Ken","Department of Rehabilitation Medicine, Wakayama Medical University, Wakayama, Japan",NA
"2111","34262919","10.3389/fmed.2021.692898","Case Report: A Rehabilitation Practice Report During ICU Management for a Patient With Multiple Disabilities Due to COVID-19 Pneumonia and COPD.","Patients with severe coronavirus disease (COVID-19) and admitted to the intensive care unit (ICU) are at high risk of developing ICU-acquired weakness and disuse syndrome. Although their medical management may include prolonged deep sedation for pulmonary protection and ventilator management, we aim for early mobilization of these patients with COVID-19. We present the case of a 71-year-old man with chronic obstructive pulmonary disease (COPD) and COVID-19 pneumonia. Passive range of motion trai","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; case report; early ambulation; rehabilitation; supplemental oxygen therapy","Umemoto","Yasunori","Department of Rehabilitation Medicine, Wakayama Medical University, Wakayama, Japan",NA
"2112","34262919","10.3389/fmed.2021.692898","Case Report: A Rehabilitation Practice Report During ICU Management for a Patient With Multiple Disabilities Due to COVID-19 Pneumonia and COPD.","Patients with severe coronavirus disease (COVID-19) and admitted to the intensive care unit (ICU) are at high risk of developing ICU-acquired weakness and disuse syndrome. Although their medical management may include prolonged deep sedation for pulmonary protection and ventilator management, we aim for early mobilization of these patients with COVID-19. We present the case of a 71-year-old man with chronic obstructive pulmonary disease (COPD) and COVID-19 pneumonia. Passive range of motion trai","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; case report; early ambulation; rehabilitation; supplemental oxygen therapy","Yasuoka","Yoshinori","Department of Rehabilitation Medicine, Wakayama Medical University, Wakayama, Japan",NA
"2113","34262919","10.3389/fmed.2021.692898","Case Report: A Rehabilitation Practice Report During ICU Management for a Patient With Multiple Disabilities Due to COVID-19 Pneumonia and COPD.","Patients with severe coronavirus disease (COVID-19) and admitted to the intensive care unit (ICU) are at high risk of developing ICU-acquired weakness and disuse syndrome. Although their medical management may include prolonged deep sedation for pulmonary protection and ventilator management, we aim for early mobilization of these patients with COVID-19. We present the case of a 71-year-old man with chronic obstructive pulmonary disease (COPD) and COVID-19 pneumonia. Passive range of motion trai","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; case report; early ambulation; rehabilitation; supplemental oxygen therapy","Minoshima","Yuta","Department of Rehabilitation Medicine, Wakayama Medical University, Wakayama, Japan",NA
"2114","34262919","10.3389/fmed.2021.692898","Case Report: A Rehabilitation Practice Report During ICU Management for a Patient With Multiple Disabilities Due to COVID-19 Pneumonia and COPD.","Patients with severe coronavirus disease (COVID-19) and admitted to the intensive care unit (ICU) are at high risk of developing ICU-acquired weakness and disuse syndrome. Although their medical management may include prolonged deep sedation for pulmonary protection and ventilator management, we aim for early mobilization of these patients with COVID-19. We present the case of a 71-year-old man with chronic obstructive pulmonary disease (COPD) and COVID-19 pneumonia. Passive range of motion trai","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; case report; early ambulation; rehabilitation; supplemental oxygen therapy","Mikami","Yukio","Department of Rehabilitation Medicine, Wakayama Medical University, Wakayama, Japan",NA
"2115","34262919","10.3389/fmed.2021.692898","Case Report: A Rehabilitation Practice Report During ICU Management for a Patient With Multiple Disabilities Due to COVID-19 Pneumonia and COPD.","Patients with severe coronavirus disease (COVID-19) and admitted to the intensive care unit (ICU) are at high risk of developing ICU-acquired weakness and disuse syndrome. Although their medical management may include prolonged deep sedation for pulmonary protection and ventilator management, we aim for early mobilization of these patients with COVID-19. We present the case of a 71-year-old man with chronic obstructive pulmonary disease (COPD) and COVID-19 pneumonia. Passive range of motion trai","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; case report; early ambulation; rehabilitation; supplemental oxygen therapy","Nishimura","Yukihide","Department of Rehabilitation Medicine, Iwate Medical University, Iwate, Japan",NA
"2116","34262919","10.3389/fmed.2021.692898","Case Report: A Rehabilitation Practice Report During ICU Management for a Patient With Multiple Disabilities Due to COVID-19 Pneumonia and COPD.","Patients with severe coronavirus disease (COVID-19) and admitted to the intensive care unit (ICU) are at high risk of developing ICU-acquired weakness and disuse syndrome. Although their medical management may include prolonged deep sedation for pulmonary protection and ventilator management, we aim for early mobilization of these patients with COVID-19. We present the case of a 71-year-old man with chronic obstructive pulmonary disease (COPD) and COVID-19 pneumonia. Passive range of motion trai","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; case report; early ambulation; rehabilitation; supplemental oxygen therapy","Miyamoto","Kyohei","Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama, Japan",NA
"2117","34262919","10.3389/fmed.2021.692898","Case Report: A Rehabilitation Practice Report During ICU Management for a Patient With Multiple Disabilities Due to COVID-19 Pneumonia and COPD.","Patients with severe coronavirus disease (COVID-19) and admitted to the intensive care unit (ICU) are at high risk of developing ICU-acquired weakness and disuse syndrome. Although their medical management may include prolonged deep sedation for pulmonary protection and ventilator management, we aim for early mobilization of these patients with COVID-19. We present the case of a 71-year-old man with chronic obstructive pulmonary disease (COPD) and COVID-19 pneumonia. Passive range of motion trai","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; case report; early ambulation; rehabilitation; supplemental oxygen therapy","Kato","Seiya","Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama, Japan",NA
"2118","34262919","10.3389/fmed.2021.692898","Case Report: A Rehabilitation Practice Report During ICU Management for a Patient With Multiple Disabilities Due to COVID-19 Pneumonia and COPD.","Patients with severe coronavirus disease (COVID-19) and admitted to the intensive care unit (ICU) are at high risk of developing ICU-acquired weakness and disuse syndrome. Although their medical management may include prolonged deep sedation for pulmonary protection and ventilator management, we aim for early mobilization of these patients with COVID-19. We present the case of a 71-year-old man with chronic obstructive pulmonary disease (COPD) and COVID-19 pneumonia. Passive range of motion trai","2021","07","16","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; case report; early ambulation; rehabilitation; supplemental oxygen therapy","Tajima","Fumihiro","Department of Rehabilitation Medicine, Wakayama Medical University, Wakayama, Japan",NA
"2119","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Pasello","Giulia","Medical Oncology Department, Istituto Oncologico Veneto IRCCS, Padova, Italy",NA
"2120","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Menis","Jessica","Medical Oncology Department, Istituto Oncologico Veneto IRCCS, Padova, Italy",NA
"2121","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Pilotto","Sara","Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy",NA
"2122","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Frega","Stefano","Medical Oncology Department, Istituto Oncologico Veneto IRCCS, Padova, Italy",NA
"2123","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Belluomini","Lorenzo","Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy",NA
"2124","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Pezzuto","Federica","University of Padova, Medical School, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova, Italy",NA
"2125","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Caliò","Anna","Department of Diagnostics and Public Health, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy",NA
"2126","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Sepulcri","Matteo","Radiation Oncology Department, Istituto Oncologico Veneto IRCCS, Padova, Italy",NA
"2127","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Cernusco","Nunzia Luna Valentina","Radiation Oncology Department, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy",NA
"2128","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Schiavon","Marco","University of Padova, Medical School, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova, Italy",NA
"2129","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Infante","Maurizio Valentino","Cardiovascular and Thoracic Department, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy",NA
"2130","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Damin","Marco","University of Padova, Medical School, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova, Italy",NA
"2131","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Micheletto","Claudio","Cardiovascular and Thoracic Department, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy",NA
"2132","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Del Bianco","Paola","Medical Oncology Department, Istituto Oncologico Veneto IRCCS, Padova, Italy",NA
"2133","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Giovannetti","Riccardo","Cardiovascular and Thoracic Department, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy",NA
"2134","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Bonanno","Laura","Medical Oncology Department, Istituto Oncologico Veneto IRCCS, Padova, Italy",NA
"2135","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Fantoni","Umberto","University of Padova, Medical School, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova, Italy",NA
"2136","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Guarneri","Valentina","Medical Oncology Department, Istituto Oncologico Veneto IRCCS, Padova, Italy",NA
"2137","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Calabrese","Fiorella","University of Padova, Medical School, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova, Italy",NA
"2138","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Rea","Federico","University of Padova, Medical School, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova, Italy",NA
"2139","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Milella","Michele","Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy",NA
"2140","34262861","10.3389/fonc.2021.669786","How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.","The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, particularly with regard to cancer patients. So far, very limited data have been presented on the impact on integrated care pathways (ICPs). We reviewed the ICPs of lung cancer patients who accessed the Veneto Institute of Oncology (IOV)/University Hospital of Padua (Center 1) and the University Hospital of Verona (Center 2) before and after the COVID-19 pandemic, through sixteen indicators chosen by the members ","2021","07","16","Front Oncol","Frontiers in oncology","COVID-19; integrated care pathway; lung cancer; multidisciplinary team discussion; pandemic","Conte","PierFranco","Medical Oncology Department, Istituto Oncologico Veneto IRCCS, Padova, Italy",NA
"2141","34262828","10.7759/cureus.16149","Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described in patients in Wuhan, China, who presented with flu-like symptoms. Since then, it has spread all over the world and in March 2020 it was labeled as a pandemic by the World Health Organization. Most common presentations include respiratory symptoms that vary from mild cough and shortness of breath to severe acute respiratory distress syndrome. Gastrointestinal symptoms like nausea, vomiting and diarrhea are also comm","2021","07","16","Cureus","Cureus","covid 19; covid-19 and cardiomyopathy; covid-19 and heart; covid-induced myocarditis; hemodynamic shock","Ghafoor","Khuzema","Internal Medicine, Atrium Health Navicent, Macon, USA",NA
"2142","34262828","10.7759/cureus.16149","Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described in patients in Wuhan, China, who presented with flu-like symptoms. Since then, it has spread all over the world and in March 2020 it was labeled as a pandemic by the World Health Organization. Most common presentations include respiratory symptoms that vary from mild cough and shortness of breath to severe acute respiratory distress syndrome. Gastrointestinal symptoms like nausea, vomiting and diarrhea are also comm","2021","07","16","Cureus","Cureus","covid 19; covid-19 and cardiomyopathy; covid-19 and heart; covid-induced myocarditis; hemodynamic shock","Ahmed","Aftab","Pulmonary and Critical Care Medicine, Atrium Health Navicent, Macon, USA",NA
"2143","34262828","10.7759/cureus.16149","Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described in patients in Wuhan, China, who presented with flu-like symptoms. Since then, it has spread all over the world and in March 2020 it was labeled as a pandemic by the World Health Organization. Most common presentations include respiratory symptoms that vary from mild cough and shortness of breath to severe acute respiratory distress syndrome. Gastrointestinal symptoms like nausea, vomiting and diarrhea are also comm","2021","07","16","Cureus","Cureus","covid 19; covid-19 and cardiomyopathy; covid-19 and heart; covid-induced myocarditis; hemodynamic shock","Abbas","Mubasher","Internal Medicine, Atrium Health Navicent, Macon, USA",NA
"2144","34262822","10.7759/cureus.15486","Cardiovascular Risk Factors and the Severity of COVID-19 Disease.","Background and objective Several cardiovascular risk factors have emerged as important determinants of severe illness and death among coronavirus disease 2019 (COVID-19) patients. However, the full impact of these cardiovascular risk factors is still under investigation. This study aimed to investigate the association between patients' level of cardiovascular risk and the severity of COVID-19. Materials and methods This observational study included all adult patients with COVID-19 hospitalized a","2021","07","16","Cureus","Cureus","covid 19; sar-cov 2 infection; severity markers; traditional cardiovascular risk factors","Motaib","Imane","Endocrinology, Diabetes, and Metabolism, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR",NA
"2145","34262822","10.7759/cureus.15486","Cardiovascular Risk Factors and the Severity of COVID-19 Disease.","Background and objective Several cardiovascular risk factors have emerged as important determinants of severe illness and death among coronavirus disease 2019 (COVID-19) patients. However, the full impact of these cardiovascular risk factors is still under investigation. This study aimed to investigate the association between patients' level of cardiovascular risk and the severity of COVID-19. Materials and methods This observational study included all adult patients with COVID-19 hospitalized a","2021","07","16","Cureus","Cureus","covid 19; sar-cov 2 infection; severity markers; traditional cardiovascular risk factors","Zbiri","Saad","Epidemiology and Public Health, Laboratory of Public Health, Health Economics, and Health Management, International School of Public Health, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR",NA
"2146","34262822","10.7759/cureus.15486","Cardiovascular Risk Factors and the Severity of COVID-19 Disease.","Background and objective Several cardiovascular risk factors have emerged as important determinants of severe illness and death among coronavirus disease 2019 (COVID-19) patients. However, the full impact of these cardiovascular risk factors is still under investigation. This study aimed to investigate the association between patients' level of cardiovascular risk and the severity of COVID-19. Materials and methods This observational study included all adult patients with COVID-19 hospitalized a","2021","07","16","Cureus","Cureus","covid 19; sar-cov 2 infection; severity markers; traditional cardiovascular risk factors","Elamari","Saloua","Endocrinology, Diabetology, Metabolic Disease, and Nutrition, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR",NA
"2147","34262822","10.7759/cureus.15486","Cardiovascular Risk Factors and the Severity of COVID-19 Disease.","Background and objective Several cardiovascular risk factors have emerged as important determinants of severe illness and death among coronavirus disease 2019 (COVID-19) patients. However, the full impact of these cardiovascular risk factors is still under investigation. This study aimed to investigate the association between patients' level of cardiovascular risk and the severity of COVID-19. Materials and methods This observational study included all adult patients with COVID-19 hospitalized a","2021","07","16","Cureus","Cureus","covid 19; sar-cov 2 infection; severity markers; traditional cardiovascular risk factors","Haoudar","Amal","Anesthesia and Critical Care, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR",NA
"2148","34262822","10.7759/cureus.15486","Cardiovascular Risk Factors and the Severity of COVID-19 Disease.","Background and objective Several cardiovascular risk factors have emerged as important determinants of severe illness and death among coronavirus disease 2019 (COVID-19) patients. However, the full impact of these cardiovascular risk factors is still under investigation. This study aimed to investigate the association between patients' level of cardiovascular risk and the severity of COVID-19. Materials and methods This observational study included all adult patients with COVID-19 hospitalized a","2021","07","16","Cureus","Cureus","covid 19; sar-cov 2 infection; severity markers; traditional cardiovascular risk factors","Chadli","Asma","Endocrinology, Diabetology, Metabolic Disease, and Nutrition, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR",NA
"2149","34262822","10.7759/cureus.15486","Cardiovascular Risk Factors and the Severity of COVID-19 Disease.","Background and objective Several cardiovascular risk factors have emerged as important determinants of severe illness and death among coronavirus disease 2019 (COVID-19) patients. However, the full impact of these cardiovascular risk factors is still under investigation. This study aimed to investigate the association between patients' level of cardiovascular risk and the severity of COVID-19. Materials and methods This observational study included all adult patients with COVID-19 hospitalized a","2021","07","16","Cureus","Cureus","covid 19; sar-cov 2 infection; severity markers; traditional cardiovascular risk factors","El Kettani","Chafik","Anesthesia and Critical Care, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR",NA
"2150","34262803","10.7759/cureus.15452","Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors.","Background Coronavirus disease 2019 (COVID-19) is a global health crisis. The literature suggests that cancer patients are more prone to be affected by COVID-19 because cancer suppresses the immune system and such patients usually present poor results. The objective of this study is to present all clinical, laboratory, and demographic characteristics of COVID-19 patients with solid tumors. Methodology This study was conducted at the Dow University of Health Sciences for a period of six months fr","2021","07","16","Cureus","Cureus","breast cancer; clinical presentation; colorectal cancer; covid-19; lung cancer; mortality; outcomes; pandemic; prostate cancer; solid tumor","Farooque","Imran","Public Health, Peoples University of Medical and Health Sciences for Women, Nawabshah, PAK",NA
"2151","34262803","10.7759/cureus.15452","Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors.","Background Coronavirus disease 2019 (COVID-19) is a global health crisis. The literature suggests that cancer patients are more prone to be affected by COVID-19 because cancer suppresses the immune system and such patients usually present poor results. The objective of this study is to present all clinical, laboratory, and demographic characteristics of COVID-19 patients with solid tumors. Methodology This study was conducted at the Dow University of Health Sciences for a period of six months fr","2021","07","16","Cureus","Cureus","breast cancer; clinical presentation; colorectal cancer; covid-19; lung cancer; mortality; outcomes; pandemic; prostate cancer; solid tumor","Farooque","Umar","Neurology, Dow University of Health Sciences, Karachi, PAK",NA
"2152","34262803","10.7759/cureus.15452","Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors.","Background Coronavirus disease 2019 (COVID-19) is a global health crisis. The literature suggests that cancer patients are more prone to be affected by COVID-19 because cancer suppresses the immune system and such patients usually present poor results. The objective of this study is to present all clinical, laboratory, and demographic characteristics of COVID-19 patients with solid tumors. Methodology This study was conducted at the Dow University of Health Sciences for a period of six months fr","2021","07","16","Cureus","Cureus","breast cancer; clinical presentation; colorectal cancer; covid-19; lung cancer; mortality; outcomes; pandemic; prostate cancer; solid tumor","Karimi","Sundas","Orthopedic Surgery, Dow University Hospital, Karachi, PAK",NA
"2153","34262803","10.7759/cureus.15452","Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors.","Background Coronavirus disease 2019 (COVID-19) is a global health crisis. The literature suggests that cancer patients are more prone to be affected by COVID-19 because cancer suppresses the immune system and such patients usually present poor results. The objective of this study is to present all clinical, laboratory, and demographic characteristics of COVID-19 patients with solid tumors. Methodology This study was conducted at the Dow University of Health Sciences for a period of six months fr","2021","07","16","Cureus","Cureus","breast cancer; clinical presentation; colorectal cancer; covid-19; lung cancer; mortality; outcomes; pandemic; prostate cancer; solid tumor","Syed","Muhammad Usman Shah","Internal Medicine, Dow University of Health Sciences, Karachi, PAK",NA
"2154","34262803","10.7759/cureus.15452","Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors.","Background Coronavirus disease 2019 (COVID-19) is a global health crisis. The literature suggests that cancer patients are more prone to be affected by COVID-19 because cancer suppresses the immune system and such patients usually present poor results. The objective of this study is to present all clinical, laboratory, and demographic characteristics of COVID-19 patients with solid tumors. Methodology This study was conducted at the Dow University of Health Sciences for a period of six months fr","2021","07","16","Cureus","Cureus","breast cancer; clinical presentation; colorectal cancer; covid-19; lung cancer; mortality; outcomes; pandemic; prostate cancer; solid tumor","Nadeem","Zubia","Medicine, Dow University of Health Sciences, Karachi, PAK",NA
"2155","34262803","10.7759/cureus.15452","Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors.","Background Coronavirus disease 2019 (COVID-19) is a global health crisis. The literature suggests that cancer patients are more prone to be affected by COVID-19 because cancer suppresses the immune system and such patients usually present poor results. The objective of this study is to present all clinical, laboratory, and demographic characteristics of COVID-19 patients with solid tumors. Methodology This study was conducted at the Dow University of Health Sciences for a period of six months fr","2021","07","16","Cureus","Cureus","breast cancer; clinical presentation; colorectal cancer; covid-19; lung cancer; mortality; outcomes; pandemic; prostate cancer; solid tumor","Zulfiqar","Arif","Medicine and Surgery, Dow Medical College, Karachi, PAK",NA
"2156","34262803","10.7759/cureus.15452","Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors.","Background Coronavirus disease 2019 (COVID-19) is a global health crisis. The literature suggests that cancer patients are more prone to be affected by COVID-19 because cancer suppresses the immune system and such patients usually present poor results. The objective of this study is to present all clinical, laboratory, and demographic characteristics of COVID-19 patients with solid tumors. Methodology This study was conducted at the Dow University of Health Sciences for a period of six months fr","2021","07","16","Cureus","Cureus","breast cancer; clinical presentation; colorectal cancer; covid-19; lung cancer; mortality; outcomes; pandemic; prostate cancer; solid tumor","Mustafa","Sufyan","Medicine, Dow Medical College, Civil Hospital, Karachi, PAK",NA
"2157","34262803","10.7759/cureus.15452","Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors.","Background Coronavirus disease 2019 (COVID-19) is a global health crisis. The literature suggests that cancer patients are more prone to be affected by COVID-19 because cancer suppresses the immune system and such patients usually present poor results. The objective of this study is to present all clinical, laboratory, and demographic characteristics of COVID-19 patients with solid tumors. Methodology This study was conducted at the Dow University of Health Sciences for a period of six months fr","2021","07","16","Cureus","Cureus","breast cancer; clinical presentation; colorectal cancer; covid-19; lung cancer; mortality; outcomes; pandemic; prostate cancer; solid tumor","Farooque","Rizwan","Internal Medicine, Sindh Medical College, Karachi, PAK",NA
"2158","34262803","10.7759/cureus.15452","Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors.","Background Coronavirus disease 2019 (COVID-19) is a global health crisis. The literature suggests that cancer patients are more prone to be affected by COVID-19 because cancer suppresses the immune system and such patients usually present poor results. The objective of this study is to present all clinical, laboratory, and demographic characteristics of COVID-19 patients with solid tumors. Methodology This study was conducted at the Dow University of Health Sciences for a period of six months fr","2021","07","16","Cureus","Cureus","breast cancer; clinical presentation; colorectal cancer; covid-19; lung cancer; mortality; outcomes; pandemic; prostate cancer; solid tumor","Sultan","Ayyaz A","Hematology/Oncology, California Cancer Associates for Research &amp",NA
"2159","34262803","10.7759/cureus.15452","Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors.","Background Coronavirus disease 2019 (COVID-19) is a global health crisis. The literature suggests that cancer patients are more prone to be affected by COVID-19 because cancer suppresses the immune system and such patients usually present poor results. The objective of this study is to present all clinical, laboratory, and demographic characteristics of COVID-19 patients with solid tumors. Methodology This study was conducted at the Dow University of Health Sciences for a period of six months fr","2021","07","16","Cureus","Cureus","breast cancer; clinical presentation; colorectal cancer; covid-19; lung cancer; mortality; outcomes; pandemic; prostate cancer; solid tumor","Hassan","Syed Adeel","Internal Medicine, University of Louisville, Louisville, USA",NA
"2160","34262802","10.7759/cureus.15451","Efficacy of Gefitinib and Methorexate in Patients With Advanced Stage and Recurrent Head and Neck Cancer.","Gefitinib, a tyrosine kinase inhibitor (TKI), is an epidermal growth factor receptor (EGFR)-blocking drug that is effective in the treatment of lung cancer with EGFR mutations; however, its benefits for head and neck cancers are uncertain. Therefore, this study aims to determine the efficacy of gefitinib and methotrexate in patients with advanced-stage or recurrent head and neck cancer. Two hundred patients of age &gt;18 years with advanced clinical stage either IVA or IVB and recurrent cases we","2021","07","16","Cureus","Cureus","cancer; efficacy; gefitinib; head and neck; methotrexate","Irshad","Razia","Medical Oncology, Jinnah Postgraduate Medical Centre, Karachi, PAK",NA
"2161","34262802","10.7759/cureus.15451","Efficacy of Gefitinib and Methorexate in Patients With Advanced Stage and Recurrent Head and Neck Cancer.","Gefitinib, a tyrosine kinase inhibitor (TKI), is an epidermal growth factor receptor (EGFR)-blocking drug that is effective in the treatment of lung cancer with EGFR mutations; however, its benefits for head and neck cancers are uncertain. Therefore, this study aims to determine the efficacy of gefitinib and methotrexate in patients with advanced-stage or recurrent head and neck cancer. Two hundred patients of age &gt;18 years with advanced clinical stage either IVA or IVB and recurrent cases we","2021","07","16","Cureus","Cureus","cancer; efficacy; gefitinib; head and neck; methotrexate","Haider","Ghulam","Medical Oncology, Jinnah Postgraduate Medical Centre, Karachi, PAK",NA
"2162","34262802","10.7759/cureus.15451","Efficacy of Gefitinib and Methorexate in Patients With Advanced Stage and Recurrent Head and Neck Cancer.","Gefitinib, a tyrosine kinase inhibitor (TKI), is an epidermal growth factor receptor (EGFR)-blocking drug that is effective in the treatment of lung cancer with EGFR mutations; however, its benefits for head and neck cancers are uncertain. Therefore, this study aims to determine the efficacy of gefitinib and methotrexate in patients with advanced-stage or recurrent head and neck cancer. Two hundred patients of age &gt;18 years with advanced clinical stage either IVA or IVB and recurrent cases we","2021","07","16","Cureus","Cureus","cancer; efficacy; gefitinib; head and neck; methotrexate","Hashmi","Madiha","Medical Oncology, Jinnah Postgraduate Medical Centre, Karachi, PAK",NA
"2163","34262802","10.7759/cureus.15451","Efficacy of Gefitinib and Methorexate in Patients With Advanced Stage and Recurrent Head and Neck Cancer.","Gefitinib, a tyrosine kinase inhibitor (TKI), is an epidermal growth factor receptor (EGFR)-blocking drug that is effective in the treatment of lung cancer with EGFR mutations; however, its benefits for head and neck cancers are uncertain. Therefore, this study aims to determine the efficacy of gefitinib and methotrexate in patients with advanced-stage or recurrent head and neck cancer. Two hundred patients of age &gt;18 years with advanced clinical stage either IVA or IVB and recurrent cases we","2021","07","16","Cureus","Cureus","cancer; efficacy; gefitinib; head and neck; methotrexate","Hassan","Anusha","Medical Oncology, Jinnah Postgraduate Medical Centre, Karachi, PAK",NA
"2164","34262795","10.21106/ijma.479","Clinical Features and Outcomes of COVID-19 Infection among Pregnant Women in South Africa.","Studies among COVID positive pregnant women are limited. Previous studies reported high rate of symptoms, comorbidities and poor fetal/neonatal outcome among women of different ethnicity. To date, no study was reported among pregnant African women. This study was conducted to determine the clinical features and outcomes of COVID-19 positive pregnant women in Ekurhuleni District in South Africa. Retrospective record review of 103 COVID-19 infected pregnant women during the period of April to Sept","2021","07","16","Int J MCH AIDS","International journal of MCH and AIDS","COVID-19; Ethnicity; Maternal and Fetal Outcome; Pregnancy; South Africa","Basu","Jayati Kusari","Ekurhuleni District Department of Health, 40, Catlin Street, Germiston 1401, P Bag - X 1005, Gemiston - 1400, South Africa",NA
"2165","34262795","10.21106/ijma.479","Clinical Features and Outcomes of COVID-19 Infection among Pregnant Women in South Africa.","Studies among COVID positive pregnant women are limited. Previous studies reported high rate of symptoms, comorbidities and poor fetal/neonatal outcome among women of different ethnicity. To date, no study was reported among pregnant African women. This study was conducted to determine the clinical features and outcomes of COVID-19 positive pregnant women in Ekurhuleni District in South Africa. Retrospective record review of 103 COVID-19 infected pregnant women during the period of April to Sept","2021","07","16","Int J MCH AIDS","International journal of MCH and AIDS","COVID-19; Ethnicity; Maternal and Fetal Outcome; Pregnancy; South Africa","Chauke","Lawrence","Ekurhuleni District Department of Health, 40, Catlin Street, Germiston 1401, P Bag - X 1005, Gemiston - 1400, South Africa",NA
"2166","34262795","10.21106/ijma.479","Clinical Features and Outcomes of COVID-19 Infection among Pregnant Women in South Africa.","Studies among COVID positive pregnant women are limited. Previous studies reported high rate of symptoms, comorbidities and poor fetal/neonatal outcome among women of different ethnicity. To date, no study was reported among pregnant African women. This study was conducted to determine the clinical features and outcomes of COVID-19 positive pregnant women in Ekurhuleni District in South Africa. Retrospective record review of 103 COVID-19 infected pregnant women during the period of April to Sept","2021","07","16","Int J MCH AIDS","International journal of MCH and AIDS","COVID-19; Ethnicity; Maternal and Fetal Outcome; Pregnancy; South Africa","Magoro","Terrance","Ekurhuleni District Department of Health, 40, Catlin Street, Germiston 1401, P Bag - X 1005, Gemiston - 1400, South Africa",NA
"2167","34262782","10.1177/20552076211028404","Developing a digital health strategy for people who use drugs: Lessons from COVID-19.","COVID-19 has significantly exacerbated negative health and social outcomes for people who use drugs (PWUD) around the world. The closure of harm reduction services, ongoing barriers to employment and housing, and pre-existing physical and mental health conditions have increased harms for diverse communities of PWUD. Adapting current models of health and human service delivery to better meet the needs of PWUD is essential in minimizing not only COVID-19 but also drug-related morbidity and mortali","2021","07","16","Digit Health","Digital health","COVID-19; Harm reduction; digital health; overdose prevention; pandemic","Perri","Melissa","Dalla Lana School of Public Health, University of Toronto, Toronto, Canada",NA
"2168","34262782","10.1177/20552076211028404","Developing a digital health strategy for people who use drugs: Lessons from COVID-19.","COVID-19 has significantly exacerbated negative health and social outcomes for people who use drugs (PWUD) around the world. The closure of harm reduction services, ongoing barriers to employment and housing, and pre-existing physical and mental health conditions have increased harms for diverse communities of PWUD. Adapting current models of health and human service delivery to better meet the needs of PWUD is essential in minimizing not only COVID-19 but also drug-related morbidity and mortali","2021","07","16","Digit Health","Digital health","COVID-19; Harm reduction; digital health; overdose prevention; pandemic","Guta","Adrian","School of Social Work, University of Windsor, Windsor, Canada",NA
"2169","34262782","10.1177/20552076211028404","Developing a digital health strategy for people who use drugs: Lessons from COVID-19.","COVID-19 has significantly exacerbated negative health and social outcomes for people who use drugs (PWUD) around the world. The closure of harm reduction services, ongoing barriers to employment and housing, and pre-existing physical and mental health conditions have increased harms for diverse communities of PWUD. Adapting current models of health and human service delivery to better meet the needs of PWUD is essential in minimizing not only COVID-19 but also drug-related morbidity and mortali","2021","07","16","Digit Health","Digital health","COVID-19; Harm reduction; digital health; overdose prevention; pandemic","Gagnon","Marilou","Canadian Institute for Substance Use Research, Victoria, Canada",NA
"2170","34262782","10.1177/20552076211028404","Developing a digital health strategy for people who use drugs: Lessons from COVID-19.","COVID-19 has significantly exacerbated negative health and social outcomes for people who use drugs (PWUD) around the world. The closure of harm reduction services, ongoing barriers to employment and housing, and pre-existing physical and mental health conditions have increased harms for diverse communities of PWUD. Adapting current models of health and human service delivery to better meet the needs of PWUD is essential in minimizing not only COVID-19 but also drug-related morbidity and mortali","2021","07","16","Digit Health","Digital health","COVID-19; Harm reduction; digital health; overdose prevention; pandemic","Bonn","Matt","Canadian Association of People Who Use Drugs, Dartmouth, Canada",NA
"2171","34262782","10.1177/20552076211028404","Developing a digital health strategy for people who use drugs: Lessons from COVID-19.","COVID-19 has significantly exacerbated negative health and social outcomes for people who use drugs (PWUD) around the world. The closure of harm reduction services, ongoing barriers to employment and housing, and pre-existing physical and mental health conditions have increased harms for diverse communities of PWUD. Adapting current models of health and human service delivery to better meet the needs of PWUD is essential in minimizing not only COVID-19 but also drug-related morbidity and mortali","2021","07","16","Digit Health","Digital health","COVID-19; Harm reduction; digital health; overdose prevention; pandemic","Leece","Pamela","Dalla Lana School of Public Health, University of Toronto, Toronto, Canada",NA
"2172","34262782","10.1177/20552076211028404","Developing a digital health strategy for people who use drugs: Lessons from COVID-19.","COVID-19 has significantly exacerbated negative health and social outcomes for people who use drugs (PWUD) around the world. The closure of harm reduction services, ongoing barriers to employment and housing, and pre-existing physical and mental health conditions have increased harms for diverse communities of PWUD. Adapting current models of health and human service delivery to better meet the needs of PWUD is essential in minimizing not only COVID-19 but also drug-related morbidity and mortali","2021","07","16","Digit Health","Digital health","COVID-19; Harm reduction; digital health; overdose prevention; pandemic","Bayoumi","Ahmed M","MAP Center for Urban Health Solutions, St. Michael's Hospital, Toronto, Canada",NA
"2173","34262782","10.1177/20552076211028404","Developing a digital health strategy for people who use drugs: Lessons from COVID-19.","COVID-19 has significantly exacerbated negative health and social outcomes for people who use drugs (PWUD) around the world. The closure of harm reduction services, ongoing barriers to employment and housing, and pre-existing physical and mental health conditions have increased harms for diverse communities of PWUD. Adapting current models of health and human service delivery to better meet the needs of PWUD is essential in minimizing not only COVID-19 but also drug-related morbidity and mortali","2021","07","16","Digit Health","Digital health","COVID-19; Harm reduction; digital health; overdose prevention; pandemic","Rai","Nanky","Department of Family and Community Medicine, University of Toronto Faculty of Medicine, Toronto, Canada",NA
"2174","34262782","10.1177/20552076211028404","Developing a digital health strategy for people who use drugs: Lessons from COVID-19.","COVID-19 has significantly exacerbated negative health and social outcomes for people who use drugs (PWUD) around the world. The closure of harm reduction services, ongoing barriers to employment and housing, and pre-existing physical and mental health conditions have increased harms for diverse communities of PWUD. Adapting current models of health and human service delivery to better meet the needs of PWUD is essential in minimizing not only COVID-19 but also drug-related morbidity and mortali","2021","07","16","Digit Health","Digital health","COVID-19; Harm reduction; digital health; overdose prevention; pandemic","Touesnard","Natasha","Canadian Association of People Who Use Drugs, Dartmouth, Canada",NA
"2175","34262782","10.1177/20552076211028404","Developing a digital health strategy for people who use drugs: Lessons from COVID-19.","COVID-19 has significantly exacerbated negative health and social outcomes for people who use drugs (PWUD) around the world. The closure of harm reduction services, ongoing barriers to employment and housing, and pre-existing physical and mental health conditions have increased harms for diverse communities of PWUD. Adapting current models of health and human service delivery to better meet the needs of PWUD is essential in minimizing not only COVID-19 but also drug-related morbidity and mortali","2021","07","16","Digit Health","Digital health","COVID-19; Harm reduction; digital health; overdose prevention; pandemic","Strike","Carol","Dalla Lana School of Public Health, University of Toronto, Toronto, Canada",NA
"2176","34262779","10.1002/ams2.678","Current status of hyperbaric oxygen therapy for COVID-19.",NA,"2021","07","16","Acute Med Surg","Acute medicine &amp; surgery",NA,"Yanagawa","Youichi","Department of Acute Critical Care Medicine Shizuoka Hospital Juntendo University Izunokuni City Japan",NA
"2177","34262774","10.1002/rcr2.749","Secondary spontaneous pneumothorax: a time to re-evaluate management.","Spontaneous pneumothorax (SP) is defined as the presence of air in the pleural cavity and remains a significant health problem. Secondary SP (SSP) is associated with underlying lung diseases, such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD), and is associated with poor outcomes. The current guidelines in the management of SSP have not been updated since the last decade; therefore, new protocols focused on the management of SSP should be e","2021","07","16","Respirol Case Rep","Respirology case reports","COVID-19; Conservative management; haemodynamic stability; interstitial lung disease; secondary spontaneous pneumothorax","Cortes-Telles","Arturo","Respiratory and Thoracic Department Hospital Regional de Alta Especialidad de la Península de Yucatan Mérida Yucatán 97130 Mexico",NA
"2178","34262774","10.1002/rcr2.749","Secondary spontaneous pneumothorax: a time to re-evaluate management.","Spontaneous pneumothorax (SP) is defined as the presence of air in the pleural cavity and remains a significant health problem. Secondary SP (SSP) is associated with underlying lung diseases, such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD), and is associated with poor outcomes. The current guidelines in the management of SSP have not been updated since the last decade; therefore, new protocols focused on the management of SSP should be e","2021","07","16","Respirol Case Rep","Respirology case reports","COVID-19; Conservative management; haemodynamic stability; interstitial lung disease; secondary spontaneous pneumothorax","Ortíz-Farias","Diana Lizbeth","Respiratory and Thoracic Department Hospital Regional de Alta Especialidad de la Península de Yucatan Mérida Yucatán 97130 Mexico",NA
"2179","34262774","10.1002/rcr2.749","Secondary spontaneous pneumothorax: a time to re-evaluate management.","Spontaneous pneumothorax (SP) is defined as the presence of air in the pleural cavity and remains a significant health problem. Secondary SP (SSP) is associated with underlying lung diseases, such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD), and is associated with poor outcomes. The current guidelines in the management of SSP have not been updated since the last decade; therefore, new protocols focused on the management of SSP should be e","2021","07","16","Respirol Case Rep","Respirology case reports","COVID-19; Conservative management; haemodynamic stability; interstitial lung disease; secondary spontaneous pneumothorax","Perez-Hernandez","Felipe","Respiratory and Thoracic Department Hospital Regional de Alta Especialidad de la Península de Yucatan Mérida Yucatán 97130 Mexico",NA
"2180","34262774","10.1002/rcr2.749","Secondary spontaneous pneumothorax: a time to re-evaluate management.","Spontaneous pneumothorax (SP) is defined as the presence of air in the pleural cavity and remains a significant health problem. Secondary SP (SSP) is associated with underlying lung diseases, such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD), and is associated with poor outcomes. The current guidelines in the management of SSP have not been updated since the last decade; therefore, new protocols focused on the management of SSP should be e","2021","07","16","Respirol Case Rep","Respirology case reports","COVID-19; Conservative management; haemodynamic stability; interstitial lung disease; secondary spontaneous pneumothorax","Rodriguez-Morejon","Dulce","Respiratory and Thoracic Department Hospital Regional de Alta Especialidad de la Península de Yucatan Mérida Yucatán 97130 Mexico",NA
"2181","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Flores-Oria","Carlos A","Division of Pulmonology, Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA",NA
"2182","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Saturno","Emilio","West Jefferson Medical Center, Marrero, LA, USA",NA
"2183","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Ramanathan","Supriya","Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA",NA
"2184","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Martinez Castillo","Diana J","Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA",NA
"2185","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Kumar","Roshni","Bellaire High School, Bellaire, TX, USA",NA
"2186","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Ferrer","Nelson","Hospital Pacifica Salud, Panama",NA
"2187","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Mossaad","Afnan","Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA",NA
"2188","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Tellez","Maria E","School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA",NA
"2189","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Jon","Cindy","Division of Pulmonology, Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA",NA
"2190","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Waters","Sara C","Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA",NA
"2191","34262773","10.1177/2050313X211029699","Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.","Severe acute respiratory syndrome coronavirus 2 has infected and caused the death of an alarming number of individuals worldwide. No specific treatment has been internationally standardized for coronavirus disease 2019 (COVID-19); however, in some cases, intravenous immunoglobulin (IVIG) has been used as adjuvant treatment in critically ill patients with COVID-19 pneumonia. We report a case of a 50-year-old man with severe COVID-19 pneumonia who received 5 days course of IVIG as adjuvant therapy","2021","07","16","SAGE Open Med Case Rep","SAGE open medical case reports","Coronavirus disease 2019; IVIG; hypoxemia; intravenous immunoglobulin; severe acute respiratory syndrome coronavirus 2","Mosquera","Ricardo A","Division of Pulmonology, Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA",NA
"2192","34262766","10.1177/20503121211029187","Weathering the storm: A qualitative study of social prescribing in urban and rural Scotland during the COVID-19 pandemic.","The non-clinical approach known as social prescribing aims to tackle multi-morbidity, reduce general practitioner (GP) workload and promote wellbeing by directing patients to community services. Usual in-person modes of delivery of social prescribing have been virtually impossible under social distancing rules. This study qualitatively examined and compared the responses of three social prescribing schemes in Scotland to the COVID-19 pandemic. We interviewed a theoretical sample of 23 stakeholde","2021","07","16","SAGE Open Med","SAGE open medicine","COVID-19; Social prescribing; community services; qualitative studies","Fixsen","Alison","College of Liberal Arts and Sciences, University of Westminster, London, UK",NA
"2193","34262766","10.1177/20503121211029187","Weathering the storm: A qualitative study of social prescribing in urban and rural Scotland during the COVID-19 pandemic.","The non-clinical approach known as social prescribing aims to tackle multi-morbidity, reduce general practitioner (GP) workload and promote wellbeing by directing patients to community services. Usual in-person modes of delivery of social prescribing have been virtually impossible under social distancing rules. This study qualitatively examined and compared the responses of three social prescribing schemes in Scotland to the COVID-19 pandemic. We interviewed a theoretical sample of 23 stakeholde","2021","07","16","SAGE Open Med","SAGE open medicine","COVID-19; Social prescribing; community services; qualitative studies","Barrett","Simon","Newcastle University, Population Health Sciences Institute, Newcastle Upon Tyne, Tyne and Wear, UK",NA
"2194","34262766","10.1177/20503121211029187","Weathering the storm: A qualitative study of social prescribing in urban and rural Scotland during the COVID-19 pandemic.","The non-clinical approach known as social prescribing aims to tackle multi-morbidity, reduce general practitioner (GP) workload and promote wellbeing by directing patients to community services. Usual in-person modes of delivery of social prescribing have been virtually impossible under social distancing rules. This study qualitatively examined and compared the responses of three social prescribing schemes in Scotland to the COVID-19 pandemic. We interviewed a theoretical sample of 23 stakeholde","2021","07","16","SAGE Open Med","SAGE open medicine","COVID-19; Social prescribing; community services; qualitative studies","Shimonovich","Michal","MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK",NA
"2195","34262763","10.1177/20503121211027778","COVID-19 and dysnatremia: A comparison between COVID-19 and non-COVID-19 respiratory illness.","To investigate the occurrence of disorders of water and sodium balance in COVID-19 in our clinic. In this retrospective chart review, patients were included if a polymerase chain test result for SARS-CoV-2 was obtained and if at least one plasma sodium concentration measurement was obtained during the period from March to June 2020. The occurrences of hyponatremia and hypernatremia were compared between 193 SARS-CoV-2-positive and 138 SARS-CoV-2-negative patients. A <U+03C7>² test was used to determine","2021","07","16","SAGE Open Med","SAGE open medicine","COVID-19; SARS coronavirus; dysnatremia; hypernatremia; hyponatremia","Voets","Philip Jgm","Department of Nephrology, Gelre Hospital, Apeldoorn, The Netherlands",NA
"2196","34262763","10.1177/20503121211027778","COVID-19 and dysnatremia: A comparison between COVID-19 and non-COVID-19 respiratory illness.","To investigate the occurrence of disorders of water and sodium balance in COVID-19 in our clinic. In this retrospective chart review, patients were included if a polymerase chain test result for SARS-CoV-2 was obtained and if at least one plasma sodium concentration measurement was obtained during the period from March to June 2020. The occurrences of hyponatremia and hypernatremia were compared between 193 SARS-CoV-2-positive and 138 SARS-CoV-2-negative patients. A <U+03C7>² test was used to determine","2021","07","16","SAGE Open Med","SAGE open medicine","COVID-19; SARS coronavirus; dysnatremia; hypernatremia; hyponatremia","Frölke","Sophie C","Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands",NA
"2197","34262763","10.1177/20503121211027778","COVID-19 and dysnatremia: A comparison between COVID-19 and non-COVID-19 respiratory illness.","To investigate the occurrence of disorders of water and sodium balance in COVID-19 in our clinic. In this retrospective chart review, patients were included if a polymerase chain test result for SARS-CoV-2 was obtained and if at least one plasma sodium concentration measurement was obtained during the period from March to June 2020. The occurrences of hyponatremia and hypernatremia were compared between 193 SARS-CoV-2-positive and 138 SARS-CoV-2-negative patients. A <U+03C7>² test was used to determine","2021","07","16","SAGE Open Med","SAGE open medicine","COVID-19; SARS coronavirus; dysnatremia; hypernatremia; hyponatremia","Vogtländer","Nils Pj","Department of Nephrology, Gelre Hospital, Apeldoorn, The Netherlands",NA
"2198","34262763","10.1177/20503121211027778","COVID-19 and dysnatremia: A comparison between COVID-19 and non-COVID-19 respiratory illness.","To investigate the occurrence of disorders of water and sodium balance in COVID-19 in our clinic. In this retrospective chart review, patients were included if a polymerase chain test result for SARS-CoV-2 was obtained and if at least one plasma sodium concentration measurement was obtained during the period from March to June 2020. The occurrences of hyponatremia and hypernatremia were compared between 193 SARS-CoV-2-positive and 138 SARS-CoV-2-negative patients. A <U+03C7>² test was used to determine","2021","07","16","SAGE Open Med","SAGE open medicine","COVID-19; SARS coronavirus; dysnatremia; hypernatremia; hyponatremia","Kaasjager","Karin Ah","Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands",NA
"2199","34262762","10.1177/20503121211026195","Mental health effect of COVID-19 pandemic among women who are pregnant and/or lactating: A systematic review and meta-analysis.","The purpose of this study is to examine the effects of coronavirus disease 2019 pandemic on the prevalence of anxiety, depression, stress, insomnia, and social dysfunction among pregnant and/or lactating women and to measure the global pooled prevalence of mental health effects among these populations in the era of coronavirus disease 2019 pandemic. Comprehensive literature searching was conducted and studies published from 1 January 2020 to 30 September 2020 reporting the prevalence of anxiety,","2021","07","16","SAGE Open Med","SAGE open medicine","Coronavirus disease 2019; Mental health; anxiety; depression; insomnia; lactating women; pregnant; social dysfunctions; stress","Demissie","Dereje Bayissa","School of Nursing, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia",NA
"2200","34262762","10.1177/20503121211026195","Mental health effect of COVID-19 pandemic among women who are pregnant and/or lactating: A systematic review and meta-analysis.","The purpose of this study is to examine the effects of coronavirus disease 2019 pandemic on the prevalence of anxiety, depression, stress, insomnia, and social dysfunction among pregnant and/or lactating women and to measure the global pooled prevalence of mental health effects among these populations in the era of coronavirus disease 2019 pandemic. Comprehensive literature searching was conducted and studies published from 1 January 2020 to 30 September 2020 reporting the prevalence of anxiety,","2021","07","16","SAGE Open Med","SAGE open medicine","Coronavirus disease 2019; Mental health; anxiety; depression; insomnia; lactating women; pregnant; social dysfunctions; stress","Bitew","Zebenay Workneh","School of Nursing, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia",NA
"2201","34262683","10.1177/20416695211027920","Effects of Masks Worn to Protect Against COVID-19 on the Perception of Facial Attractiveness.","Wearing a sanitary mask tended, in the main, to reduce the wearer's sense of perceived facial attractiveness before the COVID-19 epidemic. This phenomenon, termed the sanitary-mask effect, was explained using a two-factor model involving the occlusion of cues used for the judgment of attractiveness and unhealthiness priming (e.g., presumed illness). However, these data were collected during the pre-COVID-19 period. Thus, in this study, we examined whether the COVID-19 epidemic changed the","2021","07","16","Iperception","i-Perception","COVID-19; facial attractiveness; healthiness; sanitary mask","Kamatani","Miki","Hokkaido University, Sapporo, Japan",NA
"2202","34262683","10.1177/20416695211027920","Effects of Masks Worn to Protect Against COVID-19 on the Perception of Facial Attractiveness.","Wearing a sanitary mask tended, in the main, to reduce the wearer's sense of perceived facial attractiveness before the COVID-19 epidemic. This phenomenon, termed the sanitary-mask effect, was explained using a two-factor model involving the occlusion of cues used for the judgment of attractiveness and unhealthiness priming (e.g., presumed illness). However, these data were collected during the pre-COVID-19 period. Thus, in this study, we examined whether the COVID-19 epidemic changed the","2021","07","16","Iperception","i-Perception","COVID-19; facial attractiveness; healthiness; sanitary mask","Ito","Motohiro","Japan Society for the Promotion of Science, Tokyo, Japan",NA
"2203","34262683","10.1177/20416695211027920","Effects of Masks Worn to Protect Against COVID-19 on the Perception of Facial Attractiveness.","Wearing a sanitary mask tended, in the main, to reduce the wearer's sense of perceived facial attractiveness before the COVID-19 epidemic. This phenomenon, termed the sanitary-mask effect, was explained using a two-factor model involving the occlusion of cues used for the judgment of attractiveness and unhealthiness priming (e.g., presumed illness). However, these data were collected during the pre-COVID-19 period. Thus, in this study, we examined whether the COVID-19 epidemic changed the","2021","07","16","Iperception","i-Perception","COVID-19; facial attractiveness; healthiness; sanitary mask","Miyazaki","Yuki","Fukuyama University, Japan",NA
"2204","34262683","10.1177/20416695211027920","Effects of Masks Worn to Protect Against COVID-19 on the Perception of Facial Attractiveness.","Wearing a sanitary mask tended, in the main, to reduce the wearer's sense of perceived facial attractiveness before the COVID-19 epidemic. This phenomenon, termed the sanitary-mask effect, was explained using a two-factor model involving the occlusion of cues used for the judgment of attractiveness and unhealthiness priming (e.g., presumed illness). However, these data were collected during the pre-COVID-19 period. Thus, in this study, we examined whether the COVID-19 epidemic changed the","2021","07","16","Iperception","i-Perception","COVID-19; facial attractiveness; healthiness; sanitary mask","Kawahara","Jun I","Hokkaido University, Sapporo, Japan",NA
"2205","34262673","10.1002/jev2.12117","Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity.","Coronavirus disease-2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has lead to a global pandemic with a rising toll in infections and deaths. Better understanding of its pathogenesis will greatly improve the outcomes and treatment of affected patients. Here we compared the inflammatory and cardiovascular disease-related protein cargo of circulating large and small extracellular vesicles (EVs) from 84 hospitalized patients infected with SARS-CoV","2021","07","16","J Extracell Vesicles","Journal of extracellular vesicles","SARS-CoV-2; endothelial injury; inflammation; thrombosis","Krishnamachary","Balaji","Division of Pulmonary and Critical Care Medicine Department of Internal Medicine University of Kansas Medical Center Kansas City Kansas USA",NA
"2206","34262673","10.1002/jev2.12117","Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity.","Coronavirus disease-2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has lead to a global pandemic with a rising toll in infections and deaths. Better understanding of its pathogenesis will greatly improve the outcomes and treatment of affected patients. Here we compared the inflammatory and cardiovascular disease-related protein cargo of circulating large and small extracellular vesicles (EVs) from 84 hospitalized patients infected with SARS-CoV","2021","07","16","J Extracell Vesicles","Journal of extracellular vesicles","SARS-CoV-2; endothelial injury; inflammation; thrombosis","Cook","Christine","Division of Pulmonary and Critical Care Medicine Department of Internal Medicine University of Kansas Medical Center Kansas City Kansas USA",NA
"2207","34262673","10.1002/jev2.12117","Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity.","Coronavirus disease-2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has lead to a global pandemic with a rising toll in infections and deaths. Better understanding of its pathogenesis will greatly improve the outcomes and treatment of affected patients. Here we compared the inflammatory and cardiovascular disease-related protein cargo of circulating large and small extracellular vesicles (EVs) from 84 hospitalized patients infected with SARS-CoV","2021","07","16","J Extracell Vesicles","Journal of extracellular vesicles","SARS-CoV-2; endothelial injury; inflammation; thrombosis","Kumar","Ashok","Division of Pulmonary and Critical Care Medicine Department of Internal Medicine University of Kansas Medical Center Kansas City Kansas USA",NA
"2208","34262673","10.1002/jev2.12117","Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity.","Coronavirus disease-2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has lead to a global pandemic with a rising toll in infections and deaths. Better understanding of its pathogenesis will greatly improve the outcomes and treatment of affected patients. Here we compared the inflammatory and cardiovascular disease-related protein cargo of circulating large and small extracellular vesicles (EVs) from 84 hospitalized patients infected with SARS-CoV","2021","07","16","J Extracell Vesicles","Journal of extracellular vesicles","SARS-CoV-2; endothelial injury; inflammation; thrombosis","Spikes","Leslie","Division of Pulmonary and Critical Care Medicine Department of Internal Medicine University of Kansas Medical Center Kansas City Kansas USA",NA
"2209","34262673","10.1002/jev2.12117","Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity.","Coronavirus disease-2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has lead to a global pandemic with a rising toll in infections and deaths. Better understanding of its pathogenesis will greatly improve the outcomes and treatment of affected patients. Here we compared the inflammatory and cardiovascular disease-related protein cargo of circulating large and small extracellular vesicles (EVs) from 84 hospitalized patients infected with SARS-CoV","2021","07","16","J Extracell Vesicles","Journal of extracellular vesicles","SARS-CoV-2; endothelial injury; inflammation; thrombosis","Chalise","Prabhakar","Department of Biostatistics &amp",NA
"2210","34262673","10.1002/jev2.12117","Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity.","Coronavirus disease-2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has lead to a global pandemic with a rising toll in infections and deaths. Better understanding of its pathogenesis will greatly improve the outcomes and treatment of affected patients. Here we compared the inflammatory and cardiovascular disease-related protein cargo of circulating large and small extracellular vesicles (EVs) from 84 hospitalized patients infected with SARS-CoV","2021","07","16","J Extracell Vesicles","Journal of extracellular vesicles","SARS-CoV-2; endothelial injury; inflammation; thrombosis","Dhillon","Navneet K","Division of Pulmonary and Critical Care Medicine Department of Internal Medicine University of Kansas Medical Center Kansas City Kansas USA",NA
"2211","34262666","10.1080/20008198.2021.1929754","Mental health responses to COVID-19 around the world.","Background: The mental health impact of the COVID-19 crisis may differ from previously studied stressful events in terms of psychological reactions, specific risk factors, and symptom severity across geographic regions worldwide. Objective: To assess the impact of COVID-19 on a wide range of mental health symptoms, to identify relevant risk factors, to identify the effect of COVID-19 country impact on mental health, and to evaluate regional differences in psychological responses to COVID-19 comp","2021","07","16","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; PTSD; anxiety; depression; dissociation; global mental health; insomnia; public health; risk factors; screening","Olff","Miranda","Department of Psychiatry, Amsterdam University Medical Centers Location AMC, Amsterdam Public Health, Amsterdam, The Netherlands",NA
"2212","34262666","10.1080/20008198.2021.1929754","Mental health responses to COVID-19 around the world.","Background: The mental health impact of the COVID-19 crisis may differ from previously studied stressful events in terms of psychological reactions, specific risk factors, and symptom severity across geographic regions worldwide. Objective: To assess the impact of COVID-19 on a wide range of mental health symptoms, to identify relevant risk factors, to identify the effect of COVID-19 country impact on mental health, and to evaluate regional differences in psychological responses to COVID-19 comp","2021","07","16","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; PTSD; anxiety; depression; dissociation; global mental health; insomnia; public health; risk factors; screening","Primasari","Indira","Department of Psychiatry, Amsterdam University Medical Centers Location AMC, Amsterdam Public Health, Amsterdam, The Netherlands",NA
"2213","34262666","10.1080/20008198.2021.1929754","Mental health responses to COVID-19 around the world.","Background: The mental health impact of the COVID-19 crisis may differ from previously studied stressful events in terms of psychological reactions, specific risk factors, and symptom severity across geographic regions worldwide. Objective: To assess the impact of COVID-19 on a wide range of mental health symptoms, to identify relevant risk factors, to identify the effect of COVID-19 country impact on mental health, and to evaluate regional differences in psychological responses to COVID-19 comp","2021","07","16","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; PTSD; anxiety; depression; dissociation; global mental health; insomnia; public health; risk factors; screening","Qing","Yulan","Department of Psychiatry, Amsterdam University Medical Centers Location AMC, Amsterdam Public Health, Amsterdam, The Netherlands",NA
"2214","34262666","10.1080/20008198.2021.1929754","Mental health responses to COVID-19 around the world.","Background: The mental health impact of the COVID-19 crisis may differ from previously studied stressful events in terms of psychological reactions, specific risk factors, and symptom severity across geographic regions worldwide. Objective: To assess the impact of COVID-19 on a wide range of mental health symptoms, to identify relevant risk factors, to identify the effect of COVID-19 country impact on mental health, and to evaluate regional differences in psychological responses to COVID-19 comp","2021","07","16","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; PTSD; anxiety; depression; dissociation; global mental health; insomnia; public health; risk factors; screening","Coimbra","Bruno M","Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil",NA
"2215","34262666","10.1080/20008198.2021.1929754","Mental health responses to COVID-19 around the world.","Background: The mental health impact of the COVID-19 crisis may differ from previously studied stressful events in terms of psychological reactions, specific risk factors, and symptom severity across geographic regions worldwide. Objective: To assess the impact of COVID-19 on a wide range of mental health symptoms, to identify relevant risk factors, to identify the effect of COVID-19 country impact on mental health, and to evaluate regional differences in psychological responses to COVID-19 comp","2021","07","16","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; PTSD; anxiety; depression; dissociation; global mental health; insomnia; public health; risk factors; screening","Hovnanyan","Ani","Department of Developmental Psychology and Socialisation, University of Padua (Università degli Studi di Padova, UNIPD), Padua, Italy",NA
"2216","34262666","10.1080/20008198.2021.1929754","Mental health responses to COVID-19 around the world.","Background: The mental health impact of the COVID-19 crisis may differ from previously studied stressful events in terms of psychological reactions, specific risk factors, and symptom severity across geographic regions worldwide. Objective: To assess the impact of COVID-19 on a wide range of mental health symptoms, to identify relevant risk factors, to identify the effect of COVID-19 country impact on mental health, and to evaluate regional differences in psychological responses to COVID-19 comp","2021","07","16","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; PTSD; anxiety; depression; dissociation; global mental health; insomnia; public health; risk factors; screening","Grace","Emma","Department of International Psychology, The Chicago School of Professional Psychology, Washington, DC, USA",NA
"2217","34262666","10.1080/20008198.2021.1929754","Mental health responses to COVID-19 around the world.","Background: The mental health impact of the COVID-19 crisis may differ from previously studied stressful events in terms of psychological reactions, specific risk factors, and symptom severity across geographic regions worldwide. Objective: To assess the impact of COVID-19 on a wide range of mental health symptoms, to identify relevant risk factors, to identify the effect of COVID-19 country impact on mental health, and to evaluate regional differences in psychological responses to COVID-19 comp","2021","07","16","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; PTSD; anxiety; depression; dissociation; global mental health; insomnia; public health; risk factors; screening","Williamson","Rachel E","School of Community Service, St. Lawrence College, Kingston, Ontario, Canada",NA
"2218","34262666","10.1080/20008198.2021.1929754","Mental health responses to COVID-19 around the world.","Background: The mental health impact of the COVID-19 crisis may differ from previously studied stressful events in terms of psychological reactions, specific risk factors, and symptom severity across geographic regions worldwide. Objective: To assess the impact of COVID-19 on a wide range of mental health symptoms, to identify relevant risk factors, to identify the effect of COVID-19 country impact on mental health, and to evaluate regional differences in psychological responses to COVID-19 comp","2021","07","16","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; PTSD; anxiety; depression; dissociation; global mental health; insomnia; public health; risk factors; screening","Hoeboer","Chris M","Department of Psychiatry, Amsterdam University Medical Centers Location AMC, Amsterdam Public Health, Amsterdam, The Netherlands",NA
"2219","34262666","10.1080/20008198.2021.1929754","Mental health responses to COVID-19 around the world.","Background: The mental health impact of the COVID-19 crisis may differ from previously studied stressful events in terms of psychological reactions, specific risk factors, and symptom severity across geographic regions worldwide. Objective: To assess the impact of COVID-19 on a wide range of mental health symptoms, to identify relevant risk factors, to identify the effect of COVID-19 country impact on mental health, and to evaluate regional differences in psychological responses to COVID-19 comp","2021","07","16","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; PTSD; anxiety; depression; dissociation; global mental health; insomnia; public health; risk factors; screening","Consortium","The Gps-Ccc","Department of Psychiatry, Amsterdam University Medical Centers Location AMC, Amsterdam Public Health, Amsterdam, The Netherlands",NA
"2220","34262570","10.3389/fimmu.2021.700782","Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.","Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the C","2021","07","16","Front Immunol","Frontiers in immunology","CCR5; COVID-19; PASC; chemokines; cytokines","Patterson","Bruce K","IncellDx Inc, San Carlos, CA, United States",NA
"2221","34262570","10.3389/fimmu.2021.700782","Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.","Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the C","2021","07","16","Front Immunol","Frontiers in immunology","CCR5; COVID-19; PASC; chemokines; cytokines","Guevara-Coto","Jose","Department of Computer Science and Informatics (ECCI), Universidad de Costa Rica, San Jose, Costa Rica",NA
"2222","34262570","10.3389/fimmu.2021.700782","Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.","Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the C","2021","07","16","Front Immunol","Frontiers in immunology","CCR5; COVID-19; PASC; chemokines; cytokines","Yogendra","Ram","Lab of Tumor Chemosensitivity, CIET/DC Lab, Faculty of Microbiology, Universidad de Costa Rica, San Jose, Costa Rica",NA
"2223","34262570","10.3389/fimmu.2021.700782","Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.","Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the C","2021","07","16","Front Immunol","Frontiers in immunology","CCR5; COVID-19; PASC; chemokines; cytokines","Francisco","Edgar B","IncellDx Inc, San Carlos, CA, United States",NA
"2224","34262570","10.3389/fimmu.2021.700782","Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.","Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the C","2021","07","16","Front Immunol","Frontiers in immunology","CCR5; COVID-19; PASC; chemokines; cytokines","Long","Emily","IncellDx Inc, San Carlos, CA, United States",NA
"2225","34262570","10.3389/fimmu.2021.700782","Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.","Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the C","2021","07","16","Front Immunol","Frontiers in immunology","CCR5; COVID-19; PASC; chemokines; cytokines","Pise","Amruta","IncellDx Inc, San Carlos, CA, United States",NA
"2226","34262570","10.3389/fimmu.2021.700782","Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.","Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the C","2021","07","16","Front Immunol","Frontiers in immunology","CCR5; COVID-19; PASC; chemokines; cytokines","Rodrigues","Hallison","IncellDx Inc, San Carlos, CA, United States",NA
"2227","34262570","10.3389/fimmu.2021.700782","Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.","Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the C","2021","07","16","Front Immunol","Frontiers in immunology","CCR5; COVID-19; PASC; chemokines; cytokines","Parikh","Purvi","Department of Allergy and Immunology, NYU Langone Tisch Hospital, New York, NY, United States",NA
"2228","34262570","10.3389/fimmu.2021.700782","Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.","Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the C","2021","07","16","Front Immunol","Frontiers in immunology","CCR5; COVID-19; PASC; chemokines; cytokines","Mora","Javier","Lab of Tumor Chemosensitivity, CIET/DC Lab, Faculty of Microbiology, Universidad de Costa Rica, San Jose, Costa Rica",NA
"2229","34262570","10.3389/fimmu.2021.700782","Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.","Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the C","2021","07","16","Front Immunol","Frontiers in immunology","CCR5; COVID-19; PASC; chemokines; cytokines","Mora-Rodríguez","Rodrigo A","Lab of Tumor Chemosensitivity, CIET/DC Lab, Faculty of Microbiology, Universidad de Costa Rica, San Jose, Costa Rica",NA
"2230","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Li","Mingxi","NexVac Research Center, Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China",NA
"2231","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Guo","Jingao","University of Chinese Academy of Sciences, Beijing, China",NA
"2232","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Lu","Shuaiyao","National Kunming High-Level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China",NA
"2233","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Zhou","Runhong","AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China",NA
"2234","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Shi","Hongyang","University of Chinese Academy of Sciences, Beijing, China",NA
"2235","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Shi","Xuanling","NexVac Research Center, Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China",NA
"2236","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Cheng","Lin","Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China",NA
"2237","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Liang","Qingtai","NexVac Research Center, Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China",NA
"2238","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Liu","Hongqi","National Kunming High-Level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China",NA
"2239","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Wang","Pui","State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China",NA
"2240","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Wang","Nan","Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China",NA
"2241","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Wang","Yifeng","Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, China",NA
"2242","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Fu","Lili","NexVac Research Center, Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China",NA
"2243","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Xing","Man","Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China",NA
"2244","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Wang","Ruoke","NexVac Research Center, Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China",NA
"2245","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Ju","Bin","Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China",NA
"2246","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Liu","Li","AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China",NA
"2247","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Lau","Siu-Ying","State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China",NA
"2248","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Jia","Wenxu","NexVac Research Center, Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China",NA
"2249","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Tong","Xin","Walvax Biotechnology Co., Ltd., Kunming, China",NA
"2250","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Yuan","Lin","Walvax Biotechnology Co., Ltd., Kunming, China",NA
"2251","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Guo","Yong","Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China",NA
"2252","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Qi","Hai","Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, China",NA
"2253","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Zhang","Qi","NexVac Research Center, Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China",NA
"2254","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Huang","Zhen","Walvax Biotechnology Co., Ltd., Kunming, China",NA
"2255","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Chen","Honglin","State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China",NA
"2256","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Zhang","Zheng","Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China",NA
"2257","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Chen","Zhiwei","AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China",NA
"2258","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Peng","Xiaozhong","National Kunming High-Level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China",NA
"2259","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Zhou","Dongming","Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China",NA
"2260","34262569","10.3389/fimmu.2021.697074","Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","The development of a safe and effective vaccine against SARS-CoV-2, the causative agent of pandemic coronavirus disease-2019 (COVID-19), is a global priority. Here, we aim to develop novel SARS-CoV-2 vaccines based on a derivative of less commonly used rare adenovirus serotype AdC68 vector. Three vaccine candidates were constructed expressing either the full-length spike (AdC68-19S) or receptor-binding domain (RBD) with two different signal sequences (AdC68-19RBD and AdC68-19RBDs). Single-dose i","2021","07","16","Front Immunol","Frontiers in immunology","SARS-CoV-2 vaccine; chimpanzee adenovirus vector; protective immunity; single-dose immunization; spike protein","Zhang","Linqi","NexVac Research Center, Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China",NA
"2261","34262566","10.3389/fimmu.2021.686699","Case Report: Systemic Sclerosis After Covid-19 Infection.","The coronavirus disease (COVID-19) is a respiratory tract infection caused by the new virus SARS-CoV-2. The acute phase of the infection may in certain individuals be followed by another longer phase of disease (long COVID) of unknown etiology probably associated in certain cases with autoimmune activation. It has been shown that COVID-19 can trigger autoantibody production and in genetically predisposed patients may cause the onset or exacerbation of autoimmune diseases. We are reporting a case","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; autoimmunity; long COVID; scleroderma; systemic sclerosis","Fineschi","Serena","Department of Public Health and Caring Sciences, Unit of General Practice, Uppsala University, Uppsala, Sweden",NA
"2262","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Chan","Yi-Hao","ASTAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore, Singapore",NA
"2263","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Young","Barnaby E","National Centre for Infectious Diseases, Singapore, Singapore",NA
"2264","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Fong","Siew-Wai","ASTAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore, Singapore",NA
"2265","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Ding","Ying","National Centre for Infectious Diseases, Singapore, Singapore",NA
"2266","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Goh","Yun Shan","ASTAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore, Singapore",NA
"2267","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Chee","Rhonda Sin-Ling","ASTAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore, Singapore",NA
"2268","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Tan","Seow-Yen","Department of Infectious Diseases, Changi General Hospital, Singapore, Singapore",NA
"2269","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Kalimuddin","Shirin","Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore",NA
"2270","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Tambyah","Paul A","Department of Medicine, National University Hospital, Singapore, Singapore",NA
"2271","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Leo","Yee-Sin","National Centre for Infectious Diseases, Singapore, Singapore",NA
"2272","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Ng","Lisa F P","ASTAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore, Singapore",NA
"2273","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Lye","David Chien","National Centre for Infectious Diseases, Singapore, Singapore",NA
"2274","34262564","10.3389/fimmu.2021.680188","Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.","A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; T-cells; disease progression; remdesivir (GS-5734); tissue repair","Renia","Laurent","ASTAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore, Singapore",NA
"2275","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Hammoudeh","Sarah Musa","Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"2276","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Hammoudeh","Arabella Musa","Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"2277","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Bhamidimarri","Poorna Manasa","Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"2278","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Al Safar","Habiba","Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates",NA
"2279","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Mahboub","Bassam","Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"2280","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Künstner","Axel","Luebeck Institute of Experimental Dermatology, University of Luebeck, Luebeck, Germany",NA
"2281","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Busch","Hauke","Luebeck Institute of Experimental Dermatology, University of Luebeck, Luebeck, Germany",NA
"2282","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Halwani","Rabih","Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"2283","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Hamid","Qutayba","Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"2284","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Rahmani","Mohamed","Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"2285","34262555","10.3389/fimmu.2021.595150","Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.","As one of the current global health conundrums, COVID-19 pandemic caused a dramatic increase of cases exceeding 79 million and 1.7 million deaths worldwide. Severe presentation of COVID-19 is characterized by cytokine storm and chronic inflammation resulting in multi-organ dysfunction. Currently, it is unclear whether extrapulmonary tissues contribute to the cytokine storm mediated-disease exacerbation. In this study, we applied systems immunology analysis to investigate the immunomodulatory eff","2021","07","16","Front Immunol","Frontiers in immunology","COVID19; SARS-CoV-2; cytokine storm; extrapulmonary tissues; heart; immunopathogenesis; kidney; liver","Hamoudi","Rifat","Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"2286","34262553","10.3389/fimmu.2021.582556","Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications.","Several months ago, Chinese authorities identified an atypical pneumonia in Wuhan city, province of Hubei (China) caused by a novel coronavirus (2019-nCoV or SARS-CoV-2). The WHO announced this new disease was to be known as ""COVID-19"". Several approaches are currently underway for the treatment of this disease, but a specific cure remains to be established. This review will describe how the use of selected nutraceuticals could be helpful, in addition to pharmacological therapy, in preventing so","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; infectious diseases; inflammation; nutraceuticals","Derosa","Giuseppe","Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy",NA
"2287","34262553","10.3389/fimmu.2021.582556","Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications.","Several months ago, Chinese authorities identified an atypical pneumonia in Wuhan city, province of Hubei (China) caused by a novel coronavirus (2019-nCoV or SARS-CoV-2). The WHO announced this new disease was to be known as ""COVID-19"". Several approaches are currently underway for the treatment of this disease, but a specific cure remains to be established. This review will describe how the use of selected nutraceuticals could be helpful, in addition to pharmacological therapy, in preventing so","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; infectious diseases; inflammation; nutraceuticals","Maffioli","Pamela","Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy",NA
"2288","34262553","10.3389/fimmu.2021.582556","Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications.","Several months ago, Chinese authorities identified an atypical pneumonia in Wuhan city, province of Hubei (China) caused by a novel coronavirus (2019-nCoV or SARS-CoV-2). The WHO announced this new disease was to be known as ""COVID-19"". Several approaches are currently underway for the treatment of this disease, but a specific cure remains to be established. This review will describe how the use of selected nutraceuticals could be helpful, in addition to pharmacological therapy, in preventing so","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; infectious diseases; inflammation; nutraceuticals","D'Angelo","Angela","Laboratory of Molecular Medicine, University of Pavia, Pavia, Italy",NA
"2289","34262553","10.3389/fimmu.2021.582556","Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications.","Several months ago, Chinese authorities identified an atypical pneumonia in Wuhan city, province of Hubei (China) caused by a novel coronavirus (2019-nCoV or SARS-CoV-2). The WHO announced this new disease was to be known as ""COVID-19"". Several approaches are currently underway for the treatment of this disease, but a specific cure remains to be established. This review will describe how the use of selected nutraceuticals could be helpful, in addition to pharmacological therapy, in preventing so","2021","07","16","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; infectious diseases; inflammation; nutraceuticals","Di Pierro","Francesco","Velleja Research S.r.l., Milan, Italy",NA
"2290","34262511","10.3389/fpsyg.2021.673772","Engagement in Music-Related Activities During the COVID-19 Pandemic as a Mirror of Individual Differences in Musical Reward and Coping Strategies.","The COVID-19 pandemic and the measures taken to mitigate its impact (e.g., confinement orders) have affected people's lives in profound ways that would have been unimagable only months before the pandemic began. Media reports from the height of the pandemic's initial international surge frequently highlighted that many people were engaging in music-related activities (from singing and dancing to playing music from balconies and attending virtual concerts) to help them cope with the strain of the","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; emotional regulation; individual differences; music; music reward; musical abilities","Ferreri","Laura","Laboratoire d'Étude des Mécanismes Cognitifs, Université Lumière Lyon 2, Lyon, France",NA
"2291","34262511","10.3389/fpsyg.2021.673772","Engagement in Music-Related Activities During the COVID-19 Pandemic as a Mirror of Individual Differences in Musical Reward and Coping Strategies.","The COVID-19 pandemic and the measures taken to mitigate its impact (e.g., confinement orders) have affected people's lives in profound ways that would have been unimagable only months before the pandemic began. Media reports from the height of the pandemic's initial international surge frequently highlighted that many people were engaging in music-related activities (from singing and dancing to playing music from balconies and attending virtual concerts) to help them cope with the strain of the","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; emotional regulation; individual differences; music; music reward; musical abilities","Singer","Neomi","Montreal Neurological Institute, McGill University, Montreal, QC, Canada",NA
"2292","34262511","10.3389/fpsyg.2021.673772","Engagement in Music-Related Activities During the COVID-19 Pandemic as a Mirror of Individual Differences in Musical Reward and Coping Strategies.","The COVID-19 pandemic and the measures taken to mitigate its impact (e.g., confinement orders) have affected people's lives in profound ways that would have been unimagable only months before the pandemic began. Media reports from the height of the pandemic's initial international surge frequently highlighted that many people were engaging in music-related activities (from singing and dancing to playing music from balconies and attending virtual concerts) to help them cope with the strain of the","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; emotional regulation; individual differences; music; music reward; musical abilities","McPhee","Michael","Department of Psychology, New York University, New York, NY, United States",NA
"2293","34262511","10.3389/fpsyg.2021.673772","Engagement in Music-Related Activities During the COVID-19 Pandemic as a Mirror of Individual Differences in Musical Reward and Coping Strategies.","The COVID-19 pandemic and the measures taken to mitigate its impact (e.g., confinement orders) have affected people's lives in profound ways that would have been unimagable only months before the pandemic began. Media reports from the height of the pandemic's initial international surge frequently highlighted that many people were engaging in music-related activities (from singing and dancing to playing music from balconies and attending virtual concerts) to help them cope with the strain of the","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; emotional regulation; individual differences; music; music reward; musical abilities","Ripollés","Pablo","Department of Psychology, New York University, New York, NY, United States",NA
"2294","34262511","10.3389/fpsyg.2021.673772","Engagement in Music-Related Activities During the COVID-19 Pandemic as a Mirror of Individual Differences in Musical Reward and Coping Strategies.","The COVID-19 pandemic and the measures taken to mitigate its impact (e.g., confinement orders) have affected people's lives in profound ways that would have been unimagable only months before the pandemic began. Media reports from the height of the pandemic's initial international surge frequently highlighted that many people were engaging in music-related activities (from singing and dancing to playing music from balconies and attending virtual concerts) to help them cope with the strain of the","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; emotional regulation; individual differences; music; music reward; musical abilities","Zatorre","Robert J","Montreal Neurological Institute, McGill University, Montreal, QC, Canada",NA
"2295","34262511","10.3389/fpsyg.2021.673772","Engagement in Music-Related Activities During the COVID-19 Pandemic as a Mirror of Individual Differences in Musical Reward and Coping Strategies.","The COVID-19 pandemic and the measures taken to mitigate its impact (e.g., confinement orders) have affected people's lives in profound ways that would have been unimagable only months before the pandemic began. Media reports from the height of the pandemic's initial international surge frequently highlighted that many people were engaging in music-related activities (from singing and dancing to playing music from balconies and attending virtual concerts) to help them cope with the strain of the","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; emotional regulation; individual differences; music; music reward; musical abilities","Mas-Herrero","Ernest","Department of Cognition, Development and Education Psychology, Universitat de Barcelona, Barcelona, Spain",NA
"2296","34262509","10.3389/fpsyg.2021.668961","Perceptions of the Post First-Lockdown Era in the Current Covid-19 Pandemic: Quantitative and Qualitative Survey of the French Population.","Introduction: A pandemic with the severity of COVID-19 affects people's lives physically, as well as their daily routines, views of the world, and emotional balance. Lockdown is often an unpleasant experience due to a separation from loved ones, loss of freedom, and uncertainty over the disease status. To adjust, individuals and groups have had to adapt their perceptions of the event to the current scenario. This study aims to describe the perceptions of confined people on the changes occ","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19 pandemic; anxiety; hope; lockdown context; post lockdown perception","Fouques","Damien","CLIPSYD Laboratory UR 4430, Department of Clinical Psychology, Paris Nanterre University, Nanterre, France",NA
"2297","34262509","10.3389/fpsyg.2021.668961","Perceptions of the Post First-Lockdown Era in the Current Covid-19 Pandemic: Quantitative and Qualitative Survey of the French Population.","Introduction: A pandemic with the severity of COVID-19 affects people's lives physically, as well as their daily routines, views of the world, and emotional balance. Lockdown is often an unpleasant experience due to a separation from loved ones, loss of freedom, and uncertainty over the disease status. To adjust, individuals and groups have had to adapt their perceptions of the event to the current scenario. This study aims to describe the perceptions of confined people on the changes occ","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19 pandemic; anxiety; hope; lockdown context; post lockdown perception","Castro","Dana","CLIPSYD Laboratory UR 4430, Department of Clinical Psychology, Paris Nanterre University, Nanterre, France",NA
"2298","34262509","10.3389/fpsyg.2021.668961","Perceptions of the Post First-Lockdown Era in the Current Covid-19 Pandemic: Quantitative and Qualitative Survey of the French Population.","Introduction: A pandemic with the severity of COVID-19 affects people's lives physically, as well as their daily routines, views of the world, and emotional balance. Lockdown is often an unpleasant experience due to a separation from loved ones, loss of freedom, and uncertainty over the disease status. To adjust, individuals and groups have had to adapt their perceptions of the event to the current scenario. This study aims to describe the perceptions of confined people on the changes occ","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19 pandemic; anxiety; hope; lockdown context; post lockdown perception","Mouret","Marion","Independent Researcher in Social Psychology, Paris, France",NA
"2299","34262509","10.3389/fpsyg.2021.668961","Perceptions of the Post First-Lockdown Era in the Current Covid-19 Pandemic: Quantitative and Qualitative Survey of the French Population.","Introduction: A pandemic with the severity of COVID-19 affects people's lives physically, as well as their daily routines, views of the world, and emotional balance. Lockdown is often an unpleasant experience due to a separation from loved ones, loss of freedom, and uncertainty over the disease status. To adjust, individuals and groups have had to adapt their perceptions of the event to the current scenario. This study aims to describe the perceptions of confined people on the changes occ","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19 pandemic; anxiety; hope; lockdown context; post lockdown perception","Julien-Sweerts","Sabrina","Department of Psychology, C2S EA 6291, Université de Reims Champagne Ardenne, Reims, France",NA
"2300","34262509","10.3389/fpsyg.2021.668961","Perceptions of the Post First-Lockdown Era in the Current Covid-19 Pandemic: Quantitative and Qualitative Survey of the French Population.","Introduction: A pandemic with the severity of COVID-19 affects people's lives physically, as well as their daily routines, views of the world, and emotional balance. Lockdown is often an unpleasant experience due to a separation from loved ones, loss of freedom, and uncertainty over the disease status. To adjust, individuals and groups have had to adapt their perceptions of the event to the current scenario. This study aims to describe the perceptions of confined people on the changes occ","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19 pandemic; anxiety; hope; lockdown context; post lockdown perception","Romo","Lucia","CLIPSYD Laboratory UR 4430, Department of Clinical Psychology, Paris Nanterre University, Nanterre, France",NA
"2301","34262502","10.3389/fpsyg.2021.647402","Extra-Curricular Activities and Well-Being: Results From a Survey of Undergraduate University Students During COVID-19 Lockdown Restrictions.","Participation in extra-curricular activities has been found to associate with increased well-being. Here we investigated in a survey (n = 786) what activities university students at a Canadian university engaged in during the stressful COVID-19 pandemic lockdown in April, 2020, which coincided with a novel online exam period, and how these activities related to perceived well-being, anxiety (STAI-S), social aspects of activities, and personality. Sixty-five percentage of students scored i","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19 pandemic; anxiety; extra-curricular activities; mental health; music; stress; undergraduate students; wellness","Finnerty","Rachael","Department of Psychology, Neuroscience &amp",NA
"2302","34262502","10.3389/fpsyg.2021.647402","Extra-Curricular Activities and Well-Being: Results From a Survey of Undergraduate University Students During COVID-19 Lockdown Restrictions.","Participation in extra-curricular activities has been found to associate with increased well-being. Here we investigated in a survey (n = 786) what activities university students at a Canadian university engaged in during the stressful COVID-19 pandemic lockdown in April, 2020, which coincided with a novel online exam period, and how these activities related to perceived well-being, anxiety (STAI-S), social aspects of activities, and personality. Sixty-five percentage of students scored i","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19 pandemic; anxiety; extra-curricular activities; mental health; music; stress; undergraduate students; wellness","Marshall","Sara A","Department of Psychology, Neuroscience &amp",NA
"2303","34262502","10.3389/fpsyg.2021.647402","Extra-Curricular Activities and Well-Being: Results From a Survey of Undergraduate University Students During COVID-19 Lockdown Restrictions.","Participation in extra-curricular activities has been found to associate with increased well-being. Here we investigated in a survey (n = 786) what activities university students at a Canadian university engaged in during the stressful COVID-19 pandemic lockdown in April, 2020, which coincided with a novel online exam period, and how these activities related to perceived well-being, anxiety (STAI-S), social aspects of activities, and personality. Sixty-five percentage of students scored i","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19 pandemic; anxiety; extra-curricular activities; mental health; music; stress; undergraduate students; wellness","Imbault","Constance","Department of Psychology, Neuroscience &amp",NA
"2304","34262502","10.3389/fpsyg.2021.647402","Extra-Curricular Activities and Well-Being: Results From a Survey of Undergraduate University Students During COVID-19 Lockdown Restrictions.","Participation in extra-curricular activities has been found to associate with increased well-being. Here we investigated in a survey (n = 786) what activities university students at a Canadian university engaged in during the stressful COVID-19 pandemic lockdown in April, 2020, which coincided with a novel online exam period, and how these activities related to perceived well-being, anxiety (STAI-S), social aspects of activities, and personality. Sixty-five percentage of students scored i","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19 pandemic; anxiety; extra-curricular activities; mental health; music; stress; undergraduate students; wellness","Trainor","Laurel J","Department of Psychology, Neuroscience &amp",NA
"2305","34262499","10.3389/fpsyg.2021.590196","An Innovative Approach for Online Neuroanatomy and Neurorrehabilitation Teaching Based on 3D Virtual Anatomical Models Using Leap Motion Controller During COVID-19 Pandemic.","After the World Health Organization had declared a pandemic of coronavirus disease (COVID-19) on March 11, 2020 many governments, including the Government of Spain, declared the state of alarm enforcing a quarantine that have left millions of students confined to their homes. This home confinement has affected students of all levels, including university students, and has forced faculties to adapt online teaching strategies. Thus, traditional classroom face-to-face teaching has suddenly been rep","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; distance learning; home confinement; leap motion controller; neuroanatomy; neurorehabilitation; physiotherapy; virtual reality","Obrero-Gaitán","Esteban","Faculty of Health Sciences, University of Jaén, Jaén, Spain",NA
"2306","34262499","10.3389/fpsyg.2021.590196","An Innovative Approach for Online Neuroanatomy and Neurorrehabilitation Teaching Based on 3D Virtual Anatomical Models Using Leap Motion Controller During COVID-19 Pandemic.","After the World Health Organization had declared a pandemic of coronavirus disease (COVID-19) on March 11, 2020 many governments, including the Government of Spain, declared the state of alarm enforcing a quarantine that have left millions of students confined to their homes. This home confinement has affected students of all levels, including university students, and has forced faculties to adapt online teaching strategies. Thus, traditional classroom face-to-face teaching has suddenly been rep","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; distance learning; home confinement; leap motion controller; neuroanatomy; neurorehabilitation; physiotherapy; virtual reality","Nieto-Escamez","Francisco A","Center for Neuropsychological Assessment and Neurorehabilitation (CERNEP), University of Almería, Almeria, Spain",NA
"2307","34262499","10.3389/fpsyg.2021.590196","An Innovative Approach for Online Neuroanatomy and Neurorrehabilitation Teaching Based on 3D Virtual Anatomical Models Using Leap Motion Controller During COVID-19 Pandemic.","After the World Health Organization had declared a pandemic of coronavirus disease (COVID-19) on March 11, 2020 many governments, including the Government of Spain, declared the state of alarm enforcing a quarantine that have left millions of students confined to their homes. This home confinement has affected students of all levels, including university students, and has forced faculties to adapt online teaching strategies. Thus, traditional classroom face-to-face teaching has suddenly been rep","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; distance learning; home confinement; leap motion controller; neuroanatomy; neurorehabilitation; physiotherapy; virtual reality","Zagalaz-Anula","Noelia","Faculty of Health Sciences, University of Jaén, Jaén, Spain",NA
"2308","34262499","10.3389/fpsyg.2021.590196","An Innovative Approach for Online Neuroanatomy and Neurorrehabilitation Teaching Based on 3D Virtual Anatomical Models Using Leap Motion Controller During COVID-19 Pandemic.","After the World Health Organization had declared a pandemic of coronavirus disease (COVID-19) on March 11, 2020 many governments, including the Government of Spain, declared the state of alarm enforcing a quarantine that have left millions of students confined to their homes. This home confinement has affected students of all levels, including university students, and has forced faculties to adapt online teaching strategies. Thus, traditional classroom face-to-face teaching has suddenly been rep","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; distance learning; home confinement; leap motion controller; neuroanatomy; neurorehabilitation; physiotherapy; virtual reality","Cortés-Pérez","Irene","Faculty of Health Sciences, University of Jaén, Jaén, Spain",NA
"2309","34262498","10.3389/fpsyg.2021.560092","Fatalism in the Early Days of the COVID-19 Pandemic: Implications for Mitigation and Mental Health.","This research assessed fatalism toward COVID-19 and its role in behavioral intentions to support mitigation efforts (e. g., social distancing) and mental well-being. A COVID-19 fatalism measure was developed, and a messaging manipulation (fatalistic vs. optimistic vs. no message) was created to examine causal links between fatalism scores. Support for mitigation efforts and negative affect (anxiety, fear, depression, and insecurity) were measured to examine the consequences of fatalism toward CO","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; fatalism; media messaging; mental health; social distancing","Hayes","Joseph","Department of Psychology, Acadia University, Wolfville, NS, Canada",NA
"2310","34262498","10.3389/fpsyg.2021.560092","Fatalism in the Early Days of the COVID-19 Pandemic: Implications for Mitigation and Mental Health.","This research assessed fatalism toward COVID-19 and its role in behavioral intentions to support mitigation efforts (e. g., social distancing) and mental well-being. A COVID-19 fatalism measure was developed, and a messaging manipulation (fatalistic vs. optimistic vs. no message) was created to examine causal links between fatalism scores. Support for mitigation efforts and negative affect (anxiety, fear, depression, and insecurity) were measured to examine the consequences of fatalism toward CO","2021","07","16","Front Psychol","Frontiers in psychology","COVID-19; fatalism; media messaging; mental health; social distancing","Clerk","Laura","Department of Psychology, Acadia University, Wolfville, NS, Canada",NA
"2311","34262488","10.3389/fpsyt.2021.653245","The Association of Suicidal Ideation With Family Characteristics and Social Support of the First Batch of Students Returning to a College During the COVID-19 Epidemic Period: A Cross Sectional Study in China.","Objective: To investigate the prevalence of suicidal ideation among the first batch of students returning to a college during the COVID-19 epidemic, and to explore the correlation of suicidal ideation with family characteristics and social support. Methods: A cluster sampling survey with a self-designed questionnaire was conducted among the first batch of students returning to a college in Wuhu, China. The Positive and Negative Suicidal ideation (PANSI) and Social Support Scale (SS","2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; college students; family characteristics; social support; suicidal ideation","Chen","Yan","Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"2312","34262488","10.3389/fpsyt.2021.653245","The Association of Suicidal Ideation With Family Characteristics and Social Support of the First Batch of Students Returning to a College During the COVID-19 Epidemic Period: A Cross Sectional Study in China.","Objective: To investigate the prevalence of suicidal ideation among the first batch of students returning to a college during the COVID-19 epidemic, and to explore the correlation of suicidal ideation with family characteristics and social support. Methods: A cluster sampling survey with a self-designed questionnaire was conducted among the first batch of students returning to a college in Wuhu, China. The Positive and Negative Suicidal ideation (PANSI) and Social Support Scale (SS","2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; college students; family characteristics; social support; suicidal ideation","Zhu","Li-Jun","School of Public Health, Wannan Medical College, Wuhu, China",NA
"2313","34262488","10.3389/fpsyt.2021.653245","The Association of Suicidal Ideation With Family Characteristics and Social Support of the First Batch of Students Returning to a College During the COVID-19 Epidemic Period: A Cross Sectional Study in China.","Objective: To investigate the prevalence of suicidal ideation among the first batch of students returning to a college during the COVID-19 epidemic, and to explore the correlation of suicidal ideation with family characteristics and social support. Methods: A cluster sampling survey with a self-designed questionnaire was conducted among the first batch of students returning to a college in Wuhu, China. The Positive and Negative Suicidal ideation (PANSI) and Social Support Scale (SS","2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; college students; family characteristics; social support; suicidal ideation","Fang","Zheng-Mei","School of Public Health, Wannan Medical College, Wuhu, China",NA
"2314","34262488","10.3389/fpsyt.2021.653245","The Association of Suicidal Ideation With Family Characteristics and Social Support of the First Batch of Students Returning to a College During the COVID-19 Epidemic Period: A Cross Sectional Study in China.","Objective: To investigate the prevalence of suicidal ideation among the first batch of students returning to a college during the COVID-19 epidemic, and to explore the correlation of suicidal ideation with family characteristics and social support. Methods: A cluster sampling survey with a self-designed questionnaire was conducted among the first batch of students returning to a college in Wuhu, China. The Positive and Negative Suicidal ideation (PANSI) and Social Support Scale (SS","2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; college students; family characteristics; social support; suicidal ideation","Wu","Nan","School of Public Health, Wannan Medical College, Wuhu, China",NA
"2315","34262488","10.3389/fpsyt.2021.653245","The Association of Suicidal Ideation With Family Characteristics and Social Support of the First Batch of Students Returning to a College During the COVID-19 Epidemic Period: A Cross Sectional Study in China.","Objective: To investigate the prevalence of suicidal ideation among the first batch of students returning to a college during the COVID-19 epidemic, and to explore the correlation of suicidal ideation with family characteristics and social support. Methods: A cluster sampling survey with a self-designed questionnaire was conducted among the first batch of students returning to a college in Wuhu, China. The Positive and Negative Suicidal ideation (PANSI) and Social Support Scale (SS","2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; college students; family characteristics; social support; suicidal ideation","Du","Meng-Xue","School of Public Health, Wannan Medical College, Wuhu, China",NA
"2316","34262488","10.3389/fpsyt.2021.653245","The Association of Suicidal Ideation With Family Characteristics and Social Support of the First Batch of Students Returning to a College During the COVID-19 Epidemic Period: A Cross Sectional Study in China.","Objective: To investigate the prevalence of suicidal ideation among the first batch of students returning to a college during the COVID-19 epidemic, and to explore the correlation of suicidal ideation with family characteristics and social support. Methods: A cluster sampling survey with a self-designed questionnaire was conducted among the first batch of students returning to a college in Wuhu, China. The Positive and Negative Suicidal ideation (PANSI) and Social Support Scale (SS","2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; college students; family characteristics; social support; suicidal ideation","Jiang","Min-Min","School of Public Health, Wannan Medical College, Wuhu, China",NA
"2317","34262488","10.3389/fpsyt.2021.653245","The Association of Suicidal Ideation With Family Characteristics and Social Support of the First Batch of Students Returning to a College During the COVID-19 Epidemic Period: A Cross Sectional Study in China.","Objective: To investigate the prevalence of suicidal ideation among the first batch of students returning to a college during the COVID-19 epidemic, and to explore the correlation of suicidal ideation with family characteristics and social support. Methods: A cluster sampling survey with a self-designed questionnaire was conducted among the first batch of students returning to a college in Wuhu, China. The Positive and Negative Suicidal ideation (PANSI) and Social Support Scale (SS","2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; college students; family characteristics; social support; suicidal ideation","Wang","Jing","School of Public Health, Wannan Medical College, Wuhu, China",NA
"2318","34262488","10.3389/fpsyt.2021.653245","The Association of Suicidal Ideation With Family Characteristics and Social Support of the First Batch of Students Returning to a College During the COVID-19 Epidemic Period: A Cross Sectional Study in China.","Objective: To investigate the prevalence of suicidal ideation among the first batch of students returning to a college during the COVID-19 epidemic, and to explore the correlation of suicidal ideation with family characteristics and social support. Methods: A cluster sampling survey with a self-designed questionnaire was conducted among the first batch of students returning to a college in Wuhu, China. The Positive and Negative Suicidal ideation (PANSI) and Social Support Scale (SS","2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; college students; family characteristics; social support; suicidal ideation","Yao","Ying-Shui","School of Public Health, Wannan Medical College, Wuhu, China",NA
"2319","34262488","10.3389/fpsyt.2021.653245","The Association of Suicidal Ideation With Family Characteristics and Social Support of the First Batch of Students Returning to a College During the COVID-19 Epidemic Period: A Cross Sectional Study in China.","Objective: To investigate the prevalence of suicidal ideation among the first batch of students returning to a college during the COVID-19 epidemic, and to explore the correlation of suicidal ideation with family characteristics and social support. Methods: A cluster sampling survey with a self-designed questionnaire was conducted among the first batch of students returning to a college in Wuhu, China. The Positive and Negative Suicidal ideation (PANSI) and Social Support Scale (SS","2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; college students; family characteristics; social support; suicidal ideation","Zhou","Cheng-Chao","Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"2320","34262486","10.3389/fpsyt.2021.566809","Leveraging Technology for the Wellbeing of Individuals With Autism Spectrum Disorder and Their Families During Covid-19.",NA,"2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; applications (Apps); autism spectrum disorder; education technologies; technology","Doenyas","Ceymi","Research Center for Translational Medicine, Koç University, Istanbul, Turkey",NA
"2321","34262486","10.3389/fpsyt.2021.566809","Leveraging Technology for the Wellbeing of Individuals With Autism Spectrum Disorder and Their Families During Covid-19.",NA,"2021","07","16","Front Psychiatry","Frontiers in psychiatry","COVID-19; applications (Apps); autism spectrum disorder; education technologies; technology","Shohieb","Samaa M","Faculty of Computers and Information, Mansoura University, Mansoura, Egypt",NA
"2322","34262413","10.29219/fnr.v65.7686","Unlocking the potential for achievement of the UN Sustainable Development Goal 2 - 'Zero Hunger' - in Africa: targets, strategies, synergies and challenges.","The UN Sustainable Development Goal (SDG) 2 ('Zero Hunger') aims to end all forms of hunger and malnutrition by 2030. Thus, a range of different strategies are needed to facilitate the achievement of SDG 2 to overcome challenges and enable synergies between various SDG targets. The aim of this review is to highlight Africa's progress toward SDG 2, including targets, strategies, synergies and challenges. We scrutinized published research articles in peer-reviewed journals, UN reports and in-count","2021","07","16","Food Nutr Res","Food &amp; nutrition research","Africa; Covid pandemic; Sustainable Development Goals; United Nations; climate change; development programs; food systems; governance; malnutrition","Atukunda","Prudence","Department of Nutrition, University of Oslo, Oslo, Norway",NA
"2323","34262413","10.29219/fnr.v65.7686","Unlocking the potential for achievement of the UN Sustainable Development Goal 2 - 'Zero Hunger' - in Africa: targets, strategies, synergies and challenges.","The UN Sustainable Development Goal (SDG) 2 ('Zero Hunger') aims to end all forms of hunger and malnutrition by 2030. Thus, a range of different strategies are needed to facilitate the achievement of SDG 2 to overcome challenges and enable synergies between various SDG targets. The aim of this review is to highlight Africa's progress toward SDG 2, including targets, strategies, synergies and challenges. We scrutinized published research articles in peer-reviewed journals, UN reports and in-count","2021","07","16","Food Nutr Res","Food &amp; nutrition research","Africa; Covid pandemic; Sustainable Development Goals; United Nations; climate change; development programs; food systems; governance; malnutrition","Eide","Wenche Barth","Department of Nutrition, University of Oslo, Oslo, Norway",NA
"2324","34262413","10.29219/fnr.v65.7686","Unlocking the potential for achievement of the UN Sustainable Development Goal 2 - 'Zero Hunger' - in Africa: targets, strategies, synergies and challenges.","The UN Sustainable Development Goal (SDG) 2 ('Zero Hunger') aims to end all forms of hunger and malnutrition by 2030. Thus, a range of different strategies are needed to facilitate the achievement of SDG 2 to overcome challenges and enable synergies between various SDG targets. The aim of this review is to highlight Africa's progress toward SDG 2, including targets, strategies, synergies and challenges. We scrutinized published research articles in peer-reviewed journals, UN reports and in-count","2021","07","16","Food Nutr Res","Food &amp; nutrition research","Africa; Covid pandemic; Sustainable Development Goals; United Nations; climate change; development programs; food systems; governance; malnutrition","Kardel","Kristin R","Department of Nutrition, University of Oslo, Oslo, Norway",NA
"2325","34262413","10.29219/fnr.v65.7686","Unlocking the potential for achievement of the UN Sustainable Development Goal 2 - 'Zero Hunger' - in Africa: targets, strategies, synergies and challenges.","The UN Sustainable Development Goal (SDG) 2 ('Zero Hunger') aims to end all forms of hunger and malnutrition by 2030. Thus, a range of different strategies are needed to facilitate the achievement of SDG 2 to overcome challenges and enable synergies between various SDG targets. The aim of this review is to highlight Africa's progress toward SDG 2, including targets, strategies, synergies and challenges. We scrutinized published research articles in peer-reviewed journals, UN reports and in-count","2021","07","16","Food Nutr Res","Food &amp; nutrition research","Africa; Covid pandemic; Sustainable Development Goals; United Nations; climate change; development programs; food systems; governance; malnutrition","Iversen","Per Ole","Department of Nutrition, University of Oslo, Oslo, Norway",NA
"2326","34262413","10.29219/fnr.v65.7686","Unlocking the potential for achievement of the UN Sustainable Development Goal 2 - 'Zero Hunger' - in Africa: targets, strategies, synergies and challenges.","The UN Sustainable Development Goal (SDG) 2 ('Zero Hunger') aims to end all forms of hunger and malnutrition by 2030. Thus, a range of different strategies are needed to facilitate the achievement of SDG 2 to overcome challenges and enable synergies between various SDG targets. The aim of this review is to highlight Africa's progress toward SDG 2, including targets, strategies, synergies and challenges. We scrutinized published research articles in peer-reviewed journals, UN reports and in-count","2021","07","16","Food Nutr Res","Food &amp; nutrition research","Africa; Covid pandemic; Sustainable Development Goals; United Nations; climate change; development programs; food systems; governance; malnutrition","Westerberg","Ane C","Institute of Health Sciences, Kristiania University College, Oslo, Norway",NA
"2327","34262388","10.2147/AMEP.S310625","Online Foundation Course Program for First Year Medical Undergraduates Amidst the COVID-19 Pandemic - A New Learning Experience.","Foundation programs are conducted in medical schools for undergraduate students, since they are naïve and unaware of the medical profession in depth. The program helps them to become familiar with the undergraduate medical training. The present intake of first year medical undergraduates had joined the institute amidst the COVID-19 pandemic and hence the foundation program had to be conducted through an online platform. The present paper is a description of the online program conducted in the in","2021","07","16","Adv Med Educ Pract","Advances in medical education and practice","Zoom© platform; modules; orientation; students","Khorwal","Gitanjali","Department of Anatomy, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"2328","34262388","10.2147/AMEP.S310625","Online Foundation Course Program for First Year Medical Undergraduates Amidst the COVID-19 Pandemic - A New Learning Experience.","Foundation programs are conducted in medical schools for undergraduate students, since they are naïve and unaware of the medical profession in depth. The program helps them to become familiar with the undergraduate medical training. The present intake of first year medical undergraduates had joined the institute amidst the COVID-19 pandemic and hence the foundation program had to be conducted through an online platform. The present paper is a description of the online program conducted in the in","2021","07","16","Adv Med Educ Pract","Advances in medical education and practice","Zoom© platform; modules; orientation; students","Negi","Gita","Department of Transfusion Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"2329","34262388","10.2147/AMEP.S310625","Online Foundation Course Program for First Year Medical Undergraduates Amidst the COVID-19 Pandemic - A New Learning Experience.","Foundation programs are conducted in medical schools for undergraduate students, since they are naïve and unaware of the medical profession in depth. The program helps them to become familiar with the undergraduate medical training. The present intake of first year medical undergraduates had joined the institute amidst the COVID-19 pandemic and hence the foundation program had to be conducted through an online platform. The present paper is a description of the online program conducted in the in","2021","07","16","Adv Med Educ Pract","Advances in medical education and practice","Zoom© platform; modules; orientation; students","Bhute","Ashish","Department of Forensic Medicine and Toxicology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"2330","34262388","10.2147/AMEP.S310625","Online Foundation Course Program for First Year Medical Undergraduates Amidst the COVID-19 Pandemic - A New Learning Experience.","Foundation programs are conducted in medical schools for undergraduate students, since they are naïve and unaware of the medical profession in depth. The program helps them to become familiar with the undergraduate medical training. The present intake of first year medical undergraduates had joined the institute amidst the COVID-19 pandemic and hence the foundation program had to be conducted through an online platform. The present paper is a description of the online program conducted in the in","2021","07","16","Adv Med Educ Pract","Advances in medical education and practice","Zoom© platform; modules; orientation; students","Chandra","Harish","Department of Pathology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"2331","34262388","10.2147/AMEP.S310625","Online Foundation Course Program for First Year Medical Undergraduates Amidst the COVID-19 Pandemic - A New Learning Experience.","Foundation programs are conducted in medical schools for undergraduate students, since they are naïve and unaware of the medical profession in depth. The program helps them to become familiar with the undergraduate medical training. The present intake of first year medical undergraduates had joined the institute amidst the COVID-19 pandemic and hence the foundation program had to be conducted through an online platform. The present paper is a description of the online program conducted in the in","2021","07","16","Adv Med Educ Pract","Advances in medical education and practice","Zoom© platform; modules; orientation; students","Balasubramanian","Priyavadhana","Department of Pathology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"2332","34262388","10.2147/AMEP.S310625","Online Foundation Course Program for First Year Medical Undergraduates Amidst the COVID-19 Pandemic - A New Learning Experience.","Foundation programs are conducted in medical schools for undergraduate students, since they are naïve and unaware of the medical profession in depth. The program helps them to become familiar with the undergraduate medical training. The present intake of first year medical undergraduates had joined the institute amidst the COVID-19 pandemic and hence the foundation program had to be conducted through an online platform. The present paper is a description of the online program conducted in the in","2021","07","16","Adv Med Educ Pract","Advances in medical education and practice","Zoom© platform; modules; orientation; students","Pant","Jayanti","Department of Physiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"2333","34262375","10.2147/NSS.S313373","The Impact of Quarantine on Sleep Quality and Psychological Distress During the COVID-19 Pandemic.","We investigated the impact of isolation on sleep quality and psychological distress during the COVID-19 pandemic in Saudi Arabia. An online survey was conducted on 353 (88 isolated and 265 not isolated) individuals from May to June 2020. Subjective sleep quality was determined using the Pittsburgh sleep quality index (PSQI), and psychological distress measured using the Kessler psychological distress scale (K10). The mean age of the isolated group was 28.6 years versus 27.5 years for the non-iso","2021","07","16","Nat Sci Sleep","Nature and science of sleep","COVID-19; SARS-CoV-2; pandemic; psychological distress; quarantine; self-isolation; sleep quality","AlRasheed","Maha M","Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia",NA
"2334","34262375","10.2147/NSS.S313373","The Impact of Quarantine on Sleep Quality and Psychological Distress During the COVID-19 Pandemic.","We investigated the impact of isolation on sleep quality and psychological distress during the COVID-19 pandemic in Saudi Arabia. An online survey was conducted on 353 (88 isolated and 265 not isolated) individuals from May to June 2020. Subjective sleep quality was determined using the Pittsburgh sleep quality index (PSQI), and psychological distress measured using the Kessler psychological distress scale (K10). The mean age of the isolated group was 28.6 years versus 27.5 years for the non-iso","2021","07","16","Nat Sci Sleep","Nature and science of sleep","COVID-19; SARS-CoV-2; pandemic; psychological distress; quarantine; self-isolation; sleep quality","Alkadir","Afnan M","Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia",NA
"2335","34262375","10.2147/NSS.S313373","The Impact of Quarantine on Sleep Quality and Psychological Distress During the COVID-19 Pandemic.","We investigated the impact of isolation on sleep quality and psychological distress during the COVID-19 pandemic in Saudi Arabia. An online survey was conducted on 353 (88 isolated and 265 not isolated) individuals from May to June 2020. Subjective sleep quality was determined using the Pittsburgh sleep quality index (PSQI), and psychological distress measured using the Kessler psychological distress scale (K10). The mean age of the isolated group was 28.6 years versus 27.5 years for the non-iso","2021","07","16","Nat Sci Sleep","Nature and science of sleep","COVID-19; SARS-CoV-2; pandemic; psychological distress; quarantine; self-isolation; sleep quality","Bin Shuqiran","Khulood I","Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia",NA
"2336","34262375","10.2147/NSS.S313373","The Impact of Quarantine on Sleep Quality and Psychological Distress During the COVID-19 Pandemic.","We investigated the impact of isolation on sleep quality and psychological distress during the COVID-19 pandemic in Saudi Arabia. An online survey was conducted on 353 (88 isolated and 265 not isolated) individuals from May to June 2020. Subjective sleep quality was determined using the Pittsburgh sleep quality index (PSQI), and psychological distress measured using the Kessler psychological distress scale (K10). The mean age of the isolated group was 28.6 years versus 27.5 years for the non-iso","2021","07","16","Nat Sci Sleep","Nature and science of sleep","COVID-19; SARS-CoV-2; pandemic; psychological distress; quarantine; self-isolation; sleep quality","Al-Aqeel","Sinaa","Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia",NA
"2337","34262375","10.2147/NSS.S313373","The Impact of Quarantine on Sleep Quality and Psychological Distress During the COVID-19 Pandemic.","We investigated the impact of isolation on sleep quality and psychological distress during the COVID-19 pandemic in Saudi Arabia. An online survey was conducted on 353 (88 isolated and 265 not isolated) individuals from May to June 2020. Subjective sleep quality was determined using the Pittsburgh sleep quality index (PSQI), and psychological distress measured using the Kessler psychological distress scale (K10). The mean age of the isolated group was 28.6 years versus 27.5 years for the non-iso","2021","07","16","Nat Sci Sleep","Nature and science of sleep","COVID-19; SARS-CoV-2; pandemic; psychological distress; quarantine; self-isolation; sleep quality","Jahrami","Haitham A","Ministry of Health, Manama, Kingdom of Bahrain",NA
"2338","34262375","10.2147/NSS.S313373","The Impact of Quarantine on Sleep Quality and Psychological Distress During the COVID-19 Pandemic.","We investigated the impact of isolation on sleep quality and psychological distress during the COVID-19 pandemic in Saudi Arabia. An online survey was conducted on 353 (88 isolated and 265 not isolated) individuals from May to June 2020. Subjective sleep quality was determined using the Pittsburgh sleep quality index (PSQI), and psychological distress measured using the Kessler psychological distress scale (K10). The mean age of the isolated group was 28.6 years versus 27.5 years for the non-iso","2021","07","16","Nat Sci Sleep","Nature and science of sleep","COVID-19; SARS-CoV-2; pandemic; psychological distress; quarantine; self-isolation; sleep quality","BaHammam","Ahmed S","University Sleep Disorders Centre, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"2339","34262372","10.2147/RMHP.S306880","Covid-19 Knowledge and Perceptions Among Dental Specialists: A Cross-Sectional Online Questionnaire Survey.","The recent outbreak of coronavirus (COVID-19) caused a significant impact on dentistry. It is imperative to have sufficient knowledge of COVID-19 to manage patients in the dental operatory. To assess the knowledge and perceptions of dentists from different specialities about COVID-19 disease. Cross-sectional online survey. This study used a descriptive cross-sectional study design with a self-administered questionnaire. The questionnaire included three sets of 23 questions [Demographic-4; Source","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; dentistry; dentists; infection; questionnaire","Aldhuwayhi","Sami","Department Prosthodontics, College of Dentistry, Majmaah University, Al-majmaah, 11952, Saudi Arabia",NA
"2340","34262372","10.2147/RMHP.S306880","Covid-19 Knowledge and Perceptions Among Dental Specialists: A Cross-Sectional Online Questionnaire Survey.","The recent outbreak of coronavirus (COVID-19) caused a significant impact on dentistry. It is imperative to have sufficient knowledge of COVID-19 to manage patients in the dental operatory. To assess the knowledge and perceptions of dentists from different specialities about COVID-19 disease. Cross-sectional online survey. This study used a descriptive cross-sectional study design with a self-administered questionnaire. The questionnaire included three sets of 23 questions [Demographic-4; Source","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; dentistry; dentists; infection; questionnaire","Mallineni","Sreekanth Kumar","Department of Preventive Dental Sciences, College of Dentistry, Majmaah University, Al-majmaah, 11952, Saudi Arabia",NA
"2341","34262372","10.2147/RMHP.S306880","Covid-19 Knowledge and Perceptions Among Dental Specialists: A Cross-Sectional Online Questionnaire Survey.","The recent outbreak of coronavirus (COVID-19) caused a significant impact on dentistry. It is imperative to have sufficient knowledge of COVID-19 to manage patients in the dental operatory. To assess the knowledge and perceptions of dentists from different specialities about COVID-19 disease. Cross-sectional online survey. This study used a descriptive cross-sectional study design with a self-administered questionnaire. The questionnaire included three sets of 23 questions [Demographic-4; Source","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; dentistry; dentists; infection; questionnaire","Sakhamuri","Srinivasulu","Department of Conservative Dentistry &amp",NA
"2342","34262372","10.2147/RMHP.S306880","Covid-19 Knowledge and Perceptions Among Dental Specialists: A Cross-Sectional Online Questionnaire Survey.","The recent outbreak of coronavirus (COVID-19) caused a significant impact on dentistry. It is imperative to have sufficient knowledge of COVID-19 to manage patients in the dental operatory. To assess the knowledge and perceptions of dentists from different specialities about COVID-19 disease. Cross-sectional online survey. This study used a descriptive cross-sectional study design with a self-administered questionnaire. The questionnaire included three sets of 23 questions [Demographic-4; Source","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; dentistry; dentists; infection; questionnaire","Thakare","Amar Ashok","Department Prosthodontics, College of Dentistry, Majmaah University, Al-majmaah, 11952, Saudi Arabia",NA
"2343","34262372","10.2147/RMHP.S306880","Covid-19 Knowledge and Perceptions Among Dental Specialists: A Cross-Sectional Online Questionnaire Survey.","The recent outbreak of coronavirus (COVID-19) caused a significant impact on dentistry. It is imperative to have sufficient knowledge of COVID-19 to manage patients in the dental operatory. To assess the knowledge and perceptions of dentists from different specialities about COVID-19 disease. Cross-sectional online survey. This study used a descriptive cross-sectional study design with a self-administered questionnaire. The questionnaire included three sets of 23 questions [Demographic-4; Source","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; dentistry; dentists; infection; questionnaire","Mallineni","Sahana","Department of Periodontology, Krishna Institute of Medical Sciences, Nellore, AP, India",NA
"2344","34262372","10.2147/RMHP.S306880","Covid-19 Knowledge and Perceptions Among Dental Specialists: A Cross-Sectional Online Questionnaire Survey.","The recent outbreak of coronavirus (COVID-19) caused a significant impact on dentistry. It is imperative to have sufficient knowledge of COVID-19 to manage patients in the dental operatory. To assess the knowledge and perceptions of dentists from different specialities about COVID-19 disease. Cross-sectional online survey. This study used a descriptive cross-sectional study design with a self-administered questionnaire. The questionnaire included three sets of 23 questions [Demographic-4; Source","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; dentistry; dentists; infection; questionnaire","Sajja","Rishitha","Data Manager, Bristol Myers Squibb, New Brunswick, NJ, USA",NA
"2345","34262372","10.2147/RMHP.S306880","Covid-19 Knowledge and Perceptions Among Dental Specialists: A Cross-Sectional Online Questionnaire Survey.","The recent outbreak of coronavirus (COVID-19) caused a significant impact on dentistry. It is imperative to have sufficient knowledge of COVID-19 to manage patients in the dental operatory. To assess the knowledge and perceptions of dentists from different specialities about COVID-19 disease. Cross-sectional online survey. This study used a descriptive cross-sectional study design with a self-administered questionnaire. The questionnaire included three sets of 23 questions [Demographic-4; Source","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; dentistry; dentists; infection; questionnaire","Sethi","Mallika","Department of Periodontology, ITS Dental College, Muradnagar, Ghaziabad, Uttar Pradesh, India",NA
"2346","34262372","10.2147/RMHP.S306880","Covid-19 Knowledge and Perceptions Among Dental Specialists: A Cross-Sectional Online Questionnaire Survey.","The recent outbreak of coronavirus (COVID-19) caused a significant impact on dentistry. It is imperative to have sufficient knowledge of COVID-19 to manage patients in the dental operatory. To assess the knowledge and perceptions of dentists from different specialities about COVID-19 disease. Cross-sectional online survey. This study used a descriptive cross-sectional study design with a self-administered questionnaire. The questionnaire included three sets of 23 questions [Demographic-4; Source","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; dentistry; dentists; infection; questionnaire","Nettam","Venkatesh","Department of Orthodontics, Narayana Dental College and Hospital, Nellore, Andhra Pradesh, India",NA
"2347","34262372","10.2147/RMHP.S306880","Covid-19 Knowledge and Perceptions Among Dental Specialists: A Cross-Sectional Online Questionnaire Survey.","The recent outbreak of coronavirus (COVID-19) caused a significant impact on dentistry. It is imperative to have sufficient knowledge of COVID-19 to manage patients in the dental operatory. To assess the knowledge and perceptions of dentists from different specialities about COVID-19 disease. Cross-sectional online survey. This study used a descriptive cross-sectional study design with a self-administered questionnaire. The questionnaire included three sets of 23 questions [Demographic-4; Source","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; dentistry; dentists; infection; questionnaire","Mohammad","Azher Mohiuddin","Oral Maxillofacial Surgery, Military Hospital, Riyadh, Saudi Arabia",NA
"2348","34262370","10.2147/RMHP.S321314","Care for the Carers: An Evaluation of Job Satisfaction of Community Healthcare Workers in Charge of Infectious Disease Prevention and Control in Vietnam.","This study explored job satisfaction and associated factors among community healthcare workers (HCWs) during the COVID-19 pandemic. A cross-sectional study was conducted among 319 HCWs in charge of infectious disease prevention and control activities at all commune healthcare centers in Ho Chi Minh City. Participants completed a self-administered questionnaire which included the 36-item Job Satisfaction Survey (JSS). Most participants were male (56.7%), and the mean age was 34.7 (SD=7.1) years. ","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Vietnam; healthcare worker; infectious disease; job satisfaction","Thai","Truc Thanh","Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam",NA
"2349","34262370","10.2147/RMHP.S321314","Care for the Carers: An Evaluation of Job Satisfaction of Community Healthcare Workers in Charge of Infectious Disease Prevention and Control in Vietnam.","This study explored job satisfaction and associated factors among community healthcare workers (HCWs) during the COVID-19 pandemic. A cross-sectional study was conducted among 319 HCWs in charge of infectious disease prevention and control activities at all commune healthcare centers in Ho Chi Minh City. Participants completed a self-administered questionnaire which included the 36-item Job Satisfaction Survey (JSS). Most participants were male (56.7%), and the mean age was 34.7 (SD=7.1) years. ","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Vietnam; healthcare worker; infectious disease; job satisfaction","Le","Tuyet Anh Thi","Department of Prevention of Infectious Diseases, Ho Chi Minh Provincial Center for Disease Control, Ho Chi Minh City, Vietnam",NA
"2350","34262370","10.2147/RMHP.S321314","Care for the Carers: An Evaluation of Job Satisfaction of Community Healthcare Workers in Charge of Infectious Disease Prevention and Control in Vietnam.","This study explored job satisfaction and associated factors among community healthcare workers (HCWs) during the COVID-19 pandemic. A cross-sectional study was conducted among 319 HCWs in charge of infectious disease prevention and control activities at all commune healthcare centers in Ho Chi Minh City. Participants completed a self-administered questionnaire which included the 36-item Job Satisfaction Survey (JSS). Most participants were male (56.7%), and the mean age was 34.7 (SD=7.1) years. ","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Vietnam; healthcare worker; infectious disease; job satisfaction","Truong","Lan Thanh Thi","Department of Prevention of Infectious Diseases, Ho Chi Minh Provincial Center for Disease Control, Ho Chi Minh City, Vietnam",NA
"2351","34262370","10.2147/RMHP.S321314","Care for the Carers: An Evaluation of Job Satisfaction of Community Healthcare Workers in Charge of Infectious Disease Prevention and Control in Vietnam.","This study explored job satisfaction and associated factors among community healthcare workers (HCWs) during the COVID-19 pandemic. A cross-sectional study was conducted among 319 HCWs in charge of infectious disease prevention and control activities at all commune healthcare centers in Ho Chi Minh City. Participants completed a self-administered questionnaire which included the 36-item Job Satisfaction Survey (JSS). Most participants were male (56.7%), and the mean age was 34.7 (SD=7.1) years. ","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Vietnam; healthcare worker; infectious disease; job satisfaction","Le","Nga Hong","Department of Prevention of Infectious Diseases, Ho Chi Minh Provincial Center for Disease Control, Ho Chi Minh City, Vietnam",NA
"2352","34262370","10.2147/RMHP.S321314","Care for the Carers: An Evaluation of Job Satisfaction of Community Healthcare Workers in Charge of Infectious Disease Prevention and Control in Vietnam.","This study explored job satisfaction and associated factors among community healthcare workers (HCWs) during the COVID-19 pandemic. A cross-sectional study was conducted among 319 HCWs in charge of infectious disease prevention and control activities at all commune healthcare centers in Ho Chi Minh City. Participants completed a self-administered questionnaire which included the 36-item Job Satisfaction Survey (JSS). Most participants were male (56.7%), and the mean age was 34.7 (SD=7.1) years. ","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Vietnam; healthcare worker; infectious disease; job satisfaction","Huynh","Quynh Ngoc Ho","Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam",NA
"2353","34262370","10.2147/RMHP.S321314","Care for the Carers: An Evaluation of Job Satisfaction of Community Healthcare Workers in Charge of Infectious Disease Prevention and Control in Vietnam.","This study explored job satisfaction and associated factors among community healthcare workers (HCWs) during the COVID-19 pandemic. A cross-sectional study was conducted among 319 HCWs in charge of infectious disease prevention and control activities at all commune healthcare centers in Ho Chi Minh City. Participants completed a self-administered questionnaire which included the 36-item Job Satisfaction Survey (JSS). Most participants were male (56.7%), and the mean age was 34.7 (SD=7.1) years. ","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Vietnam; healthcare worker; infectious disease; job satisfaction","Nguyen","Tap Van","Department of Medicine and Pharmacy, Tra Vinh University, Tra Vinh City, Vietnam",NA
"2354","34262370","10.2147/RMHP.S321314","Care for the Carers: An Evaluation of Job Satisfaction of Community Healthcare Workers in Charge of Infectious Disease Prevention and Control in Vietnam.","This study explored job satisfaction and associated factors among community healthcare workers (HCWs) during the COVID-19 pandemic. A cross-sectional study was conducted among 319 HCWs in charge of infectious disease prevention and control activities at all commune healthcare centers in Ho Chi Minh City. Participants completed a self-administered questionnaire which included the 36-item Job Satisfaction Survey (JSS). Most participants were male (56.7%), and the mean age was 34.7 (SD=7.1) years. ","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Vietnam; healthcare worker; infectious disease; job satisfaction","Tran","Huong Giang Nguyen","Training and Scientific Research Department, University Medical Center, Ho Chi Minh City, Vietnam",NA
"2355","34262368","10.2147/RMHP.S306402","Knowledge, Attitude, and Perceived Risks Towards COVID-19 Pandemic and the Impact of Risk Communication Messages on Healthcare Workers in Saudi Arabia.","To investigate knowledge, attitude, and perceived risks towards COVID-19 pandemic among healthcare workers (HCWs) in Saudi Arabia. Besides, the impact of risk communication strategy on the attitude and practice of HCWs was investigated. We conducted a cross-sectional study that targeted HCWs from various Saudi health facilities. We utilized a self-administrated, online-based questionnaire designed to assess basic knowledge of COVID-19, attitude and disease perception, and the impact of risk comm","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 pandemic; Saudi Arabia; attitude; knowledge; perceived benefits; risk communication","Mushi","Abdulaziz","The Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia",NA
"2356","34262368","10.2147/RMHP.S306402","Knowledge, Attitude, and Perceived Risks Towards COVID-19 Pandemic and the Impact of Risk Communication Messages on Healthcare Workers in Saudi Arabia.","To investigate knowledge, attitude, and perceived risks towards COVID-19 pandemic among healthcare workers (HCWs) in Saudi Arabia. Besides, the impact of risk communication strategy on the attitude and practice of HCWs was investigated. We conducted a cross-sectional study that targeted HCWs from various Saudi health facilities. We utilized a self-administrated, online-based questionnaire designed to assess basic knowledge of COVID-19, attitude and disease perception, and the impact of risk comm","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 pandemic; Saudi Arabia; attitude; knowledge; perceived benefits; risk communication","Yassin","Yara","The Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia",NA
"2357","34262368","10.2147/RMHP.S306402","Knowledge, Attitude, and Perceived Risks Towards COVID-19 Pandemic and the Impact of Risk Communication Messages on Healthcare Workers in Saudi Arabia.","To investigate knowledge, attitude, and perceived risks towards COVID-19 pandemic among healthcare workers (HCWs) in Saudi Arabia. Besides, the impact of risk communication strategy on the attitude and practice of HCWs was investigated. We conducted a cross-sectional study that targeted HCWs from various Saudi health facilities. We utilized a self-administrated, online-based questionnaire designed to assess basic knowledge of COVID-19, attitude and disease perception, and the impact of risk comm","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 pandemic; Saudi Arabia; attitude; knowledge; perceived benefits; risk communication","Khan","Anas","The Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia",NA
"2358","34262368","10.2147/RMHP.S306402","Knowledge, Attitude, and Perceived Risks Towards COVID-19 Pandemic and the Impact of Risk Communication Messages on Healthcare Workers in Saudi Arabia.","To investigate knowledge, attitude, and perceived risks towards COVID-19 pandemic among healthcare workers (HCWs) in Saudi Arabia. Besides, the impact of risk communication strategy on the attitude and practice of HCWs was investigated. We conducted a cross-sectional study that targeted HCWs from various Saudi health facilities. We utilized a self-administrated, online-based questionnaire designed to assess basic knowledge of COVID-19, attitude and disease perception, and the impact of risk comm","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 pandemic; Saudi Arabia; attitude; knowledge; perceived benefits; risk communication","Yezli","Saber","The Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia",NA
"2359","34262368","10.2147/RMHP.S306402","Knowledge, Attitude, and Perceived Risks Towards COVID-19 Pandemic and the Impact of Risk Communication Messages on Healthcare Workers in Saudi Arabia.","To investigate knowledge, attitude, and perceived risks towards COVID-19 pandemic among healthcare workers (HCWs) in Saudi Arabia. Besides, the impact of risk communication strategy on the attitude and practice of HCWs was investigated. We conducted a cross-sectional study that targeted HCWs from various Saudi health facilities. We utilized a self-administrated, online-based questionnaire designed to assess basic knowledge of COVID-19, attitude and disease perception, and the impact of risk comm","2021","07","16","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 pandemic; Saudi Arabia; attitude; knowledge; perceived benefits; risk communication","Almuzaini","Yasir","The Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia",NA
"2360","34262366","10.2147/PRBM.S287477","The Impact of the COVID-19 Epidemic on Mental Health Among Residents of Assela Town.","COVID-19 has diversified problems such as physical health, mental health, psychosocial and economic impact on people all over the world. A report from Johns Hopkins University revealed that many millions of people have been infected and millions of them lost their lives due to the virus. To assess the implementation of COVID-19 prevention mechanisms and to describe the impact of COVID-19 on people's mental health in Asella town. Descriptive survey research design was used. Two hundred and eleven","2021","07","16","Psychol Res Behav Manag","Psychology research and behavior management","COVID-19; depression; mental health; state anxiety and prevention mechanisms","Disasa","Begashaw","Department of Psychology, College of Educational and Behavioral Science, Arsi University, Asella, Ethiopia",NA
"2361","34262366","10.2147/PRBM.S287477","The Impact of the COVID-19 Epidemic on Mental Health Among Residents of Assela Town.","COVID-19 has diversified problems such as physical health, mental health, psychosocial and economic impact on people all over the world. A report from Johns Hopkins University revealed that many millions of people have been infected and millions of them lost their lives due to the virus. To assess the implementation of COVID-19 prevention mechanisms and to describe the impact of COVID-19 on people's mental health in Asella town. Descriptive survey research design was used. Two hundred and eleven","2021","07","16","Psychol Res Behav Manag","Psychology research and behavior management","COVID-19; depression; mental health; state anxiety and prevention mechanisms","Teshome","Enishaw","Department of Psychology, College of Educational and Behavioral Science, Arsi University, Asella, Ethiopia",NA
"2362","34262355","10.2147/IJWH.S315467","Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in Italy.","In February 2020, Italy became the first European country to face the coronavirus disease 2019 (COVID-19) outbreak. The concerns of infection, financial worries, loss of freedom, and isolation during the ongoing pandemic can lead to negative psychological effects, including anxiety, depression, and obsessive-compulsive disorder. The main aim of our study was to evaluate the relationship between pandemic-related stress and pregnancy-specific stress and assess their role in the development of psyc","2021","07","16","Int J Womens Health","International journal of women's health","COVID-19 pandemic; anxiety; depression; obsessive-compulsive disorder; pregnancy-specific stress","Colli","Chiara","Unit of Psychiatry, Department of Medicine (DAME), University of Udine, Udine, Italy",NA
"2363","34262355","10.2147/IJWH.S315467","Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in Italy.","In February 2020, Italy became the first European country to face the coronavirus disease 2019 (COVID-19) outbreak. The concerns of infection, financial worries, loss of freedom, and isolation during the ongoing pandemic can lead to negative psychological effects, including anxiety, depression, and obsessive-compulsive disorder. The main aim of our study was to evaluate the relationship between pandemic-related stress and pregnancy-specific stress and assess their role in the development of psyc","2021","07","16","Int J Womens Health","International journal of women's health","COVID-19 pandemic; anxiety; depression; obsessive-compulsive disorder; pregnancy-specific stress","Penengo","Chiara","Unit of Psychiatry, Department of Medicine (DAME), University of Udine, Udine, Italy",NA
"2364","34262355","10.2147/IJWH.S315467","Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in Italy.","In February 2020, Italy became the first European country to face the coronavirus disease 2019 (COVID-19) outbreak. The concerns of infection, financial worries, loss of freedom, and isolation during the ongoing pandemic can lead to negative psychological effects, including anxiety, depression, and obsessive-compulsive disorder. The main aim of our study was to evaluate the relationship between pandemic-related stress and pregnancy-specific stress and assess their role in the development of psyc","2021","07","16","Int J Womens Health","International journal of women's health","COVID-19 pandemic; anxiety; depression; obsessive-compulsive disorder; pregnancy-specific stress","Garzitto","Marco","Unit of Psychiatry, Department of Medicine (DAME), University of Udine, Udine, Italy",NA
"2365","34262355","10.2147/IJWH.S315467","Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in Italy.","In February 2020, Italy became the first European country to face the coronavirus disease 2019 (COVID-19) outbreak. The concerns of infection, financial worries, loss of freedom, and isolation during the ongoing pandemic can lead to negative psychological effects, including anxiety, depression, and obsessive-compulsive disorder. The main aim of our study was to evaluate the relationship between pandemic-related stress and pregnancy-specific stress and assess their role in the development of psyc","2021","07","16","Int J Womens Health","International journal of women's health","COVID-19 pandemic; anxiety; depression; obsessive-compulsive disorder; pregnancy-specific stress","Driul","Lorenza","Obstetric-Gynaecologic Clinic, Department of Medicine (DAME), University of Udine, Udine, Italy",NA
"2366","34262355","10.2147/IJWH.S315467","Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in Italy.","In February 2020, Italy became the first European country to face the coronavirus disease 2019 (COVID-19) outbreak. The concerns of infection, financial worries, loss of freedom, and isolation during the ongoing pandemic can lead to negative psychological effects, including anxiety, depression, and obsessive-compulsive disorder. The main aim of our study was to evaluate the relationship between pandemic-related stress and pregnancy-specific stress and assess their role in the development of psyc","2021","07","16","Int J Womens Health","International journal of women's health","COVID-19 pandemic; anxiety; depression; obsessive-compulsive disorder; pregnancy-specific stress","Sala","Alessia","Obstetric-Gynaecologic Clinic, Department of Medicine (DAME), University of Udine, Udine, Italy",NA
"2367","34262355","10.2147/IJWH.S315467","Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in Italy.","In February 2020, Italy became the first European country to face the coronavirus disease 2019 (COVID-19) outbreak. The concerns of infection, financial worries, loss of freedom, and isolation during the ongoing pandemic can lead to negative psychological effects, including anxiety, depression, and obsessive-compulsive disorder. The main aim of our study was to evaluate the relationship between pandemic-related stress and pregnancy-specific stress and assess their role in the development of psyc","2021","07","16","Int J Womens Health","International journal of women's health","COVID-19 pandemic; anxiety; depression; obsessive-compulsive disorder; pregnancy-specific stress","Degano","Matilde","Obstetric-Gynaecologic Clinic, Department of Medicine (DAME), University of Udine, Udine, Italy",NA
"2368","34262355","10.2147/IJWH.S315467","Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in Italy.","In February 2020, Italy became the first European country to face the coronavirus disease 2019 (COVID-19) outbreak. The concerns of infection, financial worries, loss of freedom, and isolation during the ongoing pandemic can lead to negative psychological effects, including anxiety, depression, and obsessive-compulsive disorder. The main aim of our study was to evaluate the relationship between pandemic-related stress and pregnancy-specific stress and assess their role in the development of psyc","2021","07","16","Int J Womens Health","International journal of women's health","COVID-19 pandemic; anxiety; depression; obsessive-compulsive disorder; pregnancy-specific stress","Preis","Heidi","Department of Psychology, Stony Brook University, Stony Brook, New York, NY, 11794, USA",NA
"2369","34262355","10.2147/IJWH.S315467","Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in Italy.","In February 2020, Italy became the first European country to face the coronavirus disease 2019 (COVID-19) outbreak. The concerns of infection, financial worries, loss of freedom, and isolation during the ongoing pandemic can lead to negative psychological effects, including anxiety, depression, and obsessive-compulsive disorder. The main aim of our study was to evaluate the relationship between pandemic-related stress and pregnancy-specific stress and assess their role in the development of psyc","2021","07","16","Int J Womens Health","International journal of women's health","COVID-19 pandemic; anxiety; depression; obsessive-compulsive disorder; pregnancy-specific stress","Lobel","Marci","Department of Psychology, Stony Brook University, Stony Brook, New York, NY, 11794, USA",NA
"2370","34262355","10.2147/IJWH.S315467","Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in Italy.","In February 2020, Italy became the first European country to face the coronavirus disease 2019 (COVID-19) outbreak. The concerns of infection, financial worries, loss of freedom, and isolation during the ongoing pandemic can lead to negative psychological effects, including anxiety, depression, and obsessive-compulsive disorder. The main aim of our study was to evaluate the relationship between pandemic-related stress and pregnancy-specific stress and assess their role in the development of psyc","2021","07","16","Int J Womens Health","International journal of women's health","COVID-19 pandemic; anxiety; depression; obsessive-compulsive disorder; pregnancy-specific stress","Balestrieri","Matteo","Unit of Psychiatry, Department of Medicine (DAME), University of Udine, Udine, Italy",NA
"2371","34262332","10.2147/IJGM.S309021","Value-Added Roles of Medical Students During the COVID-19 Pandemic: Assessment of Medical Students' Perceptions and Willingness in Sri Lanka.","Since the coronavirus disease 2019 (COVID-19) pandemic is an opportune time to introduce the value-added roles of medical students, this study assessed medical students' perceptions and willingness to assist in COVID-19 health sector preparedness and response via value-added roles in Sri Lanka. A cross-sectional online survey was conducted among all medical students studying in six batches of the Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, in June 2020. A Google fo","2021","07","16","Int J Gen Med","International journal of general medicine","COVID-19; Sri Lanka; health sector response; medical students; value-added roles","Wickramasinghe","Nuwan Darshana","Department of Community Medicine, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, 50008, Sri Lanka",NA
"2372","34262332","10.2147/IJGM.S309021","Value-Added Roles of Medical Students During the COVID-19 Pandemic: Assessment of Medical Students' Perceptions and Willingness in Sri Lanka.","Since the coronavirus disease 2019 (COVID-19) pandemic is an opportune time to introduce the value-added roles of medical students, this study assessed medical students' perceptions and willingness to assist in COVID-19 health sector preparedness and response via value-added roles in Sri Lanka. A cross-sectional online survey was conducted among all medical students studying in six batches of the Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, in June 2020. A Google fo","2021","07","16","Int J Gen Med","International journal of general medicine","COVID-19; Sri Lanka; health sector response; medical students; value-added roles","Jayarathne","Shamalee Wasana","Medical Education Unit, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, 50008, Sri Lanka",NA
"2373","34262332","10.2147/IJGM.S309021","Value-Added Roles of Medical Students During the COVID-19 Pandemic: Assessment of Medical Students' Perceptions and Willingness in Sri Lanka.","Since the coronavirus disease 2019 (COVID-19) pandemic is an opportune time to introduce the value-added roles of medical students, this study assessed medical students' perceptions and willingness to assist in COVID-19 health sector preparedness and response via value-added roles in Sri Lanka. A cross-sectional online survey was conducted among all medical students studying in six batches of the Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, in June 2020. A Google fo","2021","07","16","Int J Gen Med","International journal of general medicine","COVID-19; Sri Lanka; health sector response; medical students; value-added roles","Pilapitiya","Senaka Devendra","Department of Medicine, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, 50008, Sri Lanka",NA
"2374","34262324","10.2147/JIR.S306849","N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence.","The looming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a long-lasting pandemic of coronavirus disease 2019 (COVID-19) around the globe with substantial morbidity and mortality. N-acetylcysteine, being a nutraceutical precursor of an important antioxidant glutathione, can perform several biological functions in mammals and microbes. It has consequently garnered a growing interest as a potential adjunctive therapy for coronavirus disease. Here, we review evidence conce","2021","07","16","J Inflamm Res","Journal of inflammation research","N-acetylcysteine; SARS-CoV-2; COVID-19; T lymphocytes; anti-inflammatory response; antioxidant; antiviral effect; clinical translation; coronavirus; engineering nanoparticles; glutathione; immune modulating activity; repurposing approved drugs; respiratory viral diseases; virus infected cells","Wong","Kon Ken","Department of Microbiology and Immunology, Hospital Canselor Tuanku Muhriz UKM, Cheras, Kuala Lumpur, Malaysia",NA
"2375","34262324","10.2147/JIR.S306849","N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence.","The looming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a long-lasting pandemic of coronavirus disease 2019 (COVID-19) around the globe with substantial morbidity and mortality. N-acetylcysteine, being a nutraceutical precursor of an important antioxidant glutathione, can perform several biological functions in mammals and microbes. It has consequently garnered a growing interest as a potential adjunctive therapy for coronavirus disease. Here, we review evidence conce","2021","07","16","J Inflamm Res","Journal of inflammation research","N-acetylcysteine; SARS-CoV-2; COVID-19; T lymphocytes; anti-inflammatory response; antioxidant; antiviral effect; clinical translation; coronavirus; engineering nanoparticles; glutathione; immune modulating activity; repurposing approved drugs; respiratory viral diseases; virus infected cells","Lee","Shaun Wen Huey","School of Pharmacy, Monash University, Bandar Sunway, Selangor, Malaysia",NA
"2376","34262324","10.2147/JIR.S306849","N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence.","The looming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a long-lasting pandemic of coronavirus disease 2019 (COVID-19) around the globe with substantial morbidity and mortality. N-acetylcysteine, being a nutraceutical precursor of an important antioxidant glutathione, can perform several biological functions in mammals and microbes. It has consequently garnered a growing interest as a potential adjunctive therapy for coronavirus disease. Here, we review evidence conce","2021","07","16","J Inflamm Res","Journal of inflammation research","N-acetylcysteine; SARS-CoV-2; COVID-19; T lymphocytes; anti-inflammatory response; antioxidant; antiviral effect; clinical translation; coronavirus; engineering nanoparticles; glutathione; immune modulating activity; repurposing approved drugs; respiratory viral diseases; virus infected cells","Kua","Kok Pim","Puchong Health Clinic, Petaling District Health Office, Ministry of Health Malaysia, Petaling, Selangor, Malaysia",NA
"2377","34262317","10.2147/DMSO.S285614","Assessment and Management of Diabetic Patients During the COVID-19 Pandemic.","COVID-19 has become a great challenge across the globe, particularly in developing and densely populated countries, such as India. COVID-19 is extremely infectious and is transmitted via respiratory droplets from infected persons. DM, hypertension, and cardiovascular disease are highly prevalent comorbidities associated with COVID-19. It has been observed that COVID-19 is associated with high blood-glucose levels, mainly in people with type 2 diabetes mellitus (T2DM). Several studies have shown ","2021","07","16","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; India; cardiovascular diseases; diabetes; hypertension","Verma","Amit K","Medical Biotechnology Lab, Department of Biotechnology, Jamia Millia Islamia, New Delhi, India",NA
"2378","34262317","10.2147/DMSO.S285614","Assessment and Management of Diabetic Patients During the COVID-19 Pandemic.","COVID-19 has become a great challenge across the globe, particularly in developing and densely populated countries, such as India. COVID-19 is extremely infectious and is transmitted via respiratory droplets from infected persons. DM, hypertension, and cardiovascular disease are highly prevalent comorbidities associated with COVID-19. It has been observed that COVID-19 is associated with high blood-glucose levels, mainly in people with type 2 diabetes mellitus (T2DM). Several studies have shown ","2021","07","16","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; India; cardiovascular diseases; diabetes; hypertension","Beg","Mirza Masroor Ali","Department of Biochemistry, Maulana Azad Medical College, New Delhi, India",NA
"2379","34262317","10.2147/DMSO.S285614","Assessment and Management of Diabetic Patients During the COVID-19 Pandemic.","COVID-19 has become a great challenge across the globe, particularly in developing and densely populated countries, such as India. COVID-19 is extremely infectious and is transmitted via respiratory droplets from infected persons. DM, hypertension, and cardiovascular disease are highly prevalent comorbidities associated with COVID-19. It has been observed that COVID-19 is associated with high blood-glucose levels, mainly in people with type 2 diabetes mellitus (T2DM). Several studies have shown ","2021","07","16","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; India; cardiovascular diseases; diabetes; hypertension","Bhatt","Deepti","Medical Biotechnology Lab, Department of Biotechnology, Jamia Millia Islamia, New Delhi, India",NA
"2380","34262317","10.2147/DMSO.S285614","Assessment and Management of Diabetic Patients During the COVID-19 Pandemic.","COVID-19 has become a great challenge across the globe, particularly in developing and densely populated countries, such as India. COVID-19 is extremely infectious and is transmitted via respiratory droplets from infected persons. DM, hypertension, and cardiovascular disease are highly prevalent comorbidities associated with COVID-19. It has been observed that COVID-19 is associated with high blood-glucose levels, mainly in people with type 2 diabetes mellitus (T2DM). Several studies have shown ","2021","07","16","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; India; cardiovascular diseases; diabetes; hypertension","Dev","Kapil","Medical Biotechnology Lab, Department of Biotechnology, Jamia Millia Islamia, New Delhi, India",NA
"2381","34262317","10.2147/DMSO.S285614","Assessment and Management of Diabetic Patients During the COVID-19 Pandemic.","COVID-19 has become a great challenge across the globe, particularly in developing and densely populated countries, such as India. COVID-19 is extremely infectious and is transmitted via respiratory droplets from infected persons. DM, hypertension, and cardiovascular disease are highly prevalent comorbidities associated with COVID-19. It has been observed that COVID-19 is associated with high blood-glucose levels, mainly in people with type 2 diabetes mellitus (T2DM). Several studies have shown ","2021","07","16","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; India; cardiovascular diseases; diabetes; hypertension","Alsahli","Mohammed A","Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia",NA
"2382","34262317","10.2147/DMSO.S285614","Assessment and Management of Diabetic Patients During the COVID-19 Pandemic.","COVID-19 has become a great challenge across the globe, particularly in developing and densely populated countries, such as India. COVID-19 is extremely infectious and is transmitted via respiratory droplets from infected persons. DM, hypertension, and cardiovascular disease are highly prevalent comorbidities associated with COVID-19. It has been observed that COVID-19 is associated with high blood-glucose levels, mainly in people with type 2 diabetes mellitus (T2DM). Several studies have shown ","2021","07","16","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; India; cardiovascular diseases; diabetes; hypertension","Rahmani","Arshad Husain","Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia",NA
"2383","34262317","10.2147/DMSO.S285614","Assessment and Management of Diabetic Patients During the COVID-19 Pandemic.","COVID-19 has become a great challenge across the globe, particularly in developing and densely populated countries, such as India. COVID-19 is extremely infectious and is transmitted via respiratory droplets from infected persons. DM, hypertension, and cardiovascular disease are highly prevalent comorbidities associated with COVID-19. It has been observed that COVID-19 is associated with high blood-glucose levels, mainly in people with type 2 diabetes mellitus (T2DM). Several studies have shown ","2021","07","16","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; India; cardiovascular diseases; diabetes; hypertension","Goyal","Yamini","Medical Biotechnology Lab, Department of Biotechnology, Jamia Millia Islamia, New Delhi, India",NA
"2384","34262311","10.2147/DMSO.S287121","An Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review.","Gestational diabetes mellitus (GDM) is a frequent medical complication during pregnancy. Screening and diagnostic practices for GDM are inconsistent across the world. This narrative review includes data from 87 observational studies and randomized controlled trials (RCTs), and aims to give an overview of the current evidence on screening strategies and diagnostic criteria for GDM. Screening in early pregnancy remains controversial and studies show conflicting results on the benefit of screening ","2021","07","16","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","diabetes; gestational diabetes mellitus; pregnancy; screening","Minschart","Caro","Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, 3000, Belgium",NA
"2385","34262311","10.2147/DMSO.S287121","An Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review.","Gestational diabetes mellitus (GDM) is a frequent medical complication during pregnancy. Screening and diagnostic practices for GDM are inconsistent across the world. This narrative review includes data from 87 observational studies and randomized controlled trials (RCTs), and aims to give an overview of the current evidence on screening strategies and diagnostic criteria for GDM. Screening in early pregnancy remains controversial and studies show conflicting results on the benefit of screening ","2021","07","16","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","diabetes; gestational diabetes mellitus; pregnancy; screening","Beunen","Kaat","Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, 3000, Belgium",NA
"2386","34262311","10.2147/DMSO.S287121","An Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review.","Gestational diabetes mellitus (GDM) is a frequent medical complication during pregnancy. Screening and diagnostic practices for GDM are inconsistent across the world. This narrative review includes data from 87 observational studies and randomized controlled trials (RCTs), and aims to give an overview of the current evidence on screening strategies and diagnostic criteria for GDM. Screening in early pregnancy remains controversial and studies show conflicting results on the benefit of screening ","2021","07","16","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","diabetes; gestational diabetes mellitus; pregnancy; screening","Benhalima","Katrien","Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, 3000, Belgium",NA
"2387","34262301","10.2147/IDR.S326875","Erratum: Awareness and Attitude Towards COVID-19 Vaccination and Associated Factors in Ethiopia: Cross-Sectional Study [Corrigendum].","[This corrects the article DOI: 10.2147/IDR.S316461.].","2021","07","15","Infect Drug Resist","Infection and drug resistance",NA,NA,NA,NA,NA
"2388","34262277","10.2147/NDT.S315370","One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia.","The COVID-19 crisis has already resulted in an economic and labor market shock and a rise of informal work sectors. Being an informal job, traditional coffee vending can predispose women to a myriad of mental disorders. Therefore, this study was aimed to assess depressive symptoms during the COVID-19 pandemic and associated factors among street traditional coffee vendors in Harar town, Eastern Ethiopia. A cross-sectional study was employed on 180 women engaged in street traditional coffee vendin","2021","07","16","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","coronavirus; depression; street; traditional coffee vending","Sisay","Mekonnen","Department of Pharmacology and Toxicology, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"2389","34262277","10.2147/NDT.S315370","One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia.","The COVID-19 crisis has already resulted in an economic and labor market shock and a rise of informal work sectors. Being an informal job, traditional coffee vending can predispose women to a myriad of mental disorders. Therefore, this study was aimed to assess depressive symptoms during the COVID-19 pandemic and associated factors among street traditional coffee vendors in Harar town, Eastern Ethiopia. A cross-sectional study was employed on 180 women engaged in street traditional coffee vendin","2021","07","16","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","coronavirus; depression; street; traditional coffee vending","Gashaw","Tigist","Department of Pharmacology and Toxicology, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"2390","34262277","10.2147/NDT.S315370","One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia.","The COVID-19 crisis has already resulted in an economic and labor market shock and a rise of informal work sectors. Being an informal job, traditional coffee vending can predispose women to a myriad of mental disorders. Therefore, this study was aimed to assess depressive symptoms during the COVID-19 pandemic and associated factors among street traditional coffee vendors in Harar town, Eastern Ethiopia. A cross-sectional study was employed on 180 women engaged in street traditional coffee vendin","2021","07","16","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","coronavirus; depression; street; traditional coffee vending","Degefu","Natanim","Department of Pharmaceutics, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"2391","34262277","10.2147/NDT.S315370","One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia.","The COVID-19 crisis has already resulted in an economic and labor market shock and a rise of informal work sectors. Being an informal job, traditional coffee vending can predispose women to a myriad of mental disorders. Therefore, this study was aimed to assess depressive symptoms during the COVID-19 pandemic and associated factors among street traditional coffee vendors in Harar town, Eastern Ethiopia. A cross-sectional study was employed on 180 women engaged in street traditional coffee vendin","2021","07","16","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","coronavirus; depression; street; traditional coffee vending","Hagos","Bisrat","Department of Social Pharmacy, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"2392","34262277","10.2147/NDT.S315370","One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia.","The COVID-19 crisis has already resulted in an economic and labor market shock and a rise of informal work sectors. Being an informal job, traditional coffee vending can predispose women to a myriad of mental disorders. Therefore, this study was aimed to assess depressive symptoms during the COVID-19 pandemic and associated factors among street traditional coffee vendors in Harar town, Eastern Ethiopia. A cross-sectional study was employed on 180 women engaged in street traditional coffee vendin","2021","07","16","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","coronavirus; depression; street; traditional coffee vending","Alemu","Addisu","Department of Public Health and Health Policy, School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"2393","34262277","10.2147/NDT.S315370","One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia.","The COVID-19 crisis has already resulted in an economic and labor market shock and a rise of informal work sectors. Being an informal job, traditional coffee vending can predispose women to a myriad of mental disorders. Therefore, this study was aimed to assess depressive symptoms during the COVID-19 pandemic and associated factors among street traditional coffee vendors in Harar town, Eastern Ethiopia. A cross-sectional study was employed on 180 women engaged in street traditional coffee vendin","2021","07","16","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","coronavirus; depression; street; traditional coffee vending","Teshome","Zenebu","East Harerge Zone Administration Office, Harar, Ethiopia",NA
"2394","34262277","10.2147/NDT.S315370","One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia.","The COVID-19 crisis has already resulted in an economic and labor market shock and a rise of informal work sectors. Being an informal job, traditional coffee vending can predispose women to a myriad of mental disorders. Therefore, this study was aimed to assess depressive symptoms during the COVID-19 pandemic and associated factors among street traditional coffee vendors in Harar town, Eastern Ethiopia. A cross-sectional study was employed on 180 women engaged in street traditional coffee vendin","2021","07","16","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","coronavirus; depression; street; traditional coffee vending","Admas","Mekonnen","HIV/AIDS Unit, Gender, HIV/AIDS and Special Need Affair Directorate, Haramaya University, Harar, Ethiopia",NA
"2395","34262277","10.2147/NDT.S315370","One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia.","The COVID-19 crisis has already resulted in an economic and labor market shock and a rise of informal work sectors. Being an informal job, traditional coffee vending can predispose women to a myriad of mental disorders. Therefore, this study was aimed to assess depressive symptoms during the COVID-19 pandemic and associated factors among street traditional coffee vendors in Harar town, Eastern Ethiopia. A cross-sectional study was employed on 180 women engaged in street traditional coffee vendin","2021","07","16","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","coronavirus; depression; street; traditional coffee vending","Kibret","Haregeweyn","Department of Nursing, School of Nursing and Midwifery, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"2396","34262277","10.2147/NDT.S315370","One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia.","The COVID-19 crisis has already resulted in an economic and labor market shock and a rise of informal work sectors. Being an informal job, traditional coffee vending can predispose women to a myriad of mental disorders. Therefore, this study was aimed to assess depressive symptoms during the COVID-19 pandemic and associated factors among street traditional coffee vendors in Harar town, Eastern Ethiopia. A cross-sectional study was employed on 180 women engaged in street traditional coffee vendin","2021","07","16","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","coronavirus; depression; street; traditional coffee vending","Dessie","Yadeta","Department of Public Health and Health Policy, School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"2397","34262194","10.1038/d41586-021-01917-9","This 'super antibody' for COVID fights off multiple coronaviruses.",NA,"2021","07","16","Nature","Nature","Immunology; Infection; SARS-CoV-2; Virology","Kwon","Diana",NA,NA
"2398","34262190","10.1038/d41586-021-01935-7","Long COVID and kids: scientists race to find answers.",NA,"2021","07","22","Nature","Nature","Epidemiology; Infection; SARS-CoV-2","Lewis","Dyani",NA,NA
"2399","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Barros-Martins","Joana","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2400","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Hammerschmidt","Swantje I","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2401","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Cossmann","Anne","Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany",NA
"2402","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Odak","Ivan","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2403","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Stankov","Metodi V","Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany",NA
"2404","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Morillas Ramos","Gema","Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany",NA
"2405","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Dopfer-Jablonka","Alexandra","Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany",NA
"2406","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Heidemann","Annika","Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany",NA
"2407","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Ritter","Christiane","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2408","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Friedrichsen","Michaela","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2409","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Schultze-Florey","Christian","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2410","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Ravens","Inga","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2411","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Willenzon","Stefanie","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2412","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Bubke","Anja","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2413","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Ristenpart","Jasmin","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2414","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Janssen","Anika","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2415","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Ssebyatika","George","Institute of Biochemistry, University of Lübeck, Lübeck, Germany",NA
"2416","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Bernhardt","Günter","Institute of Immunology, Hannover Medical School, Hannover, Germany",NA
"2417","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Münch","Jan","Ulm University Medical Center, Institute of Molecular Virology, Ulm, Germany",NA
"2418","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Hoffmann","Markus","Infection Biology Unit, German Primate Center, Göttingen, Germany",NA
"2419","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Pöhlmann","Stefan","Infection Biology Unit, German Primate Center, Göttingen, Germany",NA
"2420","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Krey","Thomas","Institute of Biochemistry, University of Lübeck, Lübeck, Germany",NA
"2421","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Bonjak","Berislav","Institute of Immunology, Hannover Medical School, Hannover, Germany. bosnjak.berislav@mh-hannover",NA
"2422","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Förster","Reinhold","Institute of Immunology, Hannover Medical School, Hannover, Germany. foerster.reinhold@mh-hannover",NA
"2423","34262158","10.1038/s41591-021-01449-9","Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.","Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After reports of thromboembolic events, several European governments recommended using AstraZeneca's ChAdOx1-nCov-19 (ChAd) only in individuals older than 60 years, leaving millions of already ChAd-primed individuals with the decision to receive either a second shot of ChAd or a heterologous boost with mRNA-based vaccines. However, ","2021","07","24","Nat Med","Nature medicine",NA,"Behrens","Georg M N","Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany. behrens.georg@mh-hannover",NA
"2424","34262117","10.1038/s41746-021-00481-w","Clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health.","The coronavirus disease 2019 (COVID-19) is heterogeneous and our understanding of the biological mechanisms of host response to the viral infection remains limited. Identification of meaningful clinical subphenotypes may benefit pathophysiological study, clinical practice, and clinical trials. Here, our aim was to derive and validate COVID-19 subphenotypes using machine learning and routinely collected clinical data, assess temporal patterns of these subphenotypes during the pandemic course, and","2021","07","24","NPJ Digit Med","NPJ digital medicine",NA,"Su","Chang","Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA",NA
"2425","34262117","10.1038/s41746-021-00481-w","Clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health.","The coronavirus disease 2019 (COVID-19) is heterogeneous and our understanding of the biological mechanisms of host response to the viral infection remains limited. Identification of meaningful clinical subphenotypes may benefit pathophysiological study, clinical practice, and clinical trials. Here, our aim was to derive and validate COVID-19 subphenotypes using machine learning and routinely collected clinical data, assess temporal patterns of these subphenotypes during the pandemic course, and","2021","07","24","NPJ Digit Med","NPJ digital medicine",NA,"Zhang","Yongkang","Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA",NA
"2426","34262117","10.1038/s41746-021-00481-w","Clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health.","The coronavirus disease 2019 (COVID-19) is heterogeneous and our understanding of the biological mechanisms of host response to the viral infection remains limited. Identification of meaningful clinical subphenotypes may benefit pathophysiological study, clinical practice, and clinical trials. Here, our aim was to derive and validate COVID-19 subphenotypes using machine learning and routinely collected clinical data, assess temporal patterns of these subphenotypes during the pandemic course, and","2021","07","24","NPJ Digit Med","NPJ digital medicine",NA,"Flory","James H","Memorial Sloan-Kettering Cancer Center, New York, NY, USA",NA
"2427","34262117","10.1038/s41746-021-00481-w","Clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health.","The coronavirus disease 2019 (COVID-19) is heterogeneous and our understanding of the biological mechanisms of host response to the viral infection remains limited. Identification of meaningful clinical subphenotypes may benefit pathophysiological study, clinical practice, and clinical trials. Here, our aim was to derive and validate COVID-19 subphenotypes using machine learning and routinely collected clinical data, assess temporal patterns of these subphenotypes during the pandemic course, and","2021","07","24","NPJ Digit Med","NPJ digital medicine",NA,"Weiner","Mark G","Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA",NA
"2428","34262117","10.1038/s41746-021-00481-w","Clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health.","The coronavirus disease 2019 (COVID-19) is heterogeneous and our understanding of the biological mechanisms of host response to the viral infection remains limited. Identification of meaningful clinical subphenotypes may benefit pathophysiological study, clinical practice, and clinical trials. Here, our aim was to derive and validate COVID-19 subphenotypes using machine learning and routinely collected clinical data, assess temporal patterns of these subphenotypes during the pandemic course, and","2021","07","24","NPJ Digit Med","NPJ digital medicine",NA,"Kaushal","Rainu","Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. rak2007@med.cornell","rak2007@med.cornell.edu"
"2429","34262117","10.1038/s41746-021-00481-w","Clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health.","The coronavirus disease 2019 (COVID-19) is heterogeneous and our understanding of the biological mechanisms of host response to the viral infection remains limited. Identification of meaningful clinical subphenotypes may benefit pathophysiological study, clinical practice, and clinical trials. Here, our aim was to derive and validate COVID-19 subphenotypes using machine learning and routinely collected clinical data, assess temporal patterns of these subphenotypes during the pandemic course, and","2021","07","24","NPJ Digit Med","NPJ digital medicine",NA,"Schenck","Edward J","New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA. ejs9005@med.cornell","ejs9005@med.cornell.edu"
"2430","34262117","10.1038/s41746-021-00481-w","Clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health.","The coronavirus disease 2019 (COVID-19) is heterogeneous and our understanding of the biological mechanisms of host response to the viral infection remains limited. Identification of meaningful clinical subphenotypes may benefit pathophysiological study, clinical practice, and clinical trials. Here, our aim was to derive and validate COVID-19 subphenotypes using machine learning and routinely collected clinical data, assess temporal patterns of these subphenotypes during the pandemic course, and","2021","07","24","NPJ Digit Med","NPJ digital medicine",NA,"Wang","Fei","Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. few2001@med.cornell","few2001@med.cornell.edu"
"2431","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Velavan","Thirumalaisamy P","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany. velavan@medizin.uni-tuebingen","velavan@medizin.uni"
"2432","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Kuk","Salih","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2433","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Linh","Le Thi Kieu","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2434","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Lamsfus Calle","Carlos","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2435","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Lalremruata","Albert","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2436","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Pallerla","Srinivas Reddy","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2437","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Kreidenweiss","Andrea","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2438","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Held","Jana","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2439","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Esen","Meral","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2440","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Gabor","Julian","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2441","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Neurohr","Eva Maria","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2442","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Shamsrizi","Parichehr","Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany",NA
"2443","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Fathi","Anahita","German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Brunswick, Germany",NA
"2444","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Biecker","Erwin","Zollernalb Hospital Balingen, Tübinger Straße 30, 72336, Balingen, Germany",NA
"2445","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Berg","Christoph P","Department of Internal Medicine I, University of Tübingen, Tübingen, Germany",NA
"2446","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Ramharter","Michael","Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany",NA
"2447","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Addo","Marylyn Martina","German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Brunswick, Germany",NA
"2448","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Kreuels","Benno","Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany",NA
"2449","34262116","10.1038/s41598-021-93950-x","Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.","Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all","2021","07","18","Sci Rep","Scientific reports",NA,"Kremsner","Peter G","Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany",NA
"2450","34262082","10.1038/s41598-021-93650-6","Aerosol microphysics and chemistry reveal the COVID19 lockdown impact on urban air quality.","Air quality in urban areas and megacities is dependent on emissions, physicochemical process and atmospheric conditions in a complex manner. The impact on air quality metrics of the COVID-19 lockdown measures was evaluated during two periods in Athens, Greece. The first period involved stoppage of educational and recreational activities and the second severe restrictions to all but necessary transport and workplace activities. Fresh traffic emissions and their aerosol products in terms of ultraf","2021","07","18","Sci Rep","Scientific reports",NA,"Eleftheriadis","Konstantinos","Environmental Research Laboratory, INRASTES, NCSR Demokritos, 15310 Ag. Paraskevi, Athens, Greece. elefther@ipta.demokritos","elefther@ipta.demokritos.gr"
"2451","34262082","10.1038/s41598-021-93650-6","Aerosol microphysics and chemistry reveal the COVID19 lockdown impact on urban air quality.","Air quality in urban areas and megacities is dependent on emissions, physicochemical process and atmospheric conditions in a complex manner. The impact on air quality metrics of the COVID-19 lockdown measures was evaluated during two periods in Athens, Greece. The first period involved stoppage of educational and recreational activities and the second severe restrictions to all but necessary transport and workplace activities. Fresh traffic emissions and their aerosol products in terms of ultraf","2021","07","18","Sci Rep","Scientific reports",NA,"Gini","Maria I","Environmental Research Laboratory, INRASTES, NCSR Demokritos, 15310 Ag. Paraskevi, Athens, Greece",NA
"2452","34262082","10.1038/s41598-021-93650-6","Aerosol microphysics and chemistry reveal the COVID19 lockdown impact on urban air quality.","Air quality in urban areas and megacities is dependent on emissions, physicochemical process and atmospheric conditions in a complex manner. The impact on air quality metrics of the COVID-19 lockdown measures was evaluated during two periods in Athens, Greece. The first period involved stoppage of educational and recreational activities and the second severe restrictions to all but necessary transport and workplace activities. Fresh traffic emissions and their aerosol products in terms of ultraf","2021","07","18","Sci Rep","Scientific reports",NA,"Diapouli","Evangelia","Environmental Research Laboratory, INRASTES, NCSR Demokritos, 15310 Ag. Paraskevi, Athens, Greece",NA
"2453","34262082","10.1038/s41598-021-93650-6","Aerosol microphysics and chemistry reveal the COVID19 lockdown impact on urban air quality.","Air quality in urban areas and megacities is dependent on emissions, physicochemical process and atmospheric conditions in a complex manner. The impact on air quality metrics of the COVID-19 lockdown measures was evaluated during two periods in Athens, Greece. The first period involved stoppage of educational and recreational activities and the second severe restrictions to all but necessary transport and workplace activities. Fresh traffic emissions and their aerosol products in terms of ultraf","2021","07","18","Sci Rep","Scientific reports",NA,"Vratolis","Stergios","Environmental Research Laboratory, INRASTES, NCSR Demokritos, 15310 Ag. Paraskevi, Athens, Greece",NA
"2454","34262082","10.1038/s41598-021-93650-6","Aerosol microphysics and chemistry reveal the COVID19 lockdown impact on urban air quality.","Air quality in urban areas and megacities is dependent on emissions, physicochemical process and atmospheric conditions in a complex manner. The impact on air quality metrics of the COVID-19 lockdown measures was evaluated during two periods in Athens, Greece. The first period involved stoppage of educational and recreational activities and the second severe restrictions to all but necessary transport and workplace activities. Fresh traffic emissions and their aerosol products in terms of ultraf","2021","07","18","Sci Rep","Scientific reports",NA,"Vasilatou","Vasiliki","Environmental Research Laboratory, INRASTES, NCSR Demokritos, 15310 Ag. Paraskevi, Athens, Greece",NA
"2455","34262082","10.1038/s41598-021-93650-6","Aerosol microphysics and chemistry reveal the COVID19 lockdown impact on urban air quality.","Air quality in urban areas and megacities is dependent on emissions, physicochemical process and atmospheric conditions in a complex manner. The impact on air quality metrics of the COVID-19 lockdown measures was evaluated during two periods in Athens, Greece. The first period involved stoppage of educational and recreational activities and the second severe restrictions to all but necessary transport and workplace activities. Fresh traffic emissions and their aerosol products in terms of ultraf","2021","07","18","Sci Rep","Scientific reports",NA,"Fetfatzis","Prodromos","Environmental Research Laboratory, INRASTES, NCSR Demokritos, 15310 Ag. Paraskevi, Athens, Greece",NA
"2456","34262082","10.1038/s41598-021-93650-6","Aerosol microphysics and chemistry reveal the COVID19 lockdown impact on urban air quality.","Air quality in urban areas and megacities is dependent on emissions, physicochemical process and atmospheric conditions in a complex manner. The impact on air quality metrics of the COVID-19 lockdown measures was evaluated during two periods in Athens, Greece. The first period involved stoppage of educational and recreational activities and the second severe restrictions to all but necessary transport and workplace activities. Fresh traffic emissions and their aerosol products in terms of ultraf","2021","07","18","Sci Rep","Scientific reports",NA,"Manousakas","Manousos I","Environmental Research Laboratory, INRASTES, NCSR Demokritos, 15310 Ag. Paraskevi, Athens, Greece",NA
"2457","34262075","10.1038/s41598-021-93709-4","Social cognition in individuals born preterm.","Faces hold a substantial value for effective social interactions and sharing. Covering faces with masks, due to COVID-19 regulations, may lead to difficulties in using social signals, in particular, in individuals with neurodevelopmental conditions. Daily-life social participation of individuals who were born preterm is of immense importance for their quality of life. Here we examined face tuning in individuals (aged 12.79 ± 1.89 years) who were born preterm and exhibited signs of periventricula","2021","07","18","Sci Rep","Scientific reports",NA,"Pavlova","Marina A","Department of Psychiatry and Psychotherapy Tübingen Center for Mental Health (TüCMH), Medical School and University Hospital, Eberhard Karls University of Tübingen, Calwerstr. 14, 72076, Tübingen, Germany. marina.pavlova@uni-tuebingen",NA
"2458","34262075","10.1038/s41598-021-93709-4","Social cognition in individuals born preterm.","Faces hold a substantial value for effective social interactions and sharing. Covering faces with masks, due to COVID-19 regulations, may lead to difficulties in using social signals, in particular, in individuals with neurodevelopmental conditions. Daily-life social participation of individuals who were born preterm is of immense importance for their quality of life. Here we examined face tuning in individuals (aged 12.79 ± 1.89 years) who were born preterm and exhibited signs of periventricula","2021","07","18","Sci Rep","Scientific reports",NA,"Galli","Jessica","Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2459","34262075","10.1038/s41598-021-93709-4","Social cognition in individuals born preterm.","Faces hold a substantial value for effective social interactions and sharing. Covering faces with masks, due to COVID-19 regulations, may lead to difficulties in using social signals, in particular, in individuals with neurodevelopmental conditions. Daily-life social participation of individuals who were born preterm is of immense importance for their quality of life. Here we examined face tuning in individuals (aged 12.79 ± 1.89 years) who were born preterm and exhibited signs of periventricula","2021","07","18","Sci Rep","Scientific reports",NA,"Zanetti","Federica","Department of Psychiatry and Psychotherapy Tübingen Center for Mental Health (TüCMH), Medical School and University Hospital, Eberhard Karls University of Tübingen, Calwerstr. 14, 72076, Tübingen, Germany",NA
"2460","34262075","10.1038/s41598-021-93709-4","Social cognition in individuals born preterm.","Faces hold a substantial value for effective social interactions and sharing. Covering faces with masks, due to COVID-19 regulations, may lead to difficulties in using social signals, in particular, in individuals with neurodevelopmental conditions. Daily-life social participation of individuals who were born preterm is of immense importance for their quality of life. Here we examined face tuning in individuals (aged 12.79 ± 1.89 years) who were born preterm and exhibited signs of periventricula","2021","07","18","Sci Rep","Scientific reports",NA,"Pagani","Federica","Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2461","34262075","10.1038/s41598-021-93709-4","Social cognition in individuals born preterm.","Faces hold a substantial value for effective social interactions and sharing. Covering faces with masks, due to COVID-19 regulations, may lead to difficulties in using social signals, in particular, in individuals with neurodevelopmental conditions. Daily-life social participation of individuals who were born preterm is of immense importance for their quality of life. Here we examined face tuning in individuals (aged 12.79 ± 1.89 years) who were born preterm and exhibited signs of periventricula","2021","07","18","Sci Rep","Scientific reports",NA,"Micheletti","Serena","Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2462","34262075","10.1038/s41598-021-93709-4","Social cognition in individuals born preterm.","Faces hold a substantial value for effective social interactions and sharing. Covering faces with masks, due to COVID-19 regulations, may lead to difficulties in using social signals, in particular, in individuals with neurodevelopmental conditions. Daily-life social participation of individuals who were born preterm is of immense importance for their quality of life. Here we examined face tuning in individuals (aged 12.79 ± 1.89 years) who were born preterm and exhibited signs of periventricula","2021","07","18","Sci Rep","Scientific reports",NA,"Rossi","Andrea","Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2463","34262075","10.1038/s41598-021-93709-4","Social cognition in individuals born preterm.","Faces hold a substantial value for effective social interactions and sharing. Covering faces with masks, due to COVID-19 regulations, may lead to difficulties in using social signals, in particular, in individuals with neurodevelopmental conditions. Daily-life social participation of individuals who were born preterm is of immense importance for their quality of life. Here we examined face tuning in individuals (aged 12.79 ± 1.89 years) who were born preterm and exhibited signs of periventricula","2021","07","18","Sci Rep","Scientific reports",NA,"Sokolov","Alexander N","Department of Psychiatry and Psychotherapy Tübingen Center for Mental Health (TüCMH), Medical School and University Hospital, Eberhard Karls University of Tübingen, Calwerstr. 14, 72076, Tübingen, Germany",NA
"2464","34262075","10.1038/s41598-021-93709-4","Social cognition in individuals born preterm.","Faces hold a substantial value for effective social interactions and sharing. Covering faces with masks, due to COVID-19 regulations, may lead to difficulties in using social signals, in particular, in individuals with neurodevelopmental conditions. Daily-life social participation of individuals who were born preterm is of immense importance for their quality of life. Here we examined face tuning in individuals (aged 12.79 ± 1.89 years) who were born preterm and exhibited signs of periventricula","2021","07","18","Sci Rep","Scientific reports",NA,"Fallgatter","Andreas J","Department of Psychiatry and Psychotherapy Tübingen Center for Mental Health (TüCMH), Medical School and University Hospital, Eberhard Karls University of Tübingen, Calwerstr. 14, 72076, Tübingen, Germany",NA
"2465","34262075","10.1038/s41598-021-93709-4","Social cognition in individuals born preterm.","Faces hold a substantial value for effective social interactions and sharing. Covering faces with masks, due to COVID-19 regulations, may lead to difficulties in using social signals, in particular, in individuals with neurodevelopmental conditions. Daily-life social participation of individuals who were born preterm is of immense importance for their quality of life. Here we examined face tuning in individuals (aged 12.79 ± 1.89 years) who were born preterm and exhibited signs of periventricula","2021","07","18","Sci Rep","Scientific reports",NA,"Fazzi","Elisa M","Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2466","34262069","10.1038/s41598-021-93579-w","Theoretical investigation of pre-symptomatic SARS-CoV-2 person-to-person transmission in households.","Since its emergence, the phenomenon of SARS-CoV-2 transmission by seemingly healthy individuals has become a major challenge in the effort to achieve control of the pandemic. Identifying the modes of transmission that drive this phenomenon is a perquisite in devising effective control measures, but to date it is still under debate. To address this problem, we have formulated a detailed mathematical model of discrete human actions (such as coughs, sneezes, and touching) and the continuous decay o","2021","07","18","Sci Rep","Scientific reports",NA,"Arav","Yehuda","Department of Applied Mathematics, Israel Institute for Biological Research, PO Box 19, 7410001, Ness-Ziona, Israel. yehudaa@iibr.gov","yehudaa@iibr.gov.il"
"2467","34262069","10.1038/s41598-021-93579-w","Theoretical investigation of pre-symptomatic SARS-CoV-2 person-to-person transmission in households.","Since its emergence, the phenomenon of SARS-CoV-2 transmission by seemingly healthy individuals has become a major challenge in the effort to achieve control of the pandemic. Identifying the modes of transmission that drive this phenomenon is a perquisite in devising effective control measures, but to date it is still under debate. To address this problem, we have formulated a detailed mathematical model of discrete human actions (such as coughs, sneezes, and touching) and the continuous decay o","2021","07","18","Sci Rep","Scientific reports",NA,"Klausner","Ziv","Department of Applied Mathematics, Israel Institute for Biological Research, PO Box 19, 7410001, Ness-Ziona, Israel",NA
"2468","34262069","10.1038/s41598-021-93579-w","Theoretical investigation of pre-symptomatic SARS-CoV-2 person-to-person transmission in households.","Since its emergence, the phenomenon of SARS-CoV-2 transmission by seemingly healthy individuals has become a major challenge in the effort to achieve control of the pandemic. Identifying the modes of transmission that drive this phenomenon is a perquisite in devising effective control measures, but to date it is still under debate. To address this problem, we have formulated a detailed mathematical model of discrete human actions (such as coughs, sneezes, and touching) and the continuous decay o","2021","07","18","Sci Rep","Scientific reports",NA,"Fattal","Eyal","Department of Applied Mathematics, Israel Institute for Biological Research, PO Box 19, 7410001, Ness-Ziona, Israel",NA
"2469","34262053","10.1038/s41467-021-24463-4","Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2.","The COVID-19 pandemic exposed difficulties in scaling current quantitative PCR (qPCR)-based diagnostic methodologies for large-scale infectious disease testing. Bottlenecks include lengthy multi-step processes for nucleic acid extraction followed by qPCR readouts, which require costly instrumentation and infrastructure, as well as reagent and plastic consumable shortages stemming from supply chain constraints. Here we report an Oil Immersed Lossless Total Analysis System (OIL-TAS), which integra","2021","07","22","Nat Commun","Nature communications","COVID-19; COVID-19 Nucleic Acid Testing; Equipment Design; Humans; Molecular Diagnostic Techniques; Nasopharynx; Nucleic Acid Amplification Techniques; RNA, Viral; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Time Factors; Virion","Juang","Duane S","Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA",NA
"2470","34262053","10.1038/s41467-021-24463-4","Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2.","The COVID-19 pandemic exposed difficulties in scaling current quantitative PCR (qPCR)-based diagnostic methodologies for large-scale infectious disease testing. Bottlenecks include lengthy multi-step processes for nucleic acid extraction followed by qPCR readouts, which require costly instrumentation and infrastructure, as well as reagent and plastic consumable shortages stemming from supply chain constraints. Here we report an Oil Immersed Lossless Total Analysis System (OIL-TAS), which integra","2021","07","22","Nat Commun","Nature communications","COVID-19; COVID-19 Nucleic Acid Testing; Equipment Design; Humans; Molecular Diagnostic Techniques; Nasopharynx; Nucleic Acid Amplification Techniques; RNA, Viral; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Time Factors; Virion","Juang","Terry D","Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA",NA
"2471","34262053","10.1038/s41467-021-24463-4","Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2.","The COVID-19 pandemic exposed difficulties in scaling current quantitative PCR (qPCR)-based diagnostic methodologies for large-scale infectious disease testing. Bottlenecks include lengthy multi-step processes for nucleic acid extraction followed by qPCR readouts, which require costly instrumentation and infrastructure, as well as reagent and plastic consumable shortages stemming from supply chain constraints. Here we report an Oil Immersed Lossless Total Analysis System (OIL-TAS), which integra","2021","07","22","Nat Commun","Nature communications","COVID-19; COVID-19 Nucleic Acid Testing; Equipment Design; Humans; Molecular Diagnostic Techniques; Nasopharynx; Nucleic Acid Amplification Techniques; RNA, Viral; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Time Factors; Virion","Dudley","Dawn M","Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA",NA
"2472","34262053","10.1038/s41467-021-24463-4","Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2.","The COVID-19 pandemic exposed difficulties in scaling current quantitative PCR (qPCR)-based diagnostic methodologies for large-scale infectious disease testing. Bottlenecks include lengthy multi-step processes for nucleic acid extraction followed by qPCR readouts, which require costly instrumentation and infrastructure, as well as reagent and plastic consumable shortages stemming from supply chain constraints. Here we report an Oil Immersed Lossless Total Analysis System (OIL-TAS), which integra","2021","07","22","Nat Commun","Nature communications","COVID-19; COVID-19 Nucleic Acid Testing; Equipment Design; Humans; Molecular Diagnostic Techniques; Nasopharynx; Nucleic Acid Amplification Techniques; RNA, Viral; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Time Factors; Virion","Newman","Christina M","Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA",NA
"2473","34262053","10.1038/s41467-021-24463-4","Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2.","The COVID-19 pandemic exposed difficulties in scaling current quantitative PCR (qPCR)-based diagnostic methodologies for large-scale infectious disease testing. Bottlenecks include lengthy multi-step processes for nucleic acid extraction followed by qPCR readouts, which require costly instrumentation and infrastructure, as well as reagent and plastic consumable shortages stemming from supply chain constraints. Here we report an Oil Immersed Lossless Total Analysis System (OIL-TAS), which integra","2021","07","22","Nat Commun","Nature communications","COVID-19; COVID-19 Nucleic Acid Testing; Equipment Design; Humans; Molecular Diagnostic Techniques; Nasopharynx; Nucleic Acid Amplification Techniques; RNA, Viral; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Time Factors; Virion","Accola","Molly A","UW Health Clinical Laboratories, University of Wisconsin Hospital and Clinics, Madison, WI, USA",NA
"2474","34262053","10.1038/s41467-021-24463-4","Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2.","The COVID-19 pandemic exposed difficulties in scaling current quantitative PCR (qPCR)-based diagnostic methodologies for large-scale infectious disease testing. Bottlenecks include lengthy multi-step processes for nucleic acid extraction followed by qPCR readouts, which require costly instrumentation and infrastructure, as well as reagent and plastic consumable shortages stemming from supply chain constraints. Here we report an Oil Immersed Lossless Total Analysis System (OIL-TAS), which integra","2021","07","22","Nat Commun","Nature communications","COVID-19; COVID-19 Nucleic Acid Testing; Equipment Design; Humans; Molecular Diagnostic Techniques; Nasopharynx; Nucleic Acid Amplification Techniques; RNA, Viral; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Time Factors; Virion","Rehrauer","William M","Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA",NA
"2475","34262053","10.1038/s41467-021-24463-4","Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2.","The COVID-19 pandemic exposed difficulties in scaling current quantitative PCR (qPCR)-based diagnostic methodologies for large-scale infectious disease testing. Bottlenecks include lengthy multi-step processes for nucleic acid extraction followed by qPCR readouts, which require costly instrumentation and infrastructure, as well as reagent and plastic consumable shortages stemming from supply chain constraints. Here we report an Oil Immersed Lossless Total Analysis System (OIL-TAS), which integra","2021","07","22","Nat Commun","Nature communications","COVID-19; COVID-19 Nucleic Acid Testing; Equipment Design; Humans; Molecular Diagnostic Techniques; Nasopharynx; Nucleic Acid Amplification Techniques; RNA, Viral; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Time Factors; Virion","Friedrich","Thomas C","Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA",NA
"2476","34262053","10.1038/s41467-021-24463-4","Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2.","The COVID-19 pandemic exposed difficulties in scaling current quantitative PCR (qPCR)-based diagnostic methodologies for large-scale infectious disease testing. Bottlenecks include lengthy multi-step processes for nucleic acid extraction followed by qPCR readouts, which require costly instrumentation and infrastructure, as well as reagent and plastic consumable shortages stemming from supply chain constraints. Here we report an Oil Immersed Lossless Total Analysis System (OIL-TAS), which integra","2021","07","22","Nat Commun","Nature communications","COVID-19; COVID-19 Nucleic Acid Testing; Equipment Design; Humans; Molecular Diagnostic Techniques; Nasopharynx; Nucleic Acid Amplification Techniques; RNA, Viral; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Time Factors; Virion","O'Connor","David H","Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA",NA
"2477","34262053","10.1038/s41467-021-24463-4","Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2.","The COVID-19 pandemic exposed difficulties in scaling current quantitative PCR (qPCR)-based diagnostic methodologies for large-scale infectious disease testing. Bottlenecks include lengthy multi-step processes for nucleic acid extraction followed by qPCR readouts, which require costly instrumentation and infrastructure, as well as reagent and plastic consumable shortages stemming from supply chain constraints. Here we report an Oil Immersed Lossless Total Analysis System (OIL-TAS), which integra","2021","07","22","Nat Commun","Nature communications","COVID-19; COVID-19 Nucleic Acid Testing; Equipment Design; Humans; Molecular Diagnostic Techniques; Nasopharynx; Nucleic Acid Amplification Techniques; RNA, Viral; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Time Factors; Virion","Beebe","David J","Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA. djbeebe@wisc","djbeebe@wisc.edu"
"2478","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Bui","Linh T","Translational Genomics Research Institute, Phoenix, AZ, USA",NA
"2479","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Winters","Nichelle I","Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"2480","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Chung","Mei-I","Translational Genomics Research Institute, Phoenix, AZ, USA",NA
"2481","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Joseph","Chitra","Respiratory Medicine NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK",NA
"2482","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Gutierrez","Austin J","Translational Genomics Research Institute, Phoenix, AZ, USA",NA
"2483","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Habermann","Arun C","Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"2484","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Adams","Taylor S","Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA",NA
"2485","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Schupp","Jonas C","Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA",NA
"2486","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Poli","Sergio","Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA",NA
"2487","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Peter","Lance M","Translational Genomics Research Institute, Phoenix, AZ, USA",NA
"2488","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Taylor","Chase J","Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"2489","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Blackburn","Jessica B","Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"2490","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Richmond","Bradley W","Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"2491","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Nicholson","Andrew G","National Heart and Lung Institute, Imperial College, London, UK",NA
"2492","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Rassl","Doris","Pathology Research, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK",NA
"2493","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Wallace","William A","Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, UK",NA
"2494","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Rosas","Ivan O","Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA",NA
"2495","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Jenkins","R Gisli","Respiratory Medicine NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK",NA
"2496","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Kaminski","Naftali","Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA",NA
"2497","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Kropski","Jonathan A","Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"2498","34262047","10.1038/s41467-021-24467-0","Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.","Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells expr","2021","07","22","Nat Commun","Nature communications","Alveolar Epithelial Cells; Angiotensin-Converting Enzyme 2; COVID-19; Chronic Disease; Humans; Idiopathic Pulmonary Fibrosis; Immunity, Innate; Inflammation; Lung; Lung Diseases; SARS-CoV-2; Transcriptome; Virus Internalization; Virus Replication","Banovich","Nicholas E","Translational Genomics Research Institute, Phoenix, AZ, USA. nbanovich@tgen","nbanovich@tgen.org"
"2499","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Vallet","Nicolas","Hematology Transplantation, APHP Hospital St Louis, Paris, France",NA
"2500","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Chevret","Sylvie","ECSTRRA Team, University of Paris, INSERM, UMR 1153 CRESS, Paris, France",NA
"2501","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Feghoul","Linda","Virology Department, APHP, Saint-Louis Hospital, Paris, France",NA
"2502","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Aguinaga","Lorea","Hemato-oncology Department, AP-HP, Saint-Louis Hospital, Paris, France",NA
"2503","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Bondeelle","Louise","Pneumology Department, APHP, Saint-Louis Hospital, Paris, France",NA
"2504","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Kaphan","Eleonore","Hematology Transplantation, APHP Hospital St Louis, Paris, France",NA
"2505","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Bertinchamp","Rémi","Department of Clinical Immunology, AP-HP, Saint-Louis Hospital, Paris, France",NA
"2506","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Soret","Juliette","Center of Clinical Investigation, APHP, Saint-Louis Hospital, Paris, France",NA
"2507","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Villesuzanne","Camille","Immunohematology Unit, APHP, Saint-Louis Hospital, Paris, France",NA
"2508","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","De Castro","Nathalie","Infectious Disease Department, APHP, Saint-Louis Hospital, Paris, France",NA
"2509","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Sebert","Marie","Hematology Senior, APHP, Saint-Louis Hospital, Paris, France",NA
"2510","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Boutboul","David","Department of Clinical Immunology, AP-HP, Saint-Louis Hospital, Paris, France",NA
"2511","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Lengline","Etienne","Hematology Adult, APHP, Saint-Louis Hospital, Paris, France",NA
"2512","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Tudesq","Jean-Jacques","Intensive Care Unit, APHP, Saint-Louis Hospital, Paris, France",NA
"2513","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Rabian","Florence","Hematology Adolescent and Young Adult Unit, APHP, Saint-Louis Hospital, Paris, France",NA
"2514","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Adès","Lionel","Hematology Senior, APHP, Saint-Louis Hospital, Paris, France",NA
"2515","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Xhaard","Alienor","Hematology Transplantation, APHP Hospital St Louis, Paris, France",NA
"2516","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Di Blasi","Roberta","Hemato-oncology Department, AP-HP, Saint-Louis Hospital, Paris, France",NA
"2517","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Raffoux","Emmanuel","Hematology Adult, APHP, Saint-Louis Hospital, Paris, France",NA
"2518","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Galicier","Lionel","Department of Clinical Immunology, AP-HP, Saint-Louis Hospital, Paris, France",NA
"2519","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Le Goff","Jérôme","Virology Department, APHP, Saint-Louis Hospital, Paris, France",NA
"2520","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Delaugerre","Constance","Virology Department, APHP, Saint-Louis Hospital, Paris, France",NA
"2521","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Bergeron","Anne","Pneumology Department, APHP, Saint-Louis Hospital, Paris, France",NA
"2522","34262018","10.1038/s41408-021-00512-5","Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.",NA,"2021","07","22","Blood Cancer J","Blood cancer journal","COVID-19; Follow-Up Studies; France; Hematologic Diseases; Humans; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Harel","Stéphanie","Immunohematology Unit, APHP, Saint-Louis Hospital, Paris, France. stephanie.harel@aphp","stephanie.harel@aphp.fr"
"2523","34262013","10.1038/s41392-021-00689-y","Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.",NA,"2021","07","19","Signal Transduct Target Ther","Signal transduction and targeted therapy","Aspirin; COVID-19; Histamine Antagonists; Histamine H2 Antagonists; Humans; SARS-CoV-2","Mura","Cameron","School of Data Science and Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA. cmura@virginia","cmura@virginia.edu"
"2524","34262013","10.1038/s41392-021-00689-y","Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.",NA,"2021","07","19","Signal Transduct Target Ther","Signal transduction and targeted therapy","Aspirin; COVID-19; Histamine Antagonists; Histamine H2 Antagonists; Humans; SARS-CoV-2","Preissner","Saskia","Department Oral and Maxillofacial Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. Saskia.Preissner@charite","Saskia.Preissner@charite.de"
"2525","34262013","10.1038/s41392-021-00689-y","Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.",NA,"2021","07","19","Signal Transduct Target Ther","Signal transduction and targeted therapy","Aspirin; COVID-19; Histamine Antagonists; Histamine H2 Antagonists; Humans; SARS-CoV-2","Nahles","Susanne","Department Oral and Maxillofacial Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany",NA
"2526","34262013","10.1038/s41392-021-00689-y","Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.",NA,"2021","07","19","Signal Transduct Target Ther","Signal transduction and targeted therapy","Aspirin; COVID-19; Histamine Antagonists; Histamine H2 Antagonists; Humans; SARS-CoV-2","Heiland","Max","Department Oral and Maxillofacial Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany",NA
"2527","34262013","10.1038/s41392-021-00689-y","Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.",NA,"2021","07","19","Signal Transduct Target Ther","Signal transduction and targeted therapy","Aspirin; COVID-19; Histamine Antagonists; Histamine H2 Antagonists; Humans; SARS-CoV-2","Bourne","Philip E","School of Data Science and Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA",NA
"2528","34262013","10.1038/s41392-021-00689-y","Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.",NA,"2021","07","19","Signal Transduct Target Ther","Signal transduction and targeted therapy","Aspirin; COVID-19; Histamine Antagonists; Histamine H2 Antagonists; Humans; SARS-CoV-2","Preissner","Robert","Institute of Physiology and Science-IT, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany",NA
"2529","34261984","10.1097/j.jcrs.0000000000000741","The effect of surgical abstinence on the risk of posterior capsule rupture during cataract surgery.","To evaluate the impact of surgery restrictions on cataract surgery performance. Moorfields Eye Hospital, NHS Foundation Trust, London, UK. Retrospective, observational cross-sectional study. Single-centre, retrospective review of all patients that underwent phacoemulsification surgery at Moorfields Eye Hospital, between September 2019 and January 2021. Our main outcome measure was Posterior Capsule Rupture (PCR) rate before and after COVID-19 imposed restrictions to elective cataract surgery. We","2021","07","15","J Cataract Refract Surg","Journal of cataract and refractive surgery",NA,"Matarazzo","Francesco","Moorfields Eye Hospital, NHS Foundation Trust, London, UK. UCL Institute of Ophthalmology, London, UK",NA
"2530","34261984","10.1097/j.jcrs.0000000000000741","The effect of surgical abstinence on the risk of posterior capsule rupture during cataract surgery.","To evaluate the impact of surgery restrictions on cataract surgery performance. Moorfields Eye Hospital, NHS Foundation Trust, London, UK. Retrospective, observational cross-sectional study. Single-centre, retrospective review of all patients that underwent phacoemulsification surgery at Moorfields Eye Hospital, between September 2019 and January 2021. Our main outcome measure was Posterior Capsule Rupture (PCR) rate before and after COVID-19 imposed restrictions to elective cataract surgery. We","2021","07","15","J Cataract Refract Surg","Journal of cataract and refractive surgery",NA,"Phylactou","Maria","Moorfields Eye Hospital, NHS Foundation Trust, London, UK. UCL Institute of Ophthalmology, London, UK",NA
"2531","34261984","10.1097/j.jcrs.0000000000000741","The effect of surgical abstinence on the risk of posterior capsule rupture during cataract surgery.","To evaluate the impact of surgery restrictions on cataract surgery performance. Moorfields Eye Hospital, NHS Foundation Trust, London, UK. Retrospective, observational cross-sectional study. Single-centre, retrospective review of all patients that underwent phacoemulsification surgery at Moorfields Eye Hospital, between September 2019 and January 2021. Our main outcome measure was Posterior Capsule Rupture (PCR) rate before and after COVID-19 imposed restrictions to elective cataract surgery. We","2021","07","15","J Cataract Refract Surg","Journal of cataract and refractive surgery",NA,"Day","Alexander C","Moorfields Eye Hospital, NHS Foundation Trust, London, UK. UCL Institute of Ophthalmology, London, UK",NA
"2532","34261984","10.1097/j.jcrs.0000000000000741","The effect of surgical abstinence on the risk of posterior capsule rupture during cataract surgery.","To evaluate the impact of surgery restrictions on cataract surgery performance. Moorfields Eye Hospital, NHS Foundation Trust, London, UK. Retrospective, observational cross-sectional study. Single-centre, retrospective review of all patients that underwent phacoemulsification surgery at Moorfields Eye Hospital, between September 2019 and January 2021. Our main outcome measure was Posterior Capsule Rupture (PCR) rate before and after COVID-19 imposed restrictions to elective cataract surgery. We","2021","07","15","J Cataract Refract Surg","Journal of cataract and refractive surgery",NA,"Maurino","Vincenzo","Moorfields Eye Hospital, NHS Foundation Trust, London, UK. UCL Institute of Ophthalmology, London, UK",NA
"2533","34261909","10.1097/01.ASW.0000765916.20726.41","Determining the Frequency of and Factors in Hand Dermatitis among Nurses during the COVID-19 Pandemic.","To determine the frequency of hand dermatitis among nurses during the COVID-19 pandemic and factors affecting this. The research sample consisted of 175 nurses working in state hospitals. Research data were collected via Google Survey between October and September 2020. The data were collected using a Sociodemographic Data Collection Form, and a self-assessment form was used to determine dermatological symptoms. The frequency of hand dermatitis among nurses was 70.9%. A statistically significant","2021","07","16","Adv Skin Wound Care","Advances in skin &amp; wound care",NA,"Aydin","Ayla Irem","In the Department of Pediatric Nursing, Faculty of Health Sciences, Bursa Uludag University, Turkey, Ayla Irem Aydin, MSc, RN, is a Research Assistant",NA
"2534","34261909","10.1097/01.ASW.0000765916.20726.41","Determining the Frequency of and Factors in Hand Dermatitis among Nurses during the COVID-19 Pandemic.","To determine the frequency of hand dermatitis among nurses during the COVID-19 pandemic and factors affecting this. The research sample consisted of 175 nurses working in state hospitals. Research data were collected via Google Survey between October and September 2020. The data were collected using a Sociodemographic Data Collection Form, and a self-assessment form was used to determine dermatological symptoms. The frequency of hand dermatitis among nurses was 70.9%. A statistically significant","2021","07","16","Adv Skin Wound Care","Advances in skin &amp; wound care",NA,"Atak","Meryem","In the Department of Pediatric Nursing, Faculty of Health Sciences, Bursa Uludag University, Turkey, Ayla Irem Aydin, MSc, RN, is a Research Assistant",NA
"2535","34261909","10.1097/01.ASW.0000765916.20726.41","Determining the Frequency of and Factors in Hand Dermatitis among Nurses during the COVID-19 Pandemic.","To determine the frequency of hand dermatitis among nurses during the COVID-19 pandemic and factors affecting this. The research sample consisted of 175 nurses working in state hospitals. Research data were collected via Google Survey between October and September 2020. The data were collected using a Sociodemographic Data Collection Form, and a self-assessment form was used to determine dermatological symptoms. The frequency of hand dermatitis among nurses was 70.9%. A statistically significant","2021","07","16","Adv Skin Wound Care","Advances in skin &amp; wound care",NA,"Özyazicioglu","Nurcan","In the Department of Pediatric Nursing, Faculty of Health Sciences, Bursa Uludag University, Turkey, Ayla Irem Aydin, MSc, RN, is a Research Assistant",NA
"2536","34261909","10.1097/01.ASW.0000765916.20726.41","Determining the Frequency of and Factors in Hand Dermatitis among Nurses during the COVID-19 Pandemic.","To determine the frequency of hand dermatitis among nurses during the COVID-19 pandemic and factors affecting this. The research sample consisted of 175 nurses working in state hospitals. Research data were collected via Google Survey between October and September 2020. The data were collected using a Sociodemographic Data Collection Form, and a self-assessment form was used to determine dermatological symptoms. The frequency of hand dermatitis among nurses was 70.9%. A statistically significant","2021","07","16","Adv Skin Wound Care","Advances in skin &amp; wound care",NA,"Dalkizan","Vahit","In the Department of Pediatric Nursing, Faculty of Health Sciences, Bursa Uludag University, Turkey, Ayla Irem Aydin, MSc, RN, is a Research Assistant",NA
"2537","34261902","10.1097/QCO.0000000000000762","Coronavirus disease 2019 in children.","Over the course of the coronavirus disease 2019 (COVID-19) pandemic, it has become clear that the clinical features, epidemiology, and outcomes of COVID-19 are distinct in children relative to adults. In this review, we will present recent pediatric studies informing our current understanding of COVID-19 in children, and review pediatric considerations surrounding disease transmission, currently available therapies, and vaccination. Recent studies have shed light on the clinical epidemiology of ","2021","07","15","Curr Opin Infect Dis","Current opinion in infectious diseases",NA,"Levy","Emily R","Division of Pediatric Infectious Diseases Division of Pediatric Critical Care Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota Division of Infectious Diseases, Department of Medicine Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts Division of Infectious Diseases, Department of Pediatrics Division of Critical Care Medicine, Department of Anesthesia and Critical Care, Children's Hospital of Philadelphia, Pennsylvania, USA",NA
"2538","34261902","10.1097/QCO.0000000000000762","Coronavirus disease 2019 in children.","Over the course of the coronavirus disease 2019 (COVID-19) pandemic, it has become clear that the clinical features, epidemiology, and outcomes of COVID-19 are distinct in children relative to adults. In this review, we will present recent pediatric studies informing our current understanding of COVID-19 in children, and review pediatric considerations surrounding disease transmission, currently available therapies, and vaccination. Recent studies have shed light on the clinical epidemiology of ","2021","07","15","Curr Opin Infect Dis","Current opinion in infectious diseases",NA,"Blumenthal","Jennifer","Division of Pediatric Infectious Diseases Division of Pediatric Critical Care Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota Division of Infectious Diseases, Department of Medicine Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts Division of Infectious Diseases, Department of Pediatrics Division of Critical Care Medicine, Department of Anesthesia and Critical Care, Children's Hospital of Philadelphia, Pennsylvania, USA",NA
"2539","34261902","10.1097/QCO.0000000000000762","Coronavirus disease 2019 in children.","Over the course of the coronavirus disease 2019 (COVID-19) pandemic, it has become clear that the clinical features, epidemiology, and outcomes of COVID-19 are distinct in children relative to adults. In this review, we will present recent pediatric studies informing our current understanding of COVID-19 in children, and review pediatric considerations surrounding disease transmission, currently available therapies, and vaccination. Recent studies have shed light on the clinical epidemiology of ","2021","07","15","Curr Opin Infect Dis","Current opinion in infectious diseases",NA,"Chiotos","Kathleen","Division of Pediatric Infectious Diseases Division of Pediatric Critical Care Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota Division of Infectious Diseases, Department of Medicine Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts Division of Infectious Diseases, Department of Pediatrics Division of Critical Care Medicine, Department of Anesthesia and Critical Care, Children's Hospital of Philadelphia, Pennsylvania, USA",NA
"2540","34261901","10.1097/CRD.0000000000000407","Arrhythmogenesis and COVID-19.","The ongoing coronavirus infection-2019 (COVID-19) global pandemic has had devastating impacts on the global population since 2019. Cardiac complications are a well-documented sequalae of COVID-19, with exposed patients experiencing complications such as myocardial infarction, myocarditis, and arrythmias. This article aims to review prominent literature regarding COVID-19 and its link with arrhythmias, as well as to discuss some of the possible mechanisms by which arrhythmogenesis may occur in pa","2021","07","16","Cardiol Rev","Cardiology in review",NA,"Varkey","John N","From the Department of Medicine, Stony Brook University, Stony Brook, NY and Departments of Medicine and Cardiology, New York Medical College/Westchester Medical Center, Valhalla, NY",NA
"2541","34261901","10.1097/CRD.0000000000000407","Arrhythmogenesis and COVID-19.","The ongoing coronavirus infection-2019 (COVID-19) global pandemic has had devastating impacts on the global population since 2019. Cardiac complications are a well-documented sequalae of COVID-19, with exposed patients experiencing complications such as myocardial infarction, myocarditis, and arrythmias. This article aims to review prominent literature regarding COVID-19 and its link with arrhythmias, as well as to discuss some of the possible mechanisms by which arrhythmogenesis may occur in pa","2021","07","16","Cardiol Rev","Cardiology in review",NA,"Frishman","William H","From the Department of Medicine, Stony Brook University, Stony Brook, NY and Departments of Medicine and Cardiology, New York Medical College/Westchester Medical Center, Valhalla, NY",NA
"2542","34261900","10.1097/CRD.0000000000000408","Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease 2019.","The coronavirus-2019 (COVID-19) pandemic has presented many new challenges to the healthcare community with the sheer number of individuals affected and the range of symptoms at presentation. Early findings have shown that increased age is an independent risk factor for COVID-19 severity. Diabetes and hypertension were also found to be strong independent risk factors for severe COVID-19. It was later discovered that obesity is a strong risk factor for severe disease as well. Possible mechanisms ","2021","07","16","Cardiol Rev","Cardiology in review",NA,"Fishkin","Tzvi","Department of Medicine, Westchester Medical Center, Valhalla, NY Department of Medicine, Division of Endocrinology Department of Medicine and Cardiology, New York Medical College/Westchester Medical Center, Valhalla, NY",NA
"2543","34261900","10.1097/CRD.0000000000000408","Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease 2019.","The coronavirus-2019 (COVID-19) pandemic has presented many new challenges to the healthcare community with the sheer number of individuals affected and the range of symptoms at presentation. Early findings have shown that increased age is an independent risk factor for COVID-19 severity. Diabetes and hypertension were also found to be strong independent risk factors for severe COVID-19. It was later discovered that obesity is a strong risk factor for severe disease as well. Possible mechanisms ","2021","07","16","Cardiol Rev","Cardiology in review",NA,"Goldberg","Michael D","Department of Medicine, Westchester Medical Center, Valhalla, NY Department of Medicine, Division of Endocrinology Department of Medicine and Cardiology, New York Medical College/Westchester Medical Center, Valhalla, NY",NA
"2544","34261900","10.1097/CRD.0000000000000408","Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease 2019.","The coronavirus-2019 (COVID-19) pandemic has presented many new challenges to the healthcare community with the sheer number of individuals affected and the range of symptoms at presentation. Early findings have shown that increased age is an independent risk factor for COVID-19 severity. Diabetes and hypertension were also found to be strong independent risk factors for severe COVID-19. It was later discovered that obesity is a strong risk factor for severe disease as well. Possible mechanisms ","2021","07","16","Cardiol Rev","Cardiology in review",NA,"Frishman","William H","Department of Medicine, Westchester Medical Center, Valhalla, NY Department of Medicine, Division of Endocrinology Department of Medicine and Cardiology, New York Medical College/Westchester Medical Center, Valhalla, NY",NA
"2545","34261867","10.1097/ACM.0000000000004230","Addressing Equity in Global Medical Education During the COVID-19 Pandemic: The Global Medical Education Collaborative.","The COVID-19 pandemic has presented a unique set of challenges to medical education globally. Low- and middle-income countries (LMICs) have faced unique barriers in transitioning to virtual modalities, and many medical students in LMICs experienced dramatically reduced educational time. The authors created the Global Medical Education Collaborative (GMEC) to address this problem by providing free, online, case-based tutorials to medical students in LMICs during the COVID-19 pandemic. The authors","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Posever","Natalie","N. Posever is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts. M. Sehdev is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts",NA
"2546","34261867","10.1097/ACM.0000000000004230","Addressing Equity in Global Medical Education During the COVID-19 Pandemic: The Global Medical Education Collaborative.","The COVID-19 pandemic has presented a unique set of challenges to medical education globally. Low- and middle-income countries (LMICs) have faced unique barriers in transitioning to virtual modalities, and many medical students in LMICs experienced dramatically reduced educational time. The authors created the Global Medical Education Collaborative (GMEC) to address this problem by providing free, online, case-based tutorials to medical students in LMICs during the COVID-19 pandemic. The authors","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Sehdev","Morgan","N. Posever is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts. M. Sehdev is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts",NA
"2547","34261867","10.1097/ACM.0000000000004230","Addressing Equity in Global Medical Education During the COVID-19 Pandemic: The Global Medical Education Collaborative.","The COVID-19 pandemic has presented a unique set of challenges to medical education globally. Low- and middle-income countries (LMICs) have faced unique barriers in transitioning to virtual modalities, and many medical students in LMICs experienced dramatically reduced educational time. The authors created the Global Medical Education Collaborative (GMEC) to address this problem by providing free, online, case-based tutorials to medical students in LMICs during the COVID-19 pandemic. The authors","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Sylla","Mariame","N. Posever is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts. M. Sehdev is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts",NA
"2548","34261867","10.1097/ACM.0000000000004230","Addressing Equity in Global Medical Education During the COVID-19 Pandemic: The Global Medical Education Collaborative.","The COVID-19 pandemic has presented a unique set of challenges to medical education globally. Low- and middle-income countries (LMICs) have faced unique barriers in transitioning to virtual modalities, and many medical students in LMICs experienced dramatically reduced educational time. The authors created the Global Medical Education Collaborative (GMEC) to address this problem by providing free, online, case-based tutorials to medical students in LMICs during the COVID-19 pandemic. The authors","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Mashar","Ruchir","N. Posever is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts. M. Sehdev is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts",NA
"2549","34261867","10.1097/ACM.0000000000004230","Addressing Equity in Global Medical Education During the COVID-19 Pandemic: The Global Medical Education Collaborative.","The COVID-19 pandemic has presented a unique set of challenges to medical education globally. Low- and middle-income countries (LMICs) have faced unique barriers in transitioning to virtual modalities, and many medical students in LMICs experienced dramatically reduced educational time. The authors created the Global Medical Education Collaborative (GMEC) to address this problem by providing free, online, case-based tutorials to medical students in LMICs during the COVID-19 pandemic. The authors","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Mashar","Meghavi","N. Posever is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts. M. Sehdev is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts",NA
"2550","34261867","10.1097/ACM.0000000000004230","Addressing Equity in Global Medical Education During the COVID-19 Pandemic: The Global Medical Education Collaborative.","The COVID-19 pandemic has presented a unique set of challenges to medical education globally. Low- and middle-income countries (LMICs) have faced unique barriers in transitioning to virtual modalities, and many medical students in LMICs experienced dramatically reduced educational time. The authors created the Global Medical Education Collaborative (GMEC) to address this problem by providing free, online, case-based tutorials to medical students in LMICs during the COVID-19 pandemic. The authors","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Abioye","Abubakar","N. Posever is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts. M. Sehdev is a fourth-year medical student, Harvard Medical School, Boston, Massachusetts",NA
"2551","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Trout","Lucas J","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2552","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Weisman","Ashley","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2553","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Miller","James S","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2554","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Kramer","Corina","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2555","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Keshavjee","Salmaan","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2556","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Kleinman","Arthur M","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2557","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Kulkarni","Suchitra","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2558","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Baldwin","Teressa","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2559","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Tobey","Matthew L","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2560","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Buffey","Timothy","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2561","34261866","10.1097/ACM.0000000000004239","Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska.","American Indians and Alaska Natives hold a state-conferred right to health, yet significant health and health care disparities persist. Academic medical centers are resource-rich institutions committed to public service, yet few are engaged in responsive, equitable, and lasting tribal health partnerships to address these challenges. Maniilaq Association, a rural and remote tribal health organization in Northwest Alaska, partnered with Massachusetts General Hospital and Harvard Medical School to ","2021","07","15","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Harris","N Stuart","L.J. Trout is managing partner, Siamit, Sayaqagvik director, Maniilaq Social Medicine, and lecturer on global health and social medicine, Harvard Medical School, Kotzebue, Alaska",NA
"2562","34261848","10.5582/bst.2021.01269","Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures.","In Japan, the Law Concerning the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the ""Infectious Diseases Control Law"") classifies infectious diseases as category I-V infectious diseases, pandemic influenza, and designated infectious diseases based on their infectivity, severity, and impact on public health. COVID-19 was designated as a designated infectious disease as of February 1, 2020 and then classified under pandemic influenza as of February 13, 20","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; chickenpox; infectious diseases; influenza; mycoplasma pneumonia; rotavirus gastroenteritis","Sawakami","Tatsuo","Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan",NA
"2563","34261848","10.5582/bst.2021.01269","Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures.","In Japan, the Law Concerning the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the ""Infectious Diseases Control Law"") classifies infectious diseases as category I-V infectious diseases, pandemic influenza, and designated infectious diseases based on their infectivity, severity, and impact on public health. COVID-19 was designated as a designated infectious disease as of February 1, 2020 and then classified under pandemic influenza as of February 13, 20","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; chickenpox; infectious diseases; influenza; mycoplasma pneumonia; rotavirus gastroenteritis","Karako","Kenji","Department of Human and Engineered Environmental Studies, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan",NA
"2564","34261848","10.5582/bst.2021.01269","Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures.","In Japan, the Law Concerning the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the ""Infectious Diseases Control Law"") classifies infectious diseases as category I-V infectious diseases, pandemic influenza, and designated infectious diseases based on their infectivity, severity, and impact on public health. COVID-19 was designated as a designated infectious disease as of February 1, 2020 and then classified under pandemic influenza as of February 13, 20","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; chickenpox; infectious diseases; influenza; mycoplasma pneumonia; rotavirus gastroenteritis","Song","Peipei","Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan",NA
"2565","34261848","10.5582/bst.2021.01269","Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures.","In Japan, the Law Concerning the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the ""Infectious Diseases Control Law"") classifies infectious diseases as category I-V infectious diseases, pandemic influenza, and designated infectious diseases based on their infectivity, severity, and impact on public health. COVID-19 was designated as a designated infectious disease as of February 1, 2020 and then classified under pandemic influenza as of February 13, 20","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; chickenpox; infectious diseases; influenza; mycoplasma pneumonia; rotavirus gastroenteritis","Sugiura","Wataru","Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan",NA
"2566","34261848","10.5582/bst.2021.01269","Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures.","In Japan, the Law Concerning the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the ""Infectious Diseases Control Law"") classifies infectious diseases as category I-V infectious diseases, pandemic influenza, and designated infectious diseases based on their infectivity, severity, and impact on public health. COVID-19 was designated as a designated infectious disease as of February 1, 2020 and then classified under pandemic influenza as of February 13, 20","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; chickenpox; infectious diseases; influenza; mycoplasma pneumonia; rotavirus gastroenteritis","Kokudo","Norihiro","National Center for Global Health and Medicine, Tokyo, Japan",NA
"2567","34261842","10.11236/jph.21-015","[Change in dietary consciousness and its related factors among Japanese adults under the COVID-19 pandemic: Analysis using Dietary Consciousness Scale].","Objectives This study aims to develop a dietary consciousness scale and examine its reliability and validity, as well as investigate the changes in psychological aspects that influence diet among Japanese adults during the COVID-19 pandemic and clarify its related factors.Methods An online survey was conducted from July 1, 2020 to July 3, 2020. Participants were adults aged between 20 and 69 years selected from 13 prefectures where the government declared the state of emergency from April to May","2021","07","15","Nihon Koshu Eisei Zasshi","[Nihon koshu eisei zasshi] Japanese journal of public health","COVID-19; adults; dietary consciousness; factor structure; socioeconomic factors","Hayashi","Fumi","Nutrition Ecology, Kagawa Nutrition University",NA
"2568","34261842","10.11236/jph.21-015","[Change in dietary consciousness and its related factors among Japanese adults under the COVID-19 pandemic: Analysis using Dietary Consciousness Scale].","Objectives This study aims to develop a dietary consciousness scale and examine its reliability and validity, as well as investigate the changes in psychological aspects that influence diet among Japanese adults during the COVID-19 pandemic and clarify its related factors.Methods An online survey was conducted from July 1, 2020 to July 3, 2020. Participants were adults aged between 20 and 69 years selected from 13 prefectures where the government declared the state of emergency from April to May","2021","07","15","Nihon Koshu Eisei Zasshi","[Nihon koshu eisei zasshi] Japanese journal of public health","COVID-19; adults; dietary consciousness; factor structure; socioeconomic factors","Takemi","Yukari","Nutrition Ecology, Kagawa Nutrition University",NA
"2569","34261842","10.11236/jph.21-015","[Change in dietary consciousness and its related factors among Japanese adults under the COVID-19 pandemic: Analysis using Dietary Consciousness Scale].","Objectives This study aims to develop a dietary consciousness scale and examine its reliability and validity, as well as investigate the changes in psychological aspects that influence diet among Japanese adults during the COVID-19 pandemic and clarify its related factors.Methods An online survey was conducted from July 1, 2020 to July 3, 2020. Participants were adults aged between 20 and 69 years selected from 13 prefectures where the government declared the state of emergency from April to May","2021","07","15","Nihon Koshu Eisei Zasshi","[Nihon koshu eisei zasshi] Japanese journal of public health","COVID-19; adults; dietary consciousness; factor structure; socioeconomic factors","Akaiwa","Yuki","Graduate School of Kagawa Nutrition University",NA
"2570","34261842","10.11236/jph.21-015","[Change in dietary consciousness and its related factors among Japanese adults under the COVID-19 pandemic: Analysis using Dietary Consciousness Scale].","Objectives This study aims to develop a dietary consciousness scale and examine its reliability and validity, as well as investigate the changes in psychological aspects that influence diet among Japanese adults during the COVID-19 pandemic and clarify its related factors.Methods An online survey was conducted from July 1, 2020 to July 3, 2020. Participants were adults aged between 20 and 69 years selected from 13 prefectures where the government declared the state of emergency from April to May","2021","07","15","Nihon Koshu Eisei Zasshi","[Nihon koshu eisei zasshi] Japanese journal of public health","COVID-19; adults; dietary consciousness; factor structure; socioeconomic factors","Ishikawa","Hirono","School of Public Health, Graduate School of Teikyo University",NA
"2571","34261842","10.11236/jph.21-015","[Change in dietary consciousness and its related factors among Japanese adults under the COVID-19 pandemic: Analysis using Dietary Consciousness Scale].","Objectives This study aims to develop a dietary consciousness scale and examine its reliability and validity, as well as investigate the changes in psychological aspects that influence diet among Japanese adults during the COVID-19 pandemic and clarify its related factors.Methods An online survey was conducted from July 1, 2020 to July 3, 2020. Participants were adults aged between 20 and 69 years selected from 13 prefectures where the government declared the state of emergency from April to May","2021","07","15","Nihon Koshu Eisei Zasshi","[Nihon koshu eisei zasshi] Japanese journal of public health","COVID-19; adults; dietary consciousness; factor structure; socioeconomic factors","Fukuda","Yoshiharu","School of Public Health, Graduate School of Teikyo University",NA
"2572","34261836","10.5582/bst.2021.01194","The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database.","The COVID-19 pandemic has affected not only the emergency medical system, but also patients' regular ambulatory care, as such decrease in the number of patients visiting outpatient clinics decreased in 2020 than in 2019, or the ban lifting of subsequent visits by telephone for outpatient clinics since March 2020 in lieu of ambulatory care for chronic diseases. In this context, we investigate the impact of the COVID-19 pandemic on ambulatory care at Japanese outpatient clinics for patients with c","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; administrative claims data; ambulatory care; chronic neurological disease; telemedicine","Sato","Kenichiro","Department of Neuropathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan",NA
"2573","34261836","10.5582/bst.2021.01194","The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database.","The COVID-19 pandemic has affected not only the emergency medical system, but also patients' regular ambulatory care, as such decrease in the number of patients visiting outpatient clinics decreased in 2020 than in 2019, or the ban lifting of subsequent visits by telephone for outpatient clinics since March 2020 in lieu of ambulatory care for chronic diseases. In this context, we investigate the impact of the COVID-19 pandemic on ambulatory care at Japanese outpatient clinics for patients with c","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; administrative claims data; ambulatory care; chronic neurological disease; telemedicine","Mano","Tatsuo","Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan",NA
"2574","34261836","10.5582/bst.2021.01194","The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database.","The COVID-19 pandemic has affected not only the emergency medical system, but also patients' regular ambulatory care, as such decrease in the number of patients visiting outpatient clinics decreased in 2020 than in 2019, or the ban lifting of subsequent visits by telephone for outpatient clinics since March 2020 in lieu of ambulatory care for chronic diseases. In this context, we investigate the impact of the COVID-19 pandemic on ambulatory care at Japanese outpatient clinics for patients with c","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; administrative claims data; ambulatory care; chronic neurological disease; telemedicine","Niimi","Yoshiki","Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan",NA
"2575","34261836","10.5582/bst.2021.01194","The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database.","The COVID-19 pandemic has affected not only the emergency medical system, but also patients' regular ambulatory care, as such decrease in the number of patients visiting outpatient clinics decreased in 2020 than in 2019, or the ban lifting of subsequent visits by telephone for outpatient clinics since March 2020 in lieu of ambulatory care for chronic diseases. In this context, we investigate the impact of the COVID-19 pandemic on ambulatory care at Japanese outpatient clinics for patients with c","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; administrative claims data; ambulatory care; chronic neurological disease; telemedicine","Iwata","Atsushi","Department of Neurology, Tokyo Metropolitan Geriatric Center Hospital, Tokyo, Japan",NA
"2576","34261836","10.5582/bst.2021.01194","The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database.","The COVID-19 pandemic has affected not only the emergency medical system, but also patients' regular ambulatory care, as such decrease in the number of patients visiting outpatient clinics decreased in 2020 than in 2019, or the ban lifting of subsequent visits by telephone for outpatient clinics since March 2020 in lieu of ambulatory care for chronic diseases. In this context, we investigate the impact of the COVID-19 pandemic on ambulatory care at Japanese outpatient clinics for patients with c","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; administrative claims data; ambulatory care; chronic neurological disease; telemedicine","Toda","Tatsushi","Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan",NA
"2577","34261836","10.5582/bst.2021.01194","The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database.","The COVID-19 pandemic has affected not only the emergency medical system, but also patients' regular ambulatory care, as such decrease in the number of patients visiting outpatient clinics decreased in 2020 than in 2019, or the ban lifting of subsequent visits by telephone for outpatient clinics since March 2020 in lieu of ambulatory care for chronic diseases. In this context, we investigate the impact of the COVID-19 pandemic on ambulatory care at Japanese outpatient clinics for patients with c","2021","07","15","Biosci Trends","Bioscience trends","COVID-19; administrative claims data; ambulatory care; chronic neurological disease; telemedicine","Iwatsubo","Takeshi","Department of Neuropathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan",NA
"2578","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Rolfes","Leoni","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2579","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Pawlitzki","Marc","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2580","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Pfeuffer","Steffen","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2581","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Nelke","Christopher","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2582","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Lux","Anke","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2583","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Pul","Refik","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2584","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Kleinschnitz","Christoph","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2585","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Kleinschnitz","Konstanze","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2586","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Rogall","Rebeca","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2587","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Pape","Katrin","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2588","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Bittner","Stefan","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2589","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Zipp","Frauke","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2590","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Warnke","Clemens","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2591","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Goereci","Yasemin","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2592","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Schroeter","Michael","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2593","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Ingwersen","Jens","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2594","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Aktas","Orhan","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2595","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Klotz","Luisa","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2596","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Ruck","Tobias","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2597","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Wiendl","Heinz","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2598","34261812","10.1212/NXI.0000000000001035","Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.","To evaluate the clinical consequences of extended interval dosing (EID) of ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease 2019 (COVID-19) pandemic. In our retrospective, multicenter cohort study, we compared patients with RRMS on EID (defined as =4-week delay of dose interval) with a control group on standard interval dosing (SID) at the same period (January to December 2020). Three hundred eighteen patients with RRMS were longitudinally evaluated in ","2021","07","22","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Antibodies, Monoclonal, Humanized; Antigens, CD19; B-Lymphocytes; COVID-19; Disability Evaluation; Female; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Retrospective Studies; Treatment Outcome","Meuth","Sven G","From the Department of Neurology with Institute of Translational Neurology (L.R., M.P., S.P., C.N., L.K., H.W.), University Hospital Muenster, Germany",NA
"2599","34261775","10.1073/pnas.2026731118","Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.","Over the last months, cases of SARS-CoV-2 surged repeatedly in many countries but could often be controlled with nonpharmaceutical interventions including social distancing. We analyzed deidentified Global Positioning System (GPS) tracking data from 1.15 to 1.4 million cell phones in Germany per day between March and November 2020 to identify encounters between individuals and statistically evaluate contact behavior. Using graph sampling theory, we estimated the contact index (CX), a metric for ","2021","07","22","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; epidemiology; network science; COVID-19; Cell Phone; Contact Tracing; Germany; Humans; SARS-CoV-2","Rüdiger","Sten","Machine Leaning Unit, Department of Engineering, NET CHECK GmbH, 10829 Berlin, Germany","sten.ruediger@googlemail.com"
"2600","34261775","10.1073/pnas.2026731118","Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.","Over the last months, cases of SARS-CoV-2 surged repeatedly in many countries but could often be controlled with nonpharmaceutical interventions including social distancing. We analyzed deidentified Global Positioning System (GPS) tracking data from 1.15 to 1.4 million cell phones in Germany per day between March and November 2020 to identify encounters between individuals and statistically evaluate contact behavior. Using graph sampling theory, we estimated the contact index (CX), a metric for ","2021","07","22","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; epidemiology; network science; COVID-19; Cell Phone; Contact Tracing; Germany; Humans; SARS-CoV-2","Konigorski","Stefan","Digital Health-Machine Learning, Hasso-Plattner-Institut, Universität Potsdam, 14482 Potsdam, Germany",NA
"2601","34261775","10.1073/pnas.2026731118","Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.","Over the last months, cases of SARS-CoV-2 surged repeatedly in many countries but could often be controlled with nonpharmaceutical interventions including social distancing. We analyzed deidentified Global Positioning System (GPS) tracking data from 1.15 to 1.4 million cell phones in Germany per day between March and November 2020 to identify encounters between individuals and statistically evaluate contact behavior. Using graph sampling theory, we estimated the contact index (CX), a metric for ","2021","07","22","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; epidemiology; network science; COVID-19; Cell Phone; Contact Tracing; Germany; Humans; SARS-CoV-2","Rakowski","Alexander","Digital Health-Machine Learning, Hasso-Plattner-Institut, Universität Potsdam, 14482 Potsdam, Germany",NA
"2602","34261775","10.1073/pnas.2026731118","Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.","Over the last months, cases of SARS-CoV-2 surged repeatedly in many countries but could often be controlled with nonpharmaceutical interventions including social distancing. We analyzed deidentified Global Positioning System (GPS) tracking data from 1.15 to 1.4 million cell phones in Germany per day between March and November 2020 to identify encounters between individuals and statistically evaluate contact behavior. Using graph sampling theory, we estimated the contact index (CX), a metric for ","2021","07","22","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; epidemiology; network science; COVID-19; Cell Phone; Contact Tracing; Germany; Humans; SARS-CoV-2","Edelman","Jonathan Antonio","Digital Health-Machine Learning, Hasso-Plattner-Institut, Universität Potsdam, 14482 Potsdam, Germany",NA
"2603","34261775","10.1073/pnas.2026731118","Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.","Over the last months, cases of SARS-CoV-2 surged repeatedly in many countries but could often be controlled with nonpharmaceutical interventions including social distancing. We analyzed deidentified Global Positioning System (GPS) tracking data from 1.15 to 1.4 million cell phones in Germany per day between March and November 2020 to identify encounters between individuals and statistically evaluate contact behavior. Using graph sampling theory, we estimated the contact index (CX), a metric for ","2021","07","22","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; epidemiology; network science; COVID-19; Cell Phone; Contact Tracing; Germany; Humans; SARS-CoV-2","Zernick","Detlef","Machine Leaning Unit, Department of Engineering, NET CHECK GmbH, 10829 Berlin, Germany",NA
"2604","34261775","10.1073/pnas.2026731118","Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.","Over the last months, cases of SARS-CoV-2 surged repeatedly in many countries but could often be controlled with nonpharmaceutical interventions including social distancing. We analyzed deidentified Global Positioning System (GPS) tracking data from 1.15 to 1.4 million cell phones in Germany per day between March and November 2020 to identify encounters between individuals and statistically evaluate contact behavior. Using graph sampling theory, we estimated the contact index (CX), a metric for ","2021","07","22","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; epidemiology; network science; COVID-19; Cell Phone; Contact Tracing; Germany; Humans; SARS-CoV-2","Thieme","Alexander","Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany",NA
"2605","34261775","10.1073/pnas.2026731118","Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.","Over the last months, cases of SARS-CoV-2 surged repeatedly in many countries but could often be controlled with nonpharmaceutical interventions including social distancing. We analyzed deidentified Global Positioning System (GPS) tracking data from 1.15 to 1.4 million cell phones in Germany per day between March and November 2020 to identify encounters between individuals and statistically evaluate contact behavior. Using graph sampling theory, we estimated the contact index (CX), a metric for ","2021","07","22","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; epidemiology; network science; COVID-19; Cell Phone; Contact Tracing; Germany; Humans; SARS-CoV-2","Lippert","Christoph","Digital Health-Machine Learning, Hasso-Plattner-Institut, Universität Potsdam, 14482 Potsdam, Germany",NA
"2606","34261763","10.1136/emermed-2020-210409","Impact of the COVID-19 pandemic on emergency medical service response to out-of-hospital cardiac arrests in Taiwan: a retrospective observational study.","Emergency medical service (EMS) personnel have high COVID-19 risk during resuscitation. The resuscitation protocol for patients with out-of-hospital cardiac arrest (OHCA) was modified in response to the COVID-19 pandemic. However, how the adjustments in the EMS system affected patients with OHCA remains unclear. We analysed data from the Taichung OHCA registry system. We compared OHCA outcomes and rescue records for 622 cases during the COVID-19 outbreak period (1 February to 30 April 2020) with","2021","07","18","Emerg Med J","Emergency medicine journal : EMJ","SARS; cardiac arrest; despatch; infectious diseases; prehospital care; resuscitation","Yu","Jiun-Hao","Department of Emergency Medicine, China Medical University Hospital, Hsinchu, Taiwan",NA
"2607","34261763","10.1136/emermed-2020-210409","Impact of the COVID-19 pandemic on emergency medical service response to out-of-hospital cardiac arrests in Taiwan: a retrospective observational study.","Emergency medical service (EMS) personnel have high COVID-19 risk during resuscitation. The resuscitation protocol for patients with out-of-hospital cardiac arrest (OHCA) was modified in response to the COVID-19 pandemic. However, how the adjustments in the EMS system affected patients with OHCA remains unclear. We analysed data from the Taichung OHCA registry system. We compared OHCA outcomes and rescue records for 622 cases during the COVID-19 outbreak period (1 February to 30 April 2020) with","2021","07","18","Emerg Med J","Emergency medicine journal : EMJ","SARS; cardiac arrest; despatch; infectious diseases; prehospital care; resuscitation","Liu","Chien-Yu","College of Medicine, China Medical University, Taichung, Taiwan",NA
"2608","34261763","10.1136/emermed-2020-210409","Impact of the COVID-19 pandemic on emergency medical service response to out-of-hospital cardiac arrests in Taiwan: a retrospective observational study.","Emergency medical service (EMS) personnel have high COVID-19 risk during resuscitation. The resuscitation protocol for patients with out-of-hospital cardiac arrest (OHCA) was modified in response to the COVID-19 pandemic. However, how the adjustments in the EMS system affected patients with OHCA remains unclear. We analysed data from the Taichung OHCA registry system. We compared OHCA outcomes and rescue records for 622 cases during the COVID-19 outbreak period (1 February to 30 April 2020) with","2021","07","18","Emerg Med J","Emergency medicine journal : EMJ","SARS; cardiac arrest; despatch; infectious diseases; prehospital care; resuscitation","Chen","Wei-Kung","College of Medicine, China Medical University, Taichung, Taiwan",NA
"2609","34261763","10.1136/emermed-2020-210409","Impact of the COVID-19 pandemic on emergency medical service response to out-of-hospital cardiac arrests in Taiwan: a retrospective observational study.","Emergency medical service (EMS) personnel have high COVID-19 risk during resuscitation. The resuscitation protocol for patients with out-of-hospital cardiac arrest (OHCA) was modified in response to the COVID-19 pandemic. However, how the adjustments in the EMS system affected patients with OHCA remains unclear. We analysed data from the Taichung OHCA registry system. We compared OHCA outcomes and rescue records for 622 cases during the COVID-19 outbreak period (1 February to 30 April 2020) with","2021","07","18","Emerg Med J","Emergency medicine journal : EMJ","SARS; cardiac arrest; despatch; infectious diseases; prehospital care; resuscitation","Yu","Shao-Hua","College of Medicine, China Medical University, Taichung, Taiwan",NA
"2610","34261763","10.1136/emermed-2020-210409","Impact of the COVID-19 pandemic on emergency medical service response to out-of-hospital cardiac arrests in Taiwan: a retrospective observational study.","Emergency medical service (EMS) personnel have high COVID-19 risk during resuscitation. The resuscitation protocol for patients with out-of-hospital cardiac arrest (OHCA) was modified in response to the COVID-19 pandemic. However, how the adjustments in the EMS system affected patients with OHCA remains unclear. We analysed data from the Taichung OHCA registry system. We compared OHCA outcomes and rescue records for 622 cases during the COVID-19 outbreak period (1 February to 30 April 2020) with","2021","07","18","Emerg Med J","Emergency medicine journal : EMJ","SARS; cardiac arrest; despatch; infectious diseases; prehospital care; resuscitation","Huang","Fen-Wei","Department of Emergency Medicine, China Medical University Hospital, Taichung, Taiwan",NA
"2611","34261763","10.1136/emermed-2020-210409","Impact of the COVID-19 pandemic on emergency medical service response to out-of-hospital cardiac arrests in Taiwan: a retrospective observational study.","Emergency medical service (EMS) personnel have high COVID-19 risk during resuscitation. The resuscitation protocol for patients with out-of-hospital cardiac arrest (OHCA) was modified in response to the COVID-19 pandemic. However, how the adjustments in the EMS system affected patients with OHCA remains unclear. We analysed data from the Taichung OHCA registry system. We compared OHCA outcomes and rescue records for 622 cases during the COVID-19 outbreak period (1 February to 30 April 2020) with","2021","07","18","Emerg Med J","Emergency medicine journal : EMJ","SARS; cardiac arrest; despatch; infectious diseases; prehospital care; resuscitation","Yang","Ming-Tzu","Department of Emergency Medicine, China Medical University Hospital, Taichung, Taiwan",NA
"2612","34261763","10.1136/emermed-2020-210409","Impact of the COVID-19 pandemic on emergency medical service response to out-of-hospital cardiac arrests in Taiwan: a retrospective observational study.","Emergency medical service (EMS) personnel have high COVID-19 risk during resuscitation. The resuscitation protocol for patients with out-of-hospital cardiac arrest (OHCA) was modified in response to the COVID-19 pandemic. However, how the adjustments in the EMS system affected patients with OHCA remains unclear. We analysed data from the Taichung OHCA registry system. We compared OHCA outcomes and rescue records for 622 cases during the COVID-19 outbreak period (1 February to 30 April 2020) with","2021","07","18","Emerg Med J","Emergency medicine journal : EMJ","SARS; cardiac arrest; despatch; infectious diseases; prehospital care; resuscitation","Chen","Chih-Yu","Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung, Taiwan",NA
"2613","34261763","10.1136/emermed-2020-210409","Impact of the COVID-19 pandemic on emergency medical service response to out-of-hospital cardiac arrests in Taiwan: a retrospective observational study.","Emergency medical service (EMS) personnel have high COVID-19 risk during resuscitation. The resuscitation protocol for patients with out-of-hospital cardiac arrest (OHCA) was modified in response to the COVID-19 pandemic. However, how the adjustments in the EMS system affected patients with OHCA remains unclear. We analysed data from the Taichung OHCA registry system. We compared OHCA outcomes and rescue records for 622 cases during the COVID-19 outbreak period (1 February to 30 April 2020) with","2021","07","18","Emerg Med J","Emergency medicine journal : EMJ","SARS; cardiac arrest; despatch; infectious diseases; prehospital care; resuscitation","Shih","Hong-Mo","College of Medicine, China Medical University, Taichung, Taiwan homoe042002@hotmail","homoe042002@hotmail.com"
"2614","34261760","10.1136/bmjgh-2021-006519","Health system governance and the UHC agenda: key learnings from the COVID-19 pandemic.",NA,"2021","07","19","BMJ Glob Health","BMJ global health","health policy; health systems; COVID-19; Government Programs; Humans; Pandemics; SARS-CoV-2; Universal Health Insurance","Huckel Schneider","Carmen","Menzies Centre for Health Policy and Economics, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia carmen.huckelschneider@sydney.edu","carmen.huckelschneider@sydney.edu.au"
"2615","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Bonifacio","Guendalina Beatrice","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK guendalina.bonifacio@uhs.nhs","guendalina.bonifacio@uhs.nhs.uk"
"2616","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Patel","Dharmini","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2617","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Cook","Sarah","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2618","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Purcaru","Elena","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2619","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Couzins","Michael","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2620","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Domjan","Janine","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2621","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Ryan","Suzanne","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2622","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Alareed","Ahmad","Department of Neurology, Queen Alexandra Hospital, Portsmouth, UK",NA
"2623","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Tuohy","Orla","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2624","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Slaght","Sean","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2625","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Furby","Julian","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2626","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Allen","David","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2627","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Katifi","Haider A","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2628","34261746","10.1136/jnnp-2021-327027","Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.",NA,"2021","07","15","J Neurol Neurosurg Psychiatry","Journal of neurology, neurosurgery, and psychiatry","Guillain-Barre syndrome; neuropathy","Kinton","Lucy","Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"2629","34261732","10.2337/dc21-0853","Primary Care Health Care Use for Patients With Type 2 Diabetes During the COVID-19 Pandemic.",NA,"2021","07","15","Diabetes Care","Diabetes care",NA,"Misra-Hebert","Anita D","Healthcare Delivery and Implementation Science Center, Cleveland Clinic, Cleveland, OH misraa@ccf","misraa@ccf.org"
"2630","34261732","10.2337/dc21-0853","Primary Care Health Care Use for Patients With Type 2 Diabetes During the COVID-19 Pandemic.",NA,"2021","07","15","Diabetes Care","Diabetes care",NA,"Hu","Bo","Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH",NA
"2631","34261732","10.2337/dc21-0853","Primary Care Health Care Use for Patients With Type 2 Diabetes During the COVID-19 Pandemic.",NA,"2021","07","15","Diabetes Care","Diabetes care",NA,"Pantalone","Kevin M","Department of Endocrinology, Cleveland Clinic, Cleveland, OH",NA
"2632","34261732","10.2337/dc21-0853","Primary Care Health Care Use for Patients With Type 2 Diabetes During the COVID-19 Pandemic.",NA,"2021","07","15","Diabetes Care","Diabetes care",NA,"Pfoh","Elizabeth R","Center for Value-Based Care Research, Cleveland Clinic Community Care, Cleveland, OH",NA
"2633","34261721","10.46747/cfp.6707550","Family physicians and the COVID-19 third wave.",NA,"2021","07","22","Can Fam Physician","Canadian family physician Medecin de famille canadien",NA,"Lemire","Francine",NA,NA
"2634","34261721","10.46747/cfp.6707550","Family physicians and the COVID-19 third wave.",NA,"2021","07","22","Can Fam Physician","Canadian family physician Medecin de famille canadien",NA,"Slade","Steve",NA,NA
"2635","34261711","10.46747/cfp.6707506","Caregiver burnout, gaps in care, and COVID-19: Effects on families of youth with autism and intellectual disability.",NA,"2021","07","22","Can Fam Physician","Canadian family physician Medecin de famille canadien",NA,"Young","Elizabeth","Assistant Professor in the Department of Pediatrics at the University of Toronto in Ontario, Project Investigator at the Li Ka Shing Knowledge Institute, and a general consulting and developmental pediatrician in the Department of Pediatrics at St Michael's Hospital",NA
"2636","34261711","10.46747/cfp.6707506","Caregiver burnout, gaps in care, and COVID-19: Effects on families of youth with autism and intellectual disability.",NA,"2021","07","22","Can Fam Physician","Canadian family physician Medecin de famille canadien",NA,"Milligan","Karen","Associate Professor and a clinical psychologist in the Department of Psychology at Ryerson University in Toronto, and Director of the Child Self-Regulation Lab and Supervising Psychologist at St Michael's Hospital",NA
"2637","34261711","10.46747/cfp.6707506","Caregiver burnout, gaps in care, and COVID-19: Effects on families of youth with autism and intellectual disability.",NA,"2021","07","22","Can Fam Physician","Canadian family physician Medecin de famille canadien",NA,"Henze","Megan","Transitional services facilitator with the Transitional Aged Youth Clinic, a collaboration between St Michael's Hospital, Unity Health Toronto, and Surrey Place Centre",NA
"2638","34261711","10.46747/cfp.6707506","Caregiver burnout, gaps in care, and COVID-19: Effects on families of youth with autism and intellectual disability.",NA,"2021","07","22","Can Fam Physician","Canadian family physician Medecin de famille canadien",NA,"Johnson","Shay","Social worker with the Department of Pediatrics at St Michael's Hospital and Unity Health Toronto",NA
"2639","34261711","10.46747/cfp.6707506","Caregiver burnout, gaps in care, and COVID-19: Effects on families of youth with autism and intellectual disability.",NA,"2021","07","22","Can Fam Physician","Canadian family physician Medecin de famille canadien",NA,"Weyman","Karen","Associate Professor in the Department of Family and Community Medicine at the University of Toronto and Chief of the Department of Family and Community Medicine at St Michael's Hospital and Unity Health Toronto",NA
"2640","34261692","10.1136/bmjopen-2021-051224","Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review.","Evaluate gender differences in authorship of COVID-19 articles in high-impact medical journals compared with other topics. Cross-sectional review. Medline database. Articles published from 1 January to 31 December 2020 in the seven leading general medical journals by impact factor. Article types included primary research, reviews, editorials and commentaries. Key data elements were whether the study topic was related to COVID-19 and names of the principal and the senior authors. A hierarchical a","2021","07","19","BMJ Open","BMJ open","COVID-19; education &amp; training (see medical education &amp; training); journalism (see medical journalism); medical education &amp; training; medical journalism; Authorship; COVID-19; Cross-Sectional Studies; Europe; Female; Humans; Male; Pandemics; Periodicals as Topic; SARS-CoV-2","Misra","Vaidehi","Women's College Research Institute (WCRI), Women's College Hospital, Toronto, Ontario, Canada",NA
"2641","34261692","10.1136/bmjopen-2021-051224","Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review.","Evaluate gender differences in authorship of COVID-19 articles in high-impact medical journals compared with other topics. Cross-sectional review. Medline database. Articles published from 1 January to 31 December 2020 in the seven leading general medical journals by impact factor. Article types included primary research, reviews, editorials and commentaries. Key data elements were whether the study topic was related to COVID-19 and names of the principal and the senior authors. A hierarchical a","2021","07","19","BMJ Open","BMJ open","COVID-19; education &amp; training (see medical education &amp; training); journalism (see medical journalism); medical education &amp; training; medical journalism; Authorship; COVID-19; Cross-Sectional Studies; Europe; Female; Humans; Male; Pandemics; Periodicals as Topic; SARS-CoV-2","Safi","Frozan","Department of Medicine, University of Toronto, Toronto, Ontario, Canada",NA
"2642","34261692","10.1136/bmjopen-2021-051224","Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review.","Evaluate gender differences in authorship of COVID-19 articles in high-impact medical journals compared with other topics. Cross-sectional review. Medline database. Articles published from 1 January to 31 December 2020 in the seven leading general medical journals by impact factor. Article types included primary research, reviews, editorials and commentaries. Key data elements were whether the study topic was related to COVID-19 and names of the principal and the senior authors. A hierarchical a","2021","07","19","BMJ Open","BMJ open","COVID-19; education &amp; training (see medical education &amp; training); journalism (see medical journalism); medical education &amp; training; medical journalism; Authorship; COVID-19; Cross-Sectional Studies; Europe; Female; Humans; Male; Pandemics; Periodicals as Topic; SARS-CoV-2","Brewerton","Kathryn A","Department of Medicine, University of Toronto, Toronto, Ontario, Canada",NA
"2643","34261692","10.1136/bmjopen-2021-051224","Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review.","Evaluate gender differences in authorship of COVID-19 articles in high-impact medical journals compared with other topics. Cross-sectional review. Medline database. Articles published from 1 January to 31 December 2020 in the seven leading general medical journals by impact factor. Article types included primary research, reviews, editorials and commentaries. Key data elements were whether the study topic was related to COVID-19 and names of the principal and the senior authors. A hierarchical a","2021","07","19","BMJ Open","BMJ open","COVID-19; education &amp; training (see medical education &amp; training); journalism (see medical journalism); medical education &amp; training; medical journalism; Authorship; COVID-19; Cross-Sectional Studies; Europe; Female; Humans; Male; Pandemics; Periodicals as Topic; SARS-CoV-2","Wu","Wei","Women's College Research Institute (WCRI), Women's College Hospital, Toronto, Ontario, Canada",NA
"2644","34261692","10.1136/bmjopen-2021-051224","Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review.","Evaluate gender differences in authorship of COVID-19 articles in high-impact medical journals compared with other topics. Cross-sectional review. Medline database. Articles published from 1 January to 31 December 2020 in the seven leading general medical journals by impact factor. Article types included primary research, reviews, editorials and commentaries. Key data elements were whether the study topic was related to COVID-19 and names of the principal and the senior authors. A hierarchical a","2021","07","19","BMJ Open","BMJ open","COVID-19; education &amp; training (see medical education &amp; training); journalism (see medical journalism); medical education &amp; training; medical journalism; Authorship; COVID-19; Cross-Sectional Studies; Europe; Female; Humans; Male; Pandemics; Periodicals as Topic; SARS-CoV-2","Mason","Robin","Women's College Research Institute (WCRI), Women's College Hospital, Toronto, Ontario, Canada",NA
"2645","34261692","10.1136/bmjopen-2021-051224","Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review.","Evaluate gender differences in authorship of COVID-19 articles in high-impact medical journals compared with other topics. Cross-sectional review. Medline database. Articles published from 1 January to 31 December 2020 in the seven leading general medical journals by impact factor. Article types included primary research, reviews, editorials and commentaries. Key data elements were whether the study topic was related to COVID-19 and names of the principal and the senior authors. A hierarchical a","2021","07","19","BMJ Open","BMJ open","COVID-19; education &amp; training (see medical education &amp; training); journalism (see medical journalism); medical education &amp; training; medical journalism; Authorship; COVID-19; Cross-Sectional Studies; Europe; Female; Humans; Male; Pandemics; Periodicals as Topic; SARS-CoV-2","Chan","An-Wen","Women's College Research Institute (WCRI), Women's College Hospital, Toronto, Ontario, Canada",NA
"2646","34261692","10.1136/bmjopen-2021-051224","Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review.","Evaluate gender differences in authorship of COVID-19 articles in high-impact medical journals compared with other topics. Cross-sectional review. Medline database. Articles published from 1 January to 31 December 2020 in the seven leading general medical journals by impact factor. Article types included primary research, reviews, editorials and commentaries. Key data elements were whether the study topic was related to COVID-19 and names of the principal and the senior authors. A hierarchical a","2021","07","19","BMJ Open","BMJ open","COVID-19; education &amp; training (see medical education &amp; training); journalism (see medical journalism); medical education &amp; training; medical journalism; Authorship; COVID-19; Cross-Sectional Studies; Europe; Female; Humans; Male; Pandemics; Periodicals as Topic; SARS-CoV-2","Rochon","Paula A","Women's College Research Institute (WCRI), Women's College Hospital, Toronto, Ontario, Canada",NA
"2647","34261692","10.1136/bmjopen-2021-051224","Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review.","Evaluate gender differences in authorship of COVID-19 articles in high-impact medical journals compared with other topics. Cross-sectional review. Medline database. Articles published from 1 January to 31 December 2020 in the seven leading general medical journals by impact factor. Article types included primary research, reviews, editorials and commentaries. Key data elements were whether the study topic was related to COVID-19 and names of the principal and the senior authors. A hierarchical a","2021","07","19","BMJ Open","BMJ open","COVID-19; education &amp; training (see medical education &amp; training); journalism (see medical journalism); medical education &amp; training; medical journalism; Authorship; COVID-19; Cross-Sectional Studies; Europe; Female; Humans; Male; Pandemics; Periodicals as Topic; SARS-CoV-2","Lega","Iliana C","Women's College Research Institute (WCRI), Women's College Hospital, Toronto, Ontario, Canada",NA
"2648","34261692","10.1136/bmjopen-2021-051224","Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review.","Evaluate gender differences in authorship of COVID-19 articles in high-impact medical journals compared with other topics. Cross-sectional review. Medline database. Articles published from 1 January to 31 December 2020 in the seven leading general medical journals by impact factor. Article types included primary research, reviews, editorials and commentaries. Key data elements were whether the study topic was related to COVID-19 and names of the principal and the senior authors. A hierarchical a","2021","07","19","BMJ Open","BMJ open","COVID-19; education &amp; training (see medical education &amp; training); journalism (see medical journalism); medical education &amp; training; medical journalism; Authorship; COVID-19; Cross-Sectional Studies; Europe; Female; Humans; Male; Pandemics; Periodicals as Topic; SARS-CoV-2","Abdel-Qadir","Husam","Women's College Research Institute (WCRI), Women's College Hospital, Toronto, Ontario, Canada h.abdel.qadir@utoronto","h.abdel.qadir@utoronto.ca"
"2649","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Wilmot","Emma G","Diabetes Department, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK",NA
"2650","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Evans","Mark","Wellcome Trust-MRC Institute of Metabolic Science, NIHR Cambridge Biomedicl Research Centre, Cambridge University Hospitals and University of Cambridge, Cambridge, Cambridgeshire, UK",NA
"2651","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Barnard-Kelly","Katharine","Barnard Health, BHR Limited, Hampshire, UK",NA
"2652","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Burns","M","Manchester Clinical Trials Unit, University of Manchester, Manchester, UK",NA
"2653","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Cranston","Iain","Academic Department of Diabetes and Endocrinology, Portsmouth Hospitals NHS Trust, Portsmouth, UK",NA
"2654","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Elliott","Rachel Ann","Manchester Centre for Health Economics, Divison of Population Health, University of Manchester, Manchester, UK",NA
"2655","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Gkountouras","G","Manchester Centre for Health Economics, Divison of Population Health, University of Manchester, Manchester, UK",NA
"2656","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Kanumilli","N","Northenden Group Practice, Manchester, UK",NA
"2657","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Krishan","A","Manchester Centre for Health Economics, Divison of Population Health, University of Manchester, Manchester, UK",NA
"2658","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Kotonya","C","Diabetes Department, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK",NA
"2659","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Lumley","S","The Adam Practice, Poole, UK",NA
"2660","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Narendran","P","Institute of Immunology and Immunotherapy, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK",NA
"2661","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Neupane","Sankalpa","Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, UK",NA
"2662","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Rayman","Gerry","The Ipswich Diabetes Centre and Research Unit, Ipswich Hospital NHS Trust, Suffolk, Ipswich, UK",NA
"2663","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Sutton","Christopher","Manchester Centre for Health Economics, Divison of Population Health, University of Manchester, Manchester, UK",NA
"2664","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Taxiarchi","V P","Manchester Centre for Health Economics, Divison of Population Health, University of Manchester, Manchester, UK",NA
"2665","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Thabit","H","Manchester Diabetes Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, UK",NA
"2666","34261691","10.1136/bmjopen-2021-050713","Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.","Optimising glycaemic control in type 1 diabetes (T1D) remains challenging. Flash glucose monitoring with FreeStyle Libre 2 (FSL2) is a novel alternative to the current standard of care self-monitoring of blood glucose (SMBG). No randomised controlled trials to date have explored the potential benefits of FSL2 in T1D. We aim to assess the impact of FSL2 in people with suboptimal glycaemic control T1D in comparison with SMBG. This open-label, multicentre, randomised (via stochastic minimisation), ","2021","07","19","BMJ Open","BMJ open","clinical trials; diabetes &amp; endocrinology; general diabetes; health economics; Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; COVID-19; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Multicenter Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; State Medicine; United Kingdom","Leelarathna","L","Manchester Clinical Trials Unit, University of Manchester, Manchester, UK Lalantha.Leelarathna@mft.nhs","Lalantha.Leelarathna@mft.nhs.uk"
"2667","34261689","10.1136/bmjopen-2021-048948","Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.","The nutritional sequelae of COVID-19 have not been explored in a large cohort study. To identify factors associated with the change in nutritional status between discharge and 30 days post-discharge (D30). Secondary objectives were to determine the prevalence of subjective functional loss and severe disability at D30 and their associated factors. Collected data included symptoms, nutritional status, self-evaluation of food intake, Performance Status (PS) Scale, Asthenia Scale, self-evaluation of","2021","07","19","BMJ Open","BMJ open","COVID-19; nutrition &amp; dietetics; rehabilitation medicine; Aftercare; COVID-19; Cohort Studies; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Patient Discharge; Prospective Studies; SARS-CoV-2; Survivors","Quilliot","Didier","Unité Transversale de Nutrition, CHRU de Nancy, Nancy, France d.quilliot@chru-nancy",NA
"2668","34261689","10.1136/bmjopen-2021-048948","Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.","The nutritional sequelae of COVID-19 have not been explored in a large cohort study. To identify factors associated with the change in nutritional status between discharge and 30 days post-discharge (D30). Secondary objectives were to determine the prevalence of subjective functional loss and severe disability at D30 and their associated factors. Collected data included symptoms, nutritional status, self-evaluation of food intake, Performance Status (PS) Scale, Asthenia Scale, self-evaluation of","2021","07","19","BMJ Open","BMJ open","COVID-19; nutrition &amp; dietetics; rehabilitation medicine; Aftercare; COVID-19; Cohort Studies; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Patient Discharge; Prospective Studies; SARS-CoV-2; Survivors","Gérard","Marine","Unité Transversale de Nutrition, CHRU de Nancy, Nancy, France",NA
"2669","34261689","10.1136/bmjopen-2021-048948","Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.","The nutritional sequelae of COVID-19 have not been explored in a large cohort study. To identify factors associated with the change in nutritional status between discharge and 30 days post-discharge (D30). Secondary objectives were to determine the prevalence of subjective functional loss and severe disability at D30 and their associated factors. Collected data included symptoms, nutritional status, self-evaluation of food intake, Performance Status (PS) Scale, Asthenia Scale, self-evaluation of","2021","07","19","BMJ Open","BMJ open","COVID-19; nutrition &amp; dietetics; rehabilitation medicine; Aftercare; COVID-19; Cohort Studies; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Patient Discharge; Prospective Studies; SARS-CoV-2; Survivors","Bonsack","Olivier","Unité Transversale de Nutrition, CHRU de Nancy, Nancy, France",NA
"2670","34261689","10.1136/bmjopen-2021-048948","Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.","The nutritional sequelae of COVID-19 have not been explored in a large cohort study. To identify factors associated with the change in nutritional status between discharge and 30 days post-discharge (D30). Secondary objectives were to determine the prevalence of subjective functional loss and severe disability at D30 and their associated factors. Collected data included symptoms, nutritional status, self-evaluation of food intake, Performance Status (PS) Scale, Asthenia Scale, self-evaluation of","2021","07","19","BMJ Open","BMJ open","COVID-19; nutrition &amp; dietetics; rehabilitation medicine; Aftercare; COVID-19; Cohort Studies; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Patient Discharge; Prospective Studies; SARS-CoV-2; Survivors","Malgras","Aurélie","Unité Transversale de Nutrition, CHRU de Nancy, Nancy, France",NA
"2671","34261689","10.1136/bmjopen-2021-048948","Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.","The nutritional sequelae of COVID-19 have not been explored in a large cohort study. To identify factors associated with the change in nutritional status between discharge and 30 days post-discharge (D30). Secondary objectives were to determine the prevalence of subjective functional loss and severe disability at D30 and their associated factors. Collected data included symptoms, nutritional status, self-evaluation of food intake, Performance Status (PS) Scale, Asthenia Scale, self-evaluation of","2021","07","19","BMJ Open","BMJ open","COVID-19; nutrition &amp; dietetics; rehabilitation medicine; Aftercare; COVID-19; Cohort Studies; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Patient Discharge; Prospective Studies; SARS-CoV-2; Survivors","Vaillant","Marie-France","Université Grenoble Alpes, Saint-Martin-d'Heres, France",NA
"2672","34261689","10.1136/bmjopen-2021-048948","Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.","The nutritional sequelae of COVID-19 have not been explored in a large cohort study. To identify factors associated with the change in nutritional status between discharge and 30 days post-discharge (D30). Secondary objectives were to determine the prevalence of subjective functional loss and severe disability at D30 and their associated factors. Collected data included symptoms, nutritional status, self-evaluation of food intake, Performance Status (PS) Scale, Asthenia Scale, self-evaluation of","2021","07","19","BMJ Open","BMJ open","COVID-19; nutrition &amp; dietetics; rehabilitation medicine; Aftercare; COVID-19; Cohort Studies; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Patient Discharge; Prospective Studies; SARS-CoV-2; Survivors","Di Patrizio","Paolo","General Medicine Department, University of Lorraine, Nancy, France",NA
"2673","34261689","10.1136/bmjopen-2021-048948","Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.","The nutritional sequelae of COVID-19 have not been explored in a large cohort study. To identify factors associated with the change in nutritional status between discharge and 30 days post-discharge (D30). Secondary objectives were to determine the prevalence of subjective functional loss and severe disability at D30 and their associated factors. Collected data included symptoms, nutritional status, self-evaluation of food intake, Performance Status (PS) Scale, Asthenia Scale, self-evaluation of","2021","07","19","BMJ Open","BMJ open","COVID-19; nutrition &amp; dietetics; rehabilitation medicine; Aftercare; COVID-19; Cohort Studies; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Patient Discharge; Prospective Studies; SARS-CoV-2; Survivors","Jaussaud","Roland","Internal Medicine and Clinical Immunology Department, CHRU de Nancy, Nancy, France",NA
"2674","34261689","10.1136/bmjopen-2021-048948","Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.","The nutritional sequelae of COVID-19 have not been explored in a large cohort study. To identify factors associated with the change in nutritional status between discharge and 30 days post-discharge (D30). Secondary objectives were to determine the prevalence of subjective functional loss and severe disability at D30 and their associated factors. Collected data included symptoms, nutritional status, self-evaluation of food intake, Performance Status (PS) Scale, Asthenia Scale, self-evaluation of","2021","07","19","BMJ Open","BMJ open","COVID-19; nutrition &amp; dietetics; rehabilitation medicine; Aftercare; COVID-19; Cohort Studies; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Patient Discharge; Prospective Studies; SARS-CoV-2; Survivors","Ziegler","Olivier","Endocrinology Diabetology and Nutrition Department, CHRU de Nancy, Nancy, France",NA
"2675","34261689","10.1136/bmjopen-2021-048948","Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.","The nutritional sequelae of COVID-19 have not been explored in a large cohort study. To identify factors associated with the change in nutritional status between discharge and 30 days post-discharge (D30). Secondary objectives were to determine the prevalence of subjective functional loss and severe disability at D30 and their associated factors. Collected data included symptoms, nutritional status, self-evaluation of food intake, Performance Status (PS) Scale, Asthenia Scale, self-evaluation of","2021","07","19","BMJ Open","BMJ open","COVID-19; nutrition &amp; dietetics; rehabilitation medicine; Aftercare; COVID-19; Cohort Studies; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Patient Discharge; Prospective Studies; SARS-CoV-2; Survivors","Nguyen-Thi","Phi-Linh","Medical Evaluation Department, Department of Clinical Research Support PARC, University of Lorraine, CHRU de Nancy, Nancy, France",NA
"2676","34261687","10.1136/bmjopen-2020-048380","Social isolation and its psychosocial factors in mild lockdown for the COVID-19 pandemic: a cross-sectional survey of the Japanese population.","This study investigated the sociodemographic, behavioural and psychological characteristics of socially isolated individuals during the 'mild lockdown' period of COVID-19 in Japan. A cross-sectional study. The seven prefectures where the emergency declaration was first applied in Japan. We collected data on 11 333 individuals (52.4% women, 46.3±14.6 years) living in the seven prefectures where the emergency declaration was first applied. The online survey was performed between 11 May and 12 May ","2021","07","19","BMJ Open","BMJ open","COVID-19; mental health; public health; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Japan; Male; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Sugaya","Nagisa","School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan",NA
"2677","34261687","10.1136/bmjopen-2020-048380","Social isolation and its psychosocial factors in mild lockdown for the COVID-19 pandemic: a cross-sectional survey of the Japanese population.","This study investigated the sociodemographic, behavioural and psychological characteristics of socially isolated individuals during the 'mild lockdown' period of COVID-19 in Japan. A cross-sectional study. The seven prefectures where the emergency declaration was first applied in Japan. We collected data on 11 333 individuals (52.4% women, 46.3±14.6 years) living in the seven prefectures where the emergency declaration was first applied. The online survey was performed between 11 May and 12 May ","2021","07","19","BMJ Open","BMJ open","COVID-19; mental health; public health; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Japan; Male; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Yamamoto","Tetsuya","Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Tokushima, Japan t.yamamoto@tokushima-u.ac",NA
"2678","34261687","10.1136/bmjopen-2020-048380","Social isolation and its psychosocial factors in mild lockdown for the COVID-19 pandemic: a cross-sectional survey of the Japanese population.","This study investigated the sociodemographic, behavioural and psychological characteristics of socially isolated individuals during the 'mild lockdown' period of COVID-19 in Japan. A cross-sectional study. The seven prefectures where the emergency declaration was first applied in Japan. We collected data on 11 333 individuals (52.4% women, 46.3±14.6 years) living in the seven prefectures where the emergency declaration was first applied. The online survey was performed between 11 May and 12 May ","2021","07","19","BMJ Open","BMJ open","COVID-19; mental health; public health; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Japan; Male; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Suzuki","Naho","Graduate School of Sciences and Technology for Innovation, Tokushima University Tokushima, Tokushima, Tokushima, Japan",NA
"2679","34261687","10.1136/bmjopen-2020-048380","Social isolation and its psychosocial factors in mild lockdown for the COVID-19 pandemic: a cross-sectional survey of the Japanese population.","This study investigated the sociodemographic, behavioural and psychological characteristics of socially isolated individuals during the 'mild lockdown' period of COVID-19 in Japan. A cross-sectional study. The seven prefectures where the emergency declaration was first applied in Japan. We collected data on 11 333 individuals (52.4% women, 46.3±14.6 years) living in the seven prefectures where the emergency declaration was first applied. The online survey was performed between 11 May and 12 May ","2021","07","19","BMJ Open","BMJ open","COVID-19; mental health; public health; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Japan; Male; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Uchiumi","Chigusa","Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Tokushima, Japan",NA
"2680","34261678","10.1136/bmjopen-2020-043758","Development and validation of the Oxford Pandemic Attitude Scale-COVID-19 (OPAS-C): an internet-based cross-sectional study in the UK and USA.","To develop and validate the Oxford Pandemic Attitude Scale-COVID-19 (OPAS-C), a multidimensional scale that addresses seven domains over 20 items including stress, fear, loneliness, sense of community, belief that the pandemic is a hoax or exaggerated, the use of and attitude to non-pharmaceutical interventions and vaccine hesitancy, in a single measure. Cross-sectional validation study. Internet based with respondents in the USA and UK. General community respondents using the Prolific Academic ","2021","07","19","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cross-Sectional Studies; Factor Analysis, Statistical; Humans; Internet; Pandemics; Psychometrics; Reproducibility of Results; SARS-CoV-2; Surveys and Questionnaires; United Kingdom","Kantor","Bella Nichole","Harvard University, Cambridge, Massachusetts, USA",NA
"2681","34261678","10.1136/bmjopen-2020-043758","Development and validation of the Oxford Pandemic Attitude Scale-COVID-19 (OPAS-C): an internet-based cross-sectional study in the UK and USA.","To develop and validate the Oxford Pandemic Attitude Scale-COVID-19 (OPAS-C), a multidimensional scale that addresses seven domains over 20 items including stress, fear, loneliness, sense of community, belief that the pandemic is a hoax or exaggerated, the use of and attitude to non-pharmaceutical interventions and vaccine hesitancy, in a single measure. Cross-sectional validation study. Internet based with respondents in the USA and UK. General community respondents using the Prolific Academic ","2021","07","19","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cross-Sectional Studies; Factor Analysis, Statistical; Humans; Internet; Pandemics; Psychometrics; Reproducibility of Results; SARS-CoV-2; Surveys and Questionnaires; United Kingdom","Kantor","Jonathan","Center for Global Health, Center for Clinical Epidemiology and Biostatistics, and Department of Dermatology, University of Pennsylvania Perelman School of Medicine and Florida Center for Dermatology, PA, St Augustine, Florida, USA jonkantor@gmail","jonkantor@gmail.com"
"2682","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Carlson","Peter M","Department of Human Oncology, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2683","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Mohan","Manasi","Department of Human Oncology, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2684","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Patel","Ravi B","Department of Radiation Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA",NA
"2685","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Birstler","Jen","Department of Biostatistics and Medical Informatics, Wisconsin Alumni Research Foundation, Madison, WI",NA
"2686","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Nettenstrom","Lauren","Flow Cytometry Laboratory, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2687","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Sheerar","Dagna","Flow Cytometry Laboratory, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2688","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Fox","Kathryn","Flow Cytometry Laboratory, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2689","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Rodriguez","Matthew","Department of Human Oncology, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2690","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Hoefges","Anna","Department of Human Oncology, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2691","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Hernandez","Reinier","Department of Radiology, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2692","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Zahm","Chris","Department of Medicine, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2693","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Kim","KyungMann","Department of Biostatistics and Medical Informatics, Wisconsin Alumni Research Foundation, Madison, WI",NA
"2694","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"McNeel","Douglas G","Department of Medicine, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2695","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Weichert","Jamey","Department of Radiology, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2696","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Morris","Zachary S","Department of Human Oncology, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI",NA
"2697","34261667","10.4049/jimmunol.2000656","Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.","Most shared resource flow cytometry facilities do not permit analysis of radioactive samples. We are investigating low-dose molecular targeted radionuclide therapy (MTRT) as an immunomodulator in combination with in situ tumor vaccines and need to analyze radioactive samples from MTRT-treated mice using flow cytometry. Further, the sudden shutdown of core facilities in response to the COVID-19 pandemic has created an unprecedented work stoppage. In these and other research settings, a robust and","2021","07","21","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Sondel","Paul M","Department of Human Oncology, Wisconsin Institutes for Medical Research, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI","pmsondel@humonc.wisc.edu"
"2698","34261655","10.1126/sciadv.abg2898","Meaningful messaging: Sentiment in elite social media communication with the public on the COVID-19 pandemic.","Elite messaging plays a crucial role in shaping public debate and spreading information. We examine elite political communication during an emergent international crisis to investigate the role of tone in messaging, information spread, and public reaction. By measuring tone in social media messages from members of the U.S. Congress related to the COVID-19 pandemic, we find clear partisan differences and a differential impact of tone on message engagement and information spread. This suggests tha","2021","07","18","Sci Adv","Science advances",NA,"Box-Steffensmeier","Janet M","Department of Political Science, The Ohio State University, 154 N. Oval Mall, Columbus, OH 43210, USA. box-steffensmeier.1@osu","steffensmeier.1@osu.edu"
"2699","34261655","10.1126/sciadv.abg2898","Meaningful messaging: Sentiment in elite social media communication with the public on the COVID-19 pandemic.","Elite messaging plays a crucial role in shaping public debate and spreading information. We examine elite political communication during an emergent international crisis to investigate the role of tone in messaging, information spread, and public reaction. By measuring tone in social media messages from members of the U.S. Congress related to the COVID-19 pandemic, we find clear partisan differences and a differential impact of tone on message engagement and information spread. This suggests tha","2021","07","18","Sci Adv","Science advances",NA,"Moses","Laura","Department of Political Science, The Ohio State University, 154 N. Oval Mall, Columbus, OH 43210, USA",NA
"2700","34261643","10.1136/bmj.n1797","Covid-19: France and Greece make vaccination mandatory for healthcare workers.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Wise","Jacqui","Kent",NA
"2701","34261641","10.1136/bmj.n1701","Covid 19: People with learning disabilities are highly vulnerable.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Courtenay","Ken","Faculty of Psychiatry of Intellectual Disability, Royal College of Psychiatrists, London, UK ChairFacultyPID@rcpsych.ac","ChairFacultyPID@rcpsych.ac.uk"
"2702","34261641","10.1136/bmj.n1701","Covid 19: People with learning disabilities are highly vulnerable.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Cooper","Vivien","The Challenging Behaviour Foundation, Kent, UK",NA
"2703","34261640","10.1136/bmj.n1719","No veterinarians (yet) on the Italian covid-19 scientific committee.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Di Guardo","Giovanni","Faculty of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy",NA
"2704","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Williamson","Elizabeth J","London School of Hygiene and Tropical Medicine, London, UK",NA
"2705","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"McDonald","Helen I","London School of Hygiene and Tropical Medicine, London, UK",NA
"2706","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Bhaskaran","Krishnan","London School of Hygiene and Tropical Medicine, London, UK",NA
"2707","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Walker","Alex J","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2708","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Bacon","Sebastian","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2709","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Davy","Simon","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2710","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Schultze","Anna","London School of Hygiene and Tropical Medicine, London, UK",NA
"2711","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Tomlinson","Laurie","London School of Hygiene and Tropical Medicine, London, UK",NA
"2712","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Bates","Chris","TPP, TPP House, Horsforth, Leeds, UK",NA
"2713","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Ramsay","Mary","National Institute for Health Research (NIHR) Health Protection Research Unit in Vaccines and Immunisation, London, UK",NA
"2714","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Curtis","Helen J","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2715","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Forbes","Harriet","University of Bristol, Bristol, UK",NA
"2716","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Wing","Kevin","London School of Hygiene and Tropical Medicine, London, UK",NA
"2717","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Minassian","Caroline","London School of Hygiene and Tropical Medicine, London, UK",NA
"2718","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Tazare","John","London School of Hygiene and Tropical Medicine, London, UK",NA
"2719","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Morton","Caroline E","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2720","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Nightingale","Emily","London School of Hygiene and Tropical Medicine, London, UK",NA
"2721","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Mehrkar","Amir","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2722","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Evans","Dave","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2723","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Inglesby","Peter","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2724","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"MacKenna","Brian","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2725","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Cockburn","Jonathan","TPP, TPP House, Horsforth, Leeds, UK",NA
"2726","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Rentsch","Christopher T","London School of Hygiene and Tropical Medicine, London, UK",NA
"2727","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Mathur","Rohini","London School of Hygiene and Tropical Medicine, London, UK",NA
"2728","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Wong","Angel Y S","London School of Hygiene and Tropical Medicine, London, UK",NA
"2729","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Eggo","Rosalind M","London School of Hygiene and Tropical Medicine, London, UK",NA
"2730","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Hulme","William","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2731","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Croker","Richard","The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"2732","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Parry","John","TPP, TPP House, Horsforth, Leeds, UK",NA
"2733","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Hester","Frank","TPP, TPP House, Horsforth, Leeds, UK",NA
"2734","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Harper","Sam","TPP, TPP House, Horsforth, Leeds, UK",NA
"2735","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Douglas","Ian J","London School of Hygiene and Tropical Medicine, London, UK",NA
"2736","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Evans","Stephen J W","London School of Hygiene and Tropical Medicine, London, UK",NA
"2737","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Smeeth","Liam","London School of Hygiene and Tropical Medicine, London, UK",NA
"2738","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Goldacre","Ben","National Institute for Health Research (NIHR) Health Protection Research Unit in Vaccines and Immunisation, London, UK",NA
"2739","34261639","10.1136/bmj.n1592","Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.","To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS S","2021","07","18","BMJ","BMJ (Clinical research ed.)",NA,"Kuper","Hannah","London School of Hygiene and Tropical Medicine, London, UK",NA
"2740","34261635","10.1136/bcr-2021-243975","Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson &amp; Johnson COVID-19 vaccine.","As with past illnesses, an approach has been taken to vaccinate the population and halt the spread of COVID-19. On 13 April 2021, the US Food and Drug Administration called for a halt in the administration of the Johnson &amp; Johnson (J&amp;J) COVID-19 vaccine due to reports of thrombosis and thrombocytopenia being associated with vaccination. We present the case of a 43-year-old woman with a history of dyslipidaemia, depression, gastro-oesophageal reflux disease and obesity presenting with dys","2021","07","16","BMJ Case Rep","BMJ case reports","COVID-19; drugs and medicines; infectious diseases; respiratory medicine; vaccination/immunisation; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Ischemic Attack, Transient; Pulmonary Embolism; SARS-CoV-2; Thrombocytopenia","Malik","Bilal","Internal Medicine, McLaren Health Care Corp/ MSU, Flint, Michigan, USA Bilal.Malik@mclaren","Bilal.Malik@mclaren.org"
"2741","34261635","10.1136/bcr-2021-243975","Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson &amp; Johnson COVID-19 vaccine.","As with past illnesses, an approach has been taken to vaccinate the population and halt the spread of COVID-19. On 13 April 2021, the US Food and Drug Administration called for a halt in the administration of the Johnson &amp; Johnson (J&amp;J) COVID-19 vaccine due to reports of thrombosis and thrombocytopenia being associated with vaccination. We present the case of a 43-year-old woman with a history of dyslipidaemia, depression, gastro-oesophageal reflux disease and obesity presenting with dys","2021","07","16","BMJ Case Rep","BMJ case reports","COVID-19; drugs and medicines; infectious diseases; respiratory medicine; vaccination/immunisation; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Ischemic Attack, Transient; Pulmonary Embolism; SARS-CoV-2; Thrombocytopenia","Kalantary","Atefeh","Internal Medicine, McLaren Health Care Corp/ MSU, Flint, Michigan, USA",NA
"2742","34261635","10.1136/bcr-2021-243975","Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson &amp; Johnson COVID-19 vaccine.","As with past illnesses, an approach has been taken to vaccinate the population and halt the spread of COVID-19. On 13 April 2021, the US Food and Drug Administration called for a halt in the administration of the Johnson &amp; Johnson (J&amp;J) COVID-19 vaccine due to reports of thrombosis and thrombocytopenia being associated with vaccination. We present the case of a 43-year-old woman with a history of dyslipidaemia, depression, gastro-oesophageal reflux disease and obesity presenting with dys","2021","07","16","BMJ Case Rep","BMJ case reports","COVID-19; drugs and medicines; infectious diseases; respiratory medicine; vaccination/immunisation; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Ischemic Attack, Transient; Pulmonary Embolism; SARS-CoV-2; Thrombocytopenia","Rikabi","Kamal","Internal Medicine, McLaren Health Care Corp/ MSU, Flint, Michigan, USA",NA
"2743","34261635","10.1136/bcr-2021-243975","Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson &amp; Johnson COVID-19 vaccine.","As with past illnesses, an approach has been taken to vaccinate the population and halt the spread of COVID-19. On 13 April 2021, the US Food and Drug Administration called for a halt in the administration of the Johnson &amp; Johnson (J&amp;J) COVID-19 vaccine due to reports of thrombosis and thrombocytopenia being associated with vaccination. We present the case of a 43-year-old woman with a history of dyslipidaemia, depression, gastro-oesophageal reflux disease and obesity presenting with dys","2021","07","16","BMJ Case Rep","BMJ case reports","COVID-19; drugs and medicines; infectious diseases; respiratory medicine; vaccination/immunisation; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Ischemic Attack, Transient; Pulmonary Embolism; SARS-CoV-2; Thrombocytopenia","Kunadi","Arvind","Nephrology/ Internal Medicine, McLaren Health Care Corp/ MSU, Flint, Michigan, USA",NA
"2744","34261633","10.1136/bcr-2021-243799","Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?","The novel coronavirus SARS-CoV-2 became a global pandemic in late 2019, and is still ongoing in 2021 causing significant morbidity and mortality. The advent of vaccinations heralded the turning of the tide. The Oxford jab, a vector-based vaccine was favoured due to its low cost and ease of storage. However, its potential association with thromboembolic adverse events resulted in controversy and disrupted its roll-out and use. The aetiopathogenesis of these thromboembolic events and its associati","2021","07","16","BMJ Case Rep","BMJ case reports","emergency medicine; global health; COVID-19; Celiac Artery; Humans; Male; Middle Aged; SARS-CoV-2; Splenic Artery; Splenic Infarction; Thrombosis; Vaccination","Bandapaati","Sareesh","Emergency Department, Kettering General Hospital, Kettering, Northamptonshire, UK sareesh.bandapaati@nhs","sareesh.bandapaati@nhs.net"
"2745","34261633","10.1136/bcr-2021-243799","Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?","The novel coronavirus SARS-CoV-2 became a global pandemic in late 2019, and is still ongoing in 2021 causing significant morbidity and mortality. The advent of vaccinations heralded the turning of the tide. The Oxford jab, a vector-based vaccine was favoured due to its low cost and ease of storage. However, its potential association with thromboembolic adverse events resulted in controversy and disrupted its roll-out and use. The aetiopathogenesis of these thromboembolic events and its associati","2021","07","16","BMJ Case Rep","BMJ case reports","emergency medicine; global health; COVID-19; Celiac Artery; Humans; Male; Middle Aged; SARS-CoV-2; Splenic Artery; Splenic Infarction; Thrombosis; Vaccination","Bobba","Hemababu","Emergency Department, Kettering General Hospital, Kettering, Northamptonshire, UK",NA
"2746","34261633","10.1136/bcr-2021-243799","Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?","The novel coronavirus SARS-CoV-2 became a global pandemic in late 2019, and is still ongoing in 2021 causing significant morbidity and mortality. The advent of vaccinations heralded the turning of the tide. The Oxford jab, a vector-based vaccine was favoured due to its low cost and ease of storage. However, its potential association with thromboembolic adverse events resulted in controversy and disrupted its roll-out and use. The aetiopathogenesis of these thromboembolic events and its associati","2021","07","16","BMJ Case Rep","BMJ case reports","emergency medicine; global health; COVID-19; Celiac Artery; Humans; Male; Middle Aged; SARS-CoV-2; Splenic Artery; Splenic Infarction; Thrombosis; Vaccination","Navinan","Mitrakrishnan Rayno","Cardiology Department, Kettering General Hospital, Kettering, Northamptonshire, UK",NA
"2747","34261628","10.1136/bmj.n1786","Covid-19: Regulators warn that rare Guillain-Barré cases may link to J&amp;J and AstraZeneca vaccines.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Dyer","Owen","Montreal",NA
"2748","34261623","10.1136/bmj.n1789","Covid-19: ""Freedom day"" in England could lead to ""significant third wave of hospitalisations and deaths,"" modelling predicts.",NA,"2021","07","16","BMJ","BMJ (Clinical research ed.)",NA,"Iacobucci","Gareth","The BMJ",NA
"2749","34261622","10.1136/bmj.n1776","Dying at home during covid-19: a view from primary care.",NA,"2021","07","19","BMJ","BMJ (Clinical research ed.)","COVID-19; Humans; Palliative Care; Primary Health Care; SARS-CoV-2; Terminal Care","Mitchell","Sarah","White House Surgery, Sheffield, UK",NA
"2750","34261622","10.1136/bmj.n1776","Dying at home during covid-19: a view from primary care.",NA,"2021","07","19","BMJ","BMJ (Clinical research ed.)","COVID-19; Humans; Palliative Care; Primary Health Care; SARS-CoV-2; Terminal Care","Chapman","Helen","Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK",NA
"2751","34261622","10.1136/bmj.n1776","Dying at home during covid-19: a view from primary care.",NA,"2021","07","19","BMJ","BMJ (Clinical research ed.)","COVID-19; Humans; Palliative Care; Primary Health Care; SARS-CoV-2; Terminal Care","Fowler","Iolanthe","Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK",NA
"2752","34261622","10.1136/bmj.n1776","Dying at home during covid-19: a view from primary care.",NA,"2021","07","19","BMJ","BMJ (Clinical research ed.)","COVID-19; Humans; Palliative Care; Primary Health Care; SARS-CoV-2; Terminal Care","McTague","Laura","St Luke's Hospice, Sheffield, UK",NA
"2753","34261620","10.1016/j.auec.2021.07.001","Effect of COVID-19 on management of patients with low back pain in the emergency department.","Patients presenting to Emergency Department (ED) with non-specific low back pain can receive more unnecessary, intensive and costly care than is recommended. The COVID-19 pandemic has provided an unprecedented opportunity to examine how health systems prioritise necessary care that provides clear benefits to patients. The purpose of this study was to examine the impact of COVID-19 on care of low back pain in the ED. We performed a retrospective analysis of electronic medical record data on care ","2021","07","24","Australas Emerg Care","Australasian emergency care","Ambulance; Diagnostic imaging; Emergency department; Low back pain; Opioid","Sharma","Sweekriti","Institute for Musculoskeletal Health, The University of Sydney and Sydney Local Health District, Sydney, Australia","sweekriti.sharma@sydney.edu.au"
"2754","34261620","10.1016/j.auec.2021.07.001","Effect of COVID-19 on management of patients with low back pain in the emergency department.","Patients presenting to Emergency Department (ED) with non-specific low back pain can receive more unnecessary, intensive and costly care than is recommended. The COVID-19 pandemic has provided an unprecedented opportunity to examine how health systems prioritise necessary care that provides clear benefits to patients. The purpose of this study was to examine the impact of COVID-19 on care of low back pain in the ED. We performed a retrospective analysis of electronic medical record data on care ","2021","07","24","Australas Emerg Care","Australasian emergency care","Ambulance; Diagnostic imaging; Emergency department; Low back pain; Opioid","Traeger","Adrian C","Institute for Musculoskeletal Health, The University of Sydney and Sydney Local Health District, Sydney, Australia",NA
"2755","34261620","10.1016/j.auec.2021.07.001","Effect of COVID-19 on management of patients with low back pain in the emergency department.","Patients presenting to Emergency Department (ED) with non-specific low back pain can receive more unnecessary, intensive and costly care than is recommended. The COVID-19 pandemic has provided an unprecedented opportunity to examine how health systems prioritise necessary care that provides clear benefits to patients. The purpose of this study was to examine the impact of COVID-19 on care of low back pain in the ED. We performed a retrospective analysis of electronic medical record data on care ","2021","07","24","Australas Emerg Care","Australasian emergency care","Ambulance; Diagnostic imaging; Emergency department; Low back pain; Opioid","Machado","Gustavo C","Institute for Musculoskeletal Health, The University of Sydney and Sydney Local Health District, Sydney, Australia",NA
"2756","34261620","10.1016/j.auec.2021.07.001","Effect of COVID-19 on management of patients with low back pain in the emergency department.","Patients presenting to Emergency Department (ED) with non-specific low back pain can receive more unnecessary, intensive and costly care than is recommended. The COVID-19 pandemic has provided an unprecedented opportunity to examine how health systems prioritise necessary care that provides clear benefits to patients. The purpose of this study was to examine the impact of COVID-19 on care of low back pain in the ED. We performed a retrospective analysis of electronic medical record data on care ","2021","07","24","Australas Emerg Care","Australasian emergency care","Ambulance; Diagnostic imaging; Emergency department; Low back pain; Opioid","Abdel Shaheed","Christina","Institute for Musculoskeletal Health, The University of Sydney and Sydney Local Health District, Sydney, Australia",NA
"2757","34261620","10.1016/j.auec.2021.07.001","Effect of COVID-19 on management of patients with low back pain in the emergency department.","Patients presenting to Emergency Department (ED) with non-specific low back pain can receive more unnecessary, intensive and costly care than is recommended. The COVID-19 pandemic has provided an unprecedented opportunity to examine how health systems prioritise necessary care that provides clear benefits to patients. The purpose of this study was to examine the impact of COVID-19 on care of low back pain in the ED. We performed a retrospective analysis of electronic medical record data on care ","2021","07","24","Australas Emerg Care","Australasian emergency care","Ambulance; Diagnostic imaging; Emergency department; Low back pain; Opioid","Jones","Caitlin","Institute for Musculoskeletal Health, The University of Sydney and Sydney Local Health District, Sydney, Australia",NA
"2758","34261620","10.1016/j.auec.2021.07.001","Effect of COVID-19 on management of patients with low back pain in the emergency department.","Patients presenting to Emergency Department (ED) with non-specific low back pain can receive more unnecessary, intensive and costly care than is recommended. The COVID-19 pandemic has provided an unprecedented opportunity to examine how health systems prioritise necessary care that provides clear benefits to patients. The purpose of this study was to examine the impact of COVID-19 on care of low back pain in the ED. We performed a retrospective analysis of electronic medical record data on care ","2021","07","24","Australas Emerg Care","Australasian emergency care","Ambulance; Diagnostic imaging; Emergency department; Low back pain; Opioid","Maher","Chris G","Institute for Musculoskeletal Health, The University of Sydney and Sydney Local Health District, Sydney, Australia",NA
"2759","34261612","10.1016/j.jmii.2021.06.001","Effective use of an advanced isolation unit during the COVID-19 pandemic: A retrospective cohort study.","We described a strategy for preventing virus transmission within hospitals through screening and advanced isolation during the coronavirus pandemic. Patients were screened and admitted to the adult advanced isolation unit from February to April 2020. Our process minimized exposure without delaying proper treatment and prevented virus transmission within the hospital.","2021","07","18","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Covid-19; Cross infection; Patient isolation; Severe acute respiratory syndrome coronavirus 2","Park","Youngmok","Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea",NA
"2760","34261612","10.1016/j.jmii.2021.06.001","Effective use of an advanced isolation unit during the COVID-19 pandemic: A retrospective cohort study.","We described a strategy for preventing virus transmission within hospitals through screening and advanced isolation during the coronavirus pandemic. Patients were screened and admitted to the adult advanced isolation unit from February to April 2020. Our process minimized exposure without delaying proper treatment and prevented virus transmission within the hospital.","2021","07","18","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Covid-19; Cross infection; Patient isolation; Severe acute respiratory syndrome coronavirus 2","Kwak","Se Hyun","Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea",NA
"2761","34261612","10.1016/j.jmii.2021.06.001","Effective use of an advanced isolation unit during the COVID-19 pandemic: A retrospective cohort study.","We described a strategy for preventing virus transmission within hospitals through screening and advanced isolation during the coronavirus pandemic. Patients were screened and admitted to the adult advanced isolation unit from February to April 2020. Our process minimized exposure without delaying proper treatment and prevented virus transmission within the hospital.","2021","07","18","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Covid-19; Cross infection; Patient isolation; Severe acute respiratory syndrome coronavirus 2","Chung","Kyungsoo","Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: chungks@yuhs","chungks@yuhs.ac"
"2762","34261612","10.1016/j.jmii.2021.06.001","Effective use of an advanced isolation unit during the COVID-19 pandemic: A retrospective cohort study.","We described a strategy for preventing virus transmission within hospitals through screening and advanced isolation during the coronavirus pandemic. Patients were screened and admitted to the adult advanced isolation unit from February to April 2020. Our process minimized exposure without delaying proper treatment and prevented virus transmission within the hospital.","2021","07","18","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Covid-19; Cross infection; Patient isolation; Severe acute respiratory syndrome coronavirus 2","Park","Moo Suk","Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: pms70@yuhs","pms70@yuhs.ac"
"2763","34261596","10.1016/j.crad.2021.06.010","Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply.",NA,"2021","07","21","Clin Radiol","Clinical radiology",NA,"Jothimani","D","Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India. Electronic address: dinesh.jothimani@relainstitute","dinesh.jothimani@relainstitute.com"
"2764","34261596","10.1016/j.crad.2021.06.010","Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply.",NA,"2021","07","21","Clin Radiol","Clinical radiology",NA,"Danielraj","S","Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India",NA
"2765","34261596","10.1016/j.crad.2021.06.010","Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply.",NA,"2021","07","21","Clin Radiol","Clinical radiology",NA,"Nallathambi","B","Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India",NA
"2766","34261596","10.1016/j.crad.2021.06.010","Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply.",NA,"2021","07","21","Clin Radiol","Clinical radiology",NA,"Pandurangan","B","Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India",NA
"2767","34261596","10.1016/j.crad.2021.06.010","Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply.",NA,"2021","07","21","Clin Radiol","Clinical radiology",NA,"Kalyanasundaram","S","Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India",NA
"2768","34261596","10.1016/j.crad.2021.06.010","Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply.",NA,"2021","07","21","Clin Radiol","Clinical radiology",NA,"Subbiah","K","Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India",NA
"2769","34261596","10.1016/j.crad.2021.06.010","Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply.",NA,"2021","07","21","Clin Radiol","Clinical radiology",NA,"Ramachandran","H","Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India",NA
"2770","34261596","10.1016/j.crad.2021.06.010","Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply.",NA,"2021","07","21","Clin Radiol","Clinical radiology",NA,"Venugopal","R","Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India",NA
"2771","34261596","10.1016/j.crad.2021.06.010","Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply.",NA,"2021","07","21","Clin Radiol","Clinical radiology",NA,"Dhas","D","Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India",NA
"2772","34261596","10.1016/j.crad.2021.06.010","Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply.",NA,"2021","07","21","Clin Radiol","Clinical radiology",NA,"Rela","M","Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India",NA
"2774","34261580","10.1016/j.transproceed.2021.06.027","Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia.","We aimed to evaluate the clinical characteristics and outcomes of mild-severe COVID-19 pneumonia cases in liver transplant (LT) recipients. Ten LT recipients diagnosed as having COVID-19 pneumonia in a 6-month period in our transplantation center were included. Demographic and medical data of the recipients were retrospectively collected; clinical courses, treatment responses, and outcomes were evaluated. Ten LT recipients were male, had a median age of 57 years (min-max, 36-69 years; interquart","2021","07","18","Transplant Proc","Transplantation proceedings",NA,"Kose","Adem","Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey. Electronic address: adem.kose@inonu.edu","adem.kose@inonu.edu.tr"
"2775","34261580","10.1016/j.transproceed.2021.06.027","Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia.","We aimed to evaluate the clinical characteristics and outcomes of mild-severe COVID-19 pneumonia cases in liver transplant (LT) recipients. Ten LT recipients diagnosed as having COVID-19 pneumonia in a 6-month period in our transplantation center were included. Demographic and medical data of the recipients were retrospectively collected; clinical courses, treatment responses, and outcomes were evaluated. Ten LT recipients were male, had a median age of 57 years (min-max, 36-69 years; interquart","2021","07","18","Transplant Proc","Transplantation proceedings",NA,"Toplu","Sibel Altunisik","Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey",NA
"2776","34261580","10.1016/j.transproceed.2021.06.027","Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia.","We aimed to evaluate the clinical characteristics and outcomes of mild-severe COVID-19 pneumonia cases in liver transplant (LT) recipients. Ten LT recipients diagnosed as having COVID-19 pneumonia in a 6-month period in our transplantation center were included. Demographic and medical data of the recipients were retrospectively collected; clinical courses, treatment responses, and outcomes were evaluated. Ten LT recipients were male, had a median age of 57 years (min-max, 36-69 years; interquart","2021","07","18","Transplant Proc","Transplantation proceedings",NA,"Yalcinsoy","Murat","Department of Chest Diseases, Faculty of Medicine, Inonu University, Malatya, Turkey",NA
"2777","34261580","10.1016/j.transproceed.2021.06.027","Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia.","We aimed to evaluate the clinical characteristics and outcomes of mild-severe COVID-19 pneumonia cases in liver transplant (LT) recipients. Ten LT recipients diagnosed as having COVID-19 pneumonia in a 6-month period in our transplantation center were included. Demographic and medical data of the recipients were retrospectively collected; clinical courses, treatment responses, and outcomes were evaluated. Ten LT recipients were male, had a median age of 57 years (min-max, 36-69 years; interquart","2021","07","18","Transplant Proc","Transplantation proceedings",NA,"Yakupogullari","Yusuf","Department of Medical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey",NA
"2778","34261580","10.1016/j.transproceed.2021.06.027","Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia.","We aimed to evaluate the clinical characteristics and outcomes of mild-severe COVID-19 pneumonia cases in liver transplant (LT) recipients. Ten LT recipients diagnosed as having COVID-19 pneumonia in a 6-month period in our transplantation center were included. Demographic and medical data of the recipients were retrospectively collected; clinical courses, treatment responses, and outcomes were evaluated. Ten LT recipients were male, had a median age of 57 years (min-max, 36-69 years; interquart","2021","07","18","Transplant Proc","Transplantation proceedings",NA,"Otlu","Baris","Department of Medical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey",NA
"2779","34261580","10.1016/j.transproceed.2021.06.027","Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia.","We aimed to evaluate the clinical characteristics and outcomes of mild-severe COVID-19 pneumonia cases in liver transplant (LT) recipients. Ten LT recipients diagnosed as having COVID-19 pneumonia in a 6-month period in our transplantation center were included. Demographic and medical data of the recipients were retrospectively collected; clinical courses, treatment responses, and outcomes were evaluated. Ten LT recipients were male, had a median age of 57 years (min-max, 36-69 years; interquart","2021","07","18","Transplant Proc","Transplantation proceedings",NA,"Otan","Emrah","Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya, Turkey",NA
"2780","34261580","10.1016/j.transproceed.2021.06.027","Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia.","We aimed to evaluate the clinical characteristics and outcomes of mild-severe COVID-19 pneumonia cases in liver transplant (LT) recipients. Ten LT recipients diagnosed as having COVID-19 pneumonia in a 6-month period in our transplantation center were included. Demographic and medical data of the recipients were retrospectively collected; clinical courses, treatment responses, and outcomes were evaluated. Ten LT recipients were male, had a median age of 57 years (min-max, 36-69 years; interquart","2021","07","18","Transplant Proc","Transplantation proceedings",NA,"Aydin","Cemalettin","Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya, Turkey",NA
"2781","34261580","10.1016/j.transproceed.2021.06.027","Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia.","We aimed to evaluate the clinical characteristics and outcomes of mild-severe COVID-19 pneumonia cases in liver transplant (LT) recipients. Ten LT recipients diagnosed as having COVID-19 pneumonia in a 6-month period in our transplantation center were included. Demographic and medical data of the recipients were retrospectively collected; clinical courses, treatment responses, and outcomes were evaluated. Ten LT recipients were male, had a median age of 57 years (min-max, 36-69 years; interquart","2021","07","18","Transplant Proc","Transplantation proceedings",NA,"Yilmaz","Sezai","Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya, Turkey",NA
"2782","34261580","10.1016/j.transproceed.2021.06.027","Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia.","We aimed to evaluate the clinical characteristics and outcomes of mild-severe COVID-19 pneumonia cases in liver transplant (LT) recipients. Ten LT recipients diagnosed as having COVID-19 pneumonia in a 6-month period in our transplantation center were included. Demographic and medical data of the recipients were retrospectively collected; clinical courses, treatment responses, and outcomes were evaluated. Ten LT recipients were male, had a median age of 57 years (min-max, 36-69 years; interquart","2021","07","18","Transplant Proc","Transplantation proceedings",NA,"Bayindir","Yasar","Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey",NA
"2783","34261575","10.1017/dmp.2021.230","Of Lives and Life Years: 1918 Influenza vs. Covid-19.",NA,"2021","07","15","Disaster Med Public Health Prep","Disaster medicine and public health preparedness",NA,"James","James J",NA,NA
"2784","34261574","10.1017/ice.2021.321","Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","Adverse Events; Anti spike antibodies; COVID-19; Outbreak; SARS-CoV-2; Serological response; Vaccination campaign","De Vita","Erica","Fondazione Toscana ""Gabriele Monasterio"", Pisa - Italy",NA
"2785","34261574","10.1017/ice.2021.321","Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","Adverse Events; Anti spike antibodies; COVID-19; Outbreak; SARS-CoV-2; Serological response; Vaccination campaign","Sbrana","Francesco","Fondazione Toscana ""Gabriele Monasterio"", Pisa - Italy",NA
"2786","34261574","10.1017/ice.2021.321","Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","Adverse Events; Anti spike antibodies; COVID-19; Outbreak; SARS-CoV-2; Serological response; Vaccination campaign","Quattrone","Filippo","Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa - Italy",NA
"2787","34261574","10.1017/ice.2021.321","Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","Adverse Events; Anti spike antibodies; COVID-19; Outbreak; SARS-CoV-2; Serological response; Vaccination campaign","Dal Pino","Beatrice","Fondazione Toscana ""Gabriele Monasterio"", Pisa - Italy",NA
"2788","34261574","10.1017/ice.2021.321","Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","Adverse Events; Anti spike antibodies; COVID-19; Outbreak; SARS-CoV-2; Serological response; Vaccination campaign","Megaro","Monica","Fondazione Toscana ""Gabriele Monasterio"", Pisa - Italy",NA
"2789","34261574","10.1017/ice.2021.321","Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","Adverse Events; Anti spike antibodies; COVID-19; Outbreak; SARS-CoV-2; Serological response; Vaccination campaign","Lombardi","Roberta","Fondazione Toscana ""Gabriele Monasterio"", Pisa - Italy",NA
"2790","34261574","10.1017/ice.2021.321","Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","Adverse Events; Anti spike antibodies; COVID-19; Outbreak; SARS-CoV-2; Serological response; Vaccination campaign","Prontera","Concetta","Fondazione Toscana ""Gabriele Monasterio"", Pisa - Italy",NA
"2791","34261574","10.1017/ice.2021.321","Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","Adverse Events; Anti spike antibodies; COVID-19; Outbreak; SARS-CoV-2; Serological response; Vaccination campaign","Passino","Claudio","Fondazione Toscana ""Gabriele Monasterio"", Pisa - Italy",NA
"2792","34261574","10.1017/ice.2021.321","Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","Adverse Events; Anti spike antibodies; COVID-19; Outbreak; SARS-CoV-2; Serological response; Vaccination campaign","Petrillo","Maurizio","Fondazione Toscana ""Gabriele Monasterio"", Pisa - Italy",NA
"2793","34261572","10.1017/dmp.2021.227","A Snapshot of Poverty, Diseases and War - The Democratic Republic of the Congo.","DRC's fight with EVD was just settling when WHO declared CoVid-19 to be a PHEIC on Mar 12, 2020. DRC's economic growth decelerated from its pre-COVID level of 4.4% in 2019, to an estimated 0.8% in 2020. This has caused concomitant setbacks in the treatment and control of major health issues like HIV, tuberculosis, measles, rift valley fever and malaria in the country. This coupled with civil unrest, other infectious diseases and risk to the safety of the health workers, this is a recipe for a 'p","2021","07","15","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID19; Ebola; Measles; Rift Valley Fever","Sasidharan","Shibu","Head of Department",NA
"2794","34261572","10.1017/dmp.2021.227","A Snapshot of Poverty, Diseases and War - The Democratic Republic of the Congo.","DRC's fight with EVD was just settling when WHO declared CoVid-19 to be a PHEIC on Mar 12, 2020. DRC's economic growth decelerated from its pre-COVID level of 4.4% in 2019, to an estimated 0.8% in 2020. This has caused concomitant setbacks in the treatment and control of major health issues like HIV, tuberculosis, measles, rift valley fever and malaria in the country. This coupled with civil unrest, other infectious diseases and risk to the safety of the health workers, this is a recipe for a 'p","2021","07","15","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID19; Ebola; Measles; Rift Valley Fever","Dhillon","Harpreet Singh","Psychiatry, Level III IFH, MONUSCO, Goma, DRC",NA
"2795","34261568","10.1017/ice.2021.320","Disproportionate COVID-19 vaccine distribution - A big threat for low- and middle-income countries.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Upadhyay","Prashant","Government Medical College Jalaun, Uttar Pradesh, India",NA
"2796","34261568","10.1017/ice.2021.320","Disproportionate COVID-19 vaccine distribution - A big threat for low- and middle-income countries.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Mehmood","Qasim","King Edward Medical University, Lahore, Pakistan",NA
"2797","34261568","10.1017/ice.2021.320","Disproportionate COVID-19 vaccine distribution - A big threat for low- and middle-income countries.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Jabbar","Abdul","Department of Clinical Medicine, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, 54600, LahorePunjabPakistan",NA
"2798","34261568","10.1017/ice.2021.320","Disproportionate COVID-19 vaccine distribution - A big threat for low- and middle-income countries.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Ullah","Irfan","Kabir Medical College, Gandhara University, Peshawar, Pakistan",NA
"2799","34261568","10.1017/ice.2021.320","Disproportionate COVID-19 vaccine distribution - A big threat for low- and middle-income countries.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Siddiqi","Ahsun Rizwan","POF Hospital, Wah cantt, Rawalpindi, Pakistan",NA
"2800","34261568","10.1017/ice.2021.320","Disproportionate COVID-19 vaccine distribution - A big threat for low- and middle-income countries.",NA,"2021","07","15","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Tahir","Muhammad Junaid","Lahore General Hospital, Lahore 54000, Pakistan",NA
"2801","34261567","10.1017/dmp.2021.229","General Public Perception of Social Media, Impact of Covid-19 Pandemic, and Related Misconceptions.","To investigate the general public perception of social media (SM), impact of COVID-19 (SARS-CoV-2) pandemic, and related misconceptions among Pakistani population. Cross-sectional study conducted during the peak of COVID-19 in Pakistan between May-June 2020 comprised of 2307 Pakistani male and female participants. Subjects under 18 years of age and nationality other than Pakistani were excluded. An online questionnaire was administered via the Internet using various kinds of social media. The st","2021","07","15","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID-19 impact; Pakistani population; Social media; misconceptions","Ali","Rabiya","Assistant Professor, Department of Physiology Karachi Institute of Medical Sciences (KIMS), CMH, Malir Cantt. Karachi, Pakistan",NA
"2802","34261567","10.1017/dmp.2021.229","General Public Perception of Social Media, Impact of Covid-19 Pandemic, and Related Misconceptions.","To investigate the general public perception of social media (SM), impact of COVID-19 (SARS-CoV-2) pandemic, and related misconceptions among Pakistani population. Cross-sectional study conducted during the peak of COVID-19 in Pakistan between May-June 2020 comprised of 2307 Pakistani male and female participants. Subjects under 18 years of age and nationality other than Pakistani were excluded. An online questionnaire was administered via the Internet using various kinds of social media. The st","2021","07","15","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID-19 impact; Pakistani population; Social media; misconceptions","Jawed","Shireen","Professor, Department of Physiology, Aziz Fatima Medical and Dental College Faisalabad, Pakistan",NA
"2803","34261567","10.1017/dmp.2021.229","General Public Perception of Social Media, Impact of Covid-19 Pandemic, and Related Misconceptions.","To investigate the general public perception of social media (SM), impact of COVID-19 (SARS-CoV-2) pandemic, and related misconceptions among Pakistani population. Cross-sectional study conducted during the peak of COVID-19 in Pakistan between May-June 2020 comprised of 2307 Pakistani male and female participants. Subjects under 18 years of age and nationality other than Pakistani were excluded. An online questionnaire was administered via the Internet using various kinds of social media. The st","2021","07","15","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID-19 impact; Pakistani population; Social media; misconceptions","Baig","Mukhtiar","Professor, Department of Clinical Biochemistry Faculty of Medicine, Rabigh, King Abdulaziz University, Jeddah, KSA",NA
"2804","34261567","10.1017/dmp.2021.229","General Public Perception of Social Media, Impact of Covid-19 Pandemic, and Related Misconceptions.","To investigate the general public perception of social media (SM), impact of COVID-19 (SARS-CoV-2) pandemic, and related misconceptions among Pakistani population. Cross-sectional study conducted during the peak of COVID-19 in Pakistan between May-June 2020 comprised of 2307 Pakistani male and female participants. Subjects under 18 years of age and nationality other than Pakistani were excluded. An online questionnaire was administered via the Internet using various kinds of social media. The st","2021","07","15","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID-19 impact; Pakistani population; Social media; misconceptions","Azam Malik","Ahmed","Associate Professor, Department of Family and Community Medicine, Faculty of Medicine, Rabigh, King Abdulaziz University, Jeddah, KSA and University Institute of Public Health, The University of Lahore, Pakistan",NA
"2805","34261567","10.1017/dmp.2021.229","General Public Perception of Social Media, Impact of Covid-19 Pandemic, and Related Misconceptions.","To investigate the general public perception of social media (SM), impact of COVID-19 (SARS-CoV-2) pandemic, and related misconceptions among Pakistani population. Cross-sectional study conducted during the peak of COVID-19 in Pakistan between May-June 2020 comprised of 2307 Pakistani male and female participants. Subjects under 18 years of age and nationality other than Pakistani were excluded. An online questionnaire was administered via the Internet using various kinds of social media. The st","2021","07","15","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID-19 impact; Pakistani population; Social media; misconceptions","Syed","Fatima","Aga Khan University, Karachi, Pakistan",NA
"2806","34261567","10.1017/dmp.2021.229","General Public Perception of Social Media, Impact of Covid-19 Pandemic, and Related Misconceptions.","To investigate the general public perception of social media (SM), impact of COVID-19 (SARS-CoV-2) pandemic, and related misconceptions among Pakistani population. Cross-sectional study conducted during the peak of COVID-19 in Pakistan between May-June 2020 comprised of 2307 Pakistani male and female participants. Subjects under 18 years of age and nationality other than Pakistani were excluded. An online questionnaire was administered via the Internet using various kinds of social media. The st","2021","07","15","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID-19 impact; Pakistani population; Social media; misconceptions","Rehman","Rehana","Associate Professor, Department of Biological and Biomedical Sciences Aga Khan University, Karachi, Pakistan",NA
"2807","34261566","10.1017/S1368980021003001","Food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic.","To estimate the association between food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic. Cross-sectional study. Multiple logistic regression models were used to estimate the associations between food insufficiency and mental health service utilization. U.S. Census Household Pulse Survey data collected in October 2020. Nationally representative sample of 68,611 U.S. adults. After adjusting for sociodemographic factors, experiencing food insufficiency ","2021","07","15","Public Health Nutr","Public health nutrition","COVID-19; food insecurity; food insufficiency; severe acute respiratory syndrome coronavirus 2","Nagata","Jason M","Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA",NA
"2808","34261566","10.1017/S1368980021003001","Food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic.","To estimate the association between food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic. Cross-sectional study. Multiple logistic regression models were used to estimate the associations between food insufficiency and mental health service utilization. U.S. Census Household Pulse Survey data collected in October 2020. Nationally representative sample of 68,611 U.S. adults. After adjusting for sociodemographic factors, experiencing food insufficiency ","2021","07","15","Public Health Nutr","Public health nutrition","COVID-19; food insecurity; food insufficiency; severe acute respiratory syndrome coronavirus 2","Ganson","Kyle T","Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada",NA
"2809","34261566","10.1017/S1368980021003001","Food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic.","To estimate the association between food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic. Cross-sectional study. Multiple logistic regression models were used to estimate the associations between food insufficiency and mental health service utilization. U.S. Census Household Pulse Survey data collected in October 2020. Nationally representative sample of 68,611 U.S. adults. After adjusting for sociodemographic factors, experiencing food insufficiency ","2021","07","15","Public Health Nutr","Public health nutrition","COVID-19; food insecurity; food insufficiency; severe acute respiratory syndrome coronavirus 2","Cattle","Chloe J","Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA",NA
"2810","34261566","10.1017/S1368980021003001","Food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic.","To estimate the association between food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic. Cross-sectional study. Multiple logistic regression models were used to estimate the associations between food insufficiency and mental health service utilization. U.S. Census Household Pulse Survey data collected in October 2020. Nationally representative sample of 68,611 U.S. adults. After adjusting for sociodemographic factors, experiencing food insufficiency ","2021","07","15","Public Health Nutr","Public health nutrition","COVID-19; food insecurity; food insufficiency; severe acute respiratory syndrome coronavirus 2","Whittle","Henry J","Division of Psychiatry, University College London, London, UK",NA
"2811","34261566","10.1017/S1368980021003001","Food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic.","To estimate the association between food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic. Cross-sectional study. Multiple logistic regression models were used to estimate the associations between food insufficiency and mental health service utilization. U.S. Census Household Pulse Survey data collected in October 2020. Nationally representative sample of 68,611 U.S. adults. After adjusting for sociodemographic factors, experiencing food insufficiency ","2021","07","15","Public Health Nutr","Public health nutrition","COVID-19; food insecurity; food insufficiency; severe acute respiratory syndrome coronavirus 2","Tsai","Alexander C","Center for Global Health and Mongan Institute, Massachusetts General Hospital, Boston, MA, USA",NA
"2812","34261566","10.1017/S1368980021003001","Food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic.","To estimate the association between food insufficiency and mental health service utilization in the U.S. during the COVID-19 pandemic. Cross-sectional study. Multiple logistic regression models were used to estimate the associations between food insufficiency and mental health service utilization. U.S. Census Household Pulse Survey data collected in October 2020. Nationally representative sample of 68,611 U.S. adults. After adjusting for sociodemographic factors, experiencing food insufficiency ","2021","07","15","Public Health Nutr","Public health nutrition","COVID-19; food insecurity; food insufficiency; severe acute respiratory syndrome coronavirus 2","Weiser","Sheri D","Division of HIV, Infectious Diseases and Global Medicine, School of Medicine, University of California, San Francisco, San Francisco, CA, USA",NA
"2813","34261563","10.1017/S1368980021002974","The Association Between Body Mass Index, Emotional Eating and Perceived Stress during COVID-19 Partial Quarantine in Healthy Adults.","We investigated emotional eating behaviours and perceived stress during COVID-19 partial quarantine according to BMI levels in healthy adults. Cross-sectional study. An online survey included demographic variables, eating attitude-related questions, Emotional Eater Questionnaire (EEQ), and Perceived Stress Score-14 (PSS-14) was sent via online data collection platform. Self-reported weight, height and weight changes during the quarantine were also collected. A total of 506 people age between 20-","2021","07","15","Public Health Nutr","Public health nutrition","Body Mass Index; COVID-19; Emotional Eating; Perceived Stress; Quarantine","Barcin-Güzeldere","H K","Istanbul Medeniyet University, Faculty of Health Science, Department of Nutrition and Dietetics, 34692, Istanbul",NA
"2814","34261563","10.1017/S1368980021002974","The Association Between Body Mass Index, Emotional Eating and Perceived Stress during COVID-19 Partial Quarantine in Healthy Adults.","We investigated emotional eating behaviours and perceived stress during COVID-19 partial quarantine according to BMI levels in healthy adults. Cross-sectional study. An online survey included demographic variables, eating attitude-related questions, Emotional Eater Questionnaire (EEQ), and Perceived Stress Score-14 (PSS-14) was sent via online data collection platform. Self-reported weight, height and weight changes during the quarantine were also collected. A total of 506 people age between 20-","2021","07","15","Public Health Nutr","Public health nutrition","Body Mass Index; COVID-19; Emotional Eating; Perceived Stress; Quarantine","Devrim-Lanpir","A","Istanbul Medeniyet University, Faculty of Health Science, Department of Nutrition and Dietetics, 34692, Istanbul",NA
"2815","34261560","10.1017/S1047951121003140","Cardiac Implications of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children under the age of Five Years.","Coronavirus disease 2019(COVID-19) is responsible for significant lung disease in adults. Despite mild manifestations in most children, multisystem inflammatory syndrome (MIS-C) associated with COVID-19 is well-described in older children with cardiac manifestations. However, MIS-C-related cardiac manifestations are not as well-described in younger children. The study is a retrospective analysis of MIS-C patients under age 5 years admitted between May to November 2020 to a single-center. Include","2021","07","15","Cardiol Young","Cardiology in the young","COVID-19; Cardiac; Multisystem Inflammatory Syndrome; under 5 years","Rakha","Shaimaa","Pediatric cardiology unit, Pediatrics department, Faculty of Medicine, Mansoura University, Egypt",NA
"2816","34261560","10.1017/S1047951121003140","Cardiac Implications of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children under the age of Five Years.","Coronavirus disease 2019(COVID-19) is responsible for significant lung disease in adults. Despite mild manifestations in most children, multisystem inflammatory syndrome (MIS-C) associated with COVID-19 is well-described in older children with cardiac manifestations. However, MIS-C-related cardiac manifestations are not as well-described in younger children. The study is a retrospective analysis of MIS-C patients under age 5 years admitted between May to November 2020 to a single-center. Include","2021","07","15","Cardiol Young","Cardiology in the young","COVID-19; Cardiac; Multisystem Inflammatory Syndrome; under 5 years","Sobh","Ali","Pediatric infections and immunology unit, Pediatrics department, Faculty of Medicine, Mansoura University, Egypt",NA
"2817","34261560","10.1017/S1047951121003140","Cardiac Implications of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children under the age of Five Years.","Coronavirus disease 2019(COVID-19) is responsible for significant lung disease in adults. Despite mild manifestations in most children, multisystem inflammatory syndrome (MIS-C) associated with COVID-19 is well-described in older children with cardiac manifestations. However, MIS-C-related cardiac manifestations are not as well-described in younger children. The study is a retrospective analysis of MIS-C patients under age 5 years admitted between May to November 2020 to a single-center. Include","2021","07","15","Cardiol Young","Cardiology in the young","COVID-19; Cardiac; Multisystem Inflammatory Syndrome; under 5 years","Hager","Amira H","Pediatric cardiology unit, Pediatrics department, Faculty of Medicine, Mansoura University, Egypt",NA
"2818","34261560","10.1017/S1047951121003140","Cardiac Implications of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children under the age of Five Years.","Coronavirus disease 2019(COVID-19) is responsible for significant lung disease in adults. Despite mild manifestations in most children, multisystem inflammatory syndrome (MIS-C) associated with COVID-19 is well-described in older children with cardiac manifestations. However, MIS-C-related cardiac manifestations are not as well-described in younger children. The study is a retrospective analysis of MIS-C patients under age 5 years admitted between May to November 2020 to a single-center. Include","2021","07","15","Cardiol Young","Cardiology in the young","COVID-19; Cardiac; Multisystem Inflammatory Syndrome; under 5 years","Hafez","Mona","Pediatric cardiology unit, Pediatrics department, Faculty of Medicine, Mansoura University, Egypt",NA
"2819","34261560","10.1017/S1047951121003140","Cardiac Implications of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children under the age of Five Years.","Coronavirus disease 2019(COVID-19) is responsible for significant lung disease in adults. Despite mild manifestations in most children, multisystem inflammatory syndrome (MIS-C) associated with COVID-19 is well-described in older children with cardiac manifestations. However, MIS-C-related cardiac manifestations are not as well-described in younger children. The study is a retrospective analysis of MIS-C patients under age 5 years admitted between May to November 2020 to a single-center. Include","2021","07","15","Cardiol Young","Cardiology in the young","COVID-19; Cardiac; Multisystem Inflammatory Syndrome; under 5 years","Alsawah","Gehan","Pediatric cardiology unit, Pediatrics department, Faculty of Medicine, Mansoura University, Egypt",NA
"2820","34261560","10.1017/S1047951121003140","Cardiac Implications of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children under the age of Five Years.","Coronavirus disease 2019(COVID-19) is responsible for significant lung disease in adults. Despite mild manifestations in most children, multisystem inflammatory syndrome (MIS-C) associated with COVID-19 is well-described in older children with cardiac manifestations. However, MIS-C-related cardiac manifestations are not as well-described in younger children. The study is a retrospective analysis of MIS-C patients under age 5 years admitted between May to November 2020 to a single-center. Include","2021","07","15","Cardiol Young","Cardiology in the young","COVID-19; Cardiac; Multisystem Inflammatory Syndrome; under 5 years","Abuelkheir","Mohamed Magdi","Pediatric cardiology unit, Pediatrics department, Faculty of Medicine, Mansoura University, Egypt",NA
"2821","34261560","10.1017/S1047951121003140","Cardiac Implications of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children under the age of Five Years.","Coronavirus disease 2019(COVID-19) is responsible for significant lung disease in adults. Despite mild manifestations in most children, multisystem inflammatory syndrome (MIS-C) associated with COVID-19 is well-described in older children with cardiac manifestations. However, MIS-C-related cardiac manifestations are not as well-described in younger children. The study is a retrospective analysis of MIS-C patients under age 5 years admitted between May to November 2020 to a single-center. Include","2021","07","15","Cardiol Young","Cardiology in the young","COVID-19; Cardiac; Multisystem Inflammatory Syndrome; under 5 years","Zeid","Mayada Sabry","Pediatric infections and immunology unit, Pediatrics department, Faculty of Medicine, Mansoura University, Egypt",NA
"2822","34261560","10.1017/S1047951121003140","Cardiac Implications of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children under the age of Five Years.","Coronavirus disease 2019(COVID-19) is responsible for significant lung disease in adults. Despite mild manifestations in most children, multisystem inflammatory syndrome (MIS-C) associated with COVID-19 is well-described in older children with cardiac manifestations. However, MIS-C-related cardiac manifestations are not as well-described in younger children. The study is a retrospective analysis of MIS-C patients under age 5 years admitted between May to November 2020 to a single-center. Include","2021","07","15","Cardiol Young","Cardiology in the young","COVID-19; Cardiac; Multisystem Inflammatory Syndrome; under 5 years","Nahas","Mohamed","Clinical Pathology Department, Faculty of Medicine, Mansoura University, Egypt",NA
"2823","34261560","10.1017/S1047951121003140","Cardiac Implications of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children under the age of Five Years.","Coronavirus disease 2019(COVID-19) is responsible for significant lung disease in adults. Despite mild manifestations in most children, multisystem inflammatory syndrome (MIS-C) associated with COVID-19 is well-described in older children with cardiac manifestations. However, MIS-C-related cardiac manifestations are not as well-described in younger children. The study is a retrospective analysis of MIS-C patients under age 5 years admitted between May to November 2020 to a single-center. Include","2021","07","15","Cardiol Young","Cardiology in the young","COVID-19; Cardiac; Multisystem Inflammatory Syndrome; under 5 years","Elmarsafawy","Hala","Pediatric cardiology unit, Pediatrics department, Faculty of Medicine, Mansoura University, Egypt",NA
"2824","34261546","10.1017/S1049023X21000662","Novel Respiratory Viruses in the Context of Mass-Gathering Events: A Systematic Review to Inform Event Planning from a Health Perspective.","Mass-gathering events (MGEs) occur regularly throughout the world. As people congregate at MGEs, there is an increased risk of transmission of communicable diseases. Novel respiratory viruses, such as Severe Acute Respiratory Syndrome Coronavirus-1 (SARS-CoV-1), Influenza A Virus Subtype H1N1 Strain 2009 (H1N1pdm09), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), or Coronavirus Disease 2019 (COVID-19), may require specif","2021","07","15","Prehosp Disaster Med","Prehospital and disaster medicine","COVID-19; H1N1; MERS; SARS; infectious disease; mass gathering; novel","Ranse","Jamie","Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia",NA
"2825","34261546","10.1017/S1049023X21000662","Novel Respiratory Viruses in the Context of Mass-Gathering Events: A Systematic Review to Inform Event Planning from a Health Perspective.","Mass-gathering events (MGEs) occur regularly throughout the world. As people congregate at MGEs, there is an increased risk of transmission of communicable diseases. Novel respiratory viruses, such as Severe Acute Respiratory Syndrome Coronavirus-1 (SARS-CoV-1), Influenza A Virus Subtype H1N1 Strain 2009 (H1N1pdm09), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), or Coronavirus Disease 2019 (COVID-19), may require specif","2021","07","15","Prehosp Disaster Med","Prehospital and disaster medicine","COVID-19; H1N1; MERS; SARS; infectious disease; mass gathering; novel","Beckwith","Deborah","Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia",NA
"2826","34261546","10.1017/S1049023X21000662","Novel Respiratory Viruses in the Context of Mass-Gathering Events: A Systematic Review to Inform Event Planning from a Health Perspective.","Mass-gathering events (MGEs) occur regularly throughout the world. As people congregate at MGEs, there is an increased risk of transmission of communicable diseases. Novel respiratory viruses, such as Severe Acute Respiratory Syndrome Coronavirus-1 (SARS-CoV-1), Influenza A Virus Subtype H1N1 Strain 2009 (H1N1pdm09), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), or Coronavirus Disease 2019 (COVID-19), may require specif","2021","07","15","Prehosp Disaster Med","Prehospital and disaster medicine","COVID-19; H1N1; MERS; SARS; infectious disease; mass gathering; novel","Khan","Anas","Department of Emergency Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"2827","34261546","10.1017/S1049023X21000662","Novel Respiratory Viruses in the Context of Mass-Gathering Events: A Systematic Review to Inform Event Planning from a Health Perspective.","Mass-gathering events (MGEs) occur regularly throughout the world. As people congregate at MGEs, there is an increased risk of transmission of communicable diseases. Novel respiratory viruses, such as Severe Acute Respiratory Syndrome Coronavirus-1 (SARS-CoV-1), Influenza A Virus Subtype H1N1 Strain 2009 (H1N1pdm09), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), or Coronavirus Disease 2019 (COVID-19), may require specif","2021","07","15","Prehosp Disaster Med","Prehospital and disaster medicine","COVID-19; H1N1; MERS; SARS; infectious disease; mass gathering; novel","Yezli","Saber","Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia",NA
"2828","34261546","10.1017/S1049023X21000662","Novel Respiratory Viruses in the Context of Mass-Gathering Events: A Systematic Review to Inform Event Planning from a Health Perspective.","Mass-gathering events (MGEs) occur regularly throughout the world. As people congregate at MGEs, there is an increased risk of transmission of communicable diseases. Novel respiratory viruses, such as Severe Acute Respiratory Syndrome Coronavirus-1 (SARS-CoV-1), Influenza A Virus Subtype H1N1 Strain 2009 (H1N1pdm09), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), or Coronavirus Disease 2019 (COVID-19), may require specif","2021","07","15","Prehosp Disaster Med","Prehospital and disaster medicine","COVID-19; H1N1; MERS; SARS; infectious disease; mass gathering; novel","Hertelendy","Attila J","Fellowship in Disaster Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Centre, Boston, Massachusetts, USA",NA
"2829","34261546","10.1017/S1049023X21000662","Novel Respiratory Viruses in the Context of Mass-Gathering Events: A Systematic Review to Inform Event Planning from a Health Perspective.","Mass-gathering events (MGEs) occur regularly throughout the world. As people congregate at MGEs, there is an increased risk of transmission of communicable diseases. Novel respiratory viruses, such as Severe Acute Respiratory Syndrome Coronavirus-1 (SARS-CoV-1), Influenza A Virus Subtype H1N1 Strain 2009 (H1N1pdm09), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), or Coronavirus Disease 2019 (COVID-19), may require specif","2021","07","15","Prehosp Disaster Med","Prehospital and disaster medicine","COVID-19; H1N1; MERS; SARS; infectious disease; mass gathering; novel","Hutton","Alison","School of Nursing and Midwifery, The University of Newcastle, Newcastle, New South Wales, Australia",NA
"2830","34261546","10.1017/S1049023X21000662","Novel Respiratory Viruses in the Context of Mass-Gathering Events: A Systematic Review to Inform Event Planning from a Health Perspective.","Mass-gathering events (MGEs) occur regularly throughout the world. As people congregate at MGEs, there is an increased risk of transmission of communicable diseases. Novel respiratory viruses, such as Severe Acute Respiratory Syndrome Coronavirus-1 (SARS-CoV-1), Influenza A Virus Subtype H1N1 Strain 2009 (H1N1pdm09), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), or Coronavirus Disease 2019 (COVID-19), may require specif","2021","07","15","Prehosp Disaster Med","Prehospital and disaster medicine","COVID-19; H1N1; MERS; SARS; infectious disease; mass gathering; novel","Zimmerman","Peta-Anne","Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia",NA
